data_2lvx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lvx _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 365' ' ' THR . . . . . 0.453 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 90.7 m . . . . . 0 N--CA 1.429 -1.507 0 N-CA-C 107.302 -1.369 . . . . 73.329999999999998 107.302 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 17.1 ptmt -139.16 141.18 38.02 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 121.099 -0.24 . . . . 72.219999999999999 110.913 -174.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -156.94 138.4 13.94 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.276 -1.379 . . . . 62.240000000000002 107.276 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -86.42 126.84 34.67 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.141 -0.689 . . . . 73.120000000000005 109.141 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.41 HG23 HG13 ' A' ' 431' ' ' VAL . 39.8 mt -137.17 124.6 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 106.654 -1.609 . . . . 75.319999999999993 106.654 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.58 8.47 46.58 Favored Glycine 0 C--N 1.301 -1.393 0 C-N-CA 120.91 -0.662 . . . . 73.540000000000006 113.233 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.09 -14.74 44.24 Favored Glycine 0 N--CA 1.426 -1.978 0 C-N-CA 120.702 -0.761 . . . . 62.140000000000001 112.684 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . 0.422 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 17.3 p90 -106.39 141.4 37.78 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 120.839 0.352 . . . . 74.439999999999998 110.134 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 51.3 m -83.52 120.24 25.69 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 116.18 -0.463 . . . . 73.420000000000002 109.895 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.66 134.21 34.57 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 108.612 -0.885 . . . . 75.310000000000002 108.612 174.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -133.41 125.01 28.15 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.104 -0.702 . . . . 72.549999999999997 109.104 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.453 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.6 p -121.05 122.54 67.89 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 N-CA-C 109.197 -0.668 . . . . 70.310000000000002 109.197 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.4 t -110.53 116.71 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 106.902 -1.518 . . . . 73.530000000000001 106.902 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -62.92 126.56 27.74 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.119 1.155 . . . . 75.230000000000004 114.119 -172.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 72.85 8.51 5.5 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.173 1.789 . . . . 72.400000000000006 113.276 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -116.68 -85.56 0.63 Allowed 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 112.969 0.729 . . . . 75.0 112.969 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.406 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.5 OUTLIER -162.32 162.75 28.11 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.875 -0.602 . . . . 75.340000000000003 112.254 -171.336 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 66.5 t -122.58 144.86 30.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.049 -0.978 . . . . 73.329999999999998 109.585 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.406 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 62.8 m-85 -133.94 148.33 51.17 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 123.094 0.558 . . . . 72.430000000000007 111.595 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -119.47 103.51 9.51 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.818 -1.919 . . . . 63.219999999999999 105.818 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.5 t70 69.15 -86.44 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 123.962 0.905 . . . . 75.120000000000005 109.587 -175.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.6 m -135.37 -2.66 2.46 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.935 -0.765 . . . . 73.209999999999994 108.935 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 62.8 mt -83.13 132.66 30.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.93 -0.577 . . . . 74.239999999999995 109.781 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.2 tp -76.66 115.54 16.51 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.6 -0.889 . . . . 72.319999999999993 108.6 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.527 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -79.69 -66.09 0.92 Allowed 'General case' 0 N--CA 1.39 -3.455 0 N-CA-C 108.934 -0.765 . . . . 74.099999999999994 108.934 -177.229 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.77 160.15 31.65 Favored Glycine 0 N--CA 1.413 -2.836 0 C-N-CA 118.925 -1.607 . . . . 54.350000000000001 111.604 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -104.36 145.28 30.49 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.362 -1.347 . . . . 75.230000000000004 107.362 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -66.6 116.66 7.78 Favored 'General case' 0 C--N 1.288 -2.088 0 O-C-N 123.351 0.407 . . . . 75.239999999999995 110.774 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -101.93 -48.11 4.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.107 -0.497 . . . . 75.420000000000002 111.227 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 51.3 m -159.5 141.42 13.31 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.945 -0.391 . . . . 74.430000000000007 109.945 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . 0.416 ' OE1' HD21 ' A' ' 400' ' ' LEU . 9.9 pt20 -144.37 140.47 29.08 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 120.97 0.414 . . . . 74.129999999999995 111.888 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -128.05 119.43 25.39 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.493 -0.776 . . . . 75.329999999999998 110.416 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 74.72 -101.28 1.28 Allowed Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 115.681 -0.691 . . . . 75.230000000000004 111.736 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 4.4 p-10 -131.79 15.96 4.79 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.401 0.619 . . . . 73.310000000000002 110.071 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 46.9 t -116.71 119.15 61.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 106.874 -1.528 . . . . 75.310000000000002 106.874 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.461 ' HB2' ' HH ' ' A' ' 402' ' ' TYR . 9.9 mt -118.04 130.74 56.35 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 116.207 -0.451 . . . . 72.040000000000006 110.808 -170.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -105.02 122.99 47.02 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 112.275 0.472 . . . . 74.219999999999999 112.275 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.461 ' HH ' ' HB2' ' A' ' 400' ' ' LEU . 2.2 m-85 -118.84 132.92 56.13 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.887 -1.153 . . . . 75.319999999999993 107.887 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -147.19 177.58 9.07 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 122.582 0.353 . . . . 72.409999999999997 110.179 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.5 m120 66.67 36.63 4.66 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.605 0.566 . . . . 74.049999999999997 111.226 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -79.88 -138.07 1.78 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 120.582 -0.818 . . . . 73.209999999999994 112.824 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.22 143.18 32.5 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.638 -0.505 . . . . 63.119999999999997 109.638 -178.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.469 0.494 0 N-CA-C 113.82 1.044 . . . . 73.239999999999995 113.82 -176.153 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 . . . . . 0 C--O 1.244 0.777 0 N-CA-C 105.681 -1.97 . . . . 61.219999999999999 105.681 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -63.77 160.49 17.12 Favored 'General case' 0 C--O 1.254 1.313 0 CA-C-O 121.467 0.651 . . . . 75.0 112.662 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.623 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 46.7 t -161.13 159.66 29.31 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 114.539 -1.209 . . . . 74.129999999999995 107.814 -176.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -159.78 149.93 18.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 120.852 0.358 . . . . 71.109999999999999 110.127 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.8 tt -110.63 123.8 66.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.737 -1.208 . . . . 62.210000000000001 107.737 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.3 t -106.28 126.25 61.92 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 CA-C-O 121.164 0.507 . . . . 73.420000000000002 109.924 176.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 3.6 m -108.64 112.95 25.56 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 105.819 -1.919 . . . . 64.530000000000001 105.819 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 40.6 t -100.8 112.0 32.26 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.94 0 N-CA-C 107.101 -1.444 . . . . 74.310000000000002 107.101 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -110.9 -175.37 2.7 Favored 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 120.228 -0.589 . . . . 75.209999999999994 111.4 -175.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.464 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 38.9 t -59.92 128.01 34.76 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 123.503 0.721 . . . . 74.319999999999993 110.46 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -158.76 -176.93 31.36 Favored Glycine 0 CA--C 1.492 -1.385 0 N-CA-C 110.964 -0.855 . . . . 74.129999999999995 110.964 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 42.3 t -94.38 -31.29 4.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-O 121.225 0.536 . . . . 61.210000000000001 109.615 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.84 161.09 40.77 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 116.002 -0.545 . . . . 63.340000000000003 109.559 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.1 p-10 -73.03 98.58 2.55 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 124.311 1.007 . . . . 74.530000000000001 110.398 175.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -132.44 148.22 52.4 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.912 -0.586 . . . . 74.109999999999999 110.754 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.448 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 28.2 mm -84.36 124.03 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.963 -1.866 . . . . 74.430000000000007 105.963 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 51.9 t -92.55 -47.99 13.7 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 112.888 0.699 . . . . 73.019999999999996 112.888 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 42.9 m -158.67 155.64 28.49 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.735 -0.469 . . . . 71.430000000000007 109.735 -173.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.41 HG13 HG23 ' A' ' 369' ' ' ILE . 3.2 p -141.3 111.9 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 108.672 -0.862 . . . . 74.400000000000006 108.672 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 32.0 tp -117.71 137.74 52.48 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 114.96 -1.018 . . . . 72.430000000000007 108.507 -175.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -80.58 112.59 18.08 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.962 -0.755 . . . . 73.439999999999998 108.962 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -73.75 -49.79 23.78 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 115.54 -0.755 . . . . 65.319999999999993 110.216 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -126.14 -76.2 0.58 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.166 -0.924 . . . . 75.25 108.993 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.95 -41.31 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 121.043 0.449 . . . . 73.239999999999995 110.787 173.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 98.6 m -96.84 -16.88 20.54 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.324 0.583 . . . . 72.329999999999998 110.114 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 415' ' ' SER . 37.3 tt0 -112.72 132.31 55.27 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.979 -1.01 . . . . 71.340000000000003 109.691 -177.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -125.68 150.16 47.87 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.543 -0.753 . . . . 73.420000000000002 109.273 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -105.47 117.16 33.32 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.566 -0.901 . . . . 75.200000000000003 108.566 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.6 mt -114.91 132.25 64.7 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 115.093 -0.958 . . . . 73.219999999999999 109.628 -176.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -109.31 140.16 43.34 Favored 'General case' 0 N--CA 1.408 -2.53 0 N-CA-C 108.51 -0.922 . . . . 75.109999999999999 108.51 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.448 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 77.0 mtp -138.08 168.41 19.78 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 108.484 -0.932 . . . . 74.549999999999997 108.484 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.7 mmtt -134.5 156.45 48.59 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.292 -1.003 . . . . 74.25 108.292 175.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 74.3 m -162.95 147.32 9.08 Favored Pre-proline 0 C--N 1.289 -2.04 0 C-N-CA 124.291 1.036 . . . . 73.430000000000007 109.394 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -66.14 -27.25 49.31 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.324 2.016 . . . . 71.019999999999996 111.757 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -78.72 -15.6 58.25 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.748 -0.66 . . . . 74.019999999999996 110.79 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.854 0 CA-C-O 121.68 0.752 . . . . 72.200000000000003 109.913 -179.868 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' THR . . . . . 0.47 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 95.7 m . . . . . 0 N--CA 1.416 -2.163 0 N-CA-C 107.711 -1.218 . . . . 74.120000000000005 107.711 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 0.0 OUTLIER -136.26 141.51 43.9 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.963 -0.695 . . . . 74.299999999999997 110.404 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -159.71 140.34 12.18 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.518 0.511 . . . . 73.340000000000003 110.313 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -76.34 123.92 26.7 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 110.115 -0.328 . . . . 64.439999999999998 110.115 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 48.6 mt -129.52 117.52 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 N-CA-C 106.194 -1.78 . . . . 73.25 106.194 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.73 14.01 62.14 Favored Glycine 0 C--N 1.304 -1.219 0 C-N-CA 120.781 -0.723 . . . . 53.509999999999998 112.244 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.1 -22.05 32.22 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 121.279 -0.486 . . . . 62.340000000000003 112.981 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -98.35 135.83 39.38 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 120.916 0.389 . . . . 73.040000000000006 111.204 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 85.4 m -79.86 114.54 18.85 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.765 -0.652 . . . . 73.409999999999997 110.224 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -91.46 132.92 35.91 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 108.563 -0.903 . . . . 72.340000000000003 108.563 176.344 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.472 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 37.6 ttpt -132.01 132.31 43.31 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 120.273 -0.571 . . . . 72.349999999999994 110.594 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.47 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.0 p -122.65 118.42 55.05 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 CA-C-N 115.844 -0.616 . . . . 71.329999999999998 110.076 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.54 116.02 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 106.768 -1.568 . . . . 65.150000000000006 106.768 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -64.18 132.56 50.74 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 113.522 0.934 . . . . 73.310000000000002 113.522 -173.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 65.18 23.66 12.31 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.053 -1.431 . . . . 75.510000000000005 112.286 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -136.49 -83.46 0.37 Allowed 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.505 -0.77 . . . . 71.310000000000002 112.914 176.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.426 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -165.81 160.03 16.65 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.569 0.951 . . . . 72.400000000000006 113.569 -173.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 95.9 t -116.21 146.3 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.595 1.158 . . . . 72.319999999999993 109.521 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.426 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 85.8 m-85 -134.83 152.36 51.69 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.316 0.646 . . . . 71.510000000000005 111.646 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.408 ' HB2' HD21 ' A' ' 389' ' ' LEU . 29.1 tt0 -127.63 106.68 9.32 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.337 -1.727 . . . . 70.450000000000003 106.337 171.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.5 t70 69.44 -83.35 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 124.175 0.99 . . . . 54.130000000000003 110.52 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 45.5 m -135.85 -5.49 2.18 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.961 -0.755 . . . . 72.030000000000001 108.961 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 49.7 mm -89.21 132.63 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.497 -0.774 . . . . 65.319999999999993 110.565 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 57.7 tp -76.41 116.12 16.8 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.309 -0.997 . . . . 73.329999999999998 108.309 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.463 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -79.44 -62.63 1.63 Allowed 'General case' 0 N--CA 1.393 -3.287 0 N-CA-C 109.03 -0.73 . . . . 74.349999999999994 109.03 -176.535 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.56 160.87 32.23 Favored Glycine 0 N--CA 1.42 -2.422 0 C-N-CA 119.335 -1.412 . . . . 75.239999999999995 111.903 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -104.73 151.31 23.89 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.662 -1.236 . . . . 73.519999999999996 107.662 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.41 116.75 11.11 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 121.341 0.591 . . . . 74.150000000000006 111.876 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -95.81 -47.18 6.27 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.318 -0.855 . . . . 75.430000000000007 110.541 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 38.3 t -164.95 139.27 5.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.461 -0.57 . . . . 64.109999999999999 109.461 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . 0.505 ' CB ' ' HG ' ' A' ' 400' ' ' LEU . 5.7 pm0 -141.98 129.71 21.62 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.556 -0.747 . . . . 73.319999999999993 110.621 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -128.37 127.07 41.94 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.294 -1.002 . . . . 74.129999999999995 108.294 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.93 -117.79 9.65 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.986 -0.625 . . . . 73.010000000000005 112.011 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -116.63 20.3 14.12 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.357 0.598 . . . . 75.219999999999999 110.773 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 67.4 t -124.91 128.88 73.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.45 -0.944 . . . . 75.409999999999997 108.45 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.505 ' HG ' ' CB ' ' A' ' 395' ' ' GLN . 3.9 mp -126.51 140.39 52.49 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 116.455 -0.339 . . . . 72.209999999999994 111.099 -175.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -116.68 124.88 50.78 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.132 0.573 . . . . 74.219999999999999 111.133 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.467 ' HH ' ' HB2' ' A' ' 400' ' ' LEU . 3.8 m-85 -118.16 136.19 53.77 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.061 -0.718 . . . . 73.319999999999993 109.061 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.25 178.03 8.91 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 122.654 0.382 . . . . 74.530000000000001 110.653 178.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.2 m120 66.58 33.61 6.46 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.079 0.552 . . . . 51.210000000000001 111.684 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.15 -130.4 0.44 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 120.424 -0.893 . . . . 64.099999999999994 113.051 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.78 147.53 30.45 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.402 -1.703 . . . . 75.349999999999994 106.402 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--N 1.311 -1.099 0 CA-C-O 121.839 0.828 . . . . 72.400000000000006 112.806 -175.006 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 . . . . . 0 CA--C 1.504 -0.789 0 N-CA-C 108.358 -0.979 . . . . 74.030000000000001 108.358 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -76.7 165.08 25.24 Favored 'General case' 0 C--O 1.251 1.157 0 O-C-N 123.597 0.561 . . . . 74.340000000000003 111.5 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 22.9 p -161.79 165.3 28.09 Favored 'General case' 0 N--CA 1.411 -2.397 0 CA-C-N 114.548 -1.205 . . . . 72.239999999999995 109.235 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -159.54 151.05 20.08 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.422 0.629 . . . . 72.099999999999994 110.546 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.4 tt -114.37 131.56 66.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-N 115.333 -0.848 . . . . 75.200000000000003 109.102 173.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 4.7 t -119.96 125.71 74.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-O 121.335 0.588 . . . . 73.329999999999998 110.97 177.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 21.3 p -109.77 114.59 28.3 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.091 -0.959 . . . . 73.239999999999995 108.952 174.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 37.5 t -100.48 112.48 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 108.284 -1.006 . . . . 63.119999999999997 108.284 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -110.53 -174.6 2.52 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 116.566 -0.288 . . . . 70.239999999999995 110.571 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.529 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 30.4 t -57.36 128.33 36.49 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.626 0.771 . . . . 73.129999999999995 111.678 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -154.94 -177.62 28.42 Favored Glycine 0 CA--C 1.478 -2.233 0 C-N-CA 120.467 -0.873 . . . . 72.150000000000006 111.806 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.0 t -87.34 -36.01 9.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.64 -0.874 . . . . 75.129999999999995 108.64 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -157.62 162.17 38.69 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.566 -0.901 . . . . 74.040000000000006 108.566 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 3.9 m120 -61.77 102.36 0.26 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.485 0.659 . . . . 63.409999999999997 111.41 173.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -131.9 148.28 52.53 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.938 -1.028 . . . . 71.230000000000004 109.687 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 27.0 mm -89.05 114.83 27.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 105.87 -1.9 . . . . 72.310000000000002 105.87 175.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 53.0 t -83.02 -51.27 14.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 CA-C-N 116.112 -0.494 . . . . 65.0 112.217 -174.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 49.2 m -155.36 154.45 32.03 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.7 -0.481 . . . . 64.530000000000001 109.7 -174.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 5.6 p -141.8 122.83 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 109.079 -0.711 . . . . 74.239999999999995 109.079 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 29.4 tp -131.25 136.81 48.53 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 107.385 -1.339 . . . . 74.150000000000006 107.385 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -83.56 122.14 28.16 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.977 -1.49 . . . . 75.400000000000006 106.977 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -82.92 -49.83 9.22 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.81 1.041 . . . . 74.129999999999995 113.81 -173.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -116.23 -70.26 0.81 Allowed 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.064 -0.654 . . . . 72.340000000000003 110.616 -170.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.99 -24.27 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 125.058 1.343 . . . . 74.400000000000006 109.359 178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 29.9 m -135.59 13.23 3.46 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.733 -0.84 . . . . 75.310000000000002 108.733 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 415' ' ' SER . 24.2 tt0 -136.68 119.22 15.91 Favored 'General case' 0 C--O 1.204 -1.317 0 N-CA-C 112.481 0.549 . . . . 63.329999999999998 112.481 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 26.9 m-85 -104.12 146.45 28.72 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.944 -0.571 . . . . 73.239999999999995 110.953 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -108.53 120.24 41.85 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.252 -1.018 . . . . 75.239999999999995 108.252 172.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.6 mt -120.01 131.55 72.09 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 115.259 -0.882 . . . . 74.299999999999997 110.793 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -98.56 138.32 35.93 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 108.5 -0.926 . . . . 65.120000000000005 108.5 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 80.7 mtp -138.79 164.67 29.01 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 109.988 -0.375 . . . . 74.439999999999998 109.988 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 32.7 mmtp -133.24 160.56 36.92 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.497 -0.557 . . . . 64.129999999999995 109.497 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' SER . . . . . 0.468 ' HB2' ' ND2' ' A' ' 426' ' ' ASN . 42.7 t -163.75 142.08 6.04 Favored Pre-proline 0 C--N 1.304 -1.394 0 O-C-N 124.036 0.835 . . . . 75.519999999999996 109.041 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -68.16 -26.19 36.59 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 121.973 1.782 . . . . 73.409999999999997 109.676 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.8 -7.55 58.74 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.922 -1.035 . . . . 61.229999999999997 110.652 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.716 0 CA-C-O 121.311 0.577 . . . . 71.439999999999998 109.636 176.919 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' THR . . . . . 0.45 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 58.0 m . . . . . 0 N--CA 1.445 -0.696 0 N-CA-C 109.266 -0.642 . . . . 71.349999999999994 109.266 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 18.2 ptpt -144.6 145.29 31.71 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 123.082 0.239 . . . . 74.540000000000006 111.441 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -159.4 133.71 7.7 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.556 -1.276 . . . . 71.530000000000001 107.556 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 44.2 mt-10 -84.6 125.6 32.6 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.578 -0.527 . . . . 74.409999999999997 109.578 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 47.8 mt -131.08 118.21 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 107.544 -1.28 . . . . 71.340000000000003 107.544 -174.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 67.06 13.16 61.5 Favored Glycine 0 C--N 1.313 -0.718 0 C-N-CA 120.936 -0.65 . . . . 62.210000000000001 112.365 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 112.89 -29.29 8.2 Favored Glycine 0 N--CA 1.417 -2.58 0 C-N-CA 120.946 -0.645 . . . . 74.329999999999998 112.595 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . 0.415 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 20.8 p90 -98.4 140.33 32.82 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 120.914 0.388 . . . . 75.049999999999997 111.314 -175.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 36.9 m -81.12 118.19 22.32 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 116.012 -0.54 . . . . 74.310000000000002 110.037 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.5 129.89 36.62 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 108.621 -0.881 . . . . 71.409999999999997 108.621 173.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -131.24 128.5 40.02 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.371 -0.532 . . . . 72.230000000000004 109.969 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.45 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.6 p -124.17 117.85 52.03 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-O 121.325 0.583 . . . . 73.129999999999995 109.576 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.48 116.47 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.378 -1.341 . . . . 73.510000000000005 107.378 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.451 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 91.9 m-85 -60.52 131.03 49.46 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.499 0.926 . . . . 70.450000000000003 113.499 -172.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 68.99 9.49 7.44 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 124.996 1.318 . . . . 73.219999999999999 112.612 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -120.82 -84.32 0.66 Allowed 'General case' 0 C--O 1.239 0.552 0 N-CA-C 113.164 0.801 . . . . 71.340000000000003 113.164 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.488 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -166.94 158.76 12.79 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.09 0.774 . . . . 74.109999999999999 113.09 -173.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 92.0 t -114.1 146.35 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.992 -1.003 . . . . 75.140000000000001 109.535 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.488 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 78.6 m-85 -133.98 146.1 50.12 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 123.048 0.539 . . . . 71.530000000000001 111.71 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -117.94 98.38 6.31 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 106.112 -1.81 . . . . 62.450000000000003 106.112 172.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 18.7 t70 69.94 -83.93 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 124.325 1.05 . . . . 73.409999999999997 110.636 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.3 m -136.43 3.87 2.84 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.161 -1.051 . . . . 72.129999999999995 108.161 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 65.2 mt -88.36 132.66 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 114.998 -1.001 . . . . 71.329999999999998 109.775 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 64.2 tp -78.01 110.58 13.08 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.383 -1.34 . . . . 75.019999999999996 107.383 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.53 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -76.81 -65.26 0.96 Allowed 'General case' 0 N--CA 1.393 -3.317 0 N-CA-C 109.036 -0.728 . . . . 73.010000000000005 109.036 -175.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.27 157.45 28.8 Favored Glycine 0 N--CA 1.423 -2.184 0 C-N-CA 119.791 -1.195 . . . . 72.310000000000002 111.746 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -100.65 150.02 23.16 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.057 -1.09 . . . . 71.439999999999998 108.057 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . 0.537 ' HB3' ' NE2' ' A' ' 395' ' ' GLN . 1.9 m-85 -73.04 115.9 12.92 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.205 0.526 . . . . 72.219999999999999 110.853 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . 0.415 ' C ' ' HG ' ' A' ' 394' ' ' SER . . . -98.9 -43.42 6.73 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.529 -0.76 . . . . 75.129999999999995 111.085 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' SER . . . . . 0.415 ' HG ' ' C ' ' A' ' 393' ' ' ALA . 52.9 m -155.11 143.73 20.57 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.686 -0.234 . . . . 75.129999999999995 110.515 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . 0.537 ' NE2' ' HB3' ' A' ' 392' ' ' PHE . 14.2 mp0 -129.88 133.87 47.15 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.873 -1.529 . . . . 74.040000000000006 106.873 174.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -128.91 110.91 12.51 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.782 -0.821 . . . . 73.129999999999995 108.782 173.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 72.11 -101.66 1.07 Allowed Glycine 0 N--CA 1.409 -3.114 0 C-N-CA 119.415 -1.374 . . . . 72.120000000000005 112.056 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -130.39 19.15 5.3 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 123.77 0.828 . . . . 52.530000000000001 109.124 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.95 116.75 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 N-CA-C 106.887 -1.523 . . . . 72.5 106.887 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 13.1 mt -116.46 130.47 56.78 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.806 -0.634 . . . . 70.420000000000002 110.354 -170.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -110.12 121.95 46.46 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 121.031 0.443 . . . . 74.109999999999999 111.239 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.446 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 2.9 m-85 -116.19 132.38 56.68 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.14 -1.059 . . . . 74.239999999999995 108.14 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -147.74 177.55 9.21 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 123.172 0.295 . . . . 70.239999999999995 110.96 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 14.7 m120 65.91 34.36 7.25 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 123.7 0.625 . . . . 74.400000000000006 111.24 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -79.14 -136.65 1.27 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.756 -0.735 . . . . 64.040000000000006 112.168 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -74.86 151.14 39.01 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.695 -0.854 . . . . 73.140000000000001 108.695 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 121.485 0.66 . . . . 64.519999999999996 112.167 -174.725 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 . . . . . 0 CA--C 1.494 -1.199 0 N-CA-C 106.84 -1.541 . . . . 75.040000000000006 106.84 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -77.44 158.27 30.1 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.362 0.601 . . . . 74.230000000000004 112.042 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 27.4 p -161.04 165.92 28.99 Favored 'General case' 0 N--CA 1.407 -2.614 0 CA-C-N 114.567 -1.197 . . . . 64.340000000000003 109.464 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -160.26 151.24 19.03 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.223 0.535 . . . . 75.099999999999994 110.536 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.7 tt -114.16 128.56 71.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 CA-C-N 115.415 -0.811 . . . . 75.420000000000002 109.281 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.446 ' HB ' ' OH ' ' A' ' 402' ' ' TYR . 3.4 t -114.13 127.88 71.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-O 121.561 0.696 . . . . 73.420000000000002 111.348 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 33.1 p -108.53 114.91 29.12 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 107.943 -1.132 . . . . 75.040000000000006 107.943 174.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.81 116.48 44.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.438 -0.949 . . . . 71.450000000000003 108.438 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -113.83 -173.33 2.25 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 121.021 -0.271 . . . . 74.409999999999997 111.328 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.413 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 42.9 t -58.73 129.26 41.24 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 123.621 0.768 . . . . 61.030000000000001 111.338 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -160.8 -177.6 34.04 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 110.676 -0.969 . . . . 70.349999999999994 110.676 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.44 -34.97 7.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 109.24 -0.652 . . . . 73.010000000000005 109.24 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -156.63 160.84 39.77 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 116.024 -0.535 . . . . 74.209999999999994 109.675 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 4.1 m120 -60.48 106.12 0.51 Allowed 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 123.703 0.801 . . . . 75.010000000000005 112.64 175.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -131.89 148.72 52.56 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.987 -1.006 . . . . 74.549999999999997 108.914 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 36.4 mm -90.41 120.21 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.378 -1.712 . . . . 75.150000000000006 106.378 175.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 442' ' ' LYS . 53.5 t -84.66 -48.92 16.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 112.222 0.452 . . . . 44.509999999999998 112.222 -176.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 58.2 p -164.82 163.63 21.18 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.925 -0.31 . . . . 74.450000000000003 110.66 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 4.3 p -142.04 119.84 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 123.889 0.743 . . . . 74.140000000000001 109.436 176.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . 0.408 ' HB3' ' HG ' ' A' ' 440' ' ' LEU . 26.8 tp -125.85 137.56 53.76 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.521 -0.918 . . . . 64.319999999999993 108.521 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -79.67 116.91 20.14 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.148 -1.056 . . . . 65.209999999999994 108.148 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -80.85 -58.08 3.26 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.395 -0.82 . . . . 75.340000000000003 110.649 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -109.27 -78.44 0.59 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.746 -0.661 . . . . 75.409999999999997 110.178 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.67 -40.32 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.627 0.727 . . . . 74.209999999999994 111.141 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 62.5 m -110.86 8.6 22.3 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.19 -1.041 . . . . 64.219999999999999 108.19 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.8 tt0 -131.75 131.37 42.94 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.064 -0.971 . . . . 72.219999999999999 109.568 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 43.1 m-85 -122.12 150.43 42.2 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.257 -0.883 . . . . 70.319999999999993 109.626 -175.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.408 ' HG ' ' HB3' ' A' ' 432' ' ' LEU . 4.3 pp -107.3 122.8 47.29 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 107.645 -1.242 . . . . 73.140000000000001 107.645 175.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.1 mt -118.96 129.89 74.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 CA-C-N 115.352 -0.84 . . . . 74.430000000000007 110.296 -175.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.428 ' HB3' ' HB ' ' A' ' 429' ' ' VAL . 15.7 tppt? -97.86 138.63 34.93 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.489 -0.93 . . . . 73.129999999999995 108.489 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 80.9 mtp -141.93 168.05 20.68 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 110.145 -0.317 . . . . 75.340000000000003 110.145 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.1 mmtt -135.7 160.41 38.63 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.834 -0.802 . . . . 64.420000000000002 108.834 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' SER . . . . . 0.497 ' HB2' ' ND2' ' A' ' 426' ' ' ASN . 33.6 t -166.58 147.27 5.28 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 124.058 0.849 . . . . 75.329999999999998 109.102 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.62 -26.44 53.89 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.484 2.123 . . . . 71.219999999999999 111.23 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -77.55 -18.69 56.7 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.242 -0.89 . . . . 71.140000000000001 110.646 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.954 0 CA-C-O 121.689 0.757 . . . . 70.5 109.864 -178.61 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' THR . . . . . 0.558 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 39.4 m . . . . . 0 N--CA 1.419 -2.024 0 N-CA-C 109.673 -0.491 . . . . 71.099999999999994 109.673 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.653 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 60.4 mtpt -139.36 141.53 37.6 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.072 -0.714 . . . . 72.349999999999994 109.072 176.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -161.6 136.95 7.55 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.058 -1.09 . . . . 73.420000000000002 108.058 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -86.72 122.98 31.37 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 120.805 0.336 . . . . 61.25 110.279 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 49.0 mt -133.02 123.68 48.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.174 -1.417 . . . . 63.439999999999998 107.174 -175.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.65 8.39 46.63 Favored Glycine 0 C--N 1.309 -0.968 0 C-N-CA 120.821 -0.704 . . . . 74.230000000000004 112.124 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 109.94 -23.2 21.97 Favored Glycine 0 N--CA 1.426 -1.996 0 C-N-CA 121.363 -0.446 . . . . 75.109999999999999 112.805 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -98.83 143.84 28.71 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 120.677 0.275 . . . . 64.109999999999999 110.81 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 57.0 m -86.1 121.03 28.13 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 116.486 -0.325 . . . . 73.420000000000002 110.248 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.653 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.96 137.68 32.18 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.128 -0.693 . . . . 62.43 109.128 176.072 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -131.83 129.92 41.08 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.618 -0.512 . . . . 64.239999999999995 109.618 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.558 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.0 p -124.85 117.19 49.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-O 121.068 0.461 . . . . 73.049999999999997 109.987 176.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 27.6 t -103.71 117.55 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.137 0 N-CA-C 107.063 -1.458 . . . . 72.140000000000001 107.063 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -63.88 124.35 21.3 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.555 -0.748 . . . . 74.239999999999995 111.994 -173.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 72.79 12.7 5.23 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.064 1.346 . . . . 73.209999999999994 113.127 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -125.42 -80.8 0.62 Allowed 'General case' 0 C--O 1.246 0.869 0 N-CA-C 113.645 0.98 . . . . 73.219999999999999 113.645 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -160.3 166.9 28.62 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.997 0.74 . . . . 73.450000000000003 112.997 -171.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 74.0 t -125.42 142.32 42.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.932 -1.031 . . . . 74.409999999999997 108.423 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -131.7 150.09 52.27 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 123.069 0.547 . . . . 74.400000000000006 111.641 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -122.62 103.95 9.02 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 106.912 -1.514 . . . . 74.319999999999993 106.912 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 14.5 t70 72.6 -70.76 0.15 Allowed 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.281 1.433 . . . . 63.140000000000001 109.479 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 28.6 t -152.87 -0.61 0.26 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.137 -0.938 . . . . 70.5 108.727 176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 62.6 mt -86.42 136.62 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 109.313 -0.625 . . . . 73.310000000000002 109.313 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 63.8 tp -76.27 112.54 12.86 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.288 -1.005 . . . . 73.420000000000002 108.288 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.617 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -78.93 -63.83 1.32 Allowed 'General case' 0 N--CA 1.393 -3.313 0 N-CA-C 108.507 -0.923 . . . . 74.349999999999994 108.507 -176.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.03 160.88 32.0 Favored Glycine 0 CA--C 1.478 -2.271 0 C-N-CA 119.937 -1.125 . . . . 72.129999999999995 110.974 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -109.53 149.55 29.46 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.175 -1.046 . . . . 62.100000000000001 108.175 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . 0.539 ' HD2' ' NE2' ' A' ' 395' ' ' GLN . 1.4 m-85 -69.82 122.36 19.08 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 120.814 0.34 . . . . 75.430000000000007 110.889 -176.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . 0.419 ' C ' ' HG ' ' A' ' 394' ' ' SER . . . -99.09 -48.2 4.94 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.973 -0.558 . . . . 71.120000000000005 110.909 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' SER . . . . . 0.419 ' HG ' ' C ' ' A' ' 393' ' ' ALA . 58.6 m -165.74 142.81 5.49 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.887 -1.153 . . . . 64.430000000000007 107.887 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . 0.539 ' NE2' ' HD2' ' A' ' 392' ' ' PHE . 40.0 mt-30 -126.51 141.87 51.73 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.012 -1.107 . . . . 73.450000000000003 108.012 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -129.13 110.23 11.84 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.559 -0.456 . . . . 62.409999999999997 110.294 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.19 -101.07 0.92 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 121.008 -0.615 . . . . 74.040000000000006 111.891 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -125.61 18.44 8.07 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.408 -0.59 . . . . 74.329999999999998 109.408 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.2 t -118.54 116.52 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 N-CA-C 107.322 -1.362 . . . . 73.5 107.322 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.413 HD21 ' OE1' ' A' ' 395' ' ' GLN . 14.8 mt -111.16 125.09 53.42 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 116.118 -0.492 . . . . 73.340000000000003 110.079 -171.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -105.14 123.74 48.35 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 112.997 0.74 . . . . 75.430000000000007 112.997 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 415' ' ' SER . 2.6 m-85 -117.77 139.75 50.63 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.971 -1.122 . . . . 73.200000000000003 107.971 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -142.54 175.2 9.97 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 124.275 1.03 . . . . 74.439999999999998 109.39 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 53.55 47.01 24.91 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 114.423 1.268 . . . . 74.109999999999999 114.423 173.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -80.88 -148.29 5.74 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.349 -0.841 . . . . 73.329999999999998 111.413 172.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.19 141.01 43.66 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.333 -1.358 . . . . 70.019999999999996 107.333 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 34.3 p . . . . . 0 C--N 1.311 -1.099 0 C-N-CA 123.149 0.58 . . . . 71.120000000000005 112.482 -178.66 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 . . . . . 0 CA--C 1.487 -1.454 0 N-CA-C 106.767 -1.568 . . . . 73.349999999999994 106.767 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -78.57 157.57 28.74 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.192 -0.603 . . . . 73.409999999999997 111.946 172.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 51.4 p -160.22 169.45 23.2 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 115.007 -0.997 . . . . 65.230000000000004 109.78 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -159.98 151.96 20.4 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.287 0.565 . . . . 71.510000000000005 110.553 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.4 tt -118.01 127.73 75.2 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 CA-C-N 115.06 -0.973 . . . . 73.140000000000001 108.821 174.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.7 t -113.93 129.87 69.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.336 0.589 . . . . 74.239999999999995 112.477 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 14.2 p -108.35 113.87 27.28 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.999 -1.0 . . . . 74.450000000000003 108.361 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 39.6 t -101.53 115.08 42.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 120.74 0.305 . . . . 64.329999999999998 110.291 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.482 ' OE1' ' HD2' ' A' ' 442' ' ' LYS . 47.9 mt-10 -108.07 -176.38 3.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.816 0.341 . . . . 74.219999999999999 111.113 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.417 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 36.5 t -60.24 130.99 49.37 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.006 0.922 . . . . 74.519999999999996 111.795 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 446' ' ' PRO . . . -157.86 -177.61 31.12 Favored Glycine 0 N--CA 1.421 -2.334 0 N-CA-C 109.98 -1.248 . . . . 74.209999999999994 109.98 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.36 -28.52 3.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 108.371 -0.974 . . . . 72.109999999999999 108.371 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -152.42 151.81 31.24 Favored 'General case' 0 CA--C 1.478 -1.815 0 CA-C-N 115.103 -0.953 . . . . 71.209999999999994 108.867 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.677 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 18.4 p-10 -66.73 105.43 1.56 Allowed 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 113.286 -1.779 . . . . 74.109999999999999 110.96 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -131.29 148.27 52.67 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.111 -0.95 . . . . 73.150000000000006 110.612 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 26.8 mm -88.28 120.39 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 105.969 -1.863 . . . . 75.540000000000006 105.969 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 62.9 t -83.1 -50.76 15.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-O 120.845 0.355 . . . . 64.150000000000006 111.586 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 48.4 m -164.17 164.5 22.65 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.248 -0.649 . . . . 74.109999999999999 109.248 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.05 114.38 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 123.814 0.846 . . . . 75.409999999999997 109.245 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . 0.447 ' O ' HD21 ' A' ' 440' ' ' LEU . 30.7 tp -120.85 138.86 53.85 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.895 -0.78 . . . . 73.299999999999997 108.895 -175.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -80.37 110.69 16.06 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 119.743 -0.783 . . . . 74.099999999999994 109.757 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.64 -38.53 62.47 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.027 -0.988 . . . . 74.439999999999998 111.249 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -127.64 -80.01 0.59 Allowed 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.609 -0.723 . . . . 72.450000000000003 111.683 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -166.73 -36.32 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.3 -0.864 . . . . 73.299999999999997 109.772 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 97.8 m -122.02 -2.63 9.16 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 115.108 -0.951 . . . . 73.439999999999998 109.913 174.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.554 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.6 tt0 -119.0 134.43 55.2 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.192 -0.913 . . . . 75.530000000000001 109.049 -177.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -126.04 150.18 48.31 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 123.743 0.652 . . . . 72.209999999999994 110.057 -174.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.447 HD21 ' O ' ' A' ' 432' ' ' LEU . 1.8 pt? -105.67 123.22 47.58 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.069 -1.085 . . . . 73.109999999999999 108.069 173.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.4 mt -122.26 129.93 74.93 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 CA-C-N 115.088 -0.96 . . . . 71.129999999999995 109.361 -177.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.482 ' HD2' ' OE1' ' A' ' 421' ' ' GLU . 36.5 ttpt -107.65 142.3 37.82 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 119.847 -0.741 . . . . 75.109999999999999 110.026 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 78.5 mtp -136.44 168.54 19.25 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 123.248 0.619 . . . . 54.350000000000001 109.56 -176.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.677 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 70.4 mmtt -131.93 153.52 50.19 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.179 -1.415 . . . . 72.340000000000003 107.179 175.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 74.8 m -161.78 150.33 12.74 Favored Pre-proline 0 C--N 1.287 -2.115 0 O-C-N 123.798 0.686 . . . . 75.340000000000003 110.346 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 32.9 Cg_endo -63.99 -27.16 66.18 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.832 2.355 . . . . 74.040000000000006 112.348 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.77 -12.23 57.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.708 -0.678 . . . . 65.420000000000002 111.9 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.872 0 CA-C-O 121.627 0.727 . . . . 74.049999999999997 109.845 -179.375 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' THR . . . . . 0.446 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 80.1 m . . . . . 0 N--CA 1.417 -2.089 0 N-CA-C 108.963 -0.754 . . . . 71.230000000000004 108.963 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 60.4 mtpt -133.2 140.61 47.64 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 110.106 -0.331 . . . . 65.019999999999996 110.106 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -158.08 134.33 9.42 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.395 -0.595 . . . . 73.109999999999999 109.395 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 2.8 mp0 -78.58 125.91 30.02 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 110.038 -0.356 . . . . 75.310000000000002 110.038 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 54.4 mt -130.92 117.54 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 N-CA-C 106.863 -1.532 . . . . 75.049999999999997 106.863 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 67.24 9.98 55.77 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.555 -0.831 . . . . 74.140000000000001 112.592 -177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.59 -7.7 39.56 Favored Glycine 0 N--CA 1.432 -1.597 0 C-N-CA 120.267 -0.968 . . . . 54.119999999999997 113.406 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . 0.412 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 15.4 p90 -114.0 136.61 52.72 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.94 0.37 . . . . 75.209999999999994 110.168 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 61.8 m -79.85 121.0 24.86 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 116.288 -0.414 . . . . 73.140000000000001 111.411 -178.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.658 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.6 OUTLIER -90.96 124.49 35.26 Favored 'General case' 0 N--CA 1.414 -2.244 0 C-N-CA 120.249 -0.58 . . . . 73.129999999999995 109.74 174.709 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 86.4 tttt -120.31 125.44 48.05 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.488 -0.778 . . . . 74.430000000000007 109.83 -174.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.446 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.3 p -127.64 116.14 42.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-O 121.425 0.631 . . . . 72.049999999999997 110.423 176.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.24 116.44 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 N-CA-C 107.145 -1.428 . . . . 61.329999999999998 107.145 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.44 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 75.4 m-85 -61.13 132.43 53.72 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.778 -1.101 . . . . 74.349999999999994 112.854 -171.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 64.97 17.84 11.24 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 124.6 1.16 . . . . 75.299999999999997 112.283 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -130.93 -84.42 0.52 Allowed 'General case' 0 C--O 1.243 0.722 0 N-CA-C 113.534 0.939 . . . . 74.420000000000002 113.534 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -158.65 163.73 36.63 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.726 1.01 . . . . 73.230000000000004 113.726 -170.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 99.1 t -125.55 143.7 38.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 124.505 1.122 . . . . 65.209999999999994 109.151 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -133.91 146.5 50.59 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 122.759 0.423 . . . . 75.439999999999998 111.368 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -110.99 99.42 8.31 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.402 -2.074 . . . . 73.5 105.402 172.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.4 t70 73.23 -72.93 0.11 Allowed 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 125.465 1.506 . . . . 62.299999999999997 109.816 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.9 t -148.63 -5.15 0.43 Allowed 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 114.913 -1.039 . . . . 64.420000000000002 109.093 176.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 63.8 mt -77.78 134.65 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.356 -0.979 . . . . 75.140000000000001 108.356 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 65.2 tp -75.81 113.69 13.57 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.561 -0.903 . . . . 74.019999999999996 108.561 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.517 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.6 OUTLIER -80.73 -63.51 1.39 Allowed 'General case' 0 N--CA 1.383 -3.796 0 N-CA-C 108.348 -0.982 . . . . 64.040000000000006 108.348 -176.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.48 160.39 31.33 Favored Glycine 0 N--CA 1.413 -2.886 0 C-N-CA 119.091 -1.528 . . . . 64.219999999999999 111.429 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -108.6 146.58 33.13 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 107.11 -1.441 . . . . 72.120000000000005 107.11 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . 0.44 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.4 m-85 -68.74 125.88 27.96 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 120.634 0.254 . . . . 72.319999999999993 110.585 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -100.36 -48.2 4.66 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.954 0.407 . . . . 73.230000000000004 109.947 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 42.4 p -164.22 162.02 22.38 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.686 -0.688 . . . . 73.109999999999999 109.488 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . 0.489 ' CG ' HD21 ' A' ' 400' ' ' LEU . 18.5 mp0 -128.4 122.58 31.72 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.919 -0.771 . . . . 65.420000000000002 108.919 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.14 109.99 22.63 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.371 -0.974 . . . . 74.409999999999997 108.371 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 55.68 -100.72 0.1 Allowed Glycine 0 N--CA 1.436 -1.345 0 O-C-N 123.921 0.763 . . . . 74.239999999999995 112.401 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -122.87 19.26 10.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.948 0.88 . . . . 65.329999999999998 109.436 -176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 66.8 t -123.51 116.9 49.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 107.525 -1.287 . . . . 71.239999999999995 107.525 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.489 HD21 ' CG ' ' A' ' 395' ' ' GLN . 12.1 mt -107.19 132.57 52.91 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 116.278 -0.419 . . . . 73.230000000000004 110.88 -169.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -103.63 122.82 45.79 Favored 'General case' 0 C--O 1.247 0.955 0 N-CA-C 112.718 0.636 . . . . 73.019999999999996 112.718 176.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -118.58 132.39 56.2 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.013 -1.477 . . . . 74.219999999999999 107.013 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . 0.404 ' HA ' ' CB ' ' A' ' 415' ' ' SER . 7.6 pt-20 -147.59 174.91 11.3 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 112.478 0.548 . . . . 73.400000000000006 112.478 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.21 41.22 13.68 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.704 -1.589 . . . . 73.120000000000005 111.766 170.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.37 -133.24 0.61 Allowed Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.138 -0.937 . . . . 72.310000000000002 112.607 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.8 141.96 30.12 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.436 -0.95 . . . . 75.019999999999996 108.436 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 42.9 t . . . . . 0 C--N 1.315 -0.911 0 CA-C-O 121.874 0.845 . . . . 63.530000000000001 112.232 -176.605 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 . . . . . 0 CA--C 1.497 -1.066 0 N-CA-C 107.191 -1.411 . . . . 73.230000000000004 107.191 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -76.81 162.23 27.81 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.134 -0.627 . . . . 72.040000000000006 111.026 172.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 47.4 p -164.35 163.09 22.55 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 114.905 -1.043 . . . . 44.140000000000001 108.821 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -158.94 146.9 17.9 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.169 0.509 . . . . 74.420000000000002 110.551 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 7.4 tt -113.38 126.96 70.9 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 CA-C-N 115.266 -0.879 . . . . 73.219999999999999 108.919 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 7.4 t -112.68 131.45 64.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-O 121.108 0.48 . . . . 71.219999999999999 111.937 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 35.0 p -107.26 114.14 27.99 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 107.664 -1.235 . . . . 74.530000000000001 107.664 175.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 43.1 t -100.82 112.97 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 107.537 -1.283 . . . . 73.219999999999999 107.537 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -115.58 -173.65 2.37 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.917 -0.313 . . . . 74.239999999999995 110.211 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.531 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 36.9 t -59.18 128.32 36.59 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 122.974 0.51 . . . . 52.310000000000002 111.256 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -159.8 -176.1 31.51 Favored Glycine 0 CA--C 1.493 -1.305 0 CA-C-N 115.796 -0.638 . . . . 73.140000000000001 111.529 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.0 t -80.58 -38.55 17.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 109.485 -0.561 . . . . 74.25 109.485 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -171.08 162.24 7.04 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 123.51 0.724 . . . . 71.129999999999995 109.321 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.603 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 20.9 m120 -61.52 101.38 0.18 Allowed 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.996 -1.002 . . . . 72.25 112.306 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -132.02 149.04 52.53 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.6 -1.182 . . . . 62.140000000000001 108.651 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 30.5 mm -81.51 118.23 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.791 -1.559 . . . . 65.120000000000005 106.791 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 63.8 t -81.24 -50.35 16.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-O 120.716 0.293 . . . . 65.319999999999993 111.664 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 42.4 p -166.92 165.68 15.86 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.138 -0.483 . . . . 63.100000000000001 109.972 -173.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 4.3 p -142.0 125.13 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 108.822 -0.807 . . . . 74.0 108.822 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 27.2 tp -126.48 136.58 52.8 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 107.66 -1.237 . . . . 74.239999999999995 107.66 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -81.18 108.48 14.86 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.674 -0.862 . . . . 71.329999999999998 108.674 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.31 -61.18 2.27 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 123.74 0.816 . . . . 71.530000000000001 110.781 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -109.33 -75.02 0.64 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.925 -0.58 . . . . 73.340000000000003 110.705 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -165.84 -43.02 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.795 -1.093 . . . . 72.129999999999995 109.892 -174.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 93.4 m -118.74 14.72 13.49 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 121.969 0.89 . . . . 74.420000000000002 109.539 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 415' ' ' SER . 37.1 tt0 -135.14 131.19 36.53 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.111 -1.07 . . . . 73.340000000000003 108.111 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 45.0 m-85 -123.08 150.77 42.73 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 124.005 0.816 . . . . 74.129999999999995 110.261 -174.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -110.4 122.09 46.87 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.736 -1.209 . . . . 74.310000000000002 107.736 172.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.5 mt -121.28 133.84 66.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 CA-C-N 115.41 -0.814 . . . . 73.319999999999993 109.501 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -103.48 140.84 36.95 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 109.131 -0.692 . . . . 73.349999999999994 109.131 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 87.4 mtp -138.54 163.36 32.19 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.267 -1.012 . . . . 71.120000000000005 108.267 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 73.0 mmtt -130.68 161.3 31.93 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.728 -0.842 . . . . 73.109999999999999 108.728 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' SER . . . . . 0.42 ' HB2' ' ND2' ' A' ' 426' ' ' ASN . 30.2 t -167.77 147.62 4.42 Favored Pre-proline 0 C--N 1.296 -1.742 0 O-C-N 123.746 0.654 . . . . 75.129999999999995 109.759 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.55 -21.5 29.75 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.204 1.936 . . . . 71.430000000000007 110.129 176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.4 -18.47 59.92 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.83 -1.077 . . . . 62.399999999999999 110.775 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.865 0 CA-C-O 121.751 0.786 . . . . 72.549999999999997 109.093 179.652 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' THR . . . . . 0.454 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 59.1 m . . . . . 0 N--CA 1.423 -1.781 0 N-CA-C 106.754 -1.573 . . . . 74.420000000000002 106.754 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 19.4 ptmt -142.29 141.44 32.43 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 111.989 0.366 . . . . 61.140000000000001 111.989 -176.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . 0.416 ' NH1' HG12 ' A' ' 369' ' ' ILE . 3.2 tmt_? -159.57 132.18 6.69 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.442 -0.799 . . . . 73.25 109.027 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 44.1 mt-10 -77.93 129.97 36.0 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 116.147 -0.478 . . . . 71.010000000000005 110.525 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.416 HG12 ' NH1' ' A' ' 367' ' ' ARG . 35.5 mt -135.02 121.53 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 106.831 -1.544 . . . . 74.310000000000002 106.831 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.39 11.54 56.47 Favored Glycine 0 C--N 1.308 -0.999 0 C-N-CA 120.837 -0.697 . . . . 73.209999999999994 112.646 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 110.77 -23.38 19.76 Favored Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 121.186 -0.53 . . . . 70.129999999999995 112.85 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -101.81 141.6 34.42 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 122.514 -0.403 . . . . 74.200000000000003 111.361 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 90.1 m -81.71 117.56 22.14 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.56 0.219 . . . . 53.530000000000001 110.581 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.32 133.6 34.86 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 108.36 -0.978 . . . . 74.420000000000002 108.36 174.264 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.446 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 36.8 ttpt -136.84 127.15 26.48 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 120.635 -0.426 . . . . 74.340000000000003 110.167 -176.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.454 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.5 p -120.63 119.34 59.36 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-O 121.181 0.515 . . . . 74.239999999999995 110.337 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.47 116.15 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 106.451 -1.685 . . . . 70.099999999999994 106.451 173.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.503 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 74.9 m-85 -65.56 135.7 55.44 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.018 -0.992 . . . . 63.439999999999998 113.496 -170.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 64.99 11.75 7.32 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 124.764 1.226 . . . . 73.530000000000001 112.306 -176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -122.61 -84.46 0.66 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 112.548 0.573 . . . . 73.209999999999994 112.548 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.464 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -166.09 156.59 12.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.05 0.759 . . . . 73.010000000000005 113.05 -171.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.462 HG21 ' CD2' ' A' ' 402' ' ' TYR . 60.9 t -115.05 147.59 18.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 124.293 1.037 . . . . 75.329999999999998 109.141 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.464 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 85.4 m-85 -134.72 145.32 48.37 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.04 0.536 . . . . 72.329999999999998 112.119 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -116.68 100.06 7.56 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 105.945 -1.872 . . . . 70.219999999999999 105.945 171.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.3 t70 71.52 -82.34 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 124.082 0.953 . . . . 54.109999999999999 109.901 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 36.8 t -138.52 -3.43 1.7 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.288 -1.004 . . . . 73.340000000000003 108.288 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.496 HD11 HE21 ' A' ' 406' ' ' GLN . 50.2 mm -77.19 132.47 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 108.854 -0.795 . . . . 74.439999999999998 108.854 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.1 tp -76.45 109.56 10.28 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.763 -1.569 . . . . 74.340000000000003 106.763 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.422 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.7 OUTLIER -76.41 -62.65 1.55 Allowed 'General case' 0 N--CA 1.389 -3.512 0 N-CA-C 108.94 -0.763 . . . . 71.140000000000001 108.94 -175.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.77 157.47 28.7 Favored Glycine 0 N--CA 1.425 -2.089 0 C-N-CA 118.788 -1.673 . . . . 62.25 112.3 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.2 146.02 28.06 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.186 -1.412 . . . . 75.329999999999998 107.186 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . 0.503 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 2.1 m-85 -71.84 115.81 11.49 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 109.417 -0.586 . . . . 70.239999999999995 109.417 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -99.39 -42.7 6.86 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.293 -0.412 . . . . 73.299999999999997 111.172 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 60.3 p -164.41 140.71 6.19 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.885 -0.783 . . . . 72.549999999999997 108.885 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.27 145.28 35.32 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.581 -0.282 . . . . 73.109999999999999 110.656 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -124.8 110.27 14.11 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.875 -0.787 . . . . 73.400000000000006 108.875 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 61.86 -105.76 1.01 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.886 -0.597 . . . . 74.340000000000003 113.077 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -113.96 17.07 18.13 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.101 0.477 . . . . 75.310000000000002 110.892 -176.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.3 t -120.9 118.34 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 106.405 -1.702 . . . . 75.140000000000001 106.405 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.446 ' HB2' ' HH ' ' A' ' 402' ' ' TYR . 20.1 mt -119.73 124.83 47.15 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.109 -0.636 . . . . 75.209999999999994 111.479 -169.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -100.85 122.27 43.15 Favored 'General case' 0 C--O 1.253 1.24 0 CA-C-O 121.314 0.578 . . . . 63.200000000000003 112.366 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.462 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.3 m-85 -118.35 130.24 55.89 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.454 -1.313 . . . . 75.310000000000002 107.454 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -147.22 176.04 10.28 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 122.008 0.123 . . . . 54.420000000000002 111.117 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.4 m120 64.97 36.3 7.64 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.666 0.604 . . . . 52.140000000000001 111.522 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -79.23 -140.16 1.93 Allowed Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.705 -0.76 . . . . 63.009999999999998 112.103 176.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . 0.496 HE21 HD11 ' A' ' 387' ' ' ILE . 28.9 tt0 -68.69 150.7 47.62 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 122.447 -0.443 . . . . 72.340000000000003 110.001 -177.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 C--N 1.304 -1.407 0 CA-C-O 121.544 0.688 . . . . 64.120000000000005 110.775 -175.054 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 . . . . . 0 CA--C 1.501 -0.911 0 N-CA-C 105.893 -1.891 . . . . 73.140000000000001 105.893 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 43.6 mtt180 -72.31 157.36 37.84 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.412 0.625 . . . . 71.540000000000006 112.481 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 36.2 p -163.18 165.1 24.85 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 114.612 -1.176 . . . . 65.109999999999999 109.409 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.1 148.16 16.8 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.182 0.515 . . . . 74.430000000000007 110.465 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 7.3 tt -112.86 123.89 68.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 CA-C-N 115.454 -0.794 . . . . 71.400000000000006 109.278 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 5.1 t -109.8 129.81 64.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-N 115.885 -0.598 . . . . 75.219999999999999 111.866 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.1 p -108.32 114.27 28.01 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 107.667 -1.234 . . . . 73.200000000000003 107.667 173.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 22.4 t -100.35 123.14 53.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.2 -1.407 . . . . 70.230000000000004 107.2 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -120.43 -174.12 2.72 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 120.557 -0.457 . . . . 75.0 110.898 -176.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.481 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 41.0 t -62.21 128.65 37.12 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 123.883 0.873 . . . . 36.780000000000001 111.56 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -162.55 -176.8 35.0 Favored Glycine 0 CA--C 1.495 -1.196 0 N-CA-C 111.256 -0.738 . . . . 75.120000000000005 111.256 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 98.9 t -86.48 -37.16 11.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-O 120.975 0.417 . . . . 54.149999999999999 109.877 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.444 ' HG2' ' N ' ' A' ' 426' ' ' ASN . 38.5 tt0 -155.87 162.09 40.49 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 109.278 -0.638 . . . . 73.230000000000004 109.278 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.686 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 18.8 m120 -63.36 109.1 1.48 Allowed 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 114.591 -1.186 . . . . 64.329999999999998 111.147 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -131.45 148.42 52.64 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.646 -1.161 . . . . 50.299999999999997 109.013 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 35.5 mm -90.47 113.84 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.364 -1.717 . . . . 73.010000000000005 106.364 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.3 t -80.89 -44.31 21.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 112.505 0.557 . . . . 75.409999999999997 112.505 -174.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 58.1 p -168.57 162.7 12.14 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 110.043 -0.354 . . . . 73.109999999999999 110.043 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 5.7 p -142.03 119.97 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 N-CA-C 108.81 -0.811 . . . . 61.020000000000003 108.81 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 30.9 tp -127.42 138.06 52.88 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.156 -1.053 . . . . 75.150000000000006 108.156 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -80.47 115.84 20.21 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.155 -0.683 . . . . 71.450000000000003 109.155 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -76.59 -67.35 0.71 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.478 -0.783 . . . . 52.399999999999999 111.014 -176.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -98.08 -76.5 0.53 Allowed 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.764 -0.828 . . . . 64.519999999999996 108.764 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.89 -43.85 0.04 OUTLIER 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 115.392 -0.822 . . . . 74.120000000000005 110.655 176.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 73.6 m -107.38 8.87 29.85 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.64 0.733 . . . . 74.219999999999999 109.191 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.8 tt0 -130.62 134.7 47.19 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.201 -0.909 . . . . 75.409999999999997 109.035 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -125.86 148.69 49.09 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 123.733 0.646 . . . . 73.340000000000003 109.766 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -105.2 119.24 38.56 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.499 -0.926 . . . . 75.319999999999993 108.499 174.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.4 mt -117.74 134.73 60.41 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 115.365 -0.834 . . . . 65.209999999999994 109.551 -177.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -106.17 140.99 38.27 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.806 -0.813 . . . . 74.140000000000001 108.806 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 83.1 mtp -138.74 168.56 19.54 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.641 -0.503 . . . . 74.010000000000005 109.641 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.686 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 72.9 mmtt -133.32 161.17 35.21 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.046 -0.724 . . . . 64.319999999999993 109.046 177.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 28.7 t -172.1 148.55 2.05 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.639 -0.875 . . . . 64.040000000000006 108.639 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.29 -27.49 34.5 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.049 1.832 . . . . 72.030000000000001 110.337 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -77.26 -13.51 59.92 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.812 -1.085 . . . . 73.200000000000003 110.792 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.752 0 CA-C-O 121.329 0.585 . . . . 72.319999999999993 110.147 178.441 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' THR . . . . . 0.484 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 97.4 m . . . . . 0 N--CA 1.423 -1.798 0 N-CA-C 107.137 -1.431 . . . . 74.329999999999998 107.137 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.657 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 59.2 mtpt -136.25 140.7 43.65 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.626 0.25 . . . . 70.340000000000003 110.939 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -156.74 132.94 9.8 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.116 -0.698 . . . . 64.209999999999994 109.116 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 3.4 mp0 -79.83 129.17 34.26 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 121.02 -0.272 . . . . 65.450000000000003 110.498 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 48.6 mt -136.14 121.12 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 106.117 -1.809 . . . . 73.450000000000003 106.117 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.67 3.23 19.94 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 121.421 -0.418 . . . . 52.32 113.765 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 112.06 -15.91 25.51 Favored Glycine 0 N--CA 1.433 -1.511 0 C-N-CA 120.7 -0.762 . . . . 64.120000000000005 112.627 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -102.82 141.79 35.03 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 109.77 -0.455 . . . . 75.409999999999997 109.77 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 91.9 m -87.65 124.25 33.34 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 116.43 -0.35 . . . . 63.030000000000001 110.888 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.657 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.7 OUTLIER -90.56 126.61 35.99 Favored 'General case' 0 N--CA 1.406 -2.632 0 C-N-CA 119.894 -0.722 . . . . 65.340000000000003 109.804 175.429 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -121.81 124.99 45.47 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.794 -0.817 . . . . 72.319999999999993 108.794 -175.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.484 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.4 p -125.1 124.33 67.28 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 109.888 -0.412 . . . . 74.049999999999997 109.888 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.2 t -113.67 116.29 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.692 -1.596 . . . . 72.120000000000005 106.692 173.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -62.62 126.55 27.73 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.452 -0.794 . . . . 74.530000000000001 112.846 -173.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 72.78 14.88 4.89 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 125.104 1.362 . . . . 72.349999999999994 112.985 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -126.73 -83.1 0.62 Allowed 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 113.309 0.855 . . . . 72.299999999999997 113.309 174.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.459 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.3 OUTLIER -163.3 156.45 19.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.138 0.792 . . . . 71.400000000000006 113.138 -170.166 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.425 HG21 ' CE2' ' A' ' 402' ' ' TYR . 91.6 t -116.8 145.2 22.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 124.081 0.952 . . . . 55.5 108.992 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.459 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 90.0 m-85 -134.16 147.72 50.83 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.102 0.477 . . . . 73.219999999999999 111.389 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -113.05 98.59 7.25 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.972 -1.862 . . . . 71.299999999999997 105.972 173.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.5 t70 72.45 -78.57 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 125.445 1.498 . . . . 73.540000000000006 109.266 -174.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 14.0 p -142.06 -3.06 1.11 Allowed 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 114.6 -1.182 . . . . 75.150000000000006 109.44 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 47.4 mm -80.47 132.01 32.72 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 N-CA-C 108.745 -0.835 . . . . 74.510000000000005 108.745 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 62.1 tp -75.91 113.86 13.89 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 108.797 -0.816 . . . . 74.430000000000007 108.797 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.56 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.3 OUTLIER -80.0 -63.88 1.31 Allowed 'General case' 0 N--CA 1.398 -3.052 0 N-CA-C 109.143 -0.688 . . . . 74.209999999999994 109.143 -176.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.06 156.64 27.89 Favored Glycine 0 N--CA 1.42 -2.408 0 C-N-CA 119.114 -1.517 . . . . 62.340000000000003 111.53 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.71 146.36 26.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.694 -1.595 . . . . 74.329999999999998 106.694 176.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -71.27 116.01 11.09 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.282 -0.567 . . . . 73.120000000000005 109.917 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -92.28 -47.32 7.26 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.719 -0.673 . . . . 65.049999999999997 110.408 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 42.3 p -166.68 141.16 4.12 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.939 -0.763 . . . . 61.130000000000003 108.939 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.11 145.71 34.57 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.53 -0.305 . . . . 75.450000000000003 110.265 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -128.14 110.23 12.26 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.753 -0.832 . . . . 71.319999999999993 108.753 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.59 -101.43 0.58 Allowed Glycine 0 N--CA 1.432 -1.58 0 O-C-N 123.918 0.761 . . . . 55.450000000000003 112.624 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . 0.572 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 27.4 p-10 -113.28 6.25 17.27 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.47 -0.365 . . . . 64.340000000000003 111.97 -176.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.96 116.27 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.186 0 N-CA-C 107.545 -1.28 . . . . 72.420000000000002 107.545 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 19.3 mt -114.4 123.84 50.45 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 116.057 -0.519 . . . . 74.310000000000002 110.119 -171.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.472 ' HZ2' ' HB3' ' A' ' 401' ' ' LYS . 3.2 mmmp? -108.58 122.34 46.88 Favored 'General case' 0 C--O 1.251 1.143 0 CA-C-O 120.748 0.309 . . . . 73.019999999999996 111.474 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.425 ' CE2' HG21 ' A' ' 382' ' ' VAL . 2.8 m-85 -115.68 133.82 55.65 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.413 -0.958 . . . . 75.409999999999997 108.413 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -135.11 171.3 14.62 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.553 -0.536 . . . . 72.150000000000006 109.553 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 14.3 m120 54.45 41.1 32.16 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.342 1.238 . . . . 63.399999999999999 114.342 170.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -78.32 -139.86 1.54 Allowed Glycine 0 CA--C 1.541 1.659 0 C-N-CA 120.795 -0.717 . . . . 62.32 113.479 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -63.24 149.96 44.25 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.656 0.783 . . . . 72.209999999999994 110.907 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 49.0 p . . . . . 0 N--CA 1.435 -1.176 0 N-CA-C 109.315 -0.624 . . . . 75.329999999999998 109.315 175.755 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 . . . . . 0 C--O 1.224 -0.248 0 N-CA-C 109.99 -0.374 . . . . 63.149999999999999 109.99 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -81.07 167.49 19.68 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 120.999 0.428 . . . . 74.319999999999993 111.046 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 56.4 p -162.93 160.17 24.52 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.261 -0.881 . . . . 65.540000000000006 109.064 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -157.18 136.62 12.11 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 121.21 0.528 . . . . 64.439999999999998 111.345 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.2 tt -101.43 121.86 52.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-N 115.253 -0.885 . . . . 75.530000000000001 110.42 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.488 ' CG2' ' HB ' ' A' ' 441' ' ' ILE . 3.9 t -108.57 129.53 62.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.635 -0.711 . . . . 72.540000000000006 111.746 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 13.4 p -109.84 114.89 28.82 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.188 -0.914 . . . . 75.340000000000003 108.896 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 34.1 t -100.43 114.09 38.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.871 -1.159 . . . . 64.549999999999997 107.871 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -114.12 -175.85 2.77 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 120.282 -0.567 . . . . 74.519999999999996 110.901 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 44.8 t -58.21 129.52 42.36 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.303 0.641 . . . . 71.420000000000002 111.442 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -159.94 -177.73 33.29 Favored Glycine 0 N--CA 1.434 -1.471 0 N-CA-C 110.343 -1.103 . . . . 73.219999999999999 110.343 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.35 -35.28 6.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.074 -0.713 . . . . 72.010000000000005 109.074 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -141.6 148.86 39.93 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.878 -0.601 . . . . 71.439999999999998 109.42 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.753 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.2 p-10 -67.68 99.12 0.76 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.816 -1.084 . . . . 55.420000000000002 109.977 174.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -132.43 149.9 52.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.174 -0.921 . . . . 62.140000000000001 110.526 -175.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 28.2 mm -81.28 120.7 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 106.065 -1.828 . . . . 74.310000000000002 106.065 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 50.4 t -86.77 -50.6 13.9 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 N-CA-C 111.84 0.311 . . . . 74.140000000000001 111.84 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 43.5 p -164.66 163.8 21.55 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 110.204 -0.295 . . . . 72.200000000000003 110.204 -174.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.0 117.07 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-O 121.403 0.62 . . . . 72.439999999999998 109.475 177.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 22.3 tp -114.31 134.99 54.56 Favored 'General case' 0 C--N 1.272 -2.803 0 N-CA-C 107.587 -1.264 . . . . 64.519999999999996 107.587 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -81.59 113.21 19.46 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 106.791 -1.559 . . . . 74.319999999999993 106.791 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.1 -60.8 2.1 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 108.872 -0.788 . . . . 72.239999999999995 108.872 -173.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.578 ' C ' ' HD2' ' A' ' 436' ' ' LYS . 49.9 mm-40 -107.04 -84.45 0.52 Allowed 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 106.884 -1.524 . . . . 72.019999999999996 106.884 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . 0.578 ' HD2' ' C ' ' A' ' 435' ' ' GLN . 3.9 mptp? -147.66 -56.53 0.24 Allowed 'General case' 0 CA--C 1.5 -0.942 0 C-N-CA 124.468 1.107 . . . . 72.200000000000003 109.376 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 57.3 m -90.97 -9.24 46.77 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.569 -1.196 . . . . 71.549999999999997 110.526 -176.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -114.46 128.76 56.5 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 114.48 -1.237 . . . . 64.340000000000003 109.314 -175.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 44.2 m-85 -124.84 150.23 46.63 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 123.502 0.501 . . . . 71.209999999999994 110.412 -176.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 4.3 pp -111.6 125.12 53.6 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.921 -1.511 . . . . 74.230000000000004 106.921 173.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.488 ' HB ' ' CG2' ' A' ' 418' ' ' VAL . 96.6 mt -122.16 133.13 69.4 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 116.234 -0.439 . . . . 74.430000000000007 110.602 -174.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -98.55 138.53 35.62 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 109.178 -0.675 . . . . 72.099999999999994 109.178 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 82.6 mtp -140.25 162.06 36.18 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 109.153 -0.684 . . . . 73.420000000000002 109.153 175.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.753 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.9 mmtt -132.22 161.08 34.31 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 107.257 -1.386 . . . . 72.409999999999997 107.257 175.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 36.2 t -167.42 147.01 4.46 Favored Pre-proline 0 C--N 1.286 -2.19 0 O-C-N 123.982 0.801 . . . . 73.329999999999998 109.03 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.0 -27.77 50.06 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.383 2.056 . . . . 74.209999999999994 111.339 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -78.24 -14.79 59.29 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.657 -0.701 . . . . 72.030000000000001 110.249 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.849 0 CA-C-O 121.333 0.587 . . . . 73.099999999999994 110.227 -178.303 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' THR . . . . . 0.467 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 26.1 m . . . . . 0 N--CA 1.423 -1.804 0 N-CA-C 106.123 -1.806 . . . . 71.129999999999995 106.123 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.676 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 58.5 mtpt -140.52 141.17 35.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 123.043 0.214 . . . . 71.340000000000003 110.472 -174.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -159.99 135.08 7.98 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.548 -0.908 . . . . 74.25 108.548 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -79.15 125.28 29.23 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 109.952 -0.388 . . . . 72.430000000000007 109.952 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 49.5 mt -133.87 119.12 31.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 106.893 -1.521 . . . . 75.230000000000004 106.893 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.7 14.22 62.44 Favored Glycine 0 C--N 1.308 -0.973 0 C-N-CA 120.526 -0.845 . . . . 72.140000000000001 111.977 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 101.66 -15.98 56.69 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 121.417 -0.421 . . . . 63.299999999999997 112.956 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -105.17 136.77 44.05 Favored 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 120.684 -0.407 . . . . 74.200000000000003 110.502 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 47.5 m -78.16 123.77 27.28 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.182 -0.463 . . . . 74.010000000000005 111.234 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.676 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.6 OUTLIER -93.28 124.57 37.35 Favored 'General case' 0 N--CA 1.414 -2.237 0 C-N-CA 120.433 -0.507 . . . . 64.140000000000001 110.054 173.499 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 85.1 tttt -123.47 125.13 44.36 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.678 -0.692 . . . . 72.239999999999995 110.241 -175.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.467 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.5 p -128.26 116.59 42.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-O 121.141 0.496 . . . . 70.310000000000002 110.512 177.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.3 t -113.02 117.03 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 108.009 -1.108 . . . . 72.430000000000007 108.009 175.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.508 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 42.6 m-85 -57.88 128.9 39.42 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 114.113 1.153 . . . . 75.099999999999994 114.113 -173.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 68.51 9.6 7.39 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 114.054 -1.43 . . . . 74.120000000000005 113.356 -178.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -116.3 -82.21 0.62 Allowed 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.193 0.812 . . . . 74.099999999999994 113.193 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.531 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -170.13 158.85 7.15 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 112.842 0.682 . . . . 45.140000000000001 112.842 -172.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 99.3 t -114.01 145.34 19.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 124.361 1.064 . . . . 75.140000000000001 108.878 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.531 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 72.2 m-85 -133.1 150.2 52.09 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.242 0.544 . . . . 74.319999999999993 111.452 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.466 ' HB2' HD21 ' A' ' 389' ' ' LEU . 34.1 tt0 -119.5 97.26 5.56 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 106.026 -1.842 . . . . 72.540000000000006 106.026 173.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.8 t70 70.43 -81.47 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 125.596 1.559 . . . . 75.340000000000003 111.392 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 17.8 m -135.53 0.73 2.78 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.345 -0.983 . . . . 53.310000000000002 108.345 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 48.4 mm -96.07 134.86 32.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.869 -0.605 . . . . 72.439999999999998 109.976 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.8 tp -76.45 115.31 16.08 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.702 -0.851 . . . . 74.310000000000002 108.702 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.507 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -80.41 -65.22 1.04 Allowed 'General case' 0 N--CA 1.393 -3.308 0 N-CA-C 109.366 -0.605 . . . . 63.450000000000003 109.366 -175.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -156.46 156.1 26.85 Favored Glycine 0 N--CA 1.42 -2.383 0 C-N-CA 118.817 -1.659 . . . . 73.409999999999997 112.168 -177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -99.48 143.39 29.79 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.922 -1.51 . . . . 71.030000000000001 106.922 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . 0.508 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 2.4 m-85 -71.22 115.95 10.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.584 0.231 . . . . 73.439999999999998 110.482 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -101.74 -47.7 4.53 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.352 -0.386 . . . . 71.450000000000003 111.46 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 39.3 p -157.38 140.24 15.1 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 110.083 -0.34 . . . . 74.510000000000005 110.083 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . 0.54 ' CB ' ' HG ' ' A' ' 400' ' ' LEU . 0.1 OUTLIER -147.25 145.5 29.44 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 116.121 -0.49 . . . . 52.420000000000002 111.13 178.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -128.97 110.86 12.44 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.838 -0.619 . . . . 73.510000000000005 109.473 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.8 -102.54 0.77 Allowed Glycine 0 C--N 1.31 -0.883 0 CA-C-N 115.877 -0.601 . . . . 61.109999999999999 113.956 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -116.43 17.7 15.39 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.146 0.498 . . . . 75.430000000000007 111.468 -176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.4 t -128.85 116.35 40.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 107.565 -1.272 . . . . 72.209999999999994 107.565 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.54 ' HG ' ' CB ' ' A' ' 395' ' ' GLN . 5.3 mp -120.07 139.61 52.28 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.63 0.604 . . . . 75.129999999999995 112.63 -173.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -112.32 122.69 48.42 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 115.596 -0.729 . . . . 74.430000000000007 111.885 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.464 ' HH ' ' HB2' ' A' ' 400' ' ' LEU . 2.9 m-85 -118.72 135.97 54.2 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.749 -1.204 . . . . 62.329999999999998 107.749 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . 0.407 ' HA ' ' CB ' ' A' ' 415' ' ' SER . 8.8 pt-20 -146.92 174.55 11.4 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-O 121.496 0.665 . . . . 73.219999999999999 112.719 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 64.13 33.41 11.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.609 -1.632 . . . . 73.340000000000003 112.953 168.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -72.22 -136.81 0.21 Allowed Glycine 0 CA--C 1.537 1.448 0 CA-C-N 115.599 -0.728 . . . . 71.150000000000006 113.437 176.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.58 137.92 46.49 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.567 -0.901 . . . . 74.219999999999999 108.567 -175.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 19.0 p . . . . . 0 C--N 1.306 -1.324 0 C-N-CA 124.043 0.937 . . . . 75.329999999999998 112.332 179.709 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 CA--C 1.501 -0.93 0 N-CA-C 107.997 -1.112 . . . . 73.040000000000006 107.997 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -71.39 159.34 34.72 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.299 0.571 . . . . 73.25 111.797 174.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 41.9 p -161.04 162.23 31.65 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.755 -1.112 . . . . 74.129999999999995 109.215 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -158.19 148.39 20.18 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-O 121.404 0.621 . . . . 53.350000000000001 110.862 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.2 tt -117.18 120.4 64.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 CA-C-N 115.15 -0.932 . . . . 72.530000000000001 110.022 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 8.7 t -105.2 127.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 115.663 -0.699 . . . . 74.430000000000007 111.978 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 8.7 p -108.48 114.7 28.74 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.632 -1.167 . . . . 75.209999999999994 108.559 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 38.9 t -100.88 112.8 34.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 107.595 -1.261 . . . . 74.239999999999995 107.595 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -111.73 -175.36 2.67 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 120.847 0.356 . . . . 63.450000000000003 110.716 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.605 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 36.0 t -57.77 128.23 36.0 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 124.321 1.048 . . . . 72.439999999999998 110.981 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -158.1 -177.82 31.56 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.925 -0.655 . . . . 73.109999999999999 111.676 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.35 -36.37 8.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.336 -0.616 . . . . 65.209999999999994 109.336 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -150.0 153.47 36.59 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.772 -0.825 . . . . 75.420000000000002 108.772 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.796 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.7 OUTLIER -73.03 98.54 2.55 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.59 0.71 . . . . 71.099999999999994 112.238 178.058 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -131.53 149.94 52.33 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.211 -1.359 . . . . 44.130000000000003 109.46 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 28.2 mm -78.64 118.16 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 106.306 -1.739 . . . . 72.329999999999998 106.306 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 55.5 t -80.77 -51.2 16.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 111.984 0.365 . . . . 70.239999999999995 111.984 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 33.0 t -167.06 165.22 15.81 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 109.184 -0.673 . . . . 74.129999999999995 109.184 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 4.3 p -141.39 119.12 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 108.627 -0.879 . . . . 63.130000000000003 108.627 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . 0.428 ' O ' HD21 ' A' ' 440' ' ' LEU . 25.4 tp -118.79 137.35 53.44 Favored 'General case' 0 C--N 1.271 -2.816 0 N-CA-C 107.923 -1.14 . . . . 70.109999999999999 107.923 -175.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -80.96 111.74 17.71 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.787 -0.82 . . . . 64.109999999999999 108.787 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -72.24 -54.48 9.48 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.419 -0.809 . . . . 75.209999999999994 110.269 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -116.94 -73.87 0.63 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.253 -1.017 . . . . 65.319999999999993 108.253 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -164.23 -51.79 0.03 OUTLIER 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.19 -1.368 . . . . 73.239999999999995 109.821 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 72.1 m -103.27 -9.23 19.7 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.416 -0.811 . . . . 75.430000000000007 109.167 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.5 tt0 -113.07 132.46 55.41 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.675 -1.148 . . . . 73.340000000000003 109.029 -176.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 37.3 m-85 -128.02 150.32 49.98 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.048 -0.524 . . . . 74.439999999999998 110.516 -175.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.428 HD21 ' O ' ' A' ' 432' ' ' LEU . 1.7 pt? -109.52 119.79 40.51 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.203 -1.036 . . . . 75.349999999999994 108.203 172.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.3 mt -116.24 136.18 54.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 115.287 -0.869 . . . . 71.150000000000006 109.464 -175.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -108.46 141.07 40.86 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 109.187 -0.671 . . . . 64.310000000000002 109.187 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 83.1 mtp -136.1 168.18 19.86 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.923 -1.14 . . . . 71.040000000000006 107.923 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.796 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 34.2 mmtp -134.05 161.34 35.13 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.002 -1.11 . . . . 71.010000000000005 108.002 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 33.9 t -162.68 145.9 8.7 Favored Pre-proline 0 C--N 1.291 -1.958 0 N-CA-C 108.455 -0.943 . . . . 71.420000000000002 108.455 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.98 -27.43 66.3 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.452 2.101 . . . . 74.129999999999995 111.863 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.68 -12.28 56.1 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.355 0.598 . . . . 70.349999999999994 110.976 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.907 0 CA-C-N 115.668 -0.696 . . . . 72.329999999999998 109.782 -178.151 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' THR . . . . . 0.51 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 87.8 m . . . . . 0 N--CA 1.411 -2.399 0 N-CA-C 107.163 -1.421 . . . . 72.310000000000002 107.163 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 10.0 ptmt -139.09 141.08 38.16 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.299 -0.409 . . . . 75.319999999999993 110.678 -174.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -159.94 138.44 10.44 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.112 -1.44 . . . . 73.310000000000002 107.112 -174.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -89.19 127.22 35.73 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.611 -0.514 . . . . 74.439999999999998 109.611 -176.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 44.6 mt -135.94 121.98 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 N-CA-C 106.867 -1.531 . . . . 75.120000000000005 106.867 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.66 12.64 59.62 Favored Glycine 0 C--N 1.306 -1.12 0 C-N-CA 120.571 -0.823 . . . . 72.040000000000006 112.883 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.98 -20.27 33.79 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 121.066 -0.588 . . . . 36.460000000000001 112.828 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . 0.434 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 12.1 p90 -105.05 146.65 28.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 122.802 -0.234 . . . . 74.409999999999997 110.515 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 60.4 m -86.51 126.51 34.49 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 120.957 -0.297 . . . . 75.099999999999994 110.471 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.607 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.6 OUTLIER -91.61 126.39 36.68 Favored 'General case' 0 N--CA 1.406 -2.651 0 N-CA-C 109.389 -0.597 . . . . 73.439999999999998 109.389 172.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 42.2 tttp -121.59 124.34 44.11 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.691 -0.855 . . . . 74.299999999999997 108.691 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.51 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.1 p -128.68 123.53 59.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 109.637 -0.505 . . . . 72.310000000000002 109.637 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 36.2 t -117.16 117.88 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 N-CA-C 108.083 -1.08 . . . . 73.299999999999997 108.083 174.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -53.22 125.32 17.18 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 124.393 1.058 . . . . 70.25 112.965 -174.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 69.35 12.43 8.33 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 125.189 1.395 . . . . 64.099999999999994 113.857 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -117.64 -91.22 0.55 Allowed 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 112.872 0.693 . . . . 65.540000000000006 112.872 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.475 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -161.13 157.3 25.71 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.732 0.642 . . . . 75.340000000000003 112.732 -173.395 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 82.5 t -113.69 144.24 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 124.115 0.966 . . . . 73.129999999999995 109.525 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.475 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 77.6 m-85 -133.73 147.13 51.31 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.007 0.432 . . . . 74.430000000000007 111.355 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -113.4 98.75 7.29 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.557 -1.646 . . . . 73.219999999999999 106.557 173.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.1 t70 70.17 -77.06 0.06 Allowed 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 124.886 1.274 . . . . 73.510000000000005 110.032 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.0 m -138.24 -6.38 1.59 Allowed 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.25 -0.886 . . . . 73.400000000000006 109.013 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 62.2 mt -84.88 134.76 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 116.257 -0.429 . . . . 71.439999999999998 109.905 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 56.4 tp -76.53 113.49 14.2 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.228 -1.027 . . . . 72.409999999999997 108.228 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.59 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -79.2 -63.85 1.32 Allowed 'General case' 0 N--CA 1.392 -3.337 0 N-CA-C 109.069 -0.715 . . . . 73.519999999999996 109.069 -176.13 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.53 156.82 28.18 Favored Glycine 0 N--CA 1.416 -2.65 0 C-N-CA 119.53 -1.319 . . . . 54.140000000000001 111.641 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -99.34 147.18 25.48 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.955 -1.128 . . . . 74.340000000000003 107.955 175.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -67.61 116.87 8.81 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.081 0.467 . . . . 74.109999999999999 111.233 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -97.87 -47.85 5.4 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.728 -0.669 . . . . 70.319999999999993 111.318 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 28.3 m -155.08 149.51 26.2 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.065 -0.346 . . . . 71.519999999999996 110.065 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . 0.443 ' CG ' ' HG ' ' A' ' 400' ' ' LEU . 13.8 mp0 -132.91 130.55 39.79 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 106.961 -1.496 . . . . 71.030000000000001 106.961 172.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -127.67 110.62 12.85 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.5 -0.926 . . . . 70.349999999999994 108.5 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 67.72 -101.82 0.76 Allowed Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.951 -0.568 . . . . 64.349999999999994 111.749 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -122.43 19.82 10.46 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.332 0.587 . . . . 75.140000000000001 109.907 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 46.6 t -118.37 119.07 60.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 108.273 -1.01 . . . . 71.010000000000005 108.273 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.443 ' HG ' ' CG ' ' A' ' 395' ' ' GLN . 4.9 mp -114.87 129.7 56.75 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.243 0.544 . . . . 72.140000000000001 110.619 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -113.55 125.86 54.66 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.906 -0.588 . . . . 72.010000000000005 110.265 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -118.72 136.67 53.82 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.282 -1.007 . . . . 74.120000000000005 108.282 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -144.39 174.17 11.15 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 110.315 -0.254 . . . . 61.420000000000002 110.315 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 12.7 m120 60.17 41.7 16.5 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.722 0.809 . . . . 63.32 112.205 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.59 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.7 -138.74 1.17 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.471 -0.871 . . . . 64.530000000000001 112.039 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.28 140.62 34.73 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.793 -0.817 . . . . 74.530000000000001 108.793 -178.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 47.0 m . . . . . 0 C--N 1.319 -0.745 0 N-CA-C 113.551 0.945 . . . . 74.439999999999998 113.551 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 96.0 m-70 . . . . . 0 CA--C 1.507 -0.705 0 N-CA-C 107.389 -1.337 . . . . 61.409999999999997 107.389 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -69.0 159.08 33.48 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-O 121.287 0.565 . . . . 75.120000000000005 111.707 174.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 49.0 p -161.6 164.46 29.38 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 114.762 -1.108 . . . . 74.200000000000003 109.144 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -158.7 151.02 21.58 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.123 0.487 . . . . 54.200000000000003 110.254 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 11.5 tt -118.53 124.39 73.06 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 CA-C-N 115.478 -0.783 . . . . 64.409999999999997 109.342 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.462 ' CG2' ' HB ' ' A' ' 441' ' ' ILE . 5.2 t -111.31 129.61 66.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.534 0.683 . . . . 75.310000000000002 112.093 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 14.4 p -111.45 115.17 28.78 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 115.04 -0.982 . . . . 73.450000000000003 109.094 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 47.5 t -100.69 111.86 31.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.96 -0.756 . . . . 70.150000000000006 108.96 -177.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -113.52 -174.26 2.43 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 120.662 -0.415 . . . . 63.32 111.084 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 19.6 t -59.13 127.19 30.96 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.515 0.674 . . . . 73.310000000000002 112.763 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 446' ' ' PRO . . . -154.26 -177.58 27.8 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 110.039 -1.224 . . . . 74.150000000000006 110.039 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.57 -28.19 4.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.635 0.731 . . . . 64.409999999999997 109.041 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -145.5 151.07 37.59 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.161 -0.927 . . . . 73.439999999999998 108.801 -177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.67 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.9 OUTLIER -71.15 98.82 1.75 Allowed 'General case' 0 C--N 1.309 -1.167 0 O-C-N 124.033 0.833 . . . . 52.030000000000001 110.191 175.367 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -132.51 148.59 52.39 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-N 115.225 -0.898 . . . . 64.030000000000001 111.42 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 30.8 mm -81.8 120.31 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 106.043 -1.836 . . . . 63.350000000000001 106.043 174.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 53.3 t -86.29 -50.49 14.18 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 116.228 -0.442 . . . . 75.140000000000001 112.139 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 44.0 m -159.95 160.73 33.78 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.401 -0.592 . . . . 63.210000000000001 109.401 -175.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.406 HG13 ' CE2' ' A' ' 374' ' ' TYR . 3.6 p -141.14 111.65 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-O 122.017 0.913 . . . . 73.420000000000002 108.763 176.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 28.7 tp -110.94 136.53 49.82 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 115.321 -0.854 . . . . 73.439999999999998 108.711 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -80.92 110.17 16.2 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.489 -0.93 . . . . 63.32 108.489 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -71.47 -36.85 71.33 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.37 -0.832 . . . . 71.310000000000002 111.06 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -142.07 -73.85 0.31 Allowed 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.564 -0.744 . . . . 64.510000000000005 109.308 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . 0.458 ' HB3' ' NZ ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -163.69 -49.01 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 116.112 -0.495 . . . . 74.530000000000001 110.899 175.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 75.7 m -98.04 -3.9 37.15 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.532 0.682 . . . . 71.030000000000001 110.107 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 415' ' ' SER . 34.5 tt0 -124.82 131.39 53.45 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.401 -0.818 . . . . 72.209999999999994 109.317 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -126.95 150.6 49.29 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.61 -0.723 . . . . 73.319999999999993 110.32 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -109.85 121.11 44.49 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.013 -1.106 . . . . 75.230000000000004 108.013 172.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.462 ' HB ' ' CG2' ' A' ' 418' ' ' VAL . 97.1 mt -115.51 132.87 63.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 CA-C-N 115.454 -0.794 . . . . 53.32 110.324 -175.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -98.85 136.8 38.34 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.449 -0.945 . . . . 73.349999999999994 108.449 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 82.6 mtp -137.46 157.73 45.93 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 109.835 -0.431 . . . . 61.340000000000003 109.835 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.67 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 31.7 mmtp -131.71 153.15 50.32 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.629 -1.249 . . . . 74.150000000000006 107.629 175.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 69.8 m -156.92 149.09 17.65 Favored Pre-proline 0 C--N 1.288 -2.096 0 N-CA-C 108.615 -0.883 . . . . 65.310000000000002 108.615 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 39.0 Cg_endo -67.66 -28.13 37.76 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 121.921 1.747 . . . . 74.129999999999995 111.975 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -76.28 -22.46 55.05 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.737 -0.665 . . . . 72.010000000000005 111.022 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.694 0 CA-C-O 121.741 0.781 . . . . 71.409999999999997 109.399 -178.767 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 85.3 m . . . . . 0 C--O 1.215 -0.711 0 N-CA-C 108.491 -0.929 . . . . 54.340000000000003 108.491 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 366' ' ' LYS . 0.0 OUTLIER -145.73 151.89 38.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 118.344 0.52 . . . . 71.409999999999997 111.591 -177.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -161.6 135.47 6.68 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.132 -0.692 . . . . 74.219999999999999 109.132 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.22 125.97 30.18 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 110.275 -0.268 . . . . 74.409999999999997 110.275 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 37.2 mt -134.19 119.79 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.828 -1.545 . . . . 74.409999999999997 106.828 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.66 12.64 59.62 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 121.164 -0.541 . . . . 65.209999999999994 112.07 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 105.78 -23.19 30.19 Favored Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 121.603 -0.332 . . . . 41.329999999999998 112.352 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -98.19 136.76 37.93 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 121.184 0.516 . . . . 74.120000000000005 110.548 -176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 98.9 m -79.54 116.23 19.63 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 115.525 -0.761 . . . . 64.030000000000001 110.556 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.12 133.58 34.78 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 107.868 -1.16 . . . . 65.519999999999996 107.868 175.001 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.8 ttpt -133.34 130.78 39.3 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.211 -0.595 . . . . 62.340000000000003 109.599 -175.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.0 115.92 46.42 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 O-C-N 123.584 0.552 . . . . 73.439999999999998 110.056 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.8 t -108.53 116.45 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.563 -1.273 . . . . 74.319999999999993 107.563 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -63.76 126.2 26.82 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 113.895 1.072 . . . . 72.510000000000005 113.895 -173.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 73.03 10.66 5.27 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 125.997 1.719 . . . . 74.299999999999997 113.117 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.8 -84.49 0.65 Allowed 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 112.489 0.552 . . . . 75.530000000000001 112.489 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.524 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -166.38 159.62 14.9 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.99 0.737 . . . . 74.120000000000005 112.99 -172.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 98.7 t -113.74 145.75 19.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 124.642 1.177 . . . . 72.430000000000007 109.141 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.524 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 71.1 m-85 -132.77 152.43 51.77 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 122.973 0.509 . . . . 64.319999999999993 111.986 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -124.76 102.04 7.38 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.347 -1.723 . . . . 71.120000000000005 106.347 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 14.3 t70 69.64 -83.84 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.564 1.146 . . . . 73.299999999999997 109.543 -175.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.3 m -133.28 -7.37 2.97 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 108.608 -0.886 . . . . 54.140000000000001 108.608 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 63.0 mt -80.59 132.91 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.388 -0.823 . . . . 74.319999999999993 110.127 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 64.8 tp -76.9 109.97 11.13 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.499 -0.926 . . . . 73.340000000000003 108.499 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.485 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -77.67 -65.4 0.97 Allowed 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 109.111 -0.7 . . . . 71.209999999999994 109.111 -176.67 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.23 153.58 24.66 Favored Glycine 0 N--CA 1.424 -2.103 0 C-N-CA 119.26 -1.448 . . . . 63.130000000000003 111.64 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.46 144.76 28.19 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.711 -1.218 . . . . 61.140000000000001 107.711 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -73.02 116.3 13.38 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.267 -0.642 . . . . 75.329999999999998 109.267 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -111.21 -47.99 3.14 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.939 -0.573 . . . . 72.310000000000002 110.863 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 18.7 m -145.63 138.96 26.29 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.504 -0.925 . . . . 74.239999999999995 108.504 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . 0.437 ' OE1' HD21 ' A' ' 400' ' ' LEU . 9.8 pt20 -147.4 145.32 29.21 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 120.938 0.399 . . . . 73.409999999999997 110.84 173.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -121.17 110.24 15.95 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 115.649 -0.705 . . . . 62.140000000000001 109.535 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.19 -104.27 0.79 Allowed Glycine 0 N--CA 1.436 -1.339 0 CA-C-N 115.265 -0.88 . . . . 73.420000000000002 113.823 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -116.83 18.2 14.87 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.128 0.489 . . . . 74.319999999999993 111.187 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.3 t -125.15 116.09 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 105.159 -2.163 . . . . 64.230000000000004 105.159 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.47 ' HB2' ' HH ' ' A' ' 402' ' ' TYR . 13.6 mt -118.63 136.28 53.98 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.862 -0.735 . . . . 74.040000000000006 111.241 -168.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -107.43 124.09 49.35 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.498 0.666 . . . . 74.310000000000002 112.076 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.47 ' HH ' ' HB2' ' A' ' 400' ' ' LEU . 2.9 m-85 -117.08 125.88 51.98 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.77 -1.566 . . . . 75.239999999999995 106.77 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -139.77 175.86 9.22 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 110.113 -0.329 . . . . 75.120000000000005 110.113 -176.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.0 m120 64.93 33.3 10.0 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.856 0.722 . . . . 71.209999999999994 112.503 173.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.6 -141.23 1.17 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.785 -0.722 . . . . 73.140000000000001 113.054 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.77 142.11 38.86 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.95 -1.13 . . . . 74.129999999999995 107.95 -177.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 121.413 0.625 . . . . 37.600000000000001 111.687 -179.441 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 . . . . . 0 CA--C 1.493 -1.249 0 N-CA-C 105.157 -2.164 . . . . 75.420000000000002 105.157 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -69.32 156.33 38.97 Favored 'General case' 0 C--O 1.256 1.407 0 C-N-CA 119.641 -0.824 . . . . 75.519999999999996 111.568 174.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 23.7 p -157.59 158.92 36.48 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-N 114.67 -1.15 . . . . 71.329999999999998 109.192 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -154.03 149.01 26.73 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.26 0.552 . . . . 74.310000000000002 110.656 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.4 tt -118.99 123.81 72.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 CA-C-N 115.107 -0.951 . . . . 74.5 109.816 175.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.521 ' CG2' ' HB ' ' A' ' 441' ' ' ILE . 4.1 t -109.85 130.66 62.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 115.785 -0.643 . . . . 65.299999999999997 111.231 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 20.5 p -108.46 115.01 29.3 Favored 'General case' 0 N--CA 1.409 -2.525 0 N-CA-C 108.322 -0.992 . . . . 64.450000000000003 108.322 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 38.5 t -100.36 114.72 39.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.039 -1.467 . . . . 74.049999999999997 107.039 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.02 -173.94 2.55 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.915 -0.314 . . . . 71.239999999999995 110.556 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.513 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 38.3 t -60.5 127.92 34.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.235 0.54 . . . . 75.420000000000002 111.71 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.36 -179.7 31.57 Favored Glycine 0 CA--C 1.485 -1.808 0 N-CA-C 110.535 -1.026 . . . . 74.400000000000006 110.535 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.08 -35.32 7.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.899 -0.778 . . . . 73.409999999999997 108.899 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -143.79 152.16 40.87 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.367 -0.833 . . . . 72.319999999999993 109.722 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.719 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.9 OUTLIER -69.57 97.95 1.09 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.034 -0.985 . . . . 71.239999999999995 110.586 175.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -132.16 149.56 52.36 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.851 -1.068 . . . . 54.409999999999997 109.906 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 32.6 mm -84.35 119.41 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 105.993 -1.855 . . . . 71.209999999999994 105.993 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 54.8 t -83.86 -51.04 14.65 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 CA-C-N 116.409 -0.36 . . . . 73.319999999999993 111.623 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 38.5 p -165.26 167.97 17.43 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 120.914 -0.314 . . . . 73.319999999999993 110.674 -175.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.19 126.25 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 N-CA-C 109.124 -0.695 . . . . 74.010000000000005 109.124 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . 0.421 ' O ' HD21 ' A' ' 440' ' ' LEU . 28.1 tp -126.82 137.96 53.27 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.885 -0.783 . . . . 73.540000000000006 108.885 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -81.07 113.0 18.96 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.291 -1.003 . . . . 75.420000000000002 108.291 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.02 -50.81 18.13 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-N 115.715 -0.675 . . . . 74.319999999999993 110.226 -174.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . 0.534 ' C ' ' HD2' ' A' ' 436' ' ' LYS . 49.4 mt-30 -121.47 -82.24 0.65 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.236 -0.893 . . . . 74.239999999999995 108.753 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . 0.534 ' HD2' ' C ' ' A' ' 435' ' ' GLN . 0.2 OUTLIER -145.31 -61.73 0.34 Allowed 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 108.26 -1.015 . . . . 74.019999999999996 108.26 177.025 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 92.3 m -93.64 -7.96 42.38 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.158 -1.383 . . . . 65.549999999999997 111.693 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 415' ' ' SER . 35.6 tt0 -110.39 128.6 55.66 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-N 115.291 -0.868 . . . . 64.409999999999997 109.077 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 46.4 m-85 -124.48 149.72 46.53 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.757 -0.656 . . . . 74.099999999999994 109.785 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.421 HD21 ' O ' ' A' ' 432' ' ' LEU . 1.5 pt? -111.47 119.54 39.12 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.341 -0.615 . . . . 74.219999999999999 109.341 175.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.521 ' HB ' ' CG2' ' A' ' 418' ' ' VAL . 3.8 mp -109.62 133.9 53.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.87 -0.604 . . . . 73.439999999999998 109.883 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -96.25 135.82 37.56 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 108.397 -0.964 . . . . 75.010000000000005 108.397 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 81.8 mtp -138.01 160.53 39.12 Favored 'General case' 0 CA--C 1.478 -1.802 0 N-CA-C 109.678 -0.49 . . . . 74.329999999999998 109.678 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.719 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 73.8 mmtt -131.05 160.96 33.11 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.743 -1.206 . . . . 73.319999999999993 107.743 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 40.8 t -165.45 145.04 5.49 Favored Pre-proline 0 C--N 1.284 -2.252 0 O-C-N 124.118 0.886 . . . . 71.25 109.023 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -66.42 -27.36 47.13 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.04 1.826 . . . . 75.319999999999993 110.618 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -76.52 -17.81 59.05 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.327 -0.851 . . . . 74.519999999999996 111.182 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.818 0 CA-C-O 121.546 0.688 . . . . 70.530000000000001 110.128 -179.974 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' THR . . . . . 0.465 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 84.7 m . . . . . 0 N--CA 1.432 -1.328 0 N-CA-C 106.388 -1.708 . . . . 64.109999999999999 106.388 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 0.0 OUTLIER -143.49 150.23 38.67 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.418 -0.913 . . . . 63.409999999999997 111.108 -175.399 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -162.37 136.48 6.49 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.741 -0.836 . . . . 62.520000000000003 108.741 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -77.81 124.98 28.65 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 109.815 -0.439 . . . . 70.230000000000004 109.815 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 56.4 mt -134.82 118.99 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 N-CA-C 106.883 -1.525 . . . . 73.040000000000006 106.883 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.49 13.59 60.93 Favored Glycine 0 C--N 1.305 -1.139 0 C-N-CA 120.538 -0.839 . . . . 62.399999999999999 112.675 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 105.56 -17.78 42.35 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 120.997 -0.62 . . . . 73.340000000000003 113.252 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -105.26 142.17 35.49 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 120.61 0.243 . . . . 74.519999999999996 110.595 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 97.8 m -82.25 119.75 24.49 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.099 0.476 . . . . 73.040000000000006 110.057 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.586 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -90.79 126.53 36.04 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 108.533 -0.914 . . . . 73.430000000000007 108.533 176.087 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -126.43 127.45 45.44 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.28 -0.568 . . . . 73.549999999999997 109.874 -175.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.465 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 5.9 p -124.58 117.07 49.38 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 116.16 -0.473 . . . . 72.219999999999999 111.036 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.98 116.22 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.141 -1.429 . . . . 70.319999999999993 107.141 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.521 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 95.1 m-85 -70.3 131.29 43.93 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 114.705 1.372 . . . . 73.420000000000002 114.705 -170.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 71.64 13.08 6.35 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.254 1.422 . . . . 73.109999999999999 112.232 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -125.71 -86.18 0.62 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.484 -0.78 . . . . 72.450000000000003 113.044 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.439 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -162.72 153.22 16.7 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.304 0.853 . . . . 70.140000000000001 113.304 -173.013 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 44.7 t -113.56 149.44 15.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 C-N-CA 124.054 0.942 . . . . 63.420000000000002 108.725 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.439 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 62.8 m-85 -139.63 144.7 37.81 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.348 0.405 . . . . 60.229999999999997 111.088 -177.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -107.24 110.01 21.94 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 106.346 -1.724 . . . . 74.109999999999999 106.346 169.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 17.2 t70 69.1 -87.02 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 123.76 0.824 . . . . 72.319999999999993 110.422 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 19.5 m -136.16 -1.88 2.34 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.966 -0.753 . . . . 63.130000000000003 108.966 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 47.2 mm -88.66 138.68 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 109.646 -0.501 . . . . 65.420000000000002 109.646 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.3 tp -74.25 117.69 16.35 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.24 -1.763 . . . . 75.010000000000005 106.24 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.536 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 49.7 tp -91.79 -58.41 2.43 Favored 'General case' 0 N--CA 1.381 -3.877 0 CA-C-N 115.412 -0.813 . . . . 73.439999999999998 110.856 -173.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.46 148.13 15.96 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 119.401 -1.381 . . . . 70.340000000000003 111.492 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -99.75 145.15 27.99 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.503 -1.295 . . . . 70.310000000000002 107.503 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . 0.521 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.5 m-85 -70.26 117.21 11.52 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 120.771 0.32 . . . . 75.109999999999999 111.324 -176.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -88.33 -46.81 8.89 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.925 -0.58 . . . . 73.519999999999996 110.15 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 60.6 p -169.03 160.75 10.16 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-N 115.765 -0.652 . . . . 75.120000000000005 109.599 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 14.8 mp0 -130.67 138.13 49.9 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.657 -1.238 . . . . 74.340000000000003 107.657 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -128.43 114.42 16.78 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.869 -0.789 . . . . 74.420000000000002 108.869 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 72.18 -101.44 1.05 Allowed Glycine 0 N--CA 1.422 -2.251 0 C-N-CA 119.169 -1.491 . . . . 41.520000000000003 112.056 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 21.7 p-10 -128.04 15.7 6.79 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 123.598 0.759 . . . . 75.140000000000001 109.381 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 35.9 t -118.89 121.66 67.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.459 -0.941 . . . . 75.329999999999998 108.459 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 3.2 mp -117.4 132.61 56.54 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 116.078 -0.51 . . . . 72.450000000000003 110.669 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . 0.433 ' HZ3' ' HB ' ' A' ' 417' ' ' ILE . 57.0 mmtt -106.29 125.73 51.36 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 115.903 -0.59 . . . . 53.539999999999999 111.231 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.452 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 3.7 m-85 -118.48 135.89 54.12 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.98 -1.118 . . . . 71.200000000000003 107.98 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.69 176.14 10.08 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.556 0.217 . . . . 74.040000000000006 111.538 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 14.1 m120 65.31 33.19 9.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.673 0.789 . . . . 73.230000000000004 112.386 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -73.8 -149.16 1.4 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.898 -0.667 . . . . 53.039999999999999 112.345 176.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -73.93 137.92 43.92 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 122.106 -0.644 . . . . 74.439999999999998 110.069 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 26.4 p . . . . . 0 C--N 1.311 -1.09 0 C-N-CA 124.661 1.184 . . . . 71.010000000000005 113.934 -175.124 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 106.723 -1.584 . . . . 65.340000000000003 106.723 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -76.61 158.48 31.07 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.269 0.557 . . . . 70.430000000000007 112.457 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 37.4 p -160.69 163.72 32.22 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 114.983 -1.008 . . . . 63.109999999999999 109.122 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.52 143.29 13.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 120.77 0.319 . . . . 74.530000000000001 110.584 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . 0.433 ' HB ' ' HZ3' ' A' ' 401' ' ' LYS . 7.4 tt -103.84 131.73 51.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.78 -0.822 . . . . 71.409999999999997 108.78 173.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.7 t -113.32 125.28 70.56 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-O 121.084 0.469 . . . . 73.349999999999994 110.181 174.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 1.1 m -110.07 114.45 27.97 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 105.878 -1.897 . . . . 61.030000000000001 105.878 176.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 22.0 t -101.17 117.24 46.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.357 -0.979 . . . . 74.230000000000004 108.357 -176.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -106.7 -179.05 3.83 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 120.281 -0.568 . . . . 72.129999999999995 109.935 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 40.2 t -60.56 128.99 39.34 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 123.37 0.668 . . . . 63.409999999999997 110.644 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -153.16 -177.4 26.67 Favored Glycine 0 CA--C 1.485 -1.812 0 N-CA-C 111.065 -0.814 . . . . 75.109999999999999 111.065 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.93 -30.13 4.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.498 0.666 . . . . 75.530000000000001 109.213 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -151.02 151.25 31.77 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.369 -0.832 . . . . 74.109999999999999 109.222 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.632 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.0 OUTLIER -65.34 100.23 0.46 Allowed 'General case' 0 C--N 1.311 -1.098 0 O-C-N 124.164 0.915 . . . . 74.329999999999998 110.841 174.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -131.93 149.25 52.49 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.776 -1.102 . . . . 75.329999999999998 110.246 -176.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.408 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 29.7 mm -86.87 122.25 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 106.261 -1.755 . . . . 74.439999999999998 106.261 176.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' A' ' 442' ' ' LYS . 64.9 t -84.37 -50.43 15.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 CA-C-N 116.455 -0.339 . . . . 74.040000000000006 111.653 -177.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.5 m -165.66 164.23 19.09 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.151 -0.685 . . . . 72.439999999999998 109.151 -175.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 3.3 p -141.49 125.32 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 107.253 -1.388 . . . . 73.019999999999996 107.253 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 42.8 tp -131.73 137.26 48.15 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 108.627 -0.879 . . . . 71.200000000000003 108.627 -176.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -81.64 119.04 23.3 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.45 -0.945 . . . . 61.549999999999997 108.45 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.3 -56.32 5.01 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.335 -0.848 . . . . 64.129999999999995 110.701 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -119.55 -71.49 0.73 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.739 -0.664 . . . . 74.140000000000001 110.603 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . 0.474 ' HZ1' ' HB3' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -162.39 -42.14 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.767 0 CA-C-O 121.332 0.587 . . . . 74.150000000000006 111.152 175.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 90.7 m -112.77 13.3 19.75 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.71 0.766 . . . . 62.119999999999997 109.959 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 415' ' ' SER . 31.0 tt0 -135.23 131.23 36.39 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.079 -0.964 . . . . 62.329999999999998 108.875 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -123.5 150.68 43.65 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 123.591 0.557 . . . . 74.519999999999996 111.279 -176.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -110.58 118.01 35.06 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.428 -0.953 . . . . 64.530000000000001 108.428 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 92.6 mt -119.29 133.12 67.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.294 -0.867 . . . . 63.439999999999998 109.308 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.413 ' O ' ' HB ' ' A' ' 429' ' ' VAL . 37.9 ttpt -111.53 141.38 45.18 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 109.285 -0.635 . . . . 72.209999999999994 109.285 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.408 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 79.6 mtp -136.32 169.19 18.06 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 109.272 -0.64 . . . . 75.439999999999998 109.272 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 66.8 mmtt -132.22 159.97 37.49 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.97 -1.122 . . . . 74.129999999999995 107.97 175.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 41.2 t -172.45 145.69 1.5 Allowed Pre-proline 0 C--N 1.289 -2.05 0 O-C-N 124.187 0.929 . . . . 55.420000000000002 109.707 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.0 -24.27 45.62 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.314 2.009 . . . . 72.129999999999995 110.917 176.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.09 -18.75 52.77 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.698 -0.683 . . . . 72.439999999999998 111.017 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.659 0 CA-C-O 121.66 0.743 . . . . 74.299999999999997 109.57 176.868 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 94.0 m . . . . . 0 N--CA 1.432 -1.327 0 N-CA-C 107.932 -1.136 . . . . 62.509999999999998 107.932 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.444 ' HB3' ' HG3' ' A' ' 375' ' ' LYS . 13.3 ptmm? -136.52 144.46 44.28 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.51 0.93 . . . . 75.519999999999996 113.51 -173.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -156.55 135.54 11.9 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.244 -1.391 . . . . 74.439999999999998 107.244 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 43.7 mt-10 -86.29 128.43 34.92 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 109.645 -0.502 . . . . 73.420000000000002 109.645 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.63 118.76 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 N-CA-C 107.463 -1.31 . . . . 72.5 107.463 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.24 14.41 61.68 Favored Glycine 0 C--N 1.308 -1.016 0 C-N-CA 120.612 -0.804 . . . . 73.530000000000001 112.631 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 109.15 -24.53 20.74 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 120.919 -0.658 . . . . 75.450000000000003 112.91 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -98.78 136.02 39.42 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 120.946 0.403 . . . . 64.219999999999999 111.07 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 41.3 m -77.52 115.3 17.17 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.074 -0.512 . . . . 65.430000000000007 110.206 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.423 ' HH ' HG21 ' A' ' 431' ' ' VAL . 0.2 OUTLIER -91.05 131.34 36.69 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 108.438 -0.949 . . . . 72.420000000000002 108.438 175.206 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.444 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 38.5 ttpt -135.32 125.45 26.09 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 120.165 -0.614 . . . . 55.009999999999998 109.994 -177.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.02 115.51 49.13 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 N-CA-C 108.266 -1.013 . . . . 71.230000000000004 108.266 176.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 39.5 t -104.96 115.08 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.422 0 N-CA-C 105.662 -1.977 . . . . 74.120000000000005 105.662 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.495 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 94.3 m-85 -68.72 127.52 33.34 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 114.216 1.191 . . . . 64.140000000000001 114.216 -170.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . 0.27 47.9 m-85 71.19 16.14 6.31 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 113.964 -1.471 . . . . 72.439999999999998 112.956 -176.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -125.91 -83.41 0.63 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.258 -0.883 . . . . 75.349999999999994 112.566 173.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.521 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.5 OUTLIER -161.6 162.53 30.12 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.701 0.63 . . . . 70.030000000000001 112.701 -169.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 87.1 t -121.16 143.29 33.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 124.305 1.042 . . . . 75.329999999999998 108.65 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.521 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 66.4 m-85 -132.25 144.89 50.93 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 123.209 0.604 . . . . 74.109999999999999 112.198 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -116.17 102.15 9.34 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 105.776 -1.935 . . . . 74.329999999999998 105.776 171.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.4 t70 72.38 -80.67 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 125.065 1.346 . . . . 54.509999999999998 109.569 -176.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.4 m -142.69 -1.88 1.1 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.945 -1.025 . . . . 43.210000000000001 108.352 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 49.8 mt -88.07 139.31 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.746 -0.661 . . . . 74.340000000000003 109.977 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 58.6 tp -76.43 110.29 10.84 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.56 -0.904 . . . . 61.130000000000003 108.56 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.39 -60.04 2.47 Favored 'General case' 0 N--CA 1.393 -3.324 0 N-CA-C 109.18 -0.674 . . . . 73.319999999999993 109.18 -176.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.45 160.02 31.4 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 119.475 -1.345 . . . . 63.020000000000003 111.644 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -110.11 151.32 27.38 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.942 -1.133 . . . . 62.340000000000003 107.942 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . 0.495 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.8 m-85 -73.56 127.95 34.17 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 111.777 0.288 . . . . 75.400000000000006 111.777 -175.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -110.5 -49.57 3.04 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.18 -0.608 . . . . 44.240000000000002 112.575 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 54.2 p -167.75 139.92 3.12 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.694 -0.484 . . . . 73.239999999999995 109.694 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . 0.435 ' NE2' ' HD2' ' A' ' 392' ' ' PHE . 2.4 mm-40 -118.17 147.12 43.66 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 109.989 -0.374 . . . . 65.519999999999996 109.989 -176.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -128.41 110.31 12.21 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.192 -0.67 . . . . 71.040000000000006 109.192 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.95 -108.11 2.09 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 116.145 -0.479 . . . . 71.140000000000001 112.405 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -117.23 16.77 14.86 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.28 0.562 . . . . 74.140000000000001 110.196 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 52.3 t -117.44 116.87 53.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.797 -1.186 . . . . 61.409999999999997 107.797 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.63 142.42 39.12 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.571 -0.74 . . . . 63.43 111.386 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -120.1 122.47 41.12 Favored 'General case' 0 C--O 1.25 1.097 0 CA-C-O 121.403 0.62 . . . . 71.430000000000007 111.814 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -118.3 137.32 53.15 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.934 -1.136 . . . . 74.310000000000002 107.934 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . 0.432 ' HA ' ' CB ' ' A' ' 415' ' ' SER . 46.6 mt-10 -142.47 175.59 9.66 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.008 -0.738 . . . . 74.219999999999999 109.008 -177.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.79 33.54 10.17 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.275 1.213 . . . . 73.049999999999997 114.275 171.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.72 -141.9 3.02 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 120.233 -0.984 . . . . 61.43 111.602 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -56.0 136.92 51.77 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 123.343 0.657 . . . . 64.540000000000006 110.993 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 26.4 p . . . . . 0 N--CA 1.433 -1.314 0 CA-C-O 120.919 0.39 . . . . 71.230000000000004 110.806 -179.03 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 . . . . . 0 CA--C 1.5 -0.952 0 N-CA-C 105.678 -1.971 . . . . 71.5 105.678 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -73.24 156.37 38.58 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.156 0.503 . . . . 51.200000000000003 109.872 171.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.432 ' CB ' ' HA ' ' A' ' 403' ' ' GLU . 54.2 p -160.54 169.07 23.7 Favored 'General case' 0 N--CA 1.401 -2.916 0 CA-C-N 115.306 -0.861 . . . . 74.340000000000003 109.047 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -159.07 151.07 20.93 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.364 0.602 . . . . 72.430000000000007 111.281 -177.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.1 tt -115.1 133.01 62.66 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 CA-C-N 115.08 -0.964 . . . . 73.010000000000005 108.558 173.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 4.9 t -118.57 129.68 74.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.233 0.54 . . . . 64.349999999999994 111.638 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.3 p -108.26 113.24 26.19 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.635 -1.246 . . . . 64.140000000000001 107.635 174.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 21.1 t -101.48 112.2 33.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.132 -1.062 . . . . 75.209999999999994 108.132 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 444' ' ' LYS . 41.1 mt-10 -108.16 179.52 4.19 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.988 -0.285 . . . . 64.349999999999994 110.315 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 43.2 t -59.29 128.76 38.75 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 123.464 0.706 . . . . 65.400000000000006 110.863 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.425 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -153.42 -176.89 26.37 Favored Glycine 0 CA--C 1.486 -1.723 0 C-N-CA 120.779 -0.724 . . . . 65.409999999999997 111.452 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 50.6 t -89.3 -37.31 9.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.998 -0.741 . . . . 72.219999999999999 108.998 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -150.48 160.3 43.87 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.638 -0.71 . . . . 74.299999999999997 109.31 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 70.0 m-20 -68.78 101.22 1.29 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.44 0.696 . . . . 73.25 109.709 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -131.89 148.25 52.52 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 110.432 -0.211 . . . . 74.129999999999995 110.432 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 30.5 mm -82.91 115.47 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 105.88 -1.896 . . . . 74.140000000000001 105.88 173.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 42.6 t -81.18 -47.49 19.95 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.637 0 N-CA-C 112.553 0.575 . . . . 71.049999999999997 112.553 -176.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 26.1 t -166.0 162.35 17.96 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.522 -0.918 . . . . 60.520000000000003 108.522 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.423 HG21 ' HH ' ' A' ' 374' ' ' TYR . 3.1 p -141.27 119.9 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.143 0 N-CA-C 108.666 -0.865 . . . . 71.329999999999998 108.666 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 30.7 tp -121.21 136.61 54.94 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 108.268 -1.012 . . . . 63.200000000000003 108.268 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.428 ' CD ' ' HA ' ' A' ' 436' ' ' LYS . 43.7 tt0 -81.37 116.88 21.41 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.858 -1.164 . . . . 73.120000000000005 107.858 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.47 -46.69 38.02 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.887 0.851 . . . . 64.239999999999995 109.498 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -129.29 -78.68 0.56 Allowed 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.897 -1.047 . . . . 74.400000000000006 109.28 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . 0.476 ' HB3' ' NZ ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -168.05 -40.25 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 123.367 0.667 . . . . 73.120000000000005 110.492 174.048 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 91.4 m -100.72 7.79 43.66 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.749 0.785 . . . . 74.349999999999994 109.477 174.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -136.44 129.69 31.51 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.484 -0.78 . . . . 72.319999999999993 109.944 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 43.4 m-85 -125.32 150.57 47.02 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 123.522 0.514 . . . . 75.439999999999998 110.096 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -111.9 120.92 43.55 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.369 -0.604 . . . . 75.200000000000003 109.369 172.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 4.0 mp -113.74 133.48 59.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 116.127 -0.488 . . . . 64.299999999999997 110.105 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -104.01 140.53 37.61 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 107.847 -1.168 . . . . 72.140000000000001 107.847 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 80.7 mtp -138.79 168.33 20.05 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 109.231 -0.655 . . . . 74.120000000000005 109.231 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.9 mmtt -133.53 160.02 38.7 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.146 -1.057 . . . . 75.5 108.146 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 46.2 t -165.89 146.13 5.49 Favored Pre-proline 0 C--N 1.284 -2.247 0 O-C-N 124.193 0.933 . . . . 63.43 109.894 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.2 -27.09 41.69 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.158 1.905 . . . . 65.230000000000004 110.147 174.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -78.79 -21.65 47.49 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.291 -0.868 . . . . 64.200000000000003 110.245 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -1.019 0 CA-C-O 121.162 0.506 . . . . 70.430000000000007 110.708 -179.38 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' THR . . . . . 0.45 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 93.4 m . . . . . 0 N--CA 1.422 -1.867 0 N-CA-C 107.111 -1.44 . . . . 73.329999999999998 107.111 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 56.2 mtpt -131.6 142.44 49.89 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.403 -0.362 . . . . 72.510000000000005 110.882 -175.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -160.57 135.42 7.63 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.625 -0.88 . . . . 73.099999999999994 108.625 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -79.25 122.99 27.01 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 110.019 -0.363 . . . . 61.439999999999998 110.019 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.452 HG23 HG13 ' A' ' 431' ' ' VAL . 47.4 mt -135.74 124.15 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 106.797 -1.557 . . . . 70.420000000000002 106.797 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.62 13.08 60.39 Favored Glycine 0 C--N 1.31 -0.906 0 C-N-CA 120.55 -0.833 . . . . 72.120000000000005 112.057 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.08 -24.2 27.08 Favored Glycine 0 N--CA 1.429 -1.808 0 C-N-CA 121.209 -0.52 . . . . 74.019999999999996 113.113 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . 0.474 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 22.5 p90 -103.42 147.16 27.47 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 110.17 -0.308 . . . . 75.450000000000003 110.17 -176.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 85.8 m -86.44 123.88 32.15 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 116.464 -0.335 . . . . 51.100000000000001 110.989 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.643 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.5 134.74 34.15 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 108.945 -0.761 . . . . 71.25 108.945 175.418 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -130.12 125.84 36.08 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 110.0 -0.37 . . . . 64.519999999999996 110.0 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.45 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.3 p -122.46 118.88 56.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 N-CA-C 109.451 -0.574 . . . . 74.219999999999999 109.451 175.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 49.5 t -106.17 116.99 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 106.658 -1.608 . . . . 63.219999999999999 106.658 174.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -61.43 126.7 28.28 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 114.668 1.359 . . . . 73.140000000000001 114.668 -172.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 71.07 14.35 6.77 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 113.336 -1.756 . . . . 72.310000000000002 112.465 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -124.8 -77.24 0.59 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 113.893 1.071 . . . . 73.230000000000004 113.893 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -162.76 160.97 26.0 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.882 0.697 . . . . 73.420000000000002 112.882 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 96.8 t -122.86 140.21 47.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.541 -0.754 . . . . 61.43 109.103 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -133.23 147.25 51.98 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.19 0.519 . . . . 73.209999999999994 111.872 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.403 ' HG3' ' CD1' ' A' ' 372' ' ' TYR . 35.9 tt0 -112.07 101.03 9.34 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.317 -2.105 . . . . 71.519999999999996 105.317 171.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 21.9 t70 68.19 -84.03 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 124.302 1.041 . . . . 75.150000000000006 110.109 -173.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.4 m -134.89 -6.67 2.4 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.214 -0.903 . . . . 65.409999999999997 108.678 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 45.6 mm -80.38 134.49 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 116.004 -0.544 . . . . 74.219999999999999 109.737 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 61.0 tp -76.92 113.9 15.12 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 109.035 -0.728 . . . . 73.239999999999995 109.035 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.402 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.3 OUTLIER -80.06 -63.32 1.44 Allowed 'General case' 0 N--CA 1.389 -3.511 0 N-CA-C 108.974 -0.75 . . . . 64.319999999999993 108.974 -177.179 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.89 159.41 30.64 Favored Glycine 0 N--CA 1.415 -2.742 0 C-N-CA 119.162 -1.494 . . . . 64.319999999999993 111.842 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -105.79 145.07 31.64 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.031 -1.1 . . . . 73.040000000000006 108.031 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -69.82 116.34 10.1 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.908 0.385 . . . . 74.430000000000007 110.601 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -94.79 -47.03 6.64 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.721 -0.672 . . . . 63.130000000000003 110.757 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 62.5 p -173.24 149.8 1.82 Allowed 'General case' 0 C--O 1.246 0.879 0 CA-C-N 116.021 -0.536 . . . . 72.040000000000006 109.599 -177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . 0.504 ' CD ' ' HG ' ' A' ' 400' ' ' LEU . 10.1 pt20 -143.88 142.06 30.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.186 0.517 . . . . 74.409999999999997 110.796 175.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -128.5 131.11 48.31 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.666 -0.697 . . . . 75.040000000000006 109.624 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 69.59 -107.96 2.31 Favored Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 111.365 -0.694 . . . . 52.140000000000001 111.365 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -133.07 24.41 4.22 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.83 0.824 . . . . 71.150000000000006 110.053 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.2 t -119.45 116.86 52.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.335 -0.987 . . . . 73.450000000000003 108.335 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.504 ' HG ' ' CD ' ' A' ' 395' ' ' GLN . 6.0 mp -106.71 133.55 51.21 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.16 0.584 . . . . 75.150000000000006 111.804 -174.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -113.47 121.94 45.79 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 112.513 0.56 . . . . 71.430000000000007 112.513 178.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -118.58 136.81 53.66 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.328 -0.99 . . . . 73.200000000000003 108.328 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -146.31 176.15 9.99 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.141 0.496 . . . . 74.510000000000005 111.723 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.15 33.65 9.23 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.382 -1.281 . . . . 73.409999999999997 112.679 169.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.26 -136.7 0.67 Allowed Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.445 -0.798 . . . . 51.420000000000002 112.931 177.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.34 149.6 40.52 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.816 -1.179 . . . . 73.430000000000007 107.816 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 C--N 1.306 -1.309 0 C-N-CA 124.22 1.008 . . . . 64.019999999999996 111.36 -175.63 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 . . . . . 0 CA--C 1.507 -0.699 0 N-CA-C 106.839 -1.541 . . . . 60.119999999999997 106.839 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -75.31 160.53 30.22 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.179 0.514 . . . . 73.219999999999999 111.22 172.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 36.8 p -163.29 163.46 25.29 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 114.908 -1.042 . . . . 72.329999999999998 108.643 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.75 146.32 19.25 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.217 0.532 . . . . 75.329999999999998 110.195 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.9 tt -111.25 121.29 63.59 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 CA-C-N 115.303 -0.862 . . . . 72.420000000000002 109.482 174.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.0 t -105.72 127.8 60.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.775 0.798 . . . . 74.450000000000003 111.499 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 12.5 p -107.76 111.7 24.0 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 106.836 -1.542 . . . . 74.319999999999993 106.836 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 8.6 p -106.27 120.23 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 108.891 -0.781 . . . . 62.409999999999997 108.891 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -116.2 -174.69 2.59 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 120.386 -0.526 . . . . 63.240000000000002 111.277 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 43.4 t -59.61 128.74 38.5 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 123.713 0.805 . . . . 72.349999999999994 111.2 -177.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -160.26 -177.82 33.7 Favored Glycine 0 CA--C 1.48 -2.101 0 N-CA-C 109.54 -1.424 . . . . 53.329999999999998 109.54 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 53.3 t -96.93 -27.96 3.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 121.639 0.733 . . . . 73.200000000000003 109.027 177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -141.34 146.57 36.85 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.791 -0.64 . . . . 72.150000000000006 111.234 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.631 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.6 p-10 -68.28 101.21 1.16 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.28 -1.327 . . . . 72.150000000000006 110.47 175.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -132.32 149.19 52.41 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.401 -0.818 . . . . 73.010000000000005 110.919 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 28.8 mm -88.82 117.33 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 105.841 -1.911 . . . . 63.130000000000003 105.841 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.7 -50.83 16.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-O 120.772 0.32 . . . . 74.140000000000001 111.438 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 70.3 m -167.08 163.81 15.79 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 110.041 -0.355 . . . . 72.450000000000003 110.041 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.452 HG13 HG23 ' A' ' 369' ' ' ILE . 4.2 p -141.45 127.9 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 108.08 -1.082 . . . . 73.310000000000002 108.08 176.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . 0.424 ' O ' HD21 ' A' ' 440' ' ' LEU . 29.5 tp -132.21 138.18 47.86 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.665 -0.865 . . . . 64.299999999999997 108.665 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -80.65 116.45 20.68 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.89 -0.782 . . . . 74.109999999999999 108.89 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.68 -53.74 8.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.28 0.562 . . . . 62.399999999999999 109.702 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -120.93 -72.92 0.67 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.312 -0.858 . . . . 74.439999999999998 110.37 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . 0.474 ' HG2' ' SG ' ' A' ' 437' ' ' CYS . 0.0 OUTLIER -167.51 -40.61 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.346 0.594 . . . . 75.219999999999999 110.483 175.173 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . 0.474 ' SG ' ' HG2' ' A' ' 436' ' ' LYS . 43.7 m -106.65 7.04 30.37 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.678 0.751 . . . . 71.319999999999993 109.501 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -135.48 127.92 30.47 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.155 -0.929 . . . . 71.329999999999998 109.319 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -123.96 150.22 45.03 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.713 -0.676 . . . . 75.400000000000006 109.782 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.424 HD21 ' O ' ' A' ' 432' ' ' LEU . 1.4 pt? -107.52 124.71 50.31 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.491 -0.929 . . . . 75.430000000000007 108.491 173.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.6 mt -124.75 133.37 69.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 115.332 -0.849 . . . . 73.319999999999993 109.409 -176.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -112.45 141.64 45.96 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 119.934 -0.706 . . . . 74.540000000000006 109.614 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 80.0 mtp -137.11 169.03 18.46 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 123.571 0.749 . . . . 74.140000000000001 109.059 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 69.2 mmtt -135.12 153.73 51.91 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.732 -1.21 . . . . 72.219999999999999 107.732 175.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 73.0 m -164.57 150.82 9.3 Favored Pre-proline 0 C--N 1.293 -1.89 0 C-N-CA 123.992 0.917 . . . . 62.450000000000003 109.287 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.99 -27.51 42.62 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.282 1.988 . . . . 74.239999999999995 112.045 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -73.47 -19.74 60.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.677 -0.692 . . . . 70.530000000000001 110.94 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.045 0 CA-C-O 121.478 0.656 . . . . 63.299999999999997 109.586 -177.826 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 375' ' ' LYS . 99.2 m . . . . . 0 N--CA 1.433 -1.318 0 N-CA-C 109.757 -0.46 . . . . 64.420000000000002 109.757 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 18.9 ptpt -143.94 141.14 30.07 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-O 120.801 0.334 . . . . 71.510000000000005 111.872 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -154.9 135.1 13.15 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 106.96 -1.496 . . . . 72.040000000000006 106.96 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 40.4 mt-10 -89.44 127.86 35.88 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 120.642 0.258 . . . . 74.209999999999994 110.817 -174.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 47.5 mt -137.21 125.47 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 107.133 -1.432 . . . . 75.319999999999993 107.133 -174.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.84 5.51 32.27 Favored Glycine 0 C--N 1.306 -1.102 0 C-N-CA 121.177 -0.535 . . . . 60.32 113.188 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 110.34 -13.84 30.69 Favored Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.562 -0.828 . . . . 40.5 113.072 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . 0.428 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 13.5 p90 -109.91 143.68 39.48 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 110.126 -0.324 . . . . 72.430000000000007 110.126 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 63.2 m -82.96 121.14 26.6 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.822 -0.351 . . . . 74.329999999999998 110.484 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.4 OUTLIER -90.3 125.64 35.58 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 109.335 -0.617 . . . . 74.239999999999995 109.335 173.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 365' ' ' THR . 35.1 ttpt -125.64 126.66 45.06 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.451 -0.574 . . . . 75.140000000000001 109.451 -176.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 6.7 p -123.08 115.9 47.05 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 N-CA-C 109.387 -0.597 . . . . 74.5 109.387 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.58 116.15 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 N-CA-C 106.755 -1.572 . . . . 71.319999999999993 106.755 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -63.14 126.46 27.45 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 113.086 0.773 . . . . 75.219999999999999 113.086 -172.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 72.66 6.78 5.47 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.494 1.517 . . . . 71.439999999999998 113.068 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -115.89 -83.67 0.63 Allowed 'General case' 0 C--O 1.248 0.98 0 N-CA-C 112.494 0.553 . . . . 71.120000000000005 112.494 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.526 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -165.81 159.48 16.1 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.026 0.751 . . . . 75.109999999999999 113.026 -172.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 96.5 t -113.83 145.83 19.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 124.381 1.072 . . . . 74.209999999999994 109.51 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.526 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 75.5 m-85 -133.87 144.17 48.74 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 123.322 0.649 . . . . 73.319999999999993 111.191 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.412 ' HB2' HD21 ' A' ' 389' ' ' LEU . 35.3 tt0 -111.65 103.5 11.8 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.352 -1.722 . . . . 61.229999999999997 106.352 173.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.4 t70 72.03 -76.16 0.07 Allowed 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 124.938 1.295 . . . . 65.209999999999994 109.463 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 34.0 t -145.31 -6.52 0.64 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.349 -0.982 . . . . 42.109999999999999 108.349 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 65.4 mt -81.49 136.2 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 115.617 -0.72 . . . . 74.209999999999994 109.332 -177.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 60.2 tp -76.5 116.55 17.29 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.013 -0.736 . . . . 53.549999999999997 109.013 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.566 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.3 OUTLIER -81.33 -67.81 0.75 Allowed 'General case' 0 N--CA 1.386 -3.661 0 N-CA-C 108.207 -1.034 . . . . 71.439999999999998 108.207 -178.261 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.94 157.15 28.41 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 119.528 -1.32 . . . . 70.010000000000005 111.811 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.21 146.43 26.19 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.039 -1.097 . . . . 71.019999999999996 108.039 175.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -71.25 115.97 11.03 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.475 -0.565 . . . . 71.329999999999998 109.475 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -93.16 -47.05 7.13 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.382 -0.372 . . . . 71.549999999999997 110.346 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 63.8 p -160.37 141.48 12.13 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.898 -0.778 . . . . 74.319999999999993 108.898 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.03 141.35 26.31 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 116.343 -0.389 . . . . 75.329999999999998 110.926 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -128.99 120.32 25.84 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.947 -0.76 . . . . 72.430000000000007 108.947 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.33 -103.13 0.62 Allowed Glycine 0 N--CA 1.434 -1.493 0 O-C-N 123.746 0.654 . . . . 63.109999999999999 113.33 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 26.8 p-10 -113.7 6.18 16.74 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.01 0.374 . . . . 74.019999999999996 112.01 -176.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 28.1 t -116.43 116.93 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 107.932 -1.136 . . . . 74.239999999999995 107.932 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 11.7 mt -120.01 123.91 44.63 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 115.528 -0.76 . . . . 74.409999999999997 110.278 -171.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -103.77 124.0 48.09 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-O 121.032 0.444 . . . . 74.319999999999993 111.713 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.444 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 3.1 m-85 -116.21 136.32 53.12 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.933 -1.136 . . . . 73.400000000000006 107.933 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -146.29 175.58 10.41 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.846 0.355 . . . . 65.549999999999997 111.508 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.39 35.02 20.59 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 124.664 1.186 . . . . 65.099999999999994 112.681 172.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.84 -140.43 1.13 Allowed Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.072 -0.967 . . . . 72.129999999999995 111.903 176.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.51 139.39 43.79 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.96 -0.755 . . . . 72.510000000000005 108.96 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 26.3 t . . . . . 0 C--N 1.321 -0.642 0 CA-C-O 122.026 0.917 . . . . 71.219999999999999 112.969 -172.975 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 . . . . . 0 CA--C 1.493 -1.234 0 N-CA-C 105.126 -2.175 . . . . 63.039999999999999 105.126 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 437' ' ' CYS . 83.5 mtt180 -75.22 154.6 37.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 119.478 -0.889 . . . . 72.219999999999999 110.61 169.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.611 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 21.3 p -163.39 162.2 24.79 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 114.801 -1.091 . . . . 72.319999999999993 108.831 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.54 151.72 19.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 120.824 0.345 . . . . 75.319999999999993 110.818 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.9 tt -113.31 127.74 70.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 108.987 -0.746 . . . . 71.510000000000005 108.987 172.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.603 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 4.6 t -111.4 128.65 67.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 CA-C-N 115.951 -0.568 . . . . 75.219999999999999 110.835 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.26 115.4 27.36 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 105.908 -1.886 . . . . 73.510000000000005 105.908 177.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 37.6 t -100.54 127.6 53.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 109.137 -0.69 . . . . 73.400000000000006 109.137 -175.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -117.52 -175.09 2.74 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 120.039 -0.665 . . . . 72.439999999999998 110.497 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.44 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 33.3 t -62.34 128.03 34.12 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 122.964 0.506 . . . . 72.409999999999997 110.876 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -154.08 -178.86 28.93 Favored Glycine 0 CA--C 1.492 -1.351 0 C-N-CA 120.519 -0.848 . . . . 73.430000000000007 111.591 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.4 t -85.78 -38.77 13.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 108.81 -0.811 . . . . 72.409999999999997 108.81 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -149.65 150.17 31.75 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.359 -0.837 . . . . 71.549999999999997 109.629 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.587 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.6 p-10 -51.04 100.73 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.321 -1.309 . . . . 55.530000000000001 111.089 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -131.83 144.65 51.06 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 116.268 -0.424 . . . . 72.540000000000006 110.444 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.417 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 26.8 mm -84.13 116.87 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 105.885 -1.894 . . . . 74.230000000000004 105.885 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 442' ' ' LYS . 56.0 t -82.23 -50.57 16.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 CA-C-O 120.919 0.39 . . . . 73.530000000000001 111.986 -175.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 48.7 m -161.68 162.55 29.89 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.104 -0.702 . . . . 73.129999999999995 109.104 -174.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 3.4 p -141.32 111.13 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 N-CA-C 108.754 -0.832 . . . . 75.310000000000002 108.754 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . 0.484 ' O ' HD21 ' A' ' 440' ' ' LEU . 28.8 tp -112.63 137.72 50.48 Favored 'General case' 0 N--CA 1.401 -2.885 0 N-CA-C 107.679 -1.23 . . . . 72.150000000000006 107.679 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . 0.444 ' CD ' ' HA ' ' A' ' 436' ' ' LYS . 39.2 tt0 -80.79 114.3 19.58 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 108.724 -0.843 . . . . 73.420000000000002 108.724 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -73.07 -40.18 65.27 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 115.367 -0.833 . . . . 73.140000000000001 110.496 -175.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -133.06 -77.93 0.49 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.165 -0.925 . . . . 73.450000000000003 108.752 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . 0.473 ' HZ2' ' HB3' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -167.35 -39.8 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 124.029 0.932 . . . . 74.409999999999997 110.513 173.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 414' ' ' ARG . 62.8 m -100.69 -5.03 27.11 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.697 0.761 . . . . 73.019999999999996 109.586 177.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 415' ' ' SER . 38.3 tt0 -127.04 137.63 53.09 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.207 -0.906 . . . . 74.099999999999994 109.339 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -129.02 150.52 50.39 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.819 -0.628 . . . . 75.420000000000002 110.487 -174.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.484 HD21 ' O ' ' A' ' 432' ' ' LEU . 1.8 pt? -109.39 115.57 30.21 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.55 -0.908 . . . . 73.439999999999998 108.55 173.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.5 mt -115.25 126.45 72.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.408 -0.814 . . . . 73.25 109.699 -175.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . 0.481 ' O ' ' HB ' ' A' ' 429' ' ' VAL . 38.3 ttpt -103.32 141.48 35.85 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.504 -0.925 . . . . 75.310000000000002 108.504 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.417 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.8 mtp -136.32 168.91 18.54 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 109.663 -0.495 . . . . 74.150000000000006 109.663 -176.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.8 mmtt -131.77 158.61 40.76 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.123 -1.066 . . . . 73.310000000000002 108.123 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 47.2 t -172.92 146.66 1.45 Allowed Pre-proline 0 C--N 1.287 -2.121 0 O-C-N 124.248 0.968 . . . . 74.120000000000005 108.774 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -64.49 -23.47 64.59 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.125 1.883 . . . . 63.140000000000001 110.64 176.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -68.25 -26.94 65.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.416 -0.811 . . . . 72.230000000000004 111.081 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.896 0 CA-C-O 121.365 0.603 . . . . 70.340000000000003 109.771 179.759 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' THR . . . . . 0.484 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 86.6 m . . . . . 0 N--CA 1.426 -1.64 0 N-CA-C 107.509 -1.293 . . . . 72.349999999999994 107.509 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 13.8 ptmm? -141.41 140.73 33.71 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 120.798 -0.361 . . . . 74.450000000000003 111.758 -175.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -159.81 138.59 10.7 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.356 -0.979 . . . . 74.450000000000003 108.356 -173.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -81.24 123.49 28.52 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 110.075 -0.342 . . . . 75.200000000000003 110.075 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 58.3 mt -128.58 115.9 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 106.956 -1.498 . . . . 73.420000000000002 106.956 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.76 12.67 59.94 Favored Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.598 -0.811 . . . . 64.049999999999997 112.332 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 111.04 -26.15 12.88 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 121.265 -0.493 . . . . 50.140000000000001 112.701 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -98.08 136.36 38.43 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 120.756 -0.377 . . . . 73.519999999999996 110.89 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 70.1 m -79.17 119.99 23.04 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 116.039 -0.528 . . . . 55.43 110.228 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.587 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -91.02 133.18 35.51 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.577 -0.897 . . . . 75.0 108.577 172.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 365' ' ' THR . 35.0 ttpt -133.19 125.73 30.07 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.087 -0.645 . . . . 70.400000000000006 109.706 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.484 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.9 p -120.58 116.4 49.97 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 N-CA-C 109.816 -0.438 . . . . 74.340000000000003 109.816 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 26.9 t -107.41 116.09 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 106.988 -1.486 . . . . 63.020000000000003 106.988 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.423 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 95.7 m-85 -61.74 130.51 46.12 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 113.697 0.999 . . . . 74.010000000000005 113.697 -172.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 67.17 14.38 9.75 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.52 1.128 . . . . 73.219999999999999 112.884 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -125.34 -82.52 0.63 Allowed 'General case' 0 C--O 1.242 0.696 0 N-CA-C 113.418 0.896 . . . . 73.239999999999995 113.418 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.42 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -168.32 155.2 7.62 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.946 0.721 . . . . 73.5 112.946 -174.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.78 146.49 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.044 0.938 . . . . 71.129999999999995 109.582 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.42 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 84.3 m-85 -135.08 149.27 50.04 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.399 0.679 . . . . 73.109999999999999 111.345 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -123.96 104.81 9.13 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.186 -1.783 . . . . 73.019999999999996 106.186 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.1 t70 69.17 -87.66 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.933 0.893 . . . . 74.129999999999995 110.923 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 18.8 m -133.04 0.32 3.44 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.204 -1.036 . . . . 73.439999999999998 108.204 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 45.9 mm -92.19 133.27 34.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.047 -0.979 . . . . 73.530000000000001 110.457 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 63.1 tp -75.99 114.73 14.96 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.247 -1.39 . . . . 63.5 107.247 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.449 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -78.75 -63.3 1.44 Allowed 'General case' 0 N--CA 1.386 -3.629 0 N-CA-C 108.9 -0.778 . . . . 75.329999999999998 108.9 -175.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.0 158.56 29.86 Favored Glycine 0 N--CA 1.423 -2.231 0 C-N-CA 119.258 -1.448 . . . . 73.219999999999999 112.281 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -104.08 143.31 33.07 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.305 -0.998 . . . . 74.040000000000006 108.305 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . 0.423 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.8 m-85 -68.72 116.5 9.3 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 123.506 0.504 . . . . 74.219999999999999 110.668 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.69 -47.35 5.36 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.023 -0.535 . . . . 71.129999999999995 110.958 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 48.2 t -159.0 148.19 18.66 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.147 -0.686 . . . . 42.25 109.147 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -123.28 145.75 48.44 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.27 -1.011 . . . . 73.430000000000007 108.27 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -126.62 109.08 11.71 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.899 -1.148 . . . . 54.229999999999997 107.899 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 58.66 -101.37 0.21 Allowed Glycine 0 C--O 1.253 1.301 0 CA-C-O 121.423 0.457 . . . . 72.109999999999999 113.193 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -116.07 17.12 15.94 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 124.249 1.02 . . . . 73.040000000000006 109.558 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . 0.41 ' C ' HD13 ' A' ' 400' ' ' LEU . 60.0 t -121.05 133.45 67.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.197 -1.038 . . . . 74.5 108.197 -177.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.41 HD13 ' C ' ' A' ' 399' ' ' VAL . 3.5 mp -130.33 134.34 47.11 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.513 -0.475 . . . . 75.230000000000004 111.53 -176.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -108.26 122.17 46.39 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 123.101 0.56 . . . . 72.109999999999999 112.003 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.431 ' HE2' ' CG2' ' A' ' 418' ' ' VAL . 3.0 m-85 -118.38 129.32 55.35 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.719 -1.215 . . . . 71.439999999999998 107.719 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -147.11 175.29 10.82 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 111.637 0.236 . . . . 74.400000000000006 111.637 -177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.7 m120 60.07 39.19 20.01 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.738 0.649 . . . . 71.439999999999998 111.618 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -80.65 -137.46 1.93 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.737 -0.745 . . . . 72.239999999999995 112.069 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -67.37 148.74 51.23 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.744 -0.465 . . . . 74.140000000000001 109.744 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 30.4 m . . . . . 0 C--N 1.314 -0.947 0 CA-C-O 121.208 0.527 . . . . 55.409999999999997 109.798 178.665 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 108.192 -1.04 . . . . 72.510000000000005 108.192 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -82.72 160.76 22.29 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.143 0.497 . . . . 74.540000000000006 111.506 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 22.7 p -165.27 160.54 18.47 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-N 114.645 -1.162 . . . . 63.420000000000002 109.145 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -157.33 147.87 21.18 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.161 0.505 . . . . 62.030000000000001 110.705 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.25 114.44 47.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.977 -1.12 . . . . 74.519999999999996 107.977 174.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.431 ' CG2' ' HE2' ' A' ' 402' ' ' TYR . 5.0 t -97.91 128.81 48.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-O 121.337 0.589 . . . . 71.540000000000006 110.327 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 1.4 m -113.66 114.43 26.39 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 106.372 -1.714 . . . . 72.400000000000006 106.372 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 39.1 t -100.78 118.31 47.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.618 -0.882 . . . . 73.420000000000002 108.618 -175.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -109.1 -174.88 2.62 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 120.748 0.308 . . . . 73.530000000000001 110.393 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.477 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 42.0 t -60.5 129.24 40.59 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 123.917 0.887 . . . . 71.230000000000004 111.5 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -158.86 -177.56 32.05 Favored Glycine 0 CA--C 1.491 -1.422 0 N-CA-C 110.641 -0.984 . . . . 72.010000000000005 110.641 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.07 -33.52 5.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.578 0.704 . . . . 74.329999999999998 109.125 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . 0.46 ' HG2' ' N ' ' A' ' 426' ' ' ASN . 36.6 tt0 -149.06 162.1 40.62 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.545 -0.752 . . . . 72.099999999999994 109.074 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 19.7 m120 -67.62 107.93 2.71 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 114.632 -1.167 . . . . 63.340000000000003 110.37 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -131.57 148.48 52.62 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 114.934 -1.03 . . . . 73.109999999999999 109.54 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 29.4 mm -91.45 115.06 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 106.089 -1.819 . . . . 75.25 106.089 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 53.9 t -81.12 -48.83 18.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 111.995 0.368 . . . . 55.109999999999999 111.995 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 46.9 p -166.64 163.67 16.8 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 109.565 -0.531 . . . . 74.219999999999999 109.565 -174.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 3.2 p -141.36 111.41 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 N-CA-C 108.403 -0.962 . . . . 74.420000000000002 108.403 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . 0.459 ' HB3' ' HG ' ' A' ' 440' ' ' LEU . 24.4 tp -110.44 136.51 49.48 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 114.892 -1.049 . . . . 74.409999999999997 108.408 -175.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -80.86 110.74 16.67 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.465 -1.309 . . . . 75.239999999999995 107.465 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -72.66 -42.31 64.47 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.473 -0.785 . . . . 74.319999999999993 110.222 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -132.38 -78.03 0.5 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.474 -0.936 . . . . 72.530000000000001 108.474 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.22 -50.28 0.07 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.137 0.494 . . . . 70.530000000000001 111.0 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 63.4 m -100.9 4.39 42.62 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.817 0.817 . . . . 73.239999999999995 109.822 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 415' ' ' SER . 35.9 tt0 -129.45 130.97 46.59 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.904 -1.044 . . . . 64.299999999999997 108.948 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . 0.446 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 41.1 m-85 -123.51 150.83 43.46 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.209 -0.905 . . . . 75.540000000000006 110.075 -174.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . 0.459 ' HG ' ' HB3' ' A' ' 432' ' ' LEU . 4.1 pp -111.08 124.46 52.23 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 106.992 -1.485 . . . . 73.439999999999998 106.992 173.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.7 mt -120.27 135.63 59.91 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 115.753 -0.658 . . . . 62.399999999999999 109.813 -175.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -105.7 140.25 39.04 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.235 -1.024 . . . . 74.129999999999995 108.235 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 82.7 mtp -140.08 168.7 19.2 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 109.02 -0.733 . . . . 64.519999999999996 109.02 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.9 mmtt -132.24 160.28 36.62 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.999 -0.741 . . . . 74.109999999999999 108.999 177.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 32.2 t -172.22 148.55 2.0 Allowed Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 124.138 0.899 . . . . 75.010000000000005 108.832 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.82 -27.26 51.75 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.197 1.931 . . . . 74.219999999999999 111.027 177.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -74.74 -15.79 60.76 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.281 -0.872 . . . . 70.310000000000002 111.12 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.107 0 CA-C-O 121.268 0.556 . . . . 64.409999999999997 110.08 -179.812 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 97.7 m . . . . . 0 N--CA 1.428 -1.571 0 N-CA-C 108.358 -0.978 . . . . 73.409999999999997 108.358 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 10.4 ptpp? -138.48 154.63 48.82 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 110.343 -0.243 . . . . 73.099999999999994 110.343 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -164.7 135.34 4.05 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.591 -1.263 . . . . 75.140000000000001 107.591 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -84.67 125.31 32.39 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.599 -0.519 . . . . 75.549999999999997 109.599 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 49.4 mt -130.59 116.29 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 107.236 -1.394 . . . . 75.519999999999996 107.236 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 67.28 11.71 59.59 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.823 -0.703 . . . . 51.420000000000002 112.521 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 111.94 -25.75 12.5 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.806 -0.711 . . . . 74.310000000000002 112.575 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -97.84 136.09 38.65 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 120.218 -0.593 . . . . 74.420000000000002 110.8 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 92.2 m -79.19 118.48 21.18 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 115.713 -0.676 . . . . 75.340000000000003 110.742 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -90.12 133.34 34.93 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 108.234 -1.024 . . . . 73.420000000000002 108.234 173.364 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -132.06 125.71 32.07 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.349 -0.541 . . . . 74.349999999999994 110.022 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 7.0 p -119.51 118.08 56.11 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 CA-C-N 116.031 -0.531 . . . . 71.420000000000002 109.861 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.4 t -109.25 116.14 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 106.658 -1.608 . . . . 63.439999999999998 106.658 173.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -63.11 130.88 46.54 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.15 -0.932 . . . . 75.340000000000003 113.107 -171.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 71.82 6.79 5.74 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.894 1.278 . . . . 70.200000000000003 112.314 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -119.42 -84.81 0.66 Allowed 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 116.021 -0.536 . . . . 73.409999999999997 112.19 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.513 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.3 OUTLIER -168.37 158.99 10.2 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 112.611 0.597 . . . . 44.25 112.611 -174.194 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.46 HG21 ' CE2' ' A' ' 402' ' ' TYR . 94.6 t -116.29 146.58 20.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 123.858 0.863 . . . . 74.329999999999998 109.928 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.513 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 81.1 m-85 -133.06 151.3 52.04 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.662 0.785 . . . . 71.400000000000006 111.088 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . 0.44 ' HB2' HD21 ' A' ' 389' ' ' LEU . 30.4 tt0 -126.46 109.66 12.44 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.584 -1.636 . . . . 65.340000000000003 106.584 173.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 25.0 t70 70.49 -80.66 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 124.051 0.94 . . . . 63.43 110.528 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 28.4 p -145.37 1.12 0.93 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.176 -0.92 . . . . 63.329999999999998 109.27 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 48.2 mm -91.37 137.63 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.003 -0.999 . . . . 72.230000000000004 109.558 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 57.1 tp -76.63 115.94 16.86 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.236 -1.024 . . . . 73.430000000000007 108.236 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.535 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.4 OUTLIER -79.07 -64.32 1.21 Allowed 'General case' 0 N--CA 1.392 -3.354 0 N-CA-C 109.025 -0.731 . . . . 73.329999999999998 109.025 -177.252 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.44 160.63 31.52 Favored Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 118.796 -1.668 . . . . 74.430000000000007 111.744 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -99.53 147.48 25.27 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.237 -1.764 . . . . 73.450000000000003 106.237 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -69.24 116.42 9.66 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.061 -0.656 . . . . 71.099999999999994 110.86 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -93.78 -48.1 6.46 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.675 -0.693 . . . . 70.409999999999997 110.134 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 46.8 m -154.23 142.45 20.43 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 110.303 -0.258 . . . . 72.510000000000005 110.303 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -122.2 130.99 53.71 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 106.593 -1.632 . . . . 72.409999999999997 106.593 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -128.67 109.81 11.66 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.922 -0.77 . . . . 75.019999999999996 108.922 176.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.19 -101.18 0.58 Allowed Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.988 -0.625 . . . . 41.219999999999999 111.948 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -122.48 18.95 10.5 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.269 0.557 . . . . 74.140000000000001 109.575 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.01 126.43 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 N-CA-C 107.792 -1.188 . . . . 74.099999999999994 107.792 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.458 ' HB2' ' HH ' ' A' ' 402' ' ' TYR . 22.7 mt -123.82 123.66 40.95 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 110.001 -0.37 . . . . 72.430000000000007 110.001 -172.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -106.88 125.1 50.57 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.201 -0.296 . . . . 73.030000000000001 110.201 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.46 ' CE2' HG21 ' A' ' 382' ' ' VAL . 2.4 m-85 -118.49 135.54 54.33 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.52 -0.918 . . . . 65.25 108.52 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -146.27 175.85 10.2 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 123.41 0.684 . . . . 75.310000000000002 109.771 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 14.7 m120 66.17 27.54 10.36 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.287 0.847 . . . . 62.130000000000003 113.287 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -72.6 -139.48 0.32 Allowed Glycine 0 CA--C 1.54 1.619 0 C-N-CA 121.302 -0.475 . . . . 75.400000000000006 113.764 176.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.02 144.68 38.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.309 -1.367 . . . . 75.519999999999996 107.309 -177.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 C--N 1.305 -1.335 0 CA-C-O 121.669 0.747 . . . . 74.540000000000006 111.141 -177.341 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 . . . . . 0 CA--C 1.501 -0.917 0 N-CA-C 106.678 -1.601 . . . . 64.540000000000006 106.678 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -64.99 157.15 29.05 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-O 121.677 0.751 . . . . 73.400000000000006 111.859 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 40.1 p -159.67 163.66 34.66 Favored 'General case' 0 N--CA 1.403 -2.789 0 CA-C-N 114.305 -1.316 . . . . 71.120000000000005 109.063 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.38 151.48 19.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 109.971 -0.381 . . . . 73.409999999999997 109.971 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 14.9 tt -117.67 120.98 66.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 108.663 -0.865 . . . . 73.25 108.663 173.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 4.1 t -104.01 123.65 57.89 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 CA-C-N 115.163 -0.926 . . . . 62.43 110.127 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 2.3 m -108.57 114.08 27.62 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 105.525 -2.028 . . . . 75.5 105.525 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.37 116.7 44.32 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.383 0 N-CA-C 108.154 -1.054 . . . . 75.310000000000002 108.154 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 448' ' ' ALA . 41.6 mt-10 -110.94 -173.86 2.34 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 120.961 0.41 . . . . 75.040000000000006 111.736 -176.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.471 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 39.8 t -64.1 128.67 36.83 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.635 0.774 . . . . 72.099999999999994 111.386 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 446' ' ' PRO . . . -161.1 -177.5 34.26 Favored Glycine 0 CA--C 1.492 -1.37 0 N-CA-C 109.508 -1.437 . . . . 70.109999999999999 109.508 177.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 56.2 t -96.17 -23.42 4.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.539 0.685 . . . . 62.130000000000003 109.441 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -142.67 154.44 44.34 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.906 -0.588 . . . . 72.120000000000005 110.363 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.603 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 72.0 m-20 -71.69 99.3 2.09 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.777 -1.194 . . . . 75.25 107.777 175.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -132.01 148.55 52.51 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 120.999 -0.28 . . . . 71.230000000000004 110.398 -177.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.436 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 26.7 mm -85.89 127.49 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.49 -1.67 . . . . 74.040000000000006 106.49 176.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 62.6 t -91.54 -51.03 12.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 112.356 0.502 . . . . 73.420000000000002 112.356 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 50.5 m -163.23 161.64 24.97 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.507 -0.553 . . . . 72.239999999999995 109.507 -174.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.417 HG21 ' HH ' ' A' ' 374' ' ' TYR . 3.1 p -141.4 116.8 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 123.867 0.729 . . . . 73.450000000000003 109.468 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 25.0 tp -123.87 137.34 54.66 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.214 -1.032 . . . . 74.140000000000001 108.214 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -84.21 128.41 34.55 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.714 -0.847 . . . . 64.120000000000005 108.714 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -89.22 -48.19 7.55 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.11 1.152 . . . . 65.129999999999995 114.11 -176.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -122.79 -68.21 0.9 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.191 0.519 . . . . 74.219999999999999 111.642 -172.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . 0.48 ' HB3' ' NZ ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -166.03 -27.28 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 124.031 0.932 . . . . 74.319999999999993 109.535 175.096 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 98.3 m -135.78 21.91 3.32 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.718 -0.674 . . . . 75.310000000000002 110.934 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.4 tt0 -135.29 119.61 17.86 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.289 0.566 . . . . 75.239999999999995 110.564 -176.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -109.44 134.42 51.88 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 115.623 -0.717 . . . . 74.030000000000001 110.719 -174.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.66 116.65 29.47 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.203 -1.036 . . . . 71.200000000000003 108.203 173.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 97.6 mt -118.35 135.1 59.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 115.043 -0.98 . . . . 71.040000000000006 110.309 -175.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -105.44 140.93 37.81 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.419 -0.956 . . . . 73.109999999999999 108.419 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.436 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.2 mtp -137.78 168.7 19.15 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 108.784 -0.821 . . . . 61.240000000000002 108.784 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 73.0 mmtt -131.76 161.24 33.32 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.354 -0.98 . . . . 64.099999999999994 108.354 176.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 48.5 t -164.82 146.07 6.45 Favored Pre-proline 0 C--N 1.284 -2.276 0 O-C-N 124.235 0.96 . . . . 73.209999999999994 109.025 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 30.4 Cg_endo -65.6 -27.22 53.48 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.159 1.906 . . . . 73.430000000000007 110.676 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.34 -19.96 38.26 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.516 -0.766 . . . . 71.25 110.782 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 421' ' ' GLU . . . . . . . . 0 CA--C 1.499 -1.002 0 CA-C-O 121.969 0.89 . . . . 74.420000000000002 110.415 -177.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 86.4 m . . . . . 0 N--CA 1.437 -1.077 0 N-CA-C 109.46 -0.571 . . . . 62.130000000000003 109.46 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 366' ' ' LYS . 0.0 OUTLIER -145.17 151.62 38.72 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.614 -0.435 . . . . 72.510000000000005 111.572 178.021 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -162.56 134.33 5.29 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.31 -1.367 . . . . 75.209999999999994 107.31 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -87.79 127.99 35.32 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 110.113 -0.329 . . . . 71.319999999999993 110.113 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 42.5 mt -134.46 122.64 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 106.642 -1.614 . . . . 74.420000000000002 106.642 -175.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.54 9.88 52.15 Favored Glycine 0 C--N 1.306 -1.123 0 C-N-CA 120.894 -0.669 . . . . 65.409999999999997 113.194 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 111.97 -23.57 16.49 Favored Glycine 0 N--CA 1.427 -1.94 0 C-N-CA 120.82 -0.705 . . . . 70.319999999999993 112.803 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . 0.419 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 17.0 p90 -100.98 144.61 29.71 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.625 0.25 . . . . 74.140000000000001 110.809 -177.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 87.3 m -82.47 119.39 24.15 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.817 -0.438 . . . . 75.239999999999995 109.817 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.37 125.28 35.49 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 108.451 -0.944 . . . . 60.119999999999997 108.451 172.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -126.6 130.9 51.4 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.453 -0.573 . . . . 75.109999999999999 109.453 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 6.6 p -128.07 119.29 50.69 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.928 0 CA-C-O 121.254 0.55 . . . . 75.340000000000003 110.246 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 57.9 t -108.14 116.39 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.917 0 N-CA-C 106.825 -1.546 . . . . 74.030000000000001 106.825 175.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -62.85 132.48 52.3 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.066 1.135 . . . . 74.25 114.066 -173.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 66.96 17.91 10.55 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.03 -1.441 . . . . 71.030000000000001 112.076 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -128.79 -82.75 0.58 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.309 -0.86 . . . . 55.219999999999999 113.001 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.455 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -165.55 155.93 13.29 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 113.274 0.842 . . . . 74.25 113.274 -172.358 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 88.4 t -113.78 145.28 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.388 1.075 . . . . 62.450000000000003 109.252 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . 0.455 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 85.6 m-85 -134.81 147.61 49.99 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 123.125 0.57 . . . . 75.219999999999999 111.532 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -119.39 104.71 10.6 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.151 -1.796 . . . . 73.109999999999999 106.151 173.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.4 t70 72.12 -82.96 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.725 0.81 . . . . 74.209999999999994 110.286 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 32.1 p -143.84 3.04 1.23 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.852 -1.067 . . . . 73.439999999999998 108.574 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 62.1 mt -89.21 133.91 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.967 -1.015 . . . . 75.329999999999998 109.378 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 61.2 tp -77.43 115.45 17.21 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.536 -0.913 . . . . 72.430000000000007 108.536 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.563 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -80.31 -64.54 1.17 Allowed 'General case' 0 N--CA 1.394 -3.249 0 N-CA-C 108.994 -0.743 . . . . 54.130000000000003 108.994 -177.086 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.9 158.57 30.16 Favored Glycine 0 N--CA 1.415 -2.739 0 C-N-CA 119.874 -1.155 . . . . 54.43 111.519 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -103.12 153.14 20.62 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.157 -1.423 . . . . 73.120000000000005 107.157 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . 0.493 ' HB3' HE21 ' A' ' 395' ' ' GLN . 1.7 m-85 -73.7 116.13 13.93 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 120.926 0.393 . . . . 71.340000000000003 111.306 -175.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.88 -48.12 5.03 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.608 -0.724 . . . . 71.239999999999995 110.852 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 51.1 m -157.15 137.75 13.12 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.024 0.44 . . . . 64.219999999999999 109.961 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . 0.53 ' CB ' ' HG ' ' A' ' 400' ' ' LEU . 4.8 pm0 -141.17 125.69 17.74 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 115.824 -0.626 . . . . 72.129999999999995 110.371 177.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -128.22 132.18 48.8 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.383 -0.969 . . . . 72.040000000000006 108.383 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 69.53 -103.53 1.12 Allowed Glycine 0 N--CA 1.422 -2.292 0 N-CA-C 111.057 -0.817 . . . . 73.519999999999996 111.057 -177.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -138.77 18.5 2.67 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.789 0.804 . . . . 73.420000000000002 110.297 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 63.9 t -117.1 119.78 63.02 Favored 'Isoleucine or valine' 0 C--O 1.244 0.816 0 N-CA-C 108.174 -1.047 . . . . 61.299999999999997 108.174 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.53 ' HG ' ' CB ' ' A' ' 395' ' ' GLN . 4.0 mp -113.02 135.54 53.67 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.964 -0.562 . . . . 73.239999999999995 110.971 -173.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -115.47 125.16 52.74 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.524 -0.917 . . . . 74.030000000000001 108.524 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.447 ' HH ' ' HB2' ' A' ' 400' ' ' LEU . 5.3 m-85 -115.75 141.55 47.94 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.399 -0.963 . . . . 74.400000000000006 108.399 -177.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -146.12 176.46 9.71 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.624 0.77 . . . . 72.25 109.096 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 18.7 m120 65.51 36.05 6.87 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.274 0.629 . . . . 70.230000000000004 112.677 173.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -81.01 -137.67 2.11 Favored Glycine 0 C--N 1.305 -1.177 0 C-N-CA 120.562 -0.828 . . . . 74.519999999999996 112.681 177.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.73 149.18 36.37 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 106.527 -1.657 . . . . 71.519999999999996 106.527 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 46.0 m . . . . . 0 C--N 1.301 -1.525 0 N-CA-C 113.655 0.983 . . . . 72.540000000000006 113.655 -173.767 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 108.3 -1.0 . . . . 75.150000000000006 108.3 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -77.4 164.9 25.06 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 121.043 0.449 . . . . 74.209999999999994 110.521 173.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 57.6 p -159.42 166.78 30.3 Favored 'General case' 0 N--CA 1.403 -2.818 0 CA-C-N 115.036 -0.984 . . . . 64.530000000000001 109.347 -177.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -157.55 151.8 24.74 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 109.85 -0.426 . . . . 63.25 109.85 -178.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 11.0 tt -122.18 123.14 68.22 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 CA-C-N 115.699 -0.682 . . . . 62.200000000000003 109.444 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 4.3 t -113.73 130.68 67.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 115.818 -0.628 . . . . 63.520000000000003 111.447 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 17.7 p -108.75 114.19 27.77 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 108.357 -0.979 . . . . 73.5 108.357 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 45.1 t -100.83 115.39 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 107.549 -1.278 . . . . 74.510000000000005 107.549 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -117.35 -174.68 2.65 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 121.014 -0.274 . . . . 72.510000000000005 110.471 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 38.1 t -61.37 128.71 37.65 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 122.976 0.51 . . . . 64.319999999999993 110.749 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -163.12 -177.66 36.27 Favored Glycine 0 CA--C 1.495 -1.158 0 C-N-CA 120.701 -0.761 . . . . 38.479999999999997 111.498 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.9 t -81.94 -38.91 16.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.403 0.621 . . . . 74.129999999999995 110.445 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -155.92 162.03 40.45 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.12 -0.696 . . . . 75.319999999999993 109.12 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 16.7 m120 -63.17 102.88 0.42 Allowed 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.594 1.184 . . . . 71.420000000000002 109.024 177.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -133.09 139.24 47.03 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.491 -1.3 . . . . 74.400000000000006 107.491 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 30.6 mm -89.06 110.61 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 N-CA-C 106.75 -1.574 . . . . 52.439999999999998 106.75 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 57.2 t -80.76 -44.78 21.5 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.688 0 CA-C-N 115.755 -0.657 . . . . 54.409999999999997 112.464 -173.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 35.3 p -162.26 158.4 24.25 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 120.494 -0.483 . . . . 71.310000000000002 110.727 -176.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 4.2 p -141.56 115.42 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 N-CA-C 108.547 -0.908 . . . . 73.340000000000003 108.547 175.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 29.0 tp -120.57 135.79 54.99 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.029 -1.471 . . . . 73.319999999999993 107.029 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -87.98 123.52 32.78 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.431 -1.322 . . . . 75.5 107.431 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -82.19 -46.81 13.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.856 1.058 . . . . 74.349999999999994 113.856 -174.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -121.38 -74.36 0.62 Allowed 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.438 0.637 . . . . 64.230000000000004 110.839 -172.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -175.55 -10.12 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 126.114 1.766 . . . . 75.239999999999995 109.373 176.465 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 24.7 m -136.62 5.17 2.89 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 109.528 -0.545 . . . . 75.150000000000006 109.528 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 415' ' ' SER . 31.3 tt0 -136.22 126.02 25.68 Favored 'General case' 0 C--O 1.211 -0.972 0 CA-C-O 120.837 0.351 . . . . 72.420000000000002 111.55 -173.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 28.4 m-85 -113.7 141.15 47.6 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 116.055 -0.521 . . . . 73.340000000000003 110.719 -175.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -106.29 119.42 39.21 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.373 -0.973 . . . . 74.420000000000002 108.373 173.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.8 mt -119.45 135.4 59.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.366 -0.834 . . . . 74.040000000000006 111.255 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -99.7 139.3 35.57 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 109.489 -0.56 . . . . 73.420000000000002 109.489 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 81.5 mtp -141.82 164.68 29.53 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 109.858 -0.423 . . . . 75.120000000000005 109.858 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.7 mmtt -134.78 161.35 35.44 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.961 -1.126 . . . . 64.099999999999994 107.961 176.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 31.9 t -167.2 145.88 4.29 Favored Pre-proline 0 C--N 1.289 -2.043 0 O-C-N 123.97 0.794 . . . . 62.439999999999998 109.277 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.31 -24.68 43.24 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.245 1.963 . . . . 74.540000000000006 110.862 177.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.33 -19.59 59.53 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.222 -0.899 . . . . 64.540000000000006 110.658 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.244 0 CA-C-O 121.554 0.692 . . . . 70.120000000000005 109.458 -178.152 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 93.5 m . . . . . 0 N--CA 1.435 -1.215 0 N-CA-C 108.823 -0.806 . . . . 71.140000000000001 108.823 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 10.4 ptpp? -144.23 141.05 29.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 116.444 -0.344 . . . . 74.230000000000004 110.858 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -159.02 135.82 9.51 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.033 -0.729 . . . . 73.439999999999998 109.033 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.17 129.98 35.06 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.31 -0.405 . . . . 75.040000000000006 110.582 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . 0.44 HG23 HG13 ' A' ' 431' ' ' VAL . 33.3 mt -137.95 128.11 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 106.643 -1.614 . . . . 73.519999999999996 106.643 -175.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.58 14.45 49.95 Favored Glycine 0 C--N 1.302 -1.319 0 C-N-CA 120.34 -0.933 . . . . 71.200000000000003 113.171 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 99.57 -9.88 60.78 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.749 -0.739 . . . . 75.439999999999998 113.537 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -111.29 144.07 41.05 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 122.438 -0.448 . . . . 72.040000000000006 110.571 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 38.2 m -82.16 120.5 25.41 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 110.173 -0.306 . . . . 64.329999999999998 110.173 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.4 OUTLIER -91.29 135.89 33.49 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 109.278 -0.638 . . . . 72.120000000000005 109.278 173.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -131.93 127.48 36.47 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 123.547 0.529 . . . . 73.540000000000006 109.952 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.08 120.57 55.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 120.879 0.371 . . . . 72.019999999999996 110.522 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.7 t -115.17 116.96 54.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 N-CA-C 106.837 -1.542 . . . . 73.450000000000003 106.837 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . 0.441 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 28.4 m-85 -65.32 128.49 36.07 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 114.757 1.392 . . . . 73.530000000000001 114.757 -171.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 68.28 22.38 8.1 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 113.84 -1.527 . . . . 64.010000000000005 112.288 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -132.36 -79.8 0.5 Allowed 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.438 -0.801 . . . . 73.299999999999997 113.098 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.46 154.72 12.3 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.419 0.896 . . . . 72.140000000000001 113.419 -172.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 98.9 t -119.25 145.3 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.166 0.986 . . . . 75.030000000000001 109.024 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -134.26 145.59 49.27 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.965 0.412 . . . . 72.319999999999993 111.889 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -116.84 108.26 15.62 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.419 -1.697 . . . . 72.409999999999997 106.419 172.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.2 t70 71.67 -79.65 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 124.302 1.041 . . . . 75.319999999999993 109.931 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.0 m -144.73 -4.02 0.77 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.563 -0.903 . . . . 74.409999999999997 108.563 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 50.1 mm -84.09 136.67 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.442 -0.799 . . . . 73.530000000000001 109.486 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 64.5 tp -76.2 110.73 10.94 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.799 -1.186 . . . . 73.109999999999999 107.799 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.479 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.6 OUTLIER -73.61 -63.1 1.27 Allowed 'General case' 0 N--CA 1.385 -3.682 0 N-CA-C 108.552 -0.907 . . . . 72.150000000000006 108.552 -176.271 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.94 158.7 29.99 Favored Glycine 0 N--CA 1.417 -2.585 0 C-N-CA 119.064 -1.541 . . . . 75.209999999999994 111.595 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -106.64 142.21 36.65 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.106 -1.072 . . . . 73.409999999999997 108.106 177.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . 0.543 ' HD2' ' NE2' ' A' ' 395' ' ' GLN . 1.9 m-85 -65.99 115.96 6.61 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 123.465 0.478 . . . . 75.230000000000004 110.537 -176.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -105.65 -48.47 3.65 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.074 -0.512 . . . . 73.530000000000001 111.278 -176.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 56.6 m -155.07 139.87 17.16 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.677 -0.49 . . . . 72.329999999999998 109.677 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . 0.543 ' NE2' ' HD2' ' A' ' 392' ' ' PHE . 42.7 mt-30 -134.41 136.46 43.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.242 -1.392 . . . . 75.099999999999994 107.242 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -128.78 110.76 12.45 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 109.474 -0.565 . . . . 71.209999999999994 109.474 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 70.81 -118.57 7.68 Favored Glycine 0 N--CA 1.424 -2.125 0 N-CA-C 110.665 -0.974 . . . . 70.209999999999994 110.665 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 4.2 p-10 -107.29 21.81 16.94 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.446 0.641 . . . . 74.150000000000006 110.188 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 40.1 t -124.48 116.91 48.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 107.79 -1.189 . . . . 53.229999999999997 107.79 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . 0.439 ' CD2' ' HB3' ' A' ' 395' ' ' GLN . 11.2 mt -116.34 129.51 56.29 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.882 -0.599 . . . . 73.140000000000001 110.922 -169.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -105.03 122.02 45.0 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-O 121.06 0.457 . . . . 72.319999999999993 112.168 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -117.1 119.17 34.44 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 105.807 -1.923 . . . . 72.109999999999999 105.807 176.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -135.73 173.84 11.27 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.31 -0.626 . . . . 72.430000000000007 109.31 -174.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 12.9 m120 61.04 37.48 17.93 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.965 0.791 . . . . 62.32 112.503 175.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.58 -141.82 1.24 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.185 -0.531 . . . . 72.030000000000001 112.676 176.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.82 137.58 51.93 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.435 -0.95 . . . . 73.439999999999998 108.435 -175.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 C--N 1.312 -1.028 0 C-N-CA 123.65 0.78 . . . . 70.150000000000006 112.427 -177.015 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 . . . . . 0 CA--C 1.493 -1.243 0 N-CA-C 106.484 -1.673 . . . . 75.349999999999994 106.484 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.05 153.32 41.8 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.352 0.596 . . . . 73.109999999999999 111.996 174.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.9 p -159.1 160.83 36.14 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 114.698 -1.137 . . . . 64.030000000000001 108.908 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -155.39 148.0 24.13 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 109.744 -0.465 . . . . 75.420000000000002 109.744 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.9 tt -110.94 118.52 57.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.536 -0.913 . . . . 64.439999999999998 108.536 174.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 2.9 t -97.77 125.42 50.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 CA-C-O 121.457 0.646 . . . . 74.319999999999993 109.884 177.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 2.5 m -108.43 112.23 24.53 Favored 'General case' 0 N--CA 1.385 -3.707 0 N-CA-C 104.577 -2.379 . . . . 64.120000000000005 104.577 174.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 7.9 p -102.0 121.15 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 108.655 -0.868 . . . . 73.209999999999994 108.655 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -114.94 -174.4 2.48 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 116.289 -0.414 . . . . 60.409999999999997 110.362 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.631 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 22.6 t -60.57 128.16 35.24 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 123.367 0.667 . . . . 72.340000000000003 112.572 -176.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.06 -177.75 29.56 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.606 -0.807 . . . . 63.299999999999997 111.452 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.4 t -91.76 -34.2 6.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.851 -0.796 . . . . 73.25 108.851 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -148.88 148.06 29.42 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 115.694 -0.685 . . . . 73.540000000000006 109.197 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.738 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.1 p-10 -62.36 99.64 0.15 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.991 -1.004 . . . . 64.150000000000006 111.536 176.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -131.81 149.07 52.57 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.338 -0.847 . . . . 75.239999999999995 110.156 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 28.2 mm -82.09 119.53 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.198 -1.408 . . . . 73.0 107.198 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 66.0 t -83.69 -51.37 14.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 111.886 0.328 . . . . 74.030000000000001 111.886 -177.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 59.7 m -166.04 163.52 18.23 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.438 -0.579 . . . . 70.329999999999998 109.438 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.44 HG13 HG23 ' A' ' 369' ' ' ILE . 3.5 p -141.84 116.68 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 107.956 -1.127 . . . . 74.409999999999997 107.956 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 34.1 tp -112.16 133.13 54.48 Favored 'General case' 0 C--N 1.263 -3.156 0 N-CA-C 108.143 -1.058 . . . . 72.310000000000002 108.143 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -82.15 108.52 15.68 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.596 -1.261 . . . . 74.420000000000002 107.596 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -69.75 -53.26 19.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.865 0.841 . . . . 75.540000000000006 109.47 -177.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -120.1 -77.79 0.58 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.52 -1.218 . . . . 75.519999999999996 108.577 177.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . 0.48 ' HZ3' ' HB3' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -169.94 -47.36 0.02 OUTLIER 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 124.459 1.104 . . . . 74.409999999999997 110.383 174.258 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 82.0 m -91.99 5.3 50.67 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.723 0.773 . . . . 71.319999999999993 109.562 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -136.49 124.4 22.73 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.107 -0.951 . . . . 74.519999999999996 109.08 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 54.4 m-85 -122.56 151.22 41.61 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.016 -0.538 . . . . 75.040000000000006 110.118 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -110.53 124.95 52.78 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.299 -1.371 . . . . 71.400000000000006 107.299 170.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 98.4 mt -122.78 134.94 64.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 115.813 -0.63 . . . . 75.349999999999994 109.92 -175.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -106.84 140.81 39.08 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 108.776 -0.824 . . . . 73.140000000000001 108.776 177.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 82.7 mtp -138.02 164.14 29.81 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.032 -1.099 . . . . 63.240000000000002 108.032 177.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.738 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 34.2 mmtp -129.69 151.59 50.11 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 108.063 -1.088 . . . . 72.230000000000004 108.063 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 43.4 t -164.74 147.84 7.33 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.786 -0.82 . . . . 61.530000000000001 108.786 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.97 -27.22 66.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.072 1.848 . . . . 73.519999999999996 110.244 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -69.37 -22.26 63.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.232 -0.894 . . . . 74.109999999999999 110.876 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.933 0 CA-C-O 121.358 0.599 . . . . 72.349999999999994 109.944 -179.689 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' THR . . . . . 0.412 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 92.0 m . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 109.253 -0.647 . . . . 63.43 109.253 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 19.6 ptmt -144.2 145.03 31.82 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 121.21 -0.196 . . . . 73.010000000000005 111.209 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -160.76 136.89 8.4 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.223 -1.029 . . . . 74.420000000000002 108.223 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.05 125.31 31.98 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 110.017 -0.364 . . . . 63.420000000000002 110.017 -178.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 57.3 mt -130.57 116.27 34.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 107.29 -1.374 . . . . 71.049999999999997 107.29 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.6 15.09 63.59 Favored Glycine 0 C--N 1.306 -1.107 0 C-N-CA 121.063 -0.589 . . . . 60.200000000000003 112.498 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 109.09 -25.72 17.58 Favored Glycine 0 N--CA 1.427 -1.931 0 C-N-CA 120.401 -0.904 . . . . 65.340000000000003 112.578 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -97.77 135.84 38.96 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.007 0.432 . . . . 74.540000000000006 111.286 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 85.1 m -79.19 118.5 21.2 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.856 -0.611 . . . . 70.109999999999999 110.747 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.544 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -90.66 132.47 35.76 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 108.378 -0.971 . . . . 75.540000000000006 108.378 173.637 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -132.07 127.32 35.87 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.278 -0.638 . . . . 72.109999999999999 109.278 -176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . 0.412 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.5 p -125.72 118.37 51.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-O 121.053 0.454 . . . . 75.239999999999995 110.16 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.2 t -106.66 116.9 51.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 107.031 -1.47 . . . . 73.319999999999993 107.031 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -63.65 129.04 38.52 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 114.011 1.115 . . . . 74.510000000000005 114.011 -172.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 72.7 13.52 5.19 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 126.166 1.786 . . . . 75.030000000000001 112.371 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -124.11 -83.3 0.65 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 113.088 0.773 . . . . 72.219999999999999 113.088 176.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -159.05 164.9 35.03 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 112.542 0.571 . . . . 75.530000000000001 112.542 -170.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.424 HG21 ' CD2' ' A' ' 402' ' ' TYR . 72.7 t -126.88 142.16 44.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.242 -0.89 . . . . 64.310000000000002 108.837 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -132.97 151.6 52.04 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 122.957 0.503 . . . . 75.019999999999996 111.311 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -122.18 106.27 10.99 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 106.217 -1.771 . . . . 74.430000000000007 106.217 172.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.0 t70 70.76 -74.66 0.08 Allowed 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 124.87 1.268 . . . . 74.209999999999994 110.395 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 64.1 m -146.94 -7.2 0.49 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.75 -0.659 . . . . 55.329999999999998 110.155 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 40.1 mt -87.75 135.94 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 116.311 -0.404 . . . . 73.209999999999994 110.39 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.5 tp -75.93 120.74 21.68 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.528 0.68 . . . . 60.420000000000002 109.387 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.519 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -82.83 -64.39 1.18 Allowed 'General case' 0 N--CA 1.383 -3.777 0 N-CA-C 108.597 -0.89 . . . . 71.120000000000005 108.597 -177.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.13 162.34 33.12 Favored Glycine 0 N--CA 1.421 -2.306 0 C-N-CA 118.934 -1.603 . . . . 36.43 111.986 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -108.44 146.51 33.01 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.343 -1.354 . . . . 74.239999999999995 107.343 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -64.96 116.47 6.43 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 120.882 0.373 . . . . 64.420000000000002 111.555 -175.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -94.76 -49.07 5.77 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.049 -0.523 . . . . 71.549999999999997 111.308 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 21.4 p -169.02 140.37 2.46 Favored 'General case' 0 C--O 1.252 1.22 0 N-CA-C 110.127 -0.323 . . . . 75.540000000000006 110.127 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -142.39 140.55 32.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.217 0.532 . . . . 71.329999999999998 111.726 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -128.78 128.62 44.32 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 108.689 -0.856 . . . . 72.109999999999999 108.689 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 68.82 -101.53 0.8 Allowed Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 121.008 -0.615 . . . . 72.540000000000006 112.466 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 26.2 p-10 -130.49 11.8 5.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 111.981 0.363 . . . . 71.329999999999998 111.981 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 40.7 t -111.65 116.98 54.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.923 -1.14 . . . . 74.430000000000007 107.923 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.7 mt -114.83 131.45 56.82 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.553 -0.536 . . . . 65.409999999999997 109.553 -172.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -116.37 124.43 50.05 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.322 -0.992 . . . . 65.519999999999996 108.322 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.424 ' CD2' HG21 ' A' ' 382' ' ' VAL . 3.5 m-85 -114.22 136.19 53.23 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.48 -1.304 . . . . 70.439999999999998 107.48 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -144.09 176.4 9.34 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.585 -0.524 . . . . 72.299999999999997 109.585 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.96 36.24 12.75 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.837 0.68 . . . . 71.140000000000001 112.837 177.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -80.56 -141.65 2.87 Favored Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.25 -0.976 . . . . 64.209999999999994 111.243 175.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.34 134.83 40.92 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.097 -0.705 . . . . 74.200000000000003 109.097 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 37.8 m . . . . . 0 C--N 1.323 -0.549 0 N-CA-C 113.354 0.872 . . . . 74.099999999999994 113.354 -175.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' HIS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 99.8 m-70 . . . . . 0 CA--C 1.493 -1.218 0 N-CA-C 107.798 -1.186 . . . . 71.140000000000001 107.798 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -73.22 159.19 33.83 Favored 'General case' 0 C--O 1.257 1.448 0 CA-C-O 121.374 0.607 . . . . 75.140000000000001 111.604 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 33.2 p -162.18 163.56 28.31 Favored 'General case' 0 N--CA 1.406 -2.663 0 CA-C-N 114.488 -1.233 . . . . 74.329999999999998 109.121 -177.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -159.15 144.74 16.2 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.819 -0.437 . . . . 53.439999999999998 109.819 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.8 tt -109.62 125.12 66.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.099 -1.075 . . . . 72.450000000000003 108.099 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.9 t -111.09 131.19 63.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.87 -0.605 . . . . 73.230000000000004 110.895 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.84 113.8 26.65 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 106.058 -1.83 . . . . 75.0 106.058 175.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 23.6 t -101.18 112.62 34.72 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.517 0 N-CA-C 109.256 -0.646 . . . . 75.099999999999994 109.256 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -109.93 -176.25 2.95 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.745 -0.782 . . . . 75.540000000000006 110.965 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.438 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 32.4 t -60.67 128.08 34.82 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 123.568 0.747 . . . . 72.430000000000007 111.212 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -151.23 178.93 28.31 Favored Glycine 0 N--CA 1.428 -1.835 0 N-CA-C 110.086 -1.206 . . . . 74.140000000000001 110.086 177.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 41.3 t -93.8 -26.96 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.293 -1.002 . . . . 71.030000000000001 108.293 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -141.56 157.42 45.13 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 114.894 -1.048 . . . . 75.340000000000003 109.306 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -73.16 100.16 3.0 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 106.858 -1.534 . . . . 74.430000000000007 106.858 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -132.18 141.24 49.02 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 120.687 -0.405 . . . . 74.239999999999995 111.805 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . 0.41 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 27.3 mm -83.39 118.43 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 105.767 -1.938 . . . . 74.040000000000006 105.767 174.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 55.1 t -83.17 -50.65 15.39 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-O 121.042 0.449 . . . . 73.230000000000004 111.651 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 37.4 p -161.23 159.49 28.79 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.197 -0.456 . . . . 52.439999999999998 110.5 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . 0.474 HG21 ' HH ' ' A' ' 374' ' ' TYR . 3.3 p -142.15 122.86 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 108.829 -0.804 . . . . 52.049999999999997 108.829 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 30.2 tp -131.0 137.54 49.27 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.8 -1.185 . . . . 74.329999999999998 107.8 -177.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -81.45 116.97 21.5 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.578 -0.849 . . . . 64.120000000000005 108.789 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.31 -63.97 1.12 Allowed 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.392 -0.822 . . . . 74.329999999999998 110.722 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -106.23 -76.24 0.61 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.75 -0.659 . . . . 74.310000000000002 111.821 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -162.8 -30.35 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.048 0.452 . . . . 72.400000000000006 112.172 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 86.2 m -131.16 11.65 5.04 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.576 -0.898 . . . . 74.129999999999995 108.576 176.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 415' ' ' SER . 34.8 tt0 -131.79 129.62 40.76 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.119 -0.946 . . . . 54.109999999999999 108.985 -176.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -117.91 150.41 39.26 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.682 -0.69 . . . . 74.200000000000003 110.906 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -106.4 120.9 43.1 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.598 -1.26 . . . . 72.049999999999997 107.598 172.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.7 mt -124.14 128.7 74.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-N 115.41 -0.814 . . . . 71.430000000000007 109.746 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -104.27 140.69 37.5 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.873 -0.788 . . . . 74.420000000000002 108.873 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' MET . . . . . 0.41 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.3 mtp -135.08 167.47 20.9 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 109.409 -0.589 . . . . 74.340000000000003 109.409 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.438 ' HD2' ' O ' ' A' ' 422' ' ' CYS . 72.1 mmtt -133.24 156.28 47.83 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.299 -1.371 . . . . 75.340000000000003 107.299 174.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 38.3 t -163.77 145.44 7.31 Favored Pre-proline 0 C--N 1.278 -2.542 0 O-C-N 124.075 0.86 . . . . 61.409999999999997 109.11 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.4 -21.38 47.14 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.111 1.874 . . . . 42.32 110.646 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.12 -18.58 52.99 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.803 -0.635 . . . . 71.450000000000003 110.982 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.798 0 CA-C-O 121.376 0.608 . . . . 72.430000000000007 109.857 179.02 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 97.0 m . . . . . 0 N--CA 1.425 -1.724 0 N-CA-C 107.477 -1.305 . . . . 64.140000000000001 107.477 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 57.7 mtpt -133.32 143.54 49.08 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 116.239 -0.437 . . . . 72.200000000000003 110.529 -174.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -157.95 136.85 11.45 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.057 -1.09 . . . . 64.319999999999993 108.057 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 40.5 mt-10 -87.98 127.18 35.38 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.713 0.292 . . . . 75.239999999999995 110.233 -174.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 38.0 mt -136.96 120.76 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 106.793 -1.558 . . . . 62.109999999999999 106.793 -176.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.26 13.71 60.62 Favored Glycine 0 C--N 1.304 -1.21 0 C-N-CA 120.358 -0.925 . . . . 45.340000000000003 113.137 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.09 -17.73 40.7 Favored Glycine 0 N--CA 1.429 -1.832 0 C-N-CA 121.084 -0.579 . . . . 73.049999999999997 113.107 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -106.87 139.72 40.84 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 120.683 0.278 . . . . 65.230000000000004 110.333 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 37.4 m -83.83 122.01 28.11 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 116.259 -0.428 . . . . 62.310000000000002 110.166 -178.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' TYR . . . . . 0.6 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.54 129.07 36.73 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 109.301 -0.629 . . . . 73.409999999999997 109.301 176.615 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 83.9 tttt -122.48 125.23 45.36 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 123.887 0.742 . . . . 73.239999999999995 110.108 -175.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.24 118.22 47.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 N-CA-C 109.161 -0.681 . . . . 72.329999999999998 109.161 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 40.8 t -106.73 116.5 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 106.116 -1.809 . . . . 74.319999999999993 106.116 174.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -58.9 123.06 15.22 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 123.807 0.692 . . . . 74.209999999999994 112.503 -174.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 72.98 12.23 5.11 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.587 1.555 . . . . 73.549999999999997 113.385 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -123.24 -86.84 0.64 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 113.848 1.055 . . . . 70.409999999999997 113.848 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.54 169.05 20.41 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 119.392 -0.923 . . . . 73.120000000000005 110.322 -176.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 94.9 t -124.95 138.78 53.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 107.643 -1.243 . . . . 65.439999999999998 107.643 173.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -132.91 148.1 52.29 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.143 0.497 . . . . 73.219999999999999 110.785 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -115.28 100.07 7.86 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.387 -1.709 . . . . 63.409999999999997 106.387 173.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 13.4 t70 69.89 -78.37 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 125.248 1.419 . . . . 62.140000000000001 110.019 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 27.4 m -138.01 -5.69 1.67 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.082 -0.963 . . . . 62.509999999999998 109.287 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 47.8 mm -88.39 135.63 25.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.188 -0.46 . . . . 75.409999999999997 110.016 -177.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 62.9 tp -76.23 115.1 15.63 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.995 -1.113 . . . . 71.230000000000004 107.995 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' LEU . . . . . 0.5 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.6 OUTLIER -80.21 -60.52 2.3 Favored 'General case' 0 N--CA 1.388 -3.539 0 N-CA-C 108.762 -0.829 . . . . 73.430000000000007 108.762 -175.684 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.97 158.59 29.88 Favored Glycine 0 N--CA 1.413 -2.892 0 C-N-CA 119.295 -1.431 . . . . 72.510000000000005 111.417 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -102.24 143.97 31.36 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.659 -1.608 . . . . 74.439999999999998 106.659 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -69.27 116.82 10.14 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.013 0.435 . . . . 71.030000000000001 110.737 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.11 -47.56 5.45 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.772 -0.649 . . . . 75.349999999999994 110.962 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 65.9 p -168.47 143.67 3.49 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.898 -0.408 . . . . 75.140000000000001 109.898 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -143.08 136.98 28.85 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.743 0.306 . . . . 74.0 110.503 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -112.52 119.93 39.88 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.518 -0.919 . . . . 65.25 108.518 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.11 -101.67 0.63 Allowed Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 119.651 -1.262 . . . . 38.009999999999998 113.178 177.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -123.66 10.68 9.07 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.799 1.24 . . . . 73.319999999999993 111.132 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.34 116.69 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.015 0 N-CA-C 106.85 -1.537 . . . . 64.439999999999998 106.85 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 9.3 mt -113.61 131.61 56.05 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 115.966 -0.561 . . . . 74.019999999999996 110.962 -168.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -114.27 121.76 44.68 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-O 121.392 0.615 . . . . 72.329999999999998 112.349 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -118.25 139.02 51.95 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.537 -1.282 . . . . 75.420000000000002 107.537 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -141.46 173.42 11.51 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-O 121.466 0.65 . . . . 61.020000000000003 111.45 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 51.1 46.59 26.22 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.095 -1.866 . . . . 72.519999999999996 113.16 167.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.22 -132.98 0.57 Allowed Glycine 0 C--N 1.311 -0.831 0 CA-C-N 115.839 -0.618 . . . . 61.420000000000002 112.708 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.56 142.64 38.89 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.108 -1.442 . . . . 73.140000000000001 107.108 -176.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 27.4 t . . . . . 0 N--CA 1.431 -1.375 0 CA-C-O 121.806 0.812 . . . . 73.230000000000004 111.097 -178.458 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 108.782 -0.822 . . . . 75.010000000000005 108.782 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -74.33 160.53 30.94 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.34 0.59 . . . . 74.239999999999995 111.383 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 35.5 p -165.57 162.35 19.02 Favored 'General case' 0 N--CA 1.418 -2.058 0 C-N-CA 124.366 1.066 . . . . 74.329999999999998 108.246 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -158.74 151.11 21.6 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.303 0.573 . . . . 74.209999999999994 110.8 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 11.6 tt -114.37 131.11 67.37 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 CA-C-N 115.131 -0.94 . . . . 61.340000000000003 108.828 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 4.1 t -116.72 131.04 70.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-O 121.329 0.585 . . . . 74.340000000000003 111.926 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 62.2 p -108.02 114.97 29.27 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 107.641 -1.244 . . . . 72.120000000000005 107.641 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 39.6 t -100.19 111.87 31.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 107.545 -1.279 . . . . 62.549999999999997 107.545 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -113.52 -175.14 2.61 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 110.787 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' CYS . . . . . 0.407 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 43.6 t -60.42 128.66 37.76 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.815 -0.629 . . . . 72.120000000000005 111.224 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -154.36 178.59 31.09 Favored Glycine 0 CA--C 1.476 -2.377 0 N-CA-C 110.479 -1.048 . . . . 64.25 110.479 177.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 56.0 t -90.41 -33.79 6.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 108.282 -1.007 . . . . 70.340000000000003 108.282 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -150.66 152.66 34.32 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.698 -0.683 . . . . 73.010000000000005 109.768 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.3 p-10 -60.1 98.83 0.06 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.597 -1.183 . . . . 55.210000000000001 112.427 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -133.08 146.85 52.04 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.038 -0.528 . . . . 71.310000000000002 111.783 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 31.3 mm -80.17 119.87 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 105.449 -2.056 . . . . 75.219999999999999 105.449 171.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 54.6 t -84.55 -51.16 14.2 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.867 0 N-CA-C 112.112 0.412 . . . . 63.420000000000002 112.112 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 32.6 p -160.86 162.71 32.25 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.814 -0.354 . . . . 73.510000000000005 110.837 -174.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 4.8 p -142.12 111.87 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 108.966 -0.753 . . . . 75.040000000000006 108.966 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 34.9 tp -113.97 136.45 52.89 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 108.765 -0.828 . . . . 74.430000000000007 108.765 -177.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.66 113.8 19.91 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.837 -0.801 . . . . 75.219999999999999 108.837 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.14 -70.42 0.39 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.294 -0.632 . . . . 71.030000000000001 109.294 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -100.0 -75.83 0.56 Allowed 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.551 -0.75 . . . . 75.310000000000002 109.966 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.1 -51.07 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.461 0.648 . . . . 73.25 110.437 175.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 64.3 m -100.52 13.19 35.44 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.204 -0.907 . . . . 72.5 109.019 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 415' ' ' SER . 33.4 tt0 -135.22 124.85 25.16 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-N 115.185 -0.916 . . . . 61.350000000000001 108.873 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -123.01 150.18 43.37 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.142 -0.936 . . . . 75.230000000000004 109.567 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -109.22 121.37 45.02 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.252 -1.018 . . . . 63.299999999999997 108.252 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 97.1 mt -118.08 135.25 59.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.211 -0.904 . . . . 75.120000000000005 110.012 -175.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -109.26 141.42 41.57 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 109.5 -0.556 . . . . 64.420000000000002 109.5 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 82.1 mtp -136.38 162.81 32.01 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 108.995 -0.743 . . . . 75.219999999999999 108.995 178.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 70.1 mmtt -132.87 151.49 52.02 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.164 -1.05 . . . . 73.219999999999999 108.164 176.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 68.1 m -161.24 149.15 12.44 Favored Pre-proline 0 C--N 1.295 -1.792 0 O-C-N 123.865 0.728 . . . . 70.239999999999995 109.945 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.44 -27.76 62.48 Favored 'Trans proline' 0 N--CA 1.48 0.695 0 C-N-CA 122.724 2.283 . . . . 74.420000000000002 111.95 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.58 -22.25 57.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.6 -0.727 . . . . 74.319999999999993 110.643 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.857 0 CA-C-N 115.528 -0.76 . . . . 65.049999999999997 111.049 -175.461 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.438 ' HB3' ' HB3' ' A' ' 398' ' ' ASN . 89.6 m-85 . . . . . 0 C--O 1.223 -0.312 0 N-CA-C 110.31 -0.255 . . . . 75.049999999999997 110.31 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.401 ' HD2' ' C ' ' A' ' 357' ' ' TYR . 6.4 mpt_? -134.76 173.84 11.24 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.87 -0.418 . . . . 75.040000000000006 109.87 176.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -135.84 151.75 50.36 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.877 -1.527 . . . . 74.25 106.877 174.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 25.2 mm -81.19 115.76 24.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 119.923 -0.711 . . . . 75.230000000000004 109.75 -172.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.562 ' H ' ' HD3' ' A' ' 361' ' ' LYS . 0.3 OUTLIER -79.77 141.26 36.47 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 112.466 0.543 . . . . 73.439999999999998 112.466 -176.219 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 94.41 -27.54 13.44 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.471 -0.786 . . . . 61.310000000000002 113.575 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 72.6 mtp -74.79 146.89 41.72 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.744 1.016 . . . . 75.319999999999993 113.744 -177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -93.5 126.29 38.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.493 -1.231 . . . . 74.040000000000006 107.77 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' THR . . . . . 0.453 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 90.7 m -117.53 125.58 51.1 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 107.302 -1.369 . . . . 73.329999999999998 107.302 173.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 17.1 ptmt -139.16 141.18 38.02 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 121.099 -0.24 . . . . 72.219999999999999 110.913 -174.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -156.94 138.4 13.94 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.276 -1.379 . . . . 62.240000000000002 107.276 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -86.42 126.84 34.67 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.141 -0.689 . . . . 73.120000000000005 109.141 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.41 HG23 HG13 ' A' ' 431' ' ' VAL . 39.8 mt -137.17 124.6 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 106.654 -1.609 . . . . 75.319999999999993 106.654 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.58 8.47 46.58 Favored Glycine 0 C--N 1.301 -1.393 0 C-N-CA 120.91 -0.662 . . . . 73.540000000000006 113.233 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.09 -14.74 44.24 Favored Glycine 0 N--CA 1.426 -1.978 0 C-N-CA 120.702 -0.761 . . . . 62.140000000000001 112.684 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . 0.422 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 17.3 p90 -106.39 141.4 37.78 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 120.839 0.352 . . . . 74.439999999999998 110.134 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 51.3 m -83.52 120.24 25.69 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 116.18 -0.463 . . . . 73.420000000000002 109.895 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.66 134.21 34.57 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 108.612 -0.885 . . . . 75.310000000000002 108.612 174.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -133.41 125.01 28.15 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.104 -0.702 . . . . 72.549999999999997 109.104 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.453 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.6 p -121.05 122.54 67.89 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 N-CA-C 109.197 -0.668 . . . . 70.310000000000002 109.197 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.4 t -110.53 116.71 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 106.902 -1.518 . . . . 73.530000000000001 106.902 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -62.92 126.56 27.74 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.119 1.155 . . . . 75.230000000000004 114.119 -172.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 72.85 8.51 5.5 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.173 1.789 . . . . 72.400000000000006 113.276 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -116.68 -85.56 0.63 Allowed 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 112.969 0.729 . . . . 75.0 112.969 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.406 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.5 OUTLIER -162.32 162.75 28.11 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.875 -0.602 . . . . 75.340000000000003 112.254 -171.336 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 66.5 t -122.58 144.86 30.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.049 -0.978 . . . . 73.329999999999998 109.585 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.406 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 62.8 m-85 -133.94 148.33 51.17 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 123.094 0.558 . . . . 72.430000000000007 111.595 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -119.47 103.51 9.51 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.818 -1.919 . . . . 63.219999999999999 105.818 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.5 t70 69.15 -86.44 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 123.962 0.905 . . . . 75.120000000000005 109.587 -175.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.6 m -135.37 -2.66 2.46 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.935 -0.765 . . . . 73.209999999999994 108.935 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 62.8 mt -83.13 132.66 30.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.93 -0.577 . . . . 74.239999999999995 109.781 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.2 tp -76.66 115.54 16.51 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.6 -0.889 . . . . 72.319999999999993 108.6 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.527 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -79.69 -66.09 0.92 Allowed 'General case' 0 N--CA 1.39 -3.455 0 N-CA-C 108.934 -0.765 . . . . 74.099999999999994 108.934 -177.229 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.77 160.15 31.65 Favored Glycine 0 N--CA 1.413 -2.836 0 C-N-CA 118.925 -1.607 . . . . 54.350000000000001 111.604 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -104.36 145.28 30.49 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.362 -1.347 . . . . 75.230000000000004 107.362 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -66.6 116.66 7.78 Favored 'General case' 0 C--N 1.288 -2.088 0 O-C-N 123.351 0.407 . . . . 75.239999999999995 110.774 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -101.93 -48.11 4.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.107 -0.497 . . . . 75.420000000000002 111.227 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 51.3 m -159.5 141.42 13.31 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.945 -0.391 . . . . 74.430000000000007 109.945 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . 0.416 ' OE1' HD21 ' A' ' 400' ' ' LEU . 9.9 pt20 -144.37 140.47 29.08 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 120.97 0.414 . . . . 74.129999999999995 111.888 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -128.05 119.43 25.39 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.493 -0.776 . . . . 75.329999999999998 110.416 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 74.72 -101.28 1.28 Allowed Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 115.681 -0.691 . . . . 75.230000000000004 111.736 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 4.4 p-10 -131.79 15.96 4.79 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.401 0.619 . . . . 73.310000000000002 110.071 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 46.9 t -116.71 119.15 61.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 106.874 -1.528 . . . . 75.310000000000002 106.874 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.461 ' HB2' ' HH ' ' A' ' 402' ' ' TYR . 9.9 mt -118.04 130.74 56.35 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 116.207 -0.451 . . . . 72.040000000000006 110.808 -170.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -105.02 122.99 47.02 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 112.275 0.472 . . . . 74.219999999999999 112.275 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.461 ' HH ' ' HB2' ' A' ' 400' ' ' LEU . 2.2 m-85 -118.84 132.92 56.13 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.887 -1.153 . . . . 75.319999999999993 107.887 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -147.19 177.58 9.07 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 122.582 0.353 . . . . 72.409999999999997 110.179 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.5 m120 66.67 36.63 4.66 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.605 0.566 . . . . 74.049999999999997 111.226 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -79.88 -138.07 1.78 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 120.582 -0.818 . . . . 73.209999999999994 112.824 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.22 143.18 32.5 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.638 -0.505 . . . . 63.119999999999997 109.638 -178.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.7 m -60.68 128.47 36.73 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.82 1.044 . . . . 73.239999999999995 113.82 -176.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 19.4 p -132.18 159.07 40.07 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.827 -1.175 . . . . 63.310000000000002 107.827 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -85.81 147.51 26.27 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 118.03 0.377 . . . . 75.430000000000007 111.519 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 77.43 9.83 2.48 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.737 1.615 . . . . 71.200000000000003 109.914 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -152.51 166.0 31.1 Favored Glycine 0 N--CA 1.419 -2.469 0 N-CA-C 106.312 -2.715 . . . . 52.43 106.312 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.98 -40.52 0.22 Allowed 'Trans proline' 0 C--N 1.322 -0.847 0 CA-C-N 120.56 2.18 . . . . 74.319999999999993 111.409 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -163.82 165.4 22.98 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 105.681 -1.97 . . . . 61.219999999999999 105.681 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -63.77 160.49 17.12 Favored 'General case' 0 C--O 1.254 1.313 0 CA-C-O 121.467 0.651 . . . . 75.0 112.662 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.623 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 46.7 t -161.13 159.66 29.31 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 114.539 -1.209 . . . . 74.129999999999995 107.814 -176.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -159.78 149.93 18.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 120.852 0.358 . . . . 71.109999999999999 110.127 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.8 tt -110.63 123.8 66.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.737 -1.208 . . . . 62.210000000000001 107.737 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.3 t -106.28 126.25 61.92 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 CA-C-O 121.164 0.507 . . . . 73.420000000000002 109.924 176.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 3.6 m -108.64 112.95 25.56 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 105.819 -1.919 . . . . 64.530000000000001 105.819 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 40.6 t -100.8 112.0 32.26 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.94 0 N-CA-C 107.101 -1.444 . . . . 74.310000000000002 107.101 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -110.9 -175.37 2.7 Favored 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 120.228 -0.589 . . . . 75.209999999999994 111.4 -175.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.464 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 38.9 t -59.92 128.01 34.76 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 123.503 0.721 . . . . 74.319999999999993 110.46 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -158.76 -176.93 31.36 Favored Glycine 0 CA--C 1.492 -1.385 0 N-CA-C 110.964 -0.855 . . . . 74.129999999999995 110.964 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 42.3 t -94.38 -31.29 4.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-O 121.225 0.536 . . . . 61.210000000000001 109.615 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.84 161.09 40.77 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 116.002 -0.545 . . . . 63.340000000000003 109.559 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.525 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.1 p-10 -73.03 98.58 2.55 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 124.311 1.007 . . . . 74.530000000000001 110.398 175.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -132.44 148.22 52.4 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.912 -0.586 . . . . 74.109999999999999 110.754 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.448 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 28.2 mm -84.36 124.03 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.963 -1.866 . . . . 74.430000000000007 105.963 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 51.9 t -92.55 -47.99 13.7 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 112.888 0.699 . . . . 73.019999999999996 112.888 -175.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 42.9 m -158.67 155.64 28.49 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.735 -0.469 . . . . 71.430000000000007 109.735 -173.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.41 HG13 HG23 ' A' ' 369' ' ' ILE . 3.2 p -141.3 111.9 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 108.672 -0.862 . . . . 74.400000000000006 108.672 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 32.0 tp -117.71 137.74 52.48 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 114.96 -1.018 . . . . 72.430000000000007 108.507 -175.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -80.58 112.59 18.08 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.962 -0.755 . . . . 73.439999999999998 108.962 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -73.75 -49.79 23.78 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 115.54 -0.755 . . . . 65.319999999999993 110.216 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -126.14 -76.2 0.58 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.166 -0.924 . . . . 75.25 108.993 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.95 -41.31 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 121.043 0.449 . . . . 73.239999999999995 110.787 173.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 98.6 m -96.84 -16.88 20.54 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.324 0.583 . . . . 72.329999999999998 110.114 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 415' ' ' SER . 37.3 tt0 -112.72 132.31 55.27 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.979 -1.01 . . . . 71.340000000000003 109.691 -177.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -125.68 150.16 47.87 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.543 -0.753 . . . . 73.420000000000002 109.273 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -105.47 117.16 33.32 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.566 -0.901 . . . . 75.200000000000003 108.566 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.6 mt -114.91 132.25 64.7 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 115.093 -0.958 . . . . 73.219999999999999 109.628 -176.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -109.31 140.16 43.34 Favored 'General case' 0 N--CA 1.408 -2.53 0 N-CA-C 108.51 -0.922 . . . . 75.109999999999999 108.51 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.448 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 77.0 mtp -138.08 168.41 19.78 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 108.484 -0.932 . . . . 74.549999999999997 108.484 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.7 mmtt -134.5 156.45 48.59 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.292 -1.003 . . . . 74.25 108.292 175.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 74.3 m -162.95 147.32 9.08 Favored Pre-proline 0 C--N 1.289 -2.04 0 C-N-CA 124.291 1.036 . . . . 73.430000000000007 109.394 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -66.14 -27.25 49.31 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.324 2.016 . . . . 71.019999999999996 111.757 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -78.72 -15.6 58.25 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.748 -0.66 . . . . 74.019999999999996 110.79 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -93.21 10.3 32.43 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.68 0.752 . . . . 72.200000000000003 109.913 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 7.9 t -106.6 119.67 39.91 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 106.359 -1.719 . . . . 63.399999999999999 106.359 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 26.9 t . . . . . 0 CA--C 1.553 1.06 0 O-C-N 123.991 0.807 . . . . 75.310000000000002 109.794 -176.227 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 54.6 p90 . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 120.688 0.28 . . . . 74.219999999999999 111.041 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.427 ' HA ' ' NE ' ' A' ' 358' ' ' ARG . 3.4 mmp_? -125.94 177.25 6.44 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.848 0.832 . . . . 73.310000000000002 112.29 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -143.98 151.57 39.92 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 104.057 -2.571 . . . . 73.420000000000002 104.057 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . 0.415 ' N ' HD11 ' A' ' 360' ' ' ILE . 1.8 mp -81.14 115.63 24.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 119.445 1.02 . . . . 72.109999999999999 110.256 -172.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.507 ' HA ' ' HB2' ' A' ' 378' ' ' PHE . 21.0 pttp -90.96 151.69 20.99 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.16 -1.382 . . . . 74.319999999999993 112.764 -172.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 79.74 -24.11 3.38 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 115.702 -0.681 . . . . 62.219999999999999 113.137 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 56.9 ttp -73.56 -29.27 62.32 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 123.143 0.577 . . . . 74.340000000000003 110.225 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.441 ' HG2' HG21 ' A' ' 377' ' ' VAL . 42.0 mt-10 70.72 146.97 0.07 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.145 1.378 . . . . 73.510000000000005 109.783 -176.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' THR . . . . . 0.47 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 95.7 m -124.59 120.92 33.3 Favored 'General case' 0 C--N 1.265 -3.083 0 N-CA-C 107.711 -1.218 . . . . 74.120000000000005 107.711 171.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 0.0 OUTLIER -136.26 141.51 43.9 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.963 -0.695 . . . . 74.299999999999997 110.404 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -159.71 140.34 12.18 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.518 0.511 . . . . 73.340000000000003 110.313 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -76.34 123.92 26.7 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 110.115 -0.328 . . . . 64.439999999999998 110.115 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 48.6 mt -129.52 117.52 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 N-CA-C 106.194 -1.78 . . . . 73.25 106.194 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.73 14.01 62.14 Favored Glycine 0 C--N 1.304 -1.219 0 C-N-CA 120.781 -0.723 . . . . 53.509999999999998 112.244 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.1 -22.05 32.22 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 121.279 -0.486 . . . . 62.340000000000003 112.981 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -98.35 135.83 39.38 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 120.916 0.389 . . . . 73.040000000000006 111.204 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 85.4 m -79.86 114.54 18.85 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.765 -0.652 . . . . 73.409999999999997 110.224 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -91.46 132.92 35.91 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 108.563 -0.903 . . . . 72.340000000000003 108.563 176.344 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.472 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 37.6 ttpt -132.01 132.31 43.31 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 120.273 -0.571 . . . . 72.349999999999994 110.594 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.47 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.0 p -122.65 118.42 55.05 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 CA-C-N 115.844 -0.616 . . . . 71.329999999999998 110.076 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.441 HG21 ' HG2' ' A' ' 364' ' ' GLU . 21.6 t -107.54 116.02 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 106.768 -1.568 . . . . 65.150000000000006 106.768 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.507 ' HB2' ' HA ' ' A' ' 361' ' ' LYS . 98.0 m-85 -64.18 132.56 50.74 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 113.522 0.934 . . . . 73.310000000000002 113.522 -173.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 65.18 23.66 12.31 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.053 -1.431 . . . . 75.510000000000005 112.286 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -136.49 -83.46 0.37 Allowed 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.505 -0.77 . . . . 71.310000000000002 112.914 176.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.426 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -165.81 160.03 16.65 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.569 0.951 . . . . 72.400000000000006 113.569 -173.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 95.9 t -116.21 146.3 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.595 1.158 . . . . 72.319999999999993 109.521 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.426 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 85.8 m-85 -134.83 152.36 51.69 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.316 0.646 . . . . 71.510000000000005 111.646 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.408 ' HB2' HD21 ' A' ' 389' ' ' LEU . 29.1 tt0 -127.63 106.68 9.32 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.337 -1.727 . . . . 70.450000000000003 106.337 171.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.5 t70 69.44 -83.35 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 124.175 0.99 . . . . 54.130000000000003 110.52 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 45.5 m -135.85 -5.49 2.18 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.961 -0.755 . . . . 72.030000000000001 108.961 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 49.7 mm -89.21 132.63 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.497 -0.774 . . . . 65.319999999999993 110.565 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 57.7 tp -76.41 116.12 16.8 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.309 -0.997 . . . . 73.329999999999998 108.309 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.463 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -79.44 -62.63 1.63 Allowed 'General case' 0 N--CA 1.393 -3.287 0 N-CA-C 109.03 -0.73 . . . . 74.349999999999994 109.03 -176.535 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.56 160.87 32.23 Favored Glycine 0 N--CA 1.42 -2.422 0 C-N-CA 119.335 -1.412 . . . . 75.239999999999995 111.903 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -104.73 151.31 23.89 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.662 -1.236 . . . . 73.519999999999996 107.662 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.41 116.75 11.11 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 121.341 0.591 . . . . 74.150000000000006 111.876 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -95.81 -47.18 6.27 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.318 -0.855 . . . . 75.430000000000007 110.541 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 38.3 t -164.95 139.27 5.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.461 -0.57 . . . . 64.109999999999999 109.461 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . 0.505 ' CB ' ' HG ' ' A' ' 400' ' ' LEU . 5.7 pm0 -141.98 129.71 21.62 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.556 -0.747 . . . . 73.319999999999993 110.621 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -128.37 127.07 41.94 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.294 -1.002 . . . . 74.129999999999995 108.294 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.93 -117.79 9.65 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.986 -0.625 . . . . 73.010000000000005 112.011 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -116.63 20.3 14.12 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.357 0.598 . . . . 75.219999999999999 110.773 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 67.4 t -124.91 128.88 73.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.45 -0.944 . . . . 75.409999999999997 108.45 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.505 ' HG ' ' CB ' ' A' ' 395' ' ' GLN . 3.9 mp -126.51 140.39 52.49 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 116.455 -0.339 . . . . 72.209999999999994 111.099 -175.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -116.68 124.88 50.78 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.132 0.573 . . . . 74.219999999999999 111.133 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.467 ' HH ' ' HB2' ' A' ' 400' ' ' LEU . 3.8 m-85 -118.16 136.19 53.77 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.061 -0.718 . . . . 73.319999999999993 109.061 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.25 178.03 8.91 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 122.654 0.382 . . . . 74.530000000000001 110.653 178.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.2 m120 66.58 33.61 6.46 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.079 0.552 . . . . 51.210000000000001 111.684 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.15 -130.4 0.44 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 120.424 -0.893 . . . . 64.099999999999994 113.051 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.78 147.53 30.45 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.402 -1.703 . . . . 75.349999999999994 106.402 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.8 m -60.18 137.8 58.04 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.839 0.828 . . . . 72.400000000000006 112.806 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 45.5 t -107.62 157.98 17.63 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.633 -1.988 . . . . 73.049999999999997 105.633 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' TRP . . . . . 0.457 ' CE2' ' HB3' ' A' ' 410' ' ' ASN . 7.6 p-90 -76.42 -51.27 12.16 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 118.866 -1.133 . . . . 73.109999999999999 112.112 -172.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . 0.607 ' OD1' ' HG3' ' A' ' 436' ' ' LYS . 9.3 p30 -92.69 -3.96 54.0 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.261 0.553 . . . . 74.540000000000006 111.071 -174.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -124.82 -174.41 13.99 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 108.919 -1.672 . . . . 54.439999999999998 108.919 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -84.11 -41.49 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.249 0 CA-C-N 120.275 2.038 . . . . 61.450000000000003 112.417 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -160.97 170.68 20.09 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.358 -0.979 . . . . 74.030000000000001 108.358 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -76.7 165.08 25.24 Favored 'General case' 0 C--O 1.251 1.157 0 O-C-N 123.597 0.561 . . . . 74.340000000000003 111.5 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 22.9 p -161.79 165.3 28.09 Favored 'General case' 0 N--CA 1.411 -2.397 0 CA-C-N 114.548 -1.205 . . . . 72.239999999999995 109.235 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -159.54 151.05 20.08 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.422 0.629 . . . . 72.099999999999994 110.546 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.4 tt -114.37 131.56 66.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-N 115.333 -0.848 . . . . 75.200000000000003 109.102 173.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 4.7 t -119.96 125.71 74.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-O 121.335 0.588 . . . . 73.329999999999998 110.97 177.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 21.3 p -109.77 114.59 28.3 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.091 -0.959 . . . . 73.239999999999995 108.952 174.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 37.5 t -100.48 112.48 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 108.284 -1.006 . . . . 63.119999999999997 108.284 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -110.53 -174.6 2.52 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 116.566 -0.288 . . . . 70.239999999999995 110.571 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.529 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 30.4 t -57.36 128.33 36.49 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.626 0.771 . . . . 73.129999999999995 111.678 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -154.94 -177.62 28.42 Favored Glycine 0 CA--C 1.478 -2.233 0 C-N-CA 120.467 -0.873 . . . . 72.150000000000006 111.806 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.0 t -87.34 -36.01 9.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.64 -0.874 . . . . 75.129999999999995 108.64 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -157.62 162.17 38.69 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.566 -0.901 . . . . 74.040000000000006 108.566 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 3.9 m120 -61.77 102.36 0.26 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.485 0.659 . . . . 63.409999999999997 111.41 173.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -131.9 148.28 52.53 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.938 -1.028 . . . . 71.230000000000004 109.687 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 27.0 mm -89.05 114.83 27.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 105.87 -1.9 . . . . 72.310000000000002 105.87 175.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 53.0 t -83.02 -51.27 14.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 CA-C-N 116.112 -0.494 . . . . 65.0 112.217 -174.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 49.2 m -155.36 154.45 32.03 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.7 -0.481 . . . . 64.530000000000001 109.7 -174.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 5.6 p -141.8 122.83 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 109.079 -0.711 . . . . 74.239999999999995 109.079 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 29.4 tp -131.25 136.81 48.53 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 107.385 -1.339 . . . . 74.150000000000006 107.385 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -83.56 122.14 28.16 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.977 -1.49 . . . . 75.400000000000006 106.977 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -82.92 -49.83 9.22 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.81 1.041 . . . . 74.129999999999995 113.81 -173.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -116.23 -70.26 0.81 Allowed 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.064 -0.654 . . . . 72.340000000000003 110.616 -170.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.607 ' HG3' ' OD1' ' A' ' 410' ' ' ASN . 0.0 OUTLIER -172.99 -24.27 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 125.058 1.343 . . . . 74.400000000000006 109.359 178.371 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 29.9 m -135.59 13.23 3.46 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.733 -0.84 . . . . 75.310000000000002 108.733 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 415' ' ' SER . 24.2 tt0 -136.68 119.22 15.91 Favored 'General case' 0 C--O 1.204 -1.317 0 N-CA-C 112.481 0.549 . . . . 63.329999999999998 112.481 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 26.9 m-85 -104.12 146.45 28.72 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.944 -0.571 . . . . 73.239999999999995 110.953 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -108.53 120.24 41.85 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.252 -1.018 . . . . 75.239999999999995 108.252 172.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.6 mt -120.01 131.55 72.09 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 115.259 -0.882 . . . . 74.299999999999997 110.793 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -98.56 138.32 35.93 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 108.5 -0.926 . . . . 65.120000000000005 108.5 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 80.7 mtp -138.79 164.67 29.01 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 109.988 -0.375 . . . . 74.439999999999998 109.988 177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 32.7 mmtp -133.24 160.56 36.92 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.497 -0.557 . . . . 64.129999999999995 109.497 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' SER . . . . . 0.468 ' HB2' ' ND2' ' A' ' 426' ' ' ASN . 42.7 t -163.75 142.08 6.04 Favored Pre-proline 0 C--N 1.304 -1.394 0 O-C-N 124.036 0.835 . . . . 75.519999999999996 109.041 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -68.16 -26.19 36.59 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 121.973 1.782 . . . . 73.409999999999997 109.676 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.8 -7.55 58.74 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.922 -1.035 . . . . 61.229999999999997 110.652 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -108.35 12.71 26.16 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.311 0.577 . . . . 71.439999999999998 109.636 176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 422' ' ' CYS . 37.1 t -102.02 120.58 40.64 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-O 121.357 0.598 . . . . 72.109999999999999 111.757 -174.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 106.74 -1.578 . . . . 62.439999999999998 106.74 175.502 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 . . . . . 0 CA--C 1.512 -0.512 0 N-CA-C 110.451 -0.203 . . . . 74.400000000000006 110.451 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -138.94 179.01 6.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.185 0.517 . . . . 75.519999999999996 111.397 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -143.3 153.17 42.49 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.24 -1.393 . . . . 70.400000000000006 107.24 176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 36.0 mm -80.48 127.51 39.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.469 -0.937 . . . . 65.209999999999994 108.469 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.483 ' HG3' ' CE1' ' A' ' 379' ' ' TYR . 0.4 OUTLIER -71.64 128.17 34.93 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.86 0.362 . . . . 74.120000000000005 111.242 -178.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . 0.421 ' H ' ' HB2' ' A' ' 378' ' ' PHE . . . 75.79 -99.6 1.26 Allowed Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 110.798 -0.921 . . . . 38.159999999999997 110.798 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 10.6 tmm? 50.04 -45.52 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 129.497 3.119 . . . . 72.310000000000002 115.754 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 78.24 113.5 0.07 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.009 1.723 . . . . 73.329999999999998 112.155 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' THR . . . . . 0.45 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 58.0 m -119.33 136.55 54.21 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.266 -0.642 . . . . 71.349999999999994 109.266 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 18.2 ptpt -144.6 145.29 31.71 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 123.082 0.239 . . . . 74.540000000000006 111.441 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -159.4 133.71 7.7 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.556 -1.276 . . . . 71.530000000000001 107.556 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 44.2 mt-10 -84.6 125.6 32.6 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.578 -0.527 . . . . 74.409999999999997 109.578 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 47.8 mt -131.08 118.21 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 107.544 -1.28 . . . . 71.340000000000003 107.544 -174.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 67.06 13.16 61.5 Favored Glycine 0 C--N 1.313 -0.718 0 C-N-CA 120.936 -0.65 . . . . 62.210000000000001 112.365 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 112.89 -29.29 8.2 Favored Glycine 0 N--CA 1.417 -2.58 0 C-N-CA 120.946 -0.645 . . . . 74.329999999999998 112.595 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . 0.415 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 20.8 p90 -98.4 140.33 32.82 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 120.914 0.388 . . . . 75.049999999999997 111.314 -175.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 36.9 m -81.12 118.19 22.32 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 116.012 -0.54 . . . . 74.310000000000002 110.037 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.5 129.89 36.62 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 108.621 -0.881 . . . . 71.409999999999997 108.621 173.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -131.24 128.5 40.02 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.371 -0.532 . . . . 72.230000000000004 109.969 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.45 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.6 p -124.17 117.85 52.03 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-O 121.325 0.583 . . . . 73.129999999999995 109.576 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.48 116.47 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.378 -1.341 . . . . 73.510000000000005 107.378 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.451 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 91.9 m-85 -60.52 131.03 49.46 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.499 0.926 . . . . 70.450000000000003 113.499 -172.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.483 ' CE1' ' HG3' ' A' ' 361' ' ' LYS . 95.3 m-85 68.99 9.49 7.44 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 124.996 1.318 . . . . 73.219999999999999 112.612 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -120.82 -84.32 0.66 Allowed 'General case' 0 C--O 1.239 0.552 0 N-CA-C 113.164 0.801 . . . . 71.340000000000003 113.164 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.488 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -166.94 158.76 12.79 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.09 0.774 . . . . 74.109999999999999 113.09 -173.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 92.0 t -114.1 146.35 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.992 -1.003 . . . . 75.140000000000001 109.535 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.488 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 78.6 m-85 -133.98 146.1 50.12 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 123.048 0.539 . . . . 71.530000000000001 111.71 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -117.94 98.38 6.31 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 106.112 -1.81 . . . . 62.450000000000003 106.112 172.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 18.7 t70 69.94 -83.93 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 124.325 1.05 . . . . 73.409999999999997 110.636 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.3 m -136.43 3.87 2.84 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.161 -1.051 . . . . 72.129999999999995 108.161 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 65.2 mt -88.36 132.66 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 114.998 -1.001 . . . . 71.329999999999998 109.775 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 64.2 tp -78.01 110.58 13.08 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.383 -1.34 . . . . 75.019999999999996 107.383 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.53 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -76.81 -65.26 0.96 Allowed 'General case' 0 N--CA 1.393 -3.317 0 N-CA-C 109.036 -0.728 . . . . 73.010000000000005 109.036 -175.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.27 157.45 28.8 Favored Glycine 0 N--CA 1.423 -2.184 0 C-N-CA 119.791 -1.195 . . . . 72.310000000000002 111.746 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -100.65 150.02 23.16 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.057 -1.09 . . . . 71.439999999999998 108.057 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . 0.537 ' HB3' ' NE2' ' A' ' 395' ' ' GLN . 1.9 m-85 -73.04 115.9 12.92 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.205 0.526 . . . . 72.219999999999999 110.853 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . 0.415 ' C ' ' HG ' ' A' ' 394' ' ' SER . . . -98.9 -43.42 6.73 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.529 -0.76 . . . . 75.129999999999995 111.085 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' SER . . . . . 0.415 ' HG ' ' C ' ' A' ' 393' ' ' ALA . 52.9 m -155.11 143.73 20.57 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.686 -0.234 . . . . 75.129999999999995 110.515 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . 0.537 ' NE2' ' HB3' ' A' ' 392' ' ' PHE . 14.2 mp0 -129.88 133.87 47.15 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.873 -1.529 . . . . 74.040000000000006 106.873 174.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -128.91 110.91 12.51 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.782 -0.821 . . . . 73.129999999999995 108.782 173.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 72.11 -101.66 1.07 Allowed Glycine 0 N--CA 1.409 -3.114 0 C-N-CA 119.415 -1.374 . . . . 72.120000000000005 112.056 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -130.39 19.15 5.3 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 123.77 0.828 . . . . 52.530000000000001 109.124 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.95 116.75 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 N-CA-C 106.887 -1.523 . . . . 72.5 106.887 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 13.1 mt -116.46 130.47 56.78 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.806 -0.634 . . . . 70.420000000000002 110.354 -170.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -110.12 121.95 46.46 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 121.031 0.443 . . . . 74.109999999999999 111.239 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.446 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 2.9 m-85 -116.19 132.38 56.68 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.14 -1.059 . . . . 74.239999999999995 108.14 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -147.74 177.55 9.21 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 123.172 0.295 . . . . 70.239999999999995 110.96 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 14.7 m120 65.91 34.36 7.25 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 123.7 0.625 . . . . 74.400000000000006 111.24 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -79.14 -136.65 1.27 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.756 -0.735 . . . . 64.040000000000006 112.168 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -74.86 151.14 39.01 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.695 -0.854 . . . . 73.140000000000001 108.695 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 49.7 m -60.42 133.19 55.85 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.485 0.66 . . . . 64.519999999999996 112.167 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 35.1 t -109.8 144.56 38.06 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.265 -1.754 . . . . 73.219999999999999 106.265 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -82.92 -38.99 22.08 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.567 0.698 . . . . 73.129999999999995 109.839 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . 0.44 ' ND2' ' HB2' ' A' ' 436' ' ' LYS . 9.0 p-10 -94.57 19.56 9.65 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 123.763 0.825 . . . . 71.219999999999999 111.393 -176.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.504 ' HA3' ' SG ' ' A' ' 437' ' ' CYS . . . -164.16 -163.33 16.89 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 107.829 -2.108 . . . . 65.510000000000005 107.829 177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -90.62 -42.42 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.251 0 CA-C-N 120.67 2.235 . . . . 74.540000000000006 112.717 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -162.6 166.43 24.66 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 106.84 -1.541 . . . . 75.040000000000006 106.84 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -77.44 158.27 30.1 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.362 0.601 . . . . 74.230000000000004 112.042 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 27.4 p -161.04 165.92 28.99 Favored 'General case' 0 N--CA 1.407 -2.614 0 CA-C-N 114.567 -1.197 . . . . 64.340000000000003 109.464 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -160.26 151.24 19.03 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.223 0.535 . . . . 75.099999999999994 110.536 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.7 tt -114.16 128.56 71.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 CA-C-N 115.415 -0.811 . . . . 75.420000000000002 109.281 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.446 ' HB ' ' OH ' ' A' ' 402' ' ' TYR . 3.4 t -114.13 127.88 71.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-O 121.561 0.696 . . . . 73.420000000000002 111.348 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 33.1 p -108.53 114.91 29.12 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 107.943 -1.132 . . . . 75.040000000000006 107.943 174.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.81 116.48 44.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.438 -0.949 . . . . 71.450000000000003 108.438 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -113.83 -173.33 2.25 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 121.021 -0.271 . . . . 74.409999999999997 111.328 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.413 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 42.9 t -58.73 129.26 41.24 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 123.621 0.768 . . . . 61.030000000000001 111.338 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -160.8 -177.6 34.04 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 110.676 -0.969 . . . . 70.349999999999994 110.676 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.44 -34.97 7.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 109.24 -0.652 . . . . 73.010000000000005 109.24 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -156.63 160.84 39.77 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 116.024 -0.535 . . . . 74.209999999999994 109.675 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 4.1 m120 -60.48 106.12 0.51 Allowed 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 123.703 0.801 . . . . 75.010000000000005 112.64 175.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -131.89 148.72 52.56 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.987 -1.006 . . . . 74.549999999999997 108.914 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 36.4 mm -90.41 120.21 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.378 -1.712 . . . . 75.150000000000006 106.378 175.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 442' ' ' LYS . 53.5 t -84.66 -48.92 16.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 112.222 0.452 . . . . 44.509999999999998 112.222 -176.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 58.2 p -164.82 163.63 21.18 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.925 -0.31 . . . . 74.450000000000003 110.66 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 4.3 p -142.04 119.84 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 123.889 0.743 . . . . 74.140000000000001 109.436 176.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . 0.408 ' HB3' ' HG ' ' A' ' 440' ' ' LEU . 26.8 tp -125.85 137.56 53.76 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.521 -0.918 . . . . 64.319999999999993 108.521 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -79.67 116.91 20.14 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.148 -1.056 . . . . 65.209999999999994 108.148 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -80.85 -58.08 3.26 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.395 -0.82 . . . . 75.340000000000003 110.649 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -109.27 -78.44 0.59 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.746 -0.661 . . . . 75.409999999999997 110.178 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.44 ' HB2' ' ND2' ' A' ' 410' ' ' ASN . 0.0 OUTLIER -160.67 -40.32 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.627 0.727 . . . . 74.209999999999994 111.141 175.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . 0.504 ' SG ' ' HA3' ' A' ' 411' ' ' GLY . 62.5 m -110.86 8.6 22.3 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.19 -1.041 . . . . 64.219999999999999 108.19 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.8 tt0 -131.75 131.37 42.94 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.064 -0.971 . . . . 72.219999999999999 109.568 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 43.1 m-85 -122.12 150.43 42.2 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.257 -0.883 . . . . 70.319999999999993 109.626 -175.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.408 ' HG ' ' HB3' ' A' ' 432' ' ' LEU . 4.3 pp -107.3 122.8 47.29 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 107.645 -1.242 . . . . 73.140000000000001 107.645 175.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.1 mt -118.96 129.89 74.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 CA-C-N 115.352 -0.84 . . . . 74.430000000000007 110.296 -175.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.428 ' HB3' ' HB ' ' A' ' 429' ' ' VAL . 15.7 tppt? -97.86 138.63 34.93 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.489 -0.93 . . . . 73.129999999999995 108.489 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 80.9 mtp -141.93 168.05 20.68 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 110.145 -0.317 . . . . 75.340000000000003 110.145 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.1 mmtt -135.7 160.41 38.63 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.834 -0.802 . . . . 64.420000000000002 108.834 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' SER . . . . . 0.497 ' HB2' ' ND2' ' A' ' 426' ' ' ASN . 33.6 t -166.58 147.27 5.28 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 124.058 0.849 . . . . 75.329999999999998 109.102 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.62 -26.44 53.89 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.484 2.123 . . . . 71.219999999999999 111.23 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -77.55 -18.69 56.7 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.242 -0.89 . . . . 71.140000000000001 110.646 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -96.36 13.61 27.16 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.689 0.757 . . . . 70.5 109.864 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 11.6 t -103.17 146.84 27.81 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 107.38 -1.341 . . . . 64.340000000000003 107.38 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.416 -2.166 0 N-CA-C 107.651 -1.24 . . . . 63.240000000000002 107.651 -179.133 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 58.4 t80 . . . . . 0 C--O 1.222 -0.369 0 N-CA-C 109.699 -0.482 . . . . 73.230000000000004 109.699 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -138.24 164.63 28.73 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 120.978 0.418 . . . . 72.25 110.838 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -140.94 143.11 34.39 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.527 -1.657 . . . . 74.299999999999997 106.527 170.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 50.2 mm -82.94 116.95 28.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 120.389 0.137 . . . . 74.040000000000006 110.74 -174.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.511 ' HD3' ' H ' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -82.51 131.36 35.22 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 111.925 0.343 . . . . 73.230000000000004 111.925 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . 0.434 ' H ' ' HB2' ' A' ' 378' ' ' PHE . . . 69.8 67.24 1.98 Allowed Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.577 -0.738 . . . . 55.229999999999997 112.739 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' MET . . . . . 0.446 ' HE3' ' CG ' ' A' ' 426' ' ' ASN . 51.6 ttp -146.39 -27.91 0.41 Allowed 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.815 -1.18 . . . . 72.010000000000005 107.815 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.449 ' CD ' HG13 ' A' ' 377' ' ' VAL 0.263 0.4 OUTLIER 65.7 139.53 0.02 OUTLIER 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 116.618 2.081 . . . . 73.239999999999995 116.618 170.388 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' THR . . . . . 0.558 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 39.4 m -128.56 133.36 48.35 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.513 -1.221 . . . . 71.099999999999994 109.673 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.653 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 60.4 mtpt -139.36 141.53 37.6 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.072 -0.714 . . . . 72.349999999999994 109.072 176.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -161.6 136.95 7.55 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.058 -1.09 . . . . 73.420000000000002 108.058 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -86.72 122.98 31.37 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 120.805 0.336 . . . . 61.25 110.279 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 49.0 mt -133.02 123.68 48.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.174 -1.417 . . . . 63.439999999999998 107.174 -175.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.65 8.39 46.63 Favored Glycine 0 C--N 1.309 -0.968 0 C-N-CA 120.821 -0.704 . . . . 74.230000000000004 112.124 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 109.94 -23.2 21.97 Favored Glycine 0 N--CA 1.426 -1.996 0 C-N-CA 121.363 -0.446 . . . . 75.109999999999999 112.805 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -98.83 143.84 28.71 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 120.677 0.275 . . . . 64.109999999999999 110.81 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 57.0 m -86.1 121.03 28.13 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 116.486 -0.325 . . . . 73.420000000000002 110.248 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.653 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.96 137.68 32.18 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.128 -0.693 . . . . 62.43 109.128 176.072 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -131.83 129.92 41.08 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.618 -0.512 . . . . 64.239999999999995 109.618 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.558 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.0 p -124.85 117.19 49.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-O 121.068 0.461 . . . . 73.049999999999997 109.987 176.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.449 HG13 ' CD ' ' A' ' 364' ' ' GLU . 27.6 t -103.71 117.55 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.137 0 N-CA-C 107.063 -1.458 . . . . 72.140000000000001 107.063 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.434 ' HB2' ' H ' ' A' ' 362' ' ' GLY . 88.7 m-85 -63.88 124.35 21.3 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.555 -0.748 . . . . 74.239999999999995 111.994 -173.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 72.79 12.7 5.23 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.064 1.346 . . . . 73.209999999999994 113.127 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -125.42 -80.8 0.62 Allowed 'General case' 0 C--O 1.246 0.869 0 N-CA-C 113.645 0.98 . . . . 73.219999999999999 113.645 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -160.3 166.9 28.62 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.997 0.74 . . . . 73.450000000000003 112.997 -171.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 74.0 t -125.42 142.32 42.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.932 -1.031 . . . . 74.409999999999997 108.423 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -131.7 150.09 52.27 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 123.069 0.547 . . . . 74.400000000000006 111.641 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -122.62 103.95 9.02 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 106.912 -1.514 . . . . 74.319999999999993 106.912 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 14.5 t70 72.6 -70.76 0.15 Allowed 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.281 1.433 . . . . 63.140000000000001 109.479 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 28.6 t -152.87 -0.61 0.26 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.137 -0.938 . . . . 70.5 108.727 176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 62.6 mt -86.42 136.62 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 109.313 -0.625 . . . . 73.310000000000002 109.313 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 63.8 tp -76.27 112.54 12.86 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.288 -1.005 . . . . 73.420000000000002 108.288 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.617 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -78.93 -63.83 1.32 Allowed 'General case' 0 N--CA 1.393 -3.313 0 N-CA-C 108.507 -0.923 . . . . 74.349999999999994 108.507 -176.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.03 160.88 32.0 Favored Glycine 0 CA--C 1.478 -2.271 0 C-N-CA 119.937 -1.125 . . . . 72.129999999999995 110.974 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -109.53 149.55 29.46 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.175 -1.046 . . . . 62.100000000000001 108.175 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . 0.539 ' HD2' ' NE2' ' A' ' 395' ' ' GLN . 1.4 m-85 -69.82 122.36 19.08 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 120.814 0.34 . . . . 75.430000000000007 110.889 -176.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . 0.419 ' C ' ' HG ' ' A' ' 394' ' ' SER . . . -99.09 -48.2 4.94 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.973 -0.558 . . . . 71.120000000000005 110.909 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' SER . . . . . 0.419 ' HG ' ' C ' ' A' ' 393' ' ' ALA . 58.6 m -165.74 142.81 5.49 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.887 -1.153 . . . . 64.430000000000007 107.887 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . 0.539 ' NE2' ' HD2' ' A' ' 392' ' ' PHE . 40.0 mt-30 -126.51 141.87 51.73 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.012 -1.107 . . . . 73.450000000000003 108.012 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -129.13 110.23 11.84 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.559 -0.456 . . . . 62.409999999999997 110.294 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.19 -101.07 0.92 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 121.008 -0.615 . . . . 74.040000000000006 111.891 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -125.61 18.44 8.07 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.408 -0.59 . . . . 74.329999999999998 109.408 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.2 t -118.54 116.52 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 N-CA-C 107.322 -1.362 . . . . 73.5 107.322 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.413 HD21 ' OE1' ' A' ' 395' ' ' GLN . 14.8 mt -111.16 125.09 53.42 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 116.118 -0.492 . . . . 73.340000000000003 110.079 -171.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -105.14 123.74 48.35 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 112.997 0.74 . . . . 75.430000000000007 112.997 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 415' ' ' SER . 2.6 m-85 -117.77 139.75 50.63 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.971 -1.122 . . . . 73.200000000000003 107.971 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -142.54 175.2 9.97 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 124.275 1.03 . . . . 74.439999999999998 109.39 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 53.55 47.01 24.91 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 114.423 1.268 . . . . 74.109999999999999 114.423 173.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -80.88 -148.29 5.74 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.349 -0.841 . . . . 73.329999999999998 111.413 172.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.19 141.01 43.66 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.333 -1.358 . . . . 70.019999999999996 107.333 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 34.3 p -60.78 132.98 55.6 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.149 0.58 . . . . 71.120000000000005 112.482 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 7.7 p -111.91 158.57 19.31 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.425 -0.807 . . . . 72.540000000000006 109.19 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 20.1 p-90 -76.11 -33.24 59.48 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.823 0.821 . . . . 72.439999999999998 109.539 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -95.1 12.98 26.74 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.74 -1.118 . . . . 71.430000000000007 112.674 -172.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -167.99 -170.51 32.83 Favored Glycine 0 C--N 1.306 -1.087 0 N-CA-C 109.736 -1.346 . . . . 75.109999999999999 109.736 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -85.85 -40.03 0.08 OUTLIER 'Trans proline' 0 CA--C 1.545 1.063 0 CA-C-N 119.674 1.737 . . . . 73.200000000000003 112.796 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -161.21 158.46 27.39 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.767 -1.568 . . . . 73.349999999999994 106.767 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -78.57 157.57 28.74 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.192 -0.603 . . . . 73.409999999999997 111.946 172.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 51.4 p -160.22 169.45 23.2 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 115.007 -0.997 . . . . 65.230000000000004 109.78 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -159.98 151.96 20.4 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.287 0.565 . . . . 71.510000000000005 110.553 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.4 tt -118.01 127.73 75.2 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 CA-C-N 115.06 -0.973 . . . . 73.140000000000001 108.821 174.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.7 t -113.93 129.87 69.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.336 0.589 . . . . 74.239999999999995 112.477 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 14.2 p -108.35 113.87 27.28 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.999 -1.0 . . . . 74.450000000000003 108.361 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 39.6 t -101.53 115.08 42.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 120.74 0.305 . . . . 64.329999999999998 110.291 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.482 ' OE1' ' HD2' ' A' ' 442' ' ' LYS . 47.9 mt-10 -108.07 -176.38 3.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.816 0.341 . . . . 74.219999999999999 111.113 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.417 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 36.5 t -60.24 130.99 49.37 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.006 0.922 . . . . 74.519999999999996 111.795 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 446' ' ' PRO . . . -157.86 -177.61 31.12 Favored Glycine 0 N--CA 1.421 -2.334 0 N-CA-C 109.98 -1.248 . . . . 74.209999999999994 109.98 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.36 -28.52 3.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 108.371 -0.974 . . . . 72.109999999999999 108.371 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -152.42 151.81 31.24 Favored 'General case' 0 CA--C 1.478 -1.815 0 CA-C-N 115.103 -0.953 . . . . 71.209999999999994 108.867 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.677 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 18.4 p-10 -66.73 105.43 1.56 Allowed 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 113.286 -1.779 . . . . 74.109999999999999 110.96 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -131.29 148.27 52.67 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.111 -0.95 . . . . 73.150000000000006 110.612 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 26.8 mm -88.28 120.39 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 105.969 -1.863 . . . . 75.540000000000006 105.969 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 62.9 t -83.1 -50.76 15.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-O 120.845 0.355 . . . . 64.150000000000006 111.586 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 48.4 m -164.17 164.5 22.65 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.248 -0.649 . . . . 74.109999999999999 109.248 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.05 114.38 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 123.814 0.846 . . . . 75.409999999999997 109.245 177.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . 0.447 ' O ' HD21 ' A' ' 440' ' ' LEU . 30.7 tp -120.85 138.86 53.85 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.895 -0.78 . . . . 73.299999999999997 108.895 -175.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -80.37 110.69 16.06 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 119.743 -0.783 . . . . 74.099999999999994 109.757 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.64 -38.53 62.47 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.027 -0.988 . . . . 74.439999999999998 111.249 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -127.64 -80.01 0.59 Allowed 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.609 -0.723 . . . . 72.450000000000003 111.683 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -166.73 -36.32 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.3 -0.864 . . . . 73.299999999999997 109.772 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 97.8 m -122.02 -2.63 9.16 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 115.108 -0.951 . . . . 73.439999999999998 109.913 174.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.554 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.6 tt0 -119.0 134.43 55.2 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.192 -0.913 . . . . 75.530000000000001 109.049 -177.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -126.04 150.18 48.31 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 123.743 0.652 . . . . 72.209999999999994 110.057 -174.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.447 HD21 ' O ' ' A' ' 432' ' ' LEU . 1.8 pt? -105.67 123.22 47.58 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.069 -1.085 . . . . 73.109999999999999 108.069 173.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.4 mt -122.26 129.93 74.93 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 CA-C-N 115.088 -0.96 . . . . 71.129999999999995 109.361 -177.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.482 ' HD2' ' OE1' ' A' ' 421' ' ' GLU . 36.5 ttpt -107.65 142.3 37.82 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 119.847 -0.741 . . . . 75.109999999999999 110.026 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 78.5 mtp -136.44 168.54 19.25 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 123.248 0.619 . . . . 54.350000000000001 109.56 -176.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.677 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 70.4 mmtt -131.93 153.52 50.19 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.179 -1.415 . . . . 72.340000000000003 107.179 175.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 74.8 m -161.78 150.33 12.74 Favored Pre-proline 0 C--N 1.287 -2.115 0 O-C-N 123.798 0.686 . . . . 75.340000000000003 110.346 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 32.9 Cg_endo -63.99 -27.16 66.18 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.832 2.355 . . . . 74.040000000000006 112.348 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.77 -12.23 57.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.708 -0.678 . . . . 65.420000000000002 111.9 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -99.48 13.45 33.28 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-O 121.627 0.727 . . . . 74.049999999999997 109.845 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 9.6 t -103.41 119.55 39.1 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 115.272 -0.876 . . . . 65.109999999999999 108.981 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 C--N 1.31 -1.126 0 C-N-CA 123.871 0.868 . . . . 50.200000000000003 108.853 -179.231 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 54.0 p90 . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.878 -0.416 . . . . 75.340000000000003 109.878 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 96.4 mtt180 -134.81 -116.62 0.19 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.065 0.765 . . . . 72.400000000000006 113.065 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -147.64 153.19 39.05 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.694 -0.854 . . . . 63.539999999999999 108.694 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.15 116.88 25.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.278 -1.008 . . . . 72.219999999999999 108.278 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -89.34 155.18 19.52 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.869 -0.605 . . . . 71.129999999999995 112.368 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 68.36 12.15 63.04 Favored Glycine 0 C--O 1.227 -0.302 0 CA-C-N 115.338 -0.846 . . . . 72.120000000000005 113.622 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 51.2 ttp -91.18 -28.76 17.65 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.897 0.348 . . . . 72.239999999999995 110.993 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 69.72 124.54 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.627 1.171 . . . . 72.409999999999997 111.798 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' THR . . . . . 0.446 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 80.1 m -125.82 121.36 33.06 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 108.963 -0.754 . . . . 71.230000000000004 108.963 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 60.4 mtpt -133.2 140.61 47.64 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 110.106 -0.331 . . . . 65.019999999999996 110.106 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -158.08 134.33 9.42 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.395 -0.595 . . . . 73.109999999999999 109.395 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 2.8 mp0 -78.58 125.91 30.02 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 110.038 -0.356 . . . . 75.310000000000002 110.038 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 54.4 mt -130.92 117.54 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 N-CA-C 106.863 -1.532 . . . . 75.049999999999997 106.863 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 67.24 9.98 55.77 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.555 -0.831 . . . . 74.140000000000001 112.592 -177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.59 -7.7 39.56 Favored Glycine 0 N--CA 1.432 -1.597 0 C-N-CA 120.267 -0.968 . . . . 54.119999999999997 113.406 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . 0.412 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 15.4 p90 -114.0 136.61 52.72 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.94 0.37 . . . . 75.209999999999994 110.168 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 61.8 m -79.85 121.0 24.86 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 116.288 -0.414 . . . . 73.140000000000001 111.411 -178.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.658 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.6 OUTLIER -90.96 124.49 35.26 Favored 'General case' 0 N--CA 1.414 -2.244 0 C-N-CA 120.249 -0.58 . . . . 73.129999999999995 109.74 174.709 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 86.4 tttt -120.31 125.44 48.05 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.488 -0.778 . . . . 74.430000000000007 109.83 -174.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.446 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.3 p -127.64 116.14 42.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-O 121.425 0.631 . . . . 72.049999999999997 110.423 176.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.24 116.44 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 N-CA-C 107.145 -1.428 . . . . 61.329999999999998 107.145 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.44 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 75.4 m-85 -61.13 132.43 53.72 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.778 -1.101 . . . . 74.349999999999994 112.854 -171.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 64.97 17.84 11.24 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 124.6 1.16 . . . . 75.299999999999997 112.283 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -130.93 -84.42 0.52 Allowed 'General case' 0 C--O 1.243 0.722 0 N-CA-C 113.534 0.939 . . . . 74.420000000000002 113.534 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -158.65 163.73 36.63 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.726 1.01 . . . . 73.230000000000004 113.726 -170.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 99.1 t -125.55 143.7 38.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 124.505 1.122 . . . . 65.209999999999994 109.151 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -133.91 146.5 50.59 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 122.759 0.423 . . . . 75.439999999999998 111.368 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -110.99 99.42 8.31 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.402 -2.074 . . . . 73.5 105.402 172.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.4 t70 73.23 -72.93 0.11 Allowed 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 125.465 1.506 . . . . 62.299999999999997 109.816 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.9 t -148.63 -5.15 0.43 Allowed 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 114.913 -1.039 . . . . 64.420000000000002 109.093 176.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 63.8 mt -77.78 134.65 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.356 -0.979 . . . . 75.140000000000001 108.356 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 65.2 tp -75.81 113.69 13.57 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.561 -0.903 . . . . 74.019999999999996 108.561 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.517 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.6 OUTLIER -80.73 -63.51 1.39 Allowed 'General case' 0 N--CA 1.383 -3.796 0 N-CA-C 108.348 -0.982 . . . . 64.040000000000006 108.348 -176.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.48 160.39 31.33 Favored Glycine 0 N--CA 1.413 -2.886 0 C-N-CA 119.091 -1.528 . . . . 64.219999999999999 111.429 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -108.6 146.58 33.13 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 107.11 -1.441 . . . . 72.120000000000005 107.11 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . 0.44 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.4 m-85 -68.74 125.88 27.96 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 120.634 0.254 . . . . 72.319999999999993 110.585 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -100.36 -48.2 4.66 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.954 0.407 . . . . 73.230000000000004 109.947 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 42.4 p -164.22 162.02 22.38 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.686 -0.688 . . . . 73.109999999999999 109.488 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . 0.489 ' CG ' HD21 ' A' ' 400' ' ' LEU . 18.5 mp0 -128.4 122.58 31.72 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.919 -0.771 . . . . 65.420000000000002 108.919 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.14 109.99 22.63 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.371 -0.974 . . . . 74.409999999999997 108.371 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.544 ' O ' ' HG2' ' A' ' 358' ' ' ARG . . . 55.68 -100.72 0.1 Allowed Glycine 0 N--CA 1.436 -1.345 0 O-C-N 123.921 0.763 . . . . 74.239999999999995 112.401 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -122.87 19.26 10.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.948 0.88 . . . . 65.329999999999998 109.436 -176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 66.8 t -123.51 116.9 49.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 107.525 -1.287 . . . . 71.239999999999995 107.525 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.489 HD21 ' CG ' ' A' ' 395' ' ' GLN . 12.1 mt -107.19 132.57 52.91 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 116.278 -0.419 . . . . 73.230000000000004 110.88 -169.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -103.63 122.82 45.79 Favored 'General case' 0 C--O 1.247 0.955 0 N-CA-C 112.718 0.636 . . . . 73.019999999999996 112.718 176.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -118.58 132.39 56.2 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.013 -1.477 . . . . 74.219999999999999 107.013 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . 0.404 ' HA ' ' CB ' ' A' ' 415' ' ' SER . 7.6 pt-20 -147.59 174.91 11.3 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 112.478 0.548 . . . . 73.400000000000006 112.478 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.21 41.22 13.68 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.704 -1.589 . . . . 73.120000000000005 111.766 170.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.37 -133.24 0.61 Allowed Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.138 -0.937 . . . . 72.310000000000002 112.607 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.8 141.96 30.12 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.436 -0.95 . . . . 75.019999999999996 108.436 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 42.9 t -60.7 132.75 54.87 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.874 0.845 . . . . 63.530000000000001 112.232 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . 0.509 ' HB2' ' OD1' ' A' ' 410' ' ' ASN . 5.9 p -108.93 158.53 17.6 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.611 -0.722 . . . . 75.319999999999993 110.125 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 32.9 p-90 -74.46 -28.86 61.21 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.164 0.983 . . . . 72.030000000000001 108.6 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . 0.509 ' OD1' ' HB2' ' A' ' 408' ' ' CYS . 8.3 p-10 -96.22 13.41 27.54 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.997 -1.456 . . . . 63.240000000000002 113.147 -173.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -177.26 -167.22 35.3 Favored Glycine 0 C--O 1.22 -0.72 0 N-CA-C 110.229 -1.148 . . . . 71.230000000000004 110.229 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -87.56 -39.52 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.923 0 CA-C-N 119.581 1.69 . . . . 73.319999999999993 112.486 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -159.9 158.43 30.85 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 107.191 -1.411 . . . . 73.230000000000004 107.191 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -76.81 162.23 27.81 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.134 -0.627 . . . . 72.040000000000006 111.026 172.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 47.4 p -164.35 163.09 22.55 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 114.905 -1.043 . . . . 44.140000000000001 108.821 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -158.94 146.9 17.9 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.169 0.509 . . . . 74.420000000000002 110.551 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 7.4 tt -113.38 126.96 70.9 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 CA-C-N 115.266 -0.879 . . . . 73.219999999999999 108.919 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 7.4 t -112.68 131.45 64.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-O 121.108 0.48 . . . . 71.219999999999999 111.937 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 35.0 p -107.26 114.14 27.99 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 107.664 -1.235 . . . . 74.530000000000001 107.664 175.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 43.1 t -100.82 112.97 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 107.537 -1.283 . . . . 73.219999999999999 107.537 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -115.58 -173.65 2.37 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.917 -0.313 . . . . 74.239999999999995 110.211 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.531 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 36.9 t -59.18 128.32 36.59 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 122.974 0.51 . . . . 52.310000000000002 111.256 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -159.8 -176.1 31.51 Favored Glycine 0 CA--C 1.493 -1.305 0 CA-C-N 115.796 -0.638 . . . . 73.140000000000001 111.529 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.0 t -80.58 -38.55 17.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 109.485 -0.561 . . . . 74.25 109.485 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -171.08 162.24 7.04 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 123.51 0.724 . . . . 71.129999999999995 109.321 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.603 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 20.9 m120 -61.52 101.38 0.18 Allowed 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.996 -1.002 . . . . 72.25 112.306 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -132.02 149.04 52.53 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.6 -1.182 . . . . 62.140000000000001 108.651 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 30.5 mm -81.51 118.23 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.791 -1.559 . . . . 65.120000000000005 106.791 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 63.8 t -81.24 -50.35 16.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-O 120.716 0.293 . . . . 65.319999999999993 111.664 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 42.4 p -166.92 165.68 15.86 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.138 -0.483 . . . . 63.100000000000001 109.972 -173.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 4.3 p -142.0 125.13 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 108.822 -0.807 . . . . 74.0 108.822 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 27.2 tp -126.48 136.58 52.8 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 107.66 -1.237 . . . . 74.239999999999995 107.66 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -81.18 108.48 14.86 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.674 -0.862 . . . . 71.329999999999998 108.674 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -65.31 -61.18 2.27 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 123.74 0.816 . . . . 71.530000000000001 110.781 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -109.33 -75.02 0.64 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.925 -0.58 . . . . 73.340000000000003 110.705 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -165.84 -43.02 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.795 -1.093 . . . . 72.129999999999995 109.892 -174.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 93.4 m -118.74 14.72 13.49 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 121.969 0.89 . . . . 74.420000000000002 109.539 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 415' ' ' SER . 37.1 tt0 -135.14 131.19 36.53 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.111 -1.07 . . . . 73.340000000000003 108.111 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 45.0 m-85 -123.08 150.77 42.73 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 124.005 0.816 . . . . 74.129999999999995 110.261 -174.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -110.4 122.09 46.87 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.736 -1.209 . . . . 74.310000000000002 107.736 172.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.5 mt -121.28 133.84 66.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 CA-C-N 115.41 -0.814 . . . . 73.319999999999993 109.501 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -103.48 140.84 36.95 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 109.131 -0.692 . . . . 73.349999999999994 109.131 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 87.4 mtp -138.54 163.36 32.19 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.267 -1.012 . . . . 71.120000000000005 108.267 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 73.0 mmtt -130.68 161.3 31.93 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.728 -0.842 . . . . 73.109999999999999 108.728 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' SER . . . . . 0.42 ' HB2' ' ND2' ' A' ' 426' ' ' ASN . 30.2 t -167.77 147.62 4.42 Favored Pre-proline 0 C--N 1.296 -1.742 0 O-C-N 123.746 0.654 . . . . 75.129999999999995 109.759 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.55 -21.5 29.75 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.204 1.936 . . . . 71.430000000000007 110.129 176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.4 -18.47 59.92 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.83 -1.077 . . . . 62.399999999999999 110.775 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -100.84 7.03 43.92 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.751 0.786 . . . . 72.549999999999997 109.093 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 13.2 t -103.56 121.26 42.53 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.05 -0.977 . . . . 73.040000000000006 108.914 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--N 1.295 -1.762 0 N-CA-C 108.508 -0.923 . . . . 74.430000000000007 108.508 177.361 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 CA--C 1.505 -0.761 0 N-CA-C 110.082 -0.34 . . . . 75.200000000000003 110.082 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -129.63 -179.16 5.02 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.206 0.527 . . . . 73.140000000000001 110.216 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -88.29 154.07 20.7 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.14 -0.936 . . . . 64.5 110.137 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 47.8 mm -79.21 129.89 36.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 107.053 -1.462 . . . . 71.340000000000003 107.053 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.483 ' HD3' ' H ' ' A' ' 361' ' ' LYS . 0.2 OUTLIER -109.96 158.44 18.23 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.504 0.927 . . . . 74.430000000000007 113.504 -172.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 97.03 -34.52 5.01 Favored Glycine 0 CA--C 1.504 -0.618 0 CA-C-N 115.494 -0.776 . . . . 61.329999999999998 111.949 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 51.2 ttp -76.61 132.47 39.47 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.903 0.382 . . . . 75.430000000000007 111.353 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -74.27 115.38 13.71 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.823 -0.806 . . . . 74.430000000000007 108.823 176.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' THR . . . . . 0.454 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 59.1 m -103.16 120.3 40.45 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.754 -1.573 . . . . 74.420000000000002 106.754 173.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 19.4 ptmt -142.29 141.44 32.43 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 111.989 0.366 . . . . 61.140000000000001 111.989 -176.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . 0.416 ' NH1' HG12 ' A' ' 369' ' ' ILE . 3.2 tmt_? -159.57 132.18 6.69 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.442 -0.799 . . . . 73.25 109.027 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 44.1 mt-10 -77.93 129.97 36.0 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 116.147 -0.478 . . . . 71.010000000000005 110.525 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.416 HG12 ' NH1' ' A' ' 367' ' ' ARG . 35.5 mt -135.02 121.53 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 106.831 -1.544 . . . . 74.310000000000002 106.831 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.39 11.54 56.47 Favored Glycine 0 C--N 1.308 -0.999 0 C-N-CA 120.837 -0.697 . . . . 73.209999999999994 112.646 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 110.77 -23.38 19.76 Favored Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 121.186 -0.53 . . . . 70.129999999999995 112.85 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -101.81 141.6 34.42 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 122.514 -0.403 . . . . 74.200000000000003 111.361 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 90.1 m -81.71 117.56 22.14 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.56 0.219 . . . . 53.530000000000001 110.581 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.32 133.6 34.86 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 108.36 -0.978 . . . . 74.420000000000002 108.36 174.264 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.446 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 36.8 ttpt -136.84 127.15 26.48 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 120.635 -0.426 . . . . 74.340000000000003 110.167 -176.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.454 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.5 p -120.63 119.34 59.36 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-O 121.181 0.515 . . . . 74.239999999999995 110.337 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.47 116.15 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 106.451 -1.685 . . . . 70.099999999999994 106.451 173.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.503 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 74.9 m-85 -65.56 135.7 55.44 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.018 -0.992 . . . . 63.439999999999998 113.496 -170.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 64.99 11.75 7.32 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 124.764 1.226 . . . . 73.530000000000001 112.306 -176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -122.61 -84.46 0.66 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 112.548 0.573 . . . . 73.209999999999994 112.548 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.464 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -166.09 156.59 12.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.05 0.759 . . . . 73.010000000000005 113.05 -171.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.462 HG21 ' CD2' ' A' ' 402' ' ' TYR . 60.9 t -115.05 147.59 18.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 124.293 1.037 . . . . 75.329999999999998 109.141 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.464 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 85.4 m-85 -134.72 145.32 48.37 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.04 0.536 . . . . 72.329999999999998 112.119 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -116.68 100.06 7.56 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 105.945 -1.872 . . . . 70.219999999999999 105.945 171.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.3 t70 71.52 -82.34 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 124.082 0.953 . . . . 54.109999999999999 109.901 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 36.8 t -138.52 -3.43 1.7 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.288 -1.004 . . . . 73.340000000000003 108.288 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.496 HD11 HE21 ' A' ' 406' ' ' GLN . 50.2 mm -77.19 132.47 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 108.854 -0.795 . . . . 74.439999999999998 108.854 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.1 tp -76.45 109.56 10.28 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.763 -1.569 . . . . 74.340000000000003 106.763 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.422 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.7 OUTLIER -76.41 -62.65 1.55 Allowed 'General case' 0 N--CA 1.389 -3.512 0 N-CA-C 108.94 -0.763 . . . . 71.140000000000001 108.94 -175.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.77 157.47 28.7 Favored Glycine 0 N--CA 1.425 -2.089 0 C-N-CA 118.788 -1.673 . . . . 62.25 112.3 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.2 146.02 28.06 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.186 -1.412 . . . . 75.329999999999998 107.186 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . 0.503 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 2.1 m-85 -71.84 115.81 11.49 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 109.417 -0.586 . . . . 70.239999999999995 109.417 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -99.39 -42.7 6.86 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.293 -0.412 . . . . 73.299999999999997 111.172 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 60.3 p -164.41 140.71 6.19 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.885 -0.783 . . . . 72.549999999999997 108.885 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.27 145.28 35.32 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.581 -0.282 . . . . 73.109999999999999 110.656 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -124.8 110.27 14.11 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.875 -0.787 . . . . 73.400000000000006 108.875 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 61.86 -105.76 1.01 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.886 -0.597 . . . . 74.340000000000003 113.077 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -113.96 17.07 18.13 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.101 0.477 . . . . 75.310000000000002 110.892 -176.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.3 t -120.9 118.34 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 106.405 -1.702 . . . . 75.140000000000001 106.405 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.446 ' HB2' ' HH ' ' A' ' 402' ' ' TYR . 20.1 mt -119.73 124.83 47.15 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.109 -0.636 . . . . 75.209999999999994 111.479 -169.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -100.85 122.27 43.15 Favored 'General case' 0 C--O 1.253 1.24 0 CA-C-O 121.314 0.578 . . . . 63.200000000000003 112.366 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.462 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.3 m-85 -118.35 130.24 55.89 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.454 -1.313 . . . . 75.310000000000002 107.454 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -147.22 176.04 10.28 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 122.008 0.123 . . . . 54.420000000000002 111.117 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.4 m120 64.97 36.3 7.64 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.666 0.604 . . . . 52.140000000000001 111.522 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -79.23 -140.16 1.93 Allowed Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.705 -0.76 . . . . 63.009999999999998 112.103 176.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . 0.496 HE21 HD11 ' A' ' 387' ' ' ILE . 28.9 tt0 -68.69 150.7 47.62 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 122.447 -0.443 . . . . 72.340000000000003 110.001 -177.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 44.8 m -64.82 125.47 24.93 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.544 0.688 . . . . 64.120000000000005 110.775 -175.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 46.7 t -108.26 124.11 49.8 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 105.342 -2.096 . . . . 73.519999999999996 105.342 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -66.36 -37.6 85.67 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.078 0.466 . . . . 73.310000000000002 110.823 -174.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -89.89 13.21 15.18 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.787 -0.642 . . . . 70.230000000000004 111.743 -174.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.488 ' HA3' ' SG ' ' A' ' 437' ' ' CYS . . . -158.77 -158.75 9.22 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.622 -1.791 . . . . 74.030000000000001 108.622 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -92.84 -41.55 0.03 OUTLIER 'Trans proline' 0 CA--C 1.557 1.672 0 CA-C-N 120.699 2.25 . . . . 75.409999999999997 113.02 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -168.55 161.2 11.45 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 105.893 -1.891 . . . . 73.140000000000001 105.893 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 43.6 mtt180 -72.31 157.36 37.84 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.412 0.625 . . . . 71.540000000000006 112.481 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 36.2 p -163.18 165.1 24.85 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 114.612 -1.176 . . . . 65.109999999999999 109.409 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.1 148.16 16.8 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.182 0.515 . . . . 74.430000000000007 110.465 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 7.3 tt -112.86 123.89 68.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 CA-C-N 115.454 -0.794 . . . . 71.400000000000006 109.278 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 5.1 t -109.8 129.81 64.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-N 115.885 -0.598 . . . . 75.219999999999999 111.866 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.1 p -108.32 114.27 28.01 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 107.667 -1.234 . . . . 73.200000000000003 107.667 173.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 22.4 t -100.35 123.14 53.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.2 -1.407 . . . . 70.230000000000004 107.2 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -120.43 -174.12 2.72 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 120.557 -0.457 . . . . 75.0 110.898 -176.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.481 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 41.0 t -62.21 128.65 37.12 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 123.883 0.873 . . . . 36.780000000000001 111.56 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -162.55 -176.8 35.0 Favored Glycine 0 CA--C 1.495 -1.196 0 N-CA-C 111.256 -0.738 . . . . 75.120000000000005 111.256 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 98.9 t -86.48 -37.16 11.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-O 120.975 0.417 . . . . 54.149999999999999 109.877 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.444 ' HG2' ' N ' ' A' ' 426' ' ' ASN . 38.5 tt0 -155.87 162.09 40.49 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 109.278 -0.638 . . . . 73.230000000000004 109.278 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.686 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 18.8 m120 -63.36 109.1 1.48 Allowed 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 114.591 -1.186 . . . . 64.329999999999998 111.147 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -131.45 148.42 52.64 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.646 -1.161 . . . . 50.299999999999997 109.013 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 35.5 mm -90.47 113.84 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.364 -1.717 . . . . 73.010000000000005 106.364 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.3 t -80.89 -44.31 21.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 112.505 0.557 . . . . 75.409999999999997 112.505 -174.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 58.1 p -168.57 162.7 12.14 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 110.043 -0.354 . . . . 73.109999999999999 110.043 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 5.7 p -142.03 119.97 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 N-CA-C 108.81 -0.811 . . . . 61.020000000000003 108.81 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 30.9 tp -127.42 138.06 52.88 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.156 -1.053 . . . . 75.150000000000006 108.156 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -80.47 115.84 20.21 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.155 -0.683 . . . . 71.450000000000003 109.155 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -76.59 -67.35 0.71 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.478 -0.783 . . . . 52.399999999999999 111.014 -176.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -98.08 -76.5 0.53 Allowed 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.764 -0.828 . . . . 64.519999999999996 108.764 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.89 -43.85 0.04 OUTLIER 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 115.392 -0.822 . . . . 74.120000000000005 110.655 176.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . 0.488 ' SG ' ' HA3' ' A' ' 411' ' ' GLY . 73.6 m -107.38 8.87 29.85 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.64 0.733 . . . . 74.219999999999999 109.191 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.8 tt0 -130.62 134.7 47.19 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.201 -0.909 . . . . 75.409999999999997 109.035 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -125.86 148.69 49.09 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 123.733 0.646 . . . . 73.340000000000003 109.766 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -105.2 119.24 38.56 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.499 -0.926 . . . . 75.319999999999993 108.499 174.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.4 mt -117.74 134.73 60.41 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 115.365 -0.834 . . . . 65.209999999999994 109.551 -177.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -106.17 140.99 38.27 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.806 -0.813 . . . . 74.140000000000001 108.806 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 83.1 mtp -138.74 168.56 19.54 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.641 -0.503 . . . . 74.010000000000005 109.641 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.686 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 72.9 mmtt -133.32 161.17 35.21 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.046 -0.724 . . . . 64.319999999999993 109.046 177.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 28.7 t -172.1 148.55 2.05 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.639 -0.875 . . . . 64.040000000000006 108.639 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.29 -27.49 34.5 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.049 1.832 . . . . 72.030000000000001 110.337 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -77.26 -13.51 59.92 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.812 -1.085 . . . . 73.200000000000003 110.792 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -102.63 16.96 24.93 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.329 0.585 . . . . 72.319999999999993 110.147 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . 0.414 ' HA ' ' HB2' ' A' ' 422' ' ' CYS . 19.6 t -100.31 120.11 39.43 Favored 'General case' 0 N--CA 1.411 -2.381 0 CA-C-O 121.667 0.746 . . . . 65.340000000000003 109.3 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 35.3 t . . . . . 0 N--CA 1.425 -1.676 0 N-CA-C 106.614 -1.624 . . . . 64.239999999999995 106.614 -177.359 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 36.8 p90 . . . . . 0 C--O 1.224 -0.289 0 CA-C-O 121.641 0.734 . . . . 73.519999999999996 110.426 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -146.71 174.58 11.33 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.155 -1.424 . . . . 75.239999999999995 107.155 -174.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -129.04 150.12 50.58 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.718 -0.845 . . . . 72.200000000000003 108.718 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 51.9 mt -82.55 116.87 27.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 108.959 -0.756 . . . . 74.510000000000005 108.959 -177.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.418 ' HA ' ' CB ' ' A' ' 378' ' ' PHE . 63.1 pttt -84.91 157.34 20.89 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 113.104 0.779 . . . . 73.549999999999997 113.104 -175.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 67.8 29.74 73.95 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 114.893 -1.048 . . . . 71.209999999999994 113.665 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 49.5 ttm -121.89 143.75 49.26 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.701 -0.481 . . . . 73.299999999999997 109.701 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -95.24 130.47 41.97 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 109.571 -0.529 . . . . 73.120000000000005 109.571 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' THR . . . . . 0.484 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 97.4 m -125.69 126.91 45.42 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 107.137 -1.431 . . . . 74.329999999999998 107.137 176.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.657 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 59.2 mtpt -136.25 140.7 43.65 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.626 0.25 . . . . 70.340000000000003 110.939 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -156.74 132.94 9.8 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.116 -0.698 . . . . 64.209999999999994 109.116 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 3.4 mp0 -79.83 129.17 34.26 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 121.02 -0.272 . . . . 65.450000000000003 110.498 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 48.6 mt -136.14 121.12 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 106.117 -1.809 . . . . 73.450000000000003 106.117 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.67 3.23 19.94 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 121.421 -0.418 . . . . 52.32 113.765 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 112.06 -15.91 25.51 Favored Glycine 0 N--CA 1.433 -1.511 0 C-N-CA 120.7 -0.762 . . . . 64.120000000000005 112.627 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -102.82 141.79 35.03 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 109.77 -0.455 . . . . 75.409999999999997 109.77 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 91.9 m -87.65 124.25 33.34 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 116.43 -0.35 . . . . 63.030000000000001 110.888 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.657 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.7 OUTLIER -90.56 126.61 35.99 Favored 'General case' 0 N--CA 1.406 -2.632 0 C-N-CA 119.894 -0.722 . . . . 65.340000000000003 109.804 175.429 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -121.81 124.99 45.47 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.794 -0.817 . . . . 72.319999999999993 108.794 -175.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.484 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.4 p -125.1 124.33 67.28 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 109.888 -0.412 . . . . 74.049999999999997 109.888 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.2 t -113.67 116.29 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.692 -1.596 . . . . 72.120000000000005 106.692 173.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.418 ' CB ' ' HA ' ' A' ' 361' ' ' LYS . 96.6 m-85 -62.62 126.55 27.73 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.452 -0.794 . . . . 74.530000000000001 112.846 -173.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 72.78 14.88 4.89 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 125.104 1.362 . . . . 72.349999999999994 112.985 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -126.73 -83.1 0.62 Allowed 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 113.309 0.855 . . . . 72.299999999999997 113.309 174.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.459 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.3 OUTLIER -163.3 156.45 19.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.138 0.792 . . . . 71.400000000000006 113.138 -170.166 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.425 HG21 ' CE2' ' A' ' 402' ' ' TYR . 91.6 t -116.8 145.2 22.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 124.081 0.952 . . . . 55.5 108.992 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.459 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 90.0 m-85 -134.16 147.72 50.83 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.102 0.477 . . . . 73.219999999999999 111.389 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -113.05 98.59 7.25 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.972 -1.862 . . . . 71.299999999999997 105.972 173.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.5 t70 72.45 -78.57 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 125.445 1.498 . . . . 73.540000000000006 109.266 -174.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 14.0 p -142.06 -3.06 1.11 Allowed 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 114.6 -1.182 . . . . 75.150000000000006 109.44 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 47.4 mm -80.47 132.01 32.72 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 N-CA-C 108.745 -0.835 . . . . 74.510000000000005 108.745 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 62.1 tp -75.91 113.86 13.89 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 108.797 -0.816 . . . . 74.430000000000007 108.797 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.56 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.3 OUTLIER -80.0 -63.88 1.31 Allowed 'General case' 0 N--CA 1.398 -3.052 0 N-CA-C 109.143 -0.688 . . . . 74.209999999999994 109.143 -176.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.06 156.64 27.89 Favored Glycine 0 N--CA 1.42 -2.408 0 C-N-CA 119.114 -1.517 . . . . 62.340000000000003 111.53 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.71 146.36 26.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.694 -1.595 . . . . 74.329999999999998 106.694 176.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -71.27 116.01 11.09 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.282 -0.567 . . . . 73.120000000000005 109.917 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -92.28 -47.32 7.26 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.719 -0.673 . . . . 65.049999999999997 110.408 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 42.3 p -166.68 141.16 4.12 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.939 -0.763 . . . . 61.130000000000003 108.939 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.11 145.71 34.57 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.53 -0.305 . . . . 75.450000000000003 110.265 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -128.14 110.23 12.26 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.753 -0.832 . . . . 71.319999999999993 108.753 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.59 -101.43 0.58 Allowed Glycine 0 N--CA 1.432 -1.58 0 O-C-N 123.918 0.761 . . . . 55.450000000000003 112.624 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . 0.572 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 27.4 p-10 -113.28 6.25 17.27 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.47 -0.365 . . . . 64.340000000000003 111.97 -176.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.96 116.27 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.186 0 N-CA-C 107.545 -1.28 . . . . 72.420000000000002 107.545 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 19.3 mt -114.4 123.84 50.45 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 116.057 -0.519 . . . . 74.310000000000002 110.119 -171.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.472 ' HZ2' ' HB3' ' A' ' 401' ' ' LYS . 3.2 mmmp? -108.58 122.34 46.88 Favored 'General case' 0 C--O 1.251 1.143 0 CA-C-O 120.748 0.309 . . . . 73.019999999999996 111.474 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.425 ' CE2' HG21 ' A' ' 382' ' ' VAL . 2.8 m-85 -115.68 133.82 55.65 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.413 -0.958 . . . . 75.409999999999997 108.413 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -135.11 171.3 14.62 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.553 -0.536 . . . . 72.150000000000006 109.553 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 14.3 m120 54.45 41.1 32.16 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.342 1.238 . . . . 63.399999999999999 114.342 170.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -78.32 -139.86 1.54 Allowed Glycine 0 CA--C 1.541 1.659 0 C-N-CA 120.795 -0.717 . . . . 62.32 113.479 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -63.24 149.96 44.25 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.656 0.783 . . . . 72.209999999999994 110.907 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 412' ' ' PRO . 49.0 p -60.42 118.78 6.89 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 109.315 -0.624 . . . . 75.329999999999998 109.315 175.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 51.9 t -101.0 160.23 14.55 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.845 -0.616 . . . . 72.230000000000004 109.841 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -78.82 -31.58 45.91 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.345 0.593 . . . . 73.219999999999999 110.247 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . 0.635 ' HB3' ' SG ' ' A' ' 437' ' ' CYS . 14.2 t-20 -96.8 -11.57 24.75 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.859 0.838 . . . . 54.25 110.446 -171.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -160.2 160.54 31.77 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 109.31 -1.516 . . . . 65.319999999999993 109.31 -177.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.461 ' O ' ' HA ' ' A' ' 407' ' ' SER . 11.6 Cg_endo -56.97 -38.77 95.21 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.383 2.056 . . . . 75.239999999999995 113.958 -174.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -145.12 158.87 43.7 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.99 -0.374 . . . . 63.149999999999999 109.99 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -81.07 167.49 19.68 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 120.999 0.428 . . . . 74.319999999999993 111.046 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 56.4 p -162.93 160.17 24.52 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.261 -0.881 . . . . 65.540000000000006 109.064 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -157.18 136.62 12.11 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 121.21 0.528 . . . . 64.439999999999998 111.345 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.2 tt -101.43 121.86 52.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-N 115.253 -0.885 . . . . 75.530000000000001 110.42 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.488 ' CG2' ' HB ' ' A' ' 441' ' ' ILE . 3.9 t -108.57 129.53 62.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.635 -0.711 . . . . 72.540000000000006 111.746 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 13.4 p -109.84 114.89 28.82 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.188 -0.914 . . . . 75.340000000000003 108.896 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 34.1 t -100.43 114.09 38.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.871 -1.159 . . . . 64.549999999999997 107.871 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -114.12 -175.85 2.77 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 120.282 -0.567 . . . . 74.519999999999996 110.901 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 44.8 t -58.21 129.52 42.36 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.303 0.641 . . . . 71.420000000000002 111.442 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -159.94 -177.73 33.29 Favored Glycine 0 N--CA 1.434 -1.471 0 N-CA-C 110.343 -1.103 . . . . 73.219999999999999 110.343 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.35 -35.28 6.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.074 -0.713 . . . . 72.010000000000005 109.074 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -141.6 148.86 39.93 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.878 -0.601 . . . . 71.439999999999998 109.42 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.753 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.2 p-10 -67.68 99.12 0.76 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.816 -1.084 . . . . 55.420000000000002 109.977 174.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -132.43 149.9 52.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.174 -0.921 . . . . 62.140000000000001 110.526 -175.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 28.2 mm -81.28 120.7 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 106.065 -1.828 . . . . 74.310000000000002 106.065 175.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 50.4 t -86.77 -50.6 13.9 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 N-CA-C 111.84 0.311 . . . . 74.140000000000001 111.84 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 43.5 p -164.66 163.8 21.55 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 110.204 -0.295 . . . . 72.200000000000003 110.204 -174.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 3.4 p -142.0 117.07 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-O 121.403 0.62 . . . . 72.439999999999998 109.475 177.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 22.3 tp -114.31 134.99 54.56 Favored 'General case' 0 C--N 1.272 -2.803 0 N-CA-C 107.587 -1.264 . . . . 64.519999999999996 107.587 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -81.59 113.21 19.46 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 106.791 -1.559 . . . . 74.319999999999993 106.791 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.1 -60.8 2.1 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 108.872 -0.788 . . . . 72.239999999999995 108.872 -173.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.578 ' C ' ' HD2' ' A' ' 436' ' ' LYS . 49.9 mm-40 -107.04 -84.45 0.52 Allowed 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 106.884 -1.524 . . . . 72.019999999999996 106.884 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.578 ' HD2' ' C ' ' A' ' 435' ' ' GLN . 3.9 mptp? -147.66 -56.53 0.24 Allowed 'General case' 0 CA--C 1.5 -0.942 0 C-N-CA 124.468 1.107 . . . . 72.200000000000003 109.376 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . 0.635 ' SG ' ' HB3' ' A' ' 410' ' ' ASN . 57.3 m -90.97 -9.24 46.77 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.569 -1.196 . . . . 71.549999999999997 110.526 -176.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -114.46 128.76 56.5 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 114.48 -1.237 . . . . 64.340000000000003 109.314 -175.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 44.2 m-85 -124.84 150.23 46.63 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 123.502 0.501 . . . . 71.209999999999994 110.412 -176.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 4.3 pp -111.6 125.12 53.6 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.921 -1.511 . . . . 74.230000000000004 106.921 173.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.488 ' HB ' ' CG2' ' A' ' 418' ' ' VAL . 96.6 mt -122.16 133.13 69.4 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 116.234 -0.439 . . . . 74.430000000000007 110.602 -174.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -98.55 138.53 35.62 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 109.178 -0.675 . . . . 72.099999999999994 109.178 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 82.6 mtp -140.25 162.06 36.18 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 109.153 -0.684 . . . . 73.420000000000002 109.153 175.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.753 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.9 mmtt -132.22 161.08 34.31 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 107.257 -1.386 . . . . 72.409999999999997 107.257 175.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 36.2 t -167.42 147.01 4.46 Favored Pre-proline 0 C--N 1.286 -2.19 0 O-C-N 123.982 0.801 . . . . 73.329999999999998 109.03 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.0 -27.77 50.06 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.383 2.056 . . . . 74.209999999999994 111.339 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -78.24 -14.79 59.29 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.657 -0.701 . . . . 72.030000000000001 110.249 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -95.61 8.94 41.93 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 121.333 0.587 . . . . 73.099999999999994 110.227 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 14.0 t -102.59 121.47 42.46 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 108.476 -0.935 . . . . 64.329999999999998 108.476 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 C--N 1.306 -1.297 0 N-CA-C 108.825 -0.805 . . . . 73.120000000000005 108.825 -179.702 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 120.781 0.324 . . . . 74.400000000000006 110.589 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -161.41 -176.61 5.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.838 -0.43 . . . . 75.120000000000005 109.838 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -125.69 152.22 45.54 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.715 -1.217 . . . . 60.210000000000001 107.715 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 48.2 mm -80.9 138.8 19.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.707 -1.22 . . . . 73.25 107.707 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -117.75 157.35 26.7 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.856 0.36 . . . . 73.239999999999995 111.751 -172.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . 0.496 ' H ' ' HB2' ' A' ' 378' ' ' PHE . . . 86.67 -21.79 16.87 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 116.455 1.342 . . . . 63.149999999999999 116.455 172.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.15 155.89 19.54 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 118.603 1.201 . . . . 74.049999999999997 111.363 -175.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -88.67 113.7 24.5 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.901 -0.777 . . . . 74.129999999999995 108.901 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' THR . . . . . 0.467 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 26.1 m -104.5 120.45 41.3 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.123 -1.806 . . . . 71.129999999999995 106.123 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.676 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 58.5 mtpt -140.52 141.17 35.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 123.043 0.214 . . . . 71.340000000000003 110.472 -174.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -159.99 135.08 7.98 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.548 -0.908 . . . . 74.25 108.548 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -79.15 125.28 29.23 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 109.952 -0.388 . . . . 72.430000000000007 109.952 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 49.5 mt -133.87 119.12 31.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 106.893 -1.521 . . . . 75.230000000000004 106.893 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.7 14.22 62.44 Favored Glycine 0 C--N 1.308 -0.973 0 C-N-CA 120.526 -0.845 . . . . 72.140000000000001 111.977 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 101.66 -15.98 56.69 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 121.417 -0.421 . . . . 63.299999999999997 112.956 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -105.17 136.77 44.05 Favored 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 120.684 -0.407 . . . . 74.200000000000003 110.502 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 47.5 m -78.16 123.77 27.28 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.182 -0.463 . . . . 74.010000000000005 111.234 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.676 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.6 OUTLIER -93.28 124.57 37.35 Favored 'General case' 0 N--CA 1.414 -2.237 0 C-N-CA 120.433 -0.507 . . . . 64.140000000000001 110.054 173.499 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 85.1 tttt -123.47 125.13 44.36 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.678 -0.692 . . . . 72.239999999999995 110.241 -175.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.467 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.5 p -128.26 116.59 42.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-O 121.141 0.496 . . . . 70.310000000000002 110.512 177.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.3 t -113.02 117.03 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 108.009 -1.108 . . . . 72.430000000000007 108.009 175.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.508 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 42.6 m-85 -57.88 128.9 39.42 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 114.113 1.153 . . . . 75.099999999999994 114.113 -173.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 68.51 9.6 7.39 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 114.054 -1.43 . . . . 74.120000000000005 113.356 -178.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -116.3 -82.21 0.62 Allowed 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.193 0.812 . . . . 74.099999999999994 113.193 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.531 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -170.13 158.85 7.15 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 112.842 0.682 . . . . 45.140000000000001 112.842 -172.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 99.3 t -114.01 145.34 19.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 124.361 1.064 . . . . 75.140000000000001 108.878 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.531 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 72.2 m-85 -133.1 150.2 52.09 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.242 0.544 . . . . 74.319999999999993 111.452 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.466 ' HB2' HD21 ' A' ' 389' ' ' LEU . 34.1 tt0 -119.5 97.26 5.56 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 106.026 -1.842 . . . . 72.540000000000006 106.026 173.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.8 t70 70.43 -81.47 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 125.596 1.559 . . . . 75.340000000000003 111.392 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 17.8 m -135.53 0.73 2.78 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.345 -0.983 . . . . 53.310000000000002 108.345 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 48.4 mm -96.07 134.86 32.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.869 -0.605 . . . . 72.439999999999998 109.976 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.8 tp -76.45 115.31 16.08 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.702 -0.851 . . . . 74.310000000000002 108.702 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.507 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -80.41 -65.22 1.04 Allowed 'General case' 0 N--CA 1.393 -3.308 0 N-CA-C 109.366 -0.605 . . . . 63.450000000000003 109.366 -175.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -156.46 156.1 26.85 Favored Glycine 0 N--CA 1.42 -2.383 0 C-N-CA 118.817 -1.659 . . . . 73.409999999999997 112.168 -177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -99.48 143.39 29.79 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.922 -1.51 . . . . 71.030000000000001 106.922 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . 0.508 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 2.4 m-85 -71.22 115.95 10.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.584 0.231 . . . . 73.439999999999998 110.482 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -101.74 -47.7 4.53 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.352 -0.386 . . . . 71.450000000000003 111.46 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 39.3 p -157.38 140.24 15.1 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 110.083 -0.34 . . . . 74.510000000000005 110.083 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . 0.54 ' CB ' ' HG ' ' A' ' 400' ' ' LEU . 0.1 OUTLIER -147.25 145.5 29.44 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 116.121 -0.49 . . . . 52.420000000000002 111.13 178.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -128.97 110.86 12.44 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.838 -0.619 . . . . 73.510000000000005 109.473 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.8 -102.54 0.77 Allowed Glycine 0 C--N 1.31 -0.883 0 CA-C-N 115.877 -0.601 . . . . 61.109999999999999 113.956 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -116.43 17.7 15.39 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.146 0.498 . . . . 75.430000000000007 111.468 -176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.4 t -128.85 116.35 40.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 107.565 -1.272 . . . . 72.209999999999994 107.565 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.54 ' HG ' ' CB ' ' A' ' 395' ' ' GLN . 5.3 mp -120.07 139.61 52.28 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.63 0.604 . . . . 75.129999999999995 112.63 -173.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -112.32 122.69 48.42 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 115.596 -0.729 . . . . 74.430000000000007 111.885 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.464 ' HH ' ' HB2' ' A' ' 400' ' ' LEU . 2.9 m-85 -118.72 135.97 54.2 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.749 -1.204 . . . . 62.329999999999998 107.749 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . 0.407 ' HA ' ' CB ' ' A' ' 415' ' ' SER . 8.8 pt-20 -146.92 174.55 11.4 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-O 121.496 0.665 . . . . 73.219999999999999 112.719 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 64.13 33.41 11.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.609 -1.632 . . . . 73.340000000000003 112.953 168.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -72.22 -136.81 0.21 Allowed Glycine 0 CA--C 1.537 1.448 0 CA-C-N 115.599 -0.728 . . . . 71.150000000000006 113.437 176.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.58 137.92 46.49 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.567 -0.901 . . . . 74.219999999999999 108.567 -175.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 19.0 p -63.66 117.77 7.29 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 124.043 0.937 . . . . 75.329999999999998 112.332 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 7.2 p -94.92 158.81 15.32 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.266 -0.879 . . . . 62.25 108.966 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 14.3 p-90 -77.19 -40.24 45.92 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.81 -0.756 . . . . 74.319999999999993 109.868 -176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -83.07 1.89 37.88 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 113.222 0.823 . . . . 73.510000000000005 113.222 -175.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -152.77 -163.72 11.89 Favored Glycine 0 C--N 1.304 -1.221 0 N-CA-C 109.524 -1.43 . . . . 54.329999999999998 109.524 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -95.17 -40.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.317 0 CA-C-N 119.753 1.776 . . . . 74.0 113.258 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -159.71 152.13 21.11 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 107.997 -1.112 . . . . 73.040000000000006 107.997 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -71.39 159.34 34.72 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.299 0.571 . . . . 73.25 111.797 174.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 41.9 p -161.04 162.23 31.65 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.755 -1.112 . . . . 74.129999999999995 109.215 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -158.19 148.39 20.18 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-O 121.404 0.621 . . . . 53.350000000000001 110.862 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.2 tt -117.18 120.4 64.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 CA-C-N 115.15 -0.932 . . . . 72.530000000000001 110.022 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 8.7 t -105.2 127.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 115.663 -0.699 . . . . 74.430000000000007 111.978 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 8.7 p -108.48 114.7 28.74 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.632 -1.167 . . . . 75.209999999999994 108.559 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 38.9 t -100.88 112.8 34.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 107.595 -1.261 . . . . 74.239999999999995 107.595 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -111.73 -175.36 2.67 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 120.847 0.356 . . . . 63.450000000000003 110.716 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.605 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 36.0 t -57.77 128.23 36.0 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 124.321 1.048 . . . . 72.439999999999998 110.981 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -158.1 -177.82 31.56 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.925 -0.655 . . . . 73.109999999999999 111.676 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.35 -36.37 8.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.336 -0.616 . . . . 65.209999999999994 109.336 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -150.0 153.47 36.59 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.772 -0.825 . . . . 75.420000000000002 108.772 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.796 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.7 OUTLIER -73.03 98.54 2.55 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.59 0.71 . . . . 71.099999999999994 112.238 178.058 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -131.53 149.94 52.33 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.211 -1.359 . . . . 44.130000000000003 109.46 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 28.2 mm -78.64 118.16 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 106.306 -1.739 . . . . 72.329999999999998 106.306 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 55.5 t -80.77 -51.2 16.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 111.984 0.365 . . . . 70.239999999999995 111.984 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 33.0 t -167.06 165.22 15.81 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 109.184 -0.673 . . . . 74.129999999999995 109.184 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 4.3 p -141.39 119.12 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 108.627 -0.879 . . . . 63.130000000000003 108.627 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . 0.428 ' O ' HD21 ' A' ' 440' ' ' LEU . 25.4 tp -118.79 137.35 53.44 Favored 'General case' 0 C--N 1.271 -2.816 0 N-CA-C 107.923 -1.14 . . . . 70.109999999999999 107.923 -175.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -80.96 111.74 17.71 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.787 -0.82 . . . . 64.109999999999999 108.787 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -72.24 -54.48 9.48 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.419 -0.809 . . . . 75.209999999999994 110.269 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -116.94 -73.87 0.63 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.253 -1.017 . . . . 65.319999999999993 108.253 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -164.23 -51.79 0.03 OUTLIER 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.19 -1.368 . . . . 73.239999999999995 109.821 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 72.1 m -103.27 -9.23 19.7 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.416 -0.811 . . . . 75.430000000000007 109.167 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.5 tt0 -113.07 132.46 55.41 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.675 -1.148 . . . . 73.340000000000003 109.029 -176.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 37.3 m-85 -128.02 150.32 49.98 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.048 -0.524 . . . . 74.439999999999998 110.516 -175.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.428 HD21 ' O ' ' A' ' 432' ' ' LEU . 1.7 pt? -109.52 119.79 40.51 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.203 -1.036 . . . . 75.349999999999994 108.203 172.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.3 mt -116.24 136.18 54.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 115.287 -0.869 . . . . 71.150000000000006 109.464 -175.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -108.46 141.07 40.86 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 109.187 -0.671 . . . . 64.310000000000002 109.187 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 83.1 mtp -136.1 168.18 19.86 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.923 -1.14 . . . . 71.040000000000006 107.923 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.796 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 34.2 mmtp -134.05 161.34 35.13 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.002 -1.11 . . . . 71.010000000000005 108.002 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 33.9 t -162.68 145.9 8.7 Favored Pre-proline 0 C--N 1.291 -1.958 0 N-CA-C 108.455 -0.943 . . . . 71.420000000000002 108.455 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.98 -27.43 66.3 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.452 2.101 . . . . 74.129999999999995 111.863 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.68 -12.28 56.1 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.355 0.598 . . . . 70.349999999999994 110.976 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -95.02 11.48 31.86 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 115.668 -0.696 . . . . 72.329999999999998 109.782 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 14.0 t -103.18 120.76 41.31 Favored 'General case' 0 N--CA 1.412 -2.325 0 N-CA-C 107.51 -1.293 . . . . 74.510000000000005 107.51 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--N 1.3 -1.544 0 CA-C-O 118.408 -0.806 . . . . 64.230000000000004 109.02 -178.166 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 . . . . . 0 CA--C 1.509 -0.617 0 N-CA-C 107.334 -1.358 . . . . 73.519999999999996 107.334 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -91.69 177.4 6.22 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.24 -0.652 . . . . 71.329999999999998 109.24 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -68.3 154.04 42.55 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.548 -0.538 . . . . 60.43 109.548 175.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 51.4 mm -79.53 129.96 36.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-O 121.527 0.68 . . . . 71.010000000000005 111.247 -171.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -71.07 136.32 48.21 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.664 -1.153 . . . . 73.329999999999998 111.252 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 60.63 58.78 12.11 Favored Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 117.248 1.659 . . . . 61.020000000000003 117.248 170.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 45.2 mtm -142.35 162.57 35.14 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.972 -0.751 . . . . 72.140000000000001 108.972 170.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -94.42 139.36 31.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.271 -0.64 . . . . 64.0 109.271 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' THR . . . . . 0.51 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 87.8 m -125.49 120.94 32.31 Favored 'General case' 0 C--N 1.264 -3.109 0 N-CA-C 107.163 -1.421 . . . . 72.310000000000002 107.163 168.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 10.0 ptmt -139.09 141.08 38.16 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.299 -0.409 . . . . 75.319999999999993 110.678 -174.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -159.94 138.44 10.44 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.112 -1.44 . . . . 73.310000000000002 107.112 -174.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -89.19 127.22 35.73 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.611 -0.514 . . . . 74.439999999999998 109.611 -176.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 44.6 mt -135.94 121.98 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 N-CA-C 106.867 -1.531 . . . . 75.120000000000005 106.867 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.66 12.64 59.62 Favored Glycine 0 C--N 1.306 -1.12 0 C-N-CA 120.571 -0.823 . . . . 72.040000000000006 112.883 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.98 -20.27 33.79 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 121.066 -0.588 . . . . 36.460000000000001 112.828 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . 0.434 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 12.1 p90 -105.05 146.65 28.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 122.802 -0.234 . . . . 74.409999999999997 110.515 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 60.4 m -86.51 126.51 34.49 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 120.957 -0.297 . . . . 75.099999999999994 110.471 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.607 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.6 OUTLIER -91.61 126.39 36.68 Favored 'General case' 0 N--CA 1.406 -2.651 0 N-CA-C 109.389 -0.597 . . . . 73.439999999999998 109.389 172.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 42.2 tttp -121.59 124.34 44.11 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.691 -0.855 . . . . 74.299999999999997 108.691 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.51 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.1 p -128.68 123.53 59.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 109.637 -0.505 . . . . 72.310000000000002 109.637 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 36.2 t -117.16 117.88 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 N-CA-C 108.083 -1.08 . . . . 73.299999999999997 108.083 174.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -53.22 125.32 17.18 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 124.393 1.058 . . . . 70.25 112.965 -174.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 69.35 12.43 8.33 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 125.189 1.395 . . . . 64.099999999999994 113.857 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -117.64 -91.22 0.55 Allowed 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 112.872 0.693 . . . . 65.540000000000006 112.872 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.475 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -161.13 157.3 25.71 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.732 0.642 . . . . 75.340000000000003 112.732 -173.395 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 82.5 t -113.69 144.24 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 124.115 0.966 . . . . 73.129999999999995 109.525 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.475 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 77.6 m-85 -133.73 147.13 51.31 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.007 0.432 . . . . 74.430000000000007 111.355 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -113.4 98.75 7.29 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.557 -1.646 . . . . 73.219999999999999 106.557 173.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.1 t70 70.17 -77.06 0.06 Allowed 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 124.886 1.274 . . . . 73.510000000000005 110.032 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.0 m -138.24 -6.38 1.59 Allowed 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.25 -0.886 . . . . 73.400000000000006 109.013 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 62.2 mt -84.88 134.76 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 116.257 -0.429 . . . . 71.439999999999998 109.905 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 56.4 tp -76.53 113.49 14.2 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.228 -1.027 . . . . 72.409999999999997 108.228 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.59 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -79.2 -63.85 1.32 Allowed 'General case' 0 N--CA 1.392 -3.337 0 N-CA-C 109.069 -0.715 . . . . 73.519999999999996 109.069 -176.13 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.53 156.82 28.18 Favored Glycine 0 N--CA 1.416 -2.65 0 C-N-CA 119.53 -1.319 . . . . 54.140000000000001 111.641 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -99.34 147.18 25.48 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.955 -1.128 . . . . 74.340000000000003 107.955 175.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -67.61 116.87 8.81 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.081 0.467 . . . . 74.109999999999999 111.233 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -97.87 -47.85 5.4 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.728 -0.669 . . . . 70.319999999999993 111.318 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 28.3 m -155.08 149.51 26.2 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.065 -0.346 . . . . 71.519999999999996 110.065 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . 0.443 ' CG ' ' HG ' ' A' ' 400' ' ' LEU . 13.8 mp0 -132.91 130.55 39.79 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 106.961 -1.496 . . . . 71.030000000000001 106.961 172.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -127.67 110.62 12.85 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.5 -0.926 . . . . 70.349999999999994 108.5 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 67.72 -101.82 0.76 Allowed Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.951 -0.568 . . . . 64.349999999999994 111.749 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -122.43 19.82 10.46 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.332 0.587 . . . . 75.140000000000001 109.907 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 46.6 t -118.37 119.07 60.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 108.273 -1.01 . . . . 71.010000000000005 108.273 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.443 ' HG ' ' CG ' ' A' ' 395' ' ' GLN . 4.9 mp -114.87 129.7 56.75 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.243 0.544 . . . . 72.140000000000001 110.619 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -113.55 125.86 54.66 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.906 -0.588 . . . . 72.010000000000005 110.265 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -118.72 136.67 53.82 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.282 -1.007 . . . . 74.120000000000005 108.282 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -144.39 174.17 11.15 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 110.315 -0.254 . . . . 61.420000000000002 110.315 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 12.7 m120 60.17 41.7 16.5 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.722 0.809 . . . . 63.32 112.205 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.59 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.7 -138.74 1.17 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.471 -0.871 . . . . 64.530000000000001 112.039 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.28 140.62 34.73 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.793 -0.817 . . . . 74.530000000000001 108.793 -178.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 47.0 m -60.73 123.68 18.18 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.551 0.945 . . . . 74.439999999999998 113.551 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 15.5 p -100.58 159.21 15.34 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 106.786 -1.561 . . . . 74.099999999999994 106.786 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -82.08 -28.54 32.3 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 119.146 0.884 . . . . 75.420000000000002 110.411 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -88.56 -8.48 54.7 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.585 -0.734 . . . . 74.430000000000007 110.56 -172.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -145.25 -168.71 13.11 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 109.18 -1.568 . . . . 73.200000000000003 109.18 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -85.96 -40.91 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.101 0 CA-C-N 120.018 1.909 . . . . 73.420000000000002 112.792 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 96.0 m-70 -163.39 154.36 16.53 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 107.389 -1.337 . . . . 61.409999999999997 107.389 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -69.0 159.08 33.48 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-O 121.287 0.565 . . . . 75.120000000000005 111.707 174.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 49.0 p -161.6 164.46 29.38 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 114.762 -1.108 . . . . 74.200000000000003 109.144 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -158.7 151.02 21.58 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.123 0.487 . . . . 54.200000000000003 110.254 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 11.5 tt -118.53 124.39 73.06 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 CA-C-N 115.478 -0.783 . . . . 64.409999999999997 109.342 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.462 ' CG2' ' HB ' ' A' ' 441' ' ' ILE . 5.2 t -111.31 129.61 66.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.534 0.683 . . . . 75.310000000000002 112.093 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 14.4 p -111.45 115.17 28.78 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 115.04 -0.982 . . . . 73.450000000000003 109.094 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 47.5 t -100.69 111.86 31.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.96 -0.756 . . . . 70.150000000000006 108.96 -177.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -113.52 -174.26 2.43 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 120.662 -0.415 . . . . 63.32 111.084 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 19.6 t -59.13 127.19 30.96 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.515 0.674 . . . . 73.310000000000002 112.763 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 446' ' ' PRO . . . -154.26 -177.58 27.8 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 110.039 -1.224 . . . . 74.150000000000006 110.039 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.57 -28.19 4.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.635 0.731 . . . . 64.409999999999997 109.041 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -145.5 151.07 37.59 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.161 -0.927 . . . . 73.439999999999998 108.801 -177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.67 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.9 OUTLIER -71.15 98.82 1.75 Allowed 'General case' 0 C--N 1.309 -1.167 0 O-C-N 124.033 0.833 . . . . 52.030000000000001 110.191 175.367 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -132.51 148.59 52.39 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-N 115.225 -0.898 . . . . 64.030000000000001 111.42 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 30.8 mm -81.8 120.31 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 106.043 -1.836 . . . . 63.350000000000001 106.043 174.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 53.3 t -86.29 -50.49 14.18 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 116.228 -0.442 . . . . 75.140000000000001 112.139 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 44.0 m -159.95 160.73 33.78 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.401 -0.592 . . . . 63.210000000000001 109.401 -175.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.406 HG13 ' CE2' ' A' ' 374' ' ' TYR . 3.6 p -141.14 111.65 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-O 122.017 0.913 . . . . 73.420000000000002 108.763 176.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 28.7 tp -110.94 136.53 49.82 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 115.321 -0.854 . . . . 73.439999999999998 108.711 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -80.92 110.17 16.2 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.489 -0.93 . . . . 63.32 108.489 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -71.47 -36.85 71.33 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.37 -0.832 . . . . 71.310000000000002 111.06 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -142.07 -73.85 0.31 Allowed 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.564 -0.744 . . . . 64.510000000000005 109.308 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.458 ' HB3' ' NZ ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -163.69 -49.01 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 116.112 -0.495 . . . . 74.530000000000001 110.899 175.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 75.7 m -98.04 -3.9 37.15 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.532 0.682 . . . . 71.030000000000001 110.107 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 415' ' ' SER . 34.5 tt0 -124.82 131.39 53.45 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.401 -0.818 . . . . 72.209999999999994 109.317 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -126.95 150.6 49.29 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.61 -0.723 . . . . 73.319999999999993 110.32 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -109.85 121.11 44.49 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.013 -1.106 . . . . 75.230000000000004 108.013 172.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.462 ' HB ' ' CG2' ' A' ' 418' ' ' VAL . 97.1 mt -115.51 132.87 63.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 CA-C-N 115.454 -0.794 . . . . 53.32 110.324 -175.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -98.85 136.8 38.34 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.449 -0.945 . . . . 73.349999999999994 108.449 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 82.6 mtp -137.46 157.73 45.93 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 109.835 -0.431 . . . . 61.340000000000003 109.835 177.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.67 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 31.7 mmtp -131.71 153.15 50.32 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.629 -1.249 . . . . 74.150000000000006 107.629 175.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 69.8 m -156.92 149.09 17.65 Favored Pre-proline 0 C--N 1.288 -2.096 0 N-CA-C 108.615 -0.883 . . . . 65.310000000000002 108.615 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 39.0 Cg_endo -67.66 -28.13 37.76 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 121.921 1.747 . . . . 74.129999999999995 111.975 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -76.28 -22.46 55.05 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.737 -0.665 . . . . 72.010000000000005 111.022 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -84.16 0.46 48.52 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.741 0.781 . . . . 71.409999999999997 109.399 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 11.4 t -103.92 118.65 37.19 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 107.576 -1.268 . . . . 73.519999999999996 107.576 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 52.9 m . . . . . 0 C--N 1.296 -1.742 0 N-CA-C 107.935 -1.135 . . . . 74.349999999999994 107.935 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 109.298 -0.63 . . . . 73.200000000000003 109.298 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -78.64 -17.54 55.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.345 0.593 . . . . 74.519999999999996 111.173 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -139.43 151.79 46.53 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.059 -0.719 . . . . 74.209999999999994 109.059 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 49.7 mm -81.59 116.26 25.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.886 -0.783 . . . . 62.100000000000001 108.886 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -78.81 157.26 28.43 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.924 -0.58 . . . . 75.099999999999994 111.846 -174.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 77.19 -47.16 2.58 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 114.879 0.712 . . . . 72.019999999999996 114.879 174.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 52.6 ttp -57.59 136.83 56.81 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.431 0.634 . . . . 72.349999999999994 112.64 -175.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.419 ' CB ' HG21 ' A' ' 377' ' ' VAL . 8.0 pt-20 -93.95 110.52 22.19 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.197 -0.911 . . . . 70.420000000000002 111.476 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 85.3 m -103.97 139.62 38.85 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.491 -0.929 . . . . 54.340000000000003 108.491 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 366' ' ' LYS . 0.0 OUTLIER -145.73 151.89 38.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 118.344 0.52 . . . . 71.409999999999997 111.591 -177.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -161.6 135.47 6.68 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.132 -0.692 . . . . 74.219999999999999 109.132 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.22 125.97 30.18 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 110.275 -0.268 . . . . 74.409999999999997 110.275 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 37.2 mt -134.19 119.79 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.828 -1.545 . . . . 74.409999999999997 106.828 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.66 12.64 59.62 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 121.164 -0.541 . . . . 65.209999999999994 112.07 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 105.78 -23.19 30.19 Favored Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 121.603 -0.332 . . . . 41.329999999999998 112.352 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -98.19 136.76 37.93 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 121.184 0.516 . . . . 74.120000000000005 110.548 -176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 98.9 m -79.54 116.23 19.63 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 115.525 -0.761 . . . . 64.030000000000001 110.556 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.12 133.58 34.78 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 107.868 -1.16 . . . . 65.519999999999996 107.868 175.001 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 36.8 ttpt -133.34 130.78 39.3 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.211 -0.595 . . . . 62.340000000000003 109.599 -175.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.0 115.92 46.42 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 O-C-N 123.584 0.552 . . . . 73.439999999999998 110.056 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.419 HG21 ' CB ' ' A' ' 364' ' ' GLU . 47.8 t -108.53 116.45 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.563 -1.273 . . . . 74.319999999999993 107.563 175.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -63.76 126.2 26.82 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 113.895 1.072 . . . . 72.510000000000005 113.895 -173.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 73.03 10.66 5.27 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 125.997 1.719 . . . . 74.299999999999997 113.117 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.8 -84.49 0.65 Allowed 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 112.489 0.552 . . . . 75.530000000000001 112.489 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.524 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -166.38 159.62 14.9 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.99 0.737 . . . . 74.120000000000005 112.99 -172.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 98.7 t -113.74 145.75 19.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 124.642 1.177 . . . . 72.430000000000007 109.141 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.524 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 71.1 m-85 -132.77 152.43 51.77 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 122.973 0.509 . . . . 64.319999999999993 111.986 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -124.76 102.04 7.38 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.347 -1.723 . . . . 71.120000000000005 106.347 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 14.3 t70 69.64 -83.84 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.564 1.146 . . . . 73.299999999999997 109.543 -175.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.3 m -133.28 -7.37 2.97 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 108.608 -0.886 . . . . 54.140000000000001 108.608 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 63.0 mt -80.59 132.91 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.388 -0.823 . . . . 74.319999999999993 110.127 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 64.8 tp -76.9 109.97 11.13 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.499 -0.926 . . . . 73.340000000000003 108.499 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.485 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -77.67 -65.4 0.97 Allowed 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 109.111 -0.7 . . . . 71.209999999999994 109.111 -176.67 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.23 153.58 24.66 Favored Glycine 0 N--CA 1.424 -2.103 0 C-N-CA 119.26 -1.448 . . . . 63.130000000000003 111.64 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.46 144.76 28.19 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.711 -1.218 . . . . 61.140000000000001 107.711 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -73.02 116.3 13.38 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.267 -0.642 . . . . 75.329999999999998 109.267 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -111.21 -47.99 3.14 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.939 -0.573 . . . . 72.310000000000002 110.863 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 18.7 m -145.63 138.96 26.29 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.504 -0.925 . . . . 74.239999999999995 108.504 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . 0.437 ' OE1' HD21 ' A' ' 400' ' ' LEU . 9.8 pt20 -147.4 145.32 29.21 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 120.938 0.399 . . . . 73.409999999999997 110.84 173.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -121.17 110.24 15.95 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 115.649 -0.705 . . . . 62.140000000000001 109.535 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.19 -104.27 0.79 Allowed Glycine 0 N--CA 1.436 -1.339 0 CA-C-N 115.265 -0.88 . . . . 73.420000000000002 113.823 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -116.83 18.2 14.87 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.128 0.489 . . . . 74.319999999999993 111.187 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.3 t -125.15 116.09 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 105.159 -2.163 . . . . 64.230000000000004 105.159 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.47 ' HB2' ' HH ' ' A' ' 402' ' ' TYR . 13.6 mt -118.63 136.28 53.98 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.862 -0.735 . . . . 74.040000000000006 111.241 -168.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -107.43 124.09 49.35 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.498 0.666 . . . . 74.310000000000002 112.076 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.47 ' HH ' ' HB2' ' A' ' 400' ' ' LEU . 2.9 m-85 -117.08 125.88 51.98 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.77 -1.566 . . . . 75.239999999999995 106.77 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -139.77 175.86 9.22 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 110.113 -0.329 . . . . 75.120000000000005 110.113 -176.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.0 m120 64.93 33.3 10.0 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.856 0.722 . . . . 71.209999999999994 112.503 173.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.6 -141.23 1.17 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.785 -0.722 . . . . 73.140000000000001 113.054 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.77 142.11 38.86 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.95 -1.13 . . . . 74.129999999999995 107.95 -177.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.3 m -60.79 134.74 57.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.413 0.625 . . . . 37.600000000000001 111.687 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 14.6 p -132.38 159.46 39.17 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.679 -0.691 . . . . 74.310000000000002 110.472 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -66.88 137.38 56.53 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.735 0.302 . . . . 72.25 111.615 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 80.4 -29.8 0.13 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.84 1.656 . . . . 75.349999999999994 112.426 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -107.41 174.52 19.66 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.191 -0.764 . . . . 53.229999999999997 111.191 177.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -79.51 -40.5 0.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.483 1.456 . . . . 73.319999999999993 111.878 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -163.1 162.45 25.7 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 105.157 -2.164 . . . . 75.420000000000002 105.157 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -69.32 156.33 38.97 Favored 'General case' 0 C--O 1.256 1.407 0 C-N-CA 119.641 -0.824 . . . . 75.519999999999996 111.568 174.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.528 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 23.7 p -157.59 158.92 36.48 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-N 114.67 -1.15 . . . . 71.329999999999998 109.192 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -154.03 149.01 26.73 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.26 0.552 . . . . 74.310000000000002 110.656 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.4 tt -118.99 123.81 72.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 CA-C-N 115.107 -0.951 . . . . 74.5 109.816 175.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.521 ' CG2' ' HB ' ' A' ' 441' ' ' ILE . 4.1 t -109.85 130.66 62.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 115.785 -0.643 . . . . 65.299999999999997 111.231 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 20.5 p -108.46 115.01 29.3 Favored 'General case' 0 N--CA 1.409 -2.525 0 N-CA-C 108.322 -0.992 . . . . 64.450000000000003 108.322 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 38.5 t -100.36 114.72 39.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.039 -1.467 . . . . 74.049999999999997 107.039 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.02 -173.94 2.55 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.915 -0.314 . . . . 71.239999999999995 110.556 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.513 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 38.3 t -60.5 127.92 34.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.235 0.54 . . . . 75.420000000000002 111.71 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.36 -179.7 31.57 Favored Glycine 0 CA--C 1.485 -1.808 0 N-CA-C 110.535 -1.026 . . . . 74.400000000000006 110.535 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.08 -35.32 7.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.899 -0.778 . . . . 73.409999999999997 108.899 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -143.79 152.16 40.87 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.367 -0.833 . . . . 72.319999999999993 109.722 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.719 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.9 OUTLIER -69.57 97.95 1.09 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.034 -0.985 . . . . 71.239999999999995 110.586 175.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -132.16 149.56 52.36 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.851 -1.068 . . . . 54.409999999999997 109.906 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 32.6 mm -84.35 119.41 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 105.993 -1.855 . . . . 71.209999999999994 105.993 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 54.8 t -83.86 -51.04 14.65 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 CA-C-N 116.409 -0.36 . . . . 73.319999999999993 111.623 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 38.5 p -165.26 167.97 17.43 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 120.914 -0.314 . . . . 73.319999999999993 110.674 -175.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.19 126.25 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 N-CA-C 109.124 -0.695 . . . . 74.010000000000005 109.124 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . 0.421 ' O ' HD21 ' A' ' 440' ' ' LEU . 28.1 tp -126.82 137.96 53.27 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.885 -0.783 . . . . 73.540000000000006 108.885 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -81.07 113.0 18.96 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.291 -1.003 . . . . 75.420000000000002 108.291 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.02 -50.81 18.13 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-N 115.715 -0.675 . . . . 74.319999999999993 110.226 -174.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . 0.534 ' C ' ' HD2' ' A' ' 436' ' ' LYS . 49.4 mt-30 -121.47 -82.24 0.65 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.236 -0.893 . . . . 74.239999999999995 108.753 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.534 ' HD2' ' C ' ' A' ' 435' ' ' GLN . 0.2 OUTLIER -145.31 -61.73 0.34 Allowed 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 108.26 -1.015 . . . . 74.019999999999996 108.26 177.025 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 92.3 m -93.64 -7.96 42.38 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.158 -1.383 . . . . 65.549999999999997 111.693 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 415' ' ' SER . 35.6 tt0 -110.39 128.6 55.66 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-N 115.291 -0.868 . . . . 64.409999999999997 109.077 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 46.4 m-85 -124.48 149.72 46.53 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.757 -0.656 . . . . 74.099999999999994 109.785 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.421 HD21 ' O ' ' A' ' 432' ' ' LEU . 1.5 pt? -111.47 119.54 39.12 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.341 -0.615 . . . . 74.219999999999999 109.341 175.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.521 ' HB ' ' CG2' ' A' ' 418' ' ' VAL . 3.8 mp -109.62 133.9 53.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.87 -0.604 . . . . 73.439999999999998 109.883 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -96.25 135.82 37.56 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 108.397 -0.964 . . . . 75.010000000000005 108.397 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 81.8 mtp -138.01 160.53 39.12 Favored 'General case' 0 CA--C 1.478 -1.802 0 N-CA-C 109.678 -0.49 . . . . 74.329999999999998 109.678 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.719 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 73.8 mmtt -131.05 160.96 33.11 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.743 -1.206 . . . . 73.319999999999993 107.743 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 40.8 t -165.45 145.04 5.49 Favored Pre-proline 0 C--N 1.284 -2.252 0 O-C-N 124.118 0.886 . . . . 71.25 109.023 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -66.42 -27.36 47.13 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.04 1.826 . . . . 75.319999999999993 110.618 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -76.52 -17.81 59.05 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.327 -0.851 . . . . 74.519999999999996 111.182 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -97.12 11.99 34.3 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.546 0.688 . . . . 70.530000000000001 110.128 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 16.9 t -102.81 141.02 36.32 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 115.414 -0.812 . . . . 64.409999999999997 108.988 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 N--CA 1.417 -2.081 0 N-CA-C 107.305 -1.368 . . . . 64.109999999999999 107.305 -179.25 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 . . . . . 0 CA--C 1.51 -0.574 0 N-CA-C 109.204 -0.665 . . . . 72.400000000000006 109.204 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 0.0 OUTLIER 55.35 -161.11 0.17 Allowed 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.729 0.643 . . . . 73.329999999999998 110.962 -178.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -91.9 154.55 18.78 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.766 -1.198 . . . . 64.239999999999995 107.766 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . 0.423 ' N ' HD11 ' A' ' 360' ' ' ILE . 2.4 mp -78.55 120.52 29.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.866 0.841 . . . . 74.450000000000003 110.417 -172.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.507 ' HG2' ' CD1' ' A' ' 379' ' ' TYR . 54.1 mtpt -68.92 153.89 43.0 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 114.084 -1.416 . . . . 74.299999999999997 112.395 -175.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 89.75 -58.84 3.68 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.407 -0.815 . . . . 54.039999999999999 115.05 173.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 59.0 mtm -62.7 140.21 58.7 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.079 0.466 . . . . 75.5 112.223 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -85.59 114.8 22.87 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.76 -1.57 . . . . 63.350000000000001 106.76 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' THR . . . . . 0.465 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 84.7 m -94.87 130.3 41.52 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 106.388 -1.708 . . . . 64.109999999999999 106.388 176.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 0.0 OUTLIER -143.49 150.23 38.67 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.418 -0.913 . . . . 63.409999999999997 111.108 -175.399 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -162.37 136.48 6.49 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.741 -0.836 . . . . 62.520000000000003 108.741 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -77.81 124.98 28.65 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 109.815 -0.439 . . . . 70.230000000000004 109.815 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 56.4 mt -134.82 118.99 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 N-CA-C 106.883 -1.525 . . . . 73.040000000000006 106.883 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.49 13.59 60.93 Favored Glycine 0 C--N 1.305 -1.139 0 C-N-CA 120.538 -0.839 . . . . 62.399999999999999 112.675 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 105.56 -17.78 42.35 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 120.997 -0.62 . . . . 73.340000000000003 113.252 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -105.26 142.17 35.49 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 120.61 0.243 . . . . 74.519999999999996 110.595 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 97.8 m -82.25 119.75 24.49 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.099 0.476 . . . . 73.040000000000006 110.057 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.586 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -90.79 126.53 36.04 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 108.533 -0.914 . . . . 73.430000000000007 108.533 176.087 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -126.43 127.45 45.44 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.28 -0.568 . . . . 73.549999999999997 109.874 -175.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.465 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 5.9 p -124.58 117.07 49.38 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 116.16 -0.473 . . . . 72.219999999999999 111.036 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.98 116.22 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.141 -1.429 . . . . 70.319999999999993 107.141 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.521 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 95.1 m-85 -70.3 131.29 43.93 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 114.705 1.372 . . . . 73.420000000000002 114.705 -170.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.507 ' CD1' ' HG2' ' A' ' 361' ' ' LYS . 25.4 m-85 71.64 13.08 6.35 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.254 1.422 . . . . 73.109999999999999 112.232 -176.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -125.71 -86.18 0.62 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.484 -0.78 . . . . 72.450000000000003 113.044 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.439 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -162.72 153.22 16.7 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.304 0.853 . . . . 70.140000000000001 113.304 -173.013 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 44.7 t -113.56 149.44 15.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 C-N-CA 124.054 0.942 . . . . 63.420000000000002 108.725 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.439 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 62.8 m-85 -139.63 144.7 37.81 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.348 0.405 . . . . 60.229999999999997 111.088 -177.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -107.24 110.01 21.94 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 106.346 -1.724 . . . . 74.109999999999999 106.346 169.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 17.2 t70 69.1 -87.02 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 123.76 0.824 . . . . 72.319999999999993 110.422 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 19.5 m -136.16 -1.88 2.34 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.966 -0.753 . . . . 63.130000000000003 108.966 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 47.2 mm -88.66 138.68 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 109.646 -0.501 . . . . 65.420000000000002 109.646 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.3 tp -74.25 117.69 16.35 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.24 -1.763 . . . . 75.010000000000005 106.24 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.536 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 49.7 tp -91.79 -58.41 2.43 Favored 'General case' 0 N--CA 1.381 -3.877 0 CA-C-N 115.412 -0.813 . . . . 73.439999999999998 110.856 -173.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.46 148.13 15.96 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 119.401 -1.381 . . . . 70.340000000000003 111.492 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -99.75 145.15 27.99 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.503 -1.295 . . . . 70.310000000000002 107.503 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . 0.521 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.5 m-85 -70.26 117.21 11.52 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 120.771 0.32 . . . . 75.109999999999999 111.324 -176.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -88.33 -46.81 8.89 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.925 -0.58 . . . . 73.519999999999996 110.15 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 60.6 p -169.03 160.75 10.16 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-N 115.765 -0.652 . . . . 75.120000000000005 109.599 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 14.8 mp0 -130.67 138.13 49.9 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.657 -1.238 . . . . 74.340000000000003 107.657 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -128.43 114.42 16.78 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.869 -0.789 . . . . 74.420000000000002 108.869 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 358' ' ' ARG . . . 72.18 -101.44 1.05 Allowed Glycine 0 N--CA 1.422 -2.251 0 C-N-CA 119.169 -1.491 . . . . 41.520000000000003 112.056 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 21.7 p-10 -128.04 15.7 6.79 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 123.598 0.759 . . . . 75.140000000000001 109.381 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 35.9 t -118.89 121.66 67.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.459 -0.941 . . . . 75.329999999999998 108.459 -175.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 3.2 mp -117.4 132.61 56.54 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 116.078 -0.51 . . . . 72.450000000000003 110.669 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . 0.433 ' HZ3' ' HB ' ' A' ' 417' ' ' ILE . 57.0 mmtt -106.29 125.73 51.36 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 115.903 -0.59 . . . . 53.539999999999999 111.231 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.452 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 3.7 m-85 -118.48 135.89 54.12 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.98 -1.118 . . . . 71.200000000000003 107.98 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.69 176.14 10.08 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.556 0.217 . . . . 74.040000000000006 111.538 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 14.1 m120 65.31 33.19 9.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.673 0.789 . . . . 73.230000000000004 112.386 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -73.8 -149.16 1.4 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.898 -0.667 . . . . 53.039999999999999 112.345 176.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -73.93 137.92 43.92 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 122.106 -0.644 . . . . 74.439999999999998 110.069 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 26.4 p -60.68 118.9 7.16 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 124.661 1.184 . . . . 71.010000000000005 113.934 -175.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 14.2 p -105.27 158.28 16.72 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.087 -1.449 . . . . 70.120000000000005 107.087 175.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -83.17 -27.99 29.66 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.567 -0.853 . . . . 74.349999999999994 109.536 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -91.72 19.29 6.57 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.293 -0.867 . . . . 75.409999999999997 109.866 -170.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -173.1 -171.5 37.83 Favored Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 108.029 -2.029 . . . . 74.209999999999994 108.029 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -87.02 -40.89 0.06 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.152 0 CA-C-N 120.3 2.05 . . . . 73.019999999999996 111.775 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -161.24 163.18 31.2 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 106.723 -1.584 . . . . 65.340000000000003 106.723 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -76.61 158.48 31.07 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.269 0.557 . . . . 70.430000000000007 112.457 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 37.4 p -160.69 163.72 32.22 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 114.983 -1.008 . . . . 63.109999999999999 109.122 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.52 143.29 13.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 120.77 0.319 . . . . 74.530000000000001 110.584 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . 0.433 ' HB ' ' HZ3' ' A' ' 401' ' ' LYS . 7.4 tt -103.84 131.73 51.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.78 -0.822 . . . . 71.409999999999997 108.78 173.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.7 t -113.32 125.28 70.56 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-O 121.084 0.469 . . . . 73.349999999999994 110.181 174.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 1.1 m -110.07 114.45 27.97 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 105.878 -1.897 . . . . 61.030000000000001 105.878 176.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 22.0 t -101.17 117.24 46.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.357 -0.979 . . . . 74.230000000000004 108.357 -176.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -106.7 -179.05 3.83 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 120.281 -0.568 . . . . 72.129999999999995 109.935 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 40.2 t -60.56 128.99 39.34 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 123.37 0.668 . . . . 63.409999999999997 110.644 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -153.16 -177.4 26.67 Favored Glycine 0 CA--C 1.485 -1.812 0 N-CA-C 111.065 -0.814 . . . . 75.109999999999999 111.065 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.93 -30.13 4.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.498 0.666 . . . . 75.530000000000001 109.213 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -151.02 151.25 31.77 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.369 -0.832 . . . . 74.109999999999999 109.222 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.632 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.0 OUTLIER -65.34 100.23 0.46 Allowed 'General case' 0 C--N 1.311 -1.098 0 O-C-N 124.164 0.915 . . . . 74.329999999999998 110.841 174.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -131.93 149.25 52.49 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.776 -1.102 . . . . 75.329999999999998 110.246 -176.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.408 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 29.7 mm -86.87 122.25 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 106.261 -1.755 . . . . 74.439999999999998 106.261 176.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' A' ' 442' ' ' LYS . 64.9 t -84.37 -50.43 15.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 CA-C-N 116.455 -0.339 . . . . 74.040000000000006 111.653 -177.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.5 m -165.66 164.23 19.09 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.151 -0.685 . . . . 72.439999999999998 109.151 -175.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 3.3 p -141.49 125.32 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 107.253 -1.388 . . . . 73.019999999999996 107.253 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 42.8 tp -131.73 137.26 48.15 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 108.627 -0.879 . . . . 71.200000000000003 108.627 -176.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -81.64 119.04 23.3 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.45 -0.945 . . . . 61.549999999999997 108.45 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.3 -56.32 5.01 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.335 -0.848 . . . . 64.129999999999995 110.701 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -119.55 -71.49 0.73 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.739 -0.664 . . . . 74.140000000000001 110.603 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.474 ' HZ1' ' HB3' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -162.39 -42.14 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.767 0 CA-C-O 121.332 0.587 . . . . 74.150000000000006 111.152 175.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 90.7 m -112.77 13.3 19.75 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.71 0.766 . . . . 62.119999999999997 109.959 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 415' ' ' SER . 31.0 tt0 -135.23 131.23 36.39 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.079 -0.964 . . . . 62.329999999999998 108.875 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -123.5 150.68 43.65 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 123.591 0.557 . . . . 74.519999999999996 111.279 -176.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -110.58 118.01 35.06 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.428 -0.953 . . . . 64.530000000000001 108.428 172.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 92.6 mt -119.29 133.12 67.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.294 -0.867 . . . . 63.439999999999998 109.308 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.413 ' O ' ' HB ' ' A' ' 429' ' ' VAL . 37.9 ttpt -111.53 141.38 45.18 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 109.285 -0.635 . . . . 72.209999999999994 109.285 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.408 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 79.6 mtp -136.32 169.19 18.06 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 109.272 -0.64 . . . . 75.439999999999998 109.272 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 66.8 mmtt -132.22 159.97 37.49 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.97 -1.122 . . . . 74.129999999999995 107.97 175.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 41.2 t -172.45 145.69 1.5 Allowed Pre-proline 0 C--N 1.289 -2.05 0 O-C-N 124.187 0.929 . . . . 55.420000000000002 109.707 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.0 -24.27 45.62 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.314 2.009 . . . . 72.129999999999995 110.917 176.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.09 -18.75 52.77 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.698 -0.683 . . . . 72.439999999999998 111.017 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -93.16 9.2 36.99 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.66 0.743 . . . . 74.299999999999997 109.57 176.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 10.8 t -102.29 119.34 38.65 Favored 'General case' 0 N--CA 1.408 -2.548 0 N-CA-C 106.983 -1.488 . . . . 43.200000000000003 106.983 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.425 -1.718 0 N-CA-C 107.627 -1.249 . . . . 75.519999999999996 107.627 -175.611 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.423 ' C ' ' H ' ' A' ' 359' ' ' ALA . 99.1 m-85 . . . . . 0 N--CA 1.465 0.289 0 N-CA-C 111.181 0.067 . . . . 73.319999999999993 111.181 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? 70.5 -39.47 0.44 Allowed 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.954 0.902 . . . . 54.109999999999999 111.572 -175.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.423 ' H ' ' C ' ' A' ' 357' ' ' TYR . . . -131.46 150.38 52.17 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.796 -1.187 . . . . 74.120000000000005 107.796 175.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 50.2 mm -82.65 116.7 27.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 110.208 -0.293 . . . . 73.420000000000002 110.208 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.531 ' HA ' ' CB ' ' A' ' 378' ' ' PHE . 21.9 pttp -85.9 157.43 20.18 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.72 0.637 . . . . 75.340000000000003 112.72 -175.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 84.71 -39.36 2.94 Favored Glycine 0 C--O 1.238 0.367 0 CA-C-N 116.038 -0.528 . . . . 54.25 113.473 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 55.9 ttp -77.96 139.94 39.2 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.895 0.378 . . . . 75.310000000000002 111.449 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -81.0 120.21 24.49 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.205 -0.665 . . . . 72.129999999999995 109.205 177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 94.0 m -108.12 120.77 43.29 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.932 -1.136 . . . . 62.509999999999998 107.932 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.444 ' HB3' ' HG3' ' A' ' 375' ' ' LYS . 13.3 ptmm? -136.52 144.46 44.28 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.51 0.93 . . . . 75.519999999999996 113.51 -173.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -156.55 135.54 11.9 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.244 -1.391 . . . . 74.439999999999998 107.244 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 43.7 mt-10 -86.29 128.43 34.92 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 109.645 -0.502 . . . . 73.420000000000002 109.645 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.63 118.76 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 N-CA-C 107.463 -1.31 . . . . 72.5 107.463 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.24 14.41 61.68 Favored Glycine 0 C--N 1.308 -1.016 0 C-N-CA 120.612 -0.804 . . . . 73.530000000000001 112.631 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 109.15 -24.53 20.74 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 120.919 -0.658 . . . . 75.450000000000003 112.91 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -98.78 136.02 39.42 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 120.946 0.403 . . . . 64.219999999999999 111.07 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 41.3 m -77.52 115.3 17.17 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.074 -0.512 . . . . 65.430000000000007 110.206 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.423 ' HH ' HG21 ' A' ' 431' ' ' VAL . 0.2 OUTLIER -91.05 131.34 36.69 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 108.438 -0.949 . . . . 72.420000000000002 108.438 175.206 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.444 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 38.5 ttpt -135.32 125.45 26.09 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 120.165 -0.614 . . . . 55.009999999999998 109.994 -177.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.02 115.51 49.13 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 N-CA-C 108.266 -1.013 . . . . 71.230000000000004 108.266 176.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 39.5 t -104.96 115.08 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.422 0 N-CA-C 105.662 -1.977 . . . . 74.120000000000005 105.662 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.531 ' CB ' ' HA ' ' A' ' 361' ' ' LYS . 94.3 m-85 -68.72 127.52 33.34 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 114.216 1.191 . . . . 64.140000000000001 114.216 -170.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . 0.27 47.9 m-85 71.19 16.14 6.31 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 113.964 -1.471 . . . . 72.439999999999998 112.956 -176.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -125.91 -83.41 0.63 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.258 -0.883 . . . . 75.349999999999994 112.566 173.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.521 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.5 OUTLIER -161.6 162.53 30.12 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.701 0.63 . . . . 70.030000000000001 112.701 -169.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 87.1 t -121.16 143.29 33.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 124.305 1.042 . . . . 75.329999999999998 108.65 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.521 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 66.4 m-85 -132.25 144.89 50.93 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 123.209 0.604 . . . . 74.109999999999999 112.198 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -116.17 102.15 9.34 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 105.776 -1.935 . . . . 74.329999999999998 105.776 171.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.4 t70 72.38 -80.67 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 125.065 1.346 . . . . 54.509999999999998 109.569 -176.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.4 m -142.69 -1.88 1.1 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.945 -1.025 . . . . 43.210000000000001 108.352 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 49.8 mt -88.07 139.31 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.746 -0.661 . . . . 74.340000000000003 109.977 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 58.6 tp -76.43 110.29 10.84 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.56 -0.904 . . . . 61.130000000000003 108.56 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.39 -60.04 2.47 Favored 'General case' 0 N--CA 1.393 -3.324 0 N-CA-C 109.18 -0.674 . . . . 73.319999999999993 109.18 -176.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.45 160.02 31.4 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 119.475 -1.345 . . . . 63.020000000000003 111.644 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -110.11 151.32 27.38 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.942 -1.133 . . . . 62.340000000000003 107.942 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . 0.495 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.8 m-85 -73.56 127.95 34.17 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 111.777 0.288 . . . . 75.400000000000006 111.777 -175.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -110.5 -49.57 3.04 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.18 -0.608 . . . . 44.240000000000002 112.575 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 54.2 p -167.75 139.92 3.12 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.694 -0.484 . . . . 73.239999999999995 109.694 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . 0.435 ' NE2' ' HD2' ' A' ' 392' ' ' PHE . 2.4 mm-40 -118.17 147.12 43.66 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 109.989 -0.374 . . . . 65.519999999999996 109.989 -176.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -128.41 110.31 12.21 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.192 -0.67 . . . . 71.040000000000006 109.192 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.95 -108.11 2.09 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 116.145 -0.479 . . . . 71.140000000000001 112.405 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -117.23 16.77 14.86 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.28 0.562 . . . . 74.140000000000001 110.196 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 52.3 t -117.44 116.87 53.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.797 -1.186 . . . . 61.409999999999997 107.797 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.63 142.42 39.12 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.571 -0.74 . . . . 63.43 111.386 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -120.1 122.47 41.12 Favored 'General case' 0 C--O 1.25 1.097 0 CA-C-O 121.403 0.62 . . . . 71.430000000000007 111.814 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -118.3 137.32 53.15 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.934 -1.136 . . . . 74.310000000000002 107.934 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . 0.432 ' HA ' ' CB ' ' A' ' 415' ' ' SER . 46.6 mt-10 -142.47 175.59 9.66 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.008 -0.738 . . . . 74.219999999999999 109.008 -177.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.79 33.54 10.17 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.275 1.213 . . . . 73.049999999999997 114.275 171.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.72 -141.9 3.02 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 120.233 -0.984 . . . . 61.43 111.602 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -56.0 136.92 51.77 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 123.343 0.657 . . . . 64.540000000000006 110.993 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 26.4 p -73.18 117.5 14.99 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 120.919 0.39 . . . . 71.230000000000004 110.806 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 26.4 p -110.43 159.86 17.11 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.804 -0.813 . . . . 43.340000000000003 108.804 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 9.4 p-90 -81.74 -32.62 31.43 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 120.245 -0.582 . . . . 74.420000000000002 110.715 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -81.88 -17.05 48.63 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.902 -0.59 . . . . 75.310000000000002 111.506 -170.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -138.72 -169.36 11.54 Favored Glycine 0 C--N 1.304 -1.235 0 N-CA-C 109.503 -1.439 . . . . 62.409999999999997 109.503 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -79.51 -40.49 0.25 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 CA-C-N 120.022 1.911 . . . . 74.450000000000003 110.903 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -164.61 166.41 20.23 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 105.678 -1.971 . . . . 71.5 105.678 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -73.24 156.37 38.58 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.156 0.503 . . . . 51.200000000000003 109.872 171.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.432 ' CB ' ' HA ' ' A' ' 403' ' ' GLU . 54.2 p -160.54 169.07 23.7 Favored 'General case' 0 N--CA 1.401 -2.916 0 CA-C-N 115.306 -0.861 . . . . 74.340000000000003 109.047 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -159.07 151.07 20.93 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.364 0.602 . . . . 72.430000000000007 111.281 -177.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.1 tt -115.1 133.01 62.66 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 CA-C-N 115.08 -0.964 . . . . 73.010000000000005 108.558 173.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 4.9 t -118.57 129.68 74.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.233 0.54 . . . . 64.349999999999994 111.638 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.3 p -108.26 113.24 26.19 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.635 -1.246 . . . . 64.140000000000001 107.635 174.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 21.1 t -101.48 112.2 33.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.132 -1.062 . . . . 75.209999999999994 108.132 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 444' ' ' LYS . 41.1 mt-10 -108.16 179.52 4.19 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.988 -0.285 . . . . 64.349999999999994 110.315 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 43.2 t -59.29 128.76 38.75 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 123.464 0.706 . . . . 65.400000000000006 110.863 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.425 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -153.42 -176.89 26.37 Favored Glycine 0 CA--C 1.486 -1.723 0 C-N-CA 120.779 -0.724 . . . . 65.409999999999997 111.452 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 50.6 t -89.3 -37.31 9.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.998 -0.741 . . . . 72.219999999999999 108.998 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -150.48 160.3 43.87 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.638 -0.71 . . . . 74.299999999999997 109.31 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 70.0 m-20 -68.78 101.22 1.29 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.44 0.696 . . . . 73.25 109.709 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -131.89 148.25 52.52 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 110.432 -0.211 . . . . 74.129999999999995 110.432 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 30.5 mm -82.91 115.47 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 105.88 -1.896 . . . . 74.140000000000001 105.88 173.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 42.6 t -81.18 -47.49 19.95 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.637 0 N-CA-C 112.553 0.575 . . . . 71.049999999999997 112.553 -176.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 26.1 t -166.0 162.35 17.96 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.522 -0.918 . . . . 60.520000000000003 108.522 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.423 HG21 ' HH ' ' A' ' 374' ' ' TYR . 3.1 p -141.27 119.9 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.143 0 N-CA-C 108.666 -0.865 . . . . 71.329999999999998 108.666 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 30.7 tp -121.21 136.61 54.94 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 108.268 -1.012 . . . . 63.200000000000003 108.268 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.428 ' CD ' ' HA ' ' A' ' 436' ' ' LYS . 43.7 tt0 -81.37 116.88 21.41 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.858 -1.164 . . . . 73.120000000000005 107.858 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.47 -46.69 38.02 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.887 0.851 . . . . 64.239999999999995 109.498 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -129.29 -78.68 0.56 Allowed 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.897 -1.047 . . . . 74.400000000000006 109.28 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.476 ' HB3' ' NZ ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -168.05 -40.25 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 123.367 0.667 . . . . 73.120000000000005 110.492 174.048 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 91.4 m -100.72 7.79 43.66 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.749 0.785 . . . . 74.349999999999994 109.477 174.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -136.44 129.69 31.51 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.484 -0.78 . . . . 72.319999999999993 109.944 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 43.4 m-85 -125.32 150.57 47.02 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 123.522 0.514 . . . . 75.439999999999998 110.096 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -111.9 120.92 43.55 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.369 -0.604 . . . . 75.200000000000003 109.369 172.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 4.0 mp -113.74 133.48 59.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 116.127 -0.488 . . . . 64.299999999999997 110.105 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -104.01 140.53 37.61 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 107.847 -1.168 . . . . 72.140000000000001 107.847 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 80.7 mtp -138.79 168.33 20.05 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 109.231 -0.655 . . . . 74.120000000000005 109.231 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.9 mmtt -133.53 160.02 38.7 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.146 -1.057 . . . . 75.5 108.146 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 46.2 t -165.89 146.13 5.49 Favored Pre-proline 0 C--N 1.284 -2.247 0 O-C-N 124.193 0.933 . . . . 63.43 109.894 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.2 -27.09 41.69 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.158 1.905 . . . . 65.230000000000004 110.147 174.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -78.79 -21.65 47.49 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.291 -0.868 . . . . 64.200000000000003 110.245 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -89.38 9.62 25.53 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 121.162 0.506 . . . . 70.430000000000007 110.708 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 9.0 t -103.04 119.27 38.55 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 107.821 -1.178 . . . . 73.209999999999994 107.821 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 35.6 t . . . . . 0 C--N 1.306 -1.322 0 N-CA-C 107.897 -1.149 . . . . 71.310000000000002 107.897 -178.964 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.409 ' CD2' ' HG3' ' A' ' 358' ' ' ARG . 59.9 t80 . . . . . 0 C--O 1.214 -0.78 0 N-CA-C 112.416 0.524 . . . . 65.319999999999993 112.416 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.409 ' HG3' ' CD2' ' A' ' 357' ' ' TYR . 99.0 mtt180 -115.57 19.08 15.59 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 114.205 1.187 . . . . 75.230000000000004 114.205 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -135.23 149.02 49.79 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.791 -1.559 . . . . 75.230000000000004 106.791 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 50.3 mm -82.27 115.63 25.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.531 0.681 . . . . 62.310000000000002 110.574 -173.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -70.3 155.5 40.58 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.747 -1.115 . . . . 73.420000000000002 112.975 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 80.62 -17.58 10.53 Favored Glycine 0 CA--C 1.508 -0.371 0 N-CA-C 116.099 1.199 . . . . 43.049999999999997 116.099 171.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 43.8 mtm -94.35 153.6 17.91 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.143 -1.023 . . . . 75.200000000000003 111.181 -178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -101.57 141.79 33.91 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 115.14 -0.936 . . . . 71.25 109.636 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' THR . . . . . 0.45 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 93.4 m -125.78 123.97 39.95 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.111 -1.44 . . . . 73.329999999999998 107.111 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 56.2 mtpt -131.6 142.44 49.89 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.403 -0.362 . . . . 72.510000000000005 110.882 -175.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -160.57 135.42 7.63 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.625 -0.88 . . . . 73.099999999999994 108.625 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -79.25 122.99 27.01 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 110.019 -0.363 . . . . 61.439999999999998 110.019 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.452 HG23 HG13 ' A' ' 431' ' ' VAL . 47.4 mt -135.74 124.15 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 106.797 -1.557 . . . . 70.420000000000002 106.797 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.62 13.08 60.39 Favored Glycine 0 C--N 1.31 -0.906 0 C-N-CA 120.55 -0.833 . . . . 72.120000000000005 112.057 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.08 -24.2 27.08 Favored Glycine 0 N--CA 1.429 -1.808 0 C-N-CA 121.209 -0.52 . . . . 74.019999999999996 113.113 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . 0.474 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 22.5 p90 -103.42 147.16 27.47 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 110.17 -0.308 . . . . 75.450000000000003 110.17 -176.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 85.8 m -86.44 123.88 32.15 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 116.464 -0.335 . . . . 51.100000000000001 110.989 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.643 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.5 134.74 34.15 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 108.945 -0.761 . . . . 71.25 108.945 175.418 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -130.12 125.84 36.08 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 110.0 -0.37 . . . . 64.519999999999996 110.0 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.45 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.3 p -122.46 118.88 56.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 N-CA-C 109.451 -0.574 . . . . 74.219999999999999 109.451 175.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 49.5 t -106.17 116.99 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 106.658 -1.608 . . . . 63.219999999999999 106.658 174.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -61.43 126.7 28.28 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 114.668 1.359 . . . . 73.140000000000001 114.668 -172.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 71.07 14.35 6.77 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 113.336 -1.756 . . . . 72.310000000000002 112.465 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -124.8 -77.24 0.59 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 113.893 1.071 . . . . 73.230000000000004 113.893 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -162.76 160.97 26.0 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.882 0.697 . . . . 73.420000000000002 112.882 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 96.8 t -122.86 140.21 47.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.541 -0.754 . . . . 61.43 109.103 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -133.23 147.25 51.98 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.19 0.519 . . . . 73.209999999999994 111.872 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.403 ' HG3' ' CD1' ' A' ' 372' ' ' TYR . 35.9 tt0 -112.07 101.03 9.34 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.317 -2.105 . . . . 71.519999999999996 105.317 171.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 21.9 t70 68.19 -84.03 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 124.302 1.041 . . . . 75.150000000000006 110.109 -173.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.4 m -134.89 -6.67 2.4 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.214 -0.903 . . . . 65.409999999999997 108.678 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 45.6 mm -80.38 134.49 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 116.004 -0.544 . . . . 74.219999999999999 109.737 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 61.0 tp -76.92 113.9 15.12 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 109.035 -0.728 . . . . 73.239999999999995 109.035 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.402 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.3 OUTLIER -80.06 -63.32 1.44 Allowed 'General case' 0 N--CA 1.389 -3.511 0 N-CA-C 108.974 -0.75 . . . . 64.319999999999993 108.974 -177.179 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.89 159.41 30.64 Favored Glycine 0 N--CA 1.415 -2.742 0 C-N-CA 119.162 -1.494 . . . . 64.319999999999993 111.842 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -105.79 145.07 31.64 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.031 -1.1 . . . . 73.040000000000006 108.031 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -69.82 116.34 10.1 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.908 0.385 . . . . 74.430000000000007 110.601 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -94.79 -47.03 6.64 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.721 -0.672 . . . . 63.130000000000003 110.757 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 62.5 p -173.24 149.8 1.82 Allowed 'General case' 0 C--O 1.246 0.879 0 CA-C-N 116.021 -0.536 . . . . 72.040000000000006 109.599 -177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . 0.504 ' CD ' ' HG ' ' A' ' 400' ' ' LEU . 10.1 pt20 -143.88 142.06 30.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.186 0.517 . . . . 74.409999999999997 110.796 175.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -128.5 131.11 48.31 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.666 -0.697 . . . . 75.040000000000006 109.624 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 69.59 -107.96 2.31 Favored Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 111.365 -0.694 . . . . 52.140000000000001 111.365 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -133.07 24.41 4.22 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.83 0.824 . . . . 71.150000000000006 110.053 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.2 t -119.45 116.86 52.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.335 -0.987 . . . . 73.450000000000003 108.335 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.504 ' HG ' ' CD ' ' A' ' 395' ' ' GLN . 6.0 mp -106.71 133.55 51.21 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.16 0.584 . . . . 75.150000000000006 111.804 -174.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -113.47 121.94 45.79 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 112.513 0.56 . . . . 71.430000000000007 112.513 178.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -118.58 136.81 53.66 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.328 -0.99 . . . . 73.200000000000003 108.328 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -146.31 176.15 9.99 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.141 0.496 . . . . 74.510000000000005 111.723 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.15 33.65 9.23 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.382 -1.281 . . . . 73.409999999999997 112.679 169.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.26 -136.7 0.67 Allowed Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.445 -0.798 . . . . 51.420000000000002 112.931 177.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.34 149.6 40.52 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.816 -1.179 . . . . 73.430000000000007 107.816 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 33.3 t -60.34 135.93 57.89 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 124.22 1.008 . . . . 64.019999999999996 111.36 -175.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 36.3 t -133.39 154.1 51.05 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.256 -0.884 . . . . 74.25 109.558 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -88.46 141.02 28.88 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.056 0.391 . . . . 75.340000000000003 112.056 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 76.84 12.12 2.4 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.393 1.477 . . . . 73.239999999999995 108.797 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -151.16 176.98 29.42 Favored Glycine 0 N--CA 1.416 -2.65 0 N-CA-C 107.822 -2.111 . . . . 64.310000000000002 107.822 176.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -88.65 -39.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.226 0 CA-C-N 119.706 1.753 . . . . 75.25 112.577 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -159.03 170.23 22.53 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 106.839 -1.541 . . . . 60.119999999999997 106.839 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -75.31 160.53 30.22 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.179 0.514 . . . . 73.219999999999999 111.22 172.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 36.8 p -163.29 163.46 25.29 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 114.908 -1.042 . . . . 72.329999999999998 108.643 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.75 146.32 19.25 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.217 0.532 . . . . 75.329999999999998 110.195 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.9 tt -111.25 121.29 63.59 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 CA-C-N 115.303 -0.862 . . . . 72.420000000000002 109.482 174.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.0 t -105.72 127.8 60.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.775 0.798 . . . . 74.450000000000003 111.499 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 12.5 p -107.76 111.7 24.0 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 106.836 -1.542 . . . . 74.319999999999993 106.836 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 8.6 p -106.27 120.23 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 108.891 -0.781 . . . . 62.409999999999997 108.891 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -116.2 -174.69 2.59 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 120.386 -0.526 . . . . 63.240000000000002 111.277 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 43.4 t -59.61 128.74 38.5 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 123.713 0.805 . . . . 72.349999999999994 111.2 -177.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -160.26 -177.82 33.7 Favored Glycine 0 CA--C 1.48 -2.101 0 N-CA-C 109.54 -1.424 . . . . 53.329999999999998 109.54 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 53.3 t -96.93 -27.96 3.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 121.639 0.733 . . . . 73.200000000000003 109.027 177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -141.34 146.57 36.85 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.791 -0.64 . . . . 72.150000000000006 111.234 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.631 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.6 p-10 -68.28 101.21 1.16 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.28 -1.327 . . . . 72.150000000000006 110.47 175.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -132.32 149.19 52.41 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.401 -0.818 . . . . 73.010000000000005 110.919 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 28.8 mm -88.82 117.33 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 105.841 -1.911 . . . . 63.130000000000003 105.841 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.7 -50.83 16.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-O 120.772 0.32 . . . . 74.140000000000001 111.438 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 70.3 m -167.08 163.81 15.79 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 110.041 -0.355 . . . . 72.450000000000003 110.041 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.452 HG13 HG23 ' A' ' 369' ' ' ILE . 4.2 p -141.45 127.9 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 108.08 -1.082 . . . . 73.310000000000002 108.08 176.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . 0.424 ' O ' HD21 ' A' ' 440' ' ' LEU . 29.5 tp -132.21 138.18 47.86 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.665 -0.865 . . . . 64.299999999999997 108.665 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -80.65 116.45 20.68 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.89 -0.782 . . . . 74.109999999999999 108.89 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.68 -53.74 8.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.28 0.562 . . . . 62.399999999999999 109.702 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -120.93 -72.92 0.67 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.312 -0.858 . . . . 74.439999999999998 110.37 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.474 ' HG2' ' SG ' ' A' ' 437' ' ' CYS . 0.0 OUTLIER -167.51 -40.61 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.346 0.594 . . . . 75.219999999999999 110.483 175.173 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . 0.474 ' SG ' ' HG2' ' A' ' 436' ' ' LYS . 43.7 m -106.65 7.04 30.37 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.678 0.751 . . . . 71.319999999999993 109.501 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -135.48 127.92 30.47 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.155 -0.929 . . . . 71.329999999999998 109.319 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -123.96 150.22 45.03 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.713 -0.676 . . . . 75.400000000000006 109.782 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.424 HD21 ' O ' ' A' ' 432' ' ' LEU . 1.4 pt? -107.52 124.71 50.31 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.491 -0.929 . . . . 75.430000000000007 108.491 173.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.6 mt -124.75 133.37 69.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 115.332 -0.849 . . . . 73.319999999999993 109.409 -176.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -112.45 141.64 45.96 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 119.934 -0.706 . . . . 74.540000000000006 109.614 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 80.0 mtp -137.11 169.03 18.46 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 123.571 0.749 . . . . 74.140000000000001 109.059 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 69.2 mmtt -135.12 153.73 51.91 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.732 -1.21 . . . . 72.219999999999999 107.732 175.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 73.0 m -164.57 150.82 9.3 Favored Pre-proline 0 C--N 1.293 -1.89 0 C-N-CA 123.992 0.917 . . . . 62.450000000000003 109.287 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.99 -27.51 42.62 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.282 1.988 . . . . 74.239999999999995 112.045 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -73.47 -19.74 60.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.677 -0.692 . . . . 70.530000000000001 110.94 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -93.23 8.2 41.21 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.478 0.656 . . . . 63.299999999999997 109.586 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 10.6 t -102.71 120.3 40.33 Favored 'General case' 0 N--CA 1.409 -2.522 0 N-CA-C 107.868 -1.16 . . . . 74.409999999999997 107.868 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 25.4 t . . . . . 0 C--N 1.305 -1.36 0 N-CA-C 106.769 -1.567 . . . . 75.140000000000001 106.769 -178.93 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 71.2 t80 . . . . . 0 C--O 1.241 0.631 0 N-CA-C 107.342 -1.355 . . . . 75.340000000000003 107.342 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.491 ' O ' ' HB1' ' A' ' 447' ' ' ALA . 15.5 ptp180 -98.55 177.97 5.16 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-O 120.824 0.345 . . . . 75.319999999999993 110.635 -176.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 358' ' ' ARG . . . -78.79 153.59 30.62 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.991 -0.744 . . . . 71.450000000000003 108.991 172.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 47.4 mm -78.45 115.86 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.464 0.65 . . . . 61.240000000000002 110.414 -171.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.486 ' HD3' ' H ' ' A' ' 361' ' ' LYS . 0.0 OUTLIER -77.14 157.31 31.06 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.924 -1.035 . . . . 73.150000000000006 113.676 -175.207 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 71.69 8.09 66.82 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 114.954 -1.021 . . . . 64.409999999999997 114.074 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 47.8 ttp -104.21 140.71 37.44 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 109.548 -0.538 . . . . 73.319999999999993 109.548 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.428 ' CB ' HG21 ' A' ' 377' ' ' VAL . 0.0 OUTLIER -107.76 111.34 23.46 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.651 0.738 . . . . 64.200000000000003 110.569 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 375' ' ' LYS . 99.2 m -104.01 139.96 38.41 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.468 -0.787 . . . . 64.420000000000002 109.757 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 18.9 ptpt -143.94 141.14 30.07 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-O 120.801 0.334 . . . . 71.510000000000005 111.872 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -154.9 135.1 13.15 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 106.96 -1.496 . . . . 72.040000000000006 106.96 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 40.4 mt-10 -89.44 127.86 35.88 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 120.642 0.258 . . . . 74.209999999999994 110.817 -174.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 47.5 mt -137.21 125.47 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 107.133 -1.432 . . . . 75.319999999999993 107.133 -174.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.84 5.51 32.27 Favored Glycine 0 C--N 1.306 -1.102 0 C-N-CA 121.177 -0.535 . . . . 60.32 113.188 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 110.34 -13.84 30.69 Favored Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.562 -0.828 . . . . 40.5 113.072 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . 0.428 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 13.5 p90 -109.91 143.68 39.48 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 110.126 -0.324 . . . . 72.430000000000007 110.126 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 63.2 m -82.96 121.14 26.6 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.822 -0.351 . . . . 74.329999999999998 110.484 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.564 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.4 OUTLIER -90.3 125.64 35.58 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 109.335 -0.617 . . . . 74.239999999999995 109.335 173.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 365' ' ' THR . 35.1 ttpt -125.64 126.66 45.06 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.451 -0.574 . . . . 75.140000000000001 109.451 -176.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 6.7 p -123.08 115.9 47.05 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 N-CA-C 109.387 -0.597 . . . . 74.5 109.387 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.428 HG21 ' CB ' ' A' ' 364' ' ' GLU . 48.6 t -103.58 116.15 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 N-CA-C 106.755 -1.572 . . . . 71.319999999999993 106.755 174.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -63.14 126.46 27.45 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 113.086 0.773 . . . . 75.219999999999999 113.086 -172.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 72.66 6.78 5.47 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.494 1.517 . . . . 71.439999999999998 113.068 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -115.89 -83.67 0.63 Allowed 'General case' 0 C--O 1.248 0.98 0 N-CA-C 112.494 0.553 . . . . 71.120000000000005 112.494 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.526 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -165.81 159.48 16.1 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.026 0.751 . . . . 75.109999999999999 113.026 -172.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 96.5 t -113.83 145.83 19.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 124.381 1.072 . . . . 74.209999999999994 109.51 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.526 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 75.5 m-85 -133.87 144.17 48.74 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 123.322 0.649 . . . . 73.319999999999993 111.191 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.412 ' HB2' HD21 ' A' ' 389' ' ' LEU . 35.3 tt0 -111.65 103.5 11.8 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.352 -1.722 . . . . 61.229999999999997 106.352 173.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.4 t70 72.03 -76.16 0.07 Allowed 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 124.938 1.295 . . . . 65.209999999999994 109.463 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 34.0 t -145.31 -6.52 0.64 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.349 -0.982 . . . . 42.109999999999999 108.349 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 65.4 mt -81.49 136.2 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 115.617 -0.72 . . . . 74.209999999999994 109.332 -177.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 60.2 tp -76.5 116.55 17.29 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.013 -0.736 . . . . 53.549999999999997 109.013 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.566 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.3 OUTLIER -81.33 -67.81 0.75 Allowed 'General case' 0 N--CA 1.386 -3.661 0 N-CA-C 108.207 -1.034 . . . . 71.439999999999998 108.207 -178.261 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.94 157.15 28.41 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 119.528 -1.32 . . . . 70.010000000000005 111.811 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.21 146.43 26.19 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.039 -1.097 . . . . 71.019999999999996 108.039 175.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -71.25 115.97 11.03 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.475 -0.565 . . . . 71.329999999999998 109.475 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -93.16 -47.05 7.13 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.382 -0.372 . . . . 71.549999999999997 110.346 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 63.8 p -160.37 141.48 12.13 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.898 -0.778 . . . . 74.319999999999993 108.898 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.03 141.35 26.31 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 116.343 -0.389 . . . . 75.329999999999998 110.926 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -128.99 120.32 25.84 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.947 -0.76 . . . . 72.430000000000007 108.947 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.33 -103.13 0.62 Allowed Glycine 0 N--CA 1.434 -1.493 0 O-C-N 123.746 0.654 . . . . 63.109999999999999 113.33 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 26.8 p-10 -113.7 6.18 16.74 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.01 0.374 . . . . 74.019999999999996 112.01 -176.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 28.1 t -116.43 116.93 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 107.932 -1.136 . . . . 74.239999999999995 107.932 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 11.7 mt -120.01 123.91 44.63 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 115.528 -0.76 . . . . 74.409999999999997 110.278 -171.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -103.77 124.0 48.09 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-O 121.032 0.444 . . . . 74.319999999999993 111.713 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.444 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 3.1 m-85 -116.21 136.32 53.12 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.933 -1.136 . . . . 73.400000000000006 107.933 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -146.29 175.58 10.41 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.846 0.355 . . . . 65.549999999999997 111.508 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.39 35.02 20.59 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 124.664 1.186 . . . . 65.099999999999994 112.681 172.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.84 -140.43 1.13 Allowed Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.072 -0.967 . . . . 72.129999999999995 111.903 176.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.51 139.39 43.79 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.96 -0.755 . . . . 72.510000000000005 108.96 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 26.3 t -60.2 129.16 40.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.026 0.917 . . . . 71.219999999999999 112.969 -172.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 37.4 t -132.91 127.72 34.95 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.466 -1.309 . . . . 73.409999999999997 107.466 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' TRP . . . . . 0.461 ' O ' ' HB2' ' A' ' 410' ' ' ASN . 45.5 t-105 -86.35 113.81 22.63 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 114.412 1.264 . . . . 75.209999999999994 114.412 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 409' ' ' TRP . 16.3 t-20 153.18 -32.57 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.457 0 C-N-CA 128.161 2.585 . . . . 63.039999999999999 104.544 166.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -108.06 -166.21 21.39 Favored Glycine 0 N--CA 1.417 -2.62 0 N-CA-C 106.208 -2.757 . . . . 50.420000000000002 106.208 168.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -86.5 -39.42 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.23 0 CA-C-N 120.284 2.042 . . . . 73.25 112.429 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -159.9 -177.76 6.56 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 105.126 -2.175 . . . . 63.039999999999999 105.126 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 437' ' ' CYS . 83.5 mtt180 -75.22 154.6 37.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 119.478 -0.889 . . . . 72.219999999999999 110.61 169.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.611 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 21.3 p -163.39 162.2 24.79 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 114.801 -1.091 . . . . 72.319999999999993 108.831 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.54 151.72 19.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 120.824 0.345 . . . . 75.319999999999993 110.818 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.9 tt -113.31 127.74 70.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 108.987 -0.746 . . . . 71.510000000000005 108.987 172.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.603 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 4.6 t -111.4 128.65 67.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 CA-C-N 115.951 -0.568 . . . . 75.219999999999999 110.835 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.26 115.4 27.36 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 105.908 -1.886 . . . . 73.510000000000005 105.908 177.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 37.6 t -100.54 127.6 53.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 109.137 -0.69 . . . . 73.400000000000006 109.137 -175.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -117.52 -175.09 2.74 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 120.039 -0.665 . . . . 72.439999999999998 110.497 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.44 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 33.3 t -62.34 128.03 34.12 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 122.964 0.506 . . . . 72.409999999999997 110.876 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -154.08 -178.86 28.93 Favored Glycine 0 CA--C 1.492 -1.351 0 C-N-CA 120.519 -0.848 . . . . 73.430000000000007 111.591 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.4 t -85.78 -38.77 13.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 108.81 -0.811 . . . . 72.409999999999997 108.81 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -149.65 150.17 31.75 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.359 -0.837 . . . . 71.549999999999997 109.629 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.587 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.6 p-10 -51.04 100.73 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.321 -1.309 . . . . 55.530000000000001 111.089 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -131.83 144.65 51.06 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 116.268 -0.424 . . . . 72.540000000000006 110.444 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.417 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 26.8 mm -84.13 116.87 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 105.885 -1.894 . . . . 74.230000000000004 105.885 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 442' ' ' LYS . 56.0 t -82.23 -50.57 16.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 CA-C-O 120.919 0.39 . . . . 73.530000000000001 111.986 -175.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 48.7 m -161.68 162.55 29.89 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.104 -0.702 . . . . 73.129999999999995 109.104 -174.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 3.4 p -141.32 111.13 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 N-CA-C 108.754 -0.832 . . . . 75.310000000000002 108.754 176.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . 0.484 ' O ' HD21 ' A' ' 440' ' ' LEU . 28.8 tp -112.63 137.72 50.48 Favored 'General case' 0 N--CA 1.401 -2.885 0 N-CA-C 107.679 -1.23 . . . . 72.150000000000006 107.679 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . 0.444 ' CD ' ' HA ' ' A' ' 436' ' ' LYS . 39.2 tt0 -80.79 114.3 19.58 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 108.724 -0.843 . . . . 73.420000000000002 108.724 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -73.07 -40.18 65.27 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 115.367 -0.833 . . . . 73.140000000000001 110.496 -175.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -133.06 -77.93 0.49 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.165 -0.925 . . . . 73.450000000000003 108.752 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.473 ' HZ2' ' HB3' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -167.35 -39.8 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 124.029 0.932 . . . . 74.409999999999997 110.513 173.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 414' ' ' ARG . 62.8 m -100.69 -5.03 27.11 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.697 0.761 . . . . 73.019999999999996 109.586 177.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 415' ' ' SER . 38.3 tt0 -127.04 137.63 53.09 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.207 -0.906 . . . . 74.099999999999994 109.339 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -129.02 150.52 50.39 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.819 -0.628 . . . . 75.420000000000002 110.487 -174.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.484 HD21 ' O ' ' A' ' 432' ' ' LEU . 1.8 pt? -109.39 115.57 30.21 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.55 -0.908 . . . . 73.439999999999998 108.55 173.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.5 mt -115.25 126.45 72.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.408 -0.814 . . . . 73.25 109.699 -175.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.481 ' O ' ' HB ' ' A' ' 429' ' ' VAL . 38.3 ttpt -103.32 141.48 35.85 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.504 -0.925 . . . . 75.310000000000002 108.504 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.417 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.8 mtp -136.32 168.91 18.54 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 109.663 -0.495 . . . . 74.150000000000006 109.663 -176.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.8 mmtt -131.77 158.61 40.76 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.123 -1.066 . . . . 73.310000000000002 108.123 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 47.2 t -172.92 146.66 1.45 Allowed Pre-proline 0 C--N 1.287 -2.121 0 O-C-N 124.248 0.968 . . . . 74.120000000000005 108.774 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -64.49 -23.47 64.59 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.125 1.883 . . . . 63.140000000000001 110.64 176.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 358' ' ' ARG . . . -68.25 -26.94 65.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.416 -0.811 . . . . 72.230000000000004 111.081 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -98.36 13.65 30.81 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.365 0.603 . . . . 70.340000000000003 109.771 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 19.6 t -103.15 120.12 40.12 Favored 'General case' 0 N--CA 1.415 -2.215 0 C-N-CA 120.128 -0.629 . . . . 72.510000000000005 110.642 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--N 1.308 -1.199 0 C-N-CA 125.836 1.654 . . . . 65.209999999999994 107.637 176.648 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 . . . . . 0 C--O 1.217 -0.645 0 N-CA-C 108.697 -0.853 . . . . 75.319999999999993 108.697 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -89.23 36.93 0.84 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.57 0.7 . . . . 74.040000000000006 110.709 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -146.8 149.94 34.34 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.66 -1.237 . . . . 52.119999999999997 107.66 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 50.5 mm -82.61 116.97 27.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 108.598 -0.89 . . . . 62.439999999999998 108.598 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.476 ' HA ' ' HB2' ' A' ' 378' ' ' PHE . 22.2 pttp -90.3 156.45 18.27 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 112.389 0.515 . . . . 65.430000000000007 112.389 -174.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 93.6 -19.64 51.51 Favored Glycine 0 CA--C 1.508 -0.372 0 CA-C-N 115.559 -0.746 . . . . 71.310000000000002 114.713 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 19.0 ptp -90.88 156.13 18.24 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.087 -1.045 . . . . 74.329999999999998 110.445 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.57 113.02 26.22 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 115.327 -0.851 . . . . 75.299999999999997 109.065 175.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' THR . . . . . 0.484 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 86.6 m -96.11 125.84 40.92 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.509 -1.293 . . . . 72.349999999999994 107.509 177.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 13.8 ptmm? -141.41 140.73 33.71 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 120.798 -0.361 . . . . 74.450000000000003 111.758 -175.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -159.81 138.59 10.7 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.356 -0.979 . . . . 74.450000000000003 108.356 -173.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -81.24 123.49 28.52 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 110.075 -0.342 . . . . 75.200000000000003 110.075 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 58.3 mt -128.58 115.9 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 106.956 -1.498 . . . . 73.420000000000002 106.956 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.76 12.67 59.94 Favored Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.598 -0.811 . . . . 64.049999999999997 112.332 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 111.04 -26.15 12.88 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 121.265 -0.493 . . . . 50.140000000000001 112.701 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -98.08 136.36 38.43 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 120.756 -0.377 . . . . 73.519999999999996 110.89 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 70.1 m -79.17 119.99 23.04 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 116.039 -0.528 . . . . 55.43 110.228 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.587 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -91.02 133.18 35.51 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.577 -0.897 . . . . 75.0 108.577 172.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 365' ' ' THR . 35.0 ttpt -133.19 125.73 30.07 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.087 -0.645 . . . . 70.400000000000006 109.706 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.484 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.9 p -120.58 116.4 49.97 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 N-CA-C 109.816 -0.438 . . . . 74.340000000000003 109.816 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 26.9 t -107.41 116.09 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 106.988 -1.486 . . . . 63.020000000000003 106.988 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.476 ' HB2' ' HA ' ' A' ' 361' ' ' LYS . 95.7 m-85 -61.74 130.51 46.12 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 113.697 0.999 . . . . 74.010000000000005 113.697 -172.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 67.17 14.38 9.75 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.52 1.128 . . . . 73.219999999999999 112.884 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -125.34 -82.52 0.63 Allowed 'General case' 0 C--O 1.242 0.696 0 N-CA-C 113.418 0.896 . . . . 73.239999999999995 113.418 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.42 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -168.32 155.2 7.62 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.946 0.721 . . . . 73.5 112.946 -174.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.78 146.49 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.044 0.938 . . . . 71.129999999999995 109.582 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.42 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 84.3 m-85 -135.08 149.27 50.04 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.399 0.679 . . . . 73.109999999999999 111.345 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -123.96 104.81 9.13 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.186 -1.783 . . . . 73.019999999999996 106.186 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.1 t70 69.17 -87.66 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.933 0.893 . . . . 74.129999999999995 110.923 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 18.8 m -133.04 0.32 3.44 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.204 -1.036 . . . . 73.439999999999998 108.204 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 45.9 mm -92.19 133.27 34.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.047 -0.979 . . . . 73.530000000000001 110.457 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 63.1 tp -75.99 114.73 14.96 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.247 -1.39 . . . . 63.5 107.247 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.449 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -78.75 -63.3 1.44 Allowed 'General case' 0 N--CA 1.386 -3.629 0 N-CA-C 108.9 -0.778 . . . . 75.329999999999998 108.9 -175.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.0 158.56 29.86 Favored Glycine 0 N--CA 1.423 -2.231 0 C-N-CA 119.258 -1.448 . . . . 73.219999999999999 112.281 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -104.08 143.31 33.07 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.305 -0.998 . . . . 74.040000000000006 108.305 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . 0.423 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.8 m-85 -68.72 116.5 9.3 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 123.506 0.504 . . . . 74.219999999999999 110.668 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.69 -47.35 5.36 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.023 -0.535 . . . . 71.129999999999995 110.958 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 48.2 t -159.0 148.19 18.66 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.147 -0.686 . . . . 42.25 109.147 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -123.28 145.75 48.44 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.27 -1.011 . . . . 73.430000000000007 108.27 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -126.62 109.08 11.71 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.899 -1.148 . . . . 54.229999999999997 107.899 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 58.66 -101.37 0.21 Allowed Glycine 0 C--O 1.253 1.301 0 CA-C-O 121.423 0.457 . . . . 72.109999999999999 113.193 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -116.07 17.12 15.94 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 124.249 1.02 . . . . 73.040000000000006 109.558 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . 0.41 ' C ' HD13 ' A' ' 400' ' ' LEU . 60.0 t -121.05 133.45 67.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.197 -1.038 . . . . 74.5 108.197 -177.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.41 HD13 ' C ' ' A' ' 399' ' ' VAL . 3.5 mp -130.33 134.34 47.11 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.513 -0.475 . . . . 75.230000000000004 111.53 -176.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -108.26 122.17 46.39 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 123.101 0.56 . . . . 72.109999999999999 112.003 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.431 ' HE2' ' CG2' ' A' ' 418' ' ' VAL . 3.0 m-85 -118.38 129.32 55.35 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.719 -1.215 . . . . 71.439999999999998 107.719 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -147.11 175.29 10.82 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 111.637 0.236 . . . . 74.400000000000006 111.637 -177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.7 m120 60.07 39.19 20.01 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.738 0.649 . . . . 71.439999999999998 111.618 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -80.65 -137.46 1.93 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.737 -0.745 . . . . 72.239999999999995 112.069 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -67.37 148.74 51.23 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.744 -0.465 . . . . 74.140000000000001 109.744 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 30.4 m -60.54 123.62 17.93 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.208 0.527 . . . . 55.409999999999997 109.798 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 48.9 t -99.39 144.86 28.02 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.148 -1.427 . . . . 73.319999999999993 107.148 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 21.3 p-90 -81.6 -27.0 34.45 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.713 0.768 . . . . 74.200000000000003 109.335 -177.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -99.1 9.58 43.2 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.68 -1.145 . . . . 74.109999999999999 109.295 -170.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -168.99 -158.75 13.28 Favored Glycine 0 CA--C 1.5 -0.865 0 N-CA-C 108.228 -1.949 . . . . 44.399999999999999 108.228 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -89.13 -41.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.552 1.377 0 CA-C-N 121.039 2.419 . . . . 65.530000000000001 112.832 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -158.32 171.36 20.32 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.192 -1.04 . . . . 72.510000000000005 108.192 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -82.72 160.76 22.29 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.143 0.497 . . . . 74.540000000000006 111.506 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 22.7 p -165.27 160.54 18.47 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-N 114.645 -1.162 . . . . 63.420000000000002 109.145 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -157.33 147.87 21.18 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.161 0.505 . . . . 62.030000000000001 110.705 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.25 114.44 47.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.977 -1.12 . . . . 74.519999999999996 107.977 174.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.431 ' CG2' ' HE2' ' A' ' 402' ' ' TYR . 5.0 t -97.91 128.81 48.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-O 121.337 0.589 . . . . 71.540000000000006 110.327 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 1.4 m -113.66 114.43 26.39 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 106.372 -1.714 . . . . 72.400000000000006 106.372 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 39.1 t -100.78 118.31 47.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.618 -0.882 . . . . 73.420000000000002 108.618 -175.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -109.1 -174.88 2.62 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 120.748 0.308 . . . . 73.530000000000001 110.393 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.477 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 42.0 t -60.5 129.24 40.59 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 123.917 0.887 . . . . 71.230000000000004 111.5 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -158.86 -177.56 32.05 Favored Glycine 0 CA--C 1.491 -1.422 0 N-CA-C 110.641 -0.984 . . . . 72.010000000000005 110.641 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.07 -33.52 5.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.578 0.704 . . . . 74.329999999999998 109.125 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . 0.46 ' HG2' ' N ' ' A' ' 426' ' ' ASN . 36.6 tt0 -149.06 162.1 40.62 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.545 -0.752 . . . . 72.099999999999994 109.074 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 19.7 m120 -67.62 107.93 2.71 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 114.632 -1.167 . . . . 63.340000000000003 110.37 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -131.57 148.48 52.62 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 114.934 -1.03 . . . . 73.109999999999999 109.54 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 29.4 mm -91.45 115.06 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 106.089 -1.819 . . . . 75.25 106.089 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 53.9 t -81.12 -48.83 18.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 111.995 0.368 . . . . 55.109999999999999 111.995 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 46.9 p -166.64 163.67 16.8 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 109.565 -0.531 . . . . 74.219999999999999 109.565 -174.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 3.2 p -141.36 111.41 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 N-CA-C 108.403 -0.962 . . . . 74.420000000000002 108.403 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . 0.459 ' HB3' ' HG ' ' A' ' 440' ' ' LEU . 24.4 tp -110.44 136.51 49.48 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 114.892 -1.049 . . . . 74.409999999999997 108.408 -175.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -80.86 110.74 16.67 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.465 -1.309 . . . . 75.239999999999995 107.465 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -72.66 -42.31 64.47 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.473 -0.785 . . . . 74.319999999999993 110.222 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -132.38 -78.03 0.5 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.474 -0.936 . . . . 72.530000000000001 108.474 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.22 -50.28 0.07 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.137 0.494 . . . . 70.530000000000001 111.0 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 63.4 m -100.9 4.39 42.62 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.817 0.817 . . . . 73.239999999999995 109.822 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 415' ' ' SER . 35.9 tt0 -129.45 130.97 46.59 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.904 -1.044 . . . . 64.299999999999997 108.948 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . 0.446 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 41.1 m-85 -123.51 150.83 43.46 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.209 -0.905 . . . . 75.540000000000006 110.075 -174.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.459 ' HG ' ' HB3' ' A' ' 432' ' ' LEU . 4.1 pp -111.08 124.46 52.23 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 106.992 -1.485 . . . . 73.439999999999998 106.992 173.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.7 mt -120.27 135.63 59.91 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 115.753 -0.658 . . . . 62.399999999999999 109.813 -175.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -105.7 140.25 39.04 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.235 -1.024 . . . . 74.129999999999995 108.235 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 82.7 mtp -140.08 168.7 19.2 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 109.02 -0.733 . . . . 64.519999999999996 109.02 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.9 mmtt -132.24 160.28 36.62 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.999 -0.741 . . . . 74.109999999999999 108.999 177.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 32.2 t -172.22 148.55 2.0 Allowed Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 124.138 0.899 . . . . 75.010000000000005 108.832 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.82 -27.26 51.75 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.197 1.931 . . . . 74.219999999999999 111.027 177.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -74.74 -15.79 60.76 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.281 -0.872 . . . . 70.310000000000002 111.12 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -101.27 11.4 39.38 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 121.268 0.556 . . . . 64.409999999999997 110.08 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 16.9 t -101.85 121.2 41.65 Favored 'General case' 0 N--CA 1.409 -2.507 0 CA-C-N 115.773 -0.649 . . . . 60.409999999999997 109.293 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.418 -2.027 0 N-CA-C 106.828 -1.545 . . . . 73.040000000000006 106.828 178.215 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 448' ' ' ALA . 90.4 m-85 . . . . . 0 CA--C 1.52 -0.181 0 CA-C-O 121.219 0.533 . . . . 71.340000000000003 109.92 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.416 ' H ' ' HA ' ' A' ' 448' ' ' ALA . 32.8 ttm180 -156.8 166.49 33.23 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 106.454 -1.684 . . . . 74.400000000000006 106.454 -176.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -132.4 151.41 51.88 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.969 -0.382 . . . . 74.129999999999995 109.969 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.52 116.32 25.6 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.648 0 N-CA-C 109.208 -0.664 . . . . 73.329999999999998 109.208 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.447 ' HD3' ' H ' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -80.76 155.74 26.55 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.761 -0.654 . . . . 74.230000000000004 111.5 -177.75 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 84.32 -53.53 4.84 Favored Glycine 0 C--N 1.32 -0.34 0 N-CA-C 115.086 0.795 . . . . 73.319999999999993 115.086 174.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 56.1 ttp -71.56 126.28 29.27 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.155 0.502 . . . . 75.209999999999994 110.957 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.11 144.89 42.65 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.192 -0.913 . . . . 63.219999999999999 110.911 -178.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 97.7 m -125.01 133.73 52.86 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.358 -0.978 . . . . 73.409999999999997 108.358 175.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 10.4 ptpp? -138.48 154.63 48.82 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 110.343 -0.243 . . . . 73.099999999999994 110.343 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -164.7 135.34 4.05 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.591 -1.263 . . . . 75.140000000000001 107.591 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -84.67 125.31 32.39 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.599 -0.519 . . . . 75.549999999999997 109.599 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 49.4 mt -130.59 116.29 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 107.236 -1.394 . . . . 75.519999999999996 107.236 -177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 67.28 11.71 59.59 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.823 -0.703 . . . . 51.420000000000002 112.521 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 111.94 -25.75 12.5 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.806 -0.711 . . . . 74.310000000000002 112.575 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -97.84 136.09 38.65 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 120.218 -0.593 . . . . 74.420000000000002 110.8 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 92.2 m -79.19 118.48 21.18 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 115.713 -0.676 . . . . 75.340000000000003 110.742 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -90.12 133.34 34.93 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 108.234 -1.024 . . . . 73.420000000000002 108.234 173.364 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -132.06 125.71 32.07 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.349 -0.541 . . . . 74.349999999999994 110.022 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 7.0 p -119.51 118.08 56.11 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 CA-C-N 116.031 -0.531 . . . . 71.420000000000002 109.861 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.4 t -109.25 116.14 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 106.658 -1.608 . . . . 63.439999999999998 106.658 173.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -63.11 130.88 46.54 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.15 -0.932 . . . . 75.340000000000003 113.107 -171.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 71.82 6.79 5.74 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.894 1.278 . . . . 70.200000000000003 112.314 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -119.42 -84.81 0.66 Allowed 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 116.021 -0.536 . . . . 73.409999999999997 112.19 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.513 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.3 OUTLIER -168.37 158.99 10.2 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 112.611 0.597 . . . . 44.25 112.611 -174.194 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.46 HG21 ' CE2' ' A' ' 402' ' ' TYR . 94.6 t -116.29 146.58 20.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 123.858 0.863 . . . . 74.329999999999998 109.928 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.513 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 81.1 m-85 -133.06 151.3 52.04 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.662 0.785 . . . . 71.400000000000006 111.088 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . 0.44 ' HB2' HD21 ' A' ' 389' ' ' LEU . 30.4 tt0 -126.46 109.66 12.44 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.584 -1.636 . . . . 65.340000000000003 106.584 173.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 25.0 t70 70.49 -80.66 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 124.051 0.94 . . . . 63.43 110.528 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 28.4 p -145.37 1.12 0.93 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.176 -0.92 . . . . 63.329999999999998 109.27 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 48.2 mm -91.37 137.63 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.003 -0.999 . . . . 72.230000000000004 109.558 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 57.1 tp -76.63 115.94 16.86 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.236 -1.024 . . . . 73.430000000000007 108.236 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.535 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.4 OUTLIER -79.07 -64.32 1.21 Allowed 'General case' 0 N--CA 1.392 -3.354 0 N-CA-C 109.025 -0.731 . . . . 73.329999999999998 109.025 -177.252 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.44 160.63 31.52 Favored Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 118.796 -1.668 . . . . 74.430000000000007 111.744 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -99.53 147.48 25.27 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.237 -1.764 . . . . 73.450000000000003 106.237 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -69.24 116.42 9.66 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.061 -0.656 . . . . 71.099999999999994 110.86 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -93.78 -48.1 6.46 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.675 -0.693 . . . . 70.409999999999997 110.134 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 46.8 m -154.23 142.45 20.43 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 110.303 -0.258 . . . . 72.510000000000005 110.303 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -122.2 130.99 53.71 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 106.593 -1.632 . . . . 72.409999999999997 106.593 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -128.67 109.81 11.66 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.922 -0.77 . . . . 75.019999999999996 108.922 176.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.19 -101.18 0.58 Allowed Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.988 -0.625 . . . . 41.219999999999999 111.948 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -122.48 18.95 10.5 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.269 0.557 . . . . 74.140000000000001 109.575 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.01 126.43 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 N-CA-C 107.792 -1.188 . . . . 74.099999999999994 107.792 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.458 ' HB2' ' HH ' ' A' ' 402' ' ' TYR . 22.7 mt -123.82 123.66 40.95 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 110.001 -0.37 . . . . 72.430000000000007 110.001 -172.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -106.88 125.1 50.57 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.201 -0.296 . . . . 73.030000000000001 110.201 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.46 ' CE2' HG21 ' A' ' 382' ' ' VAL . 2.4 m-85 -118.49 135.54 54.33 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.52 -0.918 . . . . 65.25 108.52 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -146.27 175.85 10.2 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 123.41 0.684 . . . . 75.310000000000002 109.771 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 14.7 m120 66.17 27.54 10.36 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.287 0.847 . . . . 62.130000000000003 113.287 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -72.6 -139.48 0.32 Allowed Glycine 0 CA--C 1.54 1.619 0 C-N-CA 121.302 -0.475 . . . . 75.400000000000006 113.764 176.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.02 144.68 38.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.309 -1.367 . . . . 75.519999999999996 107.309 -177.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 32.6 t -65.69 130.65 44.05 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.669 0.747 . . . . 74.540000000000006 111.141 -177.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 19.5 p -124.24 159.78 29.42 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.168 -1.049 . . . . 54.549999999999997 108.168 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -86.99 143.45 27.34 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 119.826 -0.75 . . . . 75.310000000000002 111.06 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 78.71 6.03 2.38 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.609 1.563 . . . . 43.109999999999999 109.854 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -146.75 172.75 27.18 Favored Glycine 0 N--CA 1.425 -2.053 0 N-CA-C 107.095 -2.402 . . . . 70.329999999999998 107.095 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -86.67 -41.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.408 0 CA-C-N 120.458 2.129 . . . . 71.420000000000002 112.792 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -161.82 155.38 21.29 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.678 -1.601 . . . . 64.540000000000006 106.678 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -64.99 157.15 29.05 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-O 121.677 0.751 . . . . 73.400000000000006 111.859 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 40.1 p -159.67 163.66 34.66 Favored 'General case' 0 N--CA 1.403 -2.789 0 CA-C-N 114.305 -1.316 . . . . 71.120000000000005 109.063 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.38 151.48 19.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 109.971 -0.381 . . . . 73.409999999999997 109.971 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 14.9 tt -117.67 120.98 66.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 108.663 -0.865 . . . . 73.25 108.663 173.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 4.1 t -104.01 123.65 57.89 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 CA-C-N 115.163 -0.926 . . . . 62.43 110.127 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 2.3 m -108.57 114.08 27.62 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 105.525 -2.028 . . . . 75.5 105.525 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.37 116.7 44.32 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.383 0 N-CA-C 108.154 -1.054 . . . . 75.310000000000002 108.154 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 448' ' ' ALA . 41.6 mt-10 -110.94 -173.86 2.34 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 120.961 0.41 . . . . 75.040000000000006 111.736 -176.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.471 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 39.8 t -64.1 128.67 36.83 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.635 0.774 . . . . 72.099999999999994 111.386 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 446' ' ' PRO . . . -161.1 -177.5 34.26 Favored Glycine 0 CA--C 1.492 -1.37 0 N-CA-C 109.508 -1.437 . . . . 70.109999999999999 109.508 177.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 56.2 t -96.17 -23.42 4.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.539 0.685 . . . . 62.130000000000003 109.441 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -142.67 154.44 44.34 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.906 -0.588 . . . . 72.120000000000005 110.363 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.603 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 72.0 m-20 -71.69 99.3 2.09 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.777 -1.194 . . . . 75.25 107.777 175.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -132.01 148.55 52.51 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 120.999 -0.28 . . . . 71.230000000000004 110.398 -177.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.436 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 26.7 mm -85.89 127.49 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.49 -1.67 . . . . 74.040000000000006 106.49 176.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 62.6 t -91.54 -51.03 12.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 112.356 0.502 . . . . 73.420000000000002 112.356 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 50.5 m -163.23 161.64 24.97 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.507 -0.553 . . . . 72.239999999999995 109.507 -174.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.417 HG21 ' HH ' ' A' ' 374' ' ' TYR . 3.1 p -141.4 116.8 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 123.867 0.729 . . . . 73.450000000000003 109.468 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 25.0 tp -123.87 137.34 54.66 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.214 -1.032 . . . . 74.140000000000001 108.214 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -84.21 128.41 34.55 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.714 -0.847 . . . . 64.120000000000005 108.714 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -89.22 -48.19 7.55 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.11 1.152 . . . . 65.129999999999995 114.11 -176.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -122.79 -68.21 0.9 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.191 0.519 . . . . 74.219999999999999 111.642 -172.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.48 ' HB3' ' NZ ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -166.03 -27.28 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 124.031 0.932 . . . . 74.319999999999993 109.535 175.096 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 98.3 m -135.78 21.91 3.32 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.718 -0.674 . . . . 75.310000000000002 110.934 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.4 tt0 -135.29 119.61 17.86 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.289 0.566 . . . . 75.239999999999995 110.564 -176.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -109.44 134.42 51.88 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 115.623 -0.717 . . . . 74.030000000000001 110.719 -174.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.66 116.65 29.47 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.203 -1.036 . . . . 71.200000000000003 108.203 173.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 97.6 mt -118.35 135.1 59.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 115.043 -0.98 . . . . 71.040000000000006 110.309 -175.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -105.44 140.93 37.81 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.419 -0.956 . . . . 73.109999999999999 108.419 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.436 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.2 mtp -137.78 168.7 19.15 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 108.784 -0.821 . . . . 61.240000000000002 108.784 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 73.0 mmtt -131.76 161.24 33.32 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.354 -0.98 . . . . 64.099999999999994 108.354 176.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 48.5 t -164.82 146.07 6.45 Favored Pre-proline 0 C--N 1.284 -2.276 0 O-C-N 124.235 0.96 . . . . 73.209999999999994 109.025 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 30.4 Cg_endo -65.6 -27.22 53.48 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.159 1.906 . . . . 73.430000000000007 110.676 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.34 -19.96 38.26 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.516 -0.766 . . . . 71.25 110.782 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . . . -86.99 9.58 19.08 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-O 121.969 0.89 . . . . 74.420000000000002 110.415 -177.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 10.4 t -103.53 175.7 5.39 Favored 'General case' 0 N--CA 1.403 -2.809 0 N-CA-C 107.702 -1.221 . . . . 75.239999999999995 107.702 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.421 -1.906 0 N-CA-C 107.306 -1.368 . . . . 61.310000000000002 107.306 177.351 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 57.2 t80 . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 108.267 -1.012 . . . . 74.25 108.267 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 73.13 0.73 3.78 Favored 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 124.977 1.311 . . . . 71.409999999999997 112.808 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -146.45 150.64 36.01 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.84 -1.17 . . . . 71.319999999999993 107.84 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 4.2 tp -81.54 116.25 25.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 122.108 0.956 . . . . 73.329999999999998 111.919 -175.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -74.17 129.79 38.52 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.439 -1.255 . . . . 74.310000000000002 110.691 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 93.5 -13.25 67.97 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.856 -0.688 . . . . 42.340000000000003 114.027 176.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 52.7 ttm -75.64 132.33 40.53 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 119.089 -1.044 . . . . 74.200000000000003 110.499 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -94.77 106.06 18.03 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.269 -1.011 . . . . 65.150000000000006 108.269 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 86.4 m -101.89 137.42 40.2 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.46 -0.571 . . . . 62.130000000000003 109.46 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 366' ' ' LYS . 0.0 OUTLIER -145.17 151.62 38.72 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.614 -0.435 . . . . 72.510000000000005 111.572 178.021 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -162.56 134.33 5.29 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.31 -1.367 . . . . 75.209999999999994 107.31 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -87.79 127.99 35.32 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 110.113 -0.329 . . . . 71.319999999999993 110.113 -175.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 42.5 mt -134.46 122.64 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 106.642 -1.614 . . . . 74.420000000000002 106.642 -175.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.54 9.88 52.15 Favored Glycine 0 C--N 1.306 -1.123 0 C-N-CA 120.894 -0.669 . . . . 65.409999999999997 113.194 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 111.97 -23.57 16.49 Favored Glycine 0 N--CA 1.427 -1.94 0 C-N-CA 120.82 -0.705 . . . . 70.319999999999993 112.803 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . 0.419 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 17.0 p90 -100.98 144.61 29.71 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.625 0.25 . . . . 74.140000000000001 110.809 -177.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 87.3 m -82.47 119.39 24.15 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.817 -0.438 . . . . 75.239999999999995 109.817 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.37 125.28 35.49 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 108.451 -0.944 . . . . 60.119999999999997 108.451 172.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -126.6 130.9 51.4 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.453 -0.573 . . . . 75.109999999999999 109.453 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 6.6 p -128.07 119.29 50.69 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.928 0 CA-C-O 121.254 0.55 . . . . 75.340000000000003 110.246 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 57.9 t -108.14 116.39 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.917 0 N-CA-C 106.825 -1.546 . . . . 74.030000000000001 106.825 175.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -62.85 132.48 52.3 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.066 1.135 . . . . 74.25 114.066 -173.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 66.96 17.91 10.55 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.03 -1.441 . . . . 71.030000000000001 112.076 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -128.79 -82.75 0.58 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.309 -0.86 . . . . 55.219999999999999 113.001 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.455 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -165.55 155.93 13.29 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 113.274 0.842 . . . . 74.25 113.274 -172.358 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 88.4 t -113.78 145.28 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.388 1.075 . . . . 62.450000000000003 109.252 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . 0.455 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 85.6 m-85 -134.81 147.61 49.99 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 123.125 0.57 . . . . 75.219999999999999 111.532 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -119.39 104.71 10.6 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.151 -1.796 . . . . 73.109999999999999 106.151 173.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.4 t70 72.12 -82.96 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.725 0.81 . . . . 74.209999999999994 110.286 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 32.1 p -143.84 3.04 1.23 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.852 -1.067 . . . . 73.439999999999998 108.574 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 62.1 mt -89.21 133.91 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.967 -1.015 . . . . 75.329999999999998 109.378 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 61.2 tp -77.43 115.45 17.21 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.536 -0.913 . . . . 72.430000000000007 108.536 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.563 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -80.31 -64.54 1.17 Allowed 'General case' 0 N--CA 1.394 -3.249 0 N-CA-C 108.994 -0.743 . . . . 54.130000000000003 108.994 -177.086 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.9 158.57 30.16 Favored Glycine 0 N--CA 1.415 -2.739 0 C-N-CA 119.874 -1.155 . . . . 54.43 111.519 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -103.12 153.14 20.62 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.157 -1.423 . . . . 73.120000000000005 107.157 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . 0.493 ' HB3' HE21 ' A' ' 395' ' ' GLN . 1.7 m-85 -73.7 116.13 13.93 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 120.926 0.393 . . . . 71.340000000000003 111.306 -175.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.88 -48.12 5.03 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.608 -0.724 . . . . 71.239999999999995 110.852 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 51.1 m -157.15 137.75 13.12 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.024 0.44 . . . . 64.219999999999999 109.961 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . 0.53 ' CB ' ' HG ' ' A' ' 400' ' ' LEU . 4.8 pm0 -141.17 125.69 17.74 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 115.824 -0.626 . . . . 72.129999999999995 110.371 177.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -128.22 132.18 48.8 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.383 -0.969 . . . . 72.040000000000006 108.383 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 69.53 -103.53 1.12 Allowed Glycine 0 N--CA 1.422 -2.292 0 N-CA-C 111.057 -0.817 . . . . 73.519999999999996 111.057 -177.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -138.77 18.5 2.67 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.789 0.804 . . . . 73.420000000000002 110.297 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 63.9 t -117.1 119.78 63.02 Favored 'Isoleucine or valine' 0 C--O 1.244 0.816 0 N-CA-C 108.174 -1.047 . . . . 61.299999999999997 108.174 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.53 ' HG ' ' CB ' ' A' ' 395' ' ' GLN . 4.0 mp -113.02 135.54 53.67 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.964 -0.562 . . . . 73.239999999999995 110.971 -173.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -115.47 125.16 52.74 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.524 -0.917 . . . . 74.030000000000001 108.524 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.447 ' HH ' ' HB2' ' A' ' 400' ' ' LEU . 5.3 m-85 -115.75 141.55 47.94 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.399 -0.963 . . . . 74.400000000000006 108.399 -177.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -146.12 176.46 9.71 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.624 0.77 . . . . 72.25 109.096 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 18.7 m120 65.51 36.05 6.87 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.274 0.629 . . . . 70.230000000000004 112.677 173.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -81.01 -137.67 2.11 Favored Glycine 0 C--N 1.305 -1.177 0 C-N-CA 120.562 -0.828 . . . . 74.519999999999996 112.681 177.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.73 149.18 36.37 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 106.527 -1.657 . . . . 71.519999999999996 106.527 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 46.0 m -61.98 142.2 57.6 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 113.655 0.983 . . . . 72.540000000000006 113.655 -173.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 48.5 t -120.58 160.03 24.05 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.364 -1.347 . . . . 72.230000000000004 107.364 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -80.59 -35.13 34.64 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.798 -0.761 . . . . 73.140000000000001 110.403 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -96.61 -7.08 35.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.95 0.881 . . . . 72.310000000000002 110.865 -170.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -141.78 169.04 25.39 Favored Glycine 0 N--CA 1.419 -2.437 0 N-CA-C 107.724 -2.15 . . . . 73.450000000000003 107.724 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.26 -39.14 13.67 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 CA-C-N 119.885 1.843 . . . . 72.439999999999998 111.038 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -152.53 171.48 18.05 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.3 -1.0 . . . . 75.150000000000006 108.3 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -77.4 164.9 25.06 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 121.043 0.449 . . . . 74.209999999999994 110.521 173.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 57.6 p -159.42 166.78 30.3 Favored 'General case' 0 N--CA 1.403 -2.818 0 CA-C-N 115.036 -0.984 . . . . 64.530000000000001 109.347 -177.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -157.55 151.8 24.74 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 109.85 -0.426 . . . . 63.25 109.85 -178.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 11.0 tt -122.18 123.14 68.22 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 CA-C-N 115.699 -0.682 . . . . 62.200000000000003 109.444 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 4.3 t -113.73 130.68 67.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 115.818 -0.628 . . . . 63.520000000000003 111.447 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 17.7 p -108.75 114.19 27.77 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 108.357 -0.979 . . . . 73.5 108.357 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 45.1 t -100.83 115.39 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 107.549 -1.278 . . . . 74.510000000000005 107.549 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -117.35 -174.68 2.65 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 121.014 -0.274 . . . . 72.510000000000005 110.471 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 38.1 t -61.37 128.71 37.65 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 122.976 0.51 . . . . 64.319999999999993 110.749 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -163.12 -177.66 36.27 Favored Glycine 0 CA--C 1.495 -1.158 0 C-N-CA 120.701 -0.761 . . . . 38.479999999999997 111.498 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.9 t -81.94 -38.91 16.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.403 0.621 . . . . 74.129999999999995 110.445 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -155.92 162.03 40.45 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.12 -0.696 . . . . 75.319999999999993 109.12 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 16.7 m120 -63.17 102.88 0.42 Allowed 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.594 1.184 . . . . 71.420000000000002 109.024 177.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -133.09 139.24 47.03 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.491 -1.3 . . . . 74.400000000000006 107.491 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 30.6 mm -89.06 110.61 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 N-CA-C 106.75 -1.574 . . . . 52.439999999999998 106.75 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 57.2 t -80.76 -44.78 21.5 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.688 0 CA-C-N 115.755 -0.657 . . . . 54.409999999999997 112.464 -173.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 35.3 p -162.26 158.4 24.25 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 120.494 -0.483 . . . . 71.310000000000002 110.727 -176.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 4.2 p -141.56 115.42 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 N-CA-C 108.547 -0.908 . . . . 73.340000000000003 108.547 175.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 29.0 tp -120.57 135.79 54.99 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.029 -1.471 . . . . 73.319999999999993 107.029 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -87.98 123.52 32.78 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.431 -1.322 . . . . 75.5 107.431 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -82.19 -46.81 13.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.856 1.058 . . . . 74.349999999999994 113.856 -174.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -121.38 -74.36 0.62 Allowed 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.438 0.637 . . . . 64.230000000000004 110.839 -172.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -175.55 -10.12 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 126.114 1.766 . . . . 75.239999999999995 109.373 176.465 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 24.7 m -136.62 5.17 2.89 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 109.528 -0.545 . . . . 75.150000000000006 109.528 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 415' ' ' SER . 31.3 tt0 -136.22 126.02 25.68 Favored 'General case' 0 C--O 1.211 -0.972 0 CA-C-O 120.837 0.351 . . . . 72.420000000000002 111.55 -173.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 28.4 m-85 -113.7 141.15 47.6 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 116.055 -0.521 . . . . 73.340000000000003 110.719 -175.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -106.29 119.42 39.21 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.373 -0.973 . . . . 74.420000000000002 108.373 173.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.8 mt -119.45 135.4 59.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.366 -0.834 . . . . 74.040000000000006 111.255 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -99.7 139.3 35.57 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 109.489 -0.56 . . . . 73.420000000000002 109.489 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 81.5 mtp -141.82 164.68 29.53 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 109.858 -0.423 . . . . 75.120000000000005 109.858 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.7 mmtt -134.78 161.35 35.44 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.961 -1.126 . . . . 64.099999999999994 107.961 176.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 31.9 t -167.2 145.88 4.29 Favored Pre-proline 0 C--N 1.289 -2.043 0 O-C-N 123.97 0.794 . . . . 62.439999999999998 109.277 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.31 -24.68 43.24 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.245 1.963 . . . . 74.540000000000006 110.862 177.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.33 -19.59 59.53 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.222 -0.899 . . . . 64.540000000000006 110.658 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -94.97 6.16 49.87 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 121.554 0.692 . . . . 70.120000000000005 109.458 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 10.5 t -103.17 119.87 39.66 Favored 'General case' 0 N--CA 1.405 -2.707 0 N-CA-C 107.313 -1.365 . . . . 70.549999999999997 107.313 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 C--N 1.296 -1.757 0 N-CA-C 108.358 -0.979 . . . . 54.130000000000003 108.358 -179.473 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 C--O 1.222 -0.388 0 CA-C-O 120.804 0.335 . . . . 74.239999999999995 110.787 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.408 ' O ' ' HB1' ' A' ' 447' ' ' ALA . 71.1 ttt180 -82.38 106.78 14.53 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 120.79 0.328 . . . . 75.0 110.137 -176.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -58.29 153.14 15.95 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.344 -0.844 . . . . 63.530000000000001 112.451 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . 0.406 ' O ' ' HE1' ' A' ' 363' ' ' MET . 71.3 mt -79.87 127.85 38.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.882 -0.599 . . . . 74.219999999999999 109.676 -174.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.526 ' HZ1' ' HB2' ' A' ' 361' ' ' LYS . 9.3 mtmp? -91.45 157.81 16.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.73 -0.668 . . . . 74.400000000000006 111.578 -173.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 82.18 -31.99 2.82 Favored Glycine 0 N--CA 1.462 0.427 0 N-CA-C 114.93 0.732 . . . . 72.239999999999995 114.93 172.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' MET . . . . . 0.406 ' HE1' ' O ' ' A' ' 360' ' ' ILE . 0.0 OUTLIER -76.03 156.77 33.71 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 117.253 0.527 . . . . 64.319999999999993 110.938 179.571 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -116.56 138.56 51.32 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-O 121.55 0.69 . . . . 74.519999999999996 110.724 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 93.5 m -124.4 139.27 54.05 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.823 -0.806 . . . . 71.140000000000001 108.823 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 10.4 ptpp? -144.23 141.05 29.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 116.444 -0.344 . . . . 74.230000000000004 110.858 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -159.02 135.82 9.51 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.033 -0.729 . . . . 73.439999999999998 109.033 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.17 129.98 35.06 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.31 -0.405 . . . . 75.040000000000006 110.582 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . 0.44 HG23 HG13 ' A' ' 431' ' ' VAL . 33.3 mt -137.95 128.11 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 106.643 -1.614 . . . . 73.519999999999996 106.643 -175.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.58 14.45 49.95 Favored Glycine 0 C--N 1.302 -1.319 0 C-N-CA 120.34 -0.933 . . . . 71.200000000000003 113.171 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 99.57 -9.88 60.78 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.749 -0.739 . . . . 75.439999999999998 113.537 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -111.29 144.07 41.05 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 122.438 -0.448 . . . . 72.040000000000006 110.571 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 38.2 m -82.16 120.5 25.41 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 110.173 -0.306 . . . . 64.329999999999998 110.173 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.4 OUTLIER -91.29 135.89 33.49 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 109.278 -0.638 . . . . 72.120000000000005 109.278 173.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -131.93 127.48 36.47 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 123.547 0.529 . . . . 73.540000000000006 109.952 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.08 120.57 55.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 120.879 0.371 . . . . 72.019999999999996 110.522 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.7 t -115.17 116.96 54.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 N-CA-C 106.837 -1.542 . . . . 73.450000000000003 106.837 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.441 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 28.4 m-85 -65.32 128.49 36.07 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 114.757 1.392 . . . . 73.530000000000001 114.757 -171.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . 0.442 ' CD1' ' HG2' ' A' ' 361' ' ' LYS . 65.3 m-85 68.28 22.38 8.1 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 113.84 -1.527 . . . . 64.010000000000005 112.288 -176.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -132.36 -79.8 0.5 Allowed 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.438 -0.801 . . . . 73.299999999999997 113.098 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.46 154.72 12.3 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.419 0.896 . . . . 72.140000000000001 113.419 -172.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 98.9 t -119.25 145.3 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.166 0.986 . . . . 75.030000000000001 109.024 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -134.26 145.59 49.27 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.965 0.412 . . . . 72.319999999999993 111.889 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -116.84 108.26 15.62 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.419 -1.697 . . . . 72.409999999999997 106.419 172.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.2 t70 71.67 -79.65 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 124.302 1.041 . . . . 75.319999999999993 109.931 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.0 m -144.73 -4.02 0.77 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.563 -0.903 . . . . 74.409999999999997 108.563 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 50.1 mm -84.09 136.67 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.442 -0.799 . . . . 73.530000000000001 109.486 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 64.5 tp -76.2 110.73 10.94 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.799 -1.186 . . . . 73.109999999999999 107.799 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.479 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.6 OUTLIER -73.61 -63.1 1.27 Allowed 'General case' 0 N--CA 1.385 -3.682 0 N-CA-C 108.552 -0.907 . . . . 72.150000000000006 108.552 -176.271 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.94 158.7 29.99 Favored Glycine 0 N--CA 1.417 -2.585 0 C-N-CA 119.064 -1.541 . . . . 75.209999999999994 111.595 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -106.64 142.21 36.65 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.106 -1.072 . . . . 73.409999999999997 108.106 177.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . 0.543 ' HD2' ' NE2' ' A' ' 395' ' ' GLN . 1.9 m-85 -65.99 115.96 6.61 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 123.465 0.478 . . . . 75.230000000000004 110.537 -176.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -105.65 -48.47 3.65 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.074 -0.512 . . . . 73.530000000000001 111.278 -176.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 56.6 m -155.07 139.87 17.16 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.677 -0.49 . . . . 72.329999999999998 109.677 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . 0.543 ' NE2' ' HD2' ' A' ' 392' ' ' PHE . 42.7 mt-30 -134.41 136.46 43.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.242 -1.392 . . . . 75.099999999999994 107.242 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -128.78 110.76 12.45 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 109.474 -0.565 . . . . 71.209999999999994 109.474 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 70.81 -118.57 7.68 Favored Glycine 0 N--CA 1.424 -2.125 0 N-CA-C 110.665 -0.974 . . . . 70.209999999999994 110.665 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 4.2 p-10 -107.29 21.81 16.94 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.446 0.641 . . . . 74.150000000000006 110.188 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 40.1 t -124.48 116.91 48.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 107.79 -1.189 . . . . 53.229999999999997 107.79 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.439 ' CD2' ' HB3' ' A' ' 395' ' ' GLN . 11.2 mt -116.34 129.51 56.29 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.882 -0.599 . . . . 73.140000000000001 110.922 -169.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -105.03 122.02 45.0 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-O 121.06 0.457 . . . . 72.319999999999993 112.168 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -117.1 119.17 34.44 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 105.807 -1.923 . . . . 72.109999999999999 105.807 176.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -135.73 173.84 11.27 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.31 -0.626 . . . . 72.430000000000007 109.31 -174.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 12.9 m120 61.04 37.48 17.93 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.965 0.791 . . . . 62.32 112.503 175.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.58 -141.82 1.24 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.185 -0.531 . . . . 72.030000000000001 112.676 176.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.82 137.58 51.93 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.435 -0.95 . . . . 73.439999999999998 108.435 -175.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 48.8 m -64.76 119.27 10.28 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 123.65 0.78 . . . . 70.150000000000006 112.427 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 12.3 p -100.62 158.17 16.14 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.257 -1.016 . . . . 63.210000000000001 108.257 176.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -86.53 -27.94 23.68 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.261 0.553 . . . . 73.340000000000003 109.725 -176.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -89.51 -0.61 57.62 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.358 -0.837 . . . . 72.310000000000002 110.523 -172.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -155.58 -159.65 9.48 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 108.642 -1.783 . . . . 73.109999999999999 108.642 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -93.11 -42.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.179 0 CA-C-N 120.215 2.008 . . . . 73.329999999999998 113.407 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -165.91 154.78 11.48 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 106.484 -1.673 . . . . 75.349999999999994 106.484 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.05 153.32 41.8 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.352 0.596 . . . . 73.109999999999999 111.996 174.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.9 p -159.1 160.83 36.14 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 114.698 -1.137 . . . . 64.030000000000001 108.908 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -155.39 148.0 24.13 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 109.744 -0.465 . . . . 75.420000000000002 109.744 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.9 tt -110.94 118.52 57.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.536 -0.913 . . . . 64.439999999999998 108.536 174.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 2.9 t -97.77 125.42 50.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 CA-C-O 121.457 0.646 . . . . 74.319999999999993 109.884 177.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 2.5 m -108.43 112.23 24.53 Favored 'General case' 0 N--CA 1.385 -3.707 0 N-CA-C 104.577 -2.379 . . . . 64.120000000000005 104.577 174.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 7.9 p -102.0 121.15 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 108.655 -0.868 . . . . 73.209999999999994 108.655 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -114.94 -174.4 2.48 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 116.289 -0.414 . . . . 60.409999999999997 110.362 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.631 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 22.6 t -60.57 128.16 35.24 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 123.367 0.667 . . . . 72.340000000000003 112.572 -176.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -156.06 -177.75 29.56 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.606 -0.807 . . . . 63.299999999999997 111.452 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.4 t -91.76 -34.2 6.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.851 -0.796 . . . . 73.25 108.851 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -148.88 148.06 29.42 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 115.694 -0.685 . . . . 73.540000000000006 109.197 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.738 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.1 p-10 -62.36 99.64 0.15 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.991 -1.004 . . . . 64.150000000000006 111.536 176.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -131.81 149.07 52.57 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.338 -0.847 . . . . 75.239999999999995 110.156 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 28.2 mm -82.09 119.53 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.198 -1.408 . . . . 73.0 107.198 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 66.0 t -83.69 -51.37 14.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 111.886 0.328 . . . . 74.030000000000001 111.886 -177.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 59.7 m -166.04 163.52 18.23 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.438 -0.579 . . . . 70.329999999999998 109.438 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.44 HG13 HG23 ' A' ' 369' ' ' ILE . 3.5 p -141.84 116.68 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 107.956 -1.127 . . . . 74.409999999999997 107.956 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 34.1 tp -112.16 133.13 54.48 Favored 'General case' 0 C--N 1.263 -3.156 0 N-CA-C 108.143 -1.058 . . . . 72.310000000000002 108.143 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -82.15 108.52 15.68 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.596 -1.261 . . . . 74.420000000000002 107.596 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -69.75 -53.26 19.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.865 0.841 . . . . 75.540000000000006 109.47 -177.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -120.1 -77.79 0.58 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.52 -1.218 . . . . 75.519999999999996 108.577 177.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.48 ' HZ3' ' HB3' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -169.94 -47.36 0.02 OUTLIER 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 124.459 1.104 . . . . 74.409999999999997 110.383 174.258 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 82.0 m -91.99 5.3 50.67 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.723 0.773 . . . . 71.319999999999993 109.562 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -136.49 124.4 22.73 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.107 -0.951 . . . . 74.519999999999996 109.08 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 54.4 m-85 -122.56 151.22 41.61 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.016 -0.538 . . . . 75.040000000000006 110.118 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -110.53 124.95 52.78 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.299 -1.371 . . . . 71.400000000000006 107.299 170.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 98.4 mt -122.78 134.94 64.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 115.813 -0.63 . . . . 75.349999999999994 109.92 -175.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -106.84 140.81 39.08 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 108.776 -0.824 . . . . 73.140000000000001 108.776 177.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 82.7 mtp -138.02 164.14 29.81 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.032 -1.099 . . . . 63.240000000000002 108.032 177.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.738 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 34.2 mmtp -129.69 151.59 50.11 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 108.063 -1.088 . . . . 72.230000000000004 108.063 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 43.4 t -164.74 147.84 7.33 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.786 -0.82 . . . . 61.530000000000001 108.786 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.97 -27.22 66.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.072 1.848 . . . . 73.519999999999996 110.244 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 358' ' ' ARG . . . -69.37 -22.26 63.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.232 -0.894 . . . . 74.109999999999999 110.876 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -101.95 8.29 41.13 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.358 0.599 . . . . 72.349999999999994 109.944 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 34.6 t -102.47 135.7 43.62 Favored 'General case' 0 N--CA 1.415 -2.221 0 CA-C-N 115.79 -0.641 . . . . 71.319999999999993 109.319 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.408 -2.558 0 N-CA-C 106.817 -1.549 . . . . 73.439999999999998 106.817 -179.586 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 53.1 t80 . . . . . 0 C--O 1.222 -0.359 0 N-CA-C 108.76 -0.83 . . . . 72.319999999999993 108.76 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -163.71 177.7 8.49 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 104.701 -2.333 . . . . 74.019999999999996 104.701 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -76.08 151.12 37.15 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 118.258 0.481 . . . . 73.340000000000003 110.004 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 4.8 tp -81.34 119.3 30.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 112.982 0.734 . . . . 74.329999999999998 112.982 -173.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.53 141.43 55.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.236 -0.893 . . . . 64.430000000000007 111.003 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 91.98 -35.17 4.09 Favored Glycine 0 CA--C 1.495 -1.198 0 CA-C-N 115.916 -0.584 . . . . 36.43 112.157 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' MET . . . . . 0.48 ' HG2' ' ND2' ' A' ' 426' ' ' ASN . 46.3 tpp -62.32 129.74 42.09 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.277 0.56 . . . . 70.129999999999995 111.162 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -106.67 119.07 38.34 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 115.343 -0.844 . . . . 74.329999999999998 108.882 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' THR . . . . . 0.412 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 92.0 m -107.74 137.94 44.85 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 109.253 -0.647 . . . . 63.43 109.253 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 19.6 ptmt -144.2 145.03 31.82 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 121.21 -0.196 . . . . 73.010000000000005 111.209 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -160.76 136.89 8.4 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.223 -1.029 . . . . 74.420000000000002 108.223 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.05 125.31 31.98 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 110.017 -0.364 . . . . 63.420000000000002 110.017 -178.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 57.3 mt -130.57 116.27 34.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 107.29 -1.374 . . . . 71.049999999999997 107.29 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.6 15.09 63.59 Favored Glycine 0 C--N 1.306 -1.107 0 C-N-CA 121.063 -0.589 . . . . 60.200000000000003 112.498 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 109.09 -25.72 17.58 Favored Glycine 0 N--CA 1.427 -1.931 0 C-N-CA 120.401 -0.904 . . . . 65.340000000000003 112.578 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -97.77 135.84 38.96 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.007 0.432 . . . . 74.540000000000006 111.286 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 85.1 m -79.19 118.5 21.2 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.856 -0.611 . . . . 70.109999999999999 110.747 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.544 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -90.66 132.47 35.76 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 108.378 -0.971 . . . . 75.540000000000006 108.378 173.637 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -132.07 127.32 35.87 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.278 -0.638 . . . . 72.109999999999999 109.278 -176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . 0.412 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.5 p -125.72 118.37 51.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-O 121.053 0.454 . . . . 75.239999999999995 110.16 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.2 t -106.66 116.9 51.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 107.031 -1.47 . . . . 73.319999999999993 107.031 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -63.65 129.04 38.52 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 114.011 1.115 . . . . 74.510000000000005 114.011 -172.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 72.7 13.52 5.19 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 126.166 1.786 . . . . 75.030000000000001 112.371 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -124.11 -83.3 0.65 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 113.088 0.773 . . . . 72.219999999999999 113.088 176.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -159.05 164.9 35.03 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 112.542 0.571 . . . . 75.530000000000001 112.542 -170.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.424 HG21 ' CD2' ' A' ' 402' ' ' TYR . 72.7 t -126.88 142.16 44.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.242 -0.89 . . . . 64.310000000000002 108.837 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -132.97 151.6 52.04 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 122.957 0.503 . . . . 75.019999999999996 111.311 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -122.18 106.27 10.99 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 106.217 -1.771 . . . . 74.430000000000007 106.217 172.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.0 t70 70.76 -74.66 0.08 Allowed 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 124.87 1.268 . . . . 74.209999999999994 110.395 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 64.1 m -146.94 -7.2 0.49 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.75 -0.659 . . . . 55.329999999999998 110.155 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 40.1 mt -87.75 135.94 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 116.311 -0.404 . . . . 73.209999999999994 110.39 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.5 tp -75.93 120.74 21.68 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.528 0.68 . . . . 60.420000000000002 109.387 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.519 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -82.83 -64.39 1.18 Allowed 'General case' 0 N--CA 1.383 -3.777 0 N-CA-C 108.597 -0.89 . . . . 71.120000000000005 108.597 -177.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.13 162.34 33.12 Favored Glycine 0 N--CA 1.421 -2.306 0 C-N-CA 118.934 -1.603 . . . . 36.43 111.986 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -108.44 146.51 33.01 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.343 -1.354 . . . . 74.239999999999995 107.343 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -64.96 116.47 6.43 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 120.882 0.373 . . . . 64.420000000000002 111.555 -175.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -94.76 -49.07 5.77 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.049 -0.523 . . . . 71.549999999999997 111.308 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 21.4 p -169.02 140.37 2.46 Favored 'General case' 0 C--O 1.252 1.22 0 N-CA-C 110.127 -0.323 . . . . 75.540000000000006 110.127 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -142.39 140.55 32.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.217 0.532 . . . . 71.329999999999998 111.726 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -128.78 128.62 44.32 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 108.689 -0.856 . . . . 72.109999999999999 108.689 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 68.82 -101.53 0.8 Allowed Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 121.008 -0.615 . . . . 72.540000000000006 112.466 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 26.2 p-10 -130.49 11.8 5.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 111.981 0.363 . . . . 71.329999999999998 111.981 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 40.7 t -111.65 116.98 54.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.923 -1.14 . . . . 74.430000000000007 107.923 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 6.7 mt -114.83 131.45 56.82 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.553 -0.536 . . . . 65.409999999999997 109.553 -172.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -116.37 124.43 50.05 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.322 -0.992 . . . . 65.519999999999996 108.322 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.424 ' CD2' HG21 ' A' ' 382' ' ' VAL . 3.5 m-85 -114.22 136.19 53.23 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.48 -1.304 . . . . 70.439999999999998 107.48 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -144.09 176.4 9.34 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.585 -0.524 . . . . 72.299999999999997 109.585 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.96 36.24 12.75 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.837 0.68 . . . . 71.140000000000001 112.837 177.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -80.56 -141.65 2.87 Favored Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.25 -0.976 . . . . 64.209999999999994 111.243 175.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.34 134.83 40.92 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.097 -0.705 . . . . 74.200000000000003 109.097 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 37.8 m -60.41 134.37 57.0 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.354 0.872 . . . . 74.099999999999994 113.354 -175.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 10.1 p -110.13 159.23 17.53 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.202 -0.908 . . . . 72.129999999999995 109.452 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 17.8 p-90 -78.82 -29.96 45.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.551 0.691 . . . . 74.209999999999994 109.839 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . 0.623 ' ND2' ' HB2' ' A' ' 436' ' ' LYS . 13.9 p-10 -98.98 8.9 44.56 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.152 -0.931 . . . . 73.349999999999994 112.617 -172.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -163.26 -172.1 30.33 Favored Glycine 0 C--N 1.308 -1.013 0 N-CA-C 109.086 -1.605 . . . . 45.119999999999997 109.086 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -83.36 -39.72 0.12 Allowed 'Trans proline' 0 CA--C 1.546 1.081 0 CA-C-N 120.057 1.929 . . . . 53.439999999999998 112.942 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 99.8 m-70 -162.01 162.29 28.81 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 107.798 -1.186 . . . . 71.140000000000001 107.798 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -73.22 159.19 33.83 Favored 'General case' 0 C--O 1.257 1.448 0 CA-C-O 121.374 0.607 . . . . 75.140000000000001 111.604 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 33.2 p -162.18 163.56 28.31 Favored 'General case' 0 N--CA 1.406 -2.663 0 CA-C-N 114.488 -1.233 . . . . 74.329999999999998 109.121 -177.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -159.15 144.74 16.2 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.819 -0.437 . . . . 53.439999999999998 109.819 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.8 tt -109.62 125.12 66.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.099 -1.075 . . . . 72.450000000000003 108.099 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.9 t -111.09 131.19 63.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.87 -0.605 . . . . 73.230000000000004 110.895 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.84 113.8 26.65 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 106.058 -1.83 . . . . 75.0 106.058 175.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 23.6 t -101.18 112.62 34.72 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.517 0 N-CA-C 109.256 -0.646 . . . . 75.099999999999994 109.256 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -109.93 -176.25 2.95 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.745 -0.782 . . . . 75.540000000000006 110.965 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.438 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 32.4 t -60.67 128.08 34.82 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 123.568 0.747 . . . . 72.430000000000007 111.212 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -151.23 178.93 28.31 Favored Glycine 0 N--CA 1.428 -1.835 0 N-CA-C 110.086 -1.206 . . . . 74.140000000000001 110.086 177.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 41.3 t -93.8 -26.96 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.293 -1.002 . . . . 71.030000000000001 108.293 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -141.56 157.42 45.13 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 114.894 -1.048 . . . . 75.340000000000003 109.306 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.48 ' ND2' ' HG2' ' A' ' 363' ' ' MET . 65.4 m-20 -73.16 100.16 3.0 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 106.858 -1.534 . . . . 74.430000000000007 106.858 174.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -132.18 141.24 49.02 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 120.687 -0.405 . . . . 74.239999999999995 111.805 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . 0.41 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 27.3 mm -83.39 118.43 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 105.767 -1.938 . . . . 74.040000000000006 105.767 174.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 55.1 t -83.17 -50.65 15.39 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-O 121.042 0.449 . . . . 73.230000000000004 111.651 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 37.4 p -161.23 159.49 28.79 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.197 -0.456 . . . . 52.439999999999998 110.5 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . 0.474 HG21 ' HH ' ' A' ' 374' ' ' TYR . 3.3 p -142.15 122.86 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 108.829 -0.804 . . . . 52.049999999999997 108.829 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 30.2 tp -131.0 137.54 49.27 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.8 -1.185 . . . . 74.329999999999998 107.8 -177.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -81.45 116.97 21.5 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.578 -0.849 . . . . 64.120000000000005 108.789 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.31 -63.97 1.12 Allowed 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.392 -0.822 . . . . 74.329999999999998 110.722 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -106.23 -76.24 0.61 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.75 -0.659 . . . . 74.310000000000002 111.821 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.623 ' HB2' ' ND2' ' A' ' 410' ' ' ASN . 44.9 pttt -162.8 -30.35 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.048 0.452 . . . . 72.400000000000006 112.172 -174.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 86.2 m -131.16 11.65 5.04 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.576 -0.898 . . . . 74.129999999999995 108.576 176.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 415' ' ' SER . 34.8 tt0 -131.79 129.62 40.76 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.119 -0.946 . . . . 54.109999999999999 108.985 -176.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -117.91 150.41 39.26 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.682 -0.69 . . . . 74.200000000000003 110.906 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -106.4 120.9 43.1 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.598 -1.26 . . . . 72.049999999999997 107.598 172.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.7 mt -124.14 128.7 74.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-N 115.41 -0.814 . . . . 71.430000000000007 109.746 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -104.27 140.69 37.5 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.873 -0.788 . . . . 74.420000000000002 108.873 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' MET . . . . . 0.41 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.3 mtp -135.08 167.47 20.9 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 109.409 -0.589 . . . . 74.340000000000003 109.409 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.438 ' HD2' ' O ' ' A' ' 422' ' ' CYS . 72.1 mmtt -133.24 156.28 47.83 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.299 -1.371 . . . . 75.340000000000003 107.299 174.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 38.3 t -163.77 145.44 7.31 Favored Pre-proline 0 C--N 1.278 -2.542 0 O-C-N 124.075 0.86 . . . . 61.409999999999997 109.11 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.4 -21.38 47.14 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.111 1.874 . . . . 42.32 110.646 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.12 -18.58 52.99 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.803 -0.635 . . . . 71.450000000000003 110.982 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -98.09 10.91 39.32 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.376 0.608 . . . . 72.430000000000007 109.857 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 12.7 t -103.39 119.94 39.85 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 108.661 -0.866 . . . . 74.430000000000007 108.661 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.428 -1.562 0 N-CA-C 107.446 -1.316 . . . . 62.020000000000003 107.446 -179.592 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 CA--C 1.512 -0.512 0 CA-C-O 120.53 0.205 . . . . 75.120000000000005 111.162 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -163.15 28.0 0.09 Allowed 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.374 -1.713 . . . . 75.219999999999999 106.374 171.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -146.7 151.75 37.72 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 104.386 -2.45 . . . . 60.100000000000001 104.386 -178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 48.0 mm -80.42 115.52 23.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.571 -0.852 . . . . 63.25 109.818 -172.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 378' ' ' PHE . 0.0 OUTLIER -88.14 152.48 21.97 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 115.167 1.543 . . . . 73.439999999999998 115.167 -173.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 89.37 -23.4 18.93 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.12 -0.946 . . . . 72.439999999999998 112.135 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 48.4 ttp -81.51 143.73 31.84 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 123.001 0.52 . . . . 75.329999999999998 110.458 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.408 ' HB3' HG21 ' A' ' 377' ' ' VAL . 10.8 pt-20 -99.31 130.83 45.63 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.313 -0.625 . . . . 64.430000000000007 109.313 174.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 97.0 m -118.71 125.49 49.79 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.477 -1.305 . . . . 64.140000000000001 107.477 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 57.7 mtpt -133.32 143.54 49.08 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 116.239 -0.437 . . . . 72.200000000000003 110.529 -174.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -157.95 136.85 11.45 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.057 -1.09 . . . . 64.319999999999993 108.057 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 40.5 mt-10 -87.98 127.18 35.38 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.713 0.292 . . . . 75.239999999999995 110.233 -174.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 38.0 mt -136.96 120.76 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 106.793 -1.558 . . . . 62.109999999999999 106.793 -176.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.26 13.71 60.62 Favored Glycine 0 C--N 1.304 -1.21 0 C-N-CA 120.358 -0.925 . . . . 45.340000000000003 113.137 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.09 -17.73 40.7 Favored Glycine 0 N--CA 1.429 -1.832 0 C-N-CA 121.084 -0.579 . . . . 73.049999999999997 113.107 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -106.87 139.72 40.84 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 120.683 0.278 . . . . 65.230000000000004 110.333 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 37.4 m -83.83 122.01 28.11 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 116.259 -0.428 . . . . 62.310000000000002 110.166 -178.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' TYR . . . . . 0.6 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.54 129.07 36.73 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 109.301 -0.629 . . . . 73.409999999999997 109.301 176.615 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 83.9 tttt -122.48 125.23 45.36 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 123.887 0.742 . . . . 73.239999999999995 110.108 -175.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.24 118.22 47.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 N-CA-C 109.161 -0.681 . . . . 72.329999999999998 109.161 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' VAL . . . . . 0.408 HG21 ' HB3' ' A' ' 364' ' ' GLU . 40.8 t -106.73 116.5 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 106.116 -1.809 . . . . 74.319999999999993 106.116 174.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' PHE . . . . . 0.44 ' HB2' ' HA ' ' A' ' 361' ' ' LYS . 95.9 m-85 -58.9 123.06 15.22 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 123.807 0.692 . . . . 74.209999999999994 112.503 -174.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 72.98 12.23 5.11 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.587 1.555 . . . . 73.549999999999997 113.385 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -123.24 -86.84 0.64 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 113.848 1.055 . . . . 70.409999999999997 113.848 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.54 169.05 20.41 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 119.392 -0.923 . . . . 73.120000000000005 110.322 -176.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 94.9 t -124.95 138.78 53.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 107.643 -1.243 . . . . 65.439999999999998 107.643 173.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -132.91 148.1 52.29 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.143 0.497 . . . . 73.219999999999999 110.785 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -115.28 100.07 7.86 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.387 -1.709 . . . . 63.409999999999997 106.387 173.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 13.4 t70 69.89 -78.37 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 125.248 1.419 . . . . 62.140000000000001 110.019 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 27.4 m -138.01 -5.69 1.67 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.082 -0.963 . . . . 62.509999999999998 109.287 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 47.8 mm -88.39 135.63 25.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.188 -0.46 . . . . 75.409999999999997 110.016 -177.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 62.9 tp -76.23 115.1 15.63 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.995 -1.113 . . . . 71.230000000000004 107.995 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' LEU . . . . . 0.5 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.6 OUTLIER -80.21 -60.52 2.3 Favored 'General case' 0 N--CA 1.388 -3.539 0 N-CA-C 108.762 -0.829 . . . . 73.430000000000007 108.762 -175.684 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.97 158.59 29.88 Favored Glycine 0 N--CA 1.413 -2.892 0 C-N-CA 119.295 -1.431 . . . . 72.510000000000005 111.417 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -102.24 143.97 31.36 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.659 -1.608 . . . . 74.439999999999998 106.659 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -69.27 116.82 10.14 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.013 0.435 . . . . 71.030000000000001 110.737 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.11 -47.56 5.45 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.772 -0.649 . . . . 75.349999999999994 110.962 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 65.9 p -168.47 143.67 3.49 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.898 -0.408 . . . . 75.140000000000001 109.898 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -143.08 136.98 28.85 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.743 0.306 . . . . 74.0 110.503 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -112.52 119.93 39.88 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.518 -0.919 . . . . 65.25 108.518 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.11 -101.67 0.63 Allowed Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 119.651 -1.262 . . . . 38.009999999999998 113.178 177.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -123.66 10.68 9.07 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.799 1.24 . . . . 73.319999999999993 111.132 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.34 116.69 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.015 0 N-CA-C 106.85 -1.537 . . . . 64.439999999999998 106.85 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 9.3 mt -113.61 131.61 56.05 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 115.966 -0.561 . . . . 74.019999999999996 110.962 -168.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -114.27 121.76 44.68 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-O 121.392 0.615 . . . . 72.329999999999998 112.349 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -118.25 139.02 51.95 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.537 -1.282 . . . . 75.420000000000002 107.537 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -141.46 173.42 11.51 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-O 121.466 0.65 . . . . 61.020000000000003 111.45 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 51.1 46.59 26.22 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.095 -1.866 . . . . 72.519999999999996 113.16 167.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.22 -132.98 0.57 Allowed Glycine 0 C--N 1.311 -0.831 0 CA-C-N 115.839 -0.618 . . . . 61.420000000000002 112.708 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.56 142.64 38.89 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.108 -1.442 . . . . 73.140000000000001 107.108 -176.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 27.4 t -64.46 128.44 35.79 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-O 121.806 0.812 . . . . 73.230000000000004 111.097 -178.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 6.0 p -99.64 158.39 15.8 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.5 -0.926 . . . . 63.450000000000003 108.5 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 28.8 p-90 -82.48 -32.14 28.97 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.074 -0.713 . . . . 74.510000000000005 109.074 -177.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -90.6 12.67 18.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.475 -0.784 . . . . 73.120000000000005 112.287 -175.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.415 ' HA3' ' SG ' ' A' ' 437' ' ' CYS . . . -167.41 -160.68 15.2 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 109.521 -1.432 . . . . 61.310000000000002 109.521 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -95.65 -40.95 0.02 OUTLIER 'Trans proline' 0 CA--C 1.564 1.99 0 CA-C-N 119.954 1.877 . . . . 75.409999999999997 114.033 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -159.15 154.23 25.16 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.062 0.945 . . . . 75.010000000000005 108.782 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -74.33 160.53 30.94 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.34 0.59 . . . . 74.239999999999995 111.383 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 35.5 p -165.57 162.35 19.02 Favored 'General case' 0 N--CA 1.418 -2.058 0 C-N-CA 124.366 1.066 . . . . 74.329999999999998 108.246 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -158.74 151.11 21.6 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.303 0.573 . . . . 74.209999999999994 110.8 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 11.6 tt -114.37 131.11 67.37 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 CA-C-N 115.131 -0.94 . . . . 61.340000000000003 108.828 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 4.1 t -116.72 131.04 70.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-O 121.329 0.585 . . . . 74.340000000000003 111.926 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 62.2 p -108.02 114.97 29.27 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 107.641 -1.244 . . . . 72.120000000000005 107.641 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 39.6 t -100.19 111.87 31.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 107.545 -1.279 . . . . 62.549999999999997 107.545 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -113.52 -175.14 2.61 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 110.787 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' CYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 449' ' ' CYS . 43.6 t -60.42 128.66 37.76 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.815 -0.629 . . . . 72.120000000000005 111.224 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -154.36 178.59 31.09 Favored Glycine 0 CA--C 1.476 -2.377 0 N-CA-C 110.479 -1.048 . . . . 64.25 110.479 177.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 56.0 t -90.41 -33.79 6.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 108.282 -1.007 . . . . 70.340000000000003 108.282 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -150.66 152.66 34.32 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.698 -0.683 . . . . 73.010000000000005 109.768 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.3 p-10 -60.1 98.83 0.06 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.597 -1.183 . . . . 55.210000000000001 112.427 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -133.08 146.85 52.04 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.038 -0.528 . . . . 71.310000000000002 111.783 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 31.3 mm -80.17 119.87 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 105.449 -2.056 . . . . 75.219999999999999 105.449 171.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 54.6 t -84.55 -51.16 14.2 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.867 0 N-CA-C 112.112 0.412 . . . . 63.420000000000002 112.112 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 32.6 p -160.86 162.71 32.25 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.814 -0.354 . . . . 73.510000000000005 110.837 -174.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' VAL . . . . . . . . . . . . . 4.8 p -142.12 111.87 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 108.966 -0.753 . . . . 75.040000000000006 108.966 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 34.9 tp -113.97 136.45 52.89 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 108.765 -0.828 . . . . 74.430000000000007 108.765 -177.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.66 113.8 19.91 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.837 -0.801 . . . . 75.219999999999999 108.837 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.14 -70.42 0.39 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.294 -0.632 . . . . 71.030000000000001 109.294 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -100.0 -75.83 0.56 Allowed 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.551 -0.75 . . . . 75.310000000000002 109.966 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.1 -51.07 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.461 0.648 . . . . 73.25 110.437 175.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' CYS . . . . . 0.415 ' SG ' ' HA3' ' A' ' 411' ' ' GLY . 64.3 m -100.52 13.19 35.44 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.204 -0.907 . . . . 72.5 109.019 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 415' ' ' SER . 33.4 tt0 -135.22 124.85 25.16 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-N 115.185 -0.916 . . . . 61.350000000000001 108.873 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -123.01 150.18 43.37 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.142 -0.936 . . . . 75.230000000000004 109.567 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -109.22 121.37 45.02 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.252 -1.018 . . . . 63.299999999999997 108.252 173.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 97.1 mt -118.08 135.25 59.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.211 -0.904 . . . . 75.120000000000005 110.012 -175.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -109.26 141.42 41.57 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 109.5 -0.556 . . . . 64.420000000000002 109.5 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 82.1 mtp -136.38 162.81 32.01 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 108.995 -0.743 . . . . 75.219999999999999 108.995 178.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 70.1 mmtt -132.87 151.49 52.02 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.164 -1.05 . . . . 73.219999999999999 108.164 176.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 68.1 m -161.24 149.15 12.44 Favored Pre-proline 0 C--N 1.295 -1.792 0 O-C-N 123.865 0.728 . . . . 70.239999999999995 109.945 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.44 -27.76 62.48 Favored 'Trans proline' 0 N--CA 1.48 0.695 0 C-N-CA 122.724 2.283 . . . . 74.420000000000002 111.95 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.58 -22.25 57.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.6 -0.727 . . . . 74.319999999999993 110.643 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -97.2 19.09 13.59 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-N 115.528 -0.76 . . . . 65.049999999999997 111.049 -175.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 422' ' ' CYS . 23.3 t -99.39 124.41 44.49 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.708 0.766 . . . . 74.120000000000005 110.911 -176.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.442 -0.848 0 CA-C-N 114.438 -1.255 . . . . 44.409999999999997 108.299 -178.663 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.468 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 90.7 m . . . . . 0 N--CA 1.429 -1.507 0 N-CA-C 107.302 -1.369 . . . . 63.43 107.302 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 17.1 ptmt -139.16 141.18 38.02 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 121.099 -0.24 . . . . 60.32 110.913 -174.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.413 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 3.6 tmt_? -156.94 138.4 13.94 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.276 -1.379 . . . . 61.420000000000002 107.276 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -86.42 126.84 34.67 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.141 -0.689 . . . . 73.120000000000005 109.141 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.51 HG21 HG12 ' A' ' 431' ' ' VAL . 39.8 mt -137.17 124.6 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 106.654 -1.609 . . . . 73.409999999999997 106.654 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.58 8.47 46.58 Favored Glycine 0 C--N 1.301 -1.393 0 C-N-CA 120.91 -0.662 . . . . 73.540000000000006 113.233 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.09 -14.74 44.24 Favored Glycine 0 N--CA 1.426 -1.978 0 C-N-CA 120.702 -0.761 . . . . 62.140000000000001 112.684 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' TYR . . . . . 0.423 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 17.3 p90 -106.39 141.4 37.78 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 120.839 0.352 . . . . 74.120000000000005 110.134 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 51.3 m -83.52 120.24 25.69 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 116.18 -0.463 . . . . 73.420000000000002 109.895 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.6 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.66 134.21 34.57 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 108.612 -0.885 . . . . 75.310000000000002 108.612 174.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -133.41 125.01 28.15 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.104 -0.702 . . . . 72.549999999999997 109.104 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.51 HG23 HG22 ' A' ' 382' ' ' VAL . 7.6 p -121.05 122.54 67.89 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 N-CA-C 109.197 -0.668 . . . . 70.310000000000002 109.197 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.4 t -110.53 116.71 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 106.902 -1.518 . . . . 73.019999999999996 106.902 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -62.92 126.56 27.74 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.119 1.155 . . . . 75.230000000000004 114.119 -172.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 72.85 8.51 5.5 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.173 1.789 . . . . 72.400000000000006 113.276 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -116.68 -85.56 0.63 Allowed 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 112.969 0.729 . . . . 75.0 112.969 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.406 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.5 OUTLIER -162.32 162.75 28.11 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.875 -0.602 . . . . 74.129999999999995 112.254 -171.336 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.51 HG22 HG23 ' A' ' 376' ' ' VAL . 66.5 t -122.58 144.86 30.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.049 -0.978 . . . . 73.329999999999998 109.585 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.406 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 62.8 m-85 -133.94 148.33 51.17 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 123.094 0.558 . . . . 72.430000000000007 111.595 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.46 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.9 tt0 -119.47 103.51 9.51 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.818 -1.919 . . . . 63.219999999999999 105.818 173.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.5 t70 69.15 -86.44 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 123.962 0.905 . . . . 75.120000000000005 109.587 -175.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.6 m -135.37 -2.66 2.46 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.935 -0.765 . . . . 65.010000000000005 108.935 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 62.8 mt -83.13 132.66 30.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.93 -0.577 . . . . 74.239999999999995 109.781 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.2 tp -76.66 115.54 16.51 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.6 -0.889 . . . . 72.319999999999993 108.6 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.536 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -79.69 -66.09 0.92 Allowed 'General case' 0 N--CA 1.39 -3.455 0 N-CA-C 108.934 -0.765 . . . . 74.099999999999994 108.934 -177.229 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.77 160.15 31.65 Favored Glycine 0 N--CA 1.413 -2.836 0 C-N-CA 118.925 -1.607 . . . . 54.350000000000001 111.604 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -104.36 145.28 30.49 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.362 -1.347 . . . . 75.230000000000004 107.362 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -66.6 116.66 7.78 Favored 'General case' 0 C--N 1.288 -2.088 0 O-C-N 123.351 0.407 . . . . 75.239999999999995 110.774 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -101.93 -48.11 4.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.107 -0.497 . . . . 75.420000000000002 111.227 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 51.3 m -159.5 141.42 13.31 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.945 -0.391 . . . . 74.430000000000007 109.945 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.407 ' HB2' ' CD2' ' A' ' 400' ' ' LEU . 9.9 pt20 -144.37 140.47 29.08 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 120.97 0.414 . . . . 74.129999999999995 111.888 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -128.05 119.43 25.39 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.493 -0.776 . . . . 75.329999999999998 110.416 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 74.72 -101.28 1.28 Allowed Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 115.681 -0.691 . . . . 75.230000000000004 111.736 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 4.4 p-10 -131.79 15.96 4.79 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.401 0.619 . . . . 73.310000000000002 110.071 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 419' ' ' THR . 46.9 t -116.71 119.15 61.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 106.874 -1.528 . . . . 75.310000000000002 106.874 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.407 ' CD2' ' HB2' ' A' ' 395' ' ' GLN . 9.9 mt -118.04 130.74 56.35 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 116.207 -0.451 . . . . 52.509999999999998 110.808 -170.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.457 ' HE3' HD12 ' A' ' 417' ' ' ILE . 22.6 mmtp -105.02 122.99 47.02 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 112.275 0.472 . . . . 73.430000000000007 112.275 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.435 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.2 m-85 -118.84 132.92 56.13 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.887 -1.153 . . . . 75.319999999999993 107.887 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -147.19 177.58 9.07 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 122.582 0.353 . . . . 72.409999999999997 110.179 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 66.67 36.63 4.66 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.605 0.566 . . . . 73.140000000000001 111.226 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -79.88 -138.07 1.78 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 120.582 -0.818 . . . . 73.209999999999994 112.824 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -81.22 143.18 32.5 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.638 -0.505 . . . . 55.219999999999999 109.638 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.469 0.494 0 N-CA-C 113.82 1.044 . . . . 73.239999999999995 113.82 -176.153 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 . . . . . 0 C--O 1.244 0.777 0 N-CA-C 105.681 -1.97 . . . . 52.009999999999998 105.681 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -63.77 160.49 17.12 Favored 'General case' 0 C--O 1.254 1.313 0 CA-C-O 121.467 0.651 . . . . 75.0 112.662 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.633 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 46.7 t -161.13 159.66 29.31 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 114.539 -1.209 . . . . 74.129999999999995 107.814 -176.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -159.78 149.93 18.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 120.852 0.358 . . . . 64.230000000000004 110.127 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' ILE . . . . . 0.457 HD12 ' HE3' ' A' ' 401' ' ' LYS . 8.8 tt -110.63 123.8 66.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.737 -1.208 . . . . 62.210000000000001 107.737 173.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.3 t -106.28 126.25 61.92 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 CA-C-O 121.164 0.507 . . . . 51.409999999999997 109.924 176.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.454 HG23 HG22 ' A' ' 399' ' ' VAL . 3.6 m -108.64 112.95 25.56 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 105.819 -1.919 . . . . 54.210000000000001 105.819 176.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 40.6 t -100.8 112.0 32.26 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.94 0 N-CA-C 107.101 -1.444 . . . . 74.129999999999995 107.101 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -110.9 -175.37 2.7 Favored 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 120.228 -0.589 . . . . 75.209999999999994 111.4 -175.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.48 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 38.9 t -59.92 128.01 34.76 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 123.503 0.721 . . . . 73.150000000000006 110.46 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -158.76 -176.93 31.36 Favored Glycine 0 CA--C 1.492 -1.385 0 N-CA-C 110.964 -0.855 . . . . 74.129999999999995 110.964 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 42.3 t -94.38 -31.29 4.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-O 121.225 0.536 . . . . 53.450000000000003 109.615 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.84 161.09 40.77 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 116.002 -0.545 . . . . 63.340000000000003 109.559 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.531 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.1 p-10 -73.03 98.58 2.55 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 124.311 1.007 . . . . 72.450000000000003 110.398 175.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -132.44 148.22 52.4 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.912 -0.586 . . . . 74.109999999999999 110.754 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.475 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 28.2 mm -84.36 124.03 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.963 -1.866 . . . . 74.430000000000007 105.963 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.435 HG11 ' HE3' ' A' ' 442' ' ' LYS . 51.9 t -92.55 -47.99 13.7 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 112.888 0.699 . . . . 73.019999999999996 112.888 -175.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 430' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 42.9 m -158.67 155.64 28.49 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.735 -0.469 . . . . 54.030000000000001 109.735 -173.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.51 HG12 HG21 ' A' ' 369' ' ' ILE . 3.2 p -141.3 111.9 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 108.672 -0.862 . . . . 63.009999999999998 108.672 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' LEU . . . . . 0.411 ' O ' HD23 ' A' ' 440' ' ' LEU . 32.0 tp -117.71 137.74 52.48 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 114.96 -1.018 . . . . 71.430000000000007 108.507 -175.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -80.58 112.59 18.08 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.962 -0.755 . . . . 73.439999999999998 108.962 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -73.75 -49.79 23.78 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 115.54 -0.755 . . . . 65.319999999999993 110.216 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -126.14 -76.2 0.58 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.166 -0.924 . . . . 75.219999999999999 108.993 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.95 -41.31 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 121.043 0.449 . . . . 71.340000000000003 110.787 173.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 98.6 m -96.84 -16.88 20.54 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.324 0.583 . . . . 72.329999999999998 110.114 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 415' ' ' SER . 37.3 tt0 -112.72 132.31 55.27 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.979 -1.01 . . . . 71.340000000000003 109.691 -177.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -125.68 150.16 47.87 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.543 -0.753 . . . . 72.150000000000006 109.273 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.5 pt? -105.47 117.16 33.32 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.566 -0.901 . . . . 75.200000000000003 108.566 173.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.6 mt -114.91 132.25 64.7 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 115.093 -0.958 . . . . 73.219999999999999 109.628 -176.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.435 ' HE3' HG11 ' A' ' 429' ' ' VAL . 36.6 ttpt -109.31 140.16 43.34 Favored 'General case' 0 N--CA 1.408 -2.53 0 N-CA-C 108.51 -0.922 . . . . 72.109999999999999 108.51 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.475 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 77.0 mtp -138.08 168.41 19.78 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 108.484 -0.932 . . . . 74.549999999999997 108.484 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.61 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 71.7 mmtt -134.5 156.45 48.59 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.292 -1.003 . . . . 53.030000000000001 108.292 175.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 74.3 m -162.95 147.32 9.08 Favored Pre-proline 0 C--N 1.289 -2.04 0 C-N-CA 124.291 1.036 . . . . 73.430000000000007 109.394 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -66.14 -27.25 49.31 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.324 2.016 . . . . 71.019999999999996 111.757 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -78.72 -15.6 58.25 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.748 -0.66 . . . . 74.019999999999996 110.79 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.854 0 CA-C-O 121.68 0.752 . . . . 72.200000000000003 109.913 -179.868 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.493 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 95.7 m . . . . . 0 N--CA 1.416 -2.163 0 N-CA-C 107.711 -1.218 . . . . 74.120000000000005 107.711 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 0.0 OUTLIER -136.26 141.51 43.9 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.963 -0.695 . . . . 74.299999999999997 110.404 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -159.71 140.34 12.18 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.518 0.511 . . . . 72.209999999999994 110.313 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -76.34 123.92 26.7 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 110.115 -0.328 . . . . 64.439999999999998 110.115 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.46 HG21 HG12 ' A' ' 431' ' ' VAL . 48.6 mt -129.52 117.52 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 N-CA-C 106.194 -1.78 . . . . 72.409999999999997 106.194 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.73 14.01 62.14 Favored Glycine 0 C--N 1.304 -1.219 0 C-N-CA 120.781 -0.723 . . . . 53.509999999999998 112.244 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.1 -22.05 32.22 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 121.279 -0.486 . . . . 62.340000000000003 112.981 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -98.35 135.83 39.38 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 120.916 0.389 . . . . 71.230000000000004 111.204 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 85.4 m -79.86 114.54 18.85 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.765 -0.652 . . . . 73.409999999999997 110.224 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -91.46 132.92 35.91 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 108.563 -0.903 . . . . 72.340000000000003 108.563 176.344 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.534 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 37.6 ttpt -132.01 132.31 43.31 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 120.273 -0.571 . . . . 72.349999999999994 110.594 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.493 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.0 p -122.65 118.42 55.05 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 CA-C-N 115.844 -0.616 . . . . 71.329999999999998 110.076 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.54 116.02 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 106.768 -1.568 . . . . 65.150000000000006 106.768 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.411 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 98.0 m-85 -64.18 132.56 50.74 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 113.522 0.934 . . . . 73.310000000000002 113.522 -173.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 65.18 23.66 12.31 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.053 -1.431 . . . . 75.510000000000005 112.286 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -136.49 -83.46 0.37 Allowed 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.505 -0.77 . . . . 71.310000000000002 112.914 176.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -165.81 160.03 16.65 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.569 0.951 . . . . 63.130000000000003 113.569 -173.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.476 HG22 HG23 ' A' ' 376' ' ' VAL . 95.9 t -116.21 146.3 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.595 1.158 . . . . 51.020000000000003 109.521 -178.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -134.83 152.36 51.69 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.316 0.646 . . . . 71.510000000000005 111.646 -178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.481 ' HB2' HD23 ' A' ' 389' ' ' LEU . 29.1 tt0 -127.63 106.68 9.32 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.337 -1.727 . . . . 70.450000000000003 106.337 171.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.5 t70 69.44 -83.35 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 124.175 0.99 . . . . 54.130000000000003 110.52 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 45.5 m -135.85 -5.49 2.18 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.961 -0.755 . . . . 44.140000000000001 108.961 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 49.7 mm -89.21 132.63 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.497 -0.774 . . . . 62.039999999999999 110.565 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 57.7 tp -76.41 116.12 16.8 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.309 -0.997 . . . . 62.439999999999998 108.309 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.2 OUTLIER -79.44 -62.63 1.63 Allowed 'General case' 0 N--CA 1.393 -3.287 0 N-CA-C 109.03 -0.73 . . . . 64.140000000000001 109.03 -176.535 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.56 160.87 32.23 Favored Glycine 0 N--CA 1.42 -2.422 0 C-N-CA 119.335 -1.412 . . . . 35.100000000000001 111.903 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -104.73 151.31 23.89 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.662 -1.236 . . . . 64.519999999999996 107.662 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.411 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.8 m-85 -70.41 116.75 11.11 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 121.341 0.591 . . . . 64.120000000000005 111.876 -176.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -95.81 -47.18 6.27 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.318 -0.855 . . . . 62.409999999999997 110.541 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 38.3 t -164.95 139.27 5.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.461 -0.57 . . . . 64.109999999999999 109.461 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.534 ' CB ' ' HG ' ' A' ' 400' ' ' LEU . 5.7 pm0 -141.98 129.71 21.62 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.556 -0.747 . . . . 73.319999999999993 110.621 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -128.37 127.07 41.94 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.294 -1.002 . . . . 74.129999999999995 108.294 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.93 -117.79 9.65 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.986 -0.625 . . . . 73.010000000000005 112.011 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -116.63 20.3 14.12 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.357 0.598 . . . . 73.239999999999995 110.773 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 67.4 t -124.91 128.88 73.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.45 -0.944 . . . . 75.409999999999997 108.45 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.534 ' HG ' ' CB ' ' A' ' 395' ' ' GLN . 3.9 mp -126.51 140.39 52.49 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 116.455 -0.339 . . . . 72.209999999999994 111.099 -175.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -116.68 124.88 50.78 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.132 0.573 . . . . 74.219999999999999 111.133 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.411 ' CD2' HG21 ' A' ' 382' ' ' VAL . 3.8 m-85 -118.16 136.19 53.77 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.061 -0.718 . . . . 73.319999999999993 109.061 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.25 178.03 8.91 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 122.654 0.382 . . . . 74.530000000000001 110.653 178.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.2 m120 66.58 33.61 6.46 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.079 0.552 . . . . 51.210000000000001 111.684 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.15 -130.4 0.44 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 120.424 -0.893 . . . . 64.099999999999994 113.051 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.78 147.53 30.45 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.402 -1.703 . . . . 65.230000000000004 106.402 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 407' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 50.8 m . . . . . 0 C--N 1.311 -1.099 0 CA-C-O 121.839 0.828 . . . . 41.030000000000001 112.806 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' HIS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 94.8 m-70 . . . . . 0 CA--C 1.504 -0.789 0 N-CA-C 108.358 -0.979 . . . . 74.030000000000001 108.358 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -76.7 165.08 25.24 Favored 'General case' 0 C--O 1.251 1.157 0 O-C-N 123.597 0.561 . . . . 45.439999999999998 111.5 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 22.9 p -161.79 165.3 28.09 Favored 'General case' 0 N--CA 1.411 -2.397 0 CA-C-N 114.548 -1.205 . . . . 72.239999999999995 109.235 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -159.54 151.05 20.08 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.422 0.629 . . . . 72.099999999999994 110.546 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.4 tt -114.37 131.56 66.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-N 115.333 -0.848 . . . . 74.430000000000007 109.102 173.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.454 HG22 ' HB ' ' A' ' 441' ' ' ILE . 4.7 t -119.96 125.71 74.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-O 121.335 0.588 . . . . 73.329999999999998 110.97 177.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 21.3 p -109.77 114.59 28.3 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.091 -0.959 . . . . 73.239999999999995 108.952 174.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 37.5 t -100.48 112.48 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 108.284 -1.006 . . . . 61.140000000000001 108.284 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -110.53 -174.6 2.52 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 116.566 -0.288 . . . . 70.239999999999995 110.571 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.547 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 30.4 t -57.36 128.33 36.49 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.626 0.771 . . . . 73.129999999999995 111.678 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.692 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -154.94 -177.62 28.42 Favored Glycine 0 CA--C 1.478 -2.233 0 C-N-CA 120.467 -0.873 . . . . 72.150000000000006 111.806 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.0 t -87.34 -36.01 9.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.64 -0.874 . . . . 75.129999999999995 108.64 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -157.62 162.17 38.69 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.566 -0.901 . . . . 74.040000000000006 108.566 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 61.5 m-20 -61.77 102.36 0.26 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.485 0.659 . . . . 63.409999999999997 111.41 173.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -131.9 148.28 52.53 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.938 -1.028 . . . . 71.230000000000004 109.687 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 27.0 mm -89.05 114.83 27.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 105.87 -1.9 . . . . 72.310000000000002 105.87 175.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 53.0 t -83.02 -51.27 14.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 CA-C-N 116.112 -0.494 . . . . 63.530000000000001 112.217 -174.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 49.2 m -155.36 154.45 32.03 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.7 -0.481 . . . . 64.530000000000001 109.7 -174.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.46 HG12 HG21 ' A' ' 369' ' ' ILE . 5.6 p -141.8 122.83 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 109.079 -0.711 . . . . 52.240000000000002 109.079 175.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 432' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 440' ' ' LEU . 29.4 tp -131.25 136.81 48.53 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 107.385 -1.339 . . . . 73.299999999999997 107.385 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -83.56 122.14 28.16 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.977 -1.49 . . . . 75.400000000000006 106.977 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.518 ' HB2' HD22 ' A' ' 440' ' ' LEU . . . -82.92 -49.83 9.22 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.81 1.041 . . . . 74.129999999999995 113.81 -173.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -116.23 -70.26 0.81 Allowed 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.064 -0.654 . . . . 71.5 110.616 -170.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 436' ' ' LYS . . . . . 0.419 ' H ' ' H ' ' A' ' 437' ' ' CYS . 0.0 OUTLIER -172.99 -24.27 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 125.058 1.343 . . . . 70.120000000000005 109.359 178.371 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 437' ' ' CYS . . . . . 0.419 ' H ' ' H ' ' A' ' 436' ' ' LYS . 29.9 m -135.59 13.23 3.46 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.733 -0.84 . . . . 64.530000000000001 108.733 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 415' ' ' SER . 24.2 tt0 -136.68 119.22 15.91 Favored 'General case' 0 C--O 1.204 -1.317 0 N-CA-C 112.481 0.549 . . . . 63.329999999999998 112.481 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 439' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 26.9 m-85 -104.12 146.45 28.72 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.944 -0.571 . . . . 72.049999999999997 110.953 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 434' ' ' ALA . 1.5 pt? -108.53 120.24 41.85 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.252 -1.018 . . . . 72.129999999999995 108.252 172.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.454 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.6 mt -120.01 131.55 72.09 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 115.259 -0.882 . . . . 74.299999999999997 110.793 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -98.56 138.32 35.93 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 108.5 -0.926 . . . . 65.120000000000005 108.5 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.419 ' SD ' HG11 ' A' ' 376' ' ' VAL . 80.7 mtp -138.79 164.67 29.01 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 109.988 -0.375 . . . . 74.439999999999998 109.988 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.692 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 32.7 mmtp -133.24 160.56 36.92 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.497 -0.557 . . . . 45.310000000000002 109.497 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 42.7 t -163.75 142.08 6.04 Favored Pre-proline 0 C--N 1.304 -1.394 0 O-C-N 124.036 0.835 . . . . 62.509999999999998 109.041 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -68.16 -26.19 36.59 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 121.973 1.782 . . . . 51.210000000000001 109.676 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.8 -7.55 58.74 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.922 -1.035 . . . . 61.229999999999997 110.652 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.716 0 CA-C-O 121.311 0.577 . . . . 71.439999999999998 109.636 176.919 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.461 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 58.0 m . . . . . 0 N--CA 1.445 -0.696 0 N-CA-C 109.266 -0.642 . . . . 71.349999999999994 109.266 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 18.2 ptpt -144.6 145.29 31.71 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 123.082 0.239 . . . . 64.530000000000001 111.441 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.46 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 4.0 tmt_? -159.4 133.71 7.7 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.556 -1.276 . . . . 71.530000000000001 107.556 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 44.2 mt-10 -84.6 125.6 32.6 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.578 -0.527 . . . . 74.409999999999997 109.578 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.457 HG21 HG12 ' A' ' 431' ' ' VAL . 47.8 mt -131.08 118.21 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 107.544 -1.28 . . . . 61.450000000000003 107.544 -174.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 67.06 13.16 61.5 Favored Glycine 0 C--N 1.313 -0.718 0 C-N-CA 120.936 -0.65 . . . . 62.210000000000001 112.365 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 112.89 -29.29 8.2 Favored Glycine 0 N--CA 1.417 -2.58 0 C-N-CA 120.946 -0.645 . . . . 74.329999999999998 112.595 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' TYR . . . . . 0.414 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 20.8 p90 -98.4 140.33 32.82 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 120.914 0.388 . . . . 64.310000000000002 111.314 -175.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 36.9 m -81.12 118.19 22.32 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 116.012 -0.54 . . . . 74.310000000000002 110.037 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.574 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.5 129.89 36.62 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 108.621 -0.881 . . . . 61.509999999999998 108.621 173.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -131.24 128.5 40.02 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.371 -0.532 . . . . 71.349999999999994 109.969 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.461 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.6 p -124.17 117.85 52.03 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-O 121.325 0.583 . . . . 73.129999999999995 109.576 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.48 116.47 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.378 -1.341 . . . . 73.510000000000005 107.378 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.474 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 91.9 m-85 -60.52 131.03 49.46 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.499 0.926 . . . . 70.450000000000003 113.499 -172.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 68.99 9.49 7.44 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 124.996 1.318 . . . . 71.25 112.612 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -120.82 -84.32 0.66 Allowed 'General case' 0 C--O 1.239 0.552 0 N-CA-C 113.164 0.801 . . . . 71.340000000000003 113.164 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -166.94 158.76 12.79 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.09 0.774 . . . . 72.25 113.09 -173.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.443 HG22 HG23 ' A' ' 376' ' ' VAL . 92.0 t -114.1 146.35 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.992 -1.003 . . . . 72.310000000000002 109.535 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -133.98 146.1 50.12 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 123.048 0.539 . . . . 71.530000000000001 111.71 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.498 ' HB2' HD23 ' A' ' 389' ' ' LEU . 35.3 tt0 -117.94 98.38 6.31 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 106.112 -1.81 . . . . 61.32 106.112 172.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 18.7 t70 69.94 -83.93 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 124.325 1.05 . . . . 73.409999999999997 110.636 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.3 m -136.43 3.87 2.84 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.161 -1.051 . . . . 72.129999999999995 108.161 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 65.2 mt -88.36 132.66 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 114.998 -1.001 . . . . 71.329999999999998 109.775 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 64.2 tp -78.01 110.58 13.08 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.383 -1.34 . . . . 75.019999999999996 107.383 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.54 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -76.81 -65.26 0.96 Allowed 'General case' 0 N--CA 1.393 -3.317 0 N-CA-C 109.036 -0.728 . . . . 73.010000000000005 109.036 -175.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.27 157.45 28.8 Favored Glycine 0 N--CA 1.423 -2.184 0 C-N-CA 119.791 -1.195 . . . . 72.310000000000002 111.746 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -100.65 150.02 23.16 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.057 -1.09 . . . . 71.439999999999998 108.057 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.474 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.9 m-85 -73.04 115.9 12.92 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.205 0.526 . . . . 55.530000000000001 110.853 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.9 -43.42 6.73 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.529 -0.76 . . . . 60.520000000000003 111.085 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 52.9 m -155.11 143.73 20.57 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.686 -0.234 . . . . 62.210000000000001 110.515 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.428 ' CG ' HD22 ' A' ' 400' ' ' LEU . 0.1 OUTLIER -129.88 133.87 47.15 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.873 -1.529 . . . . 74.040000000000006 106.873 174.542 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -128.91 110.91 12.51 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.782 -0.821 . . . . 73.129999999999995 108.782 173.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 72.11 -101.66 1.07 Allowed Glycine 0 N--CA 1.409 -3.114 0 C-N-CA 119.415 -1.374 . . . . 72.120000000000005 112.056 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -130.39 19.15 5.3 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 123.77 0.828 . . . . 44.210000000000001 109.124 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.95 116.75 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 N-CA-C 106.887 -1.523 . . . . 72.5 106.887 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.428 HD22 ' CG ' ' A' ' 395' ' ' GLN . 13.1 mt -116.46 130.47 56.78 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.806 -0.634 . . . . 70.420000000000002 110.354 -170.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -110.12 121.95 46.46 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 121.031 0.443 . . . . 74.109999999999999 111.239 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.42 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 2.9 m-85 -116.19 132.38 56.68 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.14 -1.059 . . . . 63.219999999999999 108.14 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 415' ' ' SER . 11.4 pt-20 -147.74 177.55 9.21 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 123.172 0.295 . . . . 70.239999999999995 110.96 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 65.91 34.36 7.25 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 123.7 0.625 . . . . 74.349999999999994 111.24 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -79.14 -136.65 1.27 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.756 -0.735 . . . . 64.040000000000006 112.168 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -74.86 151.14 39.01 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.695 -0.854 . . . . 73.140000000000001 108.695 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 121.485 0.66 . . . . 52.240000000000002 112.167 -174.725 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 . . . . . 0 CA--C 1.494 -1.199 0 N-CA-C 106.84 -1.541 . . . . 70.310000000000002 106.84 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -77.44 158.27 30.1 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.362 0.601 . . . . 74.230000000000004 112.042 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 27.4 p -161.04 165.92 28.99 Favored 'General case' 0 N--CA 1.407 -2.614 0 CA-C-N 114.567 -1.197 . . . . 64.340000000000003 109.464 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.26 151.24 19.03 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.223 0.535 . . . . 75.099999999999994 110.536 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.7 tt -114.16 128.56 71.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 CA-C-N 115.415 -0.811 . . . . 75.420000000000002 109.281 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.452 ' CG2' ' HB ' ' A' ' 441' ' ' ILE . 3.4 t -114.13 127.88 71.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-O 121.561 0.696 . . . . 73.420000000000002 111.348 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 33.1 p -108.53 114.91 29.12 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 107.943 -1.132 . . . . 75.040000000000006 107.943 174.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.81 116.48 44.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.438 -0.949 . . . . 71.450000000000003 108.438 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -113.83 -173.33 2.25 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 121.021 -0.271 . . . . 74.409999999999997 111.328 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.427 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 42.9 t -58.73 129.26 41.24 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 123.621 0.768 . . . . 61.030000000000001 111.338 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.479 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -160.8 -177.6 34.04 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 110.676 -0.969 . . . . 63.530000000000001 110.676 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.44 -34.97 7.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 109.24 -0.652 . . . . 73.010000000000005 109.24 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -156.63 160.84 39.77 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 116.024 -0.535 . . . . 74.209999999999994 109.675 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 59.9 m-20 -60.48 106.12 0.51 Allowed 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 123.703 0.801 . . . . 75.010000000000005 112.64 175.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -131.89 148.72 52.56 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.987 -1.006 . . . . 74.549999999999997 108.914 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 367' ' ' ARG . 36.4 mm -90.41 120.21 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.378 -1.712 . . . . 75.150000000000006 106.378 175.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 442' ' ' LYS . 53.5 t -84.66 -48.92 16.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 112.222 0.452 . . . . 44.509999999999998 112.222 -176.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 430' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 58.2 p -164.82 163.63 21.18 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.925 -0.31 . . . . 74.450000000000003 110.66 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.457 HG12 HG21 ' A' ' 369' ' ' ILE . 4.3 p -142.04 119.84 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 123.889 0.743 . . . . 74.140000000000001 109.436 176.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 26.8 tp -125.85 137.56 53.76 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.521 -0.918 . . . . 64.319999999999993 108.521 -176.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -79.67 116.91 20.14 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.148 -1.056 . . . . 63.25 108.148 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -80.85 -58.08 3.26 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.395 -0.82 . . . . 75.340000000000003 110.649 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -109.27 -78.44 0.59 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.746 -0.661 . . . . 75.409999999999997 110.178 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.67 -40.32 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.627 0.727 . . . . 55.43 111.141 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 62.5 m -110.86 8.6 22.3 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.19 -1.041 . . . . 64.219999999999999 108.19 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.8 tt0 -131.75 131.37 42.94 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.064 -0.971 . . . . 72.219999999999999 109.568 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -122.12 150.43 42.2 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.257 -0.883 . . . . 70.319999999999993 109.626 -175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 440' ' ' LEU . 4.3 pp -107.3 122.8 47.29 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 107.645 -1.242 . . . . 73.140000000000001 107.645 175.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.452 ' HB ' ' CG2' ' A' ' 418' ' ' VAL . 96.1 mt -118.96 129.89 74.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 CA-C-N 115.352 -0.84 . . . . 74.430000000000007 110.296 -175.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.469 ' HB3' ' HB ' ' A' ' 429' ' ' VAL . 15.7 tppt? -97.86 138.63 34.93 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.489 -0.93 . . . . 73.129999999999995 108.489 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.419 ' SD ' HG11 ' A' ' 376' ' ' VAL . 80.9 mtp -141.93 168.05 20.68 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 110.145 -0.317 . . . . 75.120000000000005 110.145 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.1 mmtt -135.7 160.41 38.63 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.834 -0.802 . . . . 61.43 108.834 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 33.6 t -166.58 147.27 5.28 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 124.058 0.849 . . . . 75.329999999999998 109.102 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.62 -26.44 53.89 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.484 2.123 . . . . 64.120000000000005 111.23 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -77.55 -18.69 56.7 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.242 -0.89 . . . . 42.210000000000001 110.646 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.954 0 CA-C-O 121.689 0.757 . . . . 65.140000000000001 109.864 -178.61 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.566 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 39.4 m . . . . . 0 N--CA 1.419 -2.024 0 N-CA-C 109.673 -0.491 . . . . 71.099999999999994 109.673 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.664 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 60.4 mtpt -139.36 141.53 37.6 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.072 -0.714 . . . . 72.349999999999994 109.072 176.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -161.6 136.95 7.55 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.058 -1.09 . . . . 72.140000000000001 108.058 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -86.72 122.98 31.37 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 120.805 0.336 . . . . 61.109999999999999 110.279 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.473 HG21 HG12 ' A' ' 431' ' ' VAL . 49.0 mt -133.02 123.68 48.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.174 -1.417 . . . . 63.439999999999998 107.174 -175.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.65 8.39 46.63 Favored Glycine 0 C--N 1.309 -0.968 0 C-N-CA 120.821 -0.704 . . . . 74.230000000000004 112.124 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 109.94 -23.2 21.97 Favored Glycine 0 N--CA 1.426 -1.996 0 C-N-CA 121.363 -0.446 . . . . 32.43 112.805 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -98.83 143.84 28.71 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 120.677 0.275 . . . . 64.109999999999999 110.81 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 57.0 m -86.1 121.03 28.13 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 116.486 -0.325 . . . . 70.239999999999995 110.248 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.96 137.68 32.18 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.128 -0.693 . . . . 50.039999999999999 109.128 176.072 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.486 ' HG3' ' HG2' ' A' ' 366' ' ' LYS . 37.0 ttpt -131.83 129.92 41.08 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.618 -0.512 . . . . 64.239999999999995 109.618 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.566 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.0 p -124.85 117.19 49.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-O 121.068 0.461 . . . . 73.049999999999997 109.987 176.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 377' ' ' VAL . . . . . 0.446 HG23 ' HE3' ' A' ' 375' ' ' LYS . 27.6 t -103.71 117.55 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.137 0 N-CA-C 107.063 -1.458 . . . . 62.450000000000003 107.063 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -63.88 124.35 21.3 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.555 -0.748 . . . . 70.040000000000006 111.994 -173.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 72.79 12.7 5.23 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.064 1.346 . . . . 73.209999999999994 113.127 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -125.42 -80.8 0.62 Allowed 'General case' 0 C--O 1.246 0.869 0 N-CA-C 113.645 0.98 . . . . 73.219999999999999 113.645 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -160.3 166.9 28.62 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.997 0.74 . . . . 73.450000000000003 112.997 -171.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.445 HG22 HG23 ' A' ' 376' ' ' VAL . 74.0 t -125.42 142.32 42.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.932 -1.031 . . . . 74.409999999999997 108.423 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -131.7 150.09 52.27 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 123.069 0.547 . . . . 74.400000000000006 111.641 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.5 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.6 tt0 -122.62 103.95 9.02 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 106.912 -1.514 . . . . 74.319999999999993 106.912 173.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 14.5 t70 72.6 -70.76 0.15 Allowed 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.281 1.433 . . . . 63.140000000000001 109.479 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' SER . . . . . 0.406 ' H ' ' H ' ' A' ' 387' ' ' ILE . 28.6 t -152.87 -0.61 0.26 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.137 -0.938 . . . . 33.210000000000001 108.727 176.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.406 ' H ' ' H ' ' A' ' 386' ' ' SER . 62.6 mt -86.42 136.62 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 109.313 -0.625 . . . . 73.310000000000002 109.313 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 63.8 tp -76.27 112.54 12.86 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.288 -1.005 . . . . 72.340000000000003 108.288 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.627 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -78.93 -63.83 1.32 Allowed 'General case' 0 N--CA 1.393 -3.313 0 N-CA-C 108.507 -0.923 . . . . 74.349999999999994 108.507 -176.502 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.03 160.88 32.0 Favored Glycine 0 CA--C 1.478 -2.271 0 C-N-CA 119.937 -1.125 . . . . 72.129999999999995 110.974 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -109.53 149.55 29.46 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.175 -1.046 . . . . 62.100000000000001 108.175 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.542 ' HD2' ' NE2' ' A' ' 395' ' ' GLN . 1.4 m-85 -69.82 122.36 19.08 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 120.814 0.34 . . . . 75.430000000000007 110.889 -176.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -99.09 -48.2 4.94 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.973 -0.558 . . . . 71.109999999999999 110.909 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 58.6 m -165.74 142.81 5.49 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.887 -1.153 . . . . 64.430000000000007 107.887 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.542 ' NE2' ' HD2' ' A' ' 392' ' ' PHE . 40.0 mt-30 -126.51 141.87 51.73 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.012 -1.107 . . . . 73.450000000000003 108.012 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -129.13 110.23 11.84 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.559 -0.456 . . . . 62.409999999999997 110.294 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.19 -101.07 0.92 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 121.008 -0.615 . . . . 74.040000000000006 111.891 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -125.61 18.44 8.07 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.408 -0.59 . . . . 74.329999999999998 109.408 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.2 t -118.54 116.52 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 N-CA-C 107.322 -1.362 . . . . 73.5 107.322 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' A' ' 395' ' ' GLN . 14.8 mt -111.16 125.09 53.42 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 116.118 -0.492 . . . . 73.340000000000003 110.079 -171.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -105.14 123.74 48.35 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 112.997 0.74 . . . . 75.430000000000007 112.997 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.422 ' O ' ' HB2' ' A' ' 415' ' ' SER . 2.6 m-85 -117.77 139.75 50.63 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.971 -1.122 . . . . 73.200000000000003 107.971 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 403' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 415' ' ' SER . 70.8 mm-40 -142.54 175.2 9.97 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 124.275 1.03 . . . . 74.439999999999998 109.39 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 53.55 47.01 24.91 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 114.423 1.268 . . . . 62.409999999999997 114.423 173.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.627 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -80.88 -148.29 5.74 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.349 -0.841 . . . . 73.329999999999998 111.413 172.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.19 141.01 43.66 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.333 -1.358 . . . . 70.019999999999996 107.333 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 34.3 p . . . . . 0 C--N 1.311 -1.099 0 C-N-CA 123.149 0.58 . . . . 53.100000000000001 112.482 -178.66 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 . . . . . 0 CA--C 1.487 -1.454 0 N-CA-C 106.767 -1.568 . . . . 73.239999999999995 106.767 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.404 ' HA ' ' HB3' ' A' ' 437' ' ' CYS . 58.3 mtt180 -78.57 157.57 28.74 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.192 -0.603 . . . . 73.409999999999997 111.946 172.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 51.4 p -160.22 169.45 23.2 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 115.007 -0.997 . . . . 65.230000000000004 109.78 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -159.98 151.96 20.4 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.287 0.565 . . . . 71.510000000000005 110.553 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.4 tt -118.01 127.73 75.2 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 CA-C-N 115.06 -0.973 . . . . 64.420000000000002 108.821 174.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.7 t -113.93 129.87 69.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.336 0.589 . . . . 71.140000000000001 112.477 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 14.2 p -108.35 113.87 27.28 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.999 -1.0 . . . . 63.039999999999999 108.361 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 39.6 t -101.53 115.08 42.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 120.74 0.305 . . . . 64.329999999999998 110.291 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.494 ' OE1' ' HD2' ' A' ' 442' ' ' LYS . 47.9 mt-10 -108.07 -176.38 3.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.816 0.341 . . . . 73.019999999999996 111.113 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.436 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 36.5 t -60.24 130.99 49.37 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.006 0.922 . . . . 74.519999999999996 111.795 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -157.86 -177.61 31.12 Favored Glycine 0 N--CA 1.421 -2.334 0 N-CA-C 109.98 -1.248 . . . . 74.209999999999994 109.98 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.36 -28.52 3.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 108.371 -0.974 . . . . 72.109999999999999 108.371 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -152.42 151.81 31.24 Favored 'General case' 0 CA--C 1.478 -1.815 0 CA-C-N 115.103 -0.953 . . . . 52.049999999999997 108.867 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.695 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 18.4 p-10 -66.73 105.43 1.56 Allowed 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 113.286 -1.779 . . . . 71.239999999999995 110.96 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -131.29 148.27 52.67 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.111 -0.95 . . . . 73.150000000000006 110.612 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 26.8 mm -88.28 120.39 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 105.969 -1.863 . . . . 75.540000000000006 105.969 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 62.9 t -83.1 -50.76 15.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-O 120.845 0.355 . . . . 53.109999999999999 111.586 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 48.4 m -164.17 164.5 22.65 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.248 -0.649 . . . . 62.119999999999997 109.248 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.473 HG12 HG21 ' A' ' 369' ' ' ILE . 2.8 p -142.05 114.38 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 123.814 0.846 . . . . 65.510000000000005 109.245 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 432' ' ' LEU . . . . . 0.458 ' O ' HD23 ' A' ' 440' ' ' LEU . 30.7 tp -120.85 138.86 53.85 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.895 -0.78 . . . . 73.299999999999997 108.895 -175.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -80.37 110.69 16.06 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 119.743 -0.783 . . . . 74.099999999999994 109.757 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.405 ' H ' ' HA ' ' A' ' 439' ' ' TYR . . . -74.64 -38.53 62.47 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.027 -0.988 . . . . 65.209999999999994 111.249 -175.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -127.64 -80.01 0.59 Allowed 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.609 -0.723 . . . . 72.450000000000003 111.683 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -166.73 -36.32 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.3 -0.864 . . . . 73.299999999999997 109.772 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 437' ' ' CYS . . . . . 0.404 ' HB3' ' HA ' ' A' ' 414' ' ' ARG . 97.8 m -122.02 -2.63 9.16 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 115.108 -0.951 . . . . 73.439999999999998 109.913 174.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.6 tt0 -119.0 134.43 55.2 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.192 -0.913 . . . . 75.530000000000001 109.049 -177.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 439' ' ' TYR . . . . . 0.405 ' HA ' ' H ' ' A' ' 434' ' ' ALA . 35.9 m-85 -126.04 150.18 48.31 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 123.743 0.652 . . . . 72.209999999999994 110.057 -174.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.49 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.8 pt? -105.67 123.22 47.58 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.069 -1.085 . . . . 73.109999999999999 108.069 173.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.4 mt -122.26 129.93 74.93 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 CA-C-N 115.088 -0.96 . . . . 71.129999999999995 109.361 -177.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.494 ' HD2' ' OE1' ' A' ' 421' ' ' GLU . 36.5 ttpt -107.65 142.3 37.82 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 119.847 -0.741 . . . . 73.120000000000005 110.026 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 78.5 mtp -136.44 168.54 19.25 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 123.248 0.619 . . . . 43.439999999999998 109.56 -176.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.695 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 70.4 mmtt -131.93 153.52 50.19 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.179 -1.415 . . . . 72.099999999999994 107.179 175.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 74.8 m -161.78 150.33 12.74 Favored Pre-proline 0 C--N 1.287 -2.115 0 O-C-N 123.798 0.686 . . . . 65.219999999999999 110.346 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.99 -27.16 66.18 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.832 2.355 . . . . 63.140000000000001 112.348 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.77 -12.23 57.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.708 -0.678 . . . . 61.119999999999997 111.9 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.872 0 CA-C-O 121.627 0.727 . . . . 74.049999999999997 109.845 -179.375 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.462 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 80.1 m . . . . . 0 N--CA 1.417 -2.089 0 N-CA-C 108.963 -0.754 . . . . 71.230000000000004 108.963 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 60.4 mtpt -133.2 140.61 47.64 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 110.106 -0.331 . . . . 63.32 110.106 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -158.08 134.33 9.42 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.395 -0.595 . . . . 62.119999999999997 109.395 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 2.8 mp0 -78.58 125.91 30.02 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 110.038 -0.356 . . . . 72.019999999999996 110.038 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.467 HG21 HG12 ' A' ' 431' ' ' VAL . 54.4 mt -130.92 117.54 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 N-CA-C 106.863 -1.532 . . . . 75.049999999999997 106.863 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 67.24 9.98 55.77 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.555 -0.831 . . . . 74.140000000000001 112.592 -177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.59 -7.7 39.56 Favored Glycine 0 N--CA 1.432 -1.597 0 C-N-CA 120.267 -0.968 . . . . 54.119999999999997 113.406 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' TYR . . . . . 0.404 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 15.4 p90 -114.0 136.61 52.72 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.94 0.37 . . . . 75.209999999999994 110.168 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 61.8 m -79.85 121.0 24.86 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 116.288 -0.414 . . . . 73.140000000000001 111.411 -178.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.67 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.6 OUTLIER -90.96 124.49 35.26 Favored 'General case' 0 N--CA 1.414 -2.244 0 C-N-CA 120.249 -0.58 . . . . 73.129999999999995 109.74 174.709 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 86.4 tttt -120.31 125.44 48.05 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.488 -0.778 . . . . 74.430000000000007 109.83 -174.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.462 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.3 p -127.64 116.14 42.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-O 121.425 0.631 . . . . 71.140000000000001 110.423 176.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.24 116.44 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 N-CA-C 107.145 -1.428 . . . . 61.329999999999998 107.145 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.469 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 75.4 m-85 -61.13 132.43 53.72 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.778 -1.101 . . . . 74.349999999999994 112.854 -171.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 64.97 17.84 11.24 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 124.6 1.16 . . . . 75.299999999999997 112.283 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -130.93 -84.42 0.52 Allowed 'General case' 0 C--O 1.243 0.722 0 N-CA-C 113.534 0.939 . . . . 74.420000000000002 113.534 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -158.65 163.73 36.63 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.726 1.01 . . . . 73.230000000000004 113.726 -170.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 99.1 t -125.55 143.7 38.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 124.505 1.122 . . . . 65.209999999999994 109.151 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 375' ' ' LYS . 91.6 m-85 -133.91 146.5 50.59 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 122.759 0.423 . . . . 63.210000000000001 111.368 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.533 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.8 tt0 -110.99 99.42 8.31 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.402 -2.074 . . . . 73.5 105.402 172.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.4 t70 73.23 -72.93 0.11 Allowed 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 125.465 1.506 . . . . 62.299999999999997 109.816 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.9 t -148.63 -5.15 0.43 Allowed 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 114.913 -1.039 . . . . 64.420000000000002 109.093 176.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 63.8 mt -77.78 134.65 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.356 -0.979 . . . . 75.140000000000001 108.356 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 406' ' ' GLN . 65.2 tp -75.81 113.69 13.57 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.561 -0.903 . . . . 74.019999999999996 108.561 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.533 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.6 OUTLIER -80.73 -63.51 1.39 Allowed 'General case' 0 N--CA 1.383 -3.796 0 N-CA-C 108.348 -0.982 . . . . 64.040000000000006 108.348 -176.318 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.48 160.39 31.33 Favored Glycine 0 N--CA 1.413 -2.886 0 C-N-CA 119.091 -1.528 . . . . 64.219999999999999 111.429 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -108.6 146.58 33.13 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 107.11 -1.441 . . . . 72.120000000000005 107.11 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.469 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.4 m-85 -68.74 125.88 27.96 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 120.634 0.254 . . . . 72.319999999999993 110.585 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -100.36 -48.2 4.66 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.954 0.407 . . . . 73.230000000000004 109.947 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 42.4 p -164.22 162.02 22.38 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.686 -0.688 . . . . 73.109999999999999 109.488 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.514 ' CG ' HD22 ' A' ' 400' ' ' LEU . 18.5 mp0 -128.4 122.58 31.72 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.919 -0.771 . . . . 65.420000000000002 108.919 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.14 109.99 22.63 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.371 -0.974 . . . . 74.409999999999997 108.371 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 55.68 -100.72 0.1 Allowed Glycine 0 N--CA 1.436 -1.345 0 O-C-N 123.921 0.763 . . . . 74.239999999999995 112.401 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -122.87 19.26 10.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.948 0.88 . . . . 65.329999999999998 109.436 -176.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 66.8 t -123.51 116.9 49.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 107.525 -1.287 . . . . 62.450000000000003 107.525 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.514 HD22 ' CG ' ' A' ' 395' ' ' GLN . 12.1 mt -107.19 132.57 52.91 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 116.278 -0.419 . . . . 73.230000000000004 110.88 -169.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -103.63 122.82 45.79 Favored 'General case' 0 C--O 1.247 0.955 0 N-CA-C 112.718 0.636 . . . . 73.019999999999996 112.718 176.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.47 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.5 m-85 -118.58 132.39 56.2 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.013 -1.477 . . . . 74.219999999999999 107.013 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' GLU . . . . . 0.404 ' HA ' ' CB ' ' A' ' 415' ' ' SER . 7.6 pt-20 -147.59 174.91 11.3 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 112.478 0.548 . . . . 73.400000000000006 112.478 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.21 41.22 13.68 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.704 -1.589 . . . . 73.120000000000005 111.766 170.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.37 -133.24 0.61 Allowed Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.138 -0.937 . . . . 72.310000000000002 112.607 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 20.4 tm0? -84.8 141.96 30.12 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.436 -0.95 . . . . 75.019999999999996 108.436 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 42.9 t . . . . . 0 C--N 1.315 -0.911 0 CA-C-O 121.874 0.845 . . . . 63.530000000000001 112.232 -176.605 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 . . . . . 0 CA--C 1.497 -1.066 0 N-CA-C 107.191 -1.411 . . . . 73.230000000000004 107.191 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -76.81 162.23 27.81 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.134 -0.627 . . . . 64.409999999999997 111.026 172.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 47.4 p -164.35 163.09 22.55 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 114.905 -1.043 . . . . 44.140000000000001 108.821 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -158.94 146.9 17.9 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.169 0.509 . . . . 74.420000000000002 110.551 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 7.4 tt -113.38 126.96 70.9 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 CA-C-N 115.266 -0.879 . . . . 73.219999999999999 108.919 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 7.4 t -112.68 131.45 64.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-O 121.108 0.48 . . . . 71.219999999999999 111.937 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 35.0 p -107.26 114.14 27.99 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 107.664 -1.235 . . . . 72.040000000000006 107.664 175.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 43.1 t -100.82 112.97 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 107.537 -1.283 . . . . 73.219999999999999 107.537 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -115.58 -173.65 2.37 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.917 -0.313 . . . . 74.239999999999995 110.211 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.547 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 36.9 t -59.18 128.32 36.59 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 122.974 0.51 . . . . 52.310000000000002 111.256 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -159.8 -176.1 31.51 Favored Glycine 0 CA--C 1.493 -1.305 0 CA-C-N 115.796 -0.638 . . . . 73.140000000000001 111.529 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.0 t -80.58 -38.55 17.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 109.485 -0.561 . . . . 71.200000000000003 109.485 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 446' ' ' PRO . 45.6 tt0 -171.08 162.24 7.04 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 123.51 0.724 . . . . 71.129999999999995 109.321 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 20.9 m120 -61.52 101.38 0.18 Allowed 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.996 -1.002 . . . . 72.25 112.306 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -132.02 149.04 52.53 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.6 -1.182 . . . . 62.140000000000001 108.651 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 30.5 mm -81.51 118.23 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.791 -1.559 . . . . 63.43 106.791 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 63.8 t -81.24 -50.35 16.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-O 120.716 0.293 . . . . 65.319999999999993 111.664 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 42.4 p -166.92 165.68 15.86 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.138 -0.483 . . . . 62.43 109.972 -173.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.467 HG12 HG21 ' A' ' 369' ' ' ILE . 4.3 p -142.0 125.13 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 108.822 -0.807 . . . . 74.0 108.822 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 432' ' ' LEU . . . . . 0.437 ' O ' HD23 ' A' ' 440' ' ' LEU . 27.2 tp -126.48 136.58 52.8 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 107.66 -1.237 . . . . 74.239999999999995 107.66 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -81.18 108.48 14.86 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.674 -0.862 . . . . 62.130000000000003 108.674 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 434' ' ' ALA . . . . . 0.439 ' H ' ' HA ' ' A' ' 439' ' ' TYR . . . -65.31 -61.18 2.27 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 123.74 0.816 . . . . 71.530000000000001 110.781 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -109.33 -75.02 0.64 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.925 -0.58 . . . . 73.340000000000003 110.705 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -165.84 -43.02 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.795 -1.093 . . . . 65.409999999999997 109.892 -174.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 93.4 m -118.74 14.72 13.49 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 121.969 0.89 . . . . 74.209999999999994 109.539 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 415' ' ' SER . 37.1 tt0 -135.14 131.19 36.53 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.111 -1.07 . . . . 55.340000000000003 108.111 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 439' ' ' TYR . . . . . 0.439 ' HA ' ' H ' ' A' ' 434' ' ' ALA . 45.0 m-85 -123.08 150.77 42.73 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 124.005 0.816 . . . . 74.129999999999995 110.261 -174.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.8 pt? -110.4 122.09 46.87 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.736 -1.209 . . . . 74.310000000000002 107.736 172.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.5 mt -121.28 133.84 66.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 CA-C-N 115.41 -0.814 . . . . 73.319999999999993 109.501 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -103.48 140.84 36.95 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 109.131 -0.692 . . . . 63.119999999999997 109.131 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.412 ' SD ' HG11 ' A' ' 418' ' ' VAL . 87.4 mtp -138.54 163.36 32.19 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.267 -1.012 . . . . 70.329999999999998 108.267 177.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.684 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 73.0 mmtt -130.68 161.3 31.93 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.728 -0.842 . . . . 63.240000000000002 108.728 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 445' ' ' SER . . . . . 0.417 ' HB2' ' ND2' ' A' ' 426' ' ' ASN . 30.2 t -167.77 147.62 4.42 Favored Pre-proline 0 C--N 1.296 -1.742 0 O-C-N 123.746 0.654 . . . . 74.010000000000005 109.759 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 425' ' ' GLU . 55.4 Cg_endo -70.55 -21.5 29.75 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.204 1.936 . . . . 71.430000000000007 110.129 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.4 -18.47 59.92 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.83 -1.077 . . . . 41.229999999999997 110.775 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.865 0 CA-C-O 121.751 0.786 . . . . 72.549999999999997 109.093 179.652 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.466 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 59.1 m . . . . . 0 N--CA 1.423 -1.781 0 N-CA-C 106.754 -1.573 . . . . 74.420000000000002 106.754 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 19.4 ptmt -142.29 141.44 32.43 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 111.989 0.366 . . . . 61.039999999999999 111.989 -176.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.41 ' NH1' HG12 ' A' ' 369' ' ' ILE . 3.2 tmt_? -159.57 132.18 6.69 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.442 -0.799 . . . . 71.549999999999997 109.027 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 368' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 44.1 mt-10 -77.93 129.97 36.0 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 116.147 -0.478 . . . . 71.010000000000005 110.525 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.485 HG21 HG12 ' A' ' 431' ' ' VAL . 35.5 mt -135.02 121.53 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 106.831 -1.544 . . . . 74.310000000000002 106.831 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.39 11.54 56.47 Favored Glycine 0 C--N 1.308 -0.999 0 C-N-CA 120.837 -0.697 . . . . 73.209999999999994 112.646 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 110.77 -23.38 19.76 Favored Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 121.186 -0.53 . . . . 70.129999999999995 112.85 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -101.81 141.6 34.42 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 122.514 -0.403 . . . . 74.049999999999997 111.361 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 90.1 m -81.71 117.56 22.14 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.56 0.219 . . . . 52.530000000000001 110.581 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.32 133.6 34.86 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 108.36 -0.978 . . . . 74.420000000000002 108.36 174.264 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.48 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 36.8 ttpt -136.84 127.15 26.48 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 120.635 -0.426 . . . . 72.230000000000004 110.167 -176.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.489 HG23 HG22 ' A' ' 382' ' ' VAL . 6.5 p -120.63 119.34 59.36 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-O 121.181 0.515 . . . . 74.239999999999995 110.337 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.47 116.15 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 106.451 -1.685 . . . . 52.340000000000003 106.451 173.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.527 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 74.9 m-85 -65.56 135.7 55.44 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.018 -0.992 . . . . 63.329999999999998 113.496 -170.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 64.99 11.75 7.32 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 124.764 1.226 . . . . 73.530000000000001 112.306 -176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -122.61 -84.46 0.66 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 112.548 0.573 . . . . 71.319999999999993 112.548 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -166.09 156.59 12.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.05 0.759 . . . . 73.010000000000005 113.05 -171.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.492 HG21 ' CD2' ' A' ' 402' ' ' TYR . 60.9 t -115.05 147.59 18.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 124.293 1.037 . . . . 65.209999999999994 109.141 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -134.72 145.32 48.37 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.04 0.536 . . . . 72.329999999999998 112.119 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.529 ' HB2' HD23 ' A' ' 389' ' ' LEU . 33.2 tt0 -116.68 100.06 7.56 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 105.945 -1.872 . . . . 70.219999999999999 105.945 171.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.3 t70 71.52 -82.34 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 124.082 0.953 . . . . 54.109999999999999 109.901 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 36.8 t -138.52 -3.43 1.7 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.288 -1.004 . . . . 64.140000000000001 108.288 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 50.2 mm -77.19 132.47 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 108.854 -0.795 . . . . 74.439999999999998 108.854 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.1 tp -76.45 109.56 10.28 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.763 -1.569 . . . . 74.340000000000003 106.763 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.7 OUTLIER -76.41 -62.65 1.55 Allowed 'General case' 0 N--CA 1.389 -3.512 0 N-CA-C 108.94 -0.763 . . . . 71.140000000000001 108.94 -175.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.77 157.47 28.7 Favored Glycine 0 N--CA 1.425 -2.089 0 C-N-CA 118.788 -1.673 . . . . 62.25 112.3 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -101.2 146.02 28.06 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.186 -1.412 . . . . 75.329999999999998 107.186 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.527 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 2.1 m-85 -71.84 115.81 11.49 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 109.417 -0.586 . . . . 70.239999999999995 109.417 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -99.39 -42.7 6.86 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.293 -0.412 . . . . 73.299999999999997 111.172 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 60.3 p -164.41 140.71 6.19 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.885 -0.783 . . . . 72.549999999999997 108.885 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.425 ' HB2' ' CD2' ' A' ' 400' ' ' LEU . 0.1 OUTLIER -141.27 145.28 35.32 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.581 -0.282 . . . . 52.25 110.656 177.764 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -124.8 110.27 14.11 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.875 -0.787 . . . . 73.400000000000006 108.875 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 61.86 -105.76 1.01 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.886 -0.597 . . . . 74.340000000000003 113.077 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -113.96 17.07 18.13 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.101 0.477 . . . . 75.310000000000002 110.892 -176.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.3 t -120.9 118.34 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 106.405 -1.702 . . . . 75.140000000000001 106.405 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 395' ' ' GLN . 20.1 mt -119.73 124.83 47.15 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.109 -0.636 . . . . 75.209999999999994 111.479 -169.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.437 ' HE3' HD12 ' A' ' 417' ' ' ILE . 19.3 mmtp -100.85 122.27 43.15 Favored 'General case' 0 C--O 1.253 1.24 0 CA-C-O 121.314 0.578 . . . . 61.329999999999998 112.366 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.492 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.3 m-85 -118.35 130.24 55.89 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.454 -1.313 . . . . 75.310000000000002 107.454 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 415' ' ' SER . 10.4 pt-20 -147.22 176.04 10.28 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 122.008 0.123 . . . . 54.420000000000002 111.117 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 64.97 36.3 7.64 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.666 0.604 . . . . 52.140000000000001 111.522 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -79.23 -140.16 1.93 Allowed Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.705 -0.76 . . . . 63.009999999999998 112.103 176.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -68.69 150.7 47.62 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 122.447 -0.443 . . . . 72.340000000000003 110.001 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 C--N 1.304 -1.407 0 CA-C-O 121.544 0.688 . . . . 64.120000000000005 110.775 -175.054 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 . . . . . 0 CA--C 1.501 -0.911 0 N-CA-C 105.893 -1.891 . . . . 73.140000000000001 105.893 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 43.6 mtt180 -72.31 157.36 37.84 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.412 0.625 . . . . 63.240000000000002 112.481 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 36.2 p -163.18 165.1 24.85 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 114.612 -1.176 . . . . 65.109999999999999 109.409 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.1 148.16 16.8 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.182 0.515 . . . . 74.430000000000007 110.465 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' ILE . . . . . 0.437 HD12 ' HE3' ' A' ' 401' ' ' LYS . 7.3 tt -112.86 123.89 68.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 CA-C-N 115.454 -0.794 . . . . 71.400000000000006 109.278 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.519 HG22 ' HB ' ' A' ' 441' ' ' ILE . 5.1 t -109.8 129.81 64.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-N 115.885 -0.598 . . . . 75.219999999999999 111.866 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.1 p -108.32 114.27 28.01 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 107.667 -1.234 . . . . 73.200000000000003 107.667 173.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 22.4 t -100.35 123.14 53.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.2 -1.407 . . . . 70.230000000000004 107.2 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -120.43 -174.12 2.72 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 120.557 -0.457 . . . . 71.140000000000001 110.898 -176.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.506 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 41.0 t -62.21 128.65 37.12 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 123.883 0.873 . . . . 35.420000000000002 111.56 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.51 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -162.55 -176.8 35.0 Favored Glycine 0 CA--C 1.495 -1.196 0 N-CA-C 111.256 -0.738 . . . . 75.120000000000005 111.256 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 98.9 t -86.48 -37.16 11.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-O 120.975 0.417 . . . . 54.100000000000001 109.877 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.449 ' HG2' ' N ' ' A' ' 426' ' ' ASN . 38.5 tt0 -155.87 162.09 40.49 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 109.278 -0.638 . . . . 73.230000000000004 109.278 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.692 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 49.7 m-80 -63.36 109.1 1.48 Allowed 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 114.591 -1.186 . . . . 64.329999999999998 111.147 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -131.45 148.42 52.64 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.646 -1.161 . . . . 41.420000000000002 109.013 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 35.5 mm -90.47 113.84 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.364 -1.717 . . . . 73.010000000000005 106.364 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.3 t -80.89 -44.31 21.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 112.505 0.557 . . . . 53.0 112.505 -174.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 58.1 p -168.57 162.7 12.14 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 110.043 -0.354 . . . . 73.109999999999999 110.043 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.485 HG12 HG21 ' A' ' 369' ' ' ILE . 5.7 p -142.03 119.97 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 N-CA-C 108.81 -0.811 . . . . 54.109999999999999 108.81 175.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 432' ' ' LEU . . . . . 0.435 ' O ' HD23 ' A' ' 440' ' ' LEU . 30.9 tp -127.42 138.06 52.88 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.156 -1.053 . . . . 75.150000000000006 108.156 -177.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -80.47 115.84 20.21 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.155 -0.683 . . . . 71.450000000000003 109.155 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -76.59 -67.35 0.71 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.478 -0.783 . . . . 52.399999999999999 111.014 -176.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -98.08 -76.5 0.53 Allowed 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.764 -0.828 . . . . 62.130000000000003 108.764 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.89 -43.85 0.04 OUTLIER 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 115.392 -0.822 . . . . 74.120000000000005 110.655 176.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 73.6 m -107.38 8.87 29.85 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.64 0.733 . . . . 74.219999999999999 109.191 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.8 tt0 -130.62 134.7 47.19 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.201 -0.909 . . . . 75.409999999999997 109.035 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -125.86 148.69 49.09 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 123.733 0.646 . . . . 53.530000000000001 109.766 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.456 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.6 pt? -105.2 119.24 38.56 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.499 -0.926 . . . . 75.319999999999993 108.499 174.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.519 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.4 mt -117.74 134.73 60.41 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 115.365 -0.834 . . . . 65.209999999999994 109.551 -177.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -106.17 140.99 38.27 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.806 -0.813 . . . . 74.140000000000001 108.806 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 83.1 mtp -138.74 168.56 19.54 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.641 -0.503 . . . . 62.009999999999998 109.641 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.692 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 72.9 mmtt -133.32 161.17 35.21 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.046 -0.724 . . . . 64.319999999999993 109.046 177.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 28.7 t -172.1 148.55 2.05 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.639 -0.875 . . . . 64.040000000000006 108.639 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.29 -27.49 34.5 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.049 1.832 . . . . 63.310000000000002 110.337 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -77.26 -13.51 59.92 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.812 -1.085 . . . . 73.200000000000003 110.792 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.752 0 CA-C-O 121.329 0.585 . . . . 72.319999999999993 110.147 178.441 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.499 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 97.4 m . . . . . 0 N--CA 1.423 -1.798 0 N-CA-C 107.137 -1.431 . . . . 74.329999999999998 107.137 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.669 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 59.2 mtpt -136.25 140.7 43.65 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.626 0.25 . . . . 70.340000000000003 110.939 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.427 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 4.2 tmt_? -156.74 132.94 9.8 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.116 -0.698 . . . . 64.209999999999994 109.116 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 3.4 mp0 -79.83 129.17 34.26 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 121.02 -0.272 . . . . 65.450000000000003 110.498 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.459 HG21 HG12 ' A' ' 431' ' ' VAL . 48.6 mt -136.14 121.12 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 106.117 -1.809 . . . . 60.32 106.117 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.67 3.23 19.94 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 121.421 -0.418 . . . . 52.32 113.765 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 112.06 -15.91 25.51 Favored Glycine 0 N--CA 1.433 -1.511 0 C-N-CA 120.7 -0.762 . . . . 64.120000000000005 112.627 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -102.82 141.79 35.03 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 109.77 -0.455 . . . . 75.409999999999997 109.77 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 91.9 m -87.65 124.25 33.34 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 116.43 -0.35 . . . . 63.030000000000001 110.888 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.669 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.7 OUTLIER -90.56 126.61 35.99 Favored 'General case' 0 N--CA 1.406 -2.632 0 C-N-CA 119.894 -0.722 . . . . 65.340000000000003 109.804 175.429 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -121.81 124.99 45.47 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.794 -0.817 . . . . 70.230000000000004 108.794 -175.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.499 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.4 p -125.1 124.33 67.28 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 109.888 -0.412 . . . . 71.230000000000004 109.888 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.2 t -113.67 116.29 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.692 -1.596 . . . . 72.120000000000005 106.692 173.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -62.62 126.55 27.73 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.452 -0.794 . . . . 70.010000000000005 112.846 -173.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 72.78 14.88 4.89 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 125.104 1.362 . . . . 72.349999999999994 112.985 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -126.73 -83.1 0.62 Allowed 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 113.309 0.855 . . . . 72.120000000000005 113.309 174.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -163.3 156.45 19.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.138 0.792 . . . . 71.400000000000006 113.138 -170.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.485 HG22 HG23 ' A' ' 376' ' ' VAL . 91.6 t -116.8 145.2 22.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 124.081 0.952 . . . . 55.5 108.992 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -134.16 147.72 50.83 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.102 0.477 . . . . 73.219999999999999 111.389 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.502 ' HB2' HD23 ' A' ' 389' ' ' LEU . 35.9 tt0 -113.05 98.59 7.25 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.972 -1.862 . . . . 71.299999999999997 105.972 173.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.5 t70 72.45 -78.57 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 125.445 1.498 . . . . 64.329999999999998 109.266 -174.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 14.0 p -142.06 -3.06 1.11 Allowed 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 114.6 -1.182 . . . . 72.310000000000002 109.44 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 47.4 mm -80.47 132.01 32.72 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 N-CA-C 108.745 -0.835 . . . . 74.510000000000005 108.745 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 62.1 tp -75.91 113.86 13.89 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 108.797 -0.816 . . . . 63.219999999999999 108.797 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.564 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.3 OUTLIER -80.0 -63.88 1.31 Allowed 'General case' 0 N--CA 1.398 -3.052 0 N-CA-C 109.143 -0.688 . . . . 71.129999999999995 109.143 -176.865 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.06 156.64 27.89 Favored Glycine 0 N--CA 1.42 -2.408 0 C-N-CA 119.114 -1.517 . . . . 62.340000000000003 111.53 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -99.71 146.36 26.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.694 -1.595 . . . . 74.329999999999998 106.694 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.401 ' HD2' HE21 ' A' ' 395' ' ' GLN . 1.6 m-85 -71.27 116.01 11.09 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.282 -0.567 . . . . 73.120000000000005 109.917 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -92.28 -47.32 7.26 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.719 -0.673 . . . . 42.520000000000003 110.408 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 42.3 p -166.68 141.16 4.12 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.939 -0.763 . . . . 60.109999999999999 108.939 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.412 ' HB2' HD23 ' A' ' 400' ' ' LEU . 0.1 OUTLIER -142.11 145.71 34.57 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.53 -0.305 . . . . 75.450000000000003 110.265 178.657 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -128.14 110.23 12.26 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.753 -0.832 . . . . 71.319999999999993 108.753 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.59 -101.43 0.58 Allowed Glycine 0 N--CA 1.432 -1.58 0 O-C-N 123.918 0.761 . . . . 43.520000000000003 112.624 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' ASN . . . . . 0.572 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 27.4 p-10 -113.28 6.25 17.27 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.47 -0.365 . . . . 64.340000000000003 111.97 -176.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.96 116.27 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.186 0 N-CA-C 107.545 -1.28 . . . . 72.420000000000002 107.545 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.412 HD23 ' HB2' ' A' ' 395' ' ' GLN . 19.3 mt -114.4 123.84 50.45 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 116.057 -0.519 . . . . 74.310000000000002 110.119 -171.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.426 ' NZ ' ' HB3' ' A' ' 401' ' ' LYS . 3.2 mmmp? -108.58 122.34 46.88 Favored 'General case' 0 C--O 1.251 1.143 0 CA-C-O 120.748 0.309 . . . . 61.109999999999999 111.474 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.447 ' CE2' HG21 ' A' ' 382' ' ' VAL . 2.8 m-85 -115.68 133.82 55.65 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.413 -0.958 . . . . 72.109999999999999 108.413 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -135.11 171.3 14.62 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.553 -0.536 . . . . 62.210000000000001 109.553 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 54.45 41.1 32.16 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.342 1.238 . . . . 63.399999999999999 114.342 170.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -78.32 -139.86 1.54 Allowed Glycine 0 CA--C 1.541 1.659 0 C-N-CA 120.795 -0.717 . . . . 62.32 113.479 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -63.24 149.96 44.25 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.656 0.783 . . . . 72.209999999999994 110.907 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 49.0 p . . . . . 0 N--CA 1.435 -1.176 0 N-CA-C 109.315 -0.624 . . . . 74.109999999999999 109.315 175.755 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 . . . . . 0 C--O 1.224 -0.248 0 N-CA-C 109.99 -0.374 . . . . 63.149999999999999 109.99 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -81.07 167.49 19.68 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 120.999 0.428 . . . . 74.319999999999993 111.046 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 56.4 p -162.93 160.17 24.52 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.261 -0.881 . . . . 65.540000000000006 109.064 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -157.18 136.62 12.11 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 121.21 0.528 . . . . 64.439999999999998 111.345 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.2 tt -101.43 121.86 52.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-N 115.253 -0.885 . . . . 72.150000000000006 110.42 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.529 HG22 ' HB ' ' A' ' 441' ' ' ILE . 3.9 t -108.57 129.53 62.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.635 -0.711 . . . . 72.540000000000006 111.746 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 13.4 p -109.84 114.89 28.82 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.188 -0.914 . . . . 75.340000000000003 108.896 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 34.1 t -100.43 114.09 38.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.871 -1.159 . . . . 62.049999999999997 107.871 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -114.12 -175.85 2.77 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 120.282 -0.567 . . . . 74.519999999999996 110.901 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 44.8 t -58.21 129.52 42.36 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.303 0.641 . . . . 64.340000000000003 111.442 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -159.94 -177.73 33.29 Favored Glycine 0 N--CA 1.434 -1.471 0 N-CA-C 110.343 -1.103 . . . . 73.219999999999999 110.343 177.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.35 -35.28 6.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.074 -0.713 . . . . 72.010000000000005 109.074 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -141.6 148.86 39.93 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.878 -0.601 . . . . 71.439999999999998 109.42 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.751 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.2 p-10 -67.68 99.12 0.76 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.816 -1.084 . . . . 53.43 109.977 174.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -132.43 149.9 52.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.174 -0.921 . . . . 62.140000000000001 110.526 -175.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.444 HD11 HG12 ' A' ' 376' ' ' VAL . 28.2 mm -81.28 120.7 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 106.065 -1.828 . . . . 74.310000000000002 106.065 175.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 50.4 t -86.77 -50.6 13.9 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 N-CA-C 111.84 0.311 . . . . 74.140000000000001 111.84 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 43.5 p -164.66 163.8 21.55 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 110.204 -0.295 . . . . 72.200000000000003 110.204 -174.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.459 HG12 HG21 ' A' ' 369' ' ' ILE . 3.4 p -142.0 117.07 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-O 121.403 0.62 . . . . 65.129999999999995 109.475 177.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 22.3 tp -114.31 134.99 54.56 Favored 'General case' 0 C--N 1.272 -2.803 0 N-CA-C 107.587 -1.264 . . . . 63.450000000000003 107.587 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -81.59 113.21 19.46 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 106.791 -1.559 . . . . 74.319999999999993 106.791 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.1 -60.8 2.1 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 108.872 -0.788 . . . . 62.020000000000003 108.872 -173.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.583 ' C ' ' HD2' ' A' ' 436' ' ' LYS . 49.9 mm-40 -107.04 -84.45 0.52 Allowed 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 106.884 -1.524 . . . . 72.019999999999996 106.884 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 436' ' ' LYS . . . . . 0.583 ' HD2' ' C ' ' A' ' 435' ' ' GLN . 3.9 mptp? -147.66 -56.53 0.24 Allowed 'General case' 0 CA--C 1.5 -0.942 0 C-N-CA 124.468 1.107 . . . . 64.239999999999995 109.376 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 57.3 m -90.97 -9.24 46.77 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.569 -1.196 . . . . 71.549999999999997 110.526 -176.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 415' ' ' SER . 33.8 tt0 -114.46 128.76 56.5 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 114.48 -1.237 . . . . 64.340000000000003 109.314 -175.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 44.2 m-85 -124.84 150.23 46.63 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 123.502 0.501 . . . . 61.340000000000003 110.412 -176.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 440' ' ' LEU . 4.3 pp -111.6 125.12 53.6 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.921 -1.511 . . . . 64.150000000000006 106.921 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.529 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.6 mt -122.16 133.13 69.4 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 116.234 -0.439 . . . . 65.430000000000007 110.602 -174.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -98.55 138.53 35.62 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 109.178 -0.675 . . . . 63.130000000000003 109.178 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.407 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.6 mtp -140.25 162.06 36.18 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 109.153 -0.684 . . . . 73.420000000000002 109.153 175.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.751 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.9 mmtt -132.22 161.08 34.31 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 107.257 -1.386 . . . . 72.409999999999997 107.257 175.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 36.2 t -167.42 147.01 4.46 Favored Pre-proline 0 C--N 1.286 -2.19 0 O-C-N 123.982 0.801 . . . . 73.329999999999998 109.03 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.0 -27.77 50.06 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.383 2.056 . . . . 74.209999999999994 111.339 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -78.24 -14.79 59.29 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.657 -0.701 . . . . 63.0 110.249 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.849 0 CA-C-O 121.333 0.587 . . . . 43.340000000000003 110.227 -178.303 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.479 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 26.1 m . . . . . 0 N--CA 1.423 -1.804 0 N-CA-C 106.123 -1.806 . . . . 70.120000000000005 106.123 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 58.5 mtpt -140.52 141.17 35.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 123.043 0.214 . . . . 71.340000000000003 110.472 -174.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -159.99 135.08 7.98 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.548 -0.908 . . . . 74.25 108.548 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 5.0 mp0 -79.15 125.28 29.23 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 109.952 -0.388 . . . . 72.430000000000007 109.952 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.437 HG21 HG12 ' A' ' 431' ' ' VAL . 49.5 mt -133.87 119.12 31.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 106.893 -1.521 . . . . 75.230000000000004 106.893 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.7 14.22 62.44 Favored Glycine 0 C--N 1.308 -0.973 0 C-N-CA 120.526 -0.845 . . . . 72.140000000000001 111.977 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 101.66 -15.98 56.69 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 121.417 -0.421 . . . . 63.299999999999997 112.956 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -105.17 136.77 44.05 Favored 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 120.684 -0.407 . . . . 74.200000000000003 110.502 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 47.5 m -78.16 123.77 27.28 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.182 -0.463 . . . . 74.010000000000005 111.234 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.689 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.6 OUTLIER -93.28 124.57 37.35 Favored 'General case' 0 N--CA 1.414 -2.237 0 C-N-CA 120.433 -0.507 . . . . 64.140000000000001 110.054 173.499 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 85.1 tttt -123.47 125.13 44.36 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.678 -0.692 . . . . 71.319999999999993 110.241 -175.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.479 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.5 p -128.26 116.59 42.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-O 121.141 0.496 . . . . 70.310000000000002 110.512 177.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.3 t -113.02 117.03 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 108.009 -1.108 . . . . 72.430000000000007 108.009 175.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.53 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 42.6 m-85 -57.88 128.9 39.42 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 114.113 1.153 . . . . 75.099999999999994 114.113 -173.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 68.51 9.6 7.39 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 114.054 -1.43 . . . . 74.120000000000005 113.356 -178.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -116.3 -82.21 0.62 Allowed 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.193 0.812 . . . . 74.099999999999994 113.193 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -170.13 158.85 7.15 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 112.842 0.682 . . . . 45.140000000000001 112.842 -172.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 99.3 t -114.01 145.34 19.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 124.361 1.064 . . . . 75.140000000000001 108.878 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -133.1 150.2 52.09 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.242 0.544 . . . . 73.209999999999994 111.452 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.556 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.1 tt0 -119.5 97.26 5.56 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 106.026 -1.842 . . . . 72.540000000000006 106.026 173.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.8 t70 70.43 -81.47 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 125.596 1.559 . . . . 75.340000000000003 111.392 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 17.8 m -135.53 0.73 2.78 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.345 -0.983 . . . . 53.310000000000002 108.345 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 48.4 mm -96.07 134.86 32.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.869 -0.605 . . . . 72.439999999999998 109.976 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.8 tp -76.45 115.31 16.08 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.702 -0.851 . . . . 73.239999999999995 108.702 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.556 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.5 OUTLIER -80.41 -65.22 1.04 Allowed 'General case' 0 N--CA 1.393 -3.308 0 N-CA-C 109.366 -0.605 . . . . 63.450000000000003 109.366 -175.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -156.46 156.1 26.85 Favored Glycine 0 N--CA 1.42 -2.383 0 C-N-CA 118.817 -1.659 . . . . 73.409999999999997 112.168 -177.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -99.48 143.39 29.79 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.922 -1.51 . . . . 71.030000000000001 106.922 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 2.4 m-85 -71.22 115.95 10.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.584 0.231 . . . . 73.409999999999997 110.482 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -101.74 -47.7 4.53 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.352 -0.386 . . . . 71.140000000000001 111.46 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 39.3 p -157.38 140.24 15.1 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 110.083 -0.34 . . . . 62.439999999999998 110.083 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.605 ' HB2' ' HG ' ' A' ' 400' ' ' LEU . 0.1 OUTLIER -147.25 145.5 29.44 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 116.121 -0.49 . . . . 52.420000000000002 111.13 178.263 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -128.97 110.86 12.44 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.838 -0.619 . . . . 73.510000000000005 109.473 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.8 -102.54 0.77 Allowed Glycine 0 C--N 1.31 -0.883 0 CA-C-N 115.877 -0.601 . . . . 61.109999999999999 113.956 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -116.43 17.7 15.39 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.146 0.498 . . . . 75.430000000000007 111.468 -176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.4 t -128.85 116.35 40.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 107.565 -1.272 . . . . 72.129999999999995 107.565 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.605 ' HG ' ' HB2' ' A' ' 395' ' ' GLN . 5.3 mp -120.07 139.61 52.28 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.63 0.604 . . . . 75.129999999999995 112.63 -173.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -112.32 122.69 48.42 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 115.596 -0.729 . . . . 71.099999999999994 111.885 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.41 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.9 m-85 -118.72 135.97 54.2 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.749 -1.204 . . . . 62.329999999999998 107.749 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -146.92 174.55 11.4 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-O 121.496 0.665 . . . . 71.239999999999995 112.719 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 64.13 33.41 11.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.609 -1.632 . . . . 73.340000000000003 112.953 168.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -72.22 -136.81 0.21 Allowed Glycine 0 CA--C 1.537 1.448 0 CA-C-N 115.599 -0.728 . . . . 53.399999999999999 113.437 176.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.58 137.92 46.49 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.567 -0.901 . . . . 72.310000000000002 108.567 -175.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 19.0 p . . . . . 0 C--N 1.306 -1.324 0 C-N-CA 124.043 0.937 . . . . 75.329999999999998 112.332 179.709 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 CA--C 1.501 -0.93 0 N-CA-C 107.997 -1.112 . . . . 71.019999999999996 107.997 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.424 ' HA ' ' HB3' ' A' ' 437' ' ' CYS . 89.7 mtt180 -71.39 159.34 34.72 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.299 0.571 . . . . 73.25 111.797 174.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 41.9 p -161.04 162.23 31.65 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.755 -1.112 . . . . 71.430000000000007 109.215 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -158.19 148.39 20.18 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-O 121.404 0.621 . . . . 52.229999999999997 110.862 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.2 tt -117.18 120.4 64.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 CA-C-N 115.15 -0.932 . . . . 72.319999999999993 110.022 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.536 HG22 ' HB ' ' A' ' 441' ' ' ILE . 8.7 t -105.2 127.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 115.663 -0.699 . . . . 74.430000000000007 111.978 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 8.7 p -108.48 114.7 28.74 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.632 -1.167 . . . . 75.209999999999994 108.559 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 38.9 t -100.88 112.8 34.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 107.595 -1.261 . . . . 71.049999999999997 107.595 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -111.73 -175.36 2.67 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 120.847 0.356 . . . . 63.450000000000003 110.716 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.619 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 36.0 t -57.77 128.23 36.0 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 124.321 1.048 . . . . 62.509999999999998 110.981 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.641 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -158.1 -177.82 31.56 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.925 -0.655 . . . . 64.209999999999994 111.676 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.35 -36.37 8.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.336 -0.616 . . . . 65.209999999999994 109.336 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -150.0 153.47 36.59 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.772 -0.825 . . . . 75.420000000000002 108.772 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.803 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.7 OUTLIER -73.03 98.54 2.55 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.59 0.71 . . . . 71.099999999999994 112.238 178.058 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -131.53 149.94 52.33 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.211 -1.359 . . . . 44.130000000000003 109.46 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 28.2 mm -78.64 118.16 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 106.306 -1.739 . . . . 72.329999999999998 106.306 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 55.5 t -80.77 -51.2 16.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 111.984 0.365 . . . . 70.239999999999995 111.984 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 33.0 t -167.06 165.22 15.81 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 109.184 -0.673 . . . . 74.129999999999995 109.184 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.437 HG12 HG21 ' A' ' 369' ' ' ILE . 4.3 p -141.39 119.12 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 108.627 -0.879 . . . . 63.130000000000003 108.627 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 432' ' ' LEU . . . . . 0.437 ' O ' HD23 ' A' ' 440' ' ' LEU . 25.4 tp -118.79 137.35 53.44 Favored 'General case' 0 C--N 1.271 -2.816 0 N-CA-C 107.923 -1.14 . . . . 70.109999999999999 107.923 -175.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -80.96 111.74 17.71 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.787 -0.82 . . . . 64.109999999999999 108.787 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -72.24 -54.48 9.48 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.419 -0.809 . . . . 75.209999999999994 110.269 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -116.94 -73.87 0.63 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.253 -1.017 . . . . 65.319999999999993 108.253 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -164.23 -51.79 0.03 OUTLIER 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.19 -1.368 . . . . 65.230000000000004 109.821 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' CYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 414' ' ' ARG . 72.1 m -103.27 -9.23 19.7 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.416 -0.811 . . . . 61.299999999999997 109.167 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.5 tt0 -113.07 132.46 55.41 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.675 -1.148 . . . . 71.010000000000005 109.029 -176.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 439' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 37.3 m-85 -128.02 150.32 49.98 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.048 -0.524 . . . . 74.439999999999998 110.516 -175.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.7 pt? -109.52 119.79 40.51 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.203 -1.036 . . . . 75.349999999999994 108.203 172.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.536 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.3 mt -116.24 136.18 54.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 115.287 -0.869 . . . . 71.150000000000006 109.464 -175.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -108.46 141.07 40.86 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 109.187 -0.671 . . . . 62.219999999999999 109.187 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 83.1 mtp -136.1 168.18 19.86 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.923 -1.14 . . . . 43.100000000000001 107.923 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.803 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 34.2 mmtp -134.05 161.34 35.13 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.002 -1.11 . . . . 71.010000000000005 108.002 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 33.9 t -162.68 145.9 8.7 Favored Pre-proline 0 C--N 1.291 -1.958 0 N-CA-C 108.455 -0.943 . . . . 71.420000000000002 108.455 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.98 -27.43 66.3 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.452 2.101 . . . . 74.129999999999995 111.863 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.68 -12.28 56.1 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.355 0.598 . . . . 44.520000000000003 110.976 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.907 0 CA-C-N 115.668 -0.696 . . . . 62.020000000000003 109.782 -178.151 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.525 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 87.8 m . . . . . 0 N--CA 1.411 -2.399 0 N-CA-C 107.163 -1.421 . . . . 72.310000000000002 107.163 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 10.0 ptmt -139.09 141.08 38.16 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.299 -0.409 . . . . 74.349999999999994 110.678 -174.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.418 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 3.7 tmt_? -159.94 138.44 10.44 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.112 -1.44 . . . . 73.310000000000002 107.112 -174.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 46.4 mt-10 -89.19 127.22 35.73 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.611 -0.514 . . . . 73.409999999999997 109.611 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.502 HG21 HG12 ' A' ' 431' ' ' VAL . 44.6 mt -135.94 121.98 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 N-CA-C 106.867 -1.531 . . . . 74.040000000000006 106.867 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.66 12.64 59.62 Favored Glycine 0 C--N 1.306 -1.12 0 C-N-CA 120.571 -0.823 . . . . 54.200000000000003 112.883 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.98 -20.27 33.79 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 121.066 -0.588 . . . . 32.030000000000001 112.828 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' TYR . . . . . 0.434 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 12.1 p90 -105.05 146.65 28.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 122.802 -0.234 . . . . 74.409999999999997 110.515 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 60.4 m -86.51 126.51 34.49 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 120.957 -0.297 . . . . 75.099999999999994 110.471 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.6 OUTLIER -91.61 126.39 36.68 Favored 'General case' 0 N--CA 1.406 -2.651 0 N-CA-C 109.389 -0.597 . . . . 73.439999999999998 109.389 172.696 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 42.2 tttp -121.59 124.34 44.11 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.691 -0.855 . . . . 74.109999999999999 108.691 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.525 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.1 p -128.68 123.53 59.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 109.637 -0.505 . . . . 72.310000000000002 109.637 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 36.2 t -117.16 117.88 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 N-CA-C 108.083 -1.08 . . . . 73.299999999999997 108.083 174.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.412 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 90.1 m-85 -53.22 125.32 17.18 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 124.393 1.058 . . . . 63.32 112.965 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 69.35 12.43 8.33 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 125.189 1.395 . . . . 63.210000000000001 113.857 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -117.64 -91.22 0.55 Allowed 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 112.872 0.693 . . . . 61.329999999999998 112.872 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -161.13 157.3 25.71 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.732 0.642 . . . . 74.010000000000005 112.732 -173.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.471 HG22 HG23 ' A' ' 376' ' ' VAL . 82.5 t -113.69 144.24 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 124.115 0.966 . . . . 73.129999999999995 109.525 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -133.73 147.13 51.31 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.007 0.432 . . . . 74.430000000000007 111.355 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.466 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.8 tt0 -113.4 98.75 7.29 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.557 -1.646 . . . . 73.219999999999999 106.557 173.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.1 t70 70.17 -77.06 0.06 Allowed 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 124.886 1.274 . . . . 62.43 110.032 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.0 m -138.24 -6.38 1.59 Allowed 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.25 -0.886 . . . . 73.400000000000006 109.013 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 62.2 mt -84.88 134.76 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 116.257 -0.429 . . . . 71.439999999999998 109.905 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 406' ' ' GLN . 56.4 tp -76.53 113.49 14.2 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.228 -1.027 . . . . 72.409999999999997 108.228 176.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.595 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -79.2 -63.85 1.32 Allowed 'General case' 0 N--CA 1.392 -3.337 0 N-CA-C 109.069 -0.715 . . . . 73.519999999999996 109.069 -176.13 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.53 156.82 28.18 Favored Glycine 0 N--CA 1.416 -2.65 0 C-N-CA 119.53 -1.319 . . . . 54.140000000000001 111.641 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -99.34 147.18 25.48 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.955 -1.128 . . . . 72.340000000000003 107.955 175.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.412 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 2.2 m-85 -67.61 116.87 8.81 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.081 0.467 . . . . 74.109999999999999 111.233 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -97.87 -47.85 5.4 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.728 -0.669 . . . . 63.119999999999997 111.318 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 28.3 m -155.08 149.51 26.2 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.065 -0.346 . . . . 61.240000000000002 110.065 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.458 ' CG ' ' HG ' ' A' ' 400' ' ' LEU . 13.8 mp0 -132.91 130.55 39.79 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 106.961 -1.496 . . . . 70.400000000000006 106.961 172.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -127.67 110.62 12.85 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.5 -0.926 . . . . 61.130000000000003 108.5 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 67.72 -101.82 0.76 Allowed Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.951 -0.568 . . . . 64.349999999999994 111.749 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -122.43 19.82 10.46 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.332 0.587 . . . . 73.129999999999995 109.907 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 46.6 t -118.37 119.07 60.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 108.273 -1.01 . . . . 71.010000000000005 108.273 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.458 ' HG ' ' CG ' ' A' ' 395' ' ' GLN . 4.9 mp -114.87 129.7 56.75 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.243 0.544 . . . . 61.109999999999999 110.619 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -113.55 125.86 54.66 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.906 -0.588 . . . . 72.010000000000005 110.265 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -118.72 136.67 53.82 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.282 -1.007 . . . . 74.120000000000005 108.282 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -144.39 174.17 11.15 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 110.315 -0.254 . . . . 61.420000000000002 110.315 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 60.17 41.7 16.5 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.722 0.809 . . . . 63.32 112.205 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.7 -138.74 1.17 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.471 -0.871 . . . . 64.530000000000001 112.039 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' GLN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 21.2 tm0? -81.28 140.62 34.73 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.793 -0.817 . . . . 64.340000000000003 108.793 -178.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 407' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 47.0 m . . . . . 0 C--N 1.319 -0.745 0 N-CA-C 113.551 0.945 . . . . 74.439999999999998 113.551 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' HIS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 96.0 m-70 . . . . . 0 CA--C 1.507 -0.705 0 N-CA-C 107.389 -1.337 . . . . 61.409999999999997 107.389 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -69.0 159.08 33.48 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-O 121.287 0.565 . . . . 64.25 111.707 174.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 49.0 p -161.6 164.46 29.38 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 114.762 -1.108 . . . . 74.200000000000003 109.144 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -158.7 151.02 21.58 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.123 0.487 . . . . 54.200000000000003 110.254 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 11.5 tt -118.53 124.39 73.06 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 CA-C-N 115.478 -0.783 . . . . 64.409999999999997 109.342 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.532 HG22 ' HB ' ' A' ' 441' ' ' ILE . 5.2 t -111.31 129.61 66.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.534 0.683 . . . . 75.310000000000002 112.093 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 14.4 p -111.45 115.17 28.78 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 115.04 -0.982 . . . . 73.450000000000003 109.094 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 47.5 t -100.69 111.86 31.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.96 -0.756 . . . . 61.109999999999999 108.96 -177.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -113.52 -174.26 2.43 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 120.662 -0.415 . . . . 63.32 111.084 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 19.6 t -59.13 127.19 30.96 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.515 0.674 . . . . 73.310000000000002 112.763 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.545 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -154.26 -177.58 27.8 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 110.039 -1.224 . . . . 74.150000000000006 110.039 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.57 -28.19 4.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.635 0.731 . . . . 64.409999999999997 109.041 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -145.5 151.07 37.59 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.161 -0.927 . . . . 73.439999999999998 108.801 -177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.674 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.9 OUTLIER -71.15 98.82 1.75 Allowed 'General case' 0 C--N 1.309 -1.167 0 O-C-N 124.033 0.833 . . . . 32.119999999999997 110.191 175.367 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -132.51 148.59 52.39 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-N 115.225 -0.898 . . . . 64.030000000000001 111.42 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 367' ' ' ARG . 30.8 mm -81.8 120.31 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 106.043 -1.836 . . . . 63.350000000000001 106.043 174.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.445 HG21 ' HG2' ' A' ' 444' ' ' LYS . 53.3 t -86.29 -50.49 14.18 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 116.228 -0.442 . . . . 75.140000000000001 112.139 -176.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 44.0 m -159.95 160.73 33.78 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.401 -0.592 . . . . 63.210000000000001 109.401 -175.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.502 HG12 HG21 ' A' ' 369' ' ' ILE . 3.6 p -141.14 111.65 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-O 122.017 0.913 . . . . 32.039999999999999 108.763 176.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 432' ' ' LEU . . . . . 0.429 ' O ' HD23 ' A' ' 440' ' ' LEU . 28.7 tp -110.94 136.53 49.82 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 115.321 -0.854 . . . . 73.439999999999998 108.711 -177.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -80.92 110.17 16.2 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.489 -0.93 . . . . 63.32 108.489 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -71.47 -36.85 71.33 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.37 -0.832 . . . . 70.519999999999996 111.06 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -142.07 -73.85 0.31 Allowed 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.564 -0.744 . . . . 64.510000000000005 109.308 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 436' ' ' LYS . . . . . 0.455 ' HB3' ' NZ ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -163.69 -49.01 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 116.112 -0.495 . . . . 74.530000000000001 110.899 175.362 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 75.7 m -98.04 -3.9 37.15 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.532 0.682 . . . . 71.030000000000001 110.107 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 415' ' ' SER . 34.5 tt0 -124.82 131.39 53.45 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.401 -0.818 . . . . 71.0 109.317 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -126.95 150.6 49.29 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.61 -0.723 . . . . 60.219999999999999 110.32 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.6 pt? -109.85 121.11 44.49 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.013 -1.106 . . . . 75.230000000000004 108.013 172.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.532 ' HB ' HG22 ' A' ' 418' ' ' VAL . 97.1 mt -115.51 132.87 63.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 CA-C-N 115.454 -0.794 . . . . 53.32 110.324 -175.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -98.85 136.8 38.34 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.449 -0.945 . . . . 73.349999999999994 108.449 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.459 ' SD ' HG11 ' A' ' 418' ' ' VAL . 82.6 mtp -137.46 157.73 45.93 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 109.835 -0.431 . . . . 55.229999999999997 109.835 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 31.7 mmtp -131.71 153.15 50.32 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.629 -1.249 . . . . 74.150000000000006 107.629 175.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 69.8 m -156.92 149.09 17.65 Favored Pre-proline 0 C--N 1.288 -2.096 0 N-CA-C 108.615 -0.883 . . . . 65.310000000000002 108.615 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 39.0 Cg_endo -67.66 -28.13 37.76 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 121.921 1.747 . . . . 74.129999999999995 111.975 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -76.28 -22.46 55.05 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.737 -0.665 . . . . 72.010000000000005 111.022 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.694 0 CA-C-O 121.741 0.781 . . . . 71.409999999999997 109.399 -178.767 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 85.3 m . . . . . 0 C--O 1.215 -0.711 0 N-CA-C 108.491 -0.929 . . . . 51.240000000000002 108.491 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.428 ' HB3' ' HG3' ' A' ' 375' ' ' LYS . 0.0 OUTLIER -145.73 151.89 38.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 118.344 0.52 . . . . 71.409999999999997 111.591 -177.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.511 HH11 HG12 ' A' ' 369' ' ' ILE . 4.1 tmt_? -161.6 135.47 6.68 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.132 -0.692 . . . . 74.219999999999999 109.132 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.22 125.97 30.18 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 110.275 -0.268 . . . . 71.030000000000001 110.275 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.553 HG21 HG12 ' A' ' 431' ' ' VAL . 37.2 mt -134.19 119.79 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.828 -1.545 . . . . 74.409999999999997 106.828 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.66 12.64 59.62 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 121.164 -0.541 . . . . 65.209999999999994 112.07 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 105.78 -23.19 30.19 Favored Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 121.603 -0.332 . . . . 41.329999999999998 112.352 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' TYR . . . . . 0.456 ' CD1' ' HG3' ' A' ' 384' ' ' GLN . 16.0 p90 -98.19 136.76 37.93 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 121.184 0.516 . . . . 70.099999999999994 110.548 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 98.9 m -79.54 116.23 19.63 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 115.525 -0.761 . . . . 64.030000000000001 110.556 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.12 133.58 34.78 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 107.868 -1.16 . . . . 65.519999999999996 107.868 175.001 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.428 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 36.8 ttpt -133.34 130.78 39.3 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.211 -0.595 . . . . 62.340000000000003 109.599 -175.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.409 HG23 HG22 ' A' ' 382' ' ' VAL . 7.2 p -124.0 115.92 46.42 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 O-C-N 123.584 0.552 . . . . 73.439999999999998 110.056 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.8 t -108.53 116.45 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.563 -1.273 . . . . 74.319999999999993 107.563 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -63.76 126.2 26.82 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 113.895 1.072 . . . . 61.32 113.895 -173.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 73.03 10.66 5.27 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 125.997 1.719 . . . . 64.200000000000003 113.117 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.8 -84.49 0.65 Allowed 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 112.489 0.552 . . . . 75.530000000000001 112.489 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -166.38 159.62 14.9 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.99 0.737 . . . . 74.120000000000005 112.99 -172.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.409 HG22 HG23 ' A' ' 376' ' ' VAL . 98.7 t -113.74 145.75 19.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 124.642 1.177 . . . . 72.430000000000007 109.141 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -132.77 152.43 51.77 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 122.973 0.509 . . . . 64.319999999999993 111.986 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.493 ' HB2' HD23 ' A' ' 389' ' ' LEU . 35.2 tt0 -124.76 102.04 7.38 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.347 -1.723 . . . . 71.120000000000005 106.347 173.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 14.3 t70 69.64 -83.84 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.564 1.146 . . . . 73.299999999999997 109.543 -175.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.3 m -133.28 -7.37 2.97 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 108.608 -0.886 . . . . 53.140000000000001 108.608 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 63.0 mt -80.59 132.91 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.388 -0.823 . . . . 33.140000000000001 110.127 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 64.8 tp -76.9 109.97 11.13 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.499 -0.926 . . . . 72.200000000000003 108.499 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.2 OUTLIER -77.67 -65.4 0.97 Allowed 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 109.111 -0.7 . . . . 71.209999999999994 109.111 -176.67 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.23 153.58 24.66 Favored Glycine 0 N--CA 1.424 -2.103 0 C-N-CA 119.26 -1.448 . . . . 63.130000000000003 111.64 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -99.46 144.76 28.19 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.711 -1.218 . . . . 61.140000000000001 107.711 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -73.02 116.3 13.38 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.267 -0.642 . . . . 75.109999999999999 109.267 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -111.21 -47.99 3.14 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.939 -0.573 . . . . 72.310000000000002 110.863 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 18.7 m -145.63 138.96 26.29 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.504 -0.925 . . . . 62.240000000000002 108.504 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.478 ' HB2' HD22 ' A' ' 400' ' ' LEU . 9.8 pt20 -147.4 145.32 29.21 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 120.938 0.399 . . . . 72.230000000000004 110.84 173.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -121.17 110.24 15.95 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 115.649 -0.705 . . . . 62.140000000000001 109.535 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.19 -104.27 0.79 Allowed Glycine 0 N--CA 1.436 -1.339 0 CA-C-N 115.265 -0.88 . . . . 64.549999999999997 113.823 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -116.83 18.2 14.87 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.128 0.489 . . . . 73.030000000000001 111.187 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.3 t -125.15 116.09 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 105.159 -2.163 . . . . 64.230000000000004 105.159 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.478 HD22 ' HB2' ' A' ' 395' ' ' GLN . 13.6 mt -118.63 136.28 53.98 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.862 -0.735 . . . . 53.039999999999999 111.241 -168.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.414 ' HE3' HD12 ' A' ' 417' ' ' ILE . 20.6 mmtp -107.43 124.09 49.35 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.498 0.666 . . . . 74.310000000000002 112.076 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.402 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 2.9 m-85 -117.08 125.88 51.98 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.77 -1.566 . . . . 75.239999999999995 106.77 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -139.77 175.86 9.22 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 110.113 -0.329 . . . . 75.120000000000005 110.113 -176.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 64.93 33.3 10.0 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.856 0.722 . . . . 71.209999999999994 112.503 173.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.6 -141.23 1.17 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.785 -0.722 . . . . 73.140000000000001 113.054 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.77 142.11 38.86 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.95 -1.13 . . . . 73.219999999999999 107.95 -177.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 121.413 0.625 . . . . 32.219999999999999 111.687 -179.441 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 . . . . . 0 CA--C 1.493 -1.249 0 N-CA-C 105.157 -2.164 . . . . 75.420000000000002 105.157 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -69.32 156.33 38.97 Favored 'General case' 0 C--O 1.256 1.407 0 C-N-CA 119.641 -0.824 . . . . 75.120000000000005 111.568 174.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 23.7 p -157.59 158.92 36.48 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-N 114.67 -1.15 . . . . 55.020000000000003 109.192 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -154.03 149.01 26.73 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.26 0.552 . . . . 74.310000000000002 110.656 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 417' ' ' ILE . . . . . 0.414 HD12 ' HE3' ' A' ' 401' ' ' LYS . 8.4 tt -118.99 123.81 72.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 CA-C-N 115.107 -0.951 . . . . 74.5 109.816 175.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.616 HG22 ' HB ' ' A' ' 441' ' ' ILE . 4.1 t -109.85 130.66 62.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 115.785 -0.643 . . . . 65.299999999999997 111.231 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 20.5 p -108.46 115.01 29.3 Favored 'General case' 0 N--CA 1.409 -2.525 0 N-CA-C 108.322 -0.992 . . . . 64.450000000000003 108.322 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 38.5 t -100.36 114.72 39.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.039 -1.467 . . . . 74.049999999999997 107.039 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.02 -173.94 2.55 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.915 -0.314 . . . . 71.239999999999995 110.556 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.525 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 38.3 t -60.5 127.92 34.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.235 0.54 . . . . 75.420000000000002 111.71 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.607 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -156.36 -179.7 31.57 Favored Glycine 0 CA--C 1.485 -1.808 0 N-CA-C 110.535 -1.026 . . . . 74.400000000000006 110.535 177.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.08 -35.32 7.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.899 -0.778 . . . . 72.310000000000002 108.899 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -143.79 152.16 40.87 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.367 -0.833 . . . . 72.319999999999993 109.722 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.721 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.9 OUTLIER -69.57 97.95 1.09 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.034 -0.985 . . . . 52.229999999999997 110.586 175.725 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -132.16 149.56 52.36 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.851 -1.068 . . . . 54.409999999999997 109.906 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 369' ' ' ILE . 32.6 mm -84.35 119.41 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 105.993 -1.855 . . . . 54.409999999999997 105.993 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 54.8 t -83.86 -51.04 14.65 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 CA-C-N 116.409 -0.36 . . . . 70.040000000000006 111.623 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 38.5 p -165.26 167.97 17.43 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 120.914 -0.314 . . . . 71.230000000000004 110.674 -175.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.553 HG12 HG21 ' A' ' 369' ' ' ILE . 3.3 p -142.19 126.25 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 N-CA-C 109.124 -0.695 . . . . 50.100000000000001 109.124 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' LEU . . . . . 0.438 ' O ' HD23 ' A' ' 440' ' ' LEU . 28.1 tp -126.82 137.96 53.27 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.885 -0.783 . . . . 73.540000000000006 108.885 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -81.07 113.0 18.96 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.291 -1.003 . . . . 75.420000000000002 108.291 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.02 -50.81 18.13 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-N 115.715 -0.675 . . . . 74.120000000000005 110.226 -174.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 435' ' ' GLN . . . . . 0.539 ' C ' ' HD2' ' A' ' 436' ' ' LYS . 49.4 mt-30 -121.47 -82.24 0.65 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.236 -0.893 . . . . 65.329999999999998 108.753 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 436' ' ' LYS . . . . . 0.539 ' HD2' ' C ' ' A' ' 435' ' ' GLN . 0.2 OUTLIER -145.31 -61.73 0.34 Allowed 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 108.26 -1.015 . . . . 74.019999999999996 108.26 177.025 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 92.3 m -93.64 -7.96 42.38 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.158 -1.383 . . . . 53.299999999999997 111.693 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 415' ' ' SER . 35.6 tt0 -110.39 128.6 55.66 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-N 115.291 -0.868 . . . . 64.409999999999997 109.077 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 46.4 m-85 -124.48 149.72 46.53 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.757 -0.656 . . . . 74.099999999999994 109.785 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.445 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.5 pt? -111.47 119.54 39.12 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.341 -0.615 . . . . 74.219999999999999 109.341 175.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.616 ' HB ' HG22 ' A' ' 418' ' ' VAL . 3.8 mp -109.62 133.9 53.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.87 -0.604 . . . . 63.520000000000003 109.883 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -96.25 135.82 37.56 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 108.397 -0.964 . . . . 62.340000000000003 108.397 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 81.8 mtp -138.01 160.53 39.12 Favored 'General case' 0 CA--C 1.478 -1.802 0 N-CA-C 109.678 -0.49 . . . . 74.329999999999998 109.678 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.721 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 73.8 mmtt -131.05 160.96 33.11 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.743 -1.206 . . . . 73.319999999999993 107.743 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 40.8 t -165.45 145.04 5.49 Favored Pre-proline 0 C--N 1.284 -2.252 0 O-C-N 124.118 0.886 . . . . 71.25 109.023 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -66.42 -27.36 47.13 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.04 1.826 . . . . 75.319999999999993 110.618 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -76.52 -17.81 59.05 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.327 -0.851 . . . . 74.519999999999996 111.182 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.818 0 CA-C-O 121.546 0.688 . . . . 70.530000000000001 110.128 -179.974 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.562 ' HB ' HG13 ' A' ' 376' ' ' VAL . 84.7 m . . . . . 0 N--CA 1.432 -1.328 0 N-CA-C 106.388 -1.708 . . . . 64.109999999999999 106.388 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 0.0 OUTLIER -143.49 150.23 38.67 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.418 -0.913 . . . . 52.210000000000001 111.108 -175.399 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -162.37 136.48 6.49 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.741 -0.836 . . . . 62.520000000000003 108.741 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -77.81 124.98 28.65 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 109.815 -0.439 . . . . 70.230000000000004 109.815 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.508 HG21 HG12 ' A' ' 431' ' ' VAL . 56.4 mt -134.82 118.99 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 N-CA-C 106.883 -1.525 . . . . 73.040000000000006 106.883 -178.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.49 13.59 60.93 Favored Glycine 0 C--N 1.305 -1.139 0 C-N-CA 120.538 -0.839 . . . . 62.399999999999999 112.675 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 105.56 -17.78 42.35 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 120.997 -0.62 . . . . 73.340000000000003 113.252 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -105.26 142.17 35.49 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 120.61 0.243 . . . . 72.25 110.595 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 97.8 m -82.25 119.75 24.49 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.099 0.476 . . . . 73.040000000000006 110.057 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.586 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -90.79 126.53 36.04 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 108.533 -0.914 . . . . 73.430000000000007 108.533 176.087 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -126.43 127.45 45.44 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.28 -0.568 . . . . 73.549999999999997 109.874 -175.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.616 HG23 HG22 ' A' ' 382' ' ' VAL . 5.9 p -124.58 117.07 49.38 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 116.16 -0.473 . . . . 71.219999999999999 111.036 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.98 116.22 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.141 -1.429 . . . . 70.319999999999993 107.141 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.543 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 95.1 m-85 -70.3 131.29 43.93 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 114.705 1.372 . . . . 73.420000000000002 114.705 -170.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 71.64 13.08 6.35 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.254 1.422 . . . . 70.129999999999995 112.232 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -125.71 -86.18 0.62 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.484 -0.78 . . . . 72.319999999999993 113.044 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -162.72 153.22 16.7 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.304 0.853 . . . . 70.140000000000001 113.304 -173.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 376' ' ' VAL . 44.7 t -113.56 149.44 15.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 C-N-CA 124.054 0.942 . . . . 63.420000000000002 108.725 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -139.63 144.7 37.81 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.348 0.405 . . . . 55.450000000000003 111.088 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -107.24 110.01 21.94 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 106.346 -1.724 . . . . 74.109999999999999 106.346 169.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 17.2 t70 69.1 -87.02 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 123.76 0.824 . . . . 72.319999999999993 110.422 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 19.5 m -136.16 -1.88 2.34 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.966 -0.753 . . . . 52.439999999999998 108.966 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 47.2 mm -88.66 138.68 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 109.646 -0.501 . . . . 43.219999999999999 109.646 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.3 tp -74.25 117.69 16.35 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.24 -1.763 . . . . 75.010000000000005 106.24 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.546 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 49.7 tp -91.79 -58.41 2.43 Favored 'General case' 0 N--CA 1.381 -3.877 0 CA-C-N 115.412 -0.813 . . . . 41.530000000000001 110.856 -173.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.46 148.13 15.96 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 119.401 -1.381 . . . . 70.340000000000003 111.492 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -99.75 145.15 27.99 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.503 -1.295 . . . . 70.310000000000002 107.503 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.543 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.5 m-85 -70.26 117.21 11.52 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 120.771 0.32 . . . . 63.109999999999999 111.324 -176.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -88.33 -46.81 8.89 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.925 -0.58 . . . . 73.519999999999996 110.15 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 60.6 p -169.03 160.75 10.16 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-N 115.765 -0.652 . . . . 75.120000000000005 109.599 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.463 HE21 ' HD2' ' A' ' 392' ' ' PHE . 14.8 mp0 -130.67 138.13 49.9 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.657 -1.238 . . . . 74.340000000000003 107.657 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -128.43 114.42 16.78 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.869 -0.789 . . . . 74.420000000000002 108.869 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 72.18 -101.44 1.05 Allowed Glycine 0 N--CA 1.422 -2.251 0 C-N-CA 119.169 -1.491 . . . . 41.520000000000003 112.056 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 21.7 p-10 -128.04 15.7 6.79 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 123.598 0.759 . . . . 41.420000000000002 109.381 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.432 HG22 HG23 ' A' ' 419' ' ' THR . 35.9 t -118.89 121.66 67.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.459 -0.941 . . . . 55.219999999999999 108.459 -175.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.404 ' HG ' ' CG ' ' A' ' 395' ' ' GLN . 3.2 mp -117.4 132.61 56.54 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 116.078 -0.51 . . . . 72.450000000000003 110.669 -175.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 401' ' ' LYS . . . . . 0.42 ' HE2' HD12 ' A' ' 417' ' ' ILE . 57.0 mmtt -106.29 125.73 51.36 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 115.903 -0.59 . . . . 51.539999999999999 111.231 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.422 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 3.7 m-85 -118.48 135.89 54.12 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.98 -1.118 . . . . 71.200000000000003 107.98 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.69 176.14 10.08 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.556 0.217 . . . . 74.040000000000006 111.538 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 65.31 33.19 9.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.673 0.789 . . . . 62.140000000000001 112.386 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -73.8 -149.16 1.4 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.898 -0.667 . . . . 53.039999999999999 112.345 176.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -73.93 137.92 43.92 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 122.106 -0.644 . . . . 74.439999999999998 110.069 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 26.4 p . . . . . 0 C--N 1.311 -1.09 0 C-N-CA 124.661 1.184 . . . . 71.010000000000005 113.934 -175.124 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 106.723 -1.584 . . . . 65.340000000000003 106.723 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -76.61 158.48 31.07 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.269 0.557 . . . . 64.030000000000001 112.457 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 37.4 p -160.69 163.72 32.22 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 114.983 -1.008 . . . . 55.340000000000003 109.122 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.52 143.29 13.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 120.77 0.319 . . . . 74.530000000000001 110.584 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' ILE . . . . . 0.42 HD12 ' HE2' ' A' ' 401' ' ' LYS . 7.4 tt -103.84 131.73 51.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.78 -0.822 . . . . 71.409999999999997 108.78 173.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.7 t -113.32 125.28 70.56 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-O 121.084 0.469 . . . . 73.349999999999994 110.181 174.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.432 HG23 HG22 ' A' ' 399' ' ' VAL . 1.1 m -110.07 114.45 27.97 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 105.878 -1.897 . . . . 61.030000000000001 105.878 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 22.0 t -101.17 117.24 46.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.357 -0.979 . . . . 64.310000000000002 108.357 -176.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -106.7 -179.05 3.83 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 120.281 -0.568 . . . . 72.129999999999995 109.935 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 40.2 t -60.56 128.99 39.34 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 123.37 0.668 . . . . 63.409999999999997 110.644 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.554 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -153.16 -177.4 26.67 Favored Glycine 0 CA--C 1.485 -1.812 0 N-CA-C 111.065 -0.814 . . . . 75.109999999999999 111.065 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.93 -30.13 4.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.498 0.666 . . . . 75.530000000000001 109.213 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -151.02 151.25 31.77 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.369 -0.832 . . . . 74.109999999999999 109.222 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.639 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.0 OUTLIER -65.34 100.23 0.46 Allowed 'General case' 0 C--N 1.311 -1.098 0 O-C-N 124.164 0.915 . . . . 74.329999999999998 110.841 174.704 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -131.93 149.25 52.49 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.776 -1.102 . . . . 75.329999999999998 110.246 -176.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.441 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 29.7 mm -86.87 122.25 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 106.261 -1.755 . . . . 74.439999999999998 106.261 176.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 442' ' ' LYS . 64.9 t -84.37 -50.43 15.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 CA-C-N 116.455 -0.339 . . . . 74.040000000000006 111.653 -177.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.5 m -165.66 164.23 19.09 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.151 -0.685 . . . . 72.439999999999998 109.151 -175.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.508 HG12 HG21 ' A' ' 369' ' ' ILE . 3.3 p -141.49 125.32 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 107.253 -1.388 . . . . 73.019999999999996 107.253 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 42.8 tp -131.73 137.26 48.15 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 108.627 -0.879 . . . . 71.200000000000003 108.627 -176.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -81.64 119.04 23.3 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.45 -0.945 . . . . 61.549999999999997 108.45 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.3 -56.32 5.01 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.335 -0.848 . . . . 64.129999999999995 110.701 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -119.55 -71.49 0.73 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.739 -0.664 . . . . 74.140000000000001 110.603 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 436' ' ' LYS . . . . . 0.435 ' HB3' ' NZ ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -162.39 -42.14 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.767 0 CA-C-O 121.332 0.587 . . . . 74.150000000000006 111.152 175.606 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 90.7 m -112.77 13.3 19.75 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.71 0.766 . . . . 62.119999999999997 109.959 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 415' ' ' SER . 31.0 tt0 -135.23 131.23 36.39 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.079 -0.964 . . . . 62.329999999999998 108.875 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -123.5 150.68 43.65 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 123.591 0.557 . . . . 74.519999999999996 111.279 -176.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.467 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.6 pt? -110.58 118.01 35.06 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.428 -0.953 . . . . 64.530000000000001 108.428 172.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 92.6 mt -119.29 133.12 67.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.294 -0.867 . . . . 63.439999999999998 109.308 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.412 ' O ' ' HB ' ' A' ' 429' ' ' VAL . 37.9 ttpt -111.53 141.38 45.18 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 109.285 -0.635 . . . . 55.109999999999999 109.285 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.441 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 79.6 mtp -136.32 169.19 18.06 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 109.272 -0.64 . . . . 71.549999999999997 109.272 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 66.8 mmtt -132.22 159.97 37.49 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.97 -1.122 . . . . 74.129999999999995 107.97 175.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 41.2 t -172.45 145.69 1.5 Allowed Pre-proline 0 C--N 1.289 -2.05 0 O-C-N 124.187 0.929 . . . . 55.420000000000002 109.707 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.0 -24.27 45.62 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.314 2.009 . . . . 72.129999999999995 110.917 176.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.09 -18.75 52.77 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.698 -0.683 . . . . 62.109999999999999 111.017 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.659 0 CA-C-O 121.66 0.743 . . . . 74.299999999999997 109.57 176.868 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 94.0 m . . . . . 0 N--CA 1.432 -1.327 0 N-CA-C 107.932 -1.136 . . . . 62.509999999999998 107.932 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.488 ' HB3' ' HG3' ' A' ' 375' ' ' LYS . 13.3 ptmm? -136.52 144.46 44.28 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.51 0.93 . . . . 75.519999999999996 113.51 -173.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.4 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 3.3 tmt_? -156.55 135.54 11.9 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.244 -1.391 . . . . 74.439999999999998 107.244 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 368' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 43.7 mt-10 -86.29 128.43 34.92 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 109.645 -0.502 . . . . 73.420000000000002 109.645 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.63 118.76 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 N-CA-C 107.463 -1.31 . . . . 72.5 107.463 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.24 14.41 61.68 Favored Glycine 0 C--N 1.308 -1.016 0 C-N-CA 120.612 -0.804 . . . . 73.530000000000001 112.631 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 109.15 -24.53 20.74 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 120.919 -0.658 . . . . 75.450000000000003 112.91 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -98.78 136.02 39.42 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 120.946 0.403 . . . . 64.219999999999999 111.07 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 41.3 m -77.52 115.3 17.17 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.074 -0.512 . . . . 65.430000000000007 110.206 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -91.05 131.34 36.69 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 108.438 -0.949 . . . . 72.420000000000002 108.438 175.206 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.488 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 38.5 ttpt -135.32 125.45 26.09 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 120.165 -0.614 . . . . 55.009999999999998 109.994 -177.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.487 HG12 HD11 ' A' ' 428' ' ' ILE . 7.6 p -117.02 115.51 49.13 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 N-CA-C 108.266 -1.013 . . . . 53.109999999999999 108.266 176.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 39.5 t -104.96 115.08 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.422 0 N-CA-C 105.662 -1.977 . . . . 74.120000000000005 105.662 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.521 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 94.3 m-85 -68.72 127.52 33.34 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 114.216 1.191 . . . . 64.140000000000001 114.216 -170.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . 0.27 47.9 m-85 71.19 16.14 6.31 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 113.964 -1.471 . . . . 71.430000000000007 112.956 -176.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -125.91 -83.41 0.63 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.258 -0.883 . . . . 54.340000000000003 112.566 173.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.516 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.5 OUTLIER -161.6 162.53 30.12 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.701 0.63 . . . . 52.409999999999997 112.701 -169.891 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.46 HG22 HG23 ' A' ' 376' ' ' VAL . 87.1 t -121.16 143.29 33.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 124.305 1.042 . . . . 75.329999999999998 108.65 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.516 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 66.4 m-85 -132.25 144.89 50.93 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 123.209 0.604 . . . . 63.520000000000003 112.198 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.549 ' HB2' HD23 ' A' ' 389' ' ' LEU . 33.5 tt0 -116.17 102.15 9.34 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 105.776 -1.935 . . . . 73.340000000000003 105.776 171.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.4 t70 72.38 -80.67 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 125.065 1.346 . . . . 33.229999999999997 109.569 -176.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.4 m -142.69 -1.88 1.1 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.945 -1.025 . . . . 43.030000000000001 108.352 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 49.8 mt -88.07 139.31 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.746 -0.661 . . . . 74.340000000000003 109.977 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 58.6 tp -76.43 110.29 10.84 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.56 -0.904 . . . . 61.130000000000003 108.56 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.549 HD23 ' HB2' ' A' ' 384' ' ' GLN . 1.0 OUTLIER -80.39 -60.04 2.47 Favored 'General case' 0 N--CA 1.393 -3.324 0 N-CA-C 109.18 -0.674 . . . . 73.319999999999993 109.18 -176.487 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.45 160.02 31.4 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 119.475 -1.345 . . . . 63.020000000000003 111.644 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -110.11 151.32 27.38 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.942 -1.133 . . . . 62.340000000000003 107.942 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.521 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.8 m-85 -73.56 127.95 34.17 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 111.777 0.288 . . . . 73.430000000000007 111.777 -175.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -110.5 -49.57 3.04 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.18 -0.608 . . . . 24.210000000000001 112.575 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 54.2 p -167.75 139.92 3.12 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.694 -0.484 . . . . 72.510000000000005 109.694 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.444 ' NE2' ' HD2' ' A' ' 392' ' ' PHE . 2.4 mm-40 -118.17 147.12 43.66 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 109.989 -0.374 . . . . 61.530000000000001 109.989 -176.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -128.41 110.31 12.21 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.192 -0.67 . . . . 71.040000000000006 109.192 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.95 -108.11 2.09 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 116.145 -0.479 . . . . 71.140000000000001 112.405 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -117.23 16.77 14.86 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.28 0.562 . . . . 74.140000000000001 110.196 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 52.3 t -117.44 116.87 53.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.797 -1.186 . . . . 61.409999999999997 107.797 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.63 142.42 39.12 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.571 -0.74 . . . . 63.43 111.386 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -120.1 122.47 41.12 Favored 'General case' 0 C--O 1.25 1.097 0 CA-C-O 121.403 0.62 . . . . 70.519999999999996 111.814 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -118.3 137.32 53.15 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.934 -1.136 . . . . 74.310000000000002 107.934 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 403' ' ' GLU . . . . . 0.445 ' HA ' ' CB ' ' A' ' 415' ' ' SER . 46.6 mt-10 -142.47 175.59 9.66 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.008 -0.738 . . . . 74.219999999999999 109.008 -177.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 64.79 33.54 10.17 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.275 1.213 . . . . 73.049999999999997 114.275 171.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.72 -141.9 3.02 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 120.233 -0.984 . . . . 61.43 111.602 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -56.0 136.92 51.77 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 123.343 0.657 . . . . 64.540000000000006 110.993 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 26.4 p . . . . . 0 N--CA 1.433 -1.314 0 CA-C-O 120.919 0.39 . . . . 71.230000000000004 110.806 -179.03 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 . . . . . 0 CA--C 1.5 -0.952 0 N-CA-C 105.678 -1.971 . . . . 71.120000000000005 105.678 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -73.24 156.37 38.58 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.156 0.503 . . . . 51.200000000000003 109.872 171.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.445 ' CB ' ' HA ' ' A' ' 403' ' ' GLU . 54.2 p -160.54 169.07 23.7 Favored 'General case' 0 N--CA 1.401 -2.916 0 CA-C-N 115.306 -0.861 . . . . 63.340000000000003 109.047 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -159.07 151.07 20.93 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.364 0.602 . . . . 42.409999999999997 111.281 -177.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.1 tt -115.1 133.01 62.66 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 CA-C-N 115.08 -0.964 . . . . 62.340000000000003 108.558 173.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.611 HG22 ' HB ' ' A' ' 441' ' ' ILE . 4.9 t -118.57 129.68 74.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.233 0.54 . . . . 64.349999999999994 111.638 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.3 p -108.26 113.24 26.19 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.635 -1.246 . . . . 44.109999999999999 107.635 174.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 21.1 t -101.48 112.2 33.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.132 -1.062 . . . . 75.209999999999994 108.132 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 421' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 444' ' ' LYS . 41.1 mt-10 -108.16 179.52 4.19 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.988 -0.285 . . . . 64.349999999999994 110.315 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 43.2 t -59.29 128.76 38.75 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 123.464 0.706 . . . . 65.400000000000006 110.863 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.64 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -153.42 -176.89 26.37 Favored Glycine 0 CA--C 1.486 -1.723 0 C-N-CA 120.779 -0.724 . . . . 65.409999999999997 111.452 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 50.6 t -89.3 -37.31 9.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.998 -0.741 . . . . 72.219999999999999 108.998 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -150.48 160.3 43.87 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.638 -0.71 . . . . 74.299999999999997 109.31 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 70.0 m-20 -68.78 101.22 1.29 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.44 0.696 . . . . 73.25 109.709 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -131.89 148.25 52.52 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 110.432 -0.211 . . . . 53.32 110.432 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.487 HD11 HG12 ' A' ' 376' ' ' VAL . 30.5 mm -82.91 115.47 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 105.88 -1.896 . . . . 74.140000000000001 105.88 173.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 42.6 t -81.18 -47.49 19.95 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.637 0 N-CA-C 112.553 0.575 . . . . 71.049999999999997 112.553 -176.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 26.1 t -166.0 162.35 17.96 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.522 -0.918 . . . . 60.520000000000003 108.522 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' A' ' 441' ' ' ILE . 3.1 p -141.27 119.9 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.143 0 N-CA-C 108.666 -0.865 . . . . 64.040000000000006 108.666 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 432' ' ' LEU . . . . . 0.407 ' O ' HD23 ' A' ' 440' ' ' LEU . 30.7 tp -121.21 136.61 54.94 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 108.268 -1.012 . . . . 53.240000000000002 108.268 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.449 ' CD ' ' HA ' ' A' ' 436' ' ' LYS . 43.7 tt0 -81.37 116.88 21.41 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.858 -1.164 . . . . 73.120000000000005 107.858 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.47 -46.69 38.02 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.887 0.851 . . . . 64.239999999999995 109.498 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -129.29 -78.68 0.56 Allowed 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.897 -1.047 . . . . 74.400000000000006 109.28 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 436' ' ' LYS . . . . . 0.471 ' HB3' ' NZ ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -168.05 -40.25 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 123.367 0.667 . . . . 70.010000000000005 110.492 174.048 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 91.4 m -100.72 7.79 43.66 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.749 0.785 . . . . 70.120000000000005 109.477 174.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -136.44 129.69 31.51 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.484 -0.78 . . . . 72.319999999999993 109.944 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 439' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 43.4 m-85 -125.32 150.57 47.02 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 123.522 0.514 . . . . 75.439999999999998 110.096 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 432' ' ' LEU . 1.5 pt? -111.9 120.92 43.55 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.369 -0.604 . . . . 45.140000000000001 109.369 172.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.611 ' HB ' HG22 ' A' ' 418' ' ' VAL . 4.0 mp -113.74 133.48 59.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 116.127 -0.488 . . . . 64.299999999999997 110.105 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -104.01 140.53 37.61 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 107.847 -1.168 . . . . 72.140000000000001 107.847 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.423 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 80.7 mtp -138.79 168.33 20.05 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 109.231 -0.655 . . . . 54.119999999999997 109.231 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.64 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 71.9 mmtt -133.53 160.02 38.7 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.146 -1.057 . . . . 71.439999999999998 108.146 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 46.2 t -165.89 146.13 5.49 Favored Pre-proline 0 C--N 1.284 -2.247 0 O-C-N 124.193 0.933 . . . . 60.420000000000002 109.894 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.2 -27.09 41.69 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.158 1.905 . . . . 54.130000000000003 110.147 174.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -78.79 -21.65 47.49 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.291 -0.868 . . . . 52.310000000000002 110.245 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -1.019 0 CA-C-O 121.162 0.506 . . . . 41.409999999999997 110.708 -179.38 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.461 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 93.4 m . . . . . 0 N--CA 1.422 -1.867 0 N-CA-C 107.111 -1.44 . . . . 71.409999999999997 107.111 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 56.2 mtpt -131.6 142.44 49.89 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.403 -0.362 . . . . 72.510000000000005 110.882 -175.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -160.57 135.42 7.63 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.625 -0.88 . . . . 63.450000000000003 108.625 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 2.4 mp0 -79.25 122.99 27.01 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 110.019 -0.363 . . . . 61.439999999999998 110.019 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.577 HG21 HG12 ' A' ' 431' ' ' VAL . 47.4 mt -135.74 124.15 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 106.797 -1.557 . . . . 70.420000000000002 106.797 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.62 13.08 60.39 Favored Glycine 0 C--N 1.31 -0.906 0 C-N-CA 120.55 -0.833 . . . . 72.120000000000005 112.057 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.08 -24.2 27.08 Favored Glycine 0 N--CA 1.429 -1.808 0 C-N-CA 121.209 -0.52 . . . . 74.019999999999996 113.113 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 372' ' ' TYR . . . . . 0.487 ' CD1' ' HG3' ' A' ' 384' ' ' GLN . 22.5 p90 -103.42 147.16 27.47 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 110.17 -0.308 . . . . 75.040000000000006 110.17 -176.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.522 HG21 ' HE2' ' A' ' 366' ' ' LYS . 85.8 m -86.44 123.88 32.15 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 116.464 -0.335 . . . . 51.100000000000001 110.989 -178.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.655 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.5 134.74 34.15 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 108.945 -0.761 . . . . 64.310000000000002 108.945 175.418 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.476 ' HG3' ' HG2' ' A' ' 366' ' ' LYS . 38.0 ttpt -130.12 125.84 36.08 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 110.0 -0.37 . . . . 64.519999999999996 110.0 -178.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.461 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.3 p -122.46 118.88 56.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 N-CA-C 109.451 -0.574 . . . . 74.219999999999999 109.451 175.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 49.5 t -106.17 116.99 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 106.658 -1.608 . . . . 44.109999999999999 106.658 174.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -61.43 126.7 28.28 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 114.668 1.359 . . . . 72.040000000000006 114.668 -172.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 71.07 14.35 6.77 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 113.336 -1.756 . . . . 72.129999999999995 112.465 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -124.8 -77.24 0.59 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 113.893 1.071 . . . . 73.230000000000004 113.893 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -162.76 160.97 26.0 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.882 0.697 . . . . 73.420000000000002 112.882 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.458 HG22 HG23 ' A' ' 376' ' ' VAL . 96.8 t -122.86 140.21 47.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.541 -0.754 . . . . 61.43 109.103 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -133.23 147.25 51.98 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.19 0.519 . . . . 72.540000000000006 111.872 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.52 ' HB2' HD23 ' A' ' 389' ' ' LEU . 35.9 tt0 -112.07 101.03 9.34 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.317 -2.105 . . . . 71.519999999999996 105.317 171.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 21.9 t70 68.19 -84.03 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 124.302 1.041 . . . . 75.150000000000006 110.109 -173.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.4 m -134.89 -6.67 2.4 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.214 -0.903 . . . . 65.409999999999997 108.678 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 45.6 mm -80.38 134.49 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 116.004 -0.544 . . . . 74.219999999999999 109.737 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 61.0 tp -76.92 113.9 15.12 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 109.035 -0.728 . . . . 73.239999999999995 109.035 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.3 OUTLIER -80.06 -63.32 1.44 Allowed 'General case' 0 N--CA 1.389 -3.511 0 N-CA-C 108.974 -0.75 . . . . 64.319999999999993 108.974 -177.179 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.89 159.41 30.64 Favored Glycine 0 N--CA 1.415 -2.742 0 C-N-CA 119.162 -1.494 . . . . 64.319999999999993 111.842 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -105.79 145.07 31.64 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.031 -1.1 . . . . 73.040000000000006 108.031 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -69.82 116.34 10.1 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.908 0.385 . . . . 74.430000000000007 110.601 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -94.79 -47.03 6.64 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.721 -0.672 . . . . 63.130000000000003 110.757 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 62.5 p -173.24 149.8 1.82 Allowed 'General case' 0 C--O 1.246 0.879 0 CA-C-N 116.021 -0.536 . . . . 72.040000000000006 109.599 -177.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.485 ' CD ' ' HG ' ' A' ' 400' ' ' LEU . 10.1 pt20 -143.88 142.06 30.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.186 0.517 . . . . 74.409999999999997 110.796 175.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -128.5 131.11 48.31 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.666 -0.697 . . . . 75.040000000000006 109.624 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 69.59 -107.96 2.31 Favored Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 111.365 -0.694 . . . . 52.140000000000001 111.365 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -133.07 24.41 4.22 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.83 0.824 . . . . 71.150000000000006 110.053 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.2 t -119.45 116.86 52.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.335 -0.987 . . . . 73.120000000000005 108.335 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.485 ' HG ' ' CD ' ' A' ' 395' ' ' GLN . 6.0 mp -106.71 133.55 51.21 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.16 0.584 . . . . 61.539999999999999 111.804 -174.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -113.47 121.94 45.79 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 112.513 0.56 . . . . 71.430000000000007 112.513 178.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.403 ' CE1' ' HB3' ' A' ' 400' ' ' LEU . 2.8 m-85 -118.58 136.81 53.66 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.328 -0.99 . . . . 62.340000000000003 108.328 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -146.31 176.15 9.99 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.141 0.496 . . . . 74.510000000000005 111.723 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.15 33.65 9.23 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.382 -1.281 . . . . 73.409999999999997 112.679 169.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.26 -136.7 0.67 Allowed Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.445 -0.798 . . . . 51.420000000000002 112.931 177.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.34 149.6 40.52 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.816 -1.179 . . . . 73.430000000000007 107.816 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 C--N 1.306 -1.309 0 C-N-CA 124.22 1.008 . . . . 64.019999999999996 111.36 -175.63 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 . . . . . 0 CA--C 1.507 -0.699 0 N-CA-C 106.839 -1.541 . . . . 44.43 106.839 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -75.31 160.53 30.22 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.179 0.514 . . . . 73.219999999999999 111.22 172.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 36.8 p -163.29 163.46 25.29 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 114.908 -1.042 . . . . 72.329999999999998 108.643 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.75 146.32 19.25 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.217 0.532 . . . . 75.329999999999998 110.195 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.9 tt -111.25 121.29 63.59 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 CA-C-N 115.303 -0.862 . . . . 72.420000000000002 109.482 174.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.0 t -105.72 127.8 60.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.775 0.798 . . . . 74.450000000000003 111.499 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 12.5 p -107.76 111.7 24.0 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 106.836 -1.542 . . . . 74.319999999999993 106.836 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 8.6 p -106.27 120.23 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 108.891 -0.781 . . . . 62.409999999999997 108.891 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -116.2 -174.69 2.59 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 120.386 -0.526 . . . . 63.240000000000002 111.277 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 43.4 t -59.61 128.74 38.5 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 123.713 0.805 . . . . 72.349999999999994 111.2 -177.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -160.26 -177.82 33.7 Favored Glycine 0 CA--C 1.48 -2.101 0 N-CA-C 109.54 -1.424 . . . . 53.329999999999998 109.54 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 53.3 t -96.93 -27.96 3.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 121.639 0.733 . . . . 73.200000000000003 109.027 177.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -141.34 146.57 36.85 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.791 -0.64 . . . . 72.150000000000006 111.234 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.638 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.6 p-10 -68.28 101.21 1.16 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.28 -1.327 . . . . 72.150000000000006 110.47 175.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -132.32 149.19 52.41 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.401 -0.818 . . . . 73.010000000000005 110.919 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 28.8 mm -88.82 117.33 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 105.841 -1.911 . . . . 63.130000000000003 105.841 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.7 -50.83 16.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-O 120.772 0.32 . . . . 74.140000000000001 111.438 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 70.3 m -167.08 163.81 15.79 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 110.041 -0.355 . . . . 62.020000000000003 110.041 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.577 HG12 HG21 ' A' ' 369' ' ' ILE . 4.2 p -141.45 127.9 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 108.08 -1.082 . . . . 73.310000000000002 108.08 176.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 432' ' ' LEU . . . . . 0.432 ' O ' HD23 ' A' ' 440' ' ' LEU . 29.5 tp -132.21 138.18 47.86 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.665 -0.865 . . . . 55.229999999999997 108.665 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -80.65 116.45 20.68 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.89 -0.782 . . . . 74.109999999999999 108.89 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.68 -53.74 8.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.28 0.562 . . . . 62.399999999999999 109.702 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -120.93 -72.92 0.67 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.312 -0.858 . . . . 73.310000000000002 110.37 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 436' ' ' LYS . . . . . 0.491 ' HG2' ' SG ' ' A' ' 437' ' ' CYS . 0.0 OUTLIER -167.51 -40.61 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.346 0.594 . . . . 61.149999999999999 110.483 175.173 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 437' ' ' CYS . . . . . 0.491 ' SG ' ' HG2' ' A' ' 436' ' ' LYS . 43.7 m -106.65 7.04 30.37 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.678 0.751 . . . . 71.319999999999993 109.501 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -135.48 127.92 30.47 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.155 -0.929 . . . . 71.329999999999998 109.319 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -123.96 150.22 45.03 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.713 -0.676 . . . . 71.099999999999994 109.782 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.4 pt? -107.52 124.71 50.31 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.491 -0.929 . . . . 75.430000000000007 108.491 173.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.6 mt -124.75 133.37 69.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 115.332 -0.849 . . . . 62.219999999999999 109.409 -176.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -112.45 141.64 45.96 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 119.934 -0.706 . . . . 74.109999999999999 109.614 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 80.0 mtp -137.11 169.03 18.46 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 123.571 0.749 . . . . 63.149999999999999 109.059 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.638 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 69.2 mmtt -135.12 153.73 51.91 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.732 -1.21 . . . . 72.219999999999999 107.732 175.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 73.0 m -164.57 150.82 9.3 Favored Pre-proline 0 C--N 1.293 -1.89 0 C-N-CA 123.992 0.917 . . . . 55.149999999999999 109.287 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.99 -27.51 42.62 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.282 1.988 . . . . 72.400000000000006 112.045 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -73.47 -19.74 60.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.677 -0.692 . . . . 70.530000000000001 110.94 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.045 0 CA-C-O 121.478 0.656 . . . . 63.299999999999997 109.586 -177.826 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 375' ' ' LYS . 99.2 m . . . . . 0 N--CA 1.433 -1.318 0 N-CA-C 109.757 -0.46 . . . . 64.420000000000002 109.757 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 18.9 ptpt -143.94 141.14 30.07 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-O 120.801 0.334 . . . . 71.510000000000005 111.872 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -154.9 135.1 13.15 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 106.96 -1.496 . . . . 72.040000000000006 106.96 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 40.4 mt-10 -89.44 127.86 35.88 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 120.642 0.258 . . . . 74.209999999999994 110.817 -174.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.468 HG21 HG12 ' A' ' 431' ' ' VAL . 47.5 mt -137.21 125.47 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 107.133 -1.432 . . . . 75.319999999999993 107.133 -174.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.84 5.51 32.27 Favored Glycine 0 C--N 1.306 -1.102 0 C-N-CA 121.177 -0.535 . . . . 60.32 113.188 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 110.34 -13.84 30.69 Favored Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.562 -0.828 . . . . 40.5 113.072 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 372' ' ' TYR . . . . . 0.428 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 13.5 p90 -109.91 143.68 39.48 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 110.126 -0.324 . . . . 72.430000000000007 110.126 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 63.2 m -82.96 121.14 26.6 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.822 -0.351 . . . . 62.210000000000001 110.484 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.4 OUTLIER -90.3 125.64 35.58 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 109.335 -0.617 . . . . 74.239999999999995 109.335 173.738 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 365' ' ' THR . 35.1 ttpt -125.64 126.66 45.06 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.451 -0.574 . . . . 75.140000000000001 109.451 -176.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.425 HG23 HG22 ' A' ' 382' ' ' VAL . 6.7 p -123.08 115.9 47.05 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 N-CA-C 109.387 -0.597 . . . . 74.5 109.387 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.58 116.15 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 N-CA-C 106.755 -1.572 . . . . 71.319999999999993 106.755 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -63.14 126.46 27.45 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 113.086 0.773 . . . . 63.329999999999998 113.086 -172.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 72.66 6.78 5.47 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.494 1.517 . . . . 71.439999999999998 113.068 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -115.89 -83.67 0.63 Allowed 'General case' 0 C--O 1.248 0.98 0 N-CA-C 112.494 0.553 . . . . 71.120000000000005 112.494 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -165.81 159.48 16.1 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.026 0.751 . . . . 73.140000000000001 113.026 -172.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.425 HG22 HG23 ' A' ' 376' ' ' VAL . 96.5 t -113.83 145.83 19.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 124.381 1.072 . . . . 74.209999999999994 109.51 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -133.87 144.17 48.74 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 123.322 0.649 . . . . 61.030000000000001 111.191 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.467 ' HB2' HD23 ' A' ' 389' ' ' LEU . 35.3 tt0 -111.65 103.5 11.8 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.352 -1.722 . . . . 35.25 106.352 173.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.4 t70 72.03 -76.16 0.07 Allowed 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 124.938 1.295 . . . . 65.209999999999994 109.463 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 34.0 t -145.31 -6.52 0.64 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.349 -0.982 . . . . 42.109999999999999 108.349 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 65.4 mt -81.49 136.2 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 115.617 -0.72 . . . . 74.209999999999994 109.332 -177.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 60.2 tp -76.5 116.55 17.29 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.013 -0.736 . . . . 53.549999999999997 109.013 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.568 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.3 OUTLIER -81.33 -67.81 0.75 Allowed 'General case' 0 N--CA 1.386 -3.661 0 N-CA-C 108.207 -1.034 . . . . 61.340000000000003 108.207 -178.261 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.94 157.15 28.41 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 119.528 -1.32 . . . . 70.010000000000005 111.811 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -99.21 146.43 26.19 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.039 -1.097 . . . . 52.420000000000002 108.039 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -71.25 115.97 11.03 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.475 -0.565 . . . . 71.329999999999998 109.475 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -93.16 -47.05 7.13 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.382 -0.372 . . . . 51.340000000000003 110.346 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 63.8 p -160.37 141.48 12.13 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.898 -0.778 . . . . 71.310000000000002 108.898 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.467 ' HB2' ' CD2' ' A' ' 400' ' ' LEU . 0.0 OUTLIER -147.03 141.35 26.31 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 116.343 -0.389 . . . . 63.399999999999999 110.926 -179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -128.99 120.32 25.84 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.947 -0.76 . . . . 72.430000000000007 108.947 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.33 -103.13 0.62 Allowed Glycine 0 N--CA 1.434 -1.493 0 O-C-N 123.746 0.654 . . . . 63.109999999999999 113.33 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 26.8 p-10 -113.7 6.18 16.74 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.01 0.374 . . . . 74.019999999999996 112.01 -176.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 28.1 t -116.43 116.93 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 107.932 -1.136 . . . . 74.239999999999995 107.932 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.467 ' CD2' ' HB2' ' A' ' 395' ' ' GLN . 11.7 mt -120.01 123.91 44.63 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 115.528 -0.76 . . . . 64.239999999999995 110.278 -171.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -103.77 124.0 48.09 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-O 121.032 0.444 . . . . 74.319999999999993 111.713 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.402 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 3.1 m-85 -116.21 136.32 53.12 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.933 -1.136 . . . . 64.040000000000006 107.933 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -146.29 175.58 10.41 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.846 0.355 . . . . 64.219999999999999 111.508 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.39 35.02 20.59 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 124.664 1.186 . . . . 65.099999999999994 112.681 172.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.84 -140.43 1.13 Allowed Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.072 -0.967 . . . . 72.129999999999995 111.903 176.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -74.51 139.39 43.79 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.96 -0.755 . . . . 55.43 108.96 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 26.3 t . . . . . 0 C--N 1.321 -0.642 0 CA-C-O 122.026 0.917 . . . . 71.219999999999999 112.969 -172.975 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 . . . . . 0 CA--C 1.493 -1.234 0 N-CA-C 105.126 -2.175 . . . . 53.130000000000003 105.126 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 437' ' ' CYS . 83.5 mtt180 -75.22 154.6 37.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 119.478 -0.889 . . . . 72.219999999999999 110.61 169.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 21.3 p -163.39 162.2 24.79 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 114.801 -1.091 . . . . 64.230000000000004 108.831 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.54 151.72 19.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 120.824 0.345 . . . . 75.319999999999993 110.818 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.9 tt -113.31 127.74 70.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 108.987 -0.746 . . . . 71.510000000000005 108.987 172.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 4.6 t -111.4 128.65 67.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 CA-C-N 115.951 -0.568 . . . . 74.239999999999995 110.835 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.26 115.4 27.36 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 105.908 -1.886 . . . . 62.109999999999999 105.908 177.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 37.6 t -100.54 127.6 53.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 109.137 -0.69 . . . . 73.400000000000006 109.137 -175.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -117.52 -175.09 2.74 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 120.039 -0.665 . . . . 72.439999999999998 110.497 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.461 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 33.3 t -62.34 128.03 34.12 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 122.964 0.506 . . . . 72.409999999999997 110.876 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -154.08 -178.86 28.93 Favored Glycine 0 CA--C 1.492 -1.351 0 C-N-CA 120.519 -0.848 . . . . 73.430000000000007 111.591 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.4 t -85.78 -38.77 13.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 108.81 -0.811 . . . . 72.409999999999997 108.81 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -149.65 150.17 31.75 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.359 -0.837 . . . . 71.549999999999997 109.629 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.603 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 2.6 p30 -51.04 100.73 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.321 -1.309 . . . . 55.530000000000001 111.089 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -131.83 144.65 51.06 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 116.268 -0.424 . . . . 72.540000000000006 110.444 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.458 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 26.8 mm -84.13 116.87 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 105.885 -1.894 . . . . 74.230000000000004 105.885 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 442' ' ' LYS . 56.0 t -82.23 -50.57 16.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 CA-C-O 120.919 0.39 . . . . 73.530000000000001 111.986 -175.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 48.7 m -161.68 162.55 29.89 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.104 -0.702 . . . . 73.129999999999995 109.104 -174.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.468 HG12 HG21 ' A' ' 369' ' ' ILE . 3.4 p -141.32 111.13 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 N-CA-C 108.754 -0.832 . . . . 62.039999999999999 108.754 176.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 432' ' ' LEU . . . . . 0.479 ' O ' HD23 ' A' ' 440' ' ' LEU . 28.8 tp -112.63 137.72 50.48 Favored 'General case' 0 N--CA 1.401 -2.885 0 N-CA-C 107.679 -1.23 . . . . 72.150000000000006 107.679 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 433' ' ' GLU . . . . . 0.455 ' CD ' ' HA ' ' A' ' 436' ' ' LYS . 39.2 tt0 -80.79 114.3 19.58 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 108.724 -0.843 . . . . 73.420000000000002 108.724 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -73.07 -40.18 65.27 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 115.367 -0.833 . . . . 71.109999999999999 110.496 -175.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -133.06 -77.93 0.49 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.165 -0.925 . . . . 73.450000000000003 108.752 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 436' ' ' LYS . . . . . 0.467 ' HB3' ' NZ ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -167.35 -39.8 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 124.029 0.932 . . . . 61.130000000000003 110.513 173.751 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 437' ' ' CYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 414' ' ' ARG . 62.8 m -100.69 -5.03 27.11 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.697 0.761 . . . . 73.019999999999996 109.586 177.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.626 ' HA ' ' O ' ' A' ' 415' ' ' SER . 38.3 tt0 -127.04 137.63 53.09 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.207 -0.906 . . . . 74.099999999999994 109.339 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -129.02 150.52 50.39 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.819 -0.628 . . . . 75.420000000000002 110.487 -174.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.8 pt? -109.39 115.57 30.21 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.55 -0.908 . . . . 73.040000000000006 108.55 173.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.5 mt -115.25 126.45 72.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.408 -0.814 . . . . 61.130000000000003 109.699 -175.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.48 ' O ' ' HB ' ' A' ' 429' ' ' VAL . 38.3 ttpt -103.32 141.48 35.85 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.504 -0.925 . . . . 75.310000000000002 108.504 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.458 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.8 mtp -136.32 168.91 18.54 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 109.663 -0.495 . . . . 50.43 109.663 -176.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.8 mmtt -131.77 158.61 40.76 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.123 -1.066 . . . . 73.310000000000002 108.123 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 47.2 t -172.92 146.66 1.45 Allowed Pre-proline 0 C--N 1.287 -2.121 0 O-C-N 124.248 0.968 . . . . 71.319999999999993 108.774 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -64.49 -23.47 64.59 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.125 1.883 . . . . 63.140000000000001 110.64 176.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -68.25 -26.94 65.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.416 -0.811 . . . . 72.230000000000004 111.081 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.896 0 CA-C-O 121.365 0.603 . . . . 62.100000000000001 109.771 179.759 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.495 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 86.6 m . . . . . 0 N--CA 1.426 -1.64 0 N-CA-C 107.509 -1.293 . . . . 64.310000000000002 107.509 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 13.8 ptmm? -141.41 140.73 33.71 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 120.798 -0.361 . . . . 73.120000000000005 111.758 -175.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -159.81 138.59 10.7 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.356 -0.979 . . . . 74.450000000000003 108.356 -173.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -81.24 123.49 28.52 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 110.075 -0.342 . . . . 75.200000000000003 110.075 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.457 HG21 HG12 ' A' ' 431' ' ' VAL . 58.3 mt -128.58 115.9 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 106.956 -1.498 . . . . 73.420000000000002 106.956 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.76 12.67 59.94 Favored Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.598 -0.811 . . . . 64.049999999999997 112.332 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 111.04 -26.15 12.88 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 121.265 -0.493 . . . . 50.140000000000001 112.701 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -98.08 136.36 38.43 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 120.756 -0.377 . . . . 73.519999999999996 110.89 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 70.1 m -79.17 119.99 23.04 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 116.039 -0.528 . . . . 55.229999999999997 110.228 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -91.02 133.18 35.51 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.577 -0.897 . . . . 75.0 108.577 172.876 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.457 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 35.0 ttpt -133.19 125.73 30.07 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.087 -0.645 . . . . 62.130000000000003 109.706 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.495 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.9 p -120.58 116.4 49.97 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 N-CA-C 109.816 -0.438 . . . . 74.340000000000003 109.816 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 26.9 t -107.41 116.09 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 106.988 -1.486 . . . . 63.020000000000003 106.988 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.452 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 95.7 m-85 -61.74 130.51 46.12 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 113.697 0.999 . . . . 72.340000000000003 113.697 -172.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 67.17 14.38 9.75 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.52 1.128 . . . . 73.120000000000005 112.884 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -125.34 -82.52 0.63 Allowed 'General case' 0 C--O 1.242 0.696 0 N-CA-C 113.418 0.896 . . . . 73.239999999999995 113.418 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -168.32 155.2 7.62 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.946 0.721 . . . . 73.5 112.946 -174.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.482 HG22 HG23 ' A' ' 376' ' ' VAL . 71.4 t -113.78 146.49 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.044 0.938 . . . . 71.129999999999995 109.582 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -135.08 149.27 50.04 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.399 0.679 . . . . 73.109999999999999 111.345 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.524 ' HB2' HD23 ' A' ' 389' ' ' LEU . 32.6 tt0 -123.96 104.81 9.13 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.186 -1.783 . . . . 73.019999999999996 106.186 172.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.1 t70 69.17 -87.66 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.933 0.893 . . . . 73.519999999999996 110.923 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 18.8 m -133.04 0.32 3.44 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.204 -1.036 . . . . 44.119999999999997 108.204 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 45.9 mm -92.19 133.27 34.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.047 -0.979 . . . . 73.530000000000001 110.457 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 63.1 tp -75.99 114.73 14.96 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.247 -1.39 . . . . 61.530000000000001 107.247 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.5 OUTLIER -78.75 -63.3 1.44 Allowed 'General case' 0 N--CA 1.386 -3.629 0 N-CA-C 108.9 -0.778 . . . . 52.32 108.9 -175.756 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.0 158.56 29.86 Favored Glycine 0 N--CA 1.423 -2.231 0 C-N-CA 119.258 -1.448 . . . . 73.219999999999999 112.281 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -104.08 143.31 33.07 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.305 -0.998 . . . . 74.040000000000006 108.305 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.452 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.8 m-85 -68.72 116.5 9.3 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 123.506 0.504 . . . . 72.439999999999998 110.668 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.69 -47.35 5.36 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.023 -0.535 . . . . 70.0 110.958 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 48.2 t -159.0 148.19 18.66 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.147 -0.686 . . . . 42.25 109.147 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.421 HE21 ' HD2' ' A' ' 392' ' ' PHE . 18.3 mp0 -123.28 145.75 48.44 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.27 -1.011 . . . . 70.0 108.27 174.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -126.62 109.08 11.71 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.899 -1.148 . . . . 51.229999999999997 107.899 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 58.66 -101.37 0.21 Allowed Glycine 0 C--O 1.253 1.301 0 CA-C-O 121.423 0.457 . . . . 72.109999999999999 113.193 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -116.07 17.12 15.94 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 124.249 1.02 . . . . 73.040000000000006 109.558 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' VAL . . . . . 0.51 HG13 HD11 ' A' ' 417' ' ' ILE . 60.0 t -121.05 133.45 67.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.197 -1.038 . . . . 74.5 108.197 -177.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 399' ' ' VAL . 3.5 mp -130.33 134.34 47.11 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.513 -0.475 . . . . 74.349999999999994 111.53 -176.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -108.26 122.17 46.39 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 123.101 0.56 . . . . 72.109999999999999 112.003 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.434 ' CD2' HG21 ' A' ' 382' ' ' VAL . 3.0 m-85 -118.38 129.32 55.35 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.719 -1.215 . . . . 71.439999999999998 107.719 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -147.11 175.29 10.82 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 111.637 0.236 . . . . 74.400000000000006 111.637 -177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 60.07 39.19 20.01 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.738 0.649 . . . . 62.119999999999997 111.618 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -80.65 -137.46 1.93 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.737 -0.745 . . . . 72.239999999999995 112.069 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -67.37 148.74 51.23 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.744 -0.465 . . . . 71.030000000000001 109.744 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 30.4 m . . . . . 0 C--N 1.314 -0.947 0 CA-C-O 121.208 0.527 . . . . 55.409999999999997 109.798 178.665 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 108.192 -1.04 . . . . 72.310000000000002 108.192 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -82.72 160.76 22.29 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.143 0.497 . . . . 74.540000000000006 111.506 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 22.7 p -165.27 160.54 18.47 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-N 114.645 -1.162 . . . . 63.420000000000002 109.145 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -157.33 147.87 21.18 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.161 0.505 . . . . 62.030000000000001 110.705 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 417' ' ' ILE . . . . . 0.51 HD11 HG13 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -112.25 114.44 47.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.977 -1.12 . . . . 74.519999999999996 107.977 174.028 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.552 HG22 ' HB ' ' A' ' 441' ' ' ILE . 5.0 t -97.91 128.81 48.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-O 121.337 0.589 . . . . 71.540000000000006 110.327 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 1.4 m -113.66 114.43 26.39 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 106.372 -1.714 . . . . 72.400000000000006 106.372 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 39.1 t -100.78 118.31 47.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.618 -0.882 . . . . 73.420000000000002 108.618 -175.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -109.1 -174.88 2.62 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 120.748 0.308 . . . . 54.130000000000003 110.393 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 42.0 t -60.5 129.24 40.59 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 123.917 0.887 . . . . 71.230000000000004 111.5 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.58 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -158.86 -177.56 32.05 Favored Glycine 0 CA--C 1.491 -1.422 0 N-CA-C 110.641 -0.984 . . . . 72.010000000000005 110.641 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.07 -33.52 5.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.578 0.704 . . . . 74.329999999999998 109.125 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 425' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 426' ' ' ASN . 36.6 tt0 -149.06 162.1 40.62 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.545 -0.752 . . . . 72.099999999999994 109.074 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 54.1 m-80 -67.62 107.93 2.71 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 114.632 -1.167 . . . . 63.340000000000003 110.37 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -131.57 148.48 52.62 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 114.934 -1.03 . . . . 73.109999999999999 109.54 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 29.4 mm -91.45 115.06 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 106.089 -1.819 . . . . 75.25 106.089 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 53.9 t -81.12 -48.83 18.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 111.995 0.368 . . . . 53.409999999999997 111.995 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 46.9 p -166.64 163.67 16.8 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 109.565 -0.531 . . . . 74.219999999999999 109.565 -174.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.457 HG12 HG21 ' A' ' 369' ' ' ILE . 3.2 p -141.36 111.41 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 N-CA-C 108.403 -0.962 . . . . 74.420000000000002 108.403 177.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 432' ' ' LEU . . . . . 0.451 ' HB3' ' HG ' ' A' ' 440' ' ' LEU . 24.4 tp -110.44 136.51 49.48 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 114.892 -1.049 . . . . 70.340000000000003 108.408 -175.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -80.86 110.74 16.67 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.465 -1.309 . . . . 75.239999999999995 107.465 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -72.66 -42.31 64.47 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.473 -0.785 . . . . 74.319999999999993 110.222 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -132.38 -78.03 0.5 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.474 -0.936 . . . . 64.420000000000002 108.474 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.22 -50.28 0.07 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.137 0.494 . . . . 70.530000000000001 111.0 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 63.4 m -100.9 4.39 42.62 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.817 0.817 . . . . 55.43 109.822 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 415' ' ' SER . 35.9 tt0 -129.45 130.97 46.59 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.904 -1.044 . . . . 64.299999999999997 108.948 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 439' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 41.1 m-85 -123.51 150.83 43.46 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.209 -0.905 . . . . 74.530000000000001 110.075 -174.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.451 ' HG ' ' HB3' ' A' ' 432' ' ' LEU . 4.1 pp -111.08 124.46 52.23 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 106.992 -1.485 . . . . 73.310000000000002 106.992 173.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.552 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.7 mt -120.27 135.63 59.91 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 115.753 -0.658 . . . . 51.32 109.813 -175.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -105.7 140.25 39.04 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.235 -1.024 . . . . 74.129999999999995 108.235 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.407 ' SD ' HG11 ' A' ' 376' ' ' VAL . 82.7 mtp -140.08 168.7 19.2 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 109.02 -0.733 . . . . 64.519999999999996 109.02 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.58 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 71.9 mmtt -132.24 160.28 36.62 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.999 -0.741 . . . . 71.219999999999999 108.999 177.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 32.2 t -172.22 148.55 2.0 Allowed Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 124.138 0.899 . . . . 75.010000000000005 108.832 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.82 -27.26 51.75 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.197 1.931 . . . . 74.219999999999999 111.027 177.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -74.74 -15.79 60.76 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.281 -0.872 . . . . 70.310000000000002 111.12 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.107 0 CA-C-O 121.268 0.556 . . . . 64.409999999999997 110.08 -179.812 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 97.7 m . . . . . 0 N--CA 1.428 -1.571 0 N-CA-C 108.358 -0.978 . . . . 73.409999999999997 108.358 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 10.4 ptpp? -138.48 154.63 48.82 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 110.343 -0.243 . . . . 73.099999999999994 110.343 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -164.7 135.34 4.05 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.591 -1.263 . . . . 75.140000000000001 107.591 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -84.67 125.31 32.39 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.599 -0.519 . . . . 75.549999999999997 109.599 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.518 HG21 HG12 ' A' ' 431' ' ' VAL . 49.4 mt -130.59 116.29 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 107.236 -1.394 . . . . 65.340000000000003 107.236 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 67.28 11.71 59.59 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.823 -0.703 . . . . 51.420000000000002 112.521 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 111.94 -25.75 12.5 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.806 -0.711 . . . . 74.310000000000002 112.575 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -97.84 136.09 38.65 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 120.218 -0.593 . . . . 74.349999999999994 110.8 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 92.2 m -79.19 118.48 21.18 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 115.713 -0.676 . . . . 64.140000000000001 110.742 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -90.12 133.34 34.93 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 108.234 -1.024 . . . . 60.210000000000001 108.234 173.364 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -132.06 125.71 32.07 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.349 -0.541 . . . . 74.109999999999999 110.022 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.422 HG23 HG22 ' A' ' 382' ' ' VAL . 7.0 p -119.51 118.08 56.11 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 CA-C-N 116.031 -0.531 . . . . 71.420000000000002 109.861 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.4 t -109.25 116.14 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 106.658 -1.608 . . . . 63.039999999999999 106.658 173.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.428 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 83.5 m-85 -63.11 130.88 46.54 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.15 -0.932 . . . . 75.340000000000003 113.107 -171.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 71.82 6.79 5.74 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.894 1.278 . . . . 70.200000000000003 112.314 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -119.42 -84.81 0.66 Allowed 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 116.021 -0.536 . . . . 73.409999999999997 112.19 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -168.37 158.99 10.2 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 112.611 0.597 . . . . 44.25 112.611 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 402' ' ' TYR . 94.6 t -116.29 146.58 20.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 123.858 0.863 . . . . 73.430000000000007 109.928 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -133.06 151.3 52.04 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.662 0.785 . . . . 71.400000000000006 111.088 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.521 ' HB2' HD23 ' A' ' 389' ' ' LEU . 30.4 tt0 -126.46 109.66 12.44 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.584 -1.636 . . . . 65.340000000000003 106.584 173.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 25.0 t70 70.49 -80.66 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 124.051 0.94 . . . . 63.43 110.528 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 28.4 p -145.37 1.12 0.93 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.176 -0.92 . . . . 63.329999999999998 109.27 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 48.2 mm -91.37 137.63 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.003 -0.999 . . . . 72.200000000000003 109.558 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 57.1 tp -76.63 115.94 16.86 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.236 -1.024 . . . . 61.030000000000001 108.236 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.539 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.4 OUTLIER -79.07 -64.32 1.21 Allowed 'General case' 0 N--CA 1.392 -3.354 0 N-CA-C 109.025 -0.731 . . . . 63.030000000000001 109.025 -177.252 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.44 160.63 31.52 Favored Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 118.796 -1.668 . . . . 40.140000000000001 111.744 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -99.53 147.48 25.27 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.237 -1.764 . . . . 72.120000000000005 106.237 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 2.6 m-85 -69.24 116.42 9.66 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.061 -0.656 . . . . 45.43 110.86 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -93.78 -48.1 6.46 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.675 -0.693 . . . . 70.409999999999997 110.134 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 46.8 m -154.23 142.45 20.43 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 110.303 -0.258 . . . . 65.299999999999997 110.303 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.2 130.99 53.71 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 106.593 -1.632 . . . . 72.209999999999994 106.593 174.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -128.67 109.81 11.66 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.922 -0.77 . . . . 75.019999999999996 108.922 176.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.19 -101.18 0.58 Allowed Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.988 -0.625 . . . . 34.399999999999999 111.948 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -122.48 18.95 10.5 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.269 0.557 . . . . 72.340000000000003 109.575 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.01 126.43 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 N-CA-C 107.792 -1.188 . . . . 74.099999999999994 107.792 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 22.7 mt -123.82 123.66 40.95 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 110.001 -0.37 . . . . 72.430000000000007 110.001 -172.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -106.88 125.1 50.57 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.201 -0.296 . . . . 63.039999999999999 110.201 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.485 ' CE2' HG21 ' A' ' 382' ' ' VAL . 2.4 m-85 -118.49 135.54 54.33 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.52 -0.918 . . . . 65.25 108.52 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -146.27 175.85 10.2 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 123.41 0.684 . . . . 75.310000000000002 109.771 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 66.17 27.54 10.36 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.287 0.847 . . . . 62.130000000000003 113.287 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -72.6 -139.48 0.32 Allowed Glycine 0 CA--C 1.54 1.619 0 C-N-CA 121.302 -0.475 . . . . 75.400000000000006 113.764 176.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.02 144.68 38.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.309 -1.367 . . . . 75.519999999999996 107.309 -177.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 C--N 1.305 -1.335 0 CA-C-O 121.669 0.747 . . . . 74.540000000000006 111.141 -177.341 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 . . . . . 0 CA--C 1.501 -0.917 0 N-CA-C 106.678 -1.601 . . . . 64.540000000000006 106.678 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -64.99 157.15 29.05 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-O 121.677 0.751 . . . . 73.400000000000006 111.859 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 40.1 p -159.67 163.66 34.66 Favored 'General case' 0 N--CA 1.403 -2.789 0 CA-C-N 114.305 -1.316 . . . . 71.120000000000005 109.063 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.38 151.48 19.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 109.971 -0.381 . . . . 73.409999999999997 109.971 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 14.9 tt -117.67 120.98 66.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 108.663 -0.865 . . . . 72.230000000000004 108.663 173.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.491 HG22 ' HB ' ' A' ' 441' ' ' ILE . 4.1 t -104.01 123.65 57.89 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 CA-C-N 115.163 -0.926 . . . . 62.43 110.127 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 2.3 m -108.57 114.08 27.62 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 105.525 -2.028 . . . . 75.5 105.525 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.37 116.7 44.32 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.383 0 N-CA-C 108.154 -1.054 . . . . 75.310000000000002 108.154 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -110.94 -173.86 2.34 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 120.961 0.41 . . . . 75.040000000000006 111.736 -176.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.487 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 39.8 t -64.1 128.67 36.83 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.635 0.774 . . . . 72.099999999999994 111.386 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -161.1 -177.5 34.26 Favored Glycine 0 CA--C 1.492 -1.37 0 N-CA-C 109.508 -1.437 . . . . 52.109999999999999 109.508 177.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 56.2 t -96.17 -23.42 4.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.539 0.685 . . . . 62.130000000000003 109.441 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -142.67 154.44 44.34 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.906 -0.588 . . . . 71.030000000000001 110.363 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 72.0 m-20 -71.69 99.3 2.09 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.777 -1.194 . . . . 75.25 107.777 175.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -132.01 148.55 52.51 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 120.999 -0.28 . . . . 52.229999999999997 110.398 -177.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.478 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 26.7 mm -85.89 127.49 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.49 -1.67 . . . . 73.420000000000002 106.49 176.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 62.6 t -91.54 -51.03 12.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 112.356 0.502 . . . . 73.420000000000002 112.356 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 50.5 m -163.23 161.64 24.97 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.507 -0.553 . . . . 53.039999999999999 109.507 -174.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.518 HG12 HG21 ' A' ' 369' ' ' ILE . 3.1 p -141.4 116.8 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 123.867 0.729 . . . . 73.239999999999995 109.468 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 25.0 tp -123.87 137.34 54.66 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.214 -1.032 . . . . 74.140000000000001 108.214 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -84.21 128.41 34.55 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.714 -0.847 . . . . 64.120000000000005 108.714 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -89.22 -48.19 7.55 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.11 1.152 . . . . 65.129999999999995 114.11 -176.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -122.79 -68.21 0.9 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.191 0.519 . . . . 74.219999999999999 111.642 -172.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 436' ' ' LYS . . . . . 0.482 ' HB3' ' NZ ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -166.03 -27.28 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 124.031 0.932 . . . . 73.140000000000001 109.535 175.096 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 98.3 m -135.78 21.91 3.32 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.718 -0.674 . . . . 75.310000000000002 110.934 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.4 tt0 -135.29 119.61 17.86 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.289 0.566 . . . . 75.239999999999995 110.564 -176.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -109.44 134.42 51.88 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 115.623 -0.717 . . . . 74.030000000000001 110.719 -174.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.0 OUTLIER -96.66 116.65 29.47 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.203 -1.036 . . . . 71.200000000000003 108.203 173.263 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.491 ' HB ' HG22 ' A' ' 418' ' ' VAL . 97.6 mt -118.35 135.1 59.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 115.043 -0.98 . . . . 65.540000000000006 110.309 -175.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -105.44 140.93 37.81 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.419 -0.956 . . . . 64.420000000000002 108.419 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.478 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.2 mtp -137.78 168.7 19.15 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 108.784 -0.821 . . . . 53.130000000000003 108.784 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 73.0 mmtt -131.76 161.24 33.32 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.354 -0.98 . . . . 64.099999999999994 108.354 176.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 48.5 t -164.82 146.07 6.45 Favored Pre-proline 0 C--N 1.284 -2.276 0 O-C-N 124.235 0.96 . . . . 73.209999999999994 109.025 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 30.4 Cg_endo -65.6 -27.22 53.48 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.159 1.906 . . . . 73.430000000000007 110.676 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.34 -19.96 38.26 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.516 -0.766 . . . . 63.210000000000001 110.782 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -1.002 0 CA-C-O 121.969 0.89 . . . . 74.420000000000002 110.415 -177.587 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.495 ' HB ' HG13 ' A' ' 376' ' ' VAL . 86.4 m . . . . . 0 N--CA 1.437 -1.077 0 N-CA-C 109.46 -0.571 . . . . 62.130000000000003 109.46 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 0.0 OUTLIER -145.17 151.62 38.72 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.614 -0.435 . . . . 72.510000000000005 111.572 178.021 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -162.56 134.33 5.29 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.31 -1.367 . . . . 74.049999999999997 107.31 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 45.7 mt-10 -87.79 127.99 35.32 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 110.113 -0.329 . . . . 71.319999999999993 110.113 -175.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.487 HG21 HG12 ' A' ' 431' ' ' VAL . 42.5 mt -134.46 122.64 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 106.642 -1.614 . . . . 74.420000000000002 106.642 -175.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.54 9.88 52.15 Favored Glycine 0 C--N 1.306 -1.123 0 C-N-CA 120.894 -0.669 . . . . 65.409999999999997 113.194 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 111.97 -23.57 16.49 Favored Glycine 0 N--CA 1.427 -1.94 0 C-N-CA 120.82 -0.705 . . . . 70.319999999999993 112.803 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 372' ' ' TYR . . . . . 0.419 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 17.0 p90 -100.98 144.61 29.71 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.625 0.25 . . . . 74.140000000000001 110.809 -177.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 87.3 m -82.47 119.39 24.15 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.817 -0.438 . . . . 75.239999999999995 109.817 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.37 125.28 35.49 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 108.451 -0.944 . . . . 60.119999999999997 108.451 172.738 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -126.6 130.9 51.4 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.453 -0.573 . . . . 75.109999999999999 109.453 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.512 HG23 HG22 ' A' ' 382' ' ' VAL . 6.6 p -128.07 119.29 50.69 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.928 0 CA-C-O 121.254 0.55 . . . . 75.340000000000003 110.246 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 57.9 t -108.14 116.39 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.917 0 N-CA-C 106.825 -1.546 . . . . 74.030000000000001 106.825 175.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -62.85 132.48 52.3 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.066 1.135 . . . . 74.25 114.066 -173.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 66.96 17.91 10.55 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.03 -1.441 . . . . 62.420000000000002 112.076 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -128.79 -82.75 0.58 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.309 -0.86 . . . . 54.520000000000003 113.001 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -165.55 155.93 13.29 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 113.274 0.842 . . . . 65.099999999999994 113.274 -172.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.512 HG22 HG23 ' A' ' 376' ' ' VAL . 88.4 t -113.78 145.28 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.388 1.075 . . . . 54.039999999999999 109.252 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -134.81 147.61 49.99 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 123.125 0.57 . . . . 75.219999999999999 111.532 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.528 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.2 tt0 -119.39 104.71 10.6 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.151 -1.796 . . . . 73.109999999999999 106.151 173.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.4 t70 72.12 -82.96 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.725 0.81 . . . . 63.219999999999999 110.286 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 32.1 p -143.84 3.04 1.23 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.852 -1.067 . . . . 71.420000000000002 108.574 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 62.1 mt -89.21 133.91 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.967 -1.015 . . . . 71.239999999999995 109.378 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 61.2 tp -77.43 115.45 17.21 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.536 -0.913 . . . . 61.409999999999997 108.536 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.574 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -80.31 -64.54 1.17 Allowed 'General case' 0 N--CA 1.394 -3.249 0 N-CA-C 108.994 -0.743 . . . . 51.549999999999997 108.994 -177.086 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.9 158.57 30.16 Favored Glycine 0 N--CA 1.415 -2.739 0 C-N-CA 119.874 -1.155 . . . . 54.43 111.519 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -103.12 153.14 20.62 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.157 -1.423 . . . . 65.310000000000002 107.157 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.488 ' HB3' HE22 ' A' ' 395' ' ' GLN . 1.7 m-85 -73.7 116.13 13.93 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 120.926 0.393 . . . . 71.340000000000003 111.306 -175.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.88 -48.12 5.03 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.608 -0.724 . . . . 71.239999999999995 110.852 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 51.1 m -157.15 137.75 13.12 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.024 0.44 . . . . 64.219999999999999 109.961 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.56 ' CB ' ' HG ' ' A' ' 400' ' ' LEU . 4.8 pm0 -141.17 125.69 17.74 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 115.824 -0.626 . . . . 72.129999999999995 110.371 177.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -128.22 132.18 48.8 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.383 -0.969 . . . . 63.25 108.383 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 69.53 -103.53 1.12 Allowed Glycine 0 N--CA 1.422 -2.292 0 N-CA-C 111.057 -0.817 . . . . 73.519999999999996 111.057 -177.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -138.77 18.5 2.67 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.789 0.804 . . . . 73.420000000000002 110.297 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 63.9 t -117.1 119.78 63.02 Favored 'Isoleucine or valine' 0 C--O 1.244 0.816 0 N-CA-C 108.174 -1.047 . . . . 61.299999999999997 108.174 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.56 ' HG ' ' CB ' ' A' ' 395' ' ' GLN . 4.0 mp -113.02 135.54 53.67 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.964 -0.562 . . . . 73.239999999999995 110.971 -173.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -115.47 125.16 52.74 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.524 -0.917 . . . . 71.209999999999994 108.524 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -115.75 141.55 47.94 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.399 -0.963 . . . . 74.400000000000006 108.399 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -146.12 176.46 9.71 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.624 0.77 . . . . 71.540000000000006 109.096 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 18.7 m120 65.51 36.05 6.87 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.274 0.629 . . . . 65.340000000000003 112.677 173.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -81.01 -137.67 2.11 Favored Glycine 0 C--N 1.305 -1.177 0 C-N-CA 120.562 -0.828 . . . . 55.5 112.681 177.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.73 149.18 36.37 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 106.527 -1.657 . . . . 55.130000000000003 106.527 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 407' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 46.0 m . . . . . 0 C--N 1.301 -1.525 0 N-CA-C 113.655 0.983 . . . . 61.149999999999999 113.655 -173.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 413' ' ' HIS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 90.2 m-70 . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 108.3 -1.0 . . . . 75.150000000000006 108.3 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -77.4 164.9 25.06 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 121.043 0.449 . . . . 64.549999999999997 110.521 173.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 57.6 p -159.42 166.78 30.3 Favored 'General case' 0 N--CA 1.403 -2.818 0 CA-C-N 115.036 -0.984 . . . . 62.43 109.347 -177.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -157.55 151.8 24.74 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 109.85 -0.426 . . . . 54.229999999999997 109.85 -178.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 11.0 tt -122.18 123.14 68.22 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 CA-C-N 115.699 -0.682 . . . . 62.200000000000003 109.444 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 441' ' ' ILE . 4.3 t -113.73 130.68 67.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 115.818 -0.628 . . . . 62.119999999999997 111.447 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 17.7 p -108.75 114.19 27.77 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 108.357 -0.979 . . . . 73.5 108.357 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 45.1 t -100.83 115.39 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 107.549 -1.278 . . . . 74.510000000000005 107.549 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -117.35 -174.68 2.65 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 121.014 -0.274 . . . . 72.510000000000005 110.471 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 38.1 t -61.37 128.71 37.65 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 122.976 0.51 . . . . 64.319999999999993 110.749 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.647 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -163.12 -177.66 36.27 Favored Glycine 0 CA--C 1.495 -1.158 0 C-N-CA 120.701 -0.761 . . . . 24.039999999999999 111.498 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.9 t -81.94 -38.91 16.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.403 0.621 . . . . 74.129999999999995 110.445 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -155.92 162.03 40.45 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.12 -0.696 . . . . 75.230000000000004 109.12 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 43.1 m-80 -63.17 102.88 0.42 Allowed 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.594 1.184 . . . . 71.420000000000002 109.024 177.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -133.09 139.24 47.03 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.491 -1.3 . . . . 62.520000000000003 107.491 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 30.6 mm -89.06 110.61 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 N-CA-C 106.75 -1.574 . . . . 52.439999999999998 106.75 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 57.2 t -80.76 -44.78 21.5 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.688 0 CA-C-N 115.755 -0.657 . . . . 54.409999999999997 112.464 -173.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 35.3 p -162.26 158.4 24.25 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 120.494 -0.483 . . . . 50.329999999999998 110.727 -176.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.487 HG12 HG21 ' A' ' 369' ' ' ILE . 4.2 p -141.56 115.42 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 N-CA-C 108.547 -0.908 . . . . 73.340000000000003 108.547 175.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 29.0 tp -120.57 135.79 54.99 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.029 -1.471 . . . . 63.450000000000003 107.029 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -87.98 123.52 32.78 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.431 -1.322 . . . . 75.5 107.431 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -82.19 -46.81 13.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.856 1.058 . . . . 74.349999999999994 113.856 -174.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -121.38 -74.36 0.62 Allowed 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.438 0.637 . . . . 63.140000000000001 110.839 -172.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 436' ' ' LYS . . . . . 0.412 ' HB3' ' NZ ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -175.55 -10.12 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 126.114 1.766 . . . . 63.210000000000001 109.373 176.465 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 24.7 m -136.62 5.17 2.89 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 109.528 -0.545 . . . . 74.120000000000005 109.528 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 415' ' ' SER . 31.3 tt0 -136.22 126.02 25.68 Favored 'General case' 0 C--O 1.211 -0.972 0 CA-C-O 120.837 0.351 . . . . 72.420000000000002 111.55 -173.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 439' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 28.4 m-85 -113.7 141.15 47.6 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 116.055 -0.521 . . . . 70.109999999999999 110.719 -175.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.436 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.2 pt? -106.29 119.42 39.21 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.373 -0.973 . . . . 74.420000000000002 108.373 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.486 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.8 mt -119.45 135.4 59.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.366 -0.834 . . . . 72.209999999999994 111.255 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -99.7 139.3 35.57 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 109.489 -0.56 . . . . 70.510000000000005 109.489 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 81.5 mtp -141.82 164.68 29.53 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 109.858 -0.423 . . . . 75.120000000000005 109.858 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.647 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 71.7 mmtt -134.78 161.35 35.44 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.961 -1.126 . . . . 64.099999999999994 107.961 176.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 31.9 t -167.2 145.88 4.29 Favored Pre-proline 0 C--N 1.289 -2.043 0 O-C-N 123.97 0.794 . . . . 62.439999999999998 109.277 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.31 -24.68 43.24 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.245 1.963 . . . . 74.540000000000006 110.862 177.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.33 -19.59 59.53 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.222 -0.899 . . . . 64.540000000000006 110.658 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.244 0 CA-C-O 121.554 0.692 . . . . 70.099999999999994 109.458 -178.152 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.406 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 93.5 m . . . . . 0 N--CA 1.435 -1.215 0 N-CA-C 108.823 -0.806 . . . . 71.140000000000001 108.823 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 10.4 ptpp? -144.23 141.05 29.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 116.444 -0.344 . . . . 74.230000000000004 110.858 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -159.02 135.82 9.51 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.033 -0.729 . . . . 73.439999999999998 109.033 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.17 129.98 35.06 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.31 -0.405 . . . . 75.040000000000006 110.582 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.553 HG21 HG12 ' A' ' 431' ' ' VAL . 33.3 mt -137.95 128.11 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 106.643 -1.614 . . . . 73.519999999999996 106.643 -175.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.58 14.45 49.95 Favored Glycine 0 C--N 1.302 -1.319 0 C-N-CA 120.34 -0.933 . . . . 71.200000000000003 113.171 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 99.57 -9.88 60.78 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.749 -0.739 . . . . 75.439999999999998 113.537 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 372' ' ' TYR . . . . . 0.403 ' CD1' ' HG3' ' A' ' 384' ' ' GLN . 9.0 p90 -111.29 144.07 41.05 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 122.438 -0.448 . . . . 70.019999999999996 110.571 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 38.2 m -82.16 120.5 25.41 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 110.173 -0.306 . . . . 54.240000000000002 110.173 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.4 OUTLIER -91.29 135.89 33.49 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 109.278 -0.638 . . . . 72.120000000000005 109.278 173.636 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -131.93 127.48 36.47 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 123.547 0.529 . . . . 72.109999999999999 109.952 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.452 HG23 HG22 ' A' ' 382' ' ' VAL . 7.4 p -127.08 120.57 55.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 120.879 0.371 . . . . 60.219999999999999 110.522 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.7 t -115.17 116.96 54.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 N-CA-C 106.837 -1.542 . . . . 73.450000000000003 106.837 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' PHE . . . . . 0.463 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 28.4 m-85 -65.32 128.49 36.07 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 114.757 1.392 . . . . 55.420000000000002 114.757 -171.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 68.28 22.38 8.1 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 113.84 -1.527 . . . . 64.010000000000005 112.288 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -132.36 -79.8 0.5 Allowed 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.438 -0.801 . . . . 73.299999999999997 113.098 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -165.46 154.72 12.3 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.419 0.896 . . . . 61.310000000000002 113.419 -172.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.463 HG21 ' CD2' ' A' ' 402' ' ' TYR . 98.9 t -119.25 145.3 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.166 0.986 . . . . 64.420000000000002 109.024 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -134.26 145.59 49.27 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.965 0.412 . . . . 72.319999999999993 111.889 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.514 ' HB2' HD23 ' A' ' 389' ' ' LEU . 33.4 tt0 -116.84 108.26 15.62 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.419 -1.697 . . . . 61.340000000000003 106.419 172.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.2 t70 71.67 -79.65 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 124.302 1.041 . . . . 75.319999999999993 109.931 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.0 m -144.73 -4.02 0.77 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.563 -0.903 . . . . 74.409999999999997 108.563 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 50.1 mm -84.09 136.67 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.442 -0.799 . . . . 73.530000000000001 109.486 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 64.5 tp -76.2 110.73 10.94 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.799 -1.186 . . . . 73.109999999999999 107.799 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.6 OUTLIER -73.61 -63.1 1.27 Allowed 'General case' 0 N--CA 1.385 -3.682 0 N-CA-C 108.552 -0.907 . . . . 72.150000000000006 108.552 -176.271 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.94 158.7 29.99 Favored Glycine 0 N--CA 1.417 -2.585 0 C-N-CA 119.064 -1.541 . . . . 75.209999999999994 111.595 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -106.64 142.21 36.65 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.106 -1.072 . . . . 73.319999999999993 108.106 177.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' PHE . . . . . 0.542 ' HD2' ' NE2' ' A' ' 395' ' ' GLN . 1.9 m-85 -65.99 115.96 6.61 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 123.465 0.478 . . . . 75.230000000000004 110.537 -176.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -105.65 -48.47 3.65 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.074 -0.512 . . . . 73.530000000000001 111.278 -176.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 56.6 m -155.07 139.87 17.16 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.677 -0.49 . . . . 70.549999999999997 109.677 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.542 ' NE2' ' HD2' ' A' ' 392' ' ' PHE . 42.7 mt-30 -134.41 136.46 43.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.242 -1.392 . . . . 75.099999999999994 107.242 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -128.78 110.76 12.45 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 109.474 -0.565 . . . . 71.209999999999994 109.474 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 70.81 -118.57 7.68 Favored Glycine 0 N--CA 1.424 -2.125 0 N-CA-C 110.665 -0.974 . . . . 70.209999999999994 110.665 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 4.2 p-10 -107.29 21.81 16.94 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.446 0.641 . . . . 74.150000000000006 110.188 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 40.1 t -124.48 116.91 48.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 107.79 -1.189 . . . . 53.229999999999997 107.79 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.451 ' CD2' ' HB3' ' A' ' 395' ' ' GLN . 11.2 mt -116.34 129.51 56.29 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.882 -0.599 . . . . 72.439999999999998 110.922 -169.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -105.03 122.02 45.0 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-O 121.06 0.457 . . . . 72.319999999999993 112.168 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.463 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.5 m-85 -117.1 119.17 34.44 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 105.807 -1.923 . . . . 72.109999999999999 105.807 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -135.73 173.84 11.27 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.31 -0.626 . . . . 72.430000000000007 109.31 -174.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 61.04 37.48 17.93 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.965 0.791 . . . . 62.020000000000003 112.503 175.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.58 -141.82 1.24 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.185 -0.531 . . . . 72.030000000000001 112.676 176.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.82 137.58 51.93 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.435 -0.95 . . . . 73.439999999999998 108.435 -175.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 C--N 1.312 -1.028 0 C-N-CA 123.65 0.78 . . . . 70.150000000000006 112.427 -177.015 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 . . . . . 0 CA--C 1.493 -1.243 0 N-CA-C 106.484 -1.673 . . . . 72.439999999999998 106.484 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.05 153.32 41.8 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.352 0.596 . . . . 73.109999999999999 111.996 174.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.9 p -159.1 160.83 36.14 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 114.698 -1.137 . . . . 64.030000000000001 108.908 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 416' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -155.39 148.0 24.13 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 109.744 -0.465 . . . . 75.420000000000002 109.744 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.9 tt -110.94 118.52 57.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.536 -0.913 . . . . 60.310000000000002 108.536 174.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 2.9 t -97.77 125.42 50.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 CA-C-O 121.457 0.646 . . . . 74.319999999999993 109.884 177.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 2.5 m -108.43 112.23 24.53 Favored 'General case' 0 N--CA 1.385 -3.707 0 N-CA-C 104.577 -2.379 . . . . 64.120000000000005 104.577 174.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 7.9 p -102.0 121.15 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 108.655 -0.868 . . . . 71.329999999999998 108.655 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -114.94 -174.4 2.48 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 116.289 -0.414 . . . . 53.539999999999999 110.362 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.647 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 22.6 t -60.57 128.16 35.24 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 123.367 0.667 . . . . 64.120000000000005 112.572 -176.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.549 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -156.06 -177.75 29.56 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.606 -0.807 . . . . 63.299999999999997 111.452 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.4 t -91.76 -34.2 6.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.851 -0.796 . . . . 73.25 108.851 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -148.88 148.06 29.42 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 115.694 -0.685 . . . . 73.540000000000006 109.197 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.741 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.1 p-10 -62.36 99.64 0.15 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.991 -1.004 . . . . 64.150000000000006 111.536 176.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -131.81 149.07 52.57 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.338 -0.847 . . . . 75.239999999999995 110.156 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.441 HG21 HD11 ' A' ' 369' ' ' ILE . 28.2 mm -82.09 119.53 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.198 -1.408 . . . . 73.0 107.198 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 429' ' ' VAL . . . . . 0.428 HG11 ' HD2' ' A' ' 442' ' ' LYS . 66.0 t -83.69 -51.37 14.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 111.886 0.328 . . . . 74.030000000000001 111.886 -177.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 59.7 m -166.04 163.52 18.23 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.438 -0.579 . . . . 70.329999999999998 109.438 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.553 HG12 HG21 ' A' ' 369' ' ' ILE . 3.5 p -141.84 116.68 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 107.956 -1.127 . . . . 74.409999999999997 107.956 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 34.1 tp -112.16 133.13 54.48 Favored 'General case' 0 C--N 1.263 -3.156 0 N-CA-C 108.143 -1.058 . . . . 61.030000000000001 108.143 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -82.15 108.52 15.68 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.596 -1.261 . . . . 74.420000000000002 107.596 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -69.75 -53.26 19.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.865 0.841 . . . . 75.540000000000006 109.47 -177.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -120.1 -77.79 0.58 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.52 -1.218 . . . . 74.239999999999995 108.577 177.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 436' ' ' LYS . . . . . 0.479 ' HB3' ' NZ ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -169.94 -47.36 0.02 OUTLIER 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 124.459 1.104 . . . . 74.409999999999997 110.383 174.258 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 82.0 m -91.99 5.3 50.67 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.723 0.773 . . . . 52.210000000000001 109.562 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -136.49 124.4 22.73 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.107 -0.951 . . . . 74.519999999999996 109.08 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 439' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 54.4 m-85 -122.56 151.22 41.61 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.016 -0.538 . . . . 75.040000000000006 110.118 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.47 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.6 pt? -110.53 124.95 52.78 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.299 -1.371 . . . . 62.100000000000001 107.299 170.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 98.4 mt -122.78 134.94 64.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 115.813 -0.63 . . . . 75.349999999999994 109.92 -175.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 442' ' ' LYS . . . . . 0.428 ' HD2' HG11 ' A' ' 429' ' ' VAL . 23.9 ttmm -106.84 140.81 39.08 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 108.776 -0.824 . . . . 60.219999999999999 108.776 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.402 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.7 mtp -138.02 164.14 29.81 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.032 -1.099 . . . . 63.240000000000002 108.032 177.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.741 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 34.2 mmtp -129.69 151.59 50.11 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 108.063 -1.088 . . . . 65.439999999999998 108.063 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 43.4 t -164.74 147.84 7.33 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.786 -0.82 . . . . 61.530000000000001 108.786 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.97 -27.22 66.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.072 1.848 . . . . 73.519999999999996 110.244 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -69.37 -22.26 63.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.232 -0.894 . . . . 61.43 110.876 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.933 0 CA-C-O 121.358 0.599 . . . . 72.349999999999994 109.944 -179.689 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 365' ' ' THR . . . . . 0.43 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 92.0 m . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 109.253 -0.647 . . . . 62.200000000000003 109.253 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 19.6 ptmt -144.2 145.03 31.82 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 121.21 -0.196 . . . . 61.32 111.209 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -160.76 136.89 8.4 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.223 -1.029 . . . . 74.420000000000002 108.223 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.05 125.31 31.98 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 110.017 -0.364 . . . . 51.32 110.017 -178.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.488 HG21 HG12 ' A' ' 431' ' ' VAL . 57.3 mt -130.57 116.27 34.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 107.29 -1.374 . . . . 71.049999999999997 107.29 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.6 15.09 63.59 Favored Glycine 0 C--N 1.306 -1.107 0 C-N-CA 121.063 -0.589 . . . . 60.200000000000003 112.498 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 109.09 -25.72 17.58 Favored Glycine 0 N--CA 1.427 -1.931 0 C-N-CA 120.401 -0.904 . . . . 65.340000000000003 112.578 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -97.77 135.84 38.96 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.007 0.432 . . . . 70.140000000000001 111.286 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 85.1 m -79.19 118.5 21.2 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.856 -0.611 . . . . 41.43 110.747 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.595 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -90.66 132.47 35.76 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 108.378 -0.971 . . . . 75.540000000000006 108.378 173.637 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -132.07 127.32 35.87 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.278 -0.638 . . . . 71.230000000000004 109.278 -176.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.515 HG23 HG22 ' A' ' 382' ' ' VAL . 6.5 p -125.72 118.37 51.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-O 121.053 0.454 . . . . 75.239999999999995 110.16 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.2 t -106.66 116.9 51.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 107.031 -1.47 . . . . 63.420000000000002 107.031 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -63.65 129.04 38.52 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 114.011 1.115 . . . . 74.510000000000005 114.011 -172.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 72.7 13.52 5.19 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 126.166 1.786 . . . . 75.030000000000001 112.371 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -124.11 -83.3 0.65 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 113.088 0.773 . . . . 72.219999999999999 113.088 176.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -159.05 164.9 35.03 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 112.542 0.571 . . . . 75.530000000000001 112.542 -170.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.515 HG22 HG23 ' A' ' 376' ' ' VAL . 72.7 t -126.88 142.16 44.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.242 -0.89 . . . . 64.310000000000002 108.837 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -132.97 151.6 52.04 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 122.957 0.503 . . . . 75.019999999999996 111.311 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.496 ' HB2' HD23 ' A' ' 389' ' ' LEU . 30.6 tt0 -122.18 106.27 10.99 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 106.217 -1.771 . . . . 71.519999999999996 106.217 172.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.0 t70 70.76 -74.66 0.08 Allowed 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 124.87 1.268 . . . . 72.319999999999993 110.395 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 64.1 m -146.94 -7.2 0.49 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.75 -0.659 . . . . 55.329999999999998 110.155 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 40.1 mt -87.75 135.94 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 116.311 -0.404 . . . . 72.329999999999998 110.39 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.5 tp -75.93 120.74 21.68 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.528 0.68 . . . . 42.140000000000001 109.387 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.53 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -82.83 -64.39 1.18 Allowed 'General case' 0 N--CA 1.383 -3.777 0 N-CA-C 108.597 -0.89 . . . . 71.120000000000005 108.597 -177.617 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.13 162.34 33.12 Favored Glycine 0 N--CA 1.421 -2.306 0 C-N-CA 118.934 -1.603 . . . . 31.219999999999999 111.986 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -108.44 146.51 33.01 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.343 -1.354 . . . . 74.219999999999999 107.343 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -64.96 116.47 6.43 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 120.882 0.373 . . . . 64.420000000000002 111.555 -175.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -94.76 -49.07 5.77 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.049 -0.523 . . . . 64.409999999999997 111.308 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 21.4 p -169.02 140.37 2.46 Favored 'General case' 0 C--O 1.252 1.22 0 N-CA-C 110.127 -0.323 . . . . 74.310000000000002 110.127 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.402 ' OE1' HD22 ' A' ' 400' ' ' LEU . 10.6 pt20 -142.39 140.55 32.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.217 0.532 . . . . 65.140000000000001 111.726 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -128.78 128.62 44.32 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 108.689 -0.856 . . . . 72.109999999999999 108.689 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 68.82 -101.53 0.8 Allowed Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 121.008 -0.615 . . . . 72.540000000000006 112.466 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 26.2 p-10 -130.49 11.8 5.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 111.981 0.363 . . . . 71.329999999999998 111.981 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 40.7 t -111.65 116.98 54.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.923 -1.14 . . . . 74.430000000000007 107.923 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.402 HD22 ' OE1' ' A' ' 395' ' ' GLN . 6.7 mt -114.83 131.45 56.82 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.553 -0.536 . . . . 65.129999999999995 109.553 -172.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -116.37 124.43 50.05 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.322 -0.992 . . . . 64.299999999999997 108.322 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.451 ' CD2' HG21 ' A' ' 382' ' ' VAL . 3.5 m-85 -114.22 136.19 53.23 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.48 -1.304 . . . . 53.350000000000001 107.48 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -144.09 176.4 9.34 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.585 -0.524 . . . . 61.0 109.585 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 62.96 36.24 12.75 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.837 0.68 . . . . 63.409999999999997 112.837 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -80.56 -141.65 2.87 Favored Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.25 -0.976 . . . . 64.209999999999994 111.243 175.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -75.34 134.83 40.92 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.097 -0.705 . . . . 74.200000000000003 109.097 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 37.8 m . . . . . 0 C--N 1.323 -0.549 0 N-CA-C 113.354 0.872 . . . . 74.099999999999994 113.354 -175.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 413' ' ' HIS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 99.8 m-70 . . . . . 0 CA--C 1.493 -1.218 0 N-CA-C 107.798 -1.186 . . . . 71.140000000000001 107.798 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -73.22 159.19 33.83 Favored 'General case' 0 C--O 1.257 1.448 0 CA-C-O 121.374 0.607 . . . . 75.140000000000001 111.604 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 33.2 p -162.18 163.56 28.31 Favored 'General case' 0 N--CA 1.406 -2.663 0 CA-C-N 114.488 -1.233 . . . . 74.329999999999998 109.121 -177.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -159.15 144.74 16.2 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.819 -0.437 . . . . 34.43 109.819 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.8 tt -109.62 125.12 66.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.099 -1.075 . . . . 72.450000000000003 108.099 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.9 t -111.09 131.19 63.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.87 -0.605 . . . . 73.230000000000004 110.895 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.84 113.8 26.65 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 106.058 -1.83 . . . . 75.0 106.058 175.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 420' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 23.6 t -101.18 112.62 34.72 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.517 0 N-CA-C 109.256 -0.646 . . . . 55.439999999999998 109.256 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -109.93 -176.25 2.95 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.745 -0.782 . . . . 75.540000000000006 110.965 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.452 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 32.4 t -60.67 128.08 34.82 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 123.568 0.747 . . . . 72.430000000000007 111.212 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.547 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -151.23 178.93 28.31 Favored Glycine 0 N--CA 1.428 -1.835 0 N-CA-C 110.086 -1.206 . . . . 74.140000000000001 110.086 177.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 41.3 t -93.8 -26.96 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.293 -1.002 . . . . 62.310000000000002 108.293 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -141.56 157.42 45.13 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 114.894 -1.048 . . . . 75.340000000000003 109.306 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -73.16 100.16 3.0 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 106.858 -1.534 . . . . 74.430000000000007 106.858 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -132.18 141.24 49.02 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 120.687 -0.405 . . . . 74.239999999999995 111.805 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.439 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 27.3 mm -83.39 118.43 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 105.767 -1.938 . . . . 74.040000000000006 105.767 174.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 55.1 t -83.17 -50.65 15.39 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-O 121.042 0.449 . . . . 73.230000000000004 111.651 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 37.4 p -161.23 159.49 28.79 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.197 -0.456 . . . . 52.439999999999998 110.5 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.488 HG12 HG21 ' A' ' 369' ' ' ILE . 3.3 p -142.15 122.86 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 108.829 -0.804 . . . . 52.049999999999997 108.829 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 432' ' ' LEU . . . . . 0.473 ' O ' HD23 ' A' ' 440' ' ' LEU . 30.2 tp -131.0 137.54 49.27 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.8 -1.185 . . . . 74.329999999999998 107.8 -177.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -81.45 116.97 21.5 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.578 -0.849 . . . . 64.120000000000005 108.789 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.31 -63.97 1.12 Allowed 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.392 -0.822 . . . . 74.329999999999998 110.722 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -106.23 -76.24 0.61 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.75 -0.659 . . . . 74.209999999999994 111.821 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -162.8 -30.35 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.048 0.452 . . . . 72.129999999999995 112.172 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 86.2 m -131.16 11.65 5.04 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.576 -0.898 . . . . 74.129999999999995 108.576 176.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 415' ' ' SER . 34.8 tt0 -131.79 129.62 40.76 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.119 -0.946 . . . . 54.009999999999998 108.985 -176.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -117.91 150.41 39.26 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.682 -0.69 . . . . 74.200000000000003 110.906 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.6 pt? -106.4 120.9 43.1 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.598 -1.26 . . . . 61.149999999999999 107.598 172.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.7 mt -124.14 128.7 74.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-N 115.41 -0.814 . . . . 71.430000000000007 109.746 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -104.27 140.69 37.5 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.873 -0.788 . . . . 74.420000000000002 108.873 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.439 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.3 mtp -135.08 167.47 20.9 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 109.409 -0.589 . . . . 70.540000000000006 109.409 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.547 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 72.1 mmtt -133.24 156.28 47.83 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.299 -1.371 . . . . 73.150000000000006 107.299 174.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 38.3 t -163.77 145.44 7.31 Favored Pre-proline 0 C--N 1.278 -2.542 0 O-C-N 124.075 0.86 . . . . 60.420000000000002 109.11 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.4 -21.38 47.14 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.111 1.874 . . . . 42.32 110.646 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.12 -18.58 52.99 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.803 -0.635 . . . . 71.450000000000003 110.982 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.798 0 CA-C-O 121.376 0.608 . . . . 72.430000000000007 109.857 179.02 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 97.0 m . . . . . 0 N--CA 1.425 -1.724 0 N-CA-C 107.477 -1.305 . . . . 64.140000000000001 107.477 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 366' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 57.7 mtpt -133.32 143.54 49.08 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 116.239 -0.437 . . . . 61.340000000000003 110.529 -174.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.488 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 1.9 tmt_? -157.95 136.85 11.45 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.057 -1.09 . . . . 53.219999999999999 108.057 -177.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 368' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 40.5 mt-10 -87.98 127.18 35.38 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.713 0.292 . . . . 75.239999999999995 110.233 -174.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 369' ' ' ILE . . . . . 0.554 HG21 HG12 ' A' ' 431' ' ' VAL . 38.0 mt -136.96 120.76 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 106.793 -1.558 . . . . 62.109999999999999 106.793 -176.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.26 13.71 60.62 Favored Glycine 0 C--N 1.304 -1.21 0 C-N-CA 120.358 -0.925 . . . . 45.340000000000003 113.137 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.09 -17.73 40.7 Favored Glycine 0 N--CA 1.429 -1.832 0 C-N-CA 121.084 -0.579 . . . . 73.049999999999997 113.107 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -106.87 139.72 40.84 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 120.683 0.278 . . . . 64.5 110.333 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 373' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 37.4 m -83.83 122.01 28.11 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 116.259 -0.428 . . . . 61.200000000000003 110.166 -178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 374' ' ' TYR . . . . . 0.625 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.54 129.07 36.73 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 109.301 -0.629 . . . . 73.409999999999997 109.301 176.615 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 375' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 83.9 tttt -122.48 125.23 45.36 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 123.887 0.742 . . . . 54.229999999999997 110.108 -175.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 376' ' ' VAL . . . . . 0.449 HG12 HD11 ' A' ' 428' ' ' ILE . 7.2 p -128.24 118.22 47.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 N-CA-C 109.161 -0.681 . . . . 70.510000000000005 109.161 175.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 40.8 t -106.73 116.5 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 106.116 -1.809 . . . . 74.319999999999993 106.116 174.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -58.9 123.06 15.22 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 123.807 0.692 . . . . 74.209999999999994 112.503 -174.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 72.98 12.23 5.11 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.587 1.555 . . . . 73.549999999999997 113.385 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -123.24 -86.84 0.64 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 113.848 1.055 . . . . 70.409999999999997 113.848 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.54 169.05 20.41 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 119.392 -0.923 . . . . 73.120000000000005 110.322 -176.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 94.9 t -124.95 138.78 53.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 107.643 -1.243 . . . . 65.439999999999998 107.643 173.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -132.91 148.1 52.29 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.143 0.497 . . . . 73.219999999999999 110.785 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' GLN . . . . . 0.5 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.8 tt0 -115.28 100.07 7.86 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.387 -1.709 . . . . 63.409999999999997 106.387 173.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 13.4 t70 69.89 -78.37 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 125.248 1.419 . . . . 61.450000000000003 110.019 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 27.4 m -138.01 -5.69 1.67 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.082 -0.963 . . . . 62.509999999999998 109.287 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 47.8 mm -88.39 135.63 25.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.188 -0.46 . . . . 75.409999999999997 110.016 -177.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 62.9 tp -76.23 115.1 15.63 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.995 -1.113 . . . . 71.230000000000004 107.995 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 389' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.6 OUTLIER -80.21 -60.52 2.3 Favored 'General case' 0 N--CA 1.388 -3.539 0 N-CA-C 108.762 -0.829 . . . . 72.129999999999995 108.762 -175.684 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.97 158.59 29.88 Favored Glycine 0 N--CA 1.413 -2.892 0 C-N-CA 119.295 -1.431 . . . . 44.0 111.417 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -102.24 143.97 31.36 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.659 -1.608 . . . . 74.150000000000006 106.659 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -69.27 116.82 10.14 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.013 0.435 . . . . 71.030000000000001 110.737 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.11 -47.56 5.45 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.772 -0.649 . . . . 75.349999999999994 110.962 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 65.9 p -168.47 143.67 3.49 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.898 -0.408 . . . . 75.140000000000001 109.898 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' GLN . . . . . 0.475 ' OE1' HD22 ' A' ' 400' ' ' LEU . 10.1 pt20 -143.08 136.98 28.85 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.743 0.306 . . . . 74.0 110.503 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -112.52 119.93 39.88 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.518 -0.919 . . . . 65.25 108.518 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.11 -101.67 0.63 Allowed Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 119.651 -1.262 . . . . 33.119999999999997 113.178 177.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -123.66 10.68 9.07 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.799 1.24 . . . . 64.319999999999993 111.132 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.34 116.69 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.015 0 N-CA-C 106.85 -1.537 . . . . 64.439999999999998 106.85 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 400' ' ' LEU . . . . . 0.475 HD22 ' OE1' ' A' ' 395' ' ' GLN . 9.3 mt -113.61 131.61 56.05 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 115.966 -0.561 . . . . 74.019999999999996 110.962 -168.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -114.27 121.76 44.68 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-O 121.392 0.615 . . . . 72.329999999999998 112.349 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.415 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.3 m-85 -118.25 139.02 51.95 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.537 -1.282 . . . . 75.420000000000002 107.537 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -141.46 173.42 11.51 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-O 121.466 0.65 . . . . 61.020000000000003 111.45 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 51.1 46.59 26.22 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.095 -1.866 . . . . 72.519999999999996 113.16 167.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.22 -132.98 0.57 Allowed Glycine 0 C--N 1.311 -0.831 0 CA-C-N 115.839 -0.618 . . . . 61.420000000000002 112.708 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.56 142.64 38.89 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.108 -1.442 . . . . 73.140000000000001 107.108 -176.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 407' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 27.4 t . . . . . 0 N--CA 1.431 -1.375 0 CA-C-O 121.806 0.812 . . . . 73.230000000000004 111.097 -178.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 413' ' ' HIS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 97.1 m-70 . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 108.782 -0.822 . . . . 75.010000000000005 108.782 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -74.33 160.53 30.94 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.34 0.59 . . . . 74.239999999999995 111.383 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 415' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 35.5 p -165.57 162.35 19.02 Favored 'General case' 0 N--CA 1.418 -2.058 0 C-N-CA 124.366 1.066 . . . . 74.329999999999998 108.246 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -158.74 151.11 21.6 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.303 0.573 . . . . 74.209999999999994 110.8 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 11.6 tt -114.37 131.11 67.37 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 CA-C-N 115.131 -0.94 . . . . 61.340000000000003 108.828 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 4.1 t -116.72 131.04 70.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-O 121.329 0.585 . . . . 74.340000000000003 111.926 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 62.2 p -108.02 114.97 29.27 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 107.641 -1.244 . . . . 54.130000000000003 107.641 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 39.6 t -100.19 111.87 31.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 107.545 -1.279 . . . . 62.549999999999997 107.545 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -113.52 -175.14 2.61 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 110.787 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 422' ' ' CYS . . . . . 0.425 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 43.6 t -60.42 128.66 37.76 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.815 -0.629 . . . . 72.120000000000005 111.224 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 423' ' ' GLY . . . . . 0.604 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -154.36 178.59 31.09 Favored Glycine 0 CA--C 1.476 -2.377 0 N-CA-C 110.479 -1.048 . . . . 52.539999999999999 110.479 177.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 56.0 t -90.41 -33.79 6.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 108.282 -1.007 . . . . 61.100000000000001 108.282 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -150.66 152.66 34.32 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.698 -0.683 . . . . 73.010000000000005 109.768 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.3 p-10 -60.1 98.83 0.06 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.597 -1.183 . . . . 55.210000000000001 112.427 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -133.08 146.85 52.04 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.038 -0.528 . . . . 63.439999999999998 111.783 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 367' ' ' ARG . 31.3 mm -80.17 119.87 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 105.449 -2.056 . . . . 52.530000000000001 105.449 171.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 54.6 t -84.55 -51.16 14.2 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.867 0 N-CA-C 112.112 0.412 . . . . 52.109999999999999 112.112 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 430' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 32.6 p -160.86 162.71 32.25 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.814 -0.354 . . . . 62.329999999999998 110.837 -174.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 431' ' ' VAL . . . . . 0.554 HG12 HG21 ' A' ' 369' ' ' ILE . 4.8 p -142.12 111.87 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 108.966 -0.753 . . . . 73.329999999999998 108.966 176.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 432' ' ' LEU . . . . . 0.409 ' O ' HD23 ' A' ' 440' ' ' LEU . 34.9 tp -113.97 136.45 52.89 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 108.765 -0.828 . . . . 54.539999999999999 108.765 -177.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.66 113.8 19.91 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.837 -0.801 . . . . 70.519999999999996 108.837 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.14 -70.42 0.39 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.294 -0.632 . . . . 43.409999999999997 109.294 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -100.0 -75.83 0.56 Allowed 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.551 -0.75 . . . . 75.310000000000002 109.966 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.1 -51.07 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.461 0.648 . . . . 73.25 110.437 175.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 64.3 m -100.52 13.19 35.44 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.204 -0.907 . . . . 72.5 109.019 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 438' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 415' ' ' SER . 33.4 tt0 -135.22 124.85 25.16 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-N 115.185 -0.916 . . . . 61.350000000000001 108.873 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -123.01 150.18 43.37 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.142 -0.936 . . . . 75.230000000000004 109.567 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' LEU . . . . . 0.445 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.4 pt? -109.22 121.37 45.02 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.252 -1.018 . . . . 63.109999999999999 108.252 173.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 441' ' ' ILE . . . . . 0.558 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 97.1 mt -118.08 135.25 59.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.211 -0.904 . . . . 65.109999999999999 110.012 -175.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -109.26 141.42 41.57 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 109.5 -0.556 . . . . 64.420000000000002 109.5 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' MET . . . . . 0.43 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.1 mtp -136.38 162.81 32.01 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 108.995 -0.743 . . . . 75.219999999999999 108.995 178.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 444' ' ' LYS . . . . . 0.604 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 70.1 mmtt -132.87 151.49 52.02 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.164 -1.05 . . . . 63.439999999999998 108.164 176.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 68.1 m -161.24 149.15 12.44 Favored Pre-proline 0 C--N 1.295 -1.792 0 O-C-N 123.865 0.728 . . . . 70.239999999999995 109.945 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.44 -27.76 62.48 Favored 'Trans proline' 0 N--CA 1.48 0.695 0 C-N-CA 122.724 2.283 . . . . 74.420000000000002 111.95 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.58 -22.25 57.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.6 -0.727 . . . . 74.319999999999993 110.643 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.857 0 CA-C-N 115.528 -0.76 . . . . 65.049999999999997 111.049 -175.461 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 398' ' ' ASN . 89.6 m-85 . . . . . 0 C--O 1.223 -0.312 0 N-CA-C 110.31 -0.255 . . . . 75.049999999999997 110.31 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.405 ' HD2' ' C ' ' A' ' 357' ' ' TYR . 6.4 mpt_? -134.76 173.84 11.24 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.87 -0.418 . . . . 64.120000000000005 109.87 176.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -135.84 151.75 50.36 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.877 -1.527 . . . . 73.230000000000004 106.877 174.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' ILE . . . . . 0.616 HG21 ' SD ' ' A' ' 363' ' ' MET . 25.2 mm -81.19 115.76 24.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 119.923 -0.711 . . . . 75.230000000000004 109.75 -172.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.684 ' HD3' ' H ' ' A' ' 361' ' ' LYS . 0.3 OUTLIER -79.77 141.26 36.47 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 112.466 0.543 . . . . 71.030000000000001 112.466 -176.219 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 94.41 -27.54 13.44 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.471 -0.786 . . . . 61.310000000000002 113.575 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' MET . . . . . 0.616 ' SD ' HG21 ' A' ' 360' ' ' ILE . 72.6 mtp -74.79 146.89 41.72 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.744 1.016 . . . . 72.540000000000006 113.744 -177.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -93.5 126.29 38.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.493 -1.231 . . . . 74.040000000000006 107.77 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.468 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 90.7 m -117.53 125.58 51.1 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 107.302 -1.369 . . . . 63.43 107.302 173.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 17.1 ptmt -139.16 141.18 38.02 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 121.099 -0.24 . . . . 60.32 110.913 -174.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.413 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 3.6 tmt_? -156.94 138.4 13.94 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.276 -1.379 . . . . 61.420000000000002 107.276 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -86.42 126.84 34.67 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.141 -0.689 . . . . 73.120000000000005 109.141 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.51 HG21 HG12 ' A' ' 431' ' ' VAL . 39.8 mt -137.17 124.6 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 106.654 -1.609 . . . . 73.409999999999997 106.654 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.58 8.47 46.58 Favored Glycine 0 C--N 1.301 -1.393 0 C-N-CA 120.91 -0.662 . . . . 73.540000000000006 113.233 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.09 -14.74 44.24 Favored Glycine 0 N--CA 1.426 -1.978 0 C-N-CA 120.702 -0.761 . . . . 62.140000000000001 112.684 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' TYR . . . . . 0.423 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 17.3 p90 -106.39 141.4 37.78 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 120.839 0.352 . . . . 74.120000000000005 110.134 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 51.3 m -83.52 120.24 25.69 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 116.18 -0.463 . . . . 73.420000000000002 109.895 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.6 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.66 134.21 34.57 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 108.612 -0.885 . . . . 75.310000000000002 108.612 174.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -133.41 125.01 28.15 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.104 -0.702 . . . . 72.549999999999997 109.104 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.51 HG23 HG22 ' A' ' 382' ' ' VAL . 7.6 p -121.05 122.54 67.89 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 N-CA-C 109.197 -0.668 . . . . 70.310000000000002 109.197 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.4 t -110.53 116.71 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 106.902 -1.518 . . . . 73.019999999999996 106.902 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -62.92 126.56 27.74 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.119 1.155 . . . . 75.230000000000004 114.119 -172.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 72.85 8.51 5.5 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.173 1.789 . . . . 72.400000000000006 113.276 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -116.68 -85.56 0.63 Allowed 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 112.969 0.729 . . . . 75.0 112.969 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.406 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.5 OUTLIER -162.32 162.75 28.11 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.875 -0.602 . . . . 74.129999999999995 112.254 -171.336 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.51 HG22 HG23 ' A' ' 376' ' ' VAL . 66.5 t -122.58 144.86 30.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.049 -0.978 . . . . 73.329999999999998 109.585 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.406 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 62.8 m-85 -133.94 148.33 51.17 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 123.094 0.558 . . . . 72.430000000000007 111.595 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.46 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.9 tt0 -119.47 103.51 9.51 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.818 -1.919 . . . . 63.219999999999999 105.818 173.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.5 t70 69.15 -86.44 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 123.962 0.905 . . . . 75.120000000000005 109.587 -175.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.6 m -135.37 -2.66 2.46 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.935 -0.765 . . . . 65.010000000000005 108.935 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 62.8 mt -83.13 132.66 30.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.93 -0.577 . . . . 74.239999999999995 109.781 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.2 tp -76.66 115.54 16.51 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.6 -0.889 . . . . 72.319999999999993 108.6 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.536 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -79.69 -66.09 0.92 Allowed 'General case' 0 N--CA 1.39 -3.455 0 N-CA-C 108.934 -0.765 . . . . 74.099999999999994 108.934 -177.229 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.77 160.15 31.65 Favored Glycine 0 N--CA 1.413 -2.836 0 C-N-CA 118.925 -1.607 . . . . 54.350000000000001 111.604 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -104.36 145.28 30.49 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.362 -1.347 . . . . 75.230000000000004 107.362 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -66.6 116.66 7.78 Favored 'General case' 0 C--N 1.288 -2.088 0 O-C-N 123.351 0.407 . . . . 75.239999999999995 110.774 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -101.93 -48.11 4.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.107 -0.497 . . . . 75.420000000000002 111.227 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 51.3 m -159.5 141.42 13.31 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.945 -0.391 . . . . 74.430000000000007 109.945 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.407 ' HB2' ' CD2' ' A' ' 400' ' ' LEU . 9.9 pt20 -144.37 140.47 29.08 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 120.97 0.414 . . . . 74.129999999999995 111.888 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -128.05 119.43 25.39 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.493 -0.776 . . . . 75.329999999999998 110.416 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 74.72 -101.28 1.28 Allowed Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 115.681 -0.691 . . . . 75.230000000000004 111.736 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' ASN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 357' ' ' TYR . 4.4 p-10 -131.79 15.96 4.79 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.401 0.619 . . . . 73.310000000000002 110.071 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 419' ' ' THR . 46.9 t -116.71 119.15 61.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 106.874 -1.528 . . . . 75.310000000000002 106.874 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.407 ' CD2' ' HB2' ' A' ' 395' ' ' GLN . 9.9 mt -118.04 130.74 56.35 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 116.207 -0.451 . . . . 52.509999999999998 110.808 -170.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.457 ' HE3' HD12 ' A' ' 417' ' ' ILE . 22.6 mmtp -105.02 122.99 47.02 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 112.275 0.472 . . . . 73.430000000000007 112.275 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.435 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.2 m-85 -118.84 132.92 56.13 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.887 -1.153 . . . . 75.319999999999993 107.887 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -147.19 177.58 9.07 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 122.582 0.353 . . . . 72.409999999999997 110.179 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 66.67 36.63 4.66 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.605 0.566 . . . . 73.140000000000001 111.226 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -79.88 -138.07 1.78 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 120.582 -0.818 . . . . 73.209999999999994 112.824 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -81.22 143.18 32.5 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.638 -0.505 . . . . 55.219999999999999 109.638 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.7 m -60.68 128.47 36.73 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.82 1.044 . . . . 73.239999999999995 113.82 -176.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 19.4 p -132.18 159.07 40.07 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.827 -1.175 . . . . 53.32 107.827 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -85.81 147.51 26.27 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 118.03 0.377 . . . . 71.439999999999998 111.519 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 77.43 9.83 2.48 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.737 1.615 . . . . 71.200000000000003 109.914 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -152.51 166.0 31.1 Favored Glycine 0 N--CA 1.419 -2.469 0 N-CA-C 106.312 -2.715 . . . . 52.43 106.312 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.98 -40.52 0.22 Allowed 'Trans proline' 0 C--N 1.322 -0.847 0 CA-C-N 120.56 2.18 . . . . 73.549999999999997 111.409 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -163.82 165.4 22.98 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 105.681 -1.97 . . . . 52.009999999999998 105.681 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -63.77 160.49 17.12 Favored 'General case' 0 C--O 1.254 1.313 0 CA-C-O 121.467 0.651 . . . . 75.0 112.662 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.633 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 46.7 t -161.13 159.66 29.31 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 114.539 -1.209 . . . . 74.129999999999995 107.814 -176.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -159.78 149.93 18.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 120.852 0.358 . . . . 64.230000000000004 110.127 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' ILE . . . . . 0.457 HD12 ' HE3' ' A' ' 401' ' ' LYS . 8.8 tt -110.63 123.8 66.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.737 -1.208 . . . . 62.210000000000001 107.737 173.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.3 t -106.28 126.25 61.92 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 CA-C-O 121.164 0.507 . . . . 51.409999999999997 109.924 176.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.454 HG23 HG22 ' A' ' 399' ' ' VAL . 3.6 m -108.64 112.95 25.56 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 105.819 -1.919 . . . . 54.210000000000001 105.819 176.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 40.6 t -100.8 112.0 32.26 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.94 0 N-CA-C 107.101 -1.444 . . . . 74.129999999999995 107.101 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -110.9 -175.37 2.7 Favored 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 120.228 -0.589 . . . . 75.209999999999994 111.4 -175.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.48 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 38.9 t -59.92 128.01 34.76 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 123.503 0.721 . . . . 73.150000000000006 110.46 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -158.76 -176.93 31.36 Favored Glycine 0 CA--C 1.492 -1.385 0 N-CA-C 110.964 -0.855 . . . . 74.129999999999995 110.964 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 42.3 t -94.38 -31.29 4.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-O 121.225 0.536 . . . . 53.450000000000003 109.615 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.84 161.09 40.77 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 116.002 -0.545 . . . . 63.340000000000003 109.559 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.531 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.1 p-10 -73.03 98.58 2.55 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 124.311 1.007 . . . . 72.450000000000003 110.398 175.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -132.44 148.22 52.4 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.912 -0.586 . . . . 74.109999999999999 110.754 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.475 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 28.2 mm -84.36 124.03 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.963 -1.866 . . . . 74.430000000000007 105.963 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.435 HG11 ' HE3' ' A' ' 442' ' ' LYS . 51.9 t -92.55 -47.99 13.7 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 112.888 0.699 . . . . 73.019999999999996 112.888 -175.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 430' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 42.9 m -158.67 155.64 28.49 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.735 -0.469 . . . . 54.030000000000001 109.735 -173.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.51 HG12 HG21 ' A' ' 369' ' ' ILE . 3.2 p -141.3 111.9 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 108.672 -0.862 . . . . 63.009999999999998 108.672 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' LEU . . . . . 0.411 ' O ' HD23 ' A' ' 440' ' ' LEU . 32.0 tp -117.71 137.74 52.48 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 114.96 -1.018 . . . . 71.430000000000007 108.507 -175.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -80.58 112.59 18.08 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.962 -0.755 . . . . 73.439999999999998 108.962 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -73.75 -49.79 23.78 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 115.54 -0.755 . . . . 65.319999999999993 110.216 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -126.14 -76.2 0.58 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.166 -0.924 . . . . 75.219999999999999 108.993 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.95 -41.31 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 121.043 0.449 . . . . 71.340000000000003 110.787 173.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 98.6 m -96.84 -16.88 20.54 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.324 0.583 . . . . 72.329999999999998 110.114 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 415' ' ' SER . 37.3 tt0 -112.72 132.31 55.27 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.979 -1.01 . . . . 71.340000000000003 109.691 -177.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -125.68 150.16 47.87 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.543 -0.753 . . . . 72.150000000000006 109.273 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.5 pt? -105.47 117.16 33.32 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.566 -0.901 . . . . 75.200000000000003 108.566 173.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.6 mt -114.91 132.25 64.7 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 115.093 -0.958 . . . . 73.219999999999999 109.628 -176.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.435 ' HE3' HG11 ' A' ' 429' ' ' VAL . 36.6 ttpt -109.31 140.16 43.34 Favored 'General case' 0 N--CA 1.408 -2.53 0 N-CA-C 108.51 -0.922 . . . . 72.109999999999999 108.51 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.475 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 77.0 mtp -138.08 168.41 19.78 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 108.484 -0.932 . . . . 74.549999999999997 108.484 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.61 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 71.7 mmtt -134.5 156.45 48.59 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.292 -1.003 . . . . 53.030000000000001 108.292 175.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 74.3 m -162.95 147.32 9.08 Favored Pre-proline 0 C--N 1.289 -2.04 0 C-N-CA 124.291 1.036 . . . . 73.430000000000007 109.394 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -66.14 -27.25 49.31 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.324 2.016 . . . . 71.019999999999996 111.757 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -78.72 -15.6 58.25 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.748 -0.66 . . . . 74.019999999999996 110.79 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -93.21 10.3 32.43 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.68 0.752 . . . . 72.200000000000003 109.913 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 7.9 t -106.6 119.67 39.91 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 106.359 -1.719 . . . . 50.439999999999998 106.359 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 26.9 t . . . . . 0 CA--C 1.553 1.06 0 O-C-N 123.991 0.807 . . . . 62.450000000000003 109.794 -176.227 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 54.6 p90 . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 120.688 0.28 . . . . 72.219999999999999 111.041 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.415 ' HA ' ' NE ' ' A' ' 358' ' ' ARG . 3.4 mmp_? -125.94 177.25 6.44 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.848 0.832 . . . . 73.310000000000002 112.29 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -143.98 151.57 39.92 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 104.057 -2.571 . . . . 54.43 104.057 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 360' ' ' ILE . 1.8 mp -81.14 115.63 24.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 119.445 1.02 . . . . 72.109999999999999 110.256 -172.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.539 ' HA ' ' HB2' ' A' ' 378' ' ' PHE . 21.0 pttp -90.96 151.69 20.99 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.16 -1.382 . . . . 74.319999999999993 112.764 -172.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 79.74 -24.11 3.38 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 115.702 -0.681 . . . . 62.219999999999999 113.137 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 56.9 ttp -73.56 -29.27 62.32 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 123.143 0.577 . . . . 74.340000000000003 110.225 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.547 ' HG2' HG22 ' A' ' 377' ' ' VAL . 42.0 mt-10 70.72 146.97 0.07 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.145 1.378 . . . . 71.129999999999995 109.783 -176.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.493 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 95.7 m -124.59 120.92 33.3 Favored 'General case' 0 C--N 1.265 -3.083 0 N-CA-C 107.711 -1.218 . . . . 74.120000000000005 107.711 171.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 0.0 OUTLIER -136.26 141.51 43.9 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.963 -0.695 . . . . 74.299999999999997 110.404 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -159.71 140.34 12.18 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.518 0.511 . . . . 72.209999999999994 110.313 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -76.34 123.92 26.7 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 110.115 -0.328 . . . . 64.439999999999998 110.115 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.46 HG21 HG12 ' A' ' 431' ' ' VAL . 48.6 mt -129.52 117.52 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 N-CA-C 106.194 -1.78 . . . . 72.409999999999997 106.194 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.73 14.01 62.14 Favored Glycine 0 C--N 1.304 -1.219 0 C-N-CA 120.781 -0.723 . . . . 53.509999999999998 112.244 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.1 -22.05 32.22 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 121.279 -0.486 . . . . 62.340000000000003 112.981 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -98.35 135.83 39.38 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 120.916 0.389 . . . . 71.230000000000004 111.204 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 85.4 m -79.86 114.54 18.85 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.765 -0.652 . . . . 73.409999999999997 110.224 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -91.46 132.92 35.91 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 108.563 -0.903 . . . . 72.340000000000003 108.563 176.344 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.534 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 37.6 ttpt -132.01 132.31 43.31 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 120.273 -0.571 . . . . 72.349999999999994 110.594 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.493 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.0 p -122.65 118.42 55.05 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 CA-C-N 115.844 -0.616 . . . . 71.329999999999998 110.076 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.547 HG22 ' HG2' ' A' ' 364' ' ' GLU . 21.6 t -107.54 116.02 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 106.768 -1.568 . . . . 65.150000000000006 106.768 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.539 ' HB2' ' HA ' ' A' ' 361' ' ' LYS . 98.0 m-85 -64.18 132.56 50.74 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 113.522 0.934 . . . . 73.310000000000002 113.522 -173.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 65.18 23.66 12.31 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.053 -1.431 . . . . 75.510000000000005 112.286 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -136.49 -83.46 0.37 Allowed 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.505 -0.77 . . . . 71.310000000000002 112.914 176.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -165.81 160.03 16.65 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.569 0.951 . . . . 63.130000000000003 113.569 -173.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.476 HG22 HG23 ' A' ' 376' ' ' VAL . 95.9 t -116.21 146.3 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.595 1.158 . . . . 51.020000000000003 109.521 -178.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -134.83 152.36 51.69 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.316 0.646 . . . . 71.510000000000005 111.646 -178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.481 ' HB2' HD23 ' A' ' 389' ' ' LEU . 29.1 tt0 -127.63 106.68 9.32 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.337 -1.727 . . . . 70.450000000000003 106.337 171.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.5 t70 69.44 -83.35 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 124.175 0.99 . . . . 54.130000000000003 110.52 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 45.5 m -135.85 -5.49 2.18 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.961 -0.755 . . . . 44.140000000000001 108.961 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 49.7 mm -89.21 132.63 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.497 -0.774 . . . . 62.039999999999999 110.565 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 57.7 tp -76.41 116.12 16.8 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.309 -0.997 . . . . 62.439999999999998 108.309 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.2 OUTLIER -79.44 -62.63 1.63 Allowed 'General case' 0 N--CA 1.393 -3.287 0 N-CA-C 109.03 -0.73 . . . . 64.140000000000001 109.03 -176.535 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.56 160.87 32.23 Favored Glycine 0 N--CA 1.42 -2.422 0 C-N-CA 119.335 -1.412 . . . . 35.100000000000001 111.903 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -104.73 151.31 23.89 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.662 -1.236 . . . . 64.519999999999996 107.662 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.411 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.8 m-85 -70.41 116.75 11.11 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 121.341 0.591 . . . . 64.120000000000005 111.876 -176.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -95.81 -47.18 6.27 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.318 -0.855 . . . . 62.409999999999997 110.541 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 38.3 t -164.95 139.27 5.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.461 -0.57 . . . . 64.109999999999999 109.461 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.534 ' CB ' ' HG ' ' A' ' 400' ' ' LEU . 5.7 pm0 -141.98 129.71 21.62 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.556 -0.747 . . . . 73.319999999999993 110.621 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -128.37 127.07 41.94 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.294 -1.002 . . . . 74.129999999999995 108.294 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.93 -117.79 9.65 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.986 -0.625 . . . . 73.010000000000005 112.011 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -116.63 20.3 14.12 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.357 0.598 . . . . 73.239999999999995 110.773 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 67.4 t -124.91 128.88 73.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.45 -0.944 . . . . 75.409999999999997 108.45 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.534 ' HG ' ' CB ' ' A' ' 395' ' ' GLN . 3.9 mp -126.51 140.39 52.49 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 116.455 -0.339 . . . . 72.209999999999994 111.099 -175.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -116.68 124.88 50.78 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.132 0.573 . . . . 74.219999999999999 111.133 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.411 ' CD2' HG21 ' A' ' 382' ' ' VAL . 3.8 m-85 -118.16 136.19 53.77 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.061 -0.718 . . . . 73.319999999999993 109.061 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.25 178.03 8.91 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 122.654 0.382 . . . . 74.530000000000001 110.653 178.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.2 m120 66.58 33.61 6.46 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.079 0.552 . . . . 51.210000000000001 111.684 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.15 -130.4 0.44 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 120.424 -0.893 . . . . 64.099999999999994 113.051 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.78 147.53 30.45 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.402 -1.703 . . . . 65.230000000000004 106.402 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 407' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 50.8 m -60.18 137.8 58.04 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.839 0.828 . . . . 41.030000000000001 112.806 -175.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 45.5 t -107.62 157.98 17.63 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.633 -1.988 . . . . 73.030000000000001 105.633 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' TRP . . . . . 0.453 ' CE2' ' HB3' ' A' ' 410' ' ' ASN . 7.6 p-90 -76.42 -51.27 12.16 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 118.866 -1.133 . . . . 73.109999999999999 112.112 -172.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' ASN . . . . . 0.616 ' OD1' ' HG3' ' A' ' 436' ' ' LYS . 9.3 p30 -92.69 -3.96 54.0 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.261 0.553 . . . . 63.520000000000003 111.071 -174.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -124.82 -174.41 13.99 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 108.919 -1.672 . . . . 54.439999999999998 108.919 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -84.11 -41.49 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.249 0 CA-C-N 120.275 2.038 . . . . 61.450000000000003 112.417 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' HIS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 94.8 m-70 -160.97 170.68 20.09 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.358 -0.979 . . . . 74.030000000000001 108.358 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -76.7 165.08 25.24 Favored 'General case' 0 C--O 1.251 1.157 0 O-C-N 123.597 0.561 . . . . 45.439999999999998 111.5 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 22.9 p -161.79 165.3 28.09 Favored 'General case' 0 N--CA 1.411 -2.397 0 CA-C-N 114.548 -1.205 . . . . 72.239999999999995 109.235 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -159.54 151.05 20.08 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.422 0.629 . . . . 72.099999999999994 110.546 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.4 tt -114.37 131.56 66.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-N 115.333 -0.848 . . . . 74.430000000000007 109.102 173.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.454 HG22 ' HB ' ' A' ' 441' ' ' ILE . 4.7 t -119.96 125.71 74.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-O 121.335 0.588 . . . . 73.329999999999998 110.97 177.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 21.3 p -109.77 114.59 28.3 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.091 -0.959 . . . . 73.239999999999995 108.952 174.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 37.5 t -100.48 112.48 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 108.284 -1.006 . . . . 61.140000000000001 108.284 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -110.53 -174.6 2.52 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 116.566 -0.288 . . . . 70.239999999999995 110.571 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.547 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 30.4 t -57.36 128.33 36.49 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.626 0.771 . . . . 73.129999999999995 111.678 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.692 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -154.94 -177.62 28.42 Favored Glycine 0 CA--C 1.478 -2.233 0 C-N-CA 120.467 -0.873 . . . . 72.150000000000006 111.806 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.0 t -87.34 -36.01 9.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.64 -0.874 . . . . 75.129999999999995 108.64 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -157.62 162.17 38.69 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.566 -0.901 . . . . 74.040000000000006 108.566 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 3.9 m120 -61.77 102.36 0.26 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.485 0.659 . . . . 63.409999999999997 111.41 173.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -131.9 148.28 52.53 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.938 -1.028 . . . . 71.230000000000004 109.687 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 27.0 mm -89.05 114.83 27.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 105.87 -1.9 . . . . 72.310000000000002 105.87 175.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 53.0 t -83.02 -51.27 14.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 CA-C-N 116.112 -0.494 . . . . 63.530000000000001 112.217 -174.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 49.2 m -155.36 154.45 32.03 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.7 -0.481 . . . . 64.530000000000001 109.7 -174.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.46 HG12 HG21 ' A' ' 369' ' ' ILE . 5.6 p -141.8 122.83 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 109.079 -0.711 . . . . 52.240000000000002 109.079 175.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 432' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 440' ' ' LEU . 29.4 tp -131.25 136.81 48.53 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 107.385 -1.339 . . . . 73.299999999999997 107.385 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -83.56 122.14 28.16 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.977 -1.49 . . . . 75.400000000000006 106.977 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.518 ' HB2' HD22 ' A' ' 440' ' ' LEU . . . -82.92 -49.83 9.22 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.81 1.041 . . . . 74.129999999999995 113.81 -173.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -116.23 -70.26 0.81 Allowed 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.064 -0.654 . . . . 71.5 110.616 -170.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.616 ' HG3' ' OD1' ' A' ' 410' ' ' ASN . 0.0 OUTLIER -172.99 -24.27 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 125.058 1.343 . . . . 70.120000000000005 109.359 178.371 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 437' ' ' CYS . . . . . 0.419 ' H ' ' H ' ' A' ' 436' ' ' LYS . 29.9 m -135.59 13.23 3.46 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.733 -0.84 . . . . 64.530000000000001 108.733 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 415' ' ' SER . 24.2 tt0 -136.68 119.22 15.91 Favored 'General case' 0 C--O 1.204 -1.317 0 N-CA-C 112.481 0.549 . . . . 63.329999999999998 112.481 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 439' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 26.9 m-85 -104.12 146.45 28.72 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.944 -0.571 . . . . 72.049999999999997 110.953 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 434' ' ' ALA . 1.5 pt? -108.53 120.24 41.85 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.252 -1.018 . . . . 72.129999999999995 108.252 172.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.454 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.6 mt -120.01 131.55 72.09 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 115.259 -0.882 . . . . 74.299999999999997 110.793 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -98.56 138.32 35.93 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 108.5 -0.926 . . . . 65.120000000000005 108.5 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.419 ' SD ' HG11 ' A' ' 376' ' ' VAL . 80.7 mtp -138.79 164.67 29.01 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 109.988 -0.375 . . . . 74.439999999999998 109.988 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.692 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 32.7 mmtp -133.24 160.56 36.92 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.497 -0.557 . . . . 45.310000000000002 109.497 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' SER . . . . . 0.465 ' HB2' ' ND2' ' A' ' 426' ' ' ASN . 42.7 t -163.75 142.08 6.04 Favored Pre-proline 0 C--N 1.304 -1.394 0 O-C-N 124.036 0.835 . . . . 62.509999999999998 109.041 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -68.16 -26.19 36.59 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 121.973 1.782 . . . . 51.210000000000001 109.676 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.8 -7.55 58.74 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.922 -1.035 . . . . 61.229999999999997 110.652 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -108.35 12.71 26.16 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.311 0.577 . . . . 71.439999999999998 109.636 176.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' CYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 422' ' ' CYS . 37.1 t -102.02 120.58 40.64 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-O 121.357 0.598 . . . . 72.109999999999999 111.757 -174.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 106.74 -1.578 . . . . 62.439999999999998 106.74 175.502 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' A' ' 398' ' ' ASN . 71.9 m-85 . . . . . 0 CA--C 1.512 -0.512 0 N-CA-C 110.451 -0.203 . . . . 74.400000000000006 110.451 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -138.94 179.01 6.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.185 0.517 . . . . 75.519999999999996 111.397 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -143.3 153.17 42.49 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.24 -1.393 . . . . 64.409999999999997 107.24 176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 36.0 mm -80.48 127.51 39.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.469 -0.937 . . . . 50.409999999999997 108.469 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.492 ' HG3' ' CE1' ' A' ' 379' ' ' TYR . 0.4 OUTLIER -71.64 128.17 34.93 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.86 0.362 . . . . 74.120000000000005 111.242 -178.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 362' ' ' GLY . . . . . 0.472 ' H ' ' HB2' ' A' ' 378' ' ' PHE . . . 75.79 -99.6 1.26 Allowed Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 110.798 -0.921 . . . . 34.130000000000003 110.798 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 10.6 tmm? 50.04 -45.52 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 129.497 3.119 . . . . 72.310000000000002 115.754 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 78.24 113.5 0.07 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.009 1.723 . . . . 73.329999999999998 112.155 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.461 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 58.0 m -119.33 136.55 54.21 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.266 -0.642 . . . . 71.349999999999994 109.266 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 18.2 ptpt -144.6 145.29 31.71 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 123.082 0.239 . . . . 64.530000000000001 111.441 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.46 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 4.0 tmt_? -159.4 133.71 7.7 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.556 -1.276 . . . . 71.530000000000001 107.556 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 44.2 mt-10 -84.6 125.6 32.6 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.578 -0.527 . . . . 74.409999999999997 109.578 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.457 HG21 HG12 ' A' ' 431' ' ' VAL . 47.8 mt -131.08 118.21 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 107.544 -1.28 . . . . 61.450000000000003 107.544 -174.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 67.06 13.16 61.5 Favored Glycine 0 C--N 1.313 -0.718 0 C-N-CA 120.936 -0.65 . . . . 62.210000000000001 112.365 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 112.89 -29.29 8.2 Favored Glycine 0 N--CA 1.417 -2.58 0 C-N-CA 120.946 -0.645 . . . . 74.329999999999998 112.595 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' TYR . . . . . 0.414 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 20.8 p90 -98.4 140.33 32.82 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 120.914 0.388 . . . . 64.310000000000002 111.314 -175.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 36.9 m -81.12 118.19 22.32 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 116.012 -0.54 . . . . 74.310000000000002 110.037 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.574 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.5 129.89 36.62 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 108.621 -0.881 . . . . 61.509999999999998 108.621 173.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -131.24 128.5 40.02 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.371 -0.532 . . . . 71.349999999999994 109.969 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.461 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.6 p -124.17 117.85 52.03 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-O 121.325 0.583 . . . . 73.129999999999995 109.576 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.48 116.47 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.378 -1.341 . . . . 73.510000000000005 107.378 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.474 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 91.9 m-85 -60.52 131.03 49.46 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.499 0.926 . . . . 70.450000000000003 113.499 -172.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.492 ' CE1' ' HG3' ' A' ' 361' ' ' LYS . 95.3 m-85 68.99 9.49 7.44 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 124.996 1.318 . . . . 71.25 112.612 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -120.82 -84.32 0.66 Allowed 'General case' 0 C--O 1.239 0.552 0 N-CA-C 113.164 0.801 . . . . 71.340000000000003 113.164 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -166.94 158.76 12.79 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.09 0.774 . . . . 72.25 113.09 -173.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.443 HG22 HG23 ' A' ' 376' ' ' VAL . 92.0 t -114.1 146.35 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.992 -1.003 . . . . 72.310000000000002 109.535 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -133.98 146.1 50.12 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 123.048 0.539 . . . . 71.530000000000001 111.71 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.498 ' HB2' HD23 ' A' ' 389' ' ' LEU . 35.3 tt0 -117.94 98.38 6.31 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 106.112 -1.81 . . . . 61.32 106.112 172.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 18.7 t70 69.94 -83.93 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 124.325 1.05 . . . . 73.409999999999997 110.636 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.3 m -136.43 3.87 2.84 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.161 -1.051 . . . . 72.129999999999995 108.161 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 65.2 mt -88.36 132.66 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 114.998 -1.001 . . . . 71.329999999999998 109.775 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 64.2 tp -78.01 110.58 13.08 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.383 -1.34 . . . . 75.019999999999996 107.383 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.54 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -76.81 -65.26 0.96 Allowed 'General case' 0 N--CA 1.393 -3.317 0 N-CA-C 109.036 -0.728 . . . . 73.010000000000005 109.036 -175.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.27 157.45 28.8 Favored Glycine 0 N--CA 1.423 -2.184 0 C-N-CA 119.791 -1.195 . . . . 72.310000000000002 111.746 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -100.65 150.02 23.16 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.057 -1.09 . . . . 71.439999999999998 108.057 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.474 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.9 m-85 -73.04 115.9 12.92 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.205 0.526 . . . . 55.530000000000001 110.853 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.9 -43.42 6.73 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.529 -0.76 . . . . 60.520000000000003 111.085 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 52.9 m -155.11 143.73 20.57 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.686 -0.234 . . . . 62.210000000000001 110.515 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.428 ' CG ' HD22 ' A' ' 400' ' ' LEU . 0.1 OUTLIER -129.88 133.87 47.15 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.873 -1.529 . . . . 74.040000000000006 106.873 174.542 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -128.91 110.91 12.51 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.782 -0.821 . . . . 73.129999999999995 108.782 173.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 72.11 -101.66 1.07 Allowed Glycine 0 N--CA 1.409 -3.114 0 C-N-CA 119.415 -1.374 . . . . 72.120000000000005 112.056 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' ASN . . . . . 0.423 ' HB3' ' HB3' ' A' ' 357' ' ' TYR . 5.9 p-10 -130.39 19.15 5.3 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 123.77 0.828 . . . . 44.210000000000001 109.124 -177.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.95 116.75 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 N-CA-C 106.887 -1.523 . . . . 72.5 106.887 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.428 HD22 ' CG ' ' A' ' 395' ' ' GLN . 13.1 mt -116.46 130.47 56.78 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.806 -0.634 . . . . 70.420000000000002 110.354 -170.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -110.12 121.95 46.46 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 121.031 0.443 . . . . 74.109999999999999 111.239 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.42 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 2.9 m-85 -116.19 132.38 56.68 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.14 -1.059 . . . . 63.219999999999999 108.14 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 415' ' ' SER . 11.4 pt-20 -147.74 177.55 9.21 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 123.172 0.295 . . . . 70.239999999999995 110.96 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 65.91 34.36 7.25 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 123.7 0.625 . . . . 74.349999999999994 111.24 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -79.14 -136.65 1.27 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.756 -0.735 . . . . 64.040000000000006 112.168 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -74.86 151.14 39.01 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.695 -0.854 . . . . 73.140000000000001 108.695 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 49.7 m -60.42 133.19 55.85 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.485 0.66 . . . . 52.240000000000002 112.167 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 35.1 t -109.8 144.56 38.06 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.265 -1.754 . . . . 73.219999999999999 106.265 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -82.92 -38.99 22.08 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.567 0.698 . . . . 73.129999999999995 109.839 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 436' ' ' LYS . 9.0 p-10 -94.57 19.56 9.65 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 123.763 0.825 . . . . 71.219999999999999 111.393 -176.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.496 ' HA3' ' SG ' ' A' ' 437' ' ' CYS . . . -164.16 -163.33 16.89 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 107.829 -2.108 . . . . 65.510000000000005 107.829 177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -90.62 -42.42 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.251 0 CA-C-N 120.67 2.235 . . . . 74.540000000000006 112.717 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -162.6 166.43 24.66 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 106.84 -1.541 . . . . 70.310000000000002 106.84 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -77.44 158.27 30.1 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.362 0.601 . . . . 74.230000000000004 112.042 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 27.4 p -161.04 165.92 28.99 Favored 'General case' 0 N--CA 1.407 -2.614 0 CA-C-N 114.567 -1.197 . . . . 64.340000000000003 109.464 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.26 151.24 19.03 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.223 0.535 . . . . 75.099999999999994 110.536 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.7 tt -114.16 128.56 71.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 CA-C-N 115.415 -0.811 . . . . 75.420000000000002 109.281 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.452 ' CG2' ' HB ' ' A' ' 441' ' ' ILE . 3.4 t -114.13 127.88 71.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-O 121.561 0.696 . . . . 73.420000000000002 111.348 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 33.1 p -108.53 114.91 29.12 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 107.943 -1.132 . . . . 75.040000000000006 107.943 174.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.81 116.48 44.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.438 -0.949 . . . . 71.450000000000003 108.438 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -113.83 -173.33 2.25 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 121.021 -0.271 . . . . 74.409999999999997 111.328 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.427 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 42.9 t -58.73 129.26 41.24 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 123.621 0.768 . . . . 61.030000000000001 111.338 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.479 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -160.8 -177.6 34.04 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 110.676 -0.969 . . . . 63.530000000000001 110.676 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.44 -34.97 7.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 109.24 -0.652 . . . . 73.010000000000005 109.24 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -156.63 160.84 39.77 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 116.024 -0.535 . . . . 74.209999999999994 109.675 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 59.9 m-20 -60.48 106.12 0.51 Allowed 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 123.703 0.801 . . . . 75.010000000000005 112.64 175.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -131.89 148.72 52.56 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.987 -1.006 . . . . 74.549999999999997 108.914 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 367' ' ' ARG . 36.4 mm -90.41 120.21 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.378 -1.712 . . . . 75.150000000000006 106.378 175.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 442' ' ' LYS . 53.5 t -84.66 -48.92 16.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 112.222 0.452 . . . . 44.509999999999998 112.222 -176.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 58.2 p -164.82 163.63 21.18 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.925 -0.31 . . . . 74.450000000000003 110.66 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.457 HG12 HG21 ' A' ' 369' ' ' ILE . 4.3 p -142.04 119.84 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 123.889 0.743 . . . . 74.140000000000001 109.436 176.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 26.8 tp -125.85 137.56 53.76 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.521 -0.918 . . . . 64.319999999999993 108.521 -176.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -79.67 116.91 20.14 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.148 -1.056 . . . . 63.25 108.148 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -80.85 -58.08 3.26 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.395 -0.82 . . . . 75.340000000000003 110.649 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -109.27 -78.44 0.59 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.746 -0.661 . . . . 75.409999999999997 110.178 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.439 ' HB2' ' ND2' ' A' ' 410' ' ' ASN . 0.0 OUTLIER -160.67 -40.32 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.627 0.727 . . . . 55.43 111.141 175.493 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 437' ' ' CYS . . . . . 0.496 ' SG ' ' HA3' ' A' ' 411' ' ' GLY . 62.5 m -110.86 8.6 22.3 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.19 -1.041 . . . . 64.219999999999999 108.19 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.8 tt0 -131.75 131.37 42.94 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.064 -0.971 . . . . 72.219999999999999 109.568 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -122.12 150.43 42.2 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.257 -0.883 . . . . 70.319999999999993 109.626 -175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 440' ' ' LEU . 4.3 pp -107.3 122.8 47.29 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 107.645 -1.242 . . . . 73.140000000000001 107.645 175.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.452 ' HB ' ' CG2' ' A' ' 418' ' ' VAL . 96.1 mt -118.96 129.89 74.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 CA-C-N 115.352 -0.84 . . . . 74.430000000000007 110.296 -175.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.469 ' HB3' ' HB ' ' A' ' 429' ' ' VAL . 15.7 tppt? -97.86 138.63 34.93 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.489 -0.93 . . . . 73.129999999999995 108.489 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.419 ' SD ' HG11 ' A' ' 376' ' ' VAL . 80.9 mtp -141.93 168.05 20.68 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 110.145 -0.317 . . . . 75.120000000000005 110.145 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.1 mmtt -135.7 160.41 38.63 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.834 -0.802 . . . . 61.43 108.834 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 33.6 t -166.58 147.27 5.28 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 124.058 0.849 . . . . 75.329999999999998 109.102 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.62 -26.44 53.89 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.484 2.123 . . . . 64.120000000000005 111.23 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -77.55 -18.69 56.7 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.242 -0.89 . . . . 42.210000000000001 110.646 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -96.36 13.61 27.16 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.689 0.757 . . . . 65.140000000000001 109.864 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 11.6 t -103.17 146.84 27.81 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 107.38 -1.341 . . . . 64.340000000000003 107.38 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.416 -2.166 0 N-CA-C 107.651 -1.24 . . . . 52.130000000000003 107.651 -179.133 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 58.4 t80 . . . . . 0 C--O 1.222 -0.369 0 N-CA-C 109.699 -0.482 . . . . 72.349999999999994 109.699 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.501 ' HB2' ' HB1' ' A' ' 447' ' ' ALA . 65.2 mtp180 -138.24 164.63 28.73 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 120.978 0.418 . . . . 72.25 110.838 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -140.94 143.11 34.39 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.527 -1.657 . . . . 74.299999999999997 106.527 170.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 50.2 mm -82.94 116.95 28.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 120.389 0.137 . . . . 74.040000000000006 110.74 -174.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.635 ' HD3' ' H ' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -82.51 131.36 35.22 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 111.925 0.343 . . . . 73.230000000000004 111.925 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 362' ' ' GLY . . . . . 0.453 ' H ' ' HB2' ' A' ' 378' ' ' PHE . . . 69.8 67.24 1.98 Allowed Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.577 -0.738 . . . . 55.229999999999997 112.739 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 51.6 ttp -146.39 -27.91 0.41 Allowed 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.815 -1.18 . . . . 65.140000000000001 107.815 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.45 ' CD ' HG13 ' A' ' 377' ' ' VAL 0.263 0.4 OUTLIER 65.7 139.53 0.02 OUTLIER 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 116.618 2.081 . . . . 72.120000000000005 116.618 170.388 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.566 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 39.4 m -128.56 133.36 48.35 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.513 -1.221 . . . . 71.099999999999994 109.673 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.664 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 60.4 mtpt -139.36 141.53 37.6 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.072 -0.714 . . . . 72.349999999999994 109.072 176.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -161.6 136.95 7.55 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.058 -1.09 . . . . 72.140000000000001 108.058 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -86.72 122.98 31.37 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 120.805 0.336 . . . . 61.109999999999999 110.279 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.473 HG21 HG12 ' A' ' 431' ' ' VAL . 49.0 mt -133.02 123.68 48.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.174 -1.417 . . . . 63.439999999999998 107.174 -175.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.65 8.39 46.63 Favored Glycine 0 C--N 1.309 -0.968 0 C-N-CA 120.821 -0.704 . . . . 74.230000000000004 112.124 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 109.94 -23.2 21.97 Favored Glycine 0 N--CA 1.426 -1.996 0 C-N-CA 121.363 -0.446 . . . . 32.43 112.805 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -98.83 143.84 28.71 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 120.677 0.275 . . . . 64.109999999999999 110.81 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 57.0 m -86.1 121.03 28.13 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 116.486 -0.325 . . . . 70.239999999999995 110.248 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.96 137.68 32.18 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.128 -0.693 . . . . 50.039999999999999 109.128 176.072 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.486 ' HG3' ' HG2' ' A' ' 366' ' ' LYS . 37.0 ttpt -131.83 129.92 41.08 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.618 -0.512 . . . . 64.239999999999995 109.618 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.566 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.0 p -124.85 117.19 49.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-O 121.068 0.461 . . . . 73.049999999999997 109.987 176.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.45 HG13 ' CD ' ' A' ' 364' ' ' GLU . 27.6 t -103.71 117.55 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.137 0 N-CA-C 107.063 -1.458 . . . . 62.450000000000003 107.063 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.468 ' HB2' ' HA ' ' A' ' 361' ' ' LYS . 88.7 m-85 -63.88 124.35 21.3 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.555 -0.748 . . . . 70.040000000000006 111.994 -173.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 72.79 12.7 5.23 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.064 1.346 . . . . 73.209999999999994 113.127 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -125.42 -80.8 0.62 Allowed 'General case' 0 C--O 1.246 0.869 0 N-CA-C 113.645 0.98 . . . . 73.219999999999999 113.645 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -160.3 166.9 28.62 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.997 0.74 . . . . 73.450000000000003 112.997 -171.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.445 HG22 HG23 ' A' ' 376' ' ' VAL . 74.0 t -125.42 142.32 42.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.932 -1.031 . . . . 74.409999999999997 108.423 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -131.7 150.09 52.27 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 123.069 0.547 . . . . 74.400000000000006 111.641 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.5 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.6 tt0 -122.62 103.95 9.02 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 106.912 -1.514 . . . . 74.319999999999993 106.912 173.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 14.5 t70 72.6 -70.76 0.15 Allowed 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.281 1.433 . . . . 63.140000000000001 109.479 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' SER . . . . . 0.406 ' H ' ' H ' ' A' ' 387' ' ' ILE . 28.6 t -152.87 -0.61 0.26 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.137 -0.938 . . . . 33.210000000000001 108.727 176.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.406 ' H ' ' H ' ' A' ' 386' ' ' SER . 62.6 mt -86.42 136.62 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 109.313 -0.625 . . . . 73.310000000000002 109.313 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 63.8 tp -76.27 112.54 12.86 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.288 -1.005 . . . . 72.340000000000003 108.288 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.627 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -78.93 -63.83 1.32 Allowed 'General case' 0 N--CA 1.393 -3.313 0 N-CA-C 108.507 -0.923 . . . . 74.349999999999994 108.507 -176.502 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.03 160.88 32.0 Favored Glycine 0 CA--C 1.478 -2.271 0 C-N-CA 119.937 -1.125 . . . . 72.129999999999995 110.974 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -109.53 149.55 29.46 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.175 -1.046 . . . . 62.100000000000001 108.175 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.542 ' HD2' ' NE2' ' A' ' 395' ' ' GLN . 1.4 m-85 -69.82 122.36 19.08 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 120.814 0.34 . . . . 75.430000000000007 110.889 -176.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -99.09 -48.2 4.94 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.973 -0.558 . . . . 71.109999999999999 110.909 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 58.6 m -165.74 142.81 5.49 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.887 -1.153 . . . . 64.430000000000007 107.887 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.542 ' NE2' ' HD2' ' A' ' 392' ' ' PHE . 40.0 mt-30 -126.51 141.87 51.73 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.012 -1.107 . . . . 73.450000000000003 108.012 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -129.13 110.23 11.84 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.559 -0.456 . . . . 62.409999999999997 110.294 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.19 -101.07 0.92 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 121.008 -0.615 . . . . 74.040000000000006 111.891 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -125.61 18.44 8.07 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.408 -0.59 . . . . 74.329999999999998 109.408 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.2 t -118.54 116.52 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 N-CA-C 107.322 -1.362 . . . . 73.5 107.322 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' A' ' 395' ' ' GLN . 14.8 mt -111.16 125.09 53.42 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 116.118 -0.492 . . . . 73.340000000000003 110.079 -171.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -105.14 123.74 48.35 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 112.997 0.74 . . . . 75.430000000000007 112.997 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.422 ' O ' ' HB2' ' A' ' 415' ' ' SER . 2.6 m-85 -117.77 139.75 50.63 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.971 -1.122 . . . . 73.200000000000003 107.971 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 415' ' ' SER . 70.8 mm-40 -142.54 175.2 9.97 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 124.275 1.03 . . . . 74.439999999999998 109.39 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 53.55 47.01 24.91 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 114.423 1.268 . . . . 62.409999999999997 114.423 173.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.627 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -80.88 -148.29 5.74 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.349 -0.841 . . . . 73.329999999999998 111.413 172.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.19 141.01 43.66 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.333 -1.358 . . . . 70.019999999999996 107.333 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 34.3 p -60.78 132.98 55.6 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.149 0.58 . . . . 53.100000000000001 112.482 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 7.7 p -111.91 158.57 19.31 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.425 -0.807 . . . . 72.540000000000006 109.19 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 20.1 p-90 -76.11 -33.24 59.48 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.823 0.821 . . . . 72.439999999999998 109.539 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -95.1 12.98 26.74 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.74 -1.118 . . . . 53.149999999999999 112.674 -172.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -167.99 -170.51 32.83 Favored Glycine 0 C--N 1.306 -1.087 0 N-CA-C 109.736 -1.346 . . . . 75.109999999999999 109.736 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -85.85 -40.03 0.08 OUTLIER 'Trans proline' 0 CA--C 1.545 1.063 0 CA-C-N 119.674 1.737 . . . . 73.200000000000003 112.796 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -161.21 158.46 27.39 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.767 -1.568 . . . . 73.239999999999995 106.767 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.404 ' HA ' ' HB3' ' A' ' 437' ' ' CYS . 58.3 mtt180 -78.57 157.57 28.74 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.192 -0.603 . . . . 73.409999999999997 111.946 172.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 51.4 p -160.22 169.45 23.2 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 115.007 -0.997 . . . . 65.230000000000004 109.78 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -159.98 151.96 20.4 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.287 0.565 . . . . 71.510000000000005 110.553 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.4 tt -118.01 127.73 75.2 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 CA-C-N 115.06 -0.973 . . . . 64.420000000000002 108.821 174.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.7 t -113.93 129.87 69.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.336 0.589 . . . . 71.140000000000001 112.477 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 14.2 p -108.35 113.87 27.28 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.999 -1.0 . . . . 63.039999999999999 108.361 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 39.6 t -101.53 115.08 42.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 120.74 0.305 . . . . 64.329999999999998 110.291 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.494 ' OE1' ' HD2' ' A' ' 442' ' ' LYS . 47.9 mt-10 -108.07 -176.38 3.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.816 0.341 . . . . 73.019999999999996 111.113 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.436 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 36.5 t -60.24 130.99 49.37 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.006 0.922 . . . . 74.519999999999996 111.795 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -157.86 -177.61 31.12 Favored Glycine 0 N--CA 1.421 -2.334 0 N-CA-C 109.98 -1.248 . . . . 74.209999999999994 109.98 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.36 -28.52 3.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 108.371 -0.974 . . . . 72.109999999999999 108.371 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -152.42 151.81 31.24 Favored 'General case' 0 CA--C 1.478 -1.815 0 CA-C-N 115.103 -0.953 . . . . 52.049999999999997 108.867 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.695 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 18.4 p-10 -66.73 105.43 1.56 Allowed 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 113.286 -1.779 . . . . 71.239999999999995 110.96 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -131.29 148.27 52.67 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.111 -0.95 . . . . 73.150000000000006 110.612 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 26.8 mm -88.28 120.39 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 105.969 -1.863 . . . . 75.540000000000006 105.969 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 62.9 t -83.1 -50.76 15.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-O 120.845 0.355 . . . . 53.109999999999999 111.586 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 48.4 m -164.17 164.5 22.65 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.248 -0.649 . . . . 62.119999999999997 109.248 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.473 HG12 HG21 ' A' ' 369' ' ' ILE . 2.8 p -142.05 114.38 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 123.814 0.846 . . . . 65.510000000000005 109.245 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 432' ' ' LEU . . . . . 0.458 ' O ' HD23 ' A' ' 440' ' ' LEU . 30.7 tp -120.85 138.86 53.85 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.895 -0.78 . . . . 73.299999999999997 108.895 -175.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -80.37 110.69 16.06 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 119.743 -0.783 . . . . 74.099999999999994 109.757 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.405 ' H ' ' HA ' ' A' ' 439' ' ' TYR . . . -74.64 -38.53 62.47 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.027 -0.988 . . . . 65.209999999999994 111.249 -175.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -127.64 -80.01 0.59 Allowed 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.609 -0.723 . . . . 72.450000000000003 111.683 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -166.73 -36.32 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.3 -0.864 . . . . 73.299999999999997 109.772 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' CYS . . . . . 0.404 ' HB3' ' HA ' ' A' ' 414' ' ' ARG . 97.8 m -122.02 -2.63 9.16 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 115.108 -0.951 . . . . 73.439999999999998 109.913 174.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.6 tt0 -119.0 134.43 55.2 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.192 -0.913 . . . . 75.530000000000001 109.049 -177.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 439' ' ' TYR . . . . . 0.405 ' HA ' ' H ' ' A' ' 434' ' ' ALA . 35.9 m-85 -126.04 150.18 48.31 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 123.743 0.652 . . . . 72.209999999999994 110.057 -174.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.49 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.8 pt? -105.67 123.22 47.58 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.069 -1.085 . . . . 73.109999999999999 108.069 173.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.4 mt -122.26 129.93 74.93 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 CA-C-N 115.088 -0.96 . . . . 71.129999999999995 109.361 -177.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.494 ' HD2' ' OE1' ' A' ' 421' ' ' GLU . 36.5 ttpt -107.65 142.3 37.82 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 119.847 -0.741 . . . . 73.120000000000005 110.026 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 78.5 mtp -136.44 168.54 19.25 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 123.248 0.619 . . . . 43.439999999999998 109.56 -176.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.695 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 70.4 mmtt -131.93 153.52 50.19 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.179 -1.415 . . . . 72.099999999999994 107.179 175.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 74.8 m -161.78 150.33 12.74 Favored Pre-proline 0 C--N 1.287 -2.115 0 O-C-N 123.798 0.686 . . . . 65.219999999999999 110.346 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.99 -27.16 66.18 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.832 2.355 . . . . 63.140000000000001 112.348 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 358' ' ' ARG . . . -82.77 -12.23 57.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.708 -0.678 . . . . 61.119999999999997 111.9 -177.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -99.48 13.45 33.28 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-O 121.627 0.727 . . . . 74.049999999999997 109.845 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 9.6 t -103.41 119.55 39.1 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 115.272 -0.876 . . . . 65.109999999999999 108.981 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 C--N 1.31 -1.126 0 C-N-CA 123.871 0.868 . . . . 50.200000000000003 108.853 -179.231 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' A' ' 447' ' ' ALA . 54.0 p90 . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.878 -0.416 . . . . 75.340000000000003 109.878 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 96.4 mtt180 -134.81 -116.62 0.19 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.065 0.765 . . . . 72.400000000000006 113.065 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -147.64 153.19 39.05 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.694 -0.854 . . . . 63.539999999999999 108.694 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.15 116.88 25.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.278 -1.008 . . . . 72.219999999999999 108.278 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -89.34 155.18 19.52 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.869 -0.605 . . . . 71.129999999999995 112.368 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 68.36 12.15 63.04 Favored Glycine 0 C--O 1.227 -0.302 0 CA-C-N 115.338 -0.846 . . . . 72.120000000000005 113.622 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 51.2 ttp -91.18 -28.76 17.65 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.897 0.348 . . . . 63.32 110.993 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 69.72 124.54 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.627 1.171 . . . . 72.409999999999997 111.798 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.462 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 80.1 m -125.82 121.36 33.06 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 108.963 -0.754 . . . . 71.230000000000004 108.963 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 60.4 mtpt -133.2 140.61 47.64 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 110.106 -0.331 . . . . 63.32 110.106 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -158.08 134.33 9.42 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.395 -0.595 . . . . 62.119999999999997 109.395 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 2.8 mp0 -78.58 125.91 30.02 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 110.038 -0.356 . . . . 72.019999999999996 110.038 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.467 HG21 HG12 ' A' ' 431' ' ' VAL . 54.4 mt -130.92 117.54 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 N-CA-C 106.863 -1.532 . . . . 75.049999999999997 106.863 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 67.24 9.98 55.77 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.555 -0.831 . . . . 74.140000000000001 112.592 -177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.59 -7.7 39.56 Favored Glycine 0 N--CA 1.432 -1.597 0 C-N-CA 120.267 -0.968 . . . . 54.119999999999997 113.406 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' TYR . . . . . 0.404 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 15.4 p90 -114.0 136.61 52.72 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.94 0.37 . . . . 75.209999999999994 110.168 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 61.8 m -79.85 121.0 24.86 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 116.288 -0.414 . . . . 73.140000000000001 111.411 -178.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.67 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.6 OUTLIER -90.96 124.49 35.26 Favored 'General case' 0 N--CA 1.414 -2.244 0 C-N-CA 120.249 -0.58 . . . . 73.129999999999995 109.74 174.709 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 86.4 tttt -120.31 125.44 48.05 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.488 -0.778 . . . . 74.430000000000007 109.83 -174.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.462 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.3 p -127.64 116.14 42.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-O 121.425 0.631 . . . . 71.140000000000001 110.423 176.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.24 116.44 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 N-CA-C 107.145 -1.428 . . . . 61.329999999999998 107.145 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.469 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 75.4 m-85 -61.13 132.43 53.72 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.778 -1.101 . . . . 74.349999999999994 112.854 -171.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 64.97 17.84 11.24 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 124.6 1.16 . . . . 75.299999999999997 112.283 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -130.93 -84.42 0.52 Allowed 'General case' 0 C--O 1.243 0.722 0 N-CA-C 113.534 0.939 . . . . 74.420000000000002 113.534 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -158.65 163.73 36.63 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.726 1.01 . . . . 73.230000000000004 113.726 -170.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 99.1 t -125.55 143.7 38.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 124.505 1.122 . . . . 65.209999999999994 109.151 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 375' ' ' LYS . 91.6 m-85 -133.91 146.5 50.59 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 122.759 0.423 . . . . 63.210000000000001 111.368 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.533 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.8 tt0 -110.99 99.42 8.31 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.402 -2.074 . . . . 73.5 105.402 172.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.4 t70 73.23 -72.93 0.11 Allowed 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 125.465 1.506 . . . . 62.299999999999997 109.816 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.9 t -148.63 -5.15 0.43 Allowed 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 114.913 -1.039 . . . . 64.420000000000002 109.093 176.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 63.8 mt -77.78 134.65 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.356 -0.979 . . . . 75.140000000000001 108.356 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 406' ' ' GLN . 65.2 tp -75.81 113.69 13.57 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.561 -0.903 . . . . 74.019999999999996 108.561 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.533 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.6 OUTLIER -80.73 -63.51 1.39 Allowed 'General case' 0 N--CA 1.383 -3.796 0 N-CA-C 108.348 -0.982 . . . . 64.040000000000006 108.348 -176.318 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.48 160.39 31.33 Favored Glycine 0 N--CA 1.413 -2.886 0 C-N-CA 119.091 -1.528 . . . . 64.219999999999999 111.429 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -108.6 146.58 33.13 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 107.11 -1.441 . . . . 72.120000000000005 107.11 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.469 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.4 m-85 -68.74 125.88 27.96 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 120.634 0.254 . . . . 72.319999999999993 110.585 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -100.36 -48.2 4.66 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.954 0.407 . . . . 73.230000000000004 109.947 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 42.4 p -164.22 162.02 22.38 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.686 -0.688 . . . . 73.109999999999999 109.488 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.514 ' CG ' HD22 ' A' ' 400' ' ' LEU . 18.5 mp0 -128.4 122.58 31.72 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.919 -0.771 . . . . 65.420000000000002 108.919 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.14 109.99 22.63 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.371 -0.974 . . . . 74.409999999999997 108.371 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.55 ' O ' ' HG2' ' A' ' 358' ' ' ARG . . . 55.68 -100.72 0.1 Allowed Glycine 0 N--CA 1.436 -1.345 0 O-C-N 123.921 0.763 . . . . 74.239999999999995 112.401 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -122.87 19.26 10.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.948 0.88 . . . . 65.329999999999998 109.436 -176.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 66.8 t -123.51 116.9 49.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 107.525 -1.287 . . . . 62.450000000000003 107.525 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.514 HD22 ' CG ' ' A' ' 395' ' ' GLN . 12.1 mt -107.19 132.57 52.91 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 116.278 -0.419 . . . . 73.230000000000004 110.88 -169.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -103.63 122.82 45.79 Favored 'General case' 0 C--O 1.247 0.955 0 N-CA-C 112.718 0.636 . . . . 73.019999999999996 112.718 176.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.47 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.5 m-85 -118.58 132.39 56.2 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.013 -1.477 . . . . 74.219999999999999 107.013 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.404 ' HA ' ' CB ' ' A' ' 415' ' ' SER . 7.6 pt-20 -147.59 174.91 11.3 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 112.478 0.548 . . . . 73.400000000000006 112.478 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.21 41.22 13.68 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.704 -1.589 . . . . 73.120000000000005 111.766 170.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.37 -133.24 0.61 Allowed Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.138 -0.937 . . . . 72.310000000000002 112.607 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 20.4 tm0? -84.8 141.96 30.12 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.436 -0.95 . . . . 75.019999999999996 108.436 -177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 42.9 t -60.7 132.75 54.87 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.874 0.845 . . . . 63.530000000000001 112.232 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' CYS . . . . . 0.506 ' HB2' ' OD1' ' A' ' 410' ' ' ASN . 5.9 p -108.93 158.53 17.6 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.611 -0.722 . . . . 75.319999999999993 110.125 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 32.9 p-90 -74.46 -28.86 61.21 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.164 0.983 . . . . 72.030000000000001 108.6 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' ASN . . . . . 0.506 ' OD1' ' HB2' ' A' ' 408' ' ' CYS . 8.3 p-10 -96.22 13.41 27.54 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.997 -1.456 . . . . 63.240000000000002 113.147 -173.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -177.26 -167.22 35.3 Favored Glycine 0 C--O 1.22 -0.72 0 N-CA-C 110.229 -1.148 . . . . 71.230000000000004 110.229 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -87.56 -39.52 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.923 0 CA-C-N 119.581 1.69 . . . . 64.109999999999999 112.486 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -159.9 158.43 30.85 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 107.191 -1.411 . . . . 73.230000000000004 107.191 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -76.81 162.23 27.81 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.134 -0.627 . . . . 64.409999999999997 111.026 172.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 47.4 p -164.35 163.09 22.55 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 114.905 -1.043 . . . . 44.140000000000001 108.821 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -158.94 146.9 17.9 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.169 0.509 . . . . 74.420000000000002 110.551 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 7.4 tt -113.38 126.96 70.9 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 CA-C-N 115.266 -0.879 . . . . 73.219999999999999 108.919 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 7.4 t -112.68 131.45 64.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-O 121.108 0.48 . . . . 71.219999999999999 111.937 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 35.0 p -107.26 114.14 27.99 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 107.664 -1.235 . . . . 72.040000000000006 107.664 175.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 43.1 t -100.82 112.97 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 107.537 -1.283 . . . . 73.219999999999999 107.537 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -115.58 -173.65 2.37 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.917 -0.313 . . . . 74.239999999999995 110.211 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.547 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 36.9 t -59.18 128.32 36.59 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 122.974 0.51 . . . . 52.310000000000002 111.256 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -159.8 -176.1 31.51 Favored Glycine 0 CA--C 1.493 -1.305 0 CA-C-N 115.796 -0.638 . . . . 73.140000000000001 111.529 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.0 t -80.58 -38.55 17.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 109.485 -0.561 . . . . 71.200000000000003 109.485 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 446' ' ' PRO . 45.6 tt0 -171.08 162.24 7.04 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 123.51 0.724 . . . . 71.129999999999995 109.321 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 20.9 m120 -61.52 101.38 0.18 Allowed 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.996 -1.002 . . . . 72.25 112.306 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -132.02 149.04 52.53 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.6 -1.182 . . . . 62.140000000000001 108.651 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 30.5 mm -81.51 118.23 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.791 -1.559 . . . . 63.43 106.791 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 63.8 t -81.24 -50.35 16.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-O 120.716 0.293 . . . . 65.319999999999993 111.664 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 42.4 p -166.92 165.68 15.86 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.138 -0.483 . . . . 62.43 109.972 -173.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.467 HG12 HG21 ' A' ' 369' ' ' ILE . 4.3 p -142.0 125.13 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 108.822 -0.807 . . . . 74.0 108.822 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 432' ' ' LEU . . . . . 0.437 ' O ' HD23 ' A' ' 440' ' ' LEU . 27.2 tp -126.48 136.58 52.8 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 107.66 -1.237 . . . . 74.239999999999995 107.66 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -81.18 108.48 14.86 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.674 -0.862 . . . . 62.130000000000003 108.674 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' ALA . . . . . 0.439 ' H ' ' HA ' ' A' ' 439' ' ' TYR . . . -65.31 -61.18 2.27 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 123.74 0.816 . . . . 71.530000000000001 110.781 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -109.33 -75.02 0.64 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.925 -0.58 . . . . 73.340000000000003 110.705 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -165.84 -43.02 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.795 -1.093 . . . . 65.409999999999997 109.892 -174.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 93.4 m -118.74 14.72 13.49 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 121.969 0.89 . . . . 74.209999999999994 109.539 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 415' ' ' SER . 37.1 tt0 -135.14 131.19 36.53 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.111 -1.07 . . . . 55.340000000000003 108.111 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 439' ' ' TYR . . . . . 0.439 ' HA ' ' H ' ' A' ' 434' ' ' ALA . 45.0 m-85 -123.08 150.77 42.73 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 124.005 0.816 . . . . 74.129999999999995 110.261 -174.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.8 pt? -110.4 122.09 46.87 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.736 -1.209 . . . . 74.310000000000002 107.736 172.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.5 mt -121.28 133.84 66.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 CA-C-N 115.41 -0.814 . . . . 73.319999999999993 109.501 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -103.48 140.84 36.95 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 109.131 -0.692 . . . . 63.119999999999997 109.131 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.412 ' SD ' HG11 ' A' ' 418' ' ' VAL . 87.4 mtp -138.54 163.36 32.19 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.267 -1.012 . . . . 70.329999999999998 108.267 177.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.684 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 73.0 mmtt -130.68 161.3 31.93 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.728 -0.842 . . . . 63.240000000000002 108.728 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 445' ' ' SER . . . . . 0.417 ' HB2' ' ND2' ' A' ' 426' ' ' ASN . 30.2 t -167.77 147.62 4.42 Favored Pre-proline 0 C--N 1.296 -1.742 0 O-C-N 123.746 0.654 . . . . 74.010000000000005 109.759 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 425' ' ' GLU . 55.4 Cg_endo -70.55 -21.5 29.75 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.204 1.936 . . . . 71.430000000000007 110.129 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 357' ' ' TYR . . . -75.4 -18.47 59.92 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.83 -1.077 . . . . 41.229999999999997 110.775 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -100.84 7.03 43.92 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.751 0.786 . . . . 72.549999999999997 109.093 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 13.2 t -103.56 121.26 42.53 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.05 -0.977 . . . . 73.040000000000006 108.914 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--N 1.295 -1.762 0 N-CA-C 108.508 -0.923 . . . . 74.430000000000007 108.508 177.361 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 CA--C 1.505 -0.761 0 N-CA-C 110.082 -0.34 . . . . 73.010000000000005 110.082 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -129.63 -179.16 5.02 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.206 0.527 . . . . 73.140000000000001 110.216 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -88.29 154.07 20.7 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.14 -0.936 . . . . 64.5 110.137 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 47.8 mm -79.21 129.89 36.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 107.053 -1.462 . . . . 65.420000000000002 107.053 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.584 ' HD3' ' H ' ' A' ' 361' ' ' LYS . 0.2 OUTLIER -109.96 158.44 18.23 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.504 0.927 . . . . 74.430000000000007 113.504 -172.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 97.03 -34.52 5.01 Favored Glycine 0 CA--C 1.504 -0.618 0 CA-C-N 115.494 -0.776 . . . . 61.329999999999998 111.949 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 51.2 ttp -76.61 132.47 39.47 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.903 0.382 . . . . 75.430000000000007 111.353 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -74.27 115.38 13.71 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.823 -0.806 . . . . 74.25 108.823 176.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.466 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 59.1 m -103.16 120.3 40.45 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.754 -1.573 . . . . 74.420000000000002 106.754 173.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 19.4 ptmt -142.29 141.44 32.43 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 111.989 0.366 . . . . 61.039999999999999 111.989 -176.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.41 ' NH1' HG12 ' A' ' 369' ' ' ILE . 3.2 tmt_? -159.57 132.18 6.69 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.442 -0.799 . . . . 71.549999999999997 109.027 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 44.1 mt-10 -77.93 129.97 36.0 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 116.147 -0.478 . . . . 71.010000000000005 110.525 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.485 HG21 HG12 ' A' ' 431' ' ' VAL . 35.5 mt -135.02 121.53 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 106.831 -1.544 . . . . 74.310000000000002 106.831 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.39 11.54 56.47 Favored Glycine 0 C--N 1.308 -0.999 0 C-N-CA 120.837 -0.697 . . . . 73.209999999999994 112.646 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 110.77 -23.38 19.76 Favored Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 121.186 -0.53 . . . . 70.129999999999995 112.85 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -101.81 141.6 34.42 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 122.514 -0.403 . . . . 74.049999999999997 111.361 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 90.1 m -81.71 117.56 22.14 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.56 0.219 . . . . 52.530000000000001 110.581 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.32 133.6 34.86 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 108.36 -0.978 . . . . 74.420000000000002 108.36 174.264 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.48 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 36.8 ttpt -136.84 127.15 26.48 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 120.635 -0.426 . . . . 72.230000000000004 110.167 -176.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.489 HG23 HG22 ' A' ' 382' ' ' VAL . 6.5 p -120.63 119.34 59.36 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-O 121.181 0.515 . . . . 74.239999999999995 110.337 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.47 116.15 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 106.451 -1.685 . . . . 52.340000000000003 106.451 173.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.527 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 74.9 m-85 -65.56 135.7 55.44 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.018 -0.992 . . . . 63.329999999999998 113.496 -170.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 64.99 11.75 7.32 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 124.764 1.226 . . . . 73.530000000000001 112.306 -176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -122.61 -84.46 0.66 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 112.548 0.573 . . . . 71.319999999999993 112.548 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -166.09 156.59 12.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.05 0.759 . . . . 73.010000000000005 113.05 -171.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.492 HG21 ' CD2' ' A' ' 402' ' ' TYR . 60.9 t -115.05 147.59 18.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 124.293 1.037 . . . . 65.209999999999994 109.141 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -134.72 145.32 48.37 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.04 0.536 . . . . 72.329999999999998 112.119 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.529 ' HB2' HD23 ' A' ' 389' ' ' LEU . 33.2 tt0 -116.68 100.06 7.56 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 105.945 -1.872 . . . . 70.219999999999999 105.945 171.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.3 t70 71.52 -82.34 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 124.082 0.953 . . . . 54.109999999999999 109.901 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 36.8 t -138.52 -3.43 1.7 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.288 -1.004 . . . . 64.140000000000001 108.288 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 50.2 mm -77.19 132.47 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 108.854 -0.795 . . . . 74.439999999999998 108.854 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.1 tp -76.45 109.56 10.28 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.763 -1.569 . . . . 74.340000000000003 106.763 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.7 OUTLIER -76.41 -62.65 1.55 Allowed 'General case' 0 N--CA 1.389 -3.512 0 N-CA-C 108.94 -0.763 . . . . 71.140000000000001 108.94 -175.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.77 157.47 28.7 Favored Glycine 0 N--CA 1.425 -2.089 0 C-N-CA 118.788 -1.673 . . . . 62.25 112.3 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -101.2 146.02 28.06 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.186 -1.412 . . . . 75.329999999999998 107.186 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.527 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 2.1 m-85 -71.84 115.81 11.49 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 109.417 -0.586 . . . . 70.239999999999995 109.417 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -99.39 -42.7 6.86 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.293 -0.412 . . . . 73.299999999999997 111.172 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 60.3 p -164.41 140.71 6.19 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.885 -0.783 . . . . 72.549999999999997 108.885 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.425 ' HB2' ' CD2' ' A' ' 400' ' ' LEU . 0.1 OUTLIER -141.27 145.28 35.32 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.581 -0.282 . . . . 52.25 110.656 177.764 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -124.8 110.27 14.11 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.875 -0.787 . . . . 73.400000000000006 108.875 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 61.86 -105.76 1.01 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.886 -0.597 . . . . 74.340000000000003 113.077 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -113.96 17.07 18.13 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.101 0.477 . . . . 75.310000000000002 110.892 -176.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.3 t -120.9 118.34 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 106.405 -1.702 . . . . 75.140000000000001 106.405 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 395' ' ' GLN . 20.1 mt -119.73 124.83 47.15 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.109 -0.636 . . . . 75.209999999999994 111.479 -169.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.437 ' HE3' HD12 ' A' ' 417' ' ' ILE . 19.3 mmtp -100.85 122.27 43.15 Favored 'General case' 0 C--O 1.253 1.24 0 CA-C-O 121.314 0.578 . . . . 61.329999999999998 112.366 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.492 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.3 m-85 -118.35 130.24 55.89 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.454 -1.313 . . . . 75.310000000000002 107.454 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 415' ' ' SER . 10.4 pt-20 -147.22 176.04 10.28 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 122.008 0.123 . . . . 54.420000000000002 111.117 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 64.97 36.3 7.64 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.666 0.604 . . . . 52.140000000000001 111.522 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -79.23 -140.16 1.93 Allowed Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.705 -0.76 . . . . 63.009999999999998 112.103 176.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -68.69 150.7 47.62 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 122.447 -0.443 . . . . 72.340000000000003 110.001 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 44.8 m -64.82 125.47 24.93 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.544 0.688 . . . . 64.120000000000005 110.775 -175.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 46.7 t -108.26 124.11 49.8 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 105.342 -2.096 . . . . 71.310000000000002 105.342 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -66.36 -37.6 85.67 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.078 0.466 . . . . 72.310000000000002 110.823 -174.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -89.89 13.21 15.18 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.787 -0.642 . . . . 70.230000000000004 111.743 -174.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.479 ' HA3' ' SG ' ' A' ' 437' ' ' CYS . . . -158.77 -158.75 9.22 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.622 -1.791 . . . . 71.530000000000001 108.622 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -92.84 -41.55 0.03 OUTLIER 'Trans proline' 0 CA--C 1.557 1.672 0 CA-C-N 120.699 2.25 . . . . 63.100000000000001 113.02 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -168.55 161.2 11.45 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 105.893 -1.891 . . . . 73.140000000000001 105.893 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 43.6 mtt180 -72.31 157.36 37.84 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.412 0.625 . . . . 63.240000000000002 112.481 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 36.2 p -163.18 165.1 24.85 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 114.612 -1.176 . . . . 65.109999999999999 109.409 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.1 148.16 16.8 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.182 0.515 . . . . 74.430000000000007 110.465 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' ILE . . . . . 0.437 HD12 ' HE3' ' A' ' 401' ' ' LYS . 7.3 tt -112.86 123.89 68.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 CA-C-N 115.454 -0.794 . . . . 71.400000000000006 109.278 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.519 HG22 ' HB ' ' A' ' 441' ' ' ILE . 5.1 t -109.8 129.81 64.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-N 115.885 -0.598 . . . . 75.219999999999999 111.866 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.1 p -108.32 114.27 28.01 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 107.667 -1.234 . . . . 73.200000000000003 107.667 173.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 22.4 t -100.35 123.14 53.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.2 -1.407 . . . . 70.230000000000004 107.2 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -120.43 -174.12 2.72 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 120.557 -0.457 . . . . 71.140000000000001 110.898 -176.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.506 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 41.0 t -62.21 128.65 37.12 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 123.883 0.873 . . . . 35.420000000000002 111.56 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.51 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -162.55 -176.8 35.0 Favored Glycine 0 CA--C 1.495 -1.196 0 N-CA-C 111.256 -0.738 . . . . 75.120000000000005 111.256 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 98.9 t -86.48 -37.16 11.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-O 120.975 0.417 . . . . 54.100000000000001 109.877 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.449 ' HG2' ' N ' ' A' ' 426' ' ' ASN . 38.5 tt0 -155.87 162.09 40.49 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 109.278 -0.638 . . . . 73.230000000000004 109.278 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.692 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 18.8 m120 -63.36 109.1 1.48 Allowed 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 114.591 -1.186 . . . . 64.329999999999998 111.147 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -131.45 148.42 52.64 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.646 -1.161 . . . . 41.420000000000002 109.013 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 35.5 mm -90.47 113.84 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.364 -1.717 . . . . 73.010000000000005 106.364 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.3 t -80.89 -44.31 21.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 112.505 0.557 . . . . 53.0 112.505 -174.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 58.1 p -168.57 162.7 12.14 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 110.043 -0.354 . . . . 73.109999999999999 110.043 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.485 HG12 HG21 ' A' ' 369' ' ' ILE . 5.7 p -142.03 119.97 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 N-CA-C 108.81 -0.811 . . . . 54.109999999999999 108.81 175.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 432' ' ' LEU . . . . . 0.435 ' O ' HD23 ' A' ' 440' ' ' LEU . 30.9 tp -127.42 138.06 52.88 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.156 -1.053 . . . . 75.150000000000006 108.156 -177.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -80.47 115.84 20.21 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.155 -0.683 . . . . 71.450000000000003 109.155 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -76.59 -67.35 0.71 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.478 -0.783 . . . . 52.399999999999999 111.014 -176.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -98.08 -76.5 0.53 Allowed 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.764 -0.828 . . . . 62.130000000000003 108.764 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.89 -43.85 0.04 OUTLIER 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 115.392 -0.822 . . . . 74.120000000000005 110.655 176.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 437' ' ' CYS . . . . . 0.479 ' SG ' ' HA3' ' A' ' 411' ' ' GLY . 73.6 m -107.38 8.87 29.85 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.64 0.733 . . . . 74.219999999999999 109.191 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.8 tt0 -130.62 134.7 47.19 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.201 -0.909 . . . . 75.409999999999997 109.035 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -125.86 148.69 49.09 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 123.733 0.646 . . . . 53.530000000000001 109.766 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.456 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.6 pt? -105.2 119.24 38.56 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.499 -0.926 . . . . 75.319999999999993 108.499 174.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.519 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.4 mt -117.74 134.73 60.41 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 115.365 -0.834 . . . . 65.209999999999994 109.551 -177.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -106.17 140.99 38.27 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.806 -0.813 . . . . 74.140000000000001 108.806 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 83.1 mtp -138.74 168.56 19.54 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.641 -0.503 . . . . 62.009999999999998 109.641 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.692 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 72.9 mmtt -133.32 161.17 35.21 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.046 -0.724 . . . . 64.319999999999993 109.046 177.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 28.7 t -172.1 148.55 2.05 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.639 -0.875 . . . . 64.040000000000006 108.639 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.29 -27.49 34.5 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.049 1.832 . . . . 63.310000000000002 110.337 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -77.26 -13.51 59.92 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.812 -1.085 . . . . 73.200000000000003 110.792 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -102.63 16.96 24.93 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.329 0.585 . . . . 72.319999999999993 110.147 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' CYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 422' ' ' CYS . 19.6 t -100.31 120.11 39.43 Favored 'General case' 0 N--CA 1.411 -2.381 0 CA-C-O 121.667 0.746 . . . . 65.340000000000003 109.3 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 35.3 t . . . . . 0 N--CA 1.425 -1.676 0 N-CA-C 106.614 -1.624 . . . . 64.239999999999995 106.614 -177.359 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.714 ' N ' ' HG ' ' A' ' 450' ' ' SER . 36.8 p90 . . . . . 0 C--O 1.224 -0.289 0 CA-C-O 121.641 0.734 . . . . 62.509999999999998 110.426 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -146.71 174.58 11.33 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.155 -1.424 . . . . 75.239999999999995 107.155 -174.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -129.04 150.12 50.58 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.718 -0.845 . . . . 72.200000000000003 108.718 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 51.9 mt -82.55 116.87 27.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 108.959 -0.756 . . . . 72.209999999999994 108.959 -177.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.432 ' HA ' ' CB ' ' A' ' 378' ' ' PHE . 63.1 pttt -84.91 157.34 20.89 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 113.104 0.779 . . . . 73.549999999999997 113.104 -175.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 67.8 29.74 73.95 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 114.893 -1.048 . . . . 71.209999999999994 113.665 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 49.5 ttm -121.89 143.75 49.26 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.701 -0.481 . . . . 73.299999999999997 109.701 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.491 ' HG3' HG22 ' A' ' 377' ' ' VAL . 1.4 mp0 -95.24 130.47 41.97 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 109.571 -0.529 . . . . 55.310000000000002 109.571 177.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.499 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 97.4 m -125.69 126.91 45.42 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 107.137 -1.431 . . . . 74.329999999999998 107.137 176.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.669 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 59.2 mtpt -136.25 140.7 43.65 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.626 0.25 . . . . 70.340000000000003 110.939 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.427 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 4.2 tmt_? -156.74 132.94 9.8 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.116 -0.698 . . . . 64.209999999999994 109.116 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 3.4 mp0 -79.83 129.17 34.26 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 121.02 -0.272 . . . . 65.450000000000003 110.498 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.459 HG21 HG12 ' A' ' 431' ' ' VAL . 48.6 mt -136.14 121.12 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 106.117 -1.809 . . . . 60.32 106.117 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.67 3.23 19.94 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 121.421 -0.418 . . . . 52.32 113.765 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 112.06 -15.91 25.51 Favored Glycine 0 N--CA 1.433 -1.511 0 C-N-CA 120.7 -0.762 . . . . 64.120000000000005 112.627 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -102.82 141.79 35.03 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 109.77 -0.455 . . . . 75.409999999999997 109.77 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 91.9 m -87.65 124.25 33.34 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 116.43 -0.35 . . . . 63.030000000000001 110.888 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.669 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.7 OUTLIER -90.56 126.61 35.99 Favored 'General case' 0 N--CA 1.406 -2.632 0 C-N-CA 119.894 -0.722 . . . . 65.340000000000003 109.804 175.429 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -121.81 124.99 45.47 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.794 -0.817 . . . . 70.230000000000004 108.794 -175.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.499 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.4 p -125.1 124.33 67.28 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 109.888 -0.412 . . . . 71.230000000000004 109.888 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.491 HG22 ' HG3' ' A' ' 364' ' ' GLU . 44.2 t -113.67 116.29 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.692 -1.596 . . . . 72.120000000000005 106.692 173.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.432 ' CB ' ' HA ' ' A' ' 361' ' ' LYS . 96.6 m-85 -62.62 126.55 27.73 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.452 -0.794 . . . . 70.010000000000005 112.846 -173.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 72.78 14.88 4.89 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 125.104 1.362 . . . . 72.349999999999994 112.985 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -126.73 -83.1 0.62 Allowed 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 113.309 0.855 . . . . 72.120000000000005 113.309 174.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -163.3 156.45 19.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.138 0.792 . . . . 71.400000000000006 113.138 -170.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.485 HG22 HG23 ' A' ' 376' ' ' VAL . 91.6 t -116.8 145.2 22.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 124.081 0.952 . . . . 55.5 108.992 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -134.16 147.72 50.83 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.102 0.477 . . . . 73.219999999999999 111.389 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.502 ' HB2' HD23 ' A' ' 389' ' ' LEU . 35.9 tt0 -113.05 98.59 7.25 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.972 -1.862 . . . . 71.299999999999997 105.972 173.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.5 t70 72.45 -78.57 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 125.445 1.498 . . . . 64.329999999999998 109.266 -174.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 14.0 p -142.06 -3.06 1.11 Allowed 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 114.6 -1.182 . . . . 72.310000000000002 109.44 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 47.4 mm -80.47 132.01 32.72 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 N-CA-C 108.745 -0.835 . . . . 74.510000000000005 108.745 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 62.1 tp -75.91 113.86 13.89 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 108.797 -0.816 . . . . 63.219999999999999 108.797 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.564 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.3 OUTLIER -80.0 -63.88 1.31 Allowed 'General case' 0 N--CA 1.398 -3.052 0 N-CA-C 109.143 -0.688 . . . . 71.129999999999995 109.143 -176.865 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.06 156.64 27.89 Favored Glycine 0 N--CA 1.42 -2.408 0 C-N-CA 119.114 -1.517 . . . . 62.340000000000003 111.53 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -99.71 146.36 26.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.694 -1.595 . . . . 74.329999999999998 106.694 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.401 ' HD2' HE21 ' A' ' 395' ' ' GLN . 1.6 m-85 -71.27 116.01 11.09 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.282 -0.567 . . . . 73.120000000000005 109.917 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -92.28 -47.32 7.26 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.719 -0.673 . . . . 42.520000000000003 110.408 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 42.3 p -166.68 141.16 4.12 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.939 -0.763 . . . . 60.109999999999999 108.939 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.412 ' HB2' HD23 ' A' ' 400' ' ' LEU . 0.1 OUTLIER -142.11 145.71 34.57 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.53 -0.305 . . . . 75.450000000000003 110.265 178.657 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -128.14 110.23 12.26 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.753 -0.832 . . . . 71.319999999999993 108.753 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.59 -101.43 0.58 Allowed Glycine 0 N--CA 1.432 -1.58 0 O-C-N 123.918 0.761 . . . . 43.520000000000003 112.624 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' ASN . . . . . 0.572 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 27.4 p-10 -113.28 6.25 17.27 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.47 -0.365 . . . . 64.340000000000003 111.97 -176.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.96 116.27 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.186 0 N-CA-C 107.545 -1.28 . . . . 72.420000000000002 107.545 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.412 HD23 ' HB2' ' A' ' 395' ' ' GLN . 19.3 mt -114.4 123.84 50.45 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 116.057 -0.519 . . . . 74.310000000000002 110.119 -171.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.426 ' NZ ' ' HB3' ' A' ' 401' ' ' LYS . 3.2 mmmp? -108.58 122.34 46.88 Favored 'General case' 0 C--O 1.251 1.143 0 CA-C-O 120.748 0.309 . . . . 61.109999999999999 111.474 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.447 ' CE2' HG21 ' A' ' 382' ' ' VAL . 2.8 m-85 -115.68 133.82 55.65 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.413 -0.958 . . . . 72.109999999999999 108.413 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -135.11 171.3 14.62 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.553 -0.536 . . . . 62.210000000000001 109.553 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 54.45 41.1 32.16 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.342 1.238 . . . . 63.399999999999999 114.342 170.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -78.32 -139.86 1.54 Allowed Glycine 0 CA--C 1.541 1.659 0 C-N-CA 120.795 -0.717 . . . . 62.32 113.479 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -63.24 149.96 44.25 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.656 0.783 . . . . 72.209999999999994 110.907 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 412' ' ' PRO . 49.0 p -60.42 118.78 6.89 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 109.315 -0.624 . . . . 74.109999999999999 109.315 175.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 51.9 t -101.0 160.23 14.55 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.845 -0.616 . . . . 72.230000000000004 109.841 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -78.82 -31.58 45.91 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.345 0.593 . . . . 73.219999999999999 110.247 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' ASN . . . . . 0.644 ' HB3' ' SG ' ' A' ' 437' ' ' CYS . 14.2 t-20 -96.8 -11.57 24.75 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.859 0.838 . . . . 54.25 110.446 -171.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -160.2 160.54 31.77 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 109.31 -1.516 . . . . 55.329999999999998 109.31 -177.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.478 ' O ' ' HA ' ' A' ' 407' ' ' SER . 11.6 Cg_endo -56.97 -38.77 95.21 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.383 2.056 . . . . 70.430000000000007 113.958 -174.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -145.12 158.87 43.7 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.99 -0.374 . . . . 63.149999999999999 109.99 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -81.07 167.49 19.68 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 120.999 0.428 . . . . 74.319999999999993 111.046 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 56.4 p -162.93 160.17 24.52 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.261 -0.881 . . . . 65.540000000000006 109.064 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -157.18 136.62 12.11 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 121.21 0.528 . . . . 64.439999999999998 111.345 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.2 tt -101.43 121.86 52.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-N 115.253 -0.885 . . . . 72.150000000000006 110.42 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.529 HG22 ' HB ' ' A' ' 441' ' ' ILE . 3.9 t -108.57 129.53 62.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.635 -0.711 . . . . 72.540000000000006 111.746 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 13.4 p -109.84 114.89 28.82 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.188 -0.914 . . . . 75.340000000000003 108.896 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 34.1 t -100.43 114.09 38.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.871 -1.159 . . . . 62.049999999999997 107.871 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -114.12 -175.85 2.77 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 120.282 -0.567 . . . . 74.519999999999996 110.901 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 44.8 t -58.21 129.52 42.36 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.303 0.641 . . . . 64.340000000000003 111.442 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -159.94 -177.73 33.29 Favored Glycine 0 N--CA 1.434 -1.471 0 N-CA-C 110.343 -1.103 . . . . 73.219999999999999 110.343 177.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.35 -35.28 6.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.074 -0.713 . . . . 72.010000000000005 109.074 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -141.6 148.86 39.93 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.878 -0.601 . . . . 71.439999999999998 109.42 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.751 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.2 p-10 -67.68 99.12 0.76 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.816 -1.084 . . . . 53.43 109.977 174.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -132.43 149.9 52.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.174 -0.921 . . . . 62.140000000000001 110.526 -175.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.444 HD11 HG12 ' A' ' 376' ' ' VAL . 28.2 mm -81.28 120.7 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 106.065 -1.828 . . . . 74.310000000000002 106.065 175.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 50.4 t -86.77 -50.6 13.9 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 N-CA-C 111.84 0.311 . . . . 74.140000000000001 111.84 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 43.5 p -164.66 163.8 21.55 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 110.204 -0.295 . . . . 72.200000000000003 110.204 -174.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.459 HG12 HG21 ' A' ' 369' ' ' ILE . 3.4 p -142.0 117.07 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-O 121.403 0.62 . . . . 65.129999999999995 109.475 177.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 22.3 tp -114.31 134.99 54.56 Favored 'General case' 0 C--N 1.272 -2.803 0 N-CA-C 107.587 -1.264 . . . . 63.450000000000003 107.587 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -81.59 113.21 19.46 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 106.791 -1.559 . . . . 74.319999999999993 106.791 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.1 -60.8 2.1 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 108.872 -0.788 . . . . 62.020000000000003 108.872 -173.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.583 ' C ' ' HD2' ' A' ' 436' ' ' LYS . 49.9 mm-40 -107.04 -84.45 0.52 Allowed 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 106.884 -1.524 . . . . 72.019999999999996 106.884 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.583 ' HD2' ' C ' ' A' ' 435' ' ' GLN . 3.9 mptp? -147.66 -56.53 0.24 Allowed 'General case' 0 CA--C 1.5 -0.942 0 C-N-CA 124.468 1.107 . . . . 64.239999999999995 109.376 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 437' ' ' CYS . . . . . 0.644 ' SG ' ' HB3' ' A' ' 410' ' ' ASN . 57.3 m -90.97 -9.24 46.77 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.569 -1.196 . . . . 71.549999999999997 110.526 -176.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 415' ' ' SER . 33.8 tt0 -114.46 128.76 56.5 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 114.48 -1.237 . . . . 64.340000000000003 109.314 -175.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 44.2 m-85 -124.84 150.23 46.63 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 123.502 0.501 . . . . 61.340000000000003 110.412 -176.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.426 HD12 ' O ' ' A' ' 440' ' ' LEU . 4.3 pp -111.6 125.12 53.6 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.921 -1.511 . . . . 64.150000000000006 106.921 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.529 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.6 mt -122.16 133.13 69.4 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 116.234 -0.439 . . . . 65.430000000000007 110.602 -174.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -98.55 138.53 35.62 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 109.178 -0.675 . . . . 63.130000000000003 109.178 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.407 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.6 mtp -140.25 162.06 36.18 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 109.153 -0.684 . . . . 73.420000000000002 109.153 175.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.751 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.9 mmtt -132.22 161.08 34.31 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 107.257 -1.386 . . . . 72.409999999999997 107.257 175.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 36.2 t -167.42 147.01 4.46 Favored Pre-proline 0 C--N 1.286 -2.19 0 O-C-N 123.982 0.801 . . . . 73.329999999999998 109.03 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.0 -27.77 50.06 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.383 2.056 . . . . 74.209999999999994 111.339 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -78.24 -14.79 59.29 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.657 -0.701 . . . . 63.0 110.249 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -95.61 8.94 41.93 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 121.333 0.587 . . . . 43.340000000000003 110.227 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 14.0 t -102.59 121.47 42.46 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 108.476 -0.935 . . . . 64.329999999999998 108.476 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' SER . . . . . 0.714 ' HG ' ' N ' ' A' ' 357' ' ' TYR . 40.8 m . . . . . 0 C--N 1.306 -1.297 0 N-CA-C 108.825 -0.805 . . . . 73.120000000000005 108.825 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.491 ' N ' ' HG ' ' A' ' 450' ' ' SER . 81.6 m-85 . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 120.781 0.324 . . . . 74.400000000000006 110.589 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -161.41 -176.61 5.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.838 -0.43 . . . . 75.120000000000005 109.838 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -125.69 152.22 45.54 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.715 -1.217 . . . . 60.210000000000001 107.715 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 48.2 mm -80.9 138.8 19.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.707 -1.22 . . . . 73.25 107.707 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -117.75 157.35 26.7 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.856 0.36 . . . . 73.239999999999995 111.751 -172.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' GLY . . . . . 0.53 ' H ' ' HB2' ' A' ' 378' ' ' PHE . . . 86.67 -21.79 16.87 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 116.455 1.342 . . . . 63.149999999999999 116.455 172.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.15 155.89 19.54 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 118.603 1.201 . . . . 74.049999999999997 111.363 -175.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -88.67 113.7 24.5 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.901 -0.777 . . . . 61.130000000000003 108.901 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.479 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 26.1 m -104.5 120.45 41.3 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.123 -1.806 . . . . 70.120000000000005 106.123 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 58.5 mtpt -140.52 141.17 35.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 123.043 0.214 . . . . 71.340000000000003 110.472 -174.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -159.99 135.08 7.98 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.548 -0.908 . . . . 74.25 108.548 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 5.0 mp0 -79.15 125.28 29.23 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 109.952 -0.388 . . . . 72.430000000000007 109.952 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.437 HG21 HG12 ' A' ' 431' ' ' VAL . 49.5 mt -133.87 119.12 31.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 106.893 -1.521 . . . . 75.230000000000004 106.893 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.7 14.22 62.44 Favored Glycine 0 C--N 1.308 -0.973 0 C-N-CA 120.526 -0.845 . . . . 72.140000000000001 111.977 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 101.66 -15.98 56.69 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 121.417 -0.421 . . . . 63.299999999999997 112.956 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -105.17 136.77 44.05 Favored 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 120.684 -0.407 . . . . 74.200000000000003 110.502 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 47.5 m -78.16 123.77 27.28 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.182 -0.463 . . . . 74.010000000000005 111.234 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.689 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.6 OUTLIER -93.28 124.57 37.35 Favored 'General case' 0 N--CA 1.414 -2.237 0 C-N-CA 120.433 -0.507 . . . . 64.140000000000001 110.054 173.499 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 85.1 tttt -123.47 125.13 44.36 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.678 -0.692 . . . . 71.319999999999993 110.241 -175.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.479 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.5 p -128.26 116.59 42.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-O 121.141 0.496 . . . . 70.310000000000002 110.512 177.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.3 t -113.02 117.03 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 108.009 -1.108 . . . . 72.430000000000007 108.009 175.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.53 ' HB2' ' H ' ' A' ' 362' ' ' GLY . 42.6 m-85 -57.88 128.9 39.42 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 114.113 1.153 . . . . 75.099999999999994 114.113 -173.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 68.51 9.6 7.39 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 114.054 -1.43 . . . . 74.120000000000005 113.356 -178.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -116.3 -82.21 0.62 Allowed 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.193 0.812 . . . . 74.099999999999994 113.193 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -170.13 158.85 7.15 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 112.842 0.682 . . . . 45.140000000000001 112.842 -172.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 99.3 t -114.01 145.34 19.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 124.361 1.064 . . . . 75.140000000000001 108.878 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -133.1 150.2 52.09 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.242 0.544 . . . . 73.209999999999994 111.452 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.556 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.1 tt0 -119.5 97.26 5.56 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 106.026 -1.842 . . . . 72.540000000000006 106.026 173.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.8 t70 70.43 -81.47 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 125.596 1.559 . . . . 75.340000000000003 111.392 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 17.8 m -135.53 0.73 2.78 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.345 -0.983 . . . . 53.310000000000002 108.345 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 48.4 mm -96.07 134.86 32.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.869 -0.605 . . . . 72.439999999999998 109.976 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.8 tp -76.45 115.31 16.08 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.702 -0.851 . . . . 73.239999999999995 108.702 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.556 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.5 OUTLIER -80.41 -65.22 1.04 Allowed 'General case' 0 N--CA 1.393 -3.308 0 N-CA-C 109.366 -0.605 . . . . 63.450000000000003 109.366 -175.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -156.46 156.1 26.85 Favored Glycine 0 N--CA 1.42 -2.383 0 C-N-CA 118.817 -1.659 . . . . 73.409999999999997 112.168 -177.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -99.48 143.39 29.79 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.922 -1.51 . . . . 71.030000000000001 106.922 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 2.4 m-85 -71.22 115.95 10.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.584 0.231 . . . . 73.409999999999997 110.482 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -101.74 -47.7 4.53 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.352 -0.386 . . . . 71.140000000000001 111.46 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 39.3 p -157.38 140.24 15.1 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 110.083 -0.34 . . . . 62.439999999999998 110.083 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.605 ' HB2' ' HG ' ' A' ' 400' ' ' LEU . 0.1 OUTLIER -147.25 145.5 29.44 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 116.121 -0.49 . . . . 52.420000000000002 111.13 178.263 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -128.97 110.86 12.44 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.838 -0.619 . . . . 73.510000000000005 109.473 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.8 -102.54 0.77 Allowed Glycine 0 C--N 1.31 -0.883 0 CA-C-N 115.877 -0.601 . . . . 61.109999999999999 113.956 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -116.43 17.7 15.39 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.146 0.498 . . . . 75.430000000000007 111.468 -176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.4 t -128.85 116.35 40.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 107.565 -1.272 . . . . 72.129999999999995 107.565 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.605 ' HG ' ' HB2' ' A' ' 395' ' ' GLN . 5.3 mp -120.07 139.61 52.28 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.63 0.604 . . . . 75.129999999999995 112.63 -173.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -112.32 122.69 48.42 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 115.596 -0.729 . . . . 71.099999999999994 111.885 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.41 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.9 m-85 -118.72 135.97 54.2 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.749 -1.204 . . . . 62.329999999999998 107.749 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -146.92 174.55 11.4 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-O 121.496 0.665 . . . . 71.239999999999995 112.719 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 64.13 33.41 11.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.609 -1.632 . . . . 73.340000000000003 112.953 168.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -72.22 -136.81 0.21 Allowed Glycine 0 CA--C 1.537 1.448 0 CA-C-N 115.599 -0.728 . . . . 53.399999999999999 113.437 176.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.58 137.92 46.49 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.567 -0.901 . . . . 72.310000000000002 108.567 -175.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 19.0 p -63.66 117.77 7.29 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 124.043 0.937 . . . . 75.329999999999998 112.332 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 7.2 p -94.92 158.81 15.32 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.266 -0.879 . . . . 62.25 108.966 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 14.3 p-90 -77.19 -40.24 45.92 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.81 -0.756 . . . . 74.319999999999993 109.868 -176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -83.07 1.89 37.88 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 113.222 0.823 . . . . 73.510000000000005 113.222 -175.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -152.77 -163.72 11.89 Favored Glycine 0 C--N 1.304 -1.221 0 N-CA-C 109.524 -1.43 . . . . 51.130000000000003 109.524 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -95.17 -40.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.317 0 CA-C-N 119.753 1.776 . . . . 74.0 113.258 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -159.71 152.13 21.11 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 107.997 -1.112 . . . . 71.019999999999996 107.997 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.424 ' HA ' ' HB3' ' A' ' 437' ' ' CYS . 89.7 mtt180 -71.39 159.34 34.72 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.299 0.571 . . . . 73.25 111.797 174.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 41.9 p -161.04 162.23 31.65 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.755 -1.112 . . . . 71.430000000000007 109.215 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -158.19 148.39 20.18 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-O 121.404 0.621 . . . . 52.229999999999997 110.862 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.2 tt -117.18 120.4 64.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 CA-C-N 115.15 -0.932 . . . . 72.319999999999993 110.022 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.536 HG22 ' HB ' ' A' ' 441' ' ' ILE . 8.7 t -105.2 127.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 115.663 -0.699 . . . . 74.430000000000007 111.978 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 8.7 p -108.48 114.7 28.74 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.632 -1.167 . . . . 75.209999999999994 108.559 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 38.9 t -100.88 112.8 34.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 107.595 -1.261 . . . . 71.049999999999997 107.595 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -111.73 -175.36 2.67 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 120.847 0.356 . . . . 63.450000000000003 110.716 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.619 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 36.0 t -57.77 128.23 36.0 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 124.321 1.048 . . . . 62.509999999999998 110.981 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.641 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -158.1 -177.82 31.56 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.925 -0.655 . . . . 64.209999999999994 111.676 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.35 -36.37 8.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.336 -0.616 . . . . 65.209999999999994 109.336 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -150.0 153.47 36.59 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.772 -0.825 . . . . 75.420000000000002 108.772 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.803 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.7 OUTLIER -73.03 98.54 2.55 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.59 0.71 . . . . 71.099999999999994 112.238 178.058 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -131.53 149.94 52.33 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.211 -1.359 . . . . 44.130000000000003 109.46 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 28.2 mm -78.64 118.16 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 106.306 -1.739 . . . . 72.329999999999998 106.306 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 55.5 t -80.77 -51.2 16.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 111.984 0.365 . . . . 70.239999999999995 111.984 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 33.0 t -167.06 165.22 15.81 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 109.184 -0.673 . . . . 74.129999999999995 109.184 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.437 HG12 HG21 ' A' ' 369' ' ' ILE . 4.3 p -141.39 119.12 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 108.627 -0.879 . . . . 63.130000000000003 108.627 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 432' ' ' LEU . . . . . 0.437 ' O ' HD23 ' A' ' 440' ' ' LEU . 25.4 tp -118.79 137.35 53.44 Favored 'General case' 0 C--N 1.271 -2.816 0 N-CA-C 107.923 -1.14 . . . . 70.109999999999999 107.923 -175.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -80.96 111.74 17.71 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.787 -0.82 . . . . 64.109999999999999 108.787 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -72.24 -54.48 9.48 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.419 -0.809 . . . . 75.209999999999994 110.269 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -116.94 -73.87 0.63 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.253 -1.017 . . . . 65.319999999999993 108.253 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -164.23 -51.79 0.03 OUTLIER 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.19 -1.368 . . . . 65.230000000000004 109.821 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' CYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 414' ' ' ARG . 72.1 m -103.27 -9.23 19.7 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.416 -0.811 . . . . 61.299999999999997 109.167 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.5 tt0 -113.07 132.46 55.41 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.675 -1.148 . . . . 71.010000000000005 109.029 -176.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 439' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 37.3 m-85 -128.02 150.32 49.98 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.048 -0.524 . . . . 74.439999999999998 110.516 -175.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.7 pt? -109.52 119.79 40.51 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.203 -1.036 . . . . 75.349999999999994 108.203 172.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.536 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.3 mt -116.24 136.18 54.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 115.287 -0.869 . . . . 71.150000000000006 109.464 -175.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -108.46 141.07 40.86 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 109.187 -0.671 . . . . 62.219999999999999 109.187 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 83.1 mtp -136.1 168.18 19.86 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.923 -1.14 . . . . 43.100000000000001 107.923 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.803 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 34.2 mmtp -134.05 161.34 35.13 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.002 -1.11 . . . . 71.010000000000005 108.002 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 33.9 t -162.68 145.9 8.7 Favored Pre-proline 0 C--N 1.291 -1.958 0 N-CA-C 108.455 -0.943 . . . . 71.420000000000002 108.455 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.98 -27.43 66.3 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.452 2.101 . . . . 74.129999999999995 111.863 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.68 -12.28 56.1 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.355 0.598 . . . . 44.520000000000003 110.976 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -95.02 11.48 31.86 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 115.668 -0.696 . . . . 62.020000000000003 109.782 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' CYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 422' ' ' CYS . 14.0 t -103.18 120.76 41.31 Favored 'General case' 0 N--CA 1.412 -2.325 0 N-CA-C 107.51 -1.293 . . . . 74.510000000000005 107.51 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 450' ' ' SER . . . . . 0.491 ' HG ' ' N ' ' A' ' 357' ' ' TYR . 50.8 m . . . . . 0 C--N 1.3 -1.544 0 CA-C-O 118.408 -0.806 . . . . 64.230000000000004 109.02 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.596 ' N ' ' HG ' ' A' ' 450' ' ' SER . 73.5 m-85 . . . . . 0 CA--C 1.509 -0.617 0 N-CA-C 107.334 -1.358 . . . . 73.519999999999996 107.334 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -91.69 177.4 6.22 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.24 -0.652 . . . . 71.329999999999998 109.24 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -68.3 154.04 42.55 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.548 -0.538 . . . . 51.310000000000002 109.548 175.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 51.4 mm -79.53 129.96 36.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-O 121.527 0.68 . . . . 43.219999999999999 111.247 -171.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -71.07 136.32 48.21 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.664 -1.153 . . . . 71.109999999999999 111.252 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 60.63 58.78 12.11 Favored Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 117.248 1.659 . . . . 61.020000000000003 117.248 170.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 45.2 mtm -142.35 162.57 35.14 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.972 -0.751 . . . . 72.140000000000001 108.972 170.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -94.42 139.36 31.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.271 -0.64 . . . . 64.0 109.271 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.525 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 87.8 m -125.49 120.94 32.31 Favored 'General case' 0 C--N 1.264 -3.109 0 N-CA-C 107.163 -1.421 . . . . 72.310000000000002 107.163 168.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 10.0 ptmt -139.09 141.08 38.16 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.299 -0.409 . . . . 74.349999999999994 110.678 -174.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.418 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 3.7 tmt_? -159.94 138.44 10.44 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.112 -1.44 . . . . 73.310000000000002 107.112 -174.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 46.4 mt-10 -89.19 127.22 35.73 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.611 -0.514 . . . . 73.409999999999997 109.611 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.502 HG21 HG12 ' A' ' 431' ' ' VAL . 44.6 mt -135.94 121.98 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 N-CA-C 106.867 -1.531 . . . . 74.040000000000006 106.867 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.66 12.64 59.62 Favored Glycine 0 C--N 1.306 -1.12 0 C-N-CA 120.571 -0.823 . . . . 54.200000000000003 112.883 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.98 -20.27 33.79 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 121.066 -0.588 . . . . 32.030000000000001 112.828 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' TYR . . . . . 0.434 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 12.1 p90 -105.05 146.65 28.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 122.802 -0.234 . . . . 74.409999999999997 110.515 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 60.4 m -86.51 126.51 34.49 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 120.957 -0.297 . . . . 75.099999999999994 110.471 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.6 OUTLIER -91.61 126.39 36.68 Favored 'General case' 0 N--CA 1.406 -2.651 0 N-CA-C 109.389 -0.597 . . . . 73.439999999999998 109.389 172.696 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 42.2 tttp -121.59 124.34 44.11 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.691 -0.855 . . . . 74.109999999999999 108.691 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.525 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.1 p -128.68 123.53 59.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 109.637 -0.505 . . . . 72.310000000000002 109.637 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 36.2 t -117.16 117.88 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 N-CA-C 108.083 -1.08 . . . . 73.299999999999997 108.083 174.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.412 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 90.1 m-85 -53.22 125.32 17.18 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 124.393 1.058 . . . . 63.32 112.965 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 69.35 12.43 8.33 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 125.189 1.395 . . . . 63.210000000000001 113.857 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -117.64 -91.22 0.55 Allowed 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 112.872 0.693 . . . . 61.329999999999998 112.872 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -161.13 157.3 25.71 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.732 0.642 . . . . 74.010000000000005 112.732 -173.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.471 HG22 HG23 ' A' ' 376' ' ' VAL . 82.5 t -113.69 144.24 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 124.115 0.966 . . . . 73.129999999999995 109.525 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -133.73 147.13 51.31 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.007 0.432 . . . . 74.430000000000007 111.355 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.466 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.8 tt0 -113.4 98.75 7.29 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.557 -1.646 . . . . 73.219999999999999 106.557 173.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.1 t70 70.17 -77.06 0.06 Allowed 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 124.886 1.274 . . . . 62.43 110.032 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.0 m -138.24 -6.38 1.59 Allowed 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.25 -0.886 . . . . 73.400000000000006 109.013 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 62.2 mt -84.88 134.76 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 116.257 -0.429 . . . . 71.439999999999998 109.905 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 406' ' ' GLN . 56.4 tp -76.53 113.49 14.2 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.228 -1.027 . . . . 72.409999999999997 108.228 176.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.595 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -79.2 -63.85 1.32 Allowed 'General case' 0 N--CA 1.392 -3.337 0 N-CA-C 109.069 -0.715 . . . . 73.519999999999996 109.069 -176.13 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.53 156.82 28.18 Favored Glycine 0 N--CA 1.416 -2.65 0 C-N-CA 119.53 -1.319 . . . . 54.140000000000001 111.641 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -99.34 147.18 25.48 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.955 -1.128 . . . . 72.340000000000003 107.955 175.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.412 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 2.2 m-85 -67.61 116.87 8.81 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.081 0.467 . . . . 74.109999999999999 111.233 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -97.87 -47.85 5.4 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.728 -0.669 . . . . 63.119999999999997 111.318 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 28.3 m -155.08 149.51 26.2 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.065 -0.346 . . . . 61.240000000000002 110.065 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.458 ' CG ' ' HG ' ' A' ' 400' ' ' LEU . 13.8 mp0 -132.91 130.55 39.79 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 106.961 -1.496 . . . . 70.400000000000006 106.961 172.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -127.67 110.62 12.85 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.5 -0.926 . . . . 61.130000000000003 108.5 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 67.72 -101.82 0.76 Allowed Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.951 -0.568 . . . . 64.349999999999994 111.749 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -122.43 19.82 10.46 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.332 0.587 . . . . 73.129999999999995 109.907 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 46.6 t -118.37 119.07 60.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 108.273 -1.01 . . . . 71.010000000000005 108.273 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.458 ' HG ' ' CG ' ' A' ' 395' ' ' GLN . 4.9 mp -114.87 129.7 56.75 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.243 0.544 . . . . 61.109999999999999 110.619 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -113.55 125.86 54.66 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.906 -0.588 . . . . 72.010000000000005 110.265 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -118.72 136.67 53.82 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.282 -1.007 . . . . 74.120000000000005 108.282 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -144.39 174.17 11.15 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 110.315 -0.254 . . . . 61.420000000000002 110.315 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 60.17 41.7 16.5 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.722 0.809 . . . . 63.32 112.205 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.7 -138.74 1.17 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.471 -0.871 . . . . 64.530000000000001 112.039 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' GLN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 21.2 tm0? -81.28 140.62 34.73 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.793 -0.817 . . . . 64.340000000000003 108.793 -178.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 47.0 m -60.73 123.68 18.18 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.551 0.945 . . . . 74.439999999999998 113.551 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 15.5 p -100.58 159.21 15.34 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 106.786 -1.561 . . . . 61.240000000000002 106.786 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -82.08 -28.54 32.3 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 119.146 0.884 . . . . 75.420000000000002 110.411 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -88.56 -8.48 54.7 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.585 -0.734 . . . . 74.430000000000007 110.56 -172.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -145.25 -168.71 13.11 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 109.18 -1.568 . . . . 73.200000000000003 109.18 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -85.96 -40.91 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.101 0 CA-C-N 120.018 1.909 . . . . 71.319999999999993 112.792 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' HIS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 96.0 m-70 -163.39 154.36 16.53 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 107.389 -1.337 . . . . 61.409999999999997 107.389 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -69.0 159.08 33.48 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-O 121.287 0.565 . . . . 64.25 111.707 174.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 49.0 p -161.6 164.46 29.38 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 114.762 -1.108 . . . . 74.200000000000003 109.144 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -158.7 151.02 21.58 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.123 0.487 . . . . 54.200000000000003 110.254 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 11.5 tt -118.53 124.39 73.06 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 CA-C-N 115.478 -0.783 . . . . 64.409999999999997 109.342 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.532 HG22 ' HB ' ' A' ' 441' ' ' ILE . 5.2 t -111.31 129.61 66.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.534 0.683 . . . . 75.310000000000002 112.093 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 14.4 p -111.45 115.17 28.78 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 115.04 -0.982 . . . . 73.450000000000003 109.094 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 47.5 t -100.69 111.86 31.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.96 -0.756 . . . . 61.109999999999999 108.96 -177.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -113.52 -174.26 2.43 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 120.662 -0.415 . . . . 63.32 111.084 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 19.6 t -59.13 127.19 30.96 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.515 0.674 . . . . 73.310000000000002 112.763 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.545 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -154.26 -177.58 27.8 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 110.039 -1.224 . . . . 74.150000000000006 110.039 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.57 -28.19 4.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.635 0.731 . . . . 64.409999999999997 109.041 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -145.5 151.07 37.59 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.161 -0.927 . . . . 73.439999999999998 108.801 -177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.674 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.9 OUTLIER -71.15 98.82 1.75 Allowed 'General case' 0 C--N 1.309 -1.167 0 O-C-N 124.033 0.833 . . . . 32.119999999999997 110.191 175.367 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -132.51 148.59 52.39 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-N 115.225 -0.898 . . . . 64.030000000000001 111.42 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 367' ' ' ARG . 30.8 mm -81.8 120.31 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 106.043 -1.836 . . . . 63.350000000000001 106.043 174.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.445 HG21 ' HG2' ' A' ' 444' ' ' LYS . 53.3 t -86.29 -50.49 14.18 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 116.228 -0.442 . . . . 75.140000000000001 112.139 -176.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 44.0 m -159.95 160.73 33.78 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.401 -0.592 . . . . 63.210000000000001 109.401 -175.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.502 HG12 HG21 ' A' ' 369' ' ' ILE . 3.6 p -141.14 111.65 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-O 122.017 0.913 . . . . 32.039999999999999 108.763 176.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 432' ' ' LEU . . . . . 0.429 ' O ' HD23 ' A' ' 440' ' ' LEU . 28.7 tp -110.94 136.53 49.82 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 115.321 -0.854 . . . . 73.439999999999998 108.711 -177.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -80.92 110.17 16.2 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.489 -0.93 . . . . 63.32 108.489 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -71.47 -36.85 71.33 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.37 -0.832 . . . . 70.519999999999996 111.06 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -142.07 -73.85 0.31 Allowed 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.564 -0.744 . . . . 64.510000000000005 109.308 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.455 ' HB3' ' NZ ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -163.69 -49.01 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 116.112 -0.495 . . . . 74.530000000000001 110.899 175.362 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 75.7 m -98.04 -3.9 37.15 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.532 0.682 . . . . 71.030000000000001 110.107 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 415' ' ' SER . 34.5 tt0 -124.82 131.39 53.45 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.401 -0.818 . . . . 71.0 109.317 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -126.95 150.6 49.29 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.61 -0.723 . . . . 60.219999999999999 110.32 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.6 pt? -109.85 121.11 44.49 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.013 -1.106 . . . . 75.230000000000004 108.013 172.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.532 ' HB ' HG22 ' A' ' 418' ' ' VAL . 97.1 mt -115.51 132.87 63.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 CA-C-N 115.454 -0.794 . . . . 53.32 110.324 -175.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -98.85 136.8 38.34 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.449 -0.945 . . . . 73.349999999999994 108.449 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.459 ' SD ' HG11 ' A' ' 418' ' ' VAL . 82.6 mtp -137.46 157.73 45.93 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 109.835 -0.431 . . . . 55.229999999999997 109.835 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 31.7 mmtp -131.71 153.15 50.32 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.629 -1.249 . . . . 74.150000000000006 107.629 175.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 69.8 m -156.92 149.09 17.65 Favored Pre-proline 0 C--N 1.288 -2.096 0 N-CA-C 108.615 -0.883 . . . . 65.310000000000002 108.615 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 39.0 Cg_endo -67.66 -28.13 37.76 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 121.921 1.747 . . . . 74.129999999999995 111.975 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -76.28 -22.46 55.05 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.737 -0.665 . . . . 72.010000000000005 111.022 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -84.16 0.46 48.52 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.741 0.781 . . . . 71.409999999999997 109.399 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 11.4 t -103.92 118.65 37.19 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 107.576 -1.268 . . . . 73.519999999999996 107.576 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' SER . . . . . 0.596 ' HG ' ' N ' ' A' ' 357' ' ' TYR . 52.9 m . . . . . 0 C--N 1.296 -1.742 0 N-CA-C 107.935 -1.135 . . . . 51.399999999999999 107.935 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 109.298 -0.63 . . . . 73.200000000000003 109.298 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.425 ' HB3' ' HB3' ' A' ' 398' ' ' ASN . 98.7 mtt180 -78.64 -17.54 55.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.345 0.593 . . . . 72.319999999999993 111.173 -178.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -139.43 151.79 46.53 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.059 -0.719 . . . . 73.420000000000002 109.059 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 49.7 mm -81.59 116.26 25.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.886 -0.783 . . . . 62.100000000000001 108.886 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -78.81 157.26 28.43 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.924 -0.58 . . . . 75.099999999999994 111.846 -174.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 77.19 -47.16 2.58 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 114.879 0.712 . . . . 72.019999999999996 114.879 174.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 52.6 ttp -57.59 136.83 56.81 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.431 0.634 . . . . 71.25 112.64 -175.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.455 ' HB3' HG22 ' A' ' 377' ' ' VAL . 8.0 pt-20 -93.95 110.52 22.19 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.197 -0.911 . . . . 70.420000000000002 111.476 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 85.3 m -103.97 139.62 38.85 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.491 -0.929 . . . . 51.240000000000002 108.491 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.428 ' HB3' ' HG3' ' A' ' 375' ' ' LYS . 0.0 OUTLIER -145.73 151.89 38.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 118.344 0.52 . . . . 71.409999999999997 111.591 -177.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.511 HH11 HG12 ' A' ' 369' ' ' ILE . 4.1 tmt_? -161.6 135.47 6.68 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.132 -0.692 . . . . 74.219999999999999 109.132 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.22 125.97 30.18 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 110.275 -0.268 . . . . 71.030000000000001 110.275 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.553 HG21 HG12 ' A' ' 431' ' ' VAL . 37.2 mt -134.19 119.79 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.828 -1.545 . . . . 74.409999999999997 106.828 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.66 12.64 59.62 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 121.164 -0.541 . . . . 65.209999999999994 112.07 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 105.78 -23.19 30.19 Favored Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 121.603 -0.332 . . . . 41.329999999999998 112.352 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' TYR . . . . . 0.456 ' CD1' ' HG3' ' A' ' 384' ' ' GLN . 16.0 p90 -98.19 136.76 37.93 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 121.184 0.516 . . . . 70.099999999999994 110.548 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 98.9 m -79.54 116.23 19.63 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 115.525 -0.761 . . . . 64.030000000000001 110.556 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.12 133.58 34.78 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 107.868 -1.16 . . . . 65.519999999999996 107.868 175.001 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.428 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 36.8 ttpt -133.34 130.78 39.3 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.211 -0.595 . . . . 62.340000000000003 109.599 -175.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.409 HG23 HG22 ' A' ' 382' ' ' VAL . 7.2 p -124.0 115.92 46.42 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 O-C-N 123.584 0.552 . . . . 73.439999999999998 110.056 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.455 HG22 ' HB3' ' A' ' 364' ' ' GLU . 47.8 t -108.53 116.45 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.563 -1.273 . . . . 74.319999999999993 107.563 175.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -63.76 126.2 26.82 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 113.895 1.072 . . . . 61.32 113.895 -173.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 73.03 10.66 5.27 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 125.997 1.719 . . . . 64.200000000000003 113.117 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.8 -84.49 0.65 Allowed 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 112.489 0.552 . . . . 75.530000000000001 112.489 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -166.38 159.62 14.9 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.99 0.737 . . . . 74.120000000000005 112.99 -172.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.409 HG22 HG23 ' A' ' 376' ' ' VAL . 98.7 t -113.74 145.75 19.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 124.642 1.177 . . . . 72.430000000000007 109.141 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -132.77 152.43 51.77 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 122.973 0.509 . . . . 64.319999999999993 111.986 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.493 ' HB2' HD23 ' A' ' 389' ' ' LEU . 35.2 tt0 -124.76 102.04 7.38 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.347 -1.723 . . . . 71.120000000000005 106.347 173.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 14.3 t70 69.64 -83.84 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.564 1.146 . . . . 73.299999999999997 109.543 -175.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.3 m -133.28 -7.37 2.97 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 108.608 -0.886 . . . . 53.140000000000001 108.608 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 63.0 mt -80.59 132.91 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.388 -0.823 . . . . 33.140000000000001 110.127 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 64.8 tp -76.9 109.97 11.13 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.499 -0.926 . . . . 72.200000000000003 108.499 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.2 OUTLIER -77.67 -65.4 0.97 Allowed 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 109.111 -0.7 . . . . 71.209999999999994 109.111 -176.67 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.23 153.58 24.66 Favored Glycine 0 N--CA 1.424 -2.103 0 C-N-CA 119.26 -1.448 . . . . 63.130000000000003 111.64 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -99.46 144.76 28.19 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.711 -1.218 . . . . 61.140000000000001 107.711 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -73.02 116.3 13.38 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.267 -0.642 . . . . 75.109999999999999 109.267 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -111.21 -47.99 3.14 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.939 -0.573 . . . . 72.310000000000002 110.863 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 18.7 m -145.63 138.96 26.29 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.504 -0.925 . . . . 62.240000000000002 108.504 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.478 ' HB2' HD22 ' A' ' 400' ' ' LEU . 9.8 pt20 -147.4 145.32 29.21 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 120.938 0.399 . . . . 72.230000000000004 110.84 173.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -121.17 110.24 15.95 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 115.649 -0.705 . . . . 62.140000000000001 109.535 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.19 -104.27 0.79 Allowed Glycine 0 N--CA 1.436 -1.339 0 CA-C-N 115.265 -0.88 . . . . 64.549999999999997 113.823 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' ASN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 358' ' ' ARG . 4.5 p-10 -116.83 18.2 14.87 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.128 0.489 . . . . 73.030000000000001 111.187 -176.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.3 t -125.15 116.09 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 105.159 -2.163 . . . . 64.230000000000004 105.159 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.478 HD22 ' HB2' ' A' ' 395' ' ' GLN . 13.6 mt -118.63 136.28 53.98 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.862 -0.735 . . . . 53.039999999999999 111.241 -168.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.414 ' HE3' HD12 ' A' ' 417' ' ' ILE . 20.6 mmtp -107.43 124.09 49.35 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.498 0.666 . . . . 74.310000000000002 112.076 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.402 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 2.9 m-85 -117.08 125.88 51.98 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.77 -1.566 . . . . 75.239999999999995 106.77 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -139.77 175.86 9.22 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 110.113 -0.329 . . . . 75.120000000000005 110.113 -176.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 64.93 33.3 10.0 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.856 0.722 . . . . 71.209999999999994 112.503 173.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.6 -141.23 1.17 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.785 -0.722 . . . . 73.140000000000001 113.054 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.77 142.11 38.86 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.95 -1.13 . . . . 73.219999999999999 107.95 -177.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.3 m -60.79 134.74 57.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.413 0.625 . . . . 32.219999999999999 111.687 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 14.6 p -132.38 159.46 39.17 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.679 -0.691 . . . . 74.310000000000002 110.472 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -66.88 137.38 56.53 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.735 0.302 . . . . 72.25 111.615 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 80.4 -29.8 0.13 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.84 1.656 . . . . 51.130000000000003 112.426 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -107.41 174.52 19.66 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.191 -0.764 . . . . 53.229999999999997 111.191 177.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -79.51 -40.5 0.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.483 1.456 . . . . 62.409999999999997 111.878 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -163.1 162.45 25.7 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 105.157 -2.164 . . . . 75.420000000000002 105.157 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -69.32 156.33 38.97 Favored 'General case' 0 C--O 1.256 1.407 0 C-N-CA 119.641 -0.824 . . . . 75.120000000000005 111.568 174.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 23.7 p -157.59 158.92 36.48 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-N 114.67 -1.15 . . . . 55.020000000000003 109.192 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -154.03 149.01 26.73 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.26 0.552 . . . . 74.310000000000002 110.656 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 417' ' ' ILE . . . . . 0.414 HD12 ' HE3' ' A' ' 401' ' ' LYS . 8.4 tt -118.99 123.81 72.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 CA-C-N 115.107 -0.951 . . . . 74.5 109.816 175.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.616 HG22 ' HB ' ' A' ' 441' ' ' ILE . 4.1 t -109.85 130.66 62.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 115.785 -0.643 . . . . 65.299999999999997 111.231 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 20.5 p -108.46 115.01 29.3 Favored 'General case' 0 N--CA 1.409 -2.525 0 N-CA-C 108.322 -0.992 . . . . 64.450000000000003 108.322 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 38.5 t -100.36 114.72 39.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.039 -1.467 . . . . 74.049999999999997 107.039 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.02 -173.94 2.55 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.915 -0.314 . . . . 71.239999999999995 110.556 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.525 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 38.3 t -60.5 127.92 34.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.235 0.54 . . . . 75.420000000000002 111.71 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.607 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -156.36 -179.7 31.57 Favored Glycine 0 CA--C 1.485 -1.808 0 N-CA-C 110.535 -1.026 . . . . 74.400000000000006 110.535 177.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.08 -35.32 7.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.899 -0.778 . . . . 72.310000000000002 108.899 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -143.79 152.16 40.87 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.367 -0.833 . . . . 72.319999999999993 109.722 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.721 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.9 OUTLIER -69.57 97.95 1.09 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.034 -0.985 . . . . 52.229999999999997 110.586 175.725 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -132.16 149.56 52.36 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.851 -1.068 . . . . 54.409999999999997 109.906 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 369' ' ' ILE . 32.6 mm -84.35 119.41 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 105.993 -1.855 . . . . 54.409999999999997 105.993 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 54.8 t -83.86 -51.04 14.65 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 CA-C-N 116.409 -0.36 . . . . 70.040000000000006 111.623 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 38.5 p -165.26 167.97 17.43 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 120.914 -0.314 . . . . 71.230000000000004 110.674 -175.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.553 HG12 HG21 ' A' ' 369' ' ' ILE . 3.3 p -142.19 126.25 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 N-CA-C 109.124 -0.695 . . . . 50.100000000000001 109.124 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' LEU . . . . . 0.438 ' O ' HD23 ' A' ' 440' ' ' LEU . 28.1 tp -126.82 137.96 53.27 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.885 -0.783 . . . . 73.540000000000006 108.885 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -81.07 113.0 18.96 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.291 -1.003 . . . . 75.420000000000002 108.291 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.02 -50.81 18.13 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-N 115.715 -0.675 . . . . 74.120000000000005 110.226 -174.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' GLN . . . . . 0.539 ' C ' ' HD2' ' A' ' 436' ' ' LYS . 49.4 mt-30 -121.47 -82.24 0.65 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.236 -0.893 . . . . 65.329999999999998 108.753 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.539 ' HD2' ' C ' ' A' ' 435' ' ' GLN . 0.2 OUTLIER -145.31 -61.73 0.34 Allowed 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 108.26 -1.015 . . . . 74.019999999999996 108.26 177.025 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 92.3 m -93.64 -7.96 42.38 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.158 -1.383 . . . . 53.299999999999997 111.693 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 415' ' ' SER . 35.6 tt0 -110.39 128.6 55.66 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-N 115.291 -0.868 . . . . 64.409999999999997 109.077 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 46.4 m-85 -124.48 149.72 46.53 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.757 -0.656 . . . . 74.099999999999994 109.785 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.445 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.5 pt? -111.47 119.54 39.12 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.341 -0.615 . . . . 74.219999999999999 109.341 175.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.616 ' HB ' HG22 ' A' ' 418' ' ' VAL . 3.8 mp -109.62 133.9 53.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.87 -0.604 . . . . 63.520000000000003 109.883 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -96.25 135.82 37.56 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 108.397 -0.964 . . . . 62.340000000000003 108.397 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 81.8 mtp -138.01 160.53 39.12 Favored 'General case' 0 CA--C 1.478 -1.802 0 N-CA-C 109.678 -0.49 . . . . 74.329999999999998 109.678 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.721 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 73.8 mmtt -131.05 160.96 33.11 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.743 -1.206 . . . . 73.319999999999993 107.743 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 40.8 t -165.45 145.04 5.49 Favored Pre-proline 0 C--N 1.284 -2.252 0 O-C-N 124.118 0.886 . . . . 71.25 109.023 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -66.42 -27.36 47.13 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.04 1.826 . . . . 75.319999999999993 110.618 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -76.52 -17.81 59.05 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.327 -0.851 . . . . 74.519999999999996 111.182 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -97.12 11.99 34.3 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.546 0.688 . . . . 70.530000000000001 110.128 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 16.9 t -102.81 141.02 36.32 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 115.414 -0.812 . . . . 64.209999999999994 108.988 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 N--CA 1.417 -2.081 0 N-CA-C 107.305 -1.368 . . . . 64.109999999999999 107.305 -179.25 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 . . . . . 0 CA--C 1.51 -0.574 0 N-CA-C 109.204 -0.665 . . . . 72.400000000000006 109.204 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 0.0 OUTLIER 55.35 -161.11 0.17 Allowed 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.729 0.643 . . . . 73.329999999999998 110.962 -178.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -91.9 154.55 18.78 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.766 -1.198 . . . . 64.239999999999995 107.766 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 360' ' ' ILE . 2.4 mp -78.55 120.52 29.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.866 0.841 . . . . 74.450000000000003 110.417 -172.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.517 ' HG2' ' CD1' ' A' ' 379' ' ' TYR . 54.1 mtpt -68.92 153.89 43.0 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 114.084 -1.416 . . . . 72.420000000000002 112.395 -175.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 89.75 -58.84 3.68 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.407 -0.815 . . . . 54.039999999999999 115.05 173.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 59.0 mtm -62.7 140.21 58.7 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.079 0.466 . . . . 75.5 112.223 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -85.59 114.8 22.87 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.76 -1.57 . . . . 63.350000000000001 106.76 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.562 ' HB ' HG13 ' A' ' 376' ' ' VAL . 84.7 m -94.87 130.3 41.52 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 106.388 -1.708 . . . . 64.109999999999999 106.388 176.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 0.0 OUTLIER -143.49 150.23 38.67 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.418 -0.913 . . . . 52.210000000000001 111.108 -175.399 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -162.37 136.48 6.49 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.741 -0.836 . . . . 62.520000000000003 108.741 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -77.81 124.98 28.65 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 109.815 -0.439 . . . . 70.230000000000004 109.815 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.508 HG21 HG12 ' A' ' 431' ' ' VAL . 56.4 mt -134.82 118.99 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 N-CA-C 106.883 -1.525 . . . . 73.040000000000006 106.883 -178.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.49 13.59 60.93 Favored Glycine 0 C--N 1.305 -1.139 0 C-N-CA 120.538 -0.839 . . . . 62.399999999999999 112.675 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 105.56 -17.78 42.35 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 120.997 -0.62 . . . . 73.340000000000003 113.252 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -105.26 142.17 35.49 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 120.61 0.243 . . . . 72.25 110.595 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 97.8 m -82.25 119.75 24.49 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.099 0.476 . . . . 73.040000000000006 110.057 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.586 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -90.79 126.53 36.04 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 108.533 -0.914 . . . . 73.430000000000007 108.533 176.087 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -126.43 127.45 45.44 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.28 -0.568 . . . . 73.549999999999997 109.874 -175.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.616 HG23 HG22 ' A' ' 382' ' ' VAL . 5.9 p -124.58 117.07 49.38 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 116.16 -0.473 . . . . 71.219999999999999 111.036 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.98 116.22 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.141 -1.429 . . . . 70.319999999999993 107.141 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.543 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 95.1 m-85 -70.3 131.29 43.93 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 114.705 1.372 . . . . 73.420000000000002 114.705 -170.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.517 ' CD1' ' HG2' ' A' ' 361' ' ' LYS . 25.4 m-85 71.64 13.08 6.35 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.254 1.422 . . . . 70.129999999999995 112.232 -176.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -125.71 -86.18 0.62 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.484 -0.78 . . . . 72.319999999999993 113.044 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -162.72 153.22 16.7 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.304 0.853 . . . . 70.140000000000001 113.304 -173.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 376' ' ' VAL . 44.7 t -113.56 149.44 15.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 C-N-CA 124.054 0.942 . . . . 63.420000000000002 108.725 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -139.63 144.7 37.81 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.348 0.405 . . . . 55.450000000000003 111.088 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -107.24 110.01 21.94 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 106.346 -1.724 . . . . 74.109999999999999 106.346 169.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 17.2 t70 69.1 -87.02 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 123.76 0.824 . . . . 72.319999999999993 110.422 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 19.5 m -136.16 -1.88 2.34 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.966 -0.753 . . . . 52.439999999999998 108.966 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 47.2 mm -88.66 138.68 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 109.646 -0.501 . . . . 43.219999999999999 109.646 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.3 tp -74.25 117.69 16.35 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.24 -1.763 . . . . 75.010000000000005 106.24 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.546 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 49.7 tp -91.79 -58.41 2.43 Favored 'General case' 0 N--CA 1.381 -3.877 0 CA-C-N 115.412 -0.813 . . . . 41.530000000000001 110.856 -173.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.46 148.13 15.96 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 119.401 -1.381 . . . . 70.340000000000003 111.492 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -99.75 145.15 27.99 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.503 -1.295 . . . . 70.310000000000002 107.503 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.543 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.5 m-85 -70.26 117.21 11.52 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 120.771 0.32 . . . . 63.109999999999999 111.324 -176.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -88.33 -46.81 8.89 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.925 -0.58 . . . . 73.519999999999996 110.15 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 60.6 p -169.03 160.75 10.16 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-N 115.765 -0.652 . . . . 75.120000000000005 109.599 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.463 HE21 ' HD2' ' A' ' 392' ' ' PHE . 14.8 mp0 -130.67 138.13 49.9 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.657 -1.238 . . . . 74.340000000000003 107.657 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -128.43 114.42 16.78 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.869 -0.789 . . . . 74.420000000000002 108.869 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 358' ' ' ARG . . . 72.18 -101.44 1.05 Allowed Glycine 0 N--CA 1.422 -2.251 0 C-N-CA 119.169 -1.491 . . . . 41.520000000000003 112.056 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 398' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 21.7 p-10 -128.04 15.7 6.79 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 123.598 0.759 . . . . 41.420000000000002 109.381 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.432 HG22 HG23 ' A' ' 419' ' ' THR . 35.9 t -118.89 121.66 67.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.459 -0.941 . . . . 55.219999999999999 108.459 -175.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.404 ' HG ' ' CG ' ' A' ' 395' ' ' GLN . 3.2 mp -117.4 132.61 56.54 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 116.078 -0.51 . . . . 72.450000000000003 110.669 -175.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 401' ' ' LYS . . . . . 0.42 ' HE2' HD12 ' A' ' 417' ' ' ILE . 57.0 mmtt -106.29 125.73 51.36 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 115.903 -0.59 . . . . 51.539999999999999 111.231 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.422 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 3.7 m-85 -118.48 135.89 54.12 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.98 -1.118 . . . . 71.200000000000003 107.98 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.69 176.14 10.08 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.556 0.217 . . . . 74.040000000000006 111.538 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 65.31 33.19 9.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.673 0.789 . . . . 62.140000000000001 112.386 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -73.8 -149.16 1.4 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.898 -0.667 . . . . 53.039999999999999 112.345 176.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -73.93 137.92 43.92 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 122.106 -0.644 . . . . 74.439999999999998 110.069 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 26.4 p -60.68 118.9 7.16 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 124.661 1.184 . . . . 71.010000000000005 113.934 -175.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 14.2 p -105.27 158.28 16.72 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.087 -1.449 . . . . 70.120000000000005 107.087 175.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -83.17 -27.99 29.66 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.567 -0.853 . . . . 74.349999999999994 109.536 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -91.72 19.29 6.57 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.293 -0.867 . . . . 75.409999999999997 109.866 -170.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -173.1 -171.5 37.83 Favored Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 108.029 -2.029 . . . . 74.209999999999994 108.029 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -87.02 -40.89 0.06 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.152 0 CA-C-N 120.3 2.05 . . . . 73.019999999999996 111.775 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -161.24 163.18 31.2 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 106.723 -1.584 . . . . 65.340000000000003 106.723 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -76.61 158.48 31.07 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.269 0.557 . . . . 64.030000000000001 112.457 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 37.4 p -160.69 163.72 32.22 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 114.983 -1.008 . . . . 55.340000000000003 109.122 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.52 143.29 13.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 120.77 0.319 . . . . 74.530000000000001 110.584 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' ILE . . . . . 0.42 HD12 ' HE2' ' A' ' 401' ' ' LYS . 7.4 tt -103.84 131.73 51.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.78 -0.822 . . . . 71.409999999999997 108.78 173.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.7 t -113.32 125.28 70.56 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-O 121.084 0.469 . . . . 73.349999999999994 110.181 174.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.432 HG23 HG22 ' A' ' 399' ' ' VAL . 1.1 m -110.07 114.45 27.97 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 105.878 -1.897 . . . . 61.030000000000001 105.878 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 22.0 t -101.17 117.24 46.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.357 -0.979 . . . . 64.310000000000002 108.357 -176.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -106.7 -179.05 3.83 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 120.281 -0.568 . . . . 72.129999999999995 109.935 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 40.2 t -60.56 128.99 39.34 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 123.37 0.668 . . . . 63.409999999999997 110.644 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.554 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -153.16 -177.4 26.67 Favored Glycine 0 CA--C 1.485 -1.812 0 N-CA-C 111.065 -0.814 . . . . 75.109999999999999 111.065 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.93 -30.13 4.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.498 0.666 . . . . 75.530000000000001 109.213 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -151.02 151.25 31.77 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.369 -0.832 . . . . 74.109999999999999 109.222 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.639 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.0 OUTLIER -65.34 100.23 0.46 Allowed 'General case' 0 C--N 1.311 -1.098 0 O-C-N 124.164 0.915 . . . . 74.329999999999998 110.841 174.704 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -131.93 149.25 52.49 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.776 -1.102 . . . . 75.329999999999998 110.246 -176.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.441 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 29.7 mm -86.87 122.25 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 106.261 -1.755 . . . . 74.439999999999998 106.261 176.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 442' ' ' LYS . 64.9 t -84.37 -50.43 15.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 CA-C-N 116.455 -0.339 . . . . 74.040000000000006 111.653 -177.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.5 m -165.66 164.23 19.09 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.151 -0.685 . . . . 72.439999999999998 109.151 -175.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.508 HG12 HG21 ' A' ' 369' ' ' ILE . 3.3 p -141.49 125.32 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 107.253 -1.388 . . . . 73.019999999999996 107.253 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 42.8 tp -131.73 137.26 48.15 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 108.627 -0.879 . . . . 71.200000000000003 108.627 -176.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -81.64 119.04 23.3 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.45 -0.945 . . . . 61.549999999999997 108.45 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.3 -56.32 5.01 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.335 -0.848 . . . . 64.129999999999995 110.701 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -119.55 -71.49 0.73 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.739 -0.664 . . . . 74.140000000000001 110.603 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.435 ' HB3' ' NZ ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -162.39 -42.14 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.767 0 CA-C-O 121.332 0.587 . . . . 74.150000000000006 111.152 175.606 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 90.7 m -112.77 13.3 19.75 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.71 0.766 . . . . 62.119999999999997 109.959 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 415' ' ' SER . 31.0 tt0 -135.23 131.23 36.39 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.079 -0.964 . . . . 62.329999999999998 108.875 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -123.5 150.68 43.65 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 123.591 0.557 . . . . 74.519999999999996 111.279 -176.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.467 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.6 pt? -110.58 118.01 35.06 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.428 -0.953 . . . . 64.530000000000001 108.428 172.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 92.6 mt -119.29 133.12 67.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.294 -0.867 . . . . 63.439999999999998 109.308 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.412 ' O ' ' HB ' ' A' ' 429' ' ' VAL . 37.9 ttpt -111.53 141.38 45.18 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 109.285 -0.635 . . . . 55.109999999999999 109.285 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.441 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 79.6 mtp -136.32 169.19 18.06 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 109.272 -0.64 . . . . 71.549999999999997 109.272 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 66.8 mmtt -132.22 159.97 37.49 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.97 -1.122 . . . . 74.129999999999995 107.97 175.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 41.2 t -172.45 145.69 1.5 Allowed Pre-proline 0 C--N 1.289 -2.05 0 O-C-N 124.187 0.929 . . . . 55.420000000000002 109.707 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.0 -24.27 45.62 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.314 2.009 . . . . 72.129999999999995 110.917 176.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.09 -18.75 52.77 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.698 -0.683 . . . . 62.109999999999999 111.017 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -93.16 9.2 36.99 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.66 0.743 . . . . 74.299999999999997 109.57 176.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 10.8 t -102.29 119.34 38.65 Favored 'General case' 0 N--CA 1.408 -2.548 0 N-CA-C 106.983 -1.488 . . . . 43.200000000000003 106.983 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.425 -1.718 0 N-CA-C 107.627 -1.249 . . . . 72.140000000000001 107.627 -175.611 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 N--CA 1.465 0.289 0 N-CA-C 111.181 0.067 . . . . 73.319999999999993 111.181 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? 70.5 -39.47 0.44 Allowed 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.954 0.902 . . . . 54.109999999999999 111.572 -175.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -131.46 150.38 52.17 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.796 -1.187 . . . . 74.120000000000005 107.796 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 50.2 mm -82.65 116.7 27.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 110.208 -0.293 . . . . 73.420000000000002 110.208 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.664 ' HA ' ' HB2' ' A' ' 378' ' ' PHE . 21.9 pttp -85.9 157.43 20.18 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.72 0.637 . . . . 75.340000000000003 112.72 -175.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 84.71 -39.36 2.94 Favored Glycine 0 C--O 1.238 0.367 0 CA-C-N 116.038 -0.528 . . . . 54.25 113.473 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 55.9 ttp -77.96 139.94 39.2 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.895 0.378 . . . . 74.200000000000003 111.449 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.426 ' HG2' HG22 ' A' ' 377' ' ' VAL . 38.5 mt-10 -81.0 120.21 24.49 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.205 -0.665 . . . . 72.129999999999995 109.205 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 94.0 m -108.12 120.77 43.29 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.932 -1.136 . . . . 62.509999999999998 107.932 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.488 ' HB3' ' HG3' ' A' ' 375' ' ' LYS . 13.3 ptmm? -136.52 144.46 44.28 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.51 0.93 . . . . 75.519999999999996 113.51 -173.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.4 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 3.3 tmt_? -156.55 135.54 11.9 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.244 -1.391 . . . . 74.439999999999998 107.244 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 43.7 mt-10 -86.29 128.43 34.92 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 109.645 -0.502 . . . . 73.420000000000002 109.645 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.63 118.76 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 N-CA-C 107.463 -1.31 . . . . 72.5 107.463 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.24 14.41 61.68 Favored Glycine 0 C--N 1.308 -1.016 0 C-N-CA 120.612 -0.804 . . . . 73.530000000000001 112.631 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 109.15 -24.53 20.74 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 120.919 -0.658 . . . . 75.450000000000003 112.91 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -98.78 136.02 39.42 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 120.946 0.403 . . . . 64.219999999999999 111.07 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 41.3 m -77.52 115.3 17.17 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.074 -0.512 . . . . 65.430000000000007 110.206 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -91.05 131.34 36.69 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 108.438 -0.949 . . . . 72.420000000000002 108.438 175.206 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.488 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 38.5 ttpt -135.32 125.45 26.09 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 120.165 -0.614 . . . . 55.009999999999998 109.994 -177.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.487 HG12 HD11 ' A' ' 428' ' ' ILE . 7.6 p -117.02 115.51 49.13 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 N-CA-C 108.266 -1.013 . . . . 53.109999999999999 108.266 176.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.426 HG22 ' HG2' ' A' ' 364' ' ' GLU . 39.5 t -104.96 115.08 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.422 0 N-CA-C 105.662 -1.977 . . . . 74.120000000000005 105.662 176.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.664 ' HB2' ' HA ' ' A' ' 361' ' ' LYS . 94.3 m-85 -68.72 127.52 33.34 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 114.216 1.191 . . . . 64.140000000000001 114.216 -170.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . 0.27 47.9 m-85 71.19 16.14 6.31 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 113.964 -1.471 . . . . 71.430000000000007 112.956 -176.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -125.91 -83.41 0.63 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.258 -0.883 . . . . 54.340000000000003 112.566 173.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.516 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.5 OUTLIER -161.6 162.53 30.12 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.701 0.63 . . . . 52.409999999999997 112.701 -169.891 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.46 HG22 HG23 ' A' ' 376' ' ' VAL . 87.1 t -121.16 143.29 33.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 124.305 1.042 . . . . 75.329999999999998 108.65 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.516 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 66.4 m-85 -132.25 144.89 50.93 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 123.209 0.604 . . . . 63.520000000000003 112.198 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.549 ' HB2' HD23 ' A' ' 389' ' ' LEU . 33.5 tt0 -116.17 102.15 9.34 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 105.776 -1.935 . . . . 73.340000000000003 105.776 171.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.4 t70 72.38 -80.67 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 125.065 1.346 . . . . 33.229999999999997 109.569 -176.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.4 m -142.69 -1.88 1.1 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.945 -1.025 . . . . 43.030000000000001 108.352 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 49.8 mt -88.07 139.31 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.746 -0.661 . . . . 74.340000000000003 109.977 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 58.6 tp -76.43 110.29 10.84 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.56 -0.904 . . . . 61.130000000000003 108.56 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.549 HD23 ' HB2' ' A' ' 384' ' ' GLN . 1.0 OUTLIER -80.39 -60.04 2.47 Favored 'General case' 0 N--CA 1.393 -3.324 0 N-CA-C 109.18 -0.674 . . . . 73.319999999999993 109.18 -176.487 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.45 160.02 31.4 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 119.475 -1.345 . . . . 63.020000000000003 111.644 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -110.11 151.32 27.38 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.942 -1.133 . . . . 62.340000000000003 107.942 175.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.521 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.8 m-85 -73.56 127.95 34.17 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 111.777 0.288 . . . . 73.430000000000007 111.777 -175.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -110.5 -49.57 3.04 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.18 -0.608 . . . . 24.210000000000001 112.575 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 54.2 p -167.75 139.92 3.12 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.694 -0.484 . . . . 72.510000000000005 109.694 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.444 ' NE2' ' HD2' ' A' ' 392' ' ' PHE . 2.4 mm-40 -118.17 147.12 43.66 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 109.989 -0.374 . . . . 61.530000000000001 109.989 -176.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -128.41 110.31 12.21 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.192 -0.67 . . . . 71.040000000000006 109.192 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.95 -108.11 2.09 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 116.145 -0.479 . . . . 71.140000000000001 112.405 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -117.23 16.77 14.86 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.28 0.562 . . . . 74.140000000000001 110.196 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 52.3 t -117.44 116.87 53.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.797 -1.186 . . . . 61.409999999999997 107.797 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.63 142.42 39.12 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.571 -0.74 . . . . 63.43 111.386 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -120.1 122.47 41.12 Favored 'General case' 0 C--O 1.25 1.097 0 CA-C-O 121.403 0.62 . . . . 70.519999999999996 111.814 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -118.3 137.32 53.15 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.934 -1.136 . . . . 74.310000000000002 107.934 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.445 ' HA ' ' CB ' ' A' ' 415' ' ' SER . 46.6 mt-10 -142.47 175.59 9.66 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.008 -0.738 . . . . 74.219999999999999 109.008 -177.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 64.79 33.54 10.17 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.275 1.213 . . . . 73.049999999999997 114.275 171.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.72 -141.9 3.02 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 120.233 -0.984 . . . . 61.43 111.602 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -56.0 136.92 51.77 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 123.343 0.657 . . . . 64.540000000000006 110.993 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 26.4 p -73.18 117.5 14.99 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 120.919 0.39 . . . . 71.230000000000004 110.806 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 26.4 p -110.43 159.86 17.11 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.804 -0.813 . . . . 43.340000000000003 108.804 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 9.4 p-90 -81.74 -32.62 31.43 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 120.245 -0.582 . . . . 71.409999999999997 110.715 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -81.88 -17.05 48.63 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.902 -0.59 . . . . 75.310000000000002 111.506 -170.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -138.72 -169.36 11.54 Favored Glycine 0 C--N 1.304 -1.235 0 N-CA-C 109.503 -1.439 . . . . 62.409999999999997 109.503 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -79.51 -40.49 0.25 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 CA-C-N 120.022 1.911 . . . . 74.450000000000003 110.903 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -164.61 166.41 20.23 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 105.678 -1.971 . . . . 71.120000000000005 105.678 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -73.24 156.37 38.58 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.156 0.503 . . . . 51.200000000000003 109.872 171.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.445 ' CB ' ' HA ' ' A' ' 403' ' ' GLU . 54.2 p -160.54 169.07 23.7 Favored 'General case' 0 N--CA 1.401 -2.916 0 CA-C-N 115.306 -0.861 . . . . 63.340000000000003 109.047 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -159.07 151.07 20.93 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.364 0.602 . . . . 42.409999999999997 111.281 -177.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.1 tt -115.1 133.01 62.66 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 CA-C-N 115.08 -0.964 . . . . 62.340000000000003 108.558 173.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.611 HG22 ' HB ' ' A' ' 441' ' ' ILE . 4.9 t -118.57 129.68 74.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.233 0.54 . . . . 64.349999999999994 111.638 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.3 p -108.26 113.24 26.19 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.635 -1.246 . . . . 44.109999999999999 107.635 174.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 21.1 t -101.48 112.2 33.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.132 -1.062 . . . . 75.209999999999994 108.132 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 444' ' ' LYS . 41.1 mt-10 -108.16 179.52 4.19 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.988 -0.285 . . . . 64.349999999999994 110.315 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 43.2 t -59.29 128.76 38.75 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 123.464 0.706 . . . . 65.400000000000006 110.863 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.64 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -153.42 -176.89 26.37 Favored Glycine 0 CA--C 1.486 -1.723 0 C-N-CA 120.779 -0.724 . . . . 65.409999999999997 111.452 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 50.6 t -89.3 -37.31 9.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.998 -0.741 . . . . 72.219999999999999 108.998 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -150.48 160.3 43.87 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.638 -0.71 . . . . 74.299999999999997 109.31 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 70.0 m-20 -68.78 101.22 1.29 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.44 0.696 . . . . 73.25 109.709 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -131.89 148.25 52.52 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 110.432 -0.211 . . . . 53.32 110.432 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.487 HD11 HG12 ' A' ' 376' ' ' VAL . 30.5 mm -82.91 115.47 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 105.88 -1.896 . . . . 74.140000000000001 105.88 173.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 42.6 t -81.18 -47.49 19.95 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.637 0 N-CA-C 112.553 0.575 . . . . 71.049999999999997 112.553 -176.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 26.1 t -166.0 162.35 17.96 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.522 -0.918 . . . . 60.520000000000003 108.522 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' A' ' 441' ' ' ILE . 3.1 p -141.27 119.9 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.143 0 N-CA-C 108.666 -0.865 . . . . 64.040000000000006 108.666 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 432' ' ' LEU . . . . . 0.407 ' O ' HD23 ' A' ' 440' ' ' LEU . 30.7 tp -121.21 136.61 54.94 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 108.268 -1.012 . . . . 53.240000000000002 108.268 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.449 ' CD ' ' HA ' ' A' ' 436' ' ' LYS . 43.7 tt0 -81.37 116.88 21.41 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.858 -1.164 . . . . 73.120000000000005 107.858 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.47 -46.69 38.02 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.887 0.851 . . . . 64.239999999999995 109.498 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -129.29 -78.68 0.56 Allowed 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.897 -1.047 . . . . 74.400000000000006 109.28 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.471 ' HB3' ' NZ ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -168.05 -40.25 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 123.367 0.667 . . . . 70.010000000000005 110.492 174.048 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 91.4 m -100.72 7.79 43.66 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.749 0.785 . . . . 70.120000000000005 109.477 174.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -136.44 129.69 31.51 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.484 -0.78 . . . . 72.319999999999993 109.944 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 43.4 m-85 -125.32 150.57 47.02 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 123.522 0.514 . . . . 75.439999999999998 110.096 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 432' ' ' LEU . 1.5 pt? -111.9 120.92 43.55 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.369 -0.604 . . . . 45.140000000000001 109.369 172.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.611 ' HB ' HG22 ' A' ' 418' ' ' VAL . 4.0 mp -113.74 133.48 59.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 116.127 -0.488 . . . . 64.299999999999997 110.105 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -104.01 140.53 37.61 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 107.847 -1.168 . . . . 72.140000000000001 107.847 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.423 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 80.7 mtp -138.79 168.33 20.05 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 109.231 -0.655 . . . . 54.119999999999997 109.231 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.64 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 71.9 mmtt -133.53 160.02 38.7 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.146 -1.057 . . . . 71.439999999999998 108.146 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 46.2 t -165.89 146.13 5.49 Favored Pre-proline 0 C--N 1.284 -2.247 0 O-C-N 124.193 0.933 . . . . 60.420000000000002 109.894 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.2 -27.09 41.69 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.158 1.905 . . . . 54.130000000000003 110.147 174.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -78.79 -21.65 47.49 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.291 -0.868 . . . . 52.310000000000002 110.245 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -89.38 9.62 25.53 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 121.162 0.506 . . . . 41.409999999999997 110.708 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 9.0 t -103.04 119.27 38.55 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 107.821 -1.178 . . . . 73.209999999999994 107.821 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 35.6 t . . . . . 0 C--N 1.306 -1.322 0 N-CA-C 107.897 -1.149 . . . . 71.310000000000002 107.897 -178.964 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.412 ' CD2' ' HG3' ' A' ' 358' ' ' ARG . 59.9 t80 . . . . . 0 C--O 1.214 -0.78 0 N-CA-C 112.416 0.524 . . . . 64.140000000000001 112.416 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.412 ' HG3' ' CD2' ' A' ' 357' ' ' TYR . 99.0 mtt180 -115.57 19.08 15.59 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 114.205 1.187 . . . . 72.129999999999995 114.205 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -135.23 149.02 49.79 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.791 -1.559 . . . . 71.030000000000001 106.791 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 50.3 mm -82.27 115.63 25.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.531 0.681 . . . . 62.310000000000002 110.574 -173.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -70.3 155.5 40.58 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.747 -1.115 . . . . 70.209999999999994 112.975 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 80.62 -17.58 10.53 Favored Glycine 0 CA--C 1.508 -0.371 0 N-CA-C 116.099 1.199 . . . . 43.049999999999997 116.099 171.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 43.8 mtm -94.35 153.6 17.91 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.143 -1.023 . . . . 64.209999999999994 111.181 -178.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.427 ' HB3' HG22 ' A' ' 377' ' ' VAL . 10.3 pt-20 -101.57 141.79 33.91 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 115.14 -0.936 . . . . 71.25 109.636 175.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.461 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 93.4 m -125.78 123.97 39.95 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.111 -1.44 . . . . 71.409999999999997 107.111 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 56.2 mtpt -131.6 142.44 49.89 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.403 -0.362 . . . . 72.510000000000005 110.882 -175.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -160.57 135.42 7.63 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.625 -0.88 . . . . 63.450000000000003 108.625 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 2.4 mp0 -79.25 122.99 27.01 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 110.019 -0.363 . . . . 61.439999999999998 110.019 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.577 HG21 HG12 ' A' ' 431' ' ' VAL . 47.4 mt -135.74 124.15 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 106.797 -1.557 . . . . 70.420000000000002 106.797 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.62 13.08 60.39 Favored Glycine 0 C--N 1.31 -0.906 0 C-N-CA 120.55 -0.833 . . . . 72.120000000000005 112.057 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.08 -24.2 27.08 Favored Glycine 0 N--CA 1.429 -1.808 0 C-N-CA 121.209 -0.52 . . . . 74.019999999999996 113.113 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' TYR . . . . . 0.487 ' CD1' ' HG3' ' A' ' 384' ' ' GLN . 22.5 p90 -103.42 147.16 27.47 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 110.17 -0.308 . . . . 75.040000000000006 110.17 -176.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.522 HG21 ' HE2' ' A' ' 366' ' ' LYS . 85.8 m -86.44 123.88 32.15 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 116.464 -0.335 . . . . 51.100000000000001 110.989 -178.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.655 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.5 134.74 34.15 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 108.945 -0.761 . . . . 64.310000000000002 108.945 175.418 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.476 ' HG3' ' HG2' ' A' ' 366' ' ' LYS . 38.0 ttpt -130.12 125.84 36.08 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 110.0 -0.37 . . . . 64.519999999999996 110.0 -178.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.461 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.3 p -122.46 118.88 56.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 N-CA-C 109.451 -0.574 . . . . 74.219999999999999 109.451 175.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 364' ' ' GLU . 49.5 t -106.17 116.99 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 106.658 -1.608 . . . . 44.109999999999999 106.658 174.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -61.43 126.7 28.28 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 114.668 1.359 . . . . 72.040000000000006 114.668 -172.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 71.07 14.35 6.77 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 113.336 -1.756 . . . . 72.129999999999995 112.465 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -124.8 -77.24 0.59 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 113.893 1.071 . . . . 73.230000000000004 113.893 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -162.76 160.97 26.0 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.882 0.697 . . . . 73.420000000000002 112.882 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.458 HG22 HG23 ' A' ' 376' ' ' VAL . 96.8 t -122.86 140.21 47.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.541 -0.754 . . . . 61.43 109.103 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -133.23 147.25 51.98 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.19 0.519 . . . . 72.540000000000006 111.872 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.52 ' HB2' HD23 ' A' ' 389' ' ' LEU . 35.9 tt0 -112.07 101.03 9.34 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.317 -2.105 . . . . 71.519999999999996 105.317 171.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 21.9 t70 68.19 -84.03 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 124.302 1.041 . . . . 75.150000000000006 110.109 -173.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.4 m -134.89 -6.67 2.4 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.214 -0.903 . . . . 65.409999999999997 108.678 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 45.6 mm -80.38 134.49 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 116.004 -0.544 . . . . 74.219999999999999 109.737 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 61.0 tp -76.92 113.9 15.12 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 109.035 -0.728 . . . . 73.239999999999995 109.035 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.3 OUTLIER -80.06 -63.32 1.44 Allowed 'General case' 0 N--CA 1.389 -3.511 0 N-CA-C 108.974 -0.75 . . . . 64.319999999999993 108.974 -177.179 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.89 159.41 30.64 Favored Glycine 0 N--CA 1.415 -2.742 0 C-N-CA 119.162 -1.494 . . . . 64.319999999999993 111.842 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -105.79 145.07 31.64 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.031 -1.1 . . . . 73.040000000000006 108.031 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -69.82 116.34 10.1 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.908 0.385 . . . . 74.430000000000007 110.601 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -94.79 -47.03 6.64 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.721 -0.672 . . . . 63.130000000000003 110.757 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 62.5 p -173.24 149.8 1.82 Allowed 'General case' 0 C--O 1.246 0.879 0 CA-C-N 116.021 -0.536 . . . . 72.040000000000006 109.599 -177.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.485 ' CD ' ' HG ' ' A' ' 400' ' ' LEU . 10.1 pt20 -143.88 142.06 30.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.186 0.517 . . . . 74.409999999999997 110.796 175.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -128.5 131.11 48.31 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.666 -0.697 . . . . 75.040000000000006 109.624 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 69.59 -107.96 2.31 Favored Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 111.365 -0.694 . . . . 52.140000000000001 111.365 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -133.07 24.41 4.22 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.83 0.824 . . . . 71.150000000000006 110.053 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.2 t -119.45 116.86 52.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.335 -0.987 . . . . 73.120000000000005 108.335 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.485 ' HG ' ' CD ' ' A' ' 395' ' ' GLN . 6.0 mp -106.71 133.55 51.21 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.16 0.584 . . . . 61.539999999999999 111.804 -174.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -113.47 121.94 45.79 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 112.513 0.56 . . . . 71.430000000000007 112.513 178.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.403 ' CE1' ' HB3' ' A' ' 400' ' ' LEU . 2.8 m-85 -118.58 136.81 53.66 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.328 -0.99 . . . . 62.340000000000003 108.328 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -146.31 176.15 9.99 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.141 0.496 . . . . 74.510000000000005 111.723 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.15 33.65 9.23 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.382 -1.281 . . . . 73.409999999999997 112.679 169.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.26 -136.7 0.67 Allowed Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.445 -0.798 . . . . 51.420000000000002 112.931 177.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.34 149.6 40.52 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.816 -1.179 . . . . 73.430000000000007 107.816 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 33.3 t -60.34 135.93 57.89 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 124.22 1.008 . . . . 64.019999999999996 111.36 -175.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 36.3 t -133.39 154.1 51.05 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.256 -0.884 . . . . 62.539999999999999 109.558 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -88.46 141.02 28.88 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.056 0.391 . . . . 74.450000000000003 112.056 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 76.84 12.12 2.4 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.393 1.477 . . . . 73.129999999999995 108.797 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -151.16 176.98 29.42 Favored Glycine 0 N--CA 1.416 -2.65 0 N-CA-C 107.822 -2.111 . . . . 64.310000000000002 107.822 176.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -88.65 -39.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.226 0 CA-C-N 119.706 1.753 . . . . 75.25 112.577 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -159.03 170.23 22.53 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 106.839 -1.541 . . . . 44.43 106.839 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -75.31 160.53 30.22 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.179 0.514 . . . . 73.219999999999999 111.22 172.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 36.8 p -163.29 163.46 25.29 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 114.908 -1.042 . . . . 72.329999999999998 108.643 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.75 146.32 19.25 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.217 0.532 . . . . 75.329999999999998 110.195 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.9 tt -111.25 121.29 63.59 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 CA-C-N 115.303 -0.862 . . . . 72.420000000000002 109.482 174.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.0 t -105.72 127.8 60.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.775 0.798 . . . . 74.450000000000003 111.499 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 12.5 p -107.76 111.7 24.0 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 106.836 -1.542 . . . . 74.319999999999993 106.836 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 8.6 p -106.27 120.23 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 108.891 -0.781 . . . . 62.409999999999997 108.891 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -116.2 -174.69 2.59 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 120.386 -0.526 . . . . 63.240000000000002 111.277 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 43.4 t -59.61 128.74 38.5 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 123.713 0.805 . . . . 72.349999999999994 111.2 -177.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -160.26 -177.82 33.7 Favored Glycine 0 CA--C 1.48 -2.101 0 N-CA-C 109.54 -1.424 . . . . 53.329999999999998 109.54 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 53.3 t -96.93 -27.96 3.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 121.639 0.733 . . . . 73.200000000000003 109.027 177.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -141.34 146.57 36.85 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.791 -0.64 . . . . 72.150000000000006 111.234 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.638 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.6 p-10 -68.28 101.21 1.16 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.28 -1.327 . . . . 72.150000000000006 110.47 175.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -132.32 149.19 52.41 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.401 -0.818 . . . . 73.010000000000005 110.919 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 28.8 mm -88.82 117.33 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 105.841 -1.911 . . . . 63.130000000000003 105.841 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.7 -50.83 16.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-O 120.772 0.32 . . . . 74.140000000000001 111.438 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 70.3 m -167.08 163.81 15.79 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 110.041 -0.355 . . . . 62.020000000000003 110.041 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.577 HG12 HG21 ' A' ' 369' ' ' ILE . 4.2 p -141.45 127.9 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 108.08 -1.082 . . . . 73.310000000000002 108.08 176.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 432' ' ' LEU . . . . . 0.432 ' O ' HD23 ' A' ' 440' ' ' LEU . 29.5 tp -132.21 138.18 47.86 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.665 -0.865 . . . . 55.229999999999997 108.665 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -80.65 116.45 20.68 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.89 -0.782 . . . . 74.109999999999999 108.89 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.68 -53.74 8.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.28 0.562 . . . . 62.399999999999999 109.702 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -120.93 -72.92 0.67 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.312 -0.858 . . . . 73.310000000000002 110.37 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.491 ' HG2' ' SG ' ' A' ' 437' ' ' CYS . 0.0 OUTLIER -167.51 -40.61 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.346 0.594 . . . . 61.149999999999999 110.483 175.173 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 437' ' ' CYS . . . . . 0.491 ' SG ' ' HG2' ' A' ' 436' ' ' LYS . 43.7 m -106.65 7.04 30.37 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.678 0.751 . . . . 71.319999999999993 109.501 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -135.48 127.92 30.47 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.155 -0.929 . . . . 71.329999999999998 109.319 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -123.96 150.22 45.03 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.713 -0.676 . . . . 71.099999999999994 109.782 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.4 pt? -107.52 124.71 50.31 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.491 -0.929 . . . . 75.430000000000007 108.491 173.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.6 mt -124.75 133.37 69.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 115.332 -0.849 . . . . 62.219999999999999 109.409 -176.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -112.45 141.64 45.96 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 119.934 -0.706 . . . . 74.109999999999999 109.614 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 80.0 mtp -137.11 169.03 18.46 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 123.571 0.749 . . . . 63.149999999999999 109.059 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.638 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 69.2 mmtt -135.12 153.73 51.91 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.732 -1.21 . . . . 72.219999999999999 107.732 175.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 73.0 m -164.57 150.82 9.3 Favored Pre-proline 0 C--N 1.293 -1.89 0 C-N-CA 123.992 0.917 . . . . 55.149999999999999 109.287 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.99 -27.51 42.62 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.282 1.988 . . . . 72.400000000000006 112.045 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -73.47 -19.74 60.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.677 -0.692 . . . . 70.530000000000001 110.94 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -93.23 8.2 41.21 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.478 0.656 . . . . 63.299999999999997 109.586 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 10.6 t -102.71 120.3 40.33 Favored 'General case' 0 N--CA 1.409 -2.522 0 N-CA-C 107.868 -1.16 . . . . 74.409999999999997 107.868 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 25.4 t . . . . . 0 C--N 1.305 -1.36 0 N-CA-C 106.769 -1.567 . . . . 75.140000000000001 106.769 -178.93 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 71.2 t80 . . . . . 0 C--O 1.241 0.631 0 N-CA-C 107.342 -1.355 . . . . 75.340000000000003 107.342 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.516 ' O ' ' HB1' ' A' ' 447' ' ' ALA . 15.5 ptp180 -98.55 177.97 5.16 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-O 120.824 0.345 . . . . 75.319999999999993 110.635 -176.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' A' ' 358' ' ' ARG . . . -78.79 153.59 30.62 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.991 -0.744 . . . . 71.450000000000003 108.991 172.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 47.4 mm -78.45 115.86 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.464 0.65 . . . . 61.240000000000002 110.414 -171.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.593 ' HD3' ' H ' ' A' ' 361' ' ' LYS . 0.0 OUTLIER -77.14 157.31 31.06 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.924 -1.035 . . . . 73.150000000000006 113.676 -175.207 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 71.69 8.09 66.82 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 114.954 -1.021 . . . . 64.409999999999997 114.074 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 47.8 ttp -104.21 140.71 37.44 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 109.548 -0.538 . . . . 73.319999999999993 109.548 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.45 ' CB ' HG22 ' A' ' 377' ' ' VAL . 0.0 OUTLIER -107.76 111.34 23.46 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.651 0.738 . . . . 64.200000000000003 110.569 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 375' ' ' LYS . 99.2 m -104.01 139.96 38.41 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.468 -0.787 . . . . 64.420000000000002 109.757 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 18.9 ptpt -143.94 141.14 30.07 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-O 120.801 0.334 . . . . 71.510000000000005 111.872 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -154.9 135.1 13.15 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 106.96 -1.496 . . . . 72.040000000000006 106.96 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 40.4 mt-10 -89.44 127.86 35.88 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 120.642 0.258 . . . . 74.209999999999994 110.817 -174.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.468 HG21 HG12 ' A' ' 431' ' ' VAL . 47.5 mt -137.21 125.47 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 107.133 -1.432 . . . . 75.319999999999993 107.133 -174.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.84 5.51 32.27 Favored Glycine 0 C--N 1.306 -1.102 0 C-N-CA 121.177 -0.535 . . . . 60.32 113.188 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 110.34 -13.84 30.69 Favored Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.562 -0.828 . . . . 40.5 113.072 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' TYR . . . . . 0.428 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 13.5 p90 -109.91 143.68 39.48 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 110.126 -0.324 . . . . 72.430000000000007 110.126 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 63.2 m -82.96 121.14 26.6 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.822 -0.351 . . . . 62.210000000000001 110.484 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.4 OUTLIER -90.3 125.64 35.58 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 109.335 -0.617 . . . . 74.239999999999995 109.335 173.738 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 365' ' ' THR . 35.1 ttpt -125.64 126.66 45.06 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.451 -0.574 . . . . 75.140000000000001 109.451 -176.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.425 HG23 HG22 ' A' ' 382' ' ' VAL . 6.7 p -123.08 115.9 47.05 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 N-CA-C 109.387 -0.597 . . . . 74.5 109.387 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.45 HG22 ' CB ' ' A' ' 364' ' ' GLU . 48.6 t -103.58 116.15 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 N-CA-C 106.755 -1.572 . . . . 71.319999999999993 106.755 174.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -63.14 126.46 27.45 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 113.086 0.773 . . . . 63.329999999999998 113.086 -172.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 72.66 6.78 5.47 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.494 1.517 . . . . 71.439999999999998 113.068 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -115.89 -83.67 0.63 Allowed 'General case' 0 C--O 1.248 0.98 0 N-CA-C 112.494 0.553 . . . . 71.120000000000005 112.494 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -165.81 159.48 16.1 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.026 0.751 . . . . 73.140000000000001 113.026 -172.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.425 HG22 HG23 ' A' ' 376' ' ' VAL . 96.5 t -113.83 145.83 19.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 124.381 1.072 . . . . 74.209999999999994 109.51 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -133.87 144.17 48.74 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 123.322 0.649 . . . . 61.030000000000001 111.191 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.467 ' HB2' HD23 ' A' ' 389' ' ' LEU . 35.3 tt0 -111.65 103.5 11.8 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.352 -1.722 . . . . 35.25 106.352 173.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.4 t70 72.03 -76.16 0.07 Allowed 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 124.938 1.295 . . . . 65.209999999999994 109.463 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 34.0 t -145.31 -6.52 0.64 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.349 -0.982 . . . . 42.109999999999999 108.349 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 65.4 mt -81.49 136.2 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 115.617 -0.72 . . . . 74.209999999999994 109.332 -177.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 60.2 tp -76.5 116.55 17.29 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.013 -0.736 . . . . 53.549999999999997 109.013 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.568 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.3 OUTLIER -81.33 -67.81 0.75 Allowed 'General case' 0 N--CA 1.386 -3.661 0 N-CA-C 108.207 -1.034 . . . . 61.340000000000003 108.207 -178.261 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.94 157.15 28.41 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 119.528 -1.32 . . . . 70.010000000000005 111.811 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -99.21 146.43 26.19 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.039 -1.097 . . . . 52.420000000000002 108.039 175.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -71.25 115.97 11.03 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.475 -0.565 . . . . 71.329999999999998 109.475 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -93.16 -47.05 7.13 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.382 -0.372 . . . . 51.340000000000003 110.346 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 63.8 p -160.37 141.48 12.13 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.898 -0.778 . . . . 71.310000000000002 108.898 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.467 ' HB2' ' CD2' ' A' ' 400' ' ' LEU . 0.0 OUTLIER -147.03 141.35 26.31 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 116.343 -0.389 . . . . 63.399999999999999 110.926 -179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -128.99 120.32 25.84 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.947 -0.76 . . . . 72.430000000000007 108.947 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.33 -103.13 0.62 Allowed Glycine 0 N--CA 1.434 -1.493 0 O-C-N 123.746 0.654 . . . . 63.109999999999999 113.33 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 26.8 p-10 -113.7 6.18 16.74 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.01 0.374 . . . . 74.019999999999996 112.01 -176.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 28.1 t -116.43 116.93 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 107.932 -1.136 . . . . 74.239999999999995 107.932 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.467 ' CD2' ' HB2' ' A' ' 395' ' ' GLN . 11.7 mt -120.01 123.91 44.63 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 115.528 -0.76 . . . . 64.239999999999995 110.278 -171.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -103.77 124.0 48.09 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-O 121.032 0.444 . . . . 74.319999999999993 111.713 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.402 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 3.1 m-85 -116.21 136.32 53.12 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.933 -1.136 . . . . 64.040000000000006 107.933 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -146.29 175.58 10.41 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.846 0.355 . . . . 64.219999999999999 111.508 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.39 35.02 20.59 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 124.664 1.186 . . . . 65.099999999999994 112.681 172.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.84 -140.43 1.13 Allowed Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.072 -0.967 . . . . 72.129999999999995 111.903 176.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -74.51 139.39 43.79 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.96 -0.755 . . . . 55.43 108.96 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 26.3 t -60.2 129.16 40.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.026 0.917 . . . . 71.219999999999999 112.969 -172.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 37.4 t -132.91 127.72 34.95 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.466 -1.309 . . . . 73.409999999999997 107.466 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' TRP . . . . . 0.466 ' O ' ' HB2' ' A' ' 410' ' ' ASN . 45.5 t-105 -86.35 113.81 22.63 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 114.412 1.264 . . . . 75.209999999999994 114.412 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 410' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 409' ' ' TRP . 16.3 t-20 153.18 -32.57 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.457 0 C-N-CA 128.161 2.585 . . . . 63.039999999999999 104.544 166.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -108.06 -166.21 21.39 Favored Glycine 0 N--CA 1.417 -2.62 0 N-CA-C 106.208 -2.757 . . . . 50.420000000000002 106.208 168.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -86.5 -39.42 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.23 0 CA-C-N 120.284 2.042 . . . . 73.25 112.429 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -159.9 -177.76 6.56 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 105.126 -2.175 . . . . 53.130000000000003 105.126 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 437' ' ' CYS . 83.5 mtt180 -75.22 154.6 37.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 119.478 -0.889 . . . . 72.219999999999999 110.61 169.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 21.3 p -163.39 162.2 24.79 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 114.801 -1.091 . . . . 64.230000000000004 108.831 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.54 151.72 19.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 120.824 0.345 . . . . 75.319999999999993 110.818 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.9 tt -113.31 127.74 70.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 108.987 -0.746 . . . . 71.510000000000005 108.987 172.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 4.6 t -111.4 128.65 67.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 CA-C-N 115.951 -0.568 . . . . 74.239999999999995 110.835 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.26 115.4 27.36 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 105.908 -1.886 . . . . 62.109999999999999 105.908 177.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 37.6 t -100.54 127.6 53.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 109.137 -0.69 . . . . 73.400000000000006 109.137 -175.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -117.52 -175.09 2.74 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 120.039 -0.665 . . . . 72.439999999999998 110.497 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.461 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 33.3 t -62.34 128.03 34.12 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 122.964 0.506 . . . . 72.409999999999997 110.876 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -154.08 -178.86 28.93 Favored Glycine 0 CA--C 1.492 -1.351 0 C-N-CA 120.519 -0.848 . . . . 73.430000000000007 111.591 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.4 t -85.78 -38.77 13.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 108.81 -0.811 . . . . 72.409999999999997 108.81 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -149.65 150.17 31.75 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.359 -0.837 . . . . 71.549999999999997 109.629 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.603 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 2.6 p30 -51.04 100.73 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.321 -1.309 . . . . 55.530000000000001 111.089 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -131.83 144.65 51.06 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 116.268 -0.424 . . . . 72.540000000000006 110.444 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.458 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 26.8 mm -84.13 116.87 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 105.885 -1.894 . . . . 74.230000000000004 105.885 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 442' ' ' LYS . 56.0 t -82.23 -50.57 16.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 CA-C-O 120.919 0.39 . . . . 73.530000000000001 111.986 -175.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 48.7 m -161.68 162.55 29.89 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.104 -0.702 . . . . 73.129999999999995 109.104 -174.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.468 HG12 HG21 ' A' ' 369' ' ' ILE . 3.4 p -141.32 111.13 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 N-CA-C 108.754 -0.832 . . . . 62.039999999999999 108.754 176.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 432' ' ' LEU . . . . . 0.479 ' O ' HD23 ' A' ' 440' ' ' LEU . 28.8 tp -112.63 137.72 50.48 Favored 'General case' 0 N--CA 1.401 -2.885 0 N-CA-C 107.679 -1.23 . . . . 72.150000000000006 107.679 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 433' ' ' GLU . . . . . 0.455 ' CD ' ' HA ' ' A' ' 436' ' ' LYS . 39.2 tt0 -80.79 114.3 19.58 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 108.724 -0.843 . . . . 73.420000000000002 108.724 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -73.07 -40.18 65.27 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 115.367 -0.833 . . . . 71.109999999999999 110.496 -175.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -133.06 -77.93 0.49 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.165 -0.925 . . . . 73.450000000000003 108.752 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.467 ' HB3' ' NZ ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -167.35 -39.8 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 124.029 0.932 . . . . 61.130000000000003 110.513 173.751 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 437' ' ' CYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 414' ' ' ARG . 62.8 m -100.69 -5.03 27.11 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.697 0.761 . . . . 73.019999999999996 109.586 177.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.626 ' HA ' ' O ' ' A' ' 415' ' ' SER . 38.3 tt0 -127.04 137.63 53.09 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.207 -0.906 . . . . 74.099999999999994 109.339 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -129.02 150.52 50.39 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.819 -0.628 . . . . 75.420000000000002 110.487 -174.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.8 pt? -109.39 115.57 30.21 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.55 -0.908 . . . . 73.040000000000006 108.55 173.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.5 mt -115.25 126.45 72.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.408 -0.814 . . . . 61.130000000000003 109.699 -175.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.48 ' O ' ' HB ' ' A' ' 429' ' ' VAL . 38.3 ttpt -103.32 141.48 35.85 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.504 -0.925 . . . . 75.310000000000002 108.504 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.458 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.8 mtp -136.32 168.91 18.54 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 109.663 -0.495 . . . . 50.43 109.663 -176.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.8 mmtt -131.77 158.61 40.76 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.123 -1.066 . . . . 73.310000000000002 108.123 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 47.2 t -172.92 146.66 1.45 Allowed Pre-proline 0 C--N 1.287 -2.121 0 O-C-N 124.248 0.968 . . . . 71.319999999999993 108.774 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -64.49 -23.47 64.59 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.125 1.883 . . . . 63.140000000000001 110.64 176.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 358' ' ' ARG . . . -68.25 -26.94 65.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.416 -0.811 . . . . 72.230000000000004 111.081 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -98.36 13.65 30.81 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.365 0.603 . . . . 62.100000000000001 109.771 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 19.6 t -103.15 120.12 40.12 Favored 'General case' 0 N--CA 1.415 -2.215 0 C-N-CA 120.128 -0.629 . . . . 51.039999999999999 110.642 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--N 1.308 -1.199 0 C-N-CA 125.836 1.654 . . . . 65.209999999999994 107.637 176.648 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.69 ' N ' ' HH ' ' A' ' 379' ' ' TYR . 63.7 m-85 . . . . . 0 C--O 1.217 -0.645 0 N-CA-C 108.697 -0.853 . . . . 75.319999999999993 108.697 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -89.23 36.93 0.84 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.57 0.7 . . . . 74.040000000000006 110.709 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -146.8 149.94 34.34 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.66 -1.237 . . . . 44.119999999999997 107.66 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 50.5 mm -82.61 116.97 27.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 108.598 -0.89 . . . . 62.340000000000003 108.598 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 378' ' ' PHE . 22.2 pttp -90.3 156.45 18.27 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 112.389 0.515 . . . . 62.509999999999998 112.389 -174.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 93.6 -19.64 51.51 Favored Glycine 0 CA--C 1.508 -0.372 0 CA-C-N 115.559 -0.746 . . . . 71.310000000000002 114.713 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 19.0 ptp -90.88 156.13 18.24 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.087 -1.045 . . . . 74.329999999999998 110.445 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.46 ' HB3' HG22 ' A' ' 377' ' ' VAL . 0.2 OUTLIER -103.57 113.02 26.22 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 115.327 -0.851 . . . . 75.299999999999997 109.065 175.063 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.495 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 86.6 m -96.11 125.84 40.92 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.509 -1.293 . . . . 64.310000000000002 107.509 177.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 13.8 ptmm? -141.41 140.73 33.71 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 120.798 -0.361 . . . . 73.120000000000005 111.758 -175.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -159.81 138.59 10.7 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.356 -0.979 . . . . 74.450000000000003 108.356 -173.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -81.24 123.49 28.52 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 110.075 -0.342 . . . . 75.200000000000003 110.075 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.457 HG21 HG12 ' A' ' 431' ' ' VAL . 58.3 mt -128.58 115.9 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 106.956 -1.498 . . . . 73.420000000000002 106.956 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.76 12.67 59.94 Favored Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.598 -0.811 . . . . 64.049999999999997 112.332 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 111.04 -26.15 12.88 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 121.265 -0.493 . . . . 50.140000000000001 112.701 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -98.08 136.36 38.43 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 120.756 -0.377 . . . . 73.519999999999996 110.89 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 70.1 m -79.17 119.99 23.04 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 116.039 -0.528 . . . . 55.229999999999997 110.228 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -91.02 133.18 35.51 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.577 -0.897 . . . . 75.0 108.577 172.876 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.457 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 35.0 ttpt -133.19 125.73 30.07 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.087 -0.645 . . . . 62.130000000000003 109.706 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.495 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.9 p -120.58 116.4 49.97 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 N-CA-C 109.816 -0.438 . . . . 74.340000000000003 109.816 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 364' ' ' GLU . 26.9 t -107.41 116.09 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 106.988 -1.486 . . . . 63.020000000000003 106.988 174.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.594 ' HB2' ' HA ' ' A' ' 361' ' ' LYS . 95.7 m-85 -61.74 130.51 46.12 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 113.697 0.999 . . . . 72.340000000000003 113.697 -172.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.69 ' HH ' ' N ' ' A' ' 357' ' ' TYR . 41.6 m-85 67.17 14.38 9.75 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.52 1.128 . . . . 73.120000000000005 112.884 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -125.34 -82.52 0.63 Allowed 'General case' 0 C--O 1.242 0.696 0 N-CA-C 113.418 0.896 . . . . 73.239999999999995 113.418 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -168.32 155.2 7.62 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.946 0.721 . . . . 73.5 112.946 -174.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.482 HG22 HG23 ' A' ' 376' ' ' VAL . 71.4 t -113.78 146.49 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.044 0.938 . . . . 71.129999999999995 109.582 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -135.08 149.27 50.04 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.399 0.679 . . . . 73.109999999999999 111.345 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.524 ' HB2' HD23 ' A' ' 389' ' ' LEU . 32.6 tt0 -123.96 104.81 9.13 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.186 -1.783 . . . . 73.019999999999996 106.186 172.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.1 t70 69.17 -87.66 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.933 0.893 . . . . 73.519999999999996 110.923 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 18.8 m -133.04 0.32 3.44 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.204 -1.036 . . . . 44.119999999999997 108.204 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 45.9 mm -92.19 133.27 34.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.047 -0.979 . . . . 73.530000000000001 110.457 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 63.1 tp -75.99 114.73 14.96 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.247 -1.39 . . . . 61.530000000000001 107.247 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.5 OUTLIER -78.75 -63.3 1.44 Allowed 'General case' 0 N--CA 1.386 -3.629 0 N-CA-C 108.9 -0.778 . . . . 52.32 108.9 -175.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.0 158.56 29.86 Favored Glycine 0 N--CA 1.423 -2.231 0 C-N-CA 119.258 -1.448 . . . . 73.219999999999999 112.281 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -104.08 143.31 33.07 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.305 -0.998 . . . . 74.040000000000006 108.305 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.452 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.8 m-85 -68.72 116.5 9.3 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 123.506 0.504 . . . . 72.439999999999998 110.668 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.69 -47.35 5.36 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.023 -0.535 . . . . 70.0 110.958 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 48.2 t -159.0 148.19 18.66 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.147 -0.686 . . . . 42.25 109.147 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.421 HE21 ' HD2' ' A' ' 392' ' ' PHE . 18.3 mp0 -123.28 145.75 48.44 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.27 -1.011 . . . . 70.0 108.27 174.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -126.62 109.08 11.71 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.899 -1.148 . . . . 51.229999999999997 107.899 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 58.66 -101.37 0.21 Allowed Glycine 0 C--O 1.253 1.301 0 CA-C-O 121.423 0.457 . . . . 72.109999999999999 113.193 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -116.07 17.12 15.94 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 124.249 1.02 . . . . 73.040000000000006 109.558 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' VAL . . . . . 0.51 HG13 HD11 ' A' ' 417' ' ' ILE . 60.0 t -121.05 133.45 67.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.197 -1.038 . . . . 74.5 108.197 -177.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 399' ' ' VAL . 3.5 mp -130.33 134.34 47.11 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.513 -0.475 . . . . 74.349999999999994 111.53 -176.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -108.26 122.17 46.39 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 123.101 0.56 . . . . 72.109999999999999 112.003 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.434 ' CD2' HG21 ' A' ' 382' ' ' VAL . 3.0 m-85 -118.38 129.32 55.35 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.719 -1.215 . . . . 71.439999999999998 107.719 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -147.11 175.29 10.82 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 111.637 0.236 . . . . 74.400000000000006 111.637 -177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 60.07 39.19 20.01 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.738 0.649 . . . . 62.119999999999997 111.618 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -80.65 -137.46 1.93 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.737 -0.745 . . . . 72.239999999999995 112.069 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -67.37 148.74 51.23 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.744 -0.465 . . . . 71.030000000000001 109.744 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 30.4 m -60.54 123.62 17.93 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.208 0.527 . . . . 55.409999999999997 109.798 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 48.9 t -99.39 144.86 28.02 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.148 -1.427 . . . . 73.319999999999993 107.148 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 21.3 p-90 -81.6 -27.0 34.45 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.713 0.768 . . . . 74.200000000000003 109.335 -177.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -99.1 9.58 43.2 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.68 -1.145 . . . . 74.109999999999999 109.295 -170.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -168.99 -158.75 13.28 Favored Glycine 0 CA--C 1.5 -0.865 0 N-CA-C 108.228 -1.949 . . . . 44.310000000000002 108.228 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -89.13 -41.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.552 1.377 0 CA-C-N 121.039 2.419 . . . . 63.549999999999997 112.832 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -158.32 171.36 20.32 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.192 -1.04 . . . . 72.310000000000002 108.192 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -82.72 160.76 22.29 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.143 0.497 . . . . 74.540000000000006 111.506 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 22.7 p -165.27 160.54 18.47 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-N 114.645 -1.162 . . . . 63.420000000000002 109.145 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -157.33 147.87 21.18 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.161 0.505 . . . . 62.030000000000001 110.705 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 417' ' ' ILE . . . . . 0.51 HD11 HG13 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -112.25 114.44 47.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.977 -1.12 . . . . 74.519999999999996 107.977 174.028 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.552 HG22 ' HB ' ' A' ' 441' ' ' ILE . 5.0 t -97.91 128.81 48.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-O 121.337 0.589 . . . . 71.540000000000006 110.327 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 1.4 m -113.66 114.43 26.39 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 106.372 -1.714 . . . . 72.400000000000006 106.372 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 39.1 t -100.78 118.31 47.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.618 -0.882 . . . . 73.420000000000002 108.618 -175.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -109.1 -174.88 2.62 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 120.748 0.308 . . . . 54.130000000000003 110.393 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 42.0 t -60.5 129.24 40.59 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 123.917 0.887 . . . . 71.230000000000004 111.5 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.58 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -158.86 -177.56 32.05 Favored Glycine 0 CA--C 1.491 -1.422 0 N-CA-C 110.641 -0.984 . . . . 72.010000000000005 110.641 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.07 -33.52 5.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.578 0.704 . . . . 74.329999999999998 109.125 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 426' ' ' ASN . 36.6 tt0 -149.06 162.1 40.62 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.545 -0.752 . . . . 72.099999999999994 109.074 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 54.1 m-80 -67.62 107.93 2.71 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 114.632 -1.167 . . . . 63.340000000000003 110.37 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -131.57 148.48 52.62 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 114.934 -1.03 . . . . 73.109999999999999 109.54 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 29.4 mm -91.45 115.06 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 106.089 -1.819 . . . . 75.25 106.089 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 53.9 t -81.12 -48.83 18.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 111.995 0.368 . . . . 53.409999999999997 111.995 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 46.9 p -166.64 163.67 16.8 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 109.565 -0.531 . . . . 74.219999999999999 109.565 -174.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.457 HG12 HG21 ' A' ' 369' ' ' ILE . 3.2 p -141.36 111.41 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 N-CA-C 108.403 -0.962 . . . . 74.420000000000002 108.403 177.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 432' ' ' LEU . . . . . 0.451 ' HB3' ' HG ' ' A' ' 440' ' ' LEU . 24.4 tp -110.44 136.51 49.48 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 114.892 -1.049 . . . . 70.340000000000003 108.408 -175.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -80.86 110.74 16.67 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.465 -1.309 . . . . 75.239999999999995 107.465 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -72.66 -42.31 64.47 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.473 -0.785 . . . . 74.319999999999993 110.222 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -132.38 -78.03 0.5 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.474 -0.936 . . . . 64.420000000000002 108.474 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.22 -50.28 0.07 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.137 0.494 . . . . 70.530000000000001 111.0 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 63.4 m -100.9 4.39 42.62 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.817 0.817 . . . . 55.43 109.822 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 415' ' ' SER . 35.9 tt0 -129.45 130.97 46.59 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.904 -1.044 . . . . 64.299999999999997 108.948 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 439' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 41.1 m-85 -123.51 150.83 43.46 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.209 -0.905 . . . . 74.530000000000001 110.075 -174.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.451 ' HG ' ' HB3' ' A' ' 432' ' ' LEU . 4.1 pp -111.08 124.46 52.23 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 106.992 -1.485 . . . . 73.310000000000002 106.992 173.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.552 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.7 mt -120.27 135.63 59.91 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 115.753 -0.658 . . . . 51.32 109.813 -175.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -105.7 140.25 39.04 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.235 -1.024 . . . . 74.129999999999995 108.235 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.407 ' SD ' HG11 ' A' ' 376' ' ' VAL . 82.7 mtp -140.08 168.7 19.2 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 109.02 -0.733 . . . . 64.519999999999996 109.02 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.58 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 71.9 mmtt -132.24 160.28 36.62 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.999 -0.741 . . . . 71.219999999999999 108.999 177.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 32.2 t -172.22 148.55 2.0 Allowed Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 124.138 0.899 . . . . 75.010000000000005 108.832 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.82 -27.26 51.75 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.197 1.931 . . . . 74.219999999999999 111.027 177.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -74.74 -15.79 60.76 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.281 -0.872 . . . . 70.310000000000002 111.12 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -101.27 11.4 39.38 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 121.268 0.556 . . . . 64.409999999999997 110.08 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 16.9 t -101.85 121.2 41.65 Favored 'General case' 0 N--CA 1.409 -2.507 0 CA-C-N 115.773 -0.649 . . . . 60.409999999999997 109.293 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.418 -2.027 0 N-CA-C 106.828 -1.545 . . . . 73.040000000000006 106.828 178.215 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 448' ' ' ALA . 90.4 m-85 . . . . . 0 CA--C 1.52 -0.181 0 CA-C-O 121.219 0.533 . . . . 71.150000000000006 109.92 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.432 ' H ' ' HA ' ' A' ' 448' ' ' ALA . 32.8 ttm180 -156.8 166.49 33.23 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 106.454 -1.684 . . . . 71.219999999999999 106.454 -176.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -132.4 151.41 51.88 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.969 -0.382 . . . . 74.129999999999995 109.969 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.52 116.32 25.6 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.648 0 N-CA-C 109.208 -0.664 . . . . 64.319999999999993 109.208 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -80.76 155.74 26.55 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.761 -0.654 . . . . 74.230000000000004 111.5 -177.75 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 84.32 -53.53 4.84 Favored Glycine 0 C--N 1.32 -0.34 0 N-CA-C 115.086 0.795 . . . . 33.119999999999997 115.086 174.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 56.1 ttp -71.56 126.28 29.27 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.155 0.502 . . . . 75.209999999999994 110.957 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.11 144.89 42.65 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.192 -0.913 . . . . 63.219999999999999 110.911 -178.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 97.7 m -125.01 133.73 52.86 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.358 -0.978 . . . . 73.409999999999997 108.358 175.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 10.4 ptpp? -138.48 154.63 48.82 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 110.343 -0.243 . . . . 73.099999999999994 110.343 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -164.7 135.34 4.05 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.591 -1.263 . . . . 75.140000000000001 107.591 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -84.67 125.31 32.39 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.599 -0.519 . . . . 75.549999999999997 109.599 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.518 HG21 HG12 ' A' ' 431' ' ' VAL . 49.4 mt -130.59 116.29 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 107.236 -1.394 . . . . 65.340000000000003 107.236 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 67.28 11.71 59.59 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.823 -0.703 . . . . 51.420000000000002 112.521 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 111.94 -25.75 12.5 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.806 -0.711 . . . . 74.310000000000002 112.575 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -97.84 136.09 38.65 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 120.218 -0.593 . . . . 74.349999999999994 110.8 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 92.2 m -79.19 118.48 21.18 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 115.713 -0.676 . . . . 64.140000000000001 110.742 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -90.12 133.34 34.93 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 108.234 -1.024 . . . . 60.210000000000001 108.234 173.364 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -132.06 125.71 32.07 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.349 -0.541 . . . . 74.109999999999999 110.022 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.422 HG23 HG22 ' A' ' 382' ' ' VAL . 7.0 p -119.51 118.08 56.11 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 CA-C-N 116.031 -0.531 . . . . 71.420000000000002 109.861 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.4 t -109.25 116.14 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 106.658 -1.608 . . . . 63.039999999999999 106.658 173.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.469 ' HB2' ' HA ' ' A' ' 361' ' ' LYS . 83.5 m-85 -63.11 130.88 46.54 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.15 -0.932 . . . . 75.340000000000003 113.107 -171.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 71.82 6.79 5.74 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.894 1.278 . . . . 70.200000000000003 112.314 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -119.42 -84.81 0.66 Allowed 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 116.021 -0.536 . . . . 73.409999999999997 112.19 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -168.37 158.99 10.2 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 112.611 0.597 . . . . 44.25 112.611 -174.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 402' ' ' TYR . 94.6 t -116.29 146.58 20.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 123.858 0.863 . . . . 73.430000000000007 109.928 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -133.06 151.3 52.04 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.662 0.785 . . . . 71.400000000000006 111.088 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.521 ' HB2' HD23 ' A' ' 389' ' ' LEU . 30.4 tt0 -126.46 109.66 12.44 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.584 -1.636 . . . . 65.340000000000003 106.584 173.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 25.0 t70 70.49 -80.66 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 124.051 0.94 . . . . 63.43 110.528 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 28.4 p -145.37 1.12 0.93 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.176 -0.92 . . . . 63.329999999999998 109.27 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 48.2 mm -91.37 137.63 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.003 -0.999 . . . . 72.200000000000003 109.558 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 57.1 tp -76.63 115.94 16.86 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.236 -1.024 . . . . 61.030000000000001 108.236 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.539 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.4 OUTLIER -79.07 -64.32 1.21 Allowed 'General case' 0 N--CA 1.392 -3.354 0 N-CA-C 109.025 -0.731 . . . . 63.030000000000001 109.025 -177.252 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.44 160.63 31.52 Favored Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 118.796 -1.668 . . . . 40.140000000000001 111.744 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -99.53 147.48 25.27 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.237 -1.764 . . . . 72.120000000000005 106.237 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 2.6 m-85 -69.24 116.42 9.66 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.061 -0.656 . . . . 45.43 110.86 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -93.78 -48.1 6.46 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.675 -0.693 . . . . 70.409999999999997 110.134 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 46.8 m -154.23 142.45 20.43 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 110.303 -0.258 . . . . 65.299999999999997 110.303 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.2 130.99 53.71 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 106.593 -1.632 . . . . 72.209999999999994 106.593 174.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -128.67 109.81 11.66 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.922 -0.77 . . . . 75.019999999999996 108.922 176.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.19 -101.18 0.58 Allowed Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.988 -0.625 . . . . 34.399999999999999 111.948 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -122.48 18.95 10.5 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.269 0.557 . . . . 72.340000000000003 109.575 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.01 126.43 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 N-CA-C 107.792 -1.188 . . . . 74.099999999999994 107.792 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 22.7 mt -123.82 123.66 40.95 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 110.001 -0.37 . . . . 72.430000000000007 110.001 -172.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -106.88 125.1 50.57 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.201 -0.296 . . . . 63.039999999999999 110.201 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.485 ' CE2' HG21 ' A' ' 382' ' ' VAL . 2.4 m-85 -118.49 135.54 54.33 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.52 -0.918 . . . . 65.25 108.52 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -146.27 175.85 10.2 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 123.41 0.684 . . . . 75.310000000000002 109.771 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 66.17 27.54 10.36 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.287 0.847 . . . . 62.130000000000003 113.287 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -72.6 -139.48 0.32 Allowed Glycine 0 CA--C 1.54 1.619 0 C-N-CA 121.302 -0.475 . . . . 75.400000000000006 113.764 176.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.02 144.68 38.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.309 -1.367 . . . . 75.519999999999996 107.309 -177.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 32.6 t -65.69 130.65 44.05 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.669 0.747 . . . . 74.540000000000006 111.141 -177.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 19.5 p -124.24 159.78 29.42 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.168 -1.049 . . . . 54.549999999999997 108.168 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -86.99 143.45 27.34 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 119.826 -0.75 . . . . 74.430000000000007 111.06 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 78.71 6.03 2.38 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.609 1.563 . . . . 41.530000000000001 109.854 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -146.75 172.75 27.18 Favored Glycine 0 N--CA 1.425 -2.053 0 N-CA-C 107.095 -2.402 . . . . 63.229999999999997 107.095 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -86.67 -41.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.408 0 CA-C-N 120.458 2.129 . . . . 71.420000000000002 112.792 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -161.82 155.38 21.29 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.678 -1.601 . . . . 64.540000000000006 106.678 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -64.99 157.15 29.05 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-O 121.677 0.751 . . . . 73.400000000000006 111.859 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 40.1 p -159.67 163.66 34.66 Favored 'General case' 0 N--CA 1.403 -2.789 0 CA-C-N 114.305 -1.316 . . . . 71.120000000000005 109.063 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.38 151.48 19.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 109.971 -0.381 . . . . 73.409999999999997 109.971 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 14.9 tt -117.67 120.98 66.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 108.663 -0.865 . . . . 72.230000000000004 108.663 173.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.491 HG22 ' HB ' ' A' ' 441' ' ' ILE . 4.1 t -104.01 123.65 57.89 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 CA-C-N 115.163 -0.926 . . . . 62.43 110.127 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 2.3 m -108.57 114.08 27.62 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 105.525 -2.028 . . . . 75.5 105.525 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.37 116.7 44.32 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.383 0 N-CA-C 108.154 -1.054 . . . . 75.310000000000002 108.154 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -110.94 -173.86 2.34 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 120.961 0.41 . . . . 75.040000000000006 111.736 -176.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.487 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 39.8 t -64.1 128.67 36.83 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.635 0.774 . . . . 72.099999999999994 111.386 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -161.1 -177.5 34.26 Favored Glycine 0 CA--C 1.492 -1.37 0 N-CA-C 109.508 -1.437 . . . . 52.109999999999999 109.508 177.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 56.2 t -96.17 -23.42 4.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.539 0.685 . . . . 62.130000000000003 109.441 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -142.67 154.44 44.34 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.906 -0.588 . . . . 71.030000000000001 110.363 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 72.0 m-20 -71.69 99.3 2.09 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.777 -1.194 . . . . 75.25 107.777 175.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -132.01 148.55 52.51 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 120.999 -0.28 . . . . 52.229999999999997 110.398 -177.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.478 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 26.7 mm -85.89 127.49 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.49 -1.67 . . . . 73.420000000000002 106.49 176.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 62.6 t -91.54 -51.03 12.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 112.356 0.502 . . . . 73.420000000000002 112.356 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 50.5 m -163.23 161.64 24.97 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.507 -0.553 . . . . 53.039999999999999 109.507 -174.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.518 HG12 HG21 ' A' ' 369' ' ' ILE . 3.1 p -141.4 116.8 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 123.867 0.729 . . . . 73.239999999999995 109.468 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 25.0 tp -123.87 137.34 54.66 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.214 -1.032 . . . . 74.140000000000001 108.214 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -84.21 128.41 34.55 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.714 -0.847 . . . . 64.120000000000005 108.714 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -89.22 -48.19 7.55 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.11 1.152 . . . . 65.129999999999995 114.11 -176.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -122.79 -68.21 0.9 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.191 0.519 . . . . 74.219999999999999 111.642 -172.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.482 ' HB3' ' NZ ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -166.03 -27.28 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 124.031 0.932 . . . . 73.140000000000001 109.535 175.096 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 98.3 m -135.78 21.91 3.32 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.718 -0.674 . . . . 75.310000000000002 110.934 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.4 tt0 -135.29 119.61 17.86 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.289 0.566 . . . . 75.239999999999995 110.564 -176.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -109.44 134.42 51.88 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 115.623 -0.717 . . . . 74.030000000000001 110.719 -174.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.0 OUTLIER -96.66 116.65 29.47 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.203 -1.036 . . . . 71.200000000000003 108.203 173.263 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.491 ' HB ' HG22 ' A' ' 418' ' ' VAL . 97.6 mt -118.35 135.1 59.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 115.043 -0.98 . . . . 65.540000000000006 110.309 -175.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -105.44 140.93 37.81 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.419 -0.956 . . . . 64.420000000000002 108.419 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.478 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.2 mtp -137.78 168.7 19.15 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 108.784 -0.821 . . . . 53.130000000000003 108.784 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 73.0 mmtt -131.76 161.24 33.32 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.354 -0.98 . . . . 64.099999999999994 108.354 176.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 48.5 t -164.82 146.07 6.45 Favored Pre-proline 0 C--N 1.284 -2.276 0 O-C-N 124.235 0.96 . . . . 73.209999999999994 109.025 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 30.4 Cg_endo -65.6 -27.22 53.48 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.159 1.906 . . . . 73.430000000000007 110.676 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.34 -19.96 38.26 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.516 -0.766 . . . . 63.210000000000001 110.782 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . . . -86.99 9.58 19.08 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-O 121.969 0.89 . . . . 74.420000000000002 110.415 -177.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 10.4 t -103.53 175.7 5.39 Favored 'General case' 0 N--CA 1.403 -2.809 0 N-CA-C 107.702 -1.221 . . . . 75.239999999999995 107.702 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.421 -1.906 0 N-CA-C 107.306 -1.368 . . . . 61.310000000000002 107.306 177.351 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.721 ' N ' ' HH ' ' A' ' 379' ' ' TYR . 57.2 t80 . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 108.267 -1.012 . . . . 74.25 108.267 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 73.13 0.73 3.78 Favored 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 124.977 1.311 . . . . 71.409999999999997 112.808 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -146.45 150.64 36.01 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.84 -1.17 . . . . 62.100000000000001 107.84 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 4.2 tp -81.54 116.25 25.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 122.108 0.956 . . . . 73.329999999999998 111.919 -175.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -74.17 129.79 38.52 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.439 -1.255 . . . . 74.150000000000006 110.691 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 93.5 -13.25 67.97 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.856 -0.688 . . . . 41.210000000000001 114.027 176.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 52.7 ttm -75.64 132.33 40.53 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 119.089 -1.044 . . . . 74.200000000000003 110.499 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -94.77 106.06 18.03 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.269 -1.011 . . . . 65.150000000000006 108.269 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.495 ' HB ' HG13 ' A' ' 376' ' ' VAL . 86.4 m -101.89 137.42 40.2 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.46 -0.571 . . . . 62.130000000000003 109.46 -178.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 0.0 OUTLIER -145.17 151.62 38.72 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.614 -0.435 . . . . 72.510000000000005 111.572 178.021 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -162.56 134.33 5.29 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.31 -1.367 . . . . 74.049999999999997 107.31 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 45.7 mt-10 -87.79 127.99 35.32 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 110.113 -0.329 . . . . 71.319999999999993 110.113 -175.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.487 HG21 HG12 ' A' ' 431' ' ' VAL . 42.5 mt -134.46 122.64 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 106.642 -1.614 . . . . 74.420000000000002 106.642 -175.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.54 9.88 52.15 Favored Glycine 0 C--N 1.306 -1.123 0 C-N-CA 120.894 -0.669 . . . . 65.409999999999997 113.194 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 111.97 -23.57 16.49 Favored Glycine 0 N--CA 1.427 -1.94 0 C-N-CA 120.82 -0.705 . . . . 70.319999999999993 112.803 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' TYR . . . . . 0.419 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 17.0 p90 -100.98 144.61 29.71 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.625 0.25 . . . . 74.140000000000001 110.809 -177.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 87.3 m -82.47 119.39 24.15 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.817 -0.438 . . . . 75.239999999999995 109.817 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.37 125.28 35.49 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 108.451 -0.944 . . . . 60.119999999999997 108.451 172.738 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -126.6 130.9 51.4 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.453 -0.573 . . . . 75.109999999999999 109.453 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.512 HG23 HG22 ' A' ' 382' ' ' VAL . 6.6 p -128.07 119.29 50.69 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.928 0 CA-C-O 121.254 0.55 . . . . 75.340000000000003 110.246 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 57.9 t -108.14 116.39 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.917 0 N-CA-C 106.825 -1.546 . . . . 74.030000000000001 106.825 175.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -62.85 132.48 52.3 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.066 1.135 . . . . 74.25 114.066 -173.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.721 ' HH ' ' N ' ' A' ' 357' ' ' TYR . 96.5 m-85 66.96 17.91 10.55 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.03 -1.441 . . . . 62.420000000000002 112.076 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -128.79 -82.75 0.58 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.309 -0.86 . . . . 54.520000000000003 113.001 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -165.55 155.93 13.29 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 113.274 0.842 . . . . 65.099999999999994 113.274 -172.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.512 HG22 HG23 ' A' ' 376' ' ' VAL . 88.4 t -113.78 145.28 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.388 1.075 . . . . 54.039999999999999 109.252 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -134.81 147.61 49.99 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 123.125 0.57 . . . . 75.219999999999999 111.532 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.528 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.2 tt0 -119.39 104.71 10.6 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.151 -1.796 . . . . 73.109999999999999 106.151 173.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.4 t70 72.12 -82.96 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.725 0.81 . . . . 63.219999999999999 110.286 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 32.1 p -143.84 3.04 1.23 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.852 -1.067 . . . . 71.420000000000002 108.574 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 62.1 mt -89.21 133.91 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.967 -1.015 . . . . 71.239999999999995 109.378 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 61.2 tp -77.43 115.45 17.21 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.536 -0.913 . . . . 61.409999999999997 108.536 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.574 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -80.31 -64.54 1.17 Allowed 'General case' 0 N--CA 1.394 -3.249 0 N-CA-C 108.994 -0.743 . . . . 51.549999999999997 108.994 -177.086 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.9 158.57 30.16 Favored Glycine 0 N--CA 1.415 -2.739 0 C-N-CA 119.874 -1.155 . . . . 54.43 111.519 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -103.12 153.14 20.62 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.157 -1.423 . . . . 65.310000000000002 107.157 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.488 ' HB3' HE22 ' A' ' 395' ' ' GLN . 1.7 m-85 -73.7 116.13 13.93 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 120.926 0.393 . . . . 71.340000000000003 111.306 -175.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.88 -48.12 5.03 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.608 -0.724 . . . . 71.239999999999995 110.852 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 51.1 m -157.15 137.75 13.12 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.024 0.44 . . . . 64.219999999999999 109.961 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.56 ' CB ' ' HG ' ' A' ' 400' ' ' LEU . 4.8 pm0 -141.17 125.69 17.74 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 115.824 -0.626 . . . . 72.129999999999995 110.371 177.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -128.22 132.18 48.8 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.383 -0.969 . . . . 63.25 108.383 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 69.53 -103.53 1.12 Allowed Glycine 0 N--CA 1.422 -2.292 0 N-CA-C 111.057 -0.817 . . . . 73.519999999999996 111.057 -177.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -138.77 18.5 2.67 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.789 0.804 . . . . 73.420000000000002 110.297 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 63.9 t -117.1 119.78 63.02 Favored 'Isoleucine or valine' 0 C--O 1.244 0.816 0 N-CA-C 108.174 -1.047 . . . . 61.299999999999997 108.174 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.56 ' HG ' ' CB ' ' A' ' 395' ' ' GLN . 4.0 mp -113.02 135.54 53.67 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.964 -0.562 . . . . 73.239999999999995 110.971 -173.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -115.47 125.16 52.74 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.524 -0.917 . . . . 71.209999999999994 108.524 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -115.75 141.55 47.94 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.399 -0.963 . . . . 74.400000000000006 108.399 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -146.12 176.46 9.71 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.624 0.77 . . . . 71.540000000000006 109.096 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 18.7 m120 65.51 36.05 6.87 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.274 0.629 . . . . 65.340000000000003 112.677 173.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -81.01 -137.67 2.11 Favored Glycine 0 C--N 1.305 -1.177 0 C-N-CA 120.562 -0.828 . . . . 55.5 112.681 177.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.73 149.18 36.37 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 106.527 -1.657 . . . . 55.130000000000003 106.527 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 407' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 46.0 m -61.98 142.2 57.6 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 113.655 0.983 . . . . 61.149999999999999 113.655 -173.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 48.5 t -120.58 160.03 24.05 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.364 -1.347 . . . . 72.230000000000004 107.364 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -80.59 -35.13 34.64 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.798 -0.761 . . . . 73.140000000000001 110.403 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -96.61 -7.08 35.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.95 0.881 . . . . 72.310000000000002 110.865 -170.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -141.78 169.04 25.39 Favored Glycine 0 N--CA 1.419 -2.437 0 N-CA-C 107.724 -2.15 . . . . 73.450000000000003 107.724 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.26 -39.14 13.67 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 CA-C-N 119.885 1.843 . . . . 72.439999999999998 111.038 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 413' ' ' HIS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 90.2 m-70 -152.53 171.48 18.05 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.3 -1.0 . . . . 75.150000000000006 108.3 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -77.4 164.9 25.06 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 121.043 0.449 . . . . 64.549999999999997 110.521 173.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 57.6 p -159.42 166.78 30.3 Favored 'General case' 0 N--CA 1.403 -2.818 0 CA-C-N 115.036 -0.984 . . . . 62.43 109.347 -177.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -157.55 151.8 24.74 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 109.85 -0.426 . . . . 54.229999999999997 109.85 -178.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 11.0 tt -122.18 123.14 68.22 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 CA-C-N 115.699 -0.682 . . . . 62.200000000000003 109.444 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 441' ' ' ILE . 4.3 t -113.73 130.68 67.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 115.818 -0.628 . . . . 62.119999999999997 111.447 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 17.7 p -108.75 114.19 27.77 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 108.357 -0.979 . . . . 73.5 108.357 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 45.1 t -100.83 115.39 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 107.549 -1.278 . . . . 74.510000000000005 107.549 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -117.35 -174.68 2.65 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 121.014 -0.274 . . . . 72.510000000000005 110.471 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 38.1 t -61.37 128.71 37.65 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 122.976 0.51 . . . . 64.319999999999993 110.749 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.647 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -163.12 -177.66 36.27 Favored Glycine 0 CA--C 1.495 -1.158 0 C-N-CA 120.701 -0.761 . . . . 24.039999999999999 111.498 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.9 t -81.94 -38.91 16.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.403 0.621 . . . . 74.129999999999995 110.445 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -155.92 162.03 40.45 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.12 -0.696 . . . . 75.230000000000004 109.12 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 43.1 m-80 -63.17 102.88 0.42 Allowed 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.594 1.184 . . . . 71.420000000000002 109.024 177.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -133.09 139.24 47.03 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.491 -1.3 . . . . 62.520000000000003 107.491 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 30.6 mm -89.06 110.61 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 N-CA-C 106.75 -1.574 . . . . 52.439999999999998 106.75 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 57.2 t -80.76 -44.78 21.5 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.688 0 CA-C-N 115.755 -0.657 . . . . 54.409999999999997 112.464 -173.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 35.3 p -162.26 158.4 24.25 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 120.494 -0.483 . . . . 50.329999999999998 110.727 -176.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.487 HG12 HG21 ' A' ' 369' ' ' ILE . 4.2 p -141.56 115.42 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 N-CA-C 108.547 -0.908 . . . . 73.340000000000003 108.547 175.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 29.0 tp -120.57 135.79 54.99 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.029 -1.471 . . . . 63.450000000000003 107.029 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -87.98 123.52 32.78 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.431 -1.322 . . . . 75.5 107.431 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -82.19 -46.81 13.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.856 1.058 . . . . 74.349999999999994 113.856 -174.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -121.38 -74.36 0.62 Allowed 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.438 0.637 . . . . 63.140000000000001 110.839 -172.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.412 ' HB3' ' NZ ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -175.55 -10.12 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 126.114 1.766 . . . . 63.210000000000001 109.373 176.465 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 24.7 m -136.62 5.17 2.89 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 109.528 -0.545 . . . . 74.120000000000005 109.528 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 415' ' ' SER . 31.3 tt0 -136.22 126.02 25.68 Favored 'General case' 0 C--O 1.211 -0.972 0 CA-C-O 120.837 0.351 . . . . 72.420000000000002 111.55 -173.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 439' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 28.4 m-85 -113.7 141.15 47.6 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 116.055 -0.521 . . . . 70.109999999999999 110.719 -175.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.436 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.2 pt? -106.29 119.42 39.21 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.373 -0.973 . . . . 74.420000000000002 108.373 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.486 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.8 mt -119.45 135.4 59.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.366 -0.834 . . . . 72.209999999999994 111.255 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -99.7 139.3 35.57 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 109.489 -0.56 . . . . 70.510000000000005 109.489 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 81.5 mtp -141.82 164.68 29.53 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 109.858 -0.423 . . . . 75.120000000000005 109.858 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.647 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 71.7 mmtt -134.78 161.35 35.44 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.961 -1.126 . . . . 64.099999999999994 107.961 176.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 31.9 t -167.2 145.88 4.29 Favored Pre-proline 0 C--N 1.289 -2.043 0 O-C-N 123.97 0.794 . . . . 62.439999999999998 109.277 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.31 -24.68 43.24 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.245 1.963 . . . . 74.540000000000006 110.862 177.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.33 -19.59 59.53 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.222 -0.899 . . . . 64.540000000000006 110.658 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -94.97 6.16 49.87 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 121.554 0.692 . . . . 70.099999999999994 109.458 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 10.5 t -103.17 119.87 39.66 Favored 'General case' 0 N--CA 1.405 -2.707 0 N-CA-C 107.313 -1.365 . . . . 70.549999999999997 107.313 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 C--N 1.296 -1.757 0 N-CA-C 108.358 -0.979 . . . . 54.130000000000003 108.358 -179.473 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.419 ' HB3' ' HB3' ' A' ' 398' ' ' ASN . 98.9 m-85 . . . . . 0 C--O 1.222 -0.388 0 CA-C-O 120.804 0.335 . . . . 74.239999999999995 110.787 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.421 ' O ' ' HB1' ' A' ' 447' ' ' ALA . 71.1 ttt180 -82.38 106.78 14.53 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 120.79 0.328 . . . . 74.099999999999994 110.137 -176.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -58.29 153.14 15.95 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.344 -0.844 . . . . 63.530000000000001 112.451 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 71.3 mt -79.87 127.85 38.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.882 -0.599 . . . . 74.219999999999999 109.676 -174.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.439 ' HG2' ' CD1' ' A' ' 379' ' ' TYR . 9.3 mtmp? -91.45 157.81 16.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.73 -0.668 . . . . 74.400000000000006 111.578 -173.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 82.18 -31.99 2.82 Favored Glycine 0 N--CA 1.462 0.427 0 N-CA-C 114.93 0.732 . . . . 72.239999999999995 114.93 172.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.03 156.77 33.71 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 117.253 0.527 . . . . 53.229999999999997 110.938 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -116.56 138.56 51.32 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-O 121.55 0.69 . . . . 74.519999999999996 110.724 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.406 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 93.5 m -124.4 139.27 54.05 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.823 -0.806 . . . . 71.140000000000001 108.823 177.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 10.4 ptpp? -144.23 141.05 29.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 116.444 -0.344 . . . . 74.230000000000004 110.858 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -159.02 135.82 9.51 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.033 -0.729 . . . . 73.439999999999998 109.033 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.17 129.98 35.06 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.31 -0.405 . . . . 75.040000000000006 110.582 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.553 HG21 HG12 ' A' ' 431' ' ' VAL . 33.3 mt -137.95 128.11 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 106.643 -1.614 . . . . 73.519999999999996 106.643 -175.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.58 14.45 49.95 Favored Glycine 0 C--N 1.302 -1.319 0 C-N-CA 120.34 -0.933 . . . . 71.200000000000003 113.171 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 99.57 -9.88 60.78 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.749 -0.739 . . . . 75.439999999999998 113.537 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' TYR . . . . . 0.403 ' CD1' ' HG3' ' A' ' 384' ' ' GLN . 9.0 p90 -111.29 144.07 41.05 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 122.438 -0.448 . . . . 70.019999999999996 110.571 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 38.2 m -82.16 120.5 25.41 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 110.173 -0.306 . . . . 54.240000000000002 110.173 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.4 OUTLIER -91.29 135.89 33.49 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 109.278 -0.638 . . . . 72.120000000000005 109.278 173.636 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -131.93 127.48 36.47 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 123.547 0.529 . . . . 72.109999999999999 109.952 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.452 HG23 HG22 ' A' ' 382' ' ' VAL . 7.4 p -127.08 120.57 55.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 120.879 0.371 . . . . 60.219999999999999 110.522 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.7 t -115.17 116.96 54.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 N-CA-C 106.837 -1.542 . . . . 73.450000000000003 106.837 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.463 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 28.4 m-85 -65.32 128.49 36.07 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 114.757 1.392 . . . . 55.420000000000002 114.757 -171.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 379' ' ' TYR . . . . . 0.439 ' CD1' ' HG2' ' A' ' 361' ' ' LYS . 65.3 m-85 68.28 22.38 8.1 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 113.84 -1.527 . . . . 64.010000000000005 112.288 -176.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -132.36 -79.8 0.5 Allowed 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.438 -0.801 . . . . 73.299999999999997 113.098 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -165.46 154.72 12.3 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.419 0.896 . . . . 61.310000000000002 113.419 -172.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.463 HG21 ' CD2' ' A' ' 402' ' ' TYR . 98.9 t -119.25 145.3 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.166 0.986 . . . . 64.420000000000002 109.024 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -134.26 145.59 49.27 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.965 0.412 . . . . 72.319999999999993 111.889 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.514 ' HB2' HD23 ' A' ' 389' ' ' LEU . 33.4 tt0 -116.84 108.26 15.62 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.419 -1.697 . . . . 61.340000000000003 106.419 172.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.2 t70 71.67 -79.65 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 124.302 1.041 . . . . 75.319999999999993 109.931 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.0 m -144.73 -4.02 0.77 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.563 -0.903 . . . . 74.409999999999997 108.563 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 50.1 mm -84.09 136.67 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.442 -0.799 . . . . 73.530000000000001 109.486 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 64.5 tp -76.2 110.73 10.94 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.799 -1.186 . . . . 73.109999999999999 107.799 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.6 OUTLIER -73.61 -63.1 1.27 Allowed 'General case' 0 N--CA 1.385 -3.682 0 N-CA-C 108.552 -0.907 . . . . 72.150000000000006 108.552 -176.271 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.94 158.7 29.99 Favored Glycine 0 N--CA 1.417 -2.585 0 C-N-CA 119.064 -1.541 . . . . 75.209999999999994 111.595 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -106.64 142.21 36.65 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.106 -1.072 . . . . 73.319999999999993 108.106 177.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' PHE . . . . . 0.542 ' HD2' ' NE2' ' A' ' 395' ' ' GLN . 1.9 m-85 -65.99 115.96 6.61 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 123.465 0.478 . . . . 75.230000000000004 110.537 -176.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -105.65 -48.47 3.65 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.074 -0.512 . . . . 73.530000000000001 111.278 -176.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 56.6 m -155.07 139.87 17.16 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.677 -0.49 . . . . 70.549999999999997 109.677 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.542 ' NE2' ' HD2' ' A' ' 392' ' ' PHE . 42.7 mt-30 -134.41 136.46 43.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.242 -1.392 . . . . 75.099999999999994 107.242 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -128.78 110.76 12.45 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 109.474 -0.565 . . . . 71.209999999999994 109.474 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 70.81 -118.57 7.68 Favored Glycine 0 N--CA 1.424 -2.125 0 N-CA-C 110.665 -0.974 . . . . 70.209999999999994 110.665 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' ASN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 357' ' ' TYR . 4.2 p-10 -107.29 21.81 16.94 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.446 0.641 . . . . 74.150000000000006 110.188 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 40.1 t -124.48 116.91 48.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 107.79 -1.189 . . . . 53.229999999999997 107.79 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.451 ' CD2' ' HB3' ' A' ' 395' ' ' GLN . 11.2 mt -116.34 129.51 56.29 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.882 -0.599 . . . . 72.439999999999998 110.922 -169.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -105.03 122.02 45.0 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-O 121.06 0.457 . . . . 72.319999999999993 112.168 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.463 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.5 m-85 -117.1 119.17 34.44 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 105.807 -1.923 . . . . 72.109999999999999 105.807 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -135.73 173.84 11.27 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.31 -0.626 . . . . 72.430000000000007 109.31 -174.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 61.04 37.48 17.93 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.965 0.791 . . . . 62.020000000000003 112.503 175.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.58 -141.82 1.24 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.185 -0.531 . . . . 72.030000000000001 112.676 176.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.82 137.58 51.93 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.435 -0.95 . . . . 73.439999999999998 108.435 -175.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 48.8 m -64.76 119.27 10.28 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 123.65 0.78 . . . . 70.150000000000006 112.427 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 12.3 p -100.62 158.17 16.14 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.257 -1.016 . . . . 63.210000000000001 108.257 176.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -86.53 -27.94 23.68 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.261 0.553 . . . . 73.340000000000003 109.725 -176.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -89.51 -0.61 57.62 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.358 -0.837 . . . . 72.310000000000002 110.523 -172.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -155.58 -159.65 9.48 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 108.642 -1.783 . . . . 60.399999999999999 108.642 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -93.11 -42.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.179 0 CA-C-N 120.215 2.008 . . . . 73.329999999999998 113.407 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -165.91 154.78 11.48 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 106.484 -1.673 . . . . 72.439999999999998 106.484 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.05 153.32 41.8 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.352 0.596 . . . . 73.109999999999999 111.996 174.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.9 p -159.1 160.83 36.14 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 114.698 -1.137 . . . . 64.030000000000001 108.908 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -155.39 148.0 24.13 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 109.744 -0.465 . . . . 75.420000000000002 109.744 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.9 tt -110.94 118.52 57.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.536 -0.913 . . . . 60.310000000000002 108.536 174.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 2.9 t -97.77 125.42 50.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 CA-C-O 121.457 0.646 . . . . 74.319999999999993 109.884 177.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 2.5 m -108.43 112.23 24.53 Favored 'General case' 0 N--CA 1.385 -3.707 0 N-CA-C 104.577 -2.379 . . . . 64.120000000000005 104.577 174.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 7.9 p -102.0 121.15 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 108.655 -0.868 . . . . 71.329999999999998 108.655 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -114.94 -174.4 2.48 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 116.289 -0.414 . . . . 53.539999999999999 110.362 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.647 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 22.6 t -60.57 128.16 35.24 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 123.367 0.667 . . . . 64.120000000000005 112.572 -176.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.549 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -156.06 -177.75 29.56 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.606 -0.807 . . . . 63.299999999999997 111.452 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.4 t -91.76 -34.2 6.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.851 -0.796 . . . . 73.25 108.851 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -148.88 148.06 29.42 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 115.694 -0.685 . . . . 73.540000000000006 109.197 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.741 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.1 p-10 -62.36 99.64 0.15 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.991 -1.004 . . . . 64.150000000000006 111.536 176.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -131.81 149.07 52.57 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.338 -0.847 . . . . 75.239999999999995 110.156 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.441 HG21 HD11 ' A' ' 369' ' ' ILE . 28.2 mm -82.09 119.53 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.198 -1.408 . . . . 73.0 107.198 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 429' ' ' VAL . . . . . 0.428 HG11 ' HD2' ' A' ' 442' ' ' LYS . 66.0 t -83.69 -51.37 14.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 111.886 0.328 . . . . 74.030000000000001 111.886 -177.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 59.7 m -166.04 163.52 18.23 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.438 -0.579 . . . . 70.329999999999998 109.438 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.553 HG12 HG21 ' A' ' 369' ' ' ILE . 3.5 p -141.84 116.68 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 107.956 -1.127 . . . . 74.409999999999997 107.956 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 34.1 tp -112.16 133.13 54.48 Favored 'General case' 0 C--N 1.263 -3.156 0 N-CA-C 108.143 -1.058 . . . . 61.030000000000001 108.143 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -82.15 108.52 15.68 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.596 -1.261 . . . . 74.420000000000002 107.596 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -69.75 -53.26 19.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.865 0.841 . . . . 75.540000000000006 109.47 -177.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -120.1 -77.79 0.58 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.52 -1.218 . . . . 74.239999999999995 108.577 177.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.479 ' HB3' ' NZ ' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -169.94 -47.36 0.02 OUTLIER 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 124.459 1.104 . . . . 74.409999999999997 110.383 174.258 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 82.0 m -91.99 5.3 50.67 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.723 0.773 . . . . 52.210000000000001 109.562 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -136.49 124.4 22.73 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.107 -0.951 . . . . 74.519999999999996 109.08 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 54.4 m-85 -122.56 151.22 41.61 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.016 -0.538 . . . . 75.040000000000006 110.118 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.47 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.6 pt? -110.53 124.95 52.78 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.299 -1.371 . . . . 62.100000000000001 107.299 170.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 98.4 mt -122.78 134.94 64.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 115.813 -0.63 . . . . 75.349999999999994 109.92 -175.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.428 ' HD2' HG11 ' A' ' 429' ' ' VAL . 23.9 ttmm -106.84 140.81 39.08 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 108.776 -0.824 . . . . 60.219999999999999 108.776 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.402 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.7 mtp -138.02 164.14 29.81 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.032 -1.099 . . . . 63.240000000000002 108.032 177.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.741 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 34.2 mmtp -129.69 151.59 50.11 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 108.063 -1.088 . . . . 65.439999999999998 108.063 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 43.4 t -164.74 147.84 7.33 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.786 -0.82 . . . . 61.530000000000001 108.786 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.97 -27.22 66.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.072 1.848 . . . . 73.519999999999996 110.244 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 358' ' ' ARG . . . -69.37 -22.26 63.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.232 -0.894 . . . . 61.43 110.876 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -101.95 8.29 41.13 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.358 0.599 . . . . 72.349999999999994 109.944 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' CYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 422' ' ' CYS . 34.6 t -102.47 135.7 43.62 Favored 'General case' 0 N--CA 1.415 -2.221 0 CA-C-N 115.79 -0.641 . . . . 71.319999999999993 109.319 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.408 -2.558 0 N-CA-C 106.817 -1.549 . . . . 62.43 106.817 -179.586 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 53.1 t80 . . . . . 0 C--O 1.222 -0.359 0 N-CA-C 108.76 -0.83 . . . . 72.319999999999993 108.76 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -163.71 177.7 8.49 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 104.701 -2.333 . . . . 64.450000000000003 104.701 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -76.08 151.12 37.15 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 118.258 0.481 . . . . 71.019999999999996 110.004 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' ILE . . . . . 0.432 HG23 ' HB3' ' A' ' 363' ' ' MET . 4.8 tp -81.34 119.3 30.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 112.982 0.734 . . . . 74.329999999999998 112.982 -173.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.53 141.43 55.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.236 -0.893 . . . . 62.329999999999998 111.003 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 91.98 -35.17 4.09 Favored Glycine 0 CA--C 1.495 -1.198 0 CA-C-N 115.916 -0.584 . . . . 33.409999999999997 112.157 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' MET . . . . . 0.492 ' HG2' ' ND2' ' A' ' 426' ' ' ASN . 46.3 tpp -62.32 129.74 42.09 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.277 0.56 . . . . 70.129999999999995 111.162 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.413 ' CB ' HG22 ' A' ' 377' ' ' VAL . 12.3 pt-20 -106.67 119.07 38.34 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 115.343 -0.844 . . . . 63.43 108.882 175.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' THR . . . . . 0.43 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 92.0 m -107.74 137.94 44.85 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 109.253 -0.647 . . . . 62.200000000000003 109.253 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 19.6 ptmt -144.2 145.03 31.82 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 121.21 -0.196 . . . . 61.32 111.209 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -160.76 136.89 8.4 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.223 -1.029 . . . . 74.420000000000002 108.223 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.05 125.31 31.98 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 110.017 -0.364 . . . . 51.32 110.017 -178.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.488 HG21 HG12 ' A' ' 431' ' ' VAL . 57.3 mt -130.57 116.27 34.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 107.29 -1.374 . . . . 71.049999999999997 107.29 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.6 15.09 63.59 Favored Glycine 0 C--N 1.306 -1.107 0 C-N-CA 121.063 -0.589 . . . . 60.200000000000003 112.498 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 109.09 -25.72 17.58 Favored Glycine 0 N--CA 1.427 -1.931 0 C-N-CA 120.401 -0.904 . . . . 65.340000000000003 112.578 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -97.77 135.84 38.96 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.007 0.432 . . . . 70.140000000000001 111.286 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 85.1 m -79.19 118.5 21.2 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.856 -0.611 . . . . 41.43 110.747 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.595 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -90.66 132.47 35.76 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 108.378 -0.971 . . . . 75.540000000000006 108.378 173.637 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -132.07 127.32 35.87 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.278 -0.638 . . . . 71.230000000000004 109.278 -176.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.515 HG23 HG22 ' A' ' 382' ' ' VAL . 6.5 p -125.72 118.37 51.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-O 121.053 0.454 . . . . 75.239999999999995 110.16 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.413 HG22 ' CB ' ' A' ' 364' ' ' GLU . 44.2 t -106.66 116.9 51.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 107.031 -1.47 . . . . 63.420000000000002 107.031 174.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -63.65 129.04 38.52 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 114.011 1.115 . . . . 74.510000000000005 114.011 -172.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 72.7 13.52 5.19 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 126.166 1.786 . . . . 75.030000000000001 112.371 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -124.11 -83.3 0.65 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 113.088 0.773 . . . . 72.219999999999999 113.088 176.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -159.05 164.9 35.03 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 112.542 0.571 . . . . 75.530000000000001 112.542 -170.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.515 HG22 HG23 ' A' ' 376' ' ' VAL . 72.7 t -126.88 142.16 44.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.242 -0.89 . . . . 64.310000000000002 108.837 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -132.97 151.6 52.04 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 122.957 0.503 . . . . 75.019999999999996 111.311 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.496 ' HB2' HD23 ' A' ' 389' ' ' LEU . 30.6 tt0 -122.18 106.27 10.99 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 106.217 -1.771 . . . . 71.519999999999996 106.217 172.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.0 t70 70.76 -74.66 0.08 Allowed 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 124.87 1.268 . . . . 72.319999999999993 110.395 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 64.1 m -146.94 -7.2 0.49 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.75 -0.659 . . . . 55.329999999999998 110.155 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 40.1 mt -87.75 135.94 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 116.311 -0.404 . . . . 72.329999999999998 110.39 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.5 tp -75.93 120.74 21.68 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.528 0.68 . . . . 42.140000000000001 109.387 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.53 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -82.83 -64.39 1.18 Allowed 'General case' 0 N--CA 1.383 -3.777 0 N-CA-C 108.597 -0.89 . . . . 71.120000000000005 108.597 -177.617 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.13 162.34 33.12 Favored Glycine 0 N--CA 1.421 -2.306 0 C-N-CA 118.934 -1.603 . . . . 31.219999999999999 111.986 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -108.44 146.51 33.01 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.343 -1.354 . . . . 74.219999999999999 107.343 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -64.96 116.47 6.43 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 120.882 0.373 . . . . 64.420000000000002 111.555 -175.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -94.76 -49.07 5.77 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.049 -0.523 . . . . 64.409999999999997 111.308 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 21.4 p -169.02 140.37 2.46 Favored 'General case' 0 C--O 1.252 1.22 0 N-CA-C 110.127 -0.323 . . . . 74.310000000000002 110.127 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.402 ' OE1' HD22 ' A' ' 400' ' ' LEU . 10.6 pt20 -142.39 140.55 32.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.217 0.532 . . . . 65.140000000000001 111.726 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -128.78 128.62 44.32 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 108.689 -0.856 . . . . 72.109999999999999 108.689 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 68.82 -101.53 0.8 Allowed Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 121.008 -0.615 . . . . 72.540000000000006 112.466 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 26.2 p-10 -130.49 11.8 5.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 111.981 0.363 . . . . 71.329999999999998 111.981 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 40.7 t -111.65 116.98 54.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.923 -1.14 . . . . 74.430000000000007 107.923 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.402 HD22 ' OE1' ' A' ' 395' ' ' GLN . 6.7 mt -114.83 131.45 56.82 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.553 -0.536 . . . . 65.129999999999995 109.553 -172.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -116.37 124.43 50.05 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.322 -0.992 . . . . 64.299999999999997 108.322 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.451 ' CD2' HG21 ' A' ' 382' ' ' VAL . 3.5 m-85 -114.22 136.19 53.23 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.48 -1.304 . . . . 53.350000000000001 107.48 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -144.09 176.4 9.34 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.585 -0.524 . . . . 61.0 109.585 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 62.96 36.24 12.75 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.837 0.68 . . . . 63.409999999999997 112.837 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -80.56 -141.65 2.87 Favored Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.25 -0.976 . . . . 64.209999999999994 111.243 175.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -75.34 134.83 40.92 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.097 -0.705 . . . . 74.200000000000003 109.097 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 37.8 m -60.41 134.37 57.0 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.354 0.872 . . . . 74.099999999999994 113.354 -175.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 10.1 p -110.13 159.23 17.53 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.202 -0.908 . . . . 72.129999999999995 109.452 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 17.8 p-90 -78.82 -29.96 45.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.551 0.691 . . . . 74.209999999999994 109.839 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' ASN . . . . . 0.633 ' ND2' ' HB2' ' A' ' 436' ' ' LYS . 13.9 p-10 -98.98 8.9 44.56 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.152 -0.931 . . . . 73.349999999999994 112.617 -172.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -163.26 -172.1 30.33 Favored Glycine 0 C--N 1.308 -1.013 0 N-CA-C 109.086 -1.605 . . . . 45.119999999999997 109.086 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -83.36 -39.72 0.12 Allowed 'Trans proline' 0 CA--C 1.546 1.081 0 CA-C-N 120.057 1.929 . . . . 53.420000000000002 112.942 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' HIS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 99.8 m-70 -162.01 162.29 28.81 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 107.798 -1.186 . . . . 71.140000000000001 107.798 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -73.22 159.19 33.83 Favored 'General case' 0 C--O 1.257 1.448 0 CA-C-O 121.374 0.607 . . . . 75.140000000000001 111.604 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 33.2 p -162.18 163.56 28.31 Favored 'General case' 0 N--CA 1.406 -2.663 0 CA-C-N 114.488 -1.233 . . . . 74.329999999999998 109.121 -177.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -159.15 144.74 16.2 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.819 -0.437 . . . . 34.43 109.819 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.8 tt -109.62 125.12 66.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.099 -1.075 . . . . 72.450000000000003 108.099 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.9 t -111.09 131.19 63.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.87 -0.605 . . . . 73.230000000000004 110.895 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.84 113.8 26.65 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 106.058 -1.83 . . . . 75.0 106.058 175.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 23.6 t -101.18 112.62 34.72 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.517 0 N-CA-C 109.256 -0.646 . . . . 55.439999999999998 109.256 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -109.93 -176.25 2.95 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.745 -0.782 . . . . 75.540000000000006 110.965 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.452 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 32.4 t -60.67 128.08 34.82 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 123.568 0.747 . . . . 72.430000000000007 111.212 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.547 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -151.23 178.93 28.31 Favored Glycine 0 N--CA 1.428 -1.835 0 N-CA-C 110.086 -1.206 . . . . 74.140000000000001 110.086 177.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 41.3 t -93.8 -26.96 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.293 -1.002 . . . . 62.310000000000002 108.293 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -141.56 157.42 45.13 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 114.894 -1.048 . . . . 75.340000000000003 109.306 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.492 ' ND2' ' HG2' ' A' ' 363' ' ' MET . 65.4 m-20 -73.16 100.16 3.0 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 106.858 -1.534 . . . . 74.430000000000007 106.858 174.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -132.18 141.24 49.02 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 120.687 -0.405 . . . . 74.239999999999995 111.805 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.439 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 27.3 mm -83.39 118.43 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 105.767 -1.938 . . . . 74.040000000000006 105.767 174.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 55.1 t -83.17 -50.65 15.39 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-O 121.042 0.449 . . . . 73.230000000000004 111.651 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 37.4 p -161.23 159.49 28.79 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.197 -0.456 . . . . 52.439999999999998 110.5 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.488 HG12 HG21 ' A' ' 369' ' ' ILE . 3.3 p -142.15 122.86 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 108.829 -0.804 . . . . 52.049999999999997 108.829 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 432' ' ' LEU . . . . . 0.473 ' O ' HD23 ' A' ' 440' ' ' LEU . 30.2 tp -131.0 137.54 49.27 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.8 -1.185 . . . . 74.329999999999998 107.8 -177.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -81.45 116.97 21.5 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.578 -0.849 . . . . 64.120000000000005 108.789 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.31 -63.97 1.12 Allowed 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.392 -0.822 . . . . 74.329999999999998 110.722 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -106.23 -76.24 0.61 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.75 -0.659 . . . . 74.209999999999994 111.821 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.633 ' HB2' ' ND2' ' A' ' 410' ' ' ASN . 44.9 pttt -162.8 -30.35 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.048 0.452 . . . . 72.129999999999995 112.172 -174.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 86.2 m -131.16 11.65 5.04 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.576 -0.898 . . . . 74.129999999999995 108.576 176.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 415' ' ' SER . 34.8 tt0 -131.79 129.62 40.76 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.119 -0.946 . . . . 54.009999999999998 108.985 -176.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -117.91 150.41 39.26 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.682 -0.69 . . . . 74.200000000000003 110.906 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.6 pt? -106.4 120.9 43.1 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.598 -1.26 . . . . 61.149999999999999 107.598 172.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.7 mt -124.14 128.7 74.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-N 115.41 -0.814 . . . . 71.430000000000007 109.746 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -104.27 140.69 37.5 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.873 -0.788 . . . . 74.420000000000002 108.873 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.439 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.3 mtp -135.08 167.47 20.9 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 109.409 -0.589 . . . . 70.540000000000006 109.409 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.547 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 72.1 mmtt -133.24 156.28 47.83 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.299 -1.371 . . . . 73.150000000000006 107.299 174.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 38.3 t -163.77 145.44 7.31 Favored Pre-proline 0 C--N 1.278 -2.542 0 O-C-N 124.075 0.86 . . . . 60.420000000000002 109.11 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.4 -21.38 47.14 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.111 1.874 . . . . 42.32 110.646 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.12 -18.58 52.99 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.803 -0.635 . . . . 71.450000000000003 110.982 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -98.09 10.91 39.32 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.376 0.608 . . . . 72.430000000000007 109.857 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 12.7 t -103.39 119.94 39.85 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 108.661 -0.866 . . . . 74.430000000000007 108.661 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.428 -1.562 0 N-CA-C 107.446 -1.316 . . . . 61.200000000000003 107.446 -179.592 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 CA--C 1.512 -0.512 0 CA-C-O 120.53 0.205 . . . . 73.329999999999998 111.162 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -163.15 28.0 0.09 Allowed 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.374 -1.713 . . . . 75.219999999999999 106.374 171.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -146.7 151.75 37.72 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 104.386 -2.45 . . . . 23.309999999999999 104.386 -178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 48.0 mm -80.42 115.52 23.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.571 -0.852 . . . . 63.25 109.818 -172.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.539 ' HA ' ' HB2' ' A' ' 378' ' ' PHE . 0.0 OUTLIER -88.14 152.48 21.97 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 115.167 1.543 . . . . 73.439999999999998 115.167 -173.843 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 89.37 -23.4 18.93 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.12 -0.946 . . . . 72.439999999999998 112.135 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' MET . . . . . 0.437 ' HE2' ' HB3' ' A' ' 363' ' ' MET . 48.4 ttp -81.51 143.73 31.84 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 123.001 0.52 . . . . 75.239999999999995 110.458 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.496 ' HB3' HG22 ' A' ' 377' ' ' VAL . 10.8 pt-20 -99.31 130.83 45.63 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.313 -0.625 . . . . 64.430000000000007 109.313 174.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 97.0 m -118.71 125.49 49.79 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.477 -1.305 . . . . 64.140000000000001 107.477 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 57.7 mtpt -133.32 143.54 49.08 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 116.239 -0.437 . . . . 61.340000000000003 110.529 -174.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.488 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 1.9 tmt_? -157.95 136.85 11.45 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.057 -1.09 . . . . 53.219999999999999 108.057 -177.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 40.5 mt-10 -87.98 127.18 35.38 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.713 0.292 . . . . 75.239999999999995 110.233 -174.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 369' ' ' ILE . . . . . 0.554 HG21 HG12 ' A' ' 431' ' ' VAL . 38.0 mt -136.96 120.76 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 106.793 -1.558 . . . . 62.109999999999999 106.793 -176.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.26 13.71 60.62 Favored Glycine 0 C--N 1.304 -1.21 0 C-N-CA 120.358 -0.925 . . . . 45.340000000000003 113.137 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.09 -17.73 40.7 Favored Glycine 0 N--CA 1.429 -1.832 0 C-N-CA 121.084 -0.579 . . . . 73.049999999999997 113.107 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -106.87 139.72 40.84 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 120.683 0.278 . . . . 64.5 110.333 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 37.4 m -83.83 122.01 28.11 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 116.259 -0.428 . . . . 61.200000000000003 110.166 -178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 374' ' ' TYR . . . . . 0.625 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.54 129.07 36.73 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 109.301 -0.629 . . . . 73.409999999999997 109.301 176.615 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 375' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 83.9 tttt -122.48 125.23 45.36 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 123.887 0.742 . . . . 54.229999999999997 110.108 -175.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 376' ' ' VAL . . . . . 0.449 HG12 HD11 ' A' ' 428' ' ' ILE . 7.2 p -128.24 118.22 47.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 N-CA-C 109.161 -0.681 . . . . 70.510000000000005 109.161 175.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 377' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 364' ' ' GLU . 40.8 t -106.73 116.5 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 106.116 -1.809 . . . . 74.319999999999993 106.116 174.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 378' ' ' PHE . . . . . 0.539 ' HB2' ' HA ' ' A' ' 361' ' ' LYS . 95.9 m-85 -58.9 123.06 15.22 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 123.807 0.692 . . . . 74.209999999999994 112.503 -174.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 72.98 12.23 5.11 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.587 1.555 . . . . 73.549999999999997 113.385 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -123.24 -86.84 0.64 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 113.848 1.055 . . . . 70.409999999999997 113.848 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.54 169.05 20.41 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 119.392 -0.923 . . . . 73.120000000000005 110.322 -176.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 94.9 t -124.95 138.78 53.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 107.643 -1.243 . . . . 65.439999999999998 107.643 173.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -132.91 148.1 52.29 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.143 0.497 . . . . 73.219999999999999 110.785 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' GLN . . . . . 0.5 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.8 tt0 -115.28 100.07 7.86 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.387 -1.709 . . . . 63.409999999999997 106.387 173.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 13.4 t70 69.89 -78.37 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 125.248 1.419 . . . . 61.450000000000003 110.019 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 27.4 m -138.01 -5.69 1.67 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.082 -0.963 . . . . 62.509999999999998 109.287 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 47.8 mm -88.39 135.63 25.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.188 -0.46 . . . . 75.409999999999997 110.016 -177.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 62.9 tp -76.23 115.1 15.63 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.995 -1.113 . . . . 71.230000000000004 107.995 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.6 OUTLIER -80.21 -60.52 2.3 Favored 'General case' 0 N--CA 1.388 -3.539 0 N-CA-C 108.762 -0.829 . . . . 72.129999999999995 108.762 -175.684 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.97 158.59 29.88 Favored Glycine 0 N--CA 1.413 -2.892 0 C-N-CA 119.295 -1.431 . . . . 44.0 111.417 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -102.24 143.97 31.36 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.659 -1.608 . . . . 74.150000000000006 106.659 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -69.27 116.82 10.14 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.013 0.435 . . . . 71.030000000000001 110.737 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.11 -47.56 5.45 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.772 -0.649 . . . . 75.349999999999994 110.962 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 65.9 p -168.47 143.67 3.49 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.898 -0.408 . . . . 75.140000000000001 109.898 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' GLN . . . . . 0.475 ' OE1' HD22 ' A' ' 400' ' ' LEU . 10.1 pt20 -143.08 136.98 28.85 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.743 0.306 . . . . 74.0 110.503 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -112.52 119.93 39.88 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.518 -0.919 . . . . 65.25 108.518 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.11 -101.67 0.63 Allowed Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 119.651 -1.262 . . . . 33.119999999999997 113.178 177.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -123.66 10.68 9.07 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.799 1.24 . . . . 64.319999999999993 111.132 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.34 116.69 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.015 0 N-CA-C 106.85 -1.537 . . . . 64.439999999999998 106.85 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.475 HD22 ' OE1' ' A' ' 395' ' ' GLN . 9.3 mt -113.61 131.61 56.05 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 115.966 -0.561 . . . . 74.019999999999996 110.962 -168.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -114.27 121.76 44.68 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-O 121.392 0.615 . . . . 72.329999999999998 112.349 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.415 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.3 m-85 -118.25 139.02 51.95 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.537 -1.282 . . . . 75.420000000000002 107.537 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -141.46 173.42 11.51 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-O 121.466 0.65 . . . . 61.020000000000003 111.45 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 51.1 46.59 26.22 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.095 -1.866 . . . . 72.519999999999996 113.16 167.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.22 -132.98 0.57 Allowed Glycine 0 C--N 1.311 -0.831 0 CA-C-N 115.839 -0.618 . . . . 61.420000000000002 112.708 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.56 142.64 38.89 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.108 -1.442 . . . . 73.140000000000001 107.108 -176.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 407' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 27.4 t -64.46 128.44 35.79 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-O 121.806 0.812 . . . . 73.230000000000004 111.097 -178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 6.0 p -99.64 158.39 15.8 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.5 -0.926 . . . . 54.149999999999999 108.5 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 28.8 p-90 -82.48 -32.14 28.97 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.074 -0.713 . . . . 74.510000000000005 109.074 -177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -90.6 12.67 18.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.475 -0.784 . . . . 71.329999999999998 112.287 -175.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.403 ' HA3' ' SG ' ' A' ' 437' ' ' CYS . . . -167.41 -160.68 15.2 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 109.521 -1.432 . . . . 61.310000000000002 109.521 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -95.65 -40.95 0.02 OUTLIER 'Trans proline' 0 CA--C 1.564 1.99 0 CA-C-N 119.954 1.877 . . . . 75.409999999999997 114.033 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' HIS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 97.1 m-70 -159.15 154.23 25.16 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.062 0.945 . . . . 75.010000000000005 108.782 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -74.33 160.53 30.94 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.34 0.59 . . . . 74.239999999999995 111.383 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 35.5 p -165.57 162.35 19.02 Favored 'General case' 0 N--CA 1.418 -2.058 0 C-N-CA 124.366 1.066 . . . . 74.329999999999998 108.246 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -158.74 151.11 21.6 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.303 0.573 . . . . 74.209999999999994 110.8 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 11.6 tt -114.37 131.11 67.37 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 CA-C-N 115.131 -0.94 . . . . 61.340000000000003 108.828 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 4.1 t -116.72 131.04 70.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-O 121.329 0.585 . . . . 74.340000000000003 111.926 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 62.2 p -108.02 114.97 29.27 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 107.641 -1.244 . . . . 54.130000000000003 107.641 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 39.6 t -100.19 111.87 31.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 107.545 -1.279 . . . . 62.549999999999997 107.545 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -113.52 -175.14 2.61 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 110.787 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' CYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 449' ' ' CYS . 43.6 t -60.42 128.66 37.76 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.815 -0.629 . . . . 72.120000000000005 111.224 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 423' ' ' GLY . . . . . 0.604 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -154.36 178.59 31.09 Favored Glycine 0 CA--C 1.476 -2.377 0 N-CA-C 110.479 -1.048 . . . . 52.539999999999999 110.479 177.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 56.0 t -90.41 -33.79 6.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 108.282 -1.007 . . . . 61.100000000000001 108.282 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -150.66 152.66 34.32 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.698 -0.683 . . . . 73.010000000000005 109.768 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.3 p-10 -60.1 98.83 0.06 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.597 -1.183 . . . . 55.210000000000001 112.427 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -133.08 146.85 52.04 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.038 -0.528 . . . . 63.439999999999998 111.783 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 367' ' ' ARG . 31.3 mm -80.17 119.87 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 105.449 -2.056 . . . . 52.530000000000001 105.449 171.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 54.6 t -84.55 -51.16 14.2 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.867 0 N-CA-C 112.112 0.412 . . . . 52.109999999999999 112.112 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 430' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 32.6 p -160.86 162.71 32.25 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.814 -0.354 . . . . 62.329999999999998 110.837 -174.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 431' ' ' VAL . . . . . 0.554 HG12 HG21 ' A' ' 369' ' ' ILE . 4.8 p -142.12 111.87 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 108.966 -0.753 . . . . 73.329999999999998 108.966 176.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 432' ' ' LEU . . . . . 0.409 ' O ' HD23 ' A' ' 440' ' ' LEU . 34.9 tp -113.97 136.45 52.89 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 108.765 -0.828 . . . . 54.539999999999999 108.765 -177.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.66 113.8 19.91 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.837 -0.801 . . . . 70.519999999999996 108.837 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.14 -70.42 0.39 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.294 -0.632 . . . . 43.409999999999997 109.294 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -100.0 -75.83 0.56 Allowed 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.551 -0.75 . . . . 75.310000000000002 109.966 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.1 -51.07 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.461 0.648 . . . . 73.25 110.437 175.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 437' ' ' CYS . . . . . 0.403 ' SG ' ' HA3' ' A' ' 411' ' ' GLY . 64.3 m -100.52 13.19 35.44 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.204 -0.907 . . . . 72.5 109.019 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 438' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 415' ' ' SER . 33.4 tt0 -135.22 124.85 25.16 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-N 115.185 -0.916 . . . . 61.350000000000001 108.873 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -123.01 150.18 43.37 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.142 -0.936 . . . . 75.230000000000004 109.567 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.445 HD23 ' H ' ' A' ' 440' ' ' LEU . 1.4 pt? -109.22 121.37 45.02 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.252 -1.018 . . . . 63.109999999999999 108.252 173.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 441' ' ' ILE . . . . . 0.558 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 97.1 mt -118.08 135.25 59.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.211 -0.904 . . . . 65.109999999999999 110.012 -175.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -109.26 141.42 41.57 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 109.5 -0.556 . . . . 64.420000000000002 109.5 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' MET . . . . . 0.43 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.1 mtp -136.38 162.81 32.01 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 108.995 -0.743 . . . . 75.219999999999999 108.995 178.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 444' ' ' LYS . . . . . 0.604 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 70.1 mmtt -132.87 151.49 52.02 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.164 -1.05 . . . . 63.439999999999998 108.164 176.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 68.1 m -161.24 149.15 12.44 Favored Pre-proline 0 C--N 1.295 -1.792 0 O-C-N 123.865 0.728 . . . . 70.239999999999995 109.945 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.44 -27.76 62.48 Favored 'Trans proline' 0 N--CA 1.48 0.695 0 C-N-CA 122.724 2.283 . . . . 74.420000000000002 111.95 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.58 -22.25 57.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.6 -0.727 . . . . 74.319999999999993 110.643 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -97.2 19.09 13.59 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-N 115.528 -0.76 . . . . 65.049999999999997 111.049 -175.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' CYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 422' ' ' CYS . 23.3 t -99.39 124.41 44.49 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.708 0.766 . . . . 64.519999999999996 110.911 -176.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.442 -0.848 0 CA-C-N 114.438 -1.255 . . . . 44.409999999999997 108.299 -178.663 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.468 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 90.7 m . . . . . 0 N--CA 1.429 -1.507 0 N-CA-C 107.302 -1.369 . . . . 63.43 107.302 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 17.1 ptmt -139.16 141.18 38.02 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 121.099 -0.24 . . . . 60.32 110.913 -174.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.413 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 3.6 tmt_? -156.94 138.4 13.94 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.276 -1.379 . . . . 61.42 107.276 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -86.42 126.84 34.67 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.141 -0.689 . . . . 73.12 109.141 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.51 HG21 HG12 ' A' ' 431' ' ' VAL . 39.8 mt -137.17 124.6 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 106.654 -1.609 . . . . 73.41 106.654 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.58 8.47 46.58 Favored Glycine 0 C--N 1.301 -1.393 0 C-N-CA 120.91 -0.662 . . . . 73.54 113.233 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.09 -14.74 44.24 Favored Glycine 0 N--CA 1.426 -1.978 0 C-N-CA 120.702 -0.761 . . . . 62.14 112.684 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . 0.423 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 17.3 p90 -106.39 141.4 37.78 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 120.839 0.352 . . . . 74.12 110.134 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 51.3 m -83.52 120.24 25.69 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 116.18 -0.463 . . . . 73.42 109.895 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.6 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.66 134.21 34.57 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 108.612 -0.885 . . . . 75.31 108.612 174.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -133.41 125.01 28.15 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.104 -0.702 . . . . 72.55 109.104 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.51 HG23 HG22 ' A' ' 382' ' ' VAL . 7.6 p -121.05 122.54 67.89 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 N-CA-C 109.197 -0.668 . . . . 70.31 109.197 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.4 t -110.53 116.71 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 106.902 -1.518 . . . . 73.02 106.902 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -62.92 126.56 27.74 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.119 1.155 . . . . 75.23 114.119 -172.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 72.85 8.51 5.5 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.173 1.789 . . . . 72.4 113.276 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -116.68 -85.56 0.63 Allowed 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 112.969 0.729 . . . . 75.0 112.969 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.406 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.5 OUTLIER -162.32 162.75 28.11 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.875 -0.602 . . . . 74.13 112.254 -171.336 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.51 HG22 HG23 ' A' ' 376' ' ' VAL . 66.5 t -122.58 144.86 30.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.049 -0.978 . . . . 73.33 109.585 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.406 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 62.8 m-85 -133.94 148.33 51.17 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 123.094 0.558 . . . . 72.43 111.595 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.46 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.9 tt0 -119.47 103.51 9.51 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.818 -1.919 . . . . 63.22 105.818 173.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.5 t70 69.15 -86.44 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 123.962 0.905 . . . . 75.12 109.587 -175.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.6 m -135.37 -2.66 2.46 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.935 -0.765 . . . . 65.01 108.935 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 62.8 mt -83.13 132.66 30.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.93 -0.577 . . . . 74.24 109.781 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.2 tp -76.66 115.54 16.51 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.6 -0.889 . . . . 72.32 108.6 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.536 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -79.69 -66.09 0.92 Allowed 'General case' 0 N--CA 1.39 -3.455 0 N-CA-C 108.934 -0.765 . . . . 74.1 108.934 -177.229 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.77 160.15 31.65 Favored Glycine 0 N--CA 1.413 -2.836 0 C-N-CA 118.925 -1.607 . . . . 54.35 111.604 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -104.36 145.28 30.49 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.362 -1.347 . . . . 75.23 107.362 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -66.6 116.66 7.78 Favored 'General case' 0 C--N 1.288 -2.088 0 O-C-N 123.351 0.407 . . . . 75.24 110.774 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -101.93 -48.11 4.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.107 -0.497 . . . . 75.42 111.227 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 51.3 m -159.5 141.42 13.31 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.945 -0.391 . . . . 74.43 109.945 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.407 ' HB2' ' CD2' ' A' ' 400' ' ' LEU . 9.9 pt20 -144.37 140.47 29.08 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 120.97 0.414 . . . . 74.13 111.888 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -128.05 119.43 25.39 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.493 -0.776 . . . . 75.33 110.416 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 74.72 -101.28 1.28 Allowed Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 115.681 -0.691 . . . . 75.23 111.736 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 4.4 p-10 -131.79 15.96 4.79 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.401 0.619 . . . . 73.31 110.071 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 419' ' ' THR . 46.9 t -116.71 119.15 61.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 106.874 -1.528 . . . . 75.31 106.874 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.407 ' CD2' ' HB2' ' A' ' 395' ' ' GLN . 9.9 mt -118.04 130.74 56.35 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 116.207 -0.451 . . . . 52.51 110.808 -170.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.457 ' HE3' HD12 ' A' ' 417' ' ' ILE . 22.6 mmtp -105.02 122.99 47.02 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 112.275 0.472 . . . . 73.43 112.275 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.435 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.2 m-85 -118.84 132.92 56.13 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.887 -1.153 . . . . 75.32 107.887 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -147.19 177.58 9.07 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 122.582 0.353 . . . . 72.41 110.179 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.5 m120 66.67 36.63 4.66 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.605 0.566 . . . . 73.14 111.226 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -79.88 -138.07 1.78 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 120.582 -0.818 . . . . 73.21 112.824 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.22 143.18 32.5 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.638 -0.505 . . . . 55.22 109.638 -178.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.469 0.494 0 N-CA-C 113.82 1.044 . . . . 73.24 113.82 -176.153 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 . . . . . 0 C--O 1.244 0.777 0 N-CA-C 105.681 -1.97 . . . . 52.01 105.681 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -63.77 160.49 17.12 Favored 'General case' 0 C--O 1.254 1.313 0 CA-C-O 121.467 0.651 . . . . 75.0 112.662 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.633 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 46.7 t -161.13 159.66 29.31 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 114.539 -1.209 . . . . 74.13 107.814 -176.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -159.78 149.93 18.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 120.852 0.358 . . . . 64.23 110.127 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . 0.457 HD12 ' HE3' ' A' ' 401' ' ' LYS . 8.8 tt -110.63 123.8 66.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.737 -1.208 . . . . 62.21 107.737 173.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.3 t -106.28 126.25 61.92 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 CA-C-O 121.164 0.507 . . . . 51.41 109.924 176.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.454 HG23 HG22 ' A' ' 399' ' ' VAL . 3.6 m -108.64 112.95 25.56 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 105.819 -1.919 . . . . 54.21 105.819 176.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 40.6 t -100.8 112.0 32.26 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.94 0 N-CA-C 107.101 -1.444 . . . . 74.13 107.101 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -110.9 -175.37 2.7 Favored 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 120.228 -0.589 . . . . 75.21 111.4 -175.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.48 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 38.9 t -59.92 128.01 34.76 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 123.503 0.721 . . . . 73.15 110.46 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -158.76 -176.93 31.36 Favored Glycine 0 CA--C 1.492 -1.385 0 N-CA-C 110.964 -0.855 . . . . 74.13 110.964 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 42.3 t -94.38 -31.29 4.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-O 121.225 0.536 . . . . 53.45 109.615 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.84 161.09 40.77 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 116.002 -0.545 . . . . 63.34 109.559 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.531 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.1 p-10 -73.03 98.58 2.55 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 124.311 1.007 . . . . 72.45 110.398 175.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -132.44 148.22 52.4 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.912 -0.586 . . . . 74.11 110.754 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.475 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 28.2 mm -84.36 124.03 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.963 -1.866 . . . . 74.43 105.963 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.435 HG11 ' HE3' ' A' ' 442' ' ' LYS . 51.9 t -92.55 -47.99 13.7 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 112.888 0.699 . . . . 73.02 112.888 -175.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 42.9 m -158.67 155.64 28.49 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.735 -0.469 . . . . 54.03 109.735 -173.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.51 HG12 HG21 ' A' ' 369' ' ' ILE . 3.2 p -141.3 111.9 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 108.672 -0.862 . . . . 63.01 108.672 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . 0.411 ' O ' HD23 ' A' ' 440' ' ' LEU . 32.0 tp -117.71 137.74 52.48 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 114.96 -1.018 . . . . 71.43 108.507 -175.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -80.58 112.59 18.08 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.962 -0.755 . . . . 73.44 108.962 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -73.75 -49.79 23.78 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 115.54 -0.755 . . . . 65.32 110.216 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -126.14 -76.2 0.58 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.166 -0.924 . . . . 75.22 108.993 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.95 -41.31 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 121.043 0.449 . . . . 71.34 110.787 173.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 98.6 m -96.84 -16.88 20.54 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.324 0.583 . . . . 72.33 110.114 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 415' ' ' SER . 37.3 tt0 -112.72 132.31 55.27 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.979 -1.01 . . . . 71.34 109.691 -177.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -125.68 150.16 47.87 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.543 -0.753 . . . . 72.15 109.273 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.478 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.5 pt? -105.47 117.16 33.32 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.566 -0.901 . . . . 75.2 108.566 173.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.6 mt -114.91 132.25 64.7 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 115.093 -0.958 . . . . 73.22 109.628 -176.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.435 ' HE3' HG11 ' A' ' 429' ' ' VAL . 36.6 ttpt -109.31 140.16 43.34 Favored 'General case' 0 N--CA 1.408 -2.53 0 N-CA-C 108.51 -0.922 . . . . 72.11 108.51 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.475 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 77.0 mtp -138.08 168.41 19.78 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 108.484 -0.932 . . . . 74.55 108.484 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.61 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 71.7 mmtt -134.5 156.45 48.59 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.292 -1.003 . . . . 53.03 108.292 175.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 74.3 m -162.95 147.32 9.08 Favored Pre-proline 0 C--N 1.289 -2.04 0 C-N-CA 124.291 1.036 . . . . 73.43 109.394 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -66.14 -27.25 49.31 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.324 2.016 . . . . 71.02 111.757 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -78.72 -15.6 58.25 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.748 -0.66 . . . . 74.02 110.79 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.854 0 CA-C-O 121.68 0.752 . . . . 72.2 109.913 -179.868 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.493 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 95.7 m . . . . . 0 N--CA 1.416 -2.163 0 N-CA-C 107.711 -1.218 . . . . 74.12 107.711 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 0.0 OUTLIER -136.26 141.51 43.9 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.963 -0.695 . . . . 74.3 110.404 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -159.71 140.34 12.18 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.518 0.511 . . . . 72.21 110.313 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -76.34 123.92 26.7 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 110.115 -0.328 . . . . 64.44 110.115 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.46 HG21 HG12 ' A' ' 431' ' ' VAL . 48.6 mt -129.52 117.52 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 N-CA-C 106.194 -1.78 . . . . 72.41 106.194 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.73 14.01 62.14 Favored Glycine 0 C--N 1.304 -1.219 0 C-N-CA 120.781 -0.723 . . . . 53.51 112.244 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.1 -22.05 32.22 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 121.279 -0.486 . . . . 62.34 112.981 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -98.35 135.83 39.38 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 120.916 0.389 . . . . 71.23 111.204 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 85.4 m -79.86 114.54 18.85 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.765 -0.652 . . . . 73.41 110.224 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -91.46 132.92 35.91 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 108.563 -0.903 . . . . 72.34 108.563 176.344 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.534 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 37.6 ttpt -132.01 132.31 43.31 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 120.273 -0.571 . . . . 72.35 110.594 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.493 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.0 p -122.65 118.42 55.05 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 CA-C-N 115.844 -0.616 . . . . 71.33 110.076 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.54 116.02 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 106.768 -1.568 . . . . 65.15 106.768 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.411 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 98.0 m-85 -64.18 132.56 50.74 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 113.522 0.934 . . . . 73.31 113.522 -173.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 65.18 23.66 12.31 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.053 -1.431 . . . . 75.51 112.286 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -136.49 -83.46 0.37 Allowed 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.505 -0.77 . . . . 71.31 112.914 176.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.422 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -165.81 160.03 16.65 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.569 0.951 . . . . 63.13 113.569 -173.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.476 HG22 HG23 ' A' ' 376' ' ' VAL . 95.9 t -116.21 146.3 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.595 1.158 . . . . 51.02 109.521 -178.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.422 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 85.8 m-85 -134.83 152.36 51.69 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.316 0.646 . . . . 71.51 111.646 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.481 ' HB2' HD23 ' A' ' 389' ' ' LEU . 29.1 tt0 -127.63 106.68 9.32 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.337 -1.727 . . . . 70.45 106.337 171.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.5 t70 69.44 -83.35 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 124.175 0.99 . . . . 54.13 110.52 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 45.5 m -135.85 -5.49 2.18 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.961 -0.755 . . . . 44.14 108.961 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 49.7 mm -89.21 132.63 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.497 -0.774 . . . . 62.04 110.565 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 57.7 tp -76.41 116.12 16.8 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.309 -0.997 . . . . 62.44 108.309 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.2 OUTLIER -79.44 -62.63 1.63 Allowed 'General case' 0 N--CA 1.393 -3.287 0 N-CA-C 109.03 -0.73 . . . . 64.14 109.03 -176.535 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.56 160.87 32.23 Favored Glycine 0 N--CA 1.42 -2.422 0 C-N-CA 119.335 -1.412 . . . . 35.1 111.903 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -104.73 151.31 23.89 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.662 -1.236 . . . . 64.52 107.662 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.411 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.8 m-85 -70.41 116.75 11.11 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 121.341 0.591 . . . . 64.12 111.876 -176.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -95.81 -47.18 6.27 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.318 -0.855 . . . . 62.41 110.541 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 38.3 t -164.95 139.27 5.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.461 -0.57 . . . . 64.11 109.461 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.534 ' CB ' ' HG ' ' A' ' 400' ' ' LEU . 5.7 pm0 -141.98 129.71 21.62 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.556 -0.747 . . . . 73.32 110.621 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -128.37 127.07 41.94 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.294 -1.002 . . . . 74.13 108.294 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.93 -117.79 9.65 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.986 -0.625 . . . . 73.01 112.011 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -116.63 20.3 14.12 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.357 0.598 . . . . 73.24 110.773 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 67.4 t -124.91 128.88 73.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.45 -0.944 . . . . 75.41 108.45 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.534 ' HG ' ' CB ' ' A' ' 395' ' ' GLN . 3.9 mp -126.51 140.39 52.49 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 116.455 -0.339 . . . . 72.21 111.099 -175.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -116.68 124.88 50.78 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.132 0.573 . . . . 74.22 111.133 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.411 ' CD2' HG21 ' A' ' 382' ' ' VAL . 3.8 m-85 -118.16 136.19 53.77 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.061 -0.718 . . . . 73.32 109.061 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.25 178.03 8.91 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 122.654 0.382 . . . . 74.53 110.653 178.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.2 m120 66.58 33.61 6.46 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.079 0.552 . . . . 51.21 111.684 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.15 -130.4 0.44 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 120.424 -0.893 . . . . 64.1 113.051 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.78 147.53 30.45 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.402 -1.703 . . . . 65.23 106.402 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 50.8 m . . . . . 0 C--N 1.311 -1.099 0 CA-C-O 121.839 0.828 . . . . 41.03 112.806 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' HIS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 94.8 m-70 . . . . . 0 CA--C 1.504 -0.789 0 N-CA-C 108.358 -0.979 . . . . 74.03 108.358 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -76.7 165.08 25.24 Favored 'General case' 0 C--O 1.251 1.157 0 O-C-N 123.597 0.561 . . . . 45.44 111.5 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 22.9 p -161.79 165.3 28.09 Favored 'General case' 0 N--CA 1.411 -2.397 0 CA-C-N 114.548 -1.205 . . . . 72.24 109.235 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -159.54 151.05 20.08 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.422 0.629 . . . . 72.1 110.546 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.4 tt -114.37 131.56 66.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-N 115.333 -0.848 . . . . 74.43 109.102 173.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.454 HG22 ' HB ' ' A' ' 441' ' ' ILE . 4.7 t -119.96 125.71 74.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-O 121.335 0.588 . . . . 73.33 110.97 177.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 21.3 p -109.77 114.59 28.3 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.091 -0.959 . . . . 73.24 108.952 174.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 37.5 t -100.48 112.48 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 108.284 -1.006 . . . . 61.14 108.284 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -110.53 -174.6 2.52 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 116.566 -0.288 . . . . 70.24 110.571 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.547 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 30.4 t -57.36 128.33 36.49 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.626 0.771 . . . . 73.13 111.678 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.692 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -154.94 -177.62 28.42 Favored Glycine 0 CA--C 1.478 -2.233 0 C-N-CA 120.467 -0.873 . . . . 72.15 111.806 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.0 t -87.34 -36.01 9.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.64 -0.874 . . . . 75.13 108.64 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -157.62 162.17 38.69 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.566 -0.901 . . . . 74.04 108.566 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 3.9 m120 -61.77 102.36 0.26 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.485 0.659 . . . . 63.41 111.41 173.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -131.9 148.28 52.53 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.938 -1.028 . . . . 71.23 109.687 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 27.0 mm -89.05 114.83 27.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 105.87 -1.9 . . . . 72.31 105.87 175.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 53.0 t -83.02 -51.27 14.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 CA-C-N 116.112 -0.494 . . . . 63.53 112.217 -174.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 49.2 m -155.36 154.45 32.03 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.7 -0.481 . . . . 64.53 109.7 -174.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.46 HG12 HG21 ' A' ' 369' ' ' ILE . 5.6 p -141.8 122.83 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 109.079 -0.711 . . . . 52.24 109.079 175.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 440' ' ' LEU . 29.4 tp -131.25 136.81 48.53 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 107.385 -1.339 . . . . 73.3 107.385 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -83.56 122.14 28.16 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.977 -1.49 . . . . 75.4 106.977 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.518 ' HB2' HD22 ' A' ' 440' ' ' LEU . . . -82.92 -49.83 9.22 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.81 1.041 . . . . 74.13 113.81 -173.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -116.23 -70.26 0.81 Allowed 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.064 -0.654 . . . . 71.5 110.616 -170.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . 0.419 ' H ' ' H ' ' A' ' 437' ' ' CYS . 0.0 OUTLIER -172.99 -24.27 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 125.058 1.343 . . . . 70.12 109.359 178.371 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . 0.419 ' H ' ' H ' ' A' ' 436' ' ' LYS . 29.9 m -135.59 13.23 3.46 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.733 -0.84 . . . . 64.53 108.733 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 415' ' ' SER . 24.2 tt0 -136.68 119.22 15.91 Favored 'General case' 0 C--O 1.204 -1.317 0 N-CA-C 112.481 0.549 . . . . 63.33 112.481 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 26.9 m-85 -104.12 146.45 28.72 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.944 -0.571 . . . . 72.05 110.953 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 434' ' ' ALA . 1.5 pt? -108.53 120.24 41.85 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.252 -1.018 . . . . 72.13 108.252 172.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.454 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.6 mt -120.01 131.55 72.09 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 115.259 -0.882 . . . . 74.3 110.793 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -98.56 138.32 35.93 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 108.5 -0.926 . . . . 65.12 108.5 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.419 ' SD ' HG11 ' A' ' 376' ' ' VAL . 80.7 mtp -138.79 164.67 29.01 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 109.988 -0.375 . . . . 74.44 109.988 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.692 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 32.7 mmtp -133.24 160.56 36.92 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.497 -0.557 . . . . 45.31 109.497 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . 0.465 ' HB2' ' ND2' ' A' ' 426' ' ' ASN . 42.7 t -163.75 142.08 6.04 Favored Pre-proline 0 C--N 1.304 -1.394 0 O-C-N 124.036 0.835 . . . . 62.51 109.041 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -68.16 -26.19 36.59 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 121.973 1.782 . . . . 51.21 109.676 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.8 -7.55 58.74 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.922 -1.035 . . . . 61.23 110.652 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.716 0 CA-C-O 121.311 0.577 . . . . 71.44 109.636 176.919 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.461 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 58.0 m . . . . . 0 N--CA 1.445 -0.696 0 N-CA-C 109.266 -0.642 . . . . 71.35 109.266 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 18.2 ptpt -144.6 145.29 31.71 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 123.082 0.239 . . . . 64.53 111.441 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.46 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 4.0 tmt_? -159.4 133.71 7.7 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.556 -1.276 . . . . 71.53 107.556 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 44.2 mt-10 -84.6 125.6 32.6 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.578 -0.527 . . . . 74.41 109.578 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.457 HG21 HG12 ' A' ' 431' ' ' VAL . 47.8 mt -131.08 118.21 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 107.544 -1.28 . . . . 61.45 107.544 -174.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 67.06 13.16 61.5 Favored Glycine 0 C--N 1.313 -0.718 0 C-N-CA 120.936 -0.65 . . . . 62.21 112.365 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 112.89 -29.29 8.2 Favored Glycine 0 N--CA 1.417 -2.58 0 C-N-CA 120.946 -0.645 . . . . 74.33 112.595 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . 0.414 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 20.8 p90 -98.4 140.33 32.82 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 120.914 0.388 . . . . 64.31 111.314 -175.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 36.9 m -81.12 118.19 22.32 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 116.012 -0.54 . . . . 74.31 110.037 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.574 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.5 129.89 36.62 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 108.621 -0.881 . . . . 61.51 108.621 173.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -131.24 128.5 40.02 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.371 -0.532 . . . . 71.35 109.969 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.461 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.6 p -124.17 117.85 52.03 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-O 121.325 0.583 . . . . 73.13 109.576 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.48 116.47 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.378 -1.341 . . . . 73.51 107.378 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.474 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 91.9 m-85 -60.52 131.03 49.46 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.499 0.926 . . . . 70.45 113.499 -172.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 68.99 9.49 7.44 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 124.996 1.318 . . . . 71.25 112.612 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -120.82 -84.32 0.66 Allowed 'General case' 0 C--O 1.239 0.552 0 N-CA-C 113.164 0.801 . . . . 71.34 113.164 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.487 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -166.94 158.76 12.79 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.09 0.774 . . . . 72.25 113.09 -173.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.443 HG22 HG23 ' A' ' 376' ' ' VAL . 92.0 t -114.1 146.35 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.992 -1.003 . . . . 72.31 109.535 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.487 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 78.6 m-85 -133.98 146.1 50.12 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 123.048 0.539 . . . . 71.53 111.71 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.498 ' HB2' HD23 ' A' ' 389' ' ' LEU . 35.3 tt0 -117.94 98.38 6.31 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 106.112 -1.81 . . . . 61.32 106.112 172.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 18.7 t70 69.94 -83.93 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 124.325 1.05 . . . . 73.41 110.636 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.3 m -136.43 3.87 2.84 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.161 -1.051 . . . . 72.13 108.161 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 65.2 mt -88.36 132.66 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 114.998 -1.001 . . . . 71.33 109.775 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 64.2 tp -78.01 110.58 13.08 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.383 -1.34 . . . . 75.02 107.383 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.54 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -76.81 -65.26 0.96 Allowed 'General case' 0 N--CA 1.393 -3.317 0 N-CA-C 109.036 -0.728 . . . . 73.01 109.036 -175.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.27 157.45 28.8 Favored Glycine 0 N--CA 1.423 -2.184 0 C-N-CA 119.791 -1.195 . . . . 72.31 111.746 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -100.65 150.02 23.16 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.057 -1.09 . . . . 71.44 108.057 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.544 ' HB3' ' NE2' ' A' ' 395' ' ' GLN . 1.9 m-85 -73.04 115.9 12.92 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.205 0.526 . . . . 55.53 110.853 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.9 -43.42 6.73 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.529 -0.76 . . . . 60.52 111.085 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 52.9 m -155.11 143.73 20.57 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.686 -0.234 . . . . 62.21 110.515 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.544 ' NE2' ' HB3' ' A' ' 392' ' ' PHE . 14.2 mp0 -129.88 133.87 47.15 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.873 -1.529 . . . . 74.04 106.873 174.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -128.91 110.91 12.51 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.782 -0.821 . . . . 73.13 108.782 173.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 72.11 -101.66 1.07 Allowed Glycine 0 N--CA 1.409 -3.114 0 C-N-CA 119.415 -1.374 . . . . 72.12 112.056 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -130.39 19.15 5.3 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 123.77 0.828 . . . . 44.21 109.124 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.95 116.75 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 N-CA-C 106.887 -1.523 . . . . 72.5 106.887 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.428 HD22 ' CG ' ' A' ' 395' ' ' GLN . 13.1 mt -116.46 130.47 56.78 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.806 -0.634 . . . . 70.42 110.354 -170.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -110.12 121.95 46.46 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 121.031 0.443 . . . . 74.11 111.239 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.42 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 2.9 m-85 -116.19 132.38 56.68 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.14 -1.059 . . . . 63.22 108.14 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 415' ' ' SER . 11.4 pt-20 -147.74 177.55 9.21 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 123.172 0.295 . . . . 70.24 110.96 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 14.7 m120 65.91 34.36 7.25 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 123.7 0.625 . . . . 74.35 111.24 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -79.14 -136.65 1.27 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.756 -0.735 . . . . 64.04 112.168 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -74.86 151.14 39.01 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.695 -0.854 . . . . 73.14 108.695 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 121.485 0.66 . . . . 52.24 112.167 -174.725 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 . . . . . 0 CA--C 1.494 -1.199 0 N-CA-C 106.84 -1.541 . . . . 70.31 106.84 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -77.44 158.27 30.1 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.362 0.601 . . . . 74.23 112.042 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 27.4 p -161.04 165.92 28.99 Favored 'General case' 0 N--CA 1.407 -2.614 0 CA-C-N 114.567 -1.197 . . . . 64.34 109.464 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.26 151.24 19.03 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.223 0.535 . . . . 75.1 110.536 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.7 tt -114.16 128.56 71.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 CA-C-N 115.415 -0.811 . . . . 75.42 109.281 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.452 ' CG2' ' HB ' ' A' ' 441' ' ' ILE . 3.4 t -114.13 127.88 71.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-O 121.561 0.696 . . . . 73.42 111.348 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 33.1 p -108.53 114.91 29.12 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 107.943 -1.132 . . . . 75.04 107.943 174.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.81 116.48 44.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.438 -0.949 . . . . 71.45 108.438 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -113.83 -173.33 2.25 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 121.021 -0.271 . . . . 74.41 111.328 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.427 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 42.9 t -58.73 129.26 41.24 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 123.621 0.768 . . . . 61.03 111.338 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.479 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -160.8 -177.6 34.04 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 110.676 -0.969 . . . . 63.53 110.676 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.44 -34.97 7.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 109.24 -0.652 . . . . 73.01 109.24 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -156.63 160.84 39.77 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 116.024 -0.535 . . . . 74.21 109.675 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 4.1 m120 -60.48 106.12 0.51 Allowed 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 123.703 0.801 . . . . 75.01 112.64 175.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -131.89 148.72 52.56 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.987 -1.006 . . . . 74.55 108.914 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 367' ' ' ARG . 36.4 mm -90.41 120.21 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.378 -1.712 . . . . 75.15 106.378 175.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 442' ' ' LYS . 53.5 t -84.66 -48.92 16.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 112.222 0.452 . . . . 44.51 112.222 -176.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 58.2 p -164.82 163.63 21.18 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.925 -0.31 . . . . 74.45 110.66 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.457 HG12 HG21 ' A' ' 369' ' ' ILE . 4.3 p -142.04 119.84 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 123.889 0.743 . . . . 74.14 109.436 176.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 26.8 tp -125.85 137.56 53.76 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.521 -0.918 . . . . 64.32 108.521 -176.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -79.67 116.91 20.14 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.148 -1.056 . . . . 63.25 108.148 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -80.85 -58.08 3.26 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.395 -0.82 . . . . 75.34 110.649 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -109.27 -78.44 0.59 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.746 -0.661 . . . . 75.41 110.178 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.67 -40.32 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.627 0.727 . . . . 55.43 111.141 175.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 62.5 m -110.86 8.6 22.3 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.19 -1.041 . . . . 64.22 108.19 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.8 tt0 -131.75 131.37 42.94 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.064 -0.971 . . . . 72.22 109.568 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -122.12 150.43 42.2 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.257 -0.883 . . . . 70.32 109.626 -175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 440' ' ' LEU . 4.3 pp -107.3 122.8 47.29 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 107.645 -1.242 . . . . 73.14 107.645 175.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.452 ' HB ' ' CG2' ' A' ' 418' ' ' VAL . 96.1 mt -118.96 129.89 74.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 CA-C-N 115.352 -0.84 . . . . 74.43 110.296 -175.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.469 ' HB3' ' HB ' ' A' ' 429' ' ' VAL . 15.7 tppt? -97.86 138.63 34.93 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.489 -0.93 . . . . 73.13 108.489 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.419 ' SD ' HG11 ' A' ' 376' ' ' VAL . 80.9 mtp -141.93 168.05 20.68 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 110.145 -0.317 . . . . 75.12 110.145 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.1 mmtt -135.7 160.41 38.63 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.834 -0.802 . . . . 61.43 108.834 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . 0.497 ' HB2' ' ND2' ' A' ' 426' ' ' ASN . 33.6 t -166.58 147.27 5.28 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 124.058 0.849 . . . . 75.33 109.102 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.62 -26.44 53.89 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.484 2.123 . . . . 64.12 111.23 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -77.55 -18.69 56.7 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.242 -0.89 . . . . 42.21 110.646 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.954 0 CA-C-O 121.689 0.757 . . . . 65.14 109.864 -178.61 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.566 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 39.4 m . . . . . 0 N--CA 1.419 -2.024 0 N-CA-C 109.673 -0.491 . . . . 71.1 109.673 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.664 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 60.4 mtpt -139.36 141.53 37.6 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.072 -0.714 . . . . 72.35 109.072 176.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -161.6 136.95 7.55 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.058 -1.09 . . . . 72.14 108.058 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -86.72 122.98 31.37 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 120.805 0.336 . . . . 61.11 110.279 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.473 HG21 HG12 ' A' ' 431' ' ' VAL . 49.0 mt -133.02 123.68 48.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.174 -1.417 . . . . 63.44 107.174 -175.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.65 8.39 46.63 Favored Glycine 0 C--N 1.309 -0.968 0 C-N-CA 120.821 -0.704 . . . . 74.23 112.124 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 109.94 -23.2 21.97 Favored Glycine 0 N--CA 1.426 -1.996 0 C-N-CA 121.363 -0.446 . . . . 32.43 112.805 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -98.83 143.84 28.71 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 120.677 0.275 . . . . 64.11 110.81 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 57.0 m -86.1 121.03 28.13 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 116.486 -0.325 . . . . 70.24 110.248 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.96 137.68 32.18 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.128 -0.693 . . . . 50.04 109.128 176.072 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.486 ' HG3' ' HG2' ' A' ' 366' ' ' LYS . 37.0 ttpt -131.83 129.92 41.08 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.618 -0.512 . . . . 64.24 109.618 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.566 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.0 p -124.85 117.19 49.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-O 121.068 0.461 . . . . 73.05 109.987 176.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . 0.446 HG23 ' HE3' ' A' ' 375' ' ' LYS . 27.6 t -103.71 117.55 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.137 0 N-CA-C 107.063 -1.458 . . . . 62.45 107.063 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -63.88 124.35 21.3 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.555 -0.748 . . . . 70.04 111.994 -173.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 72.79 12.7 5.23 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.064 1.346 . . . . 73.21 113.127 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -125.42 -80.8 0.62 Allowed 'General case' 0 C--O 1.246 0.869 0 N-CA-C 113.645 0.98 . . . . 73.22 113.645 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -160.3 166.9 28.62 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.997 0.74 . . . . 73.45 112.997 -171.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.445 HG22 HG23 ' A' ' 376' ' ' VAL . 74.0 t -125.42 142.32 42.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.932 -1.031 . . . . 74.41 108.423 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -131.7 150.09 52.27 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 123.069 0.547 . . . . 74.4 111.641 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.5 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.6 tt0 -122.62 103.95 9.02 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 106.912 -1.514 . . . . 74.32 106.912 173.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 14.5 t70 72.6 -70.76 0.15 Allowed 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.281 1.433 . . . . 63.14 109.479 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . 0.406 ' H ' ' H ' ' A' ' 387' ' ' ILE . 28.6 t -152.87 -0.61 0.26 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.137 -0.938 . . . . 33.21 108.727 176.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.406 ' H ' ' H ' ' A' ' 386' ' ' SER . 62.6 mt -86.42 136.62 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 109.313 -0.625 . . . . 73.31 109.313 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.523 HD21 HD21 ' A' ' 391' ' ' ASN . 63.8 tp -76.27 112.54 12.86 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.288 -1.005 . . . . 72.34 108.288 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.627 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -78.93 -63.83 1.32 Allowed 'General case' 0 N--CA 1.393 -3.313 0 N-CA-C 108.507 -0.923 . . . . 74.35 108.507 -176.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.03 160.88 32.0 Favored Glycine 0 CA--C 1.478 -2.271 0 C-N-CA 119.937 -1.125 . . . . 72.13 110.974 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.523 HD21 HD21 ' A' ' 388' ' ' LEU . 49.3 m-80 -109.53 149.55 29.46 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.175 -1.046 . . . . 62.1 108.175 176.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.542 ' HD2' ' NE2' ' A' ' 395' ' ' GLN . 1.4 m-85 -69.82 122.36 19.08 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 120.814 0.34 . . . . 75.43 110.889 -176.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -99.09 -48.2 4.94 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.973 -0.558 . . . . 71.11 110.909 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 58.6 m -165.74 142.81 5.49 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.887 -1.153 . . . . 64.43 107.887 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.542 ' NE2' ' HD2' ' A' ' 392' ' ' PHE . 40.0 mt-30 -126.51 141.87 51.73 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.012 -1.107 . . . . 73.45 108.012 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -129.13 110.23 11.84 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.559 -0.456 . . . . 62.41 110.294 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.19 -101.07 0.92 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 121.008 -0.615 . . . . 74.04 111.891 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -125.61 18.44 8.07 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.408 -0.59 . . . . 74.33 109.408 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.2 t -118.54 116.52 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 N-CA-C 107.322 -1.362 . . . . 73.5 107.322 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' A' ' 395' ' ' GLN . 14.8 mt -111.16 125.09 53.42 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 116.118 -0.492 . . . . 73.34 110.079 -171.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -105.14 123.74 48.35 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 112.997 0.74 . . . . 75.43 112.997 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.422 ' O ' ' HB2' ' A' ' 415' ' ' SER . 2.6 m-85 -117.77 139.75 50.63 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.971 -1.122 . . . . 73.2 107.971 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 415' ' ' SER . 70.8 mm-40 -142.54 175.2 9.97 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 124.275 1.03 . . . . 74.44 109.39 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 53.55 47.01 24.91 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 114.423 1.268 . . . . 62.41 114.423 173.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.627 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -80.88 -148.29 5.74 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.349 -0.841 . . . . 73.33 111.413 172.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.19 141.01 43.66 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.333 -1.358 . . . . 70.02 107.333 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 34.3 p . . . . . 0 C--N 1.311 -1.099 0 C-N-CA 123.149 0.58 . . . . 53.1 112.482 -178.66 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 . . . . . 0 CA--C 1.487 -1.454 0 N-CA-C 106.767 -1.568 . . . . 73.24 106.767 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.404 ' HA ' ' HB3' ' A' ' 437' ' ' CYS . 58.3 mtt180 -78.57 157.57 28.74 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.192 -0.603 . . . . 73.41 111.946 172.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 51.4 p -160.22 169.45 23.2 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 115.007 -0.997 . . . . 65.23 109.78 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -159.98 151.96 20.4 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.287 0.565 . . . . 71.51 110.553 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.4 tt -118.01 127.73 75.2 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 CA-C-N 115.06 -0.973 . . . . 64.42 108.821 174.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.7 t -113.93 129.87 69.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.336 0.589 . . . . 71.14 112.477 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 14.2 p -108.35 113.87 27.28 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.999 -1.0 . . . . 63.04 108.361 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 39.6 t -101.53 115.08 42.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 120.74 0.305 . . . . 64.33 110.291 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.494 ' OE1' ' HD2' ' A' ' 442' ' ' LYS . 47.9 mt-10 -108.07 -176.38 3.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.816 0.341 . . . . 73.02 111.113 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.436 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 36.5 t -60.24 130.99 49.37 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.006 0.922 . . . . 74.52 111.795 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -157.86 -177.61 31.12 Favored Glycine 0 N--CA 1.421 -2.334 0 N-CA-C 109.98 -1.248 . . . . 74.21 109.98 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.36 -28.52 3.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 108.371 -0.974 . . . . 72.11 108.371 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -152.42 151.81 31.24 Favored 'General case' 0 CA--C 1.478 -1.815 0 CA-C-N 115.103 -0.953 . . . . 52.05 108.867 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.695 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 18.4 p-10 -66.73 105.43 1.56 Allowed 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 113.286 -1.779 . . . . 71.24 110.96 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -131.29 148.27 52.67 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.111 -0.95 . . . . 73.15 110.612 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 26.8 mm -88.28 120.39 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 105.969 -1.863 . . . . 75.54 105.969 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 62.9 t -83.1 -50.76 15.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-O 120.845 0.355 . . . . 53.11 111.586 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 48.4 m -164.17 164.5 22.65 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.248 -0.649 . . . . 62.12 109.248 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.473 HG12 HG21 ' A' ' 369' ' ' ILE . 2.8 p -142.05 114.38 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 123.814 0.846 . . . . 65.51 109.245 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . 0.458 ' O ' HD23 ' A' ' 440' ' ' LEU . 30.7 tp -120.85 138.86 53.85 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.895 -0.78 . . . . 73.3 108.895 -175.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -80.37 110.69 16.06 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 119.743 -0.783 . . . . 74.1 109.757 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.405 ' H ' ' HA ' ' A' ' 439' ' ' TYR . . . -74.64 -38.53 62.47 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.027 -0.988 . . . . 65.21 111.249 -175.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -127.64 -80.01 0.59 Allowed 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.609 -0.723 . . . . 72.45 111.683 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -166.73 -36.32 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.3 -0.864 . . . . 73.3 109.772 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . 0.404 ' HB3' ' HA ' ' A' ' 414' ' ' ARG . 97.8 m -122.02 -2.63 9.16 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 115.108 -0.951 . . . . 73.44 109.913 174.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.6 tt0 -119.0 134.43 55.2 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.192 -0.913 . . . . 75.53 109.049 -177.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . 0.405 ' HA ' ' H ' ' A' ' 434' ' ' ALA . 35.9 m-85 -126.04 150.18 48.31 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 123.743 0.652 . . . . 72.21 110.057 -174.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.8 pt? -105.67 123.22 47.58 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.069 -1.085 . . . . 73.11 108.069 173.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.4 mt -122.26 129.93 74.93 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 CA-C-N 115.088 -0.96 . . . . 71.13 109.361 -177.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.494 ' HD2' ' OE1' ' A' ' 421' ' ' GLU . 36.5 ttpt -107.65 142.3 37.82 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 119.847 -0.741 . . . . 73.12 110.026 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 78.5 mtp -136.44 168.54 19.25 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 123.248 0.619 . . . . 43.44 109.56 -176.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.695 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 70.4 mmtt -131.93 153.52 50.19 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.179 -1.415 . . . . 72.1 107.179 175.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 74.8 m -161.78 150.33 12.74 Favored Pre-proline 0 C--N 1.287 -2.115 0 O-C-N 123.798 0.686 . . . . 65.22 110.346 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.99 -27.16 66.18 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.832 2.355 . . . . 63.14 112.348 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.77 -12.23 57.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.708 -0.678 . . . . 61.12 111.9 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.872 0 CA-C-O 121.627 0.727 . . . . 74.05 109.845 -179.375 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.462 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 80.1 m . . . . . 0 N--CA 1.417 -2.089 0 N-CA-C 108.963 -0.754 . . . . 71.23 108.963 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 60.4 mtpt -133.2 140.61 47.64 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 110.106 -0.331 . . . . 63.32 110.106 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -158.08 134.33 9.42 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.395 -0.595 . . . . 62.12 109.395 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 2.8 mp0 -78.58 125.91 30.02 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 110.038 -0.356 . . . . 72.02 110.038 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.467 HG21 HG12 ' A' ' 431' ' ' VAL . 54.4 mt -130.92 117.54 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 N-CA-C 106.863 -1.532 . . . . 75.05 106.863 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 67.24 9.98 55.77 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.555 -0.831 . . . . 74.14 112.592 -177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.59 -7.7 39.56 Favored Glycine 0 N--CA 1.432 -1.597 0 C-N-CA 120.267 -0.968 . . . . 54.12 113.406 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . 0.404 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 15.4 p90 -114.0 136.61 52.72 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.94 0.37 . . . . 75.21 110.168 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 61.8 m -79.85 121.0 24.86 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 116.288 -0.414 . . . . 73.14 111.411 -178.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.67 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.6 OUTLIER -90.96 124.49 35.26 Favored 'General case' 0 N--CA 1.414 -2.244 0 C-N-CA 120.249 -0.58 . . . . 73.13 109.74 174.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 86.4 tttt -120.31 125.44 48.05 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.488 -0.778 . . . . 74.43 109.83 -174.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.462 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.3 p -127.64 116.14 42.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-O 121.425 0.631 . . . . 71.14 110.423 176.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.24 116.44 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 N-CA-C 107.145 -1.428 . . . . 61.33 107.145 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.469 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 75.4 m-85 -61.13 132.43 53.72 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.778 -1.101 . . . . 74.35 112.854 -171.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 64.97 17.84 11.24 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 124.6 1.16 . . . . 75.3 112.283 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -130.93 -84.42 0.52 Allowed 'General case' 0 C--O 1.243 0.722 0 N-CA-C 113.534 0.939 . . . . 74.42 113.534 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -158.65 163.73 36.63 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.726 1.01 . . . . 73.23 113.726 -170.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 99.1 t -125.55 143.7 38.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 124.505 1.122 . . . . 65.21 109.151 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 375' ' ' LYS . 91.6 m-85 -133.91 146.5 50.59 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 122.759 0.423 . . . . 63.21 111.368 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.533 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.8 tt0 -110.99 99.42 8.31 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.402 -2.074 . . . . 73.5 105.402 172.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.4 t70 73.23 -72.93 0.11 Allowed 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 125.465 1.506 . . . . 62.3 109.816 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.9 t -148.63 -5.15 0.43 Allowed 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 114.913 -1.039 . . . . 64.42 109.093 176.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 63.8 mt -77.78 134.65 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.356 -0.979 . . . . 75.14 108.356 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.428 HD21 HD21 ' A' ' 391' ' ' ASN . 65.2 tp -75.81 113.69 13.57 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.561 -0.903 . . . . 74.02 108.561 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.533 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.6 OUTLIER -80.73 -63.51 1.39 Allowed 'General case' 0 N--CA 1.383 -3.796 0 N-CA-C 108.348 -0.982 . . . . 64.04 108.348 -176.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.48 160.39 31.33 Favored Glycine 0 N--CA 1.413 -2.886 0 C-N-CA 119.091 -1.528 . . . . 64.22 111.429 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.428 HD21 HD21 ' A' ' 388' ' ' LEU . 41.6 m-80 -108.6 146.58 33.13 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 107.11 -1.441 . . . . 72.12 107.11 176.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.469 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.4 m-85 -68.74 125.88 27.96 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 120.634 0.254 . . . . 72.32 110.585 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -100.36 -48.2 4.66 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.954 0.407 . . . . 73.23 109.947 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 42.4 p -164.22 162.02 22.38 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.686 -0.688 . . . . 73.11 109.488 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.514 ' CG ' HD22 ' A' ' 400' ' ' LEU . 18.5 mp0 -128.4 122.58 31.72 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.919 -0.771 . . . . 65.42 108.919 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.14 109.99 22.63 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.371 -0.974 . . . . 74.41 108.371 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 55.68 -100.72 0.1 Allowed Glycine 0 N--CA 1.436 -1.345 0 O-C-N 123.921 0.763 . . . . 74.24 112.401 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -122.87 19.26 10.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.948 0.88 . . . . 65.33 109.436 -176.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 66.8 t -123.51 116.9 49.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 107.525 -1.287 . . . . 62.45 107.525 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.514 HD22 ' CG ' ' A' ' 395' ' ' GLN . 12.1 mt -107.19 132.57 52.91 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 116.278 -0.419 . . . . 73.23 110.88 -169.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -103.63 122.82 45.79 Favored 'General case' 0 C--O 1.247 0.955 0 N-CA-C 112.718 0.636 . . . . 73.02 112.718 176.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.47 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.5 m-85 -118.58 132.39 56.2 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.013 -1.477 . . . . 74.22 107.013 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . 0.404 ' HA ' ' CB ' ' A' ' 415' ' ' SER . 7.6 pt-20 -147.59 174.91 11.3 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 112.478 0.548 . . . . 73.4 112.478 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.21 41.22 13.68 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.704 -1.589 . . . . 73.12 111.766 170.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.37 -133.24 0.61 Allowed Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.138 -0.937 . . . . 72.31 112.607 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 1.0 OUTLIER -84.8 141.96 30.12 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.436 -0.95 . . . . 75.02 108.436 -177.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 42.9 t . . . . . 0 C--N 1.315 -0.911 0 CA-C-O 121.874 0.845 . . . . 63.53 112.232 -176.605 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 . . . . . 0 CA--C 1.497 -1.066 0 N-CA-C 107.191 -1.411 . . . . 73.23 107.191 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -76.81 162.23 27.81 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.134 -0.627 . . . . 64.41 111.026 172.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 47.4 p -164.35 163.09 22.55 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 114.905 -1.043 . . . . 44.14 108.821 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -158.94 146.9 17.9 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.169 0.509 . . . . 74.42 110.551 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 7.4 tt -113.38 126.96 70.9 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 CA-C-N 115.266 -0.879 . . . . 73.22 108.919 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.564 HG22 ' HB ' ' A' ' 441' ' ' ILE . 7.4 t -112.68 131.45 64.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-O 121.108 0.48 . . . . 71.22 111.937 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 35.0 p -107.26 114.14 27.99 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 107.664 -1.235 . . . . 72.04 107.664 175.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 43.1 t -100.82 112.97 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 107.537 -1.283 . . . . 73.22 107.537 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -115.58 -173.65 2.37 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.917 -0.313 . . . . 74.24 110.211 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.547 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 36.9 t -59.18 128.32 36.59 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 122.974 0.51 . . . . 52.31 111.256 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -159.8 -176.1 31.51 Favored Glycine 0 CA--C 1.493 -1.305 0 CA-C-N 115.796 -0.638 . . . . 73.14 111.529 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.0 t -80.58 -38.55 17.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 109.485 -0.561 . . . . 71.2 109.485 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 446' ' ' PRO . 45.6 tt0 -171.08 162.24 7.04 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 123.51 0.724 . . . . 71.13 109.321 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 20.9 m120 -61.52 101.38 0.18 Allowed 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.996 -1.002 . . . . 72.25 112.306 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -132.02 149.04 52.53 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.6 -1.182 . . . . 62.14 108.651 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 30.5 mm -81.51 118.23 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.791 -1.559 . . . . 63.43 106.791 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 63.8 t -81.24 -50.35 16.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-O 120.716 0.293 . . . . 65.32 111.664 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 42.4 p -166.92 165.68 15.86 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.138 -0.483 . . . . 62.43 109.972 -173.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.467 HG12 HG21 ' A' ' 369' ' ' ILE . 4.3 p -142.0 125.13 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 108.822 -0.807 . . . . 74.0 108.822 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . 0.437 ' O ' HD23 ' A' ' 440' ' ' LEU . 27.2 tp -126.48 136.58 52.8 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 107.66 -1.237 . . . . 74.24 107.66 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -81.18 108.48 14.86 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.674 -0.862 . . . . 62.13 108.674 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . 0.439 ' H ' ' HA ' ' A' ' 439' ' ' TYR . . . -65.31 -61.18 2.27 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 123.74 0.816 . . . . 71.53 110.781 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -109.33 -75.02 0.64 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.925 -0.58 . . . . 73.34 110.705 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -165.84 -43.02 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.795 -1.093 . . . . 65.41 109.892 -174.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 93.4 m -118.74 14.72 13.49 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 121.969 0.89 . . . . 74.21 109.539 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 415' ' ' SER . 37.1 tt0 -135.14 131.19 36.53 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.111 -1.07 . . . . 55.34 108.111 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . 0.439 ' HA ' ' H ' ' A' ' 434' ' ' ALA . 45.0 m-85 -123.08 150.77 42.73 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 124.005 0.816 . . . . 74.13 110.261 -174.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.8 pt? -110.4 122.09 46.87 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.736 -1.209 . . . . 74.31 107.736 172.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.564 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.5 mt -121.28 133.84 66.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 CA-C-N 115.41 -0.814 . . . . 73.32 109.501 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -103.48 140.84 36.95 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 109.131 -0.692 . . . . 63.12 109.131 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.412 ' SD ' HG11 ' A' ' 418' ' ' VAL . 87.4 mtp -138.54 163.36 32.19 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.267 -1.012 . . . . 70.33 108.267 177.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.684 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 73.0 mmtt -130.68 161.3 31.93 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.728 -0.842 . . . . 63.24 108.728 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . 0.417 ' HB2' ' ND2' ' A' ' 426' ' ' ASN . 30.2 t -167.77 147.62 4.42 Favored Pre-proline 0 C--N 1.296 -1.742 0 O-C-N 123.746 0.654 . . . . 74.01 109.759 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 425' ' ' GLU . 55.4 Cg_endo -70.55 -21.5 29.75 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.204 1.936 . . . . 71.43 110.129 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.4 -18.47 59.92 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.83 -1.077 . . . . 41.23 110.775 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.865 0 CA-C-O 121.751 0.786 . . . . 72.55 109.093 179.652 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.466 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 59.1 m . . . . . 0 N--CA 1.423 -1.781 0 N-CA-C 106.754 -1.573 . . . . 74.42 106.754 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 19.4 ptmt -142.29 141.44 32.43 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 111.989 0.366 . . . . 61.04 111.989 -176.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.41 ' NH1' HG12 ' A' ' 369' ' ' ILE . 3.2 tmt_? -159.57 132.18 6.69 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.442 -0.799 . . . . 71.55 109.027 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 44.1 mt-10 -77.93 129.97 36.0 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 116.147 -0.478 . . . . 71.01 110.525 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.485 HG21 HG12 ' A' ' 431' ' ' VAL . 35.5 mt -135.02 121.53 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 106.831 -1.544 . . . . 74.31 106.831 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.39 11.54 56.47 Favored Glycine 0 C--N 1.308 -0.999 0 C-N-CA 120.837 -0.697 . . . . 73.21 112.646 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 110.77 -23.38 19.76 Favored Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 121.186 -0.53 . . . . 70.13 112.85 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -101.81 141.6 34.42 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 122.514 -0.403 . . . . 74.05 111.361 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 90.1 m -81.71 117.56 22.14 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.56 0.219 . . . . 52.53 110.581 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.32 133.6 34.86 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 108.36 -0.978 . . . . 74.42 108.36 174.264 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.48 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 36.8 ttpt -136.84 127.15 26.48 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 120.635 -0.426 . . . . 72.23 110.167 -176.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.489 HG23 HG22 ' A' ' 382' ' ' VAL . 6.5 p -120.63 119.34 59.36 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-O 121.181 0.515 . . . . 74.24 110.337 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.47 116.15 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 106.451 -1.685 . . . . 52.34 106.451 173.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.527 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 74.9 m-85 -65.56 135.7 55.44 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.018 -0.992 . . . . 63.33 113.496 -170.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 64.99 11.75 7.32 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 124.764 1.226 . . . . 73.53 112.306 -176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -122.61 -84.46 0.66 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 112.548 0.573 . . . . 71.32 112.548 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.46 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -166.09 156.59 12.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.05 0.759 . . . . 73.01 113.05 -171.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.492 HG21 ' CD2' ' A' ' 402' ' ' TYR . 60.9 t -115.05 147.59 18.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 124.293 1.037 . . . . 65.21 109.141 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.46 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 85.4 m-85 -134.72 145.32 48.37 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.04 0.536 . . . . 72.33 112.119 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.529 ' HB2' HD23 ' A' ' 389' ' ' LEU . 33.2 tt0 -116.68 100.06 7.56 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 105.945 -1.872 . . . . 70.22 105.945 171.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.3 t70 71.52 -82.34 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 124.082 0.953 . . . . 54.11 109.901 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 36.8 t -138.52 -3.43 1.7 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.288 -1.004 . . . . 64.14 108.288 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.634 HD12 HE22 ' A' ' 406' ' ' GLN . 50.2 mm -77.19 132.47 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 108.854 -0.795 . . . . 74.44 108.854 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.1 tp -76.45 109.56 10.28 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.763 -1.569 . . . . 74.34 106.763 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.7 OUTLIER -76.41 -62.65 1.55 Allowed 'General case' 0 N--CA 1.389 -3.512 0 N-CA-C 108.94 -0.763 . . . . 71.14 108.94 -175.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.77 157.47 28.7 Favored Glycine 0 N--CA 1.425 -2.089 0 C-N-CA 118.788 -1.673 . . . . 62.25 112.3 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.2 146.02 28.06 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.186 -1.412 . . . . 75.33 107.186 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.527 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 2.1 m-85 -71.84 115.81 11.49 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 109.417 -0.586 . . . . 70.24 109.417 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -99.39 -42.7 6.86 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.293 -0.412 . . . . 73.3 111.172 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 60.3 p -164.41 140.71 6.19 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.885 -0.783 . . . . 72.55 108.885 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.425 ' HB2' ' CD2' ' A' ' 400' ' ' LEU . 0.1 OUTLIER -141.27 145.28 35.32 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.581 -0.282 . . . . 52.25 110.656 177.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -124.8 110.27 14.11 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.875 -0.787 . . . . 73.4 108.875 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 61.86 -105.76 1.01 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.886 -0.597 . . . . 74.34 113.077 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -113.96 17.07 18.13 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.101 0.477 . . . . 75.31 110.892 -176.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.3 t -120.9 118.34 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 106.405 -1.702 . . . . 75.14 106.405 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 395' ' ' GLN . 20.1 mt -119.73 124.83 47.15 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.109 -0.636 . . . . 75.21 111.479 -169.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.437 ' HE3' HD12 ' A' ' 417' ' ' ILE . 19.3 mmtp -100.85 122.27 43.15 Favored 'General case' 0 C--O 1.253 1.24 0 CA-C-O 121.314 0.578 . . . . 61.33 112.366 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.492 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.3 m-85 -118.35 130.24 55.89 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.454 -1.313 . . . . 75.31 107.454 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 415' ' ' SER . 10.4 pt-20 -147.22 176.04 10.28 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 122.008 0.123 . . . . 54.42 111.117 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.4 m120 64.97 36.3 7.64 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.666 0.604 . . . . 52.14 111.522 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -79.23 -140.16 1.93 Allowed Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.705 -0.76 . . . . 63.01 112.103 176.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.634 HE22 HD12 ' A' ' 387' ' ' ILE . 28.9 tt0 -68.69 150.7 47.62 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 122.447 -0.443 . . . . 72.34 110.001 -177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 C--N 1.304 -1.407 0 CA-C-O 121.544 0.688 . . . . 64.12 110.775 -175.054 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 . . . . . 0 CA--C 1.501 -0.911 0 N-CA-C 105.893 -1.891 . . . . 73.14 105.893 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 43.6 mtt180 -72.31 157.36 37.84 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.412 0.625 . . . . 63.24 112.481 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 36.2 p -163.18 165.1 24.85 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 114.612 -1.176 . . . . 65.11 109.409 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.1 148.16 16.8 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.182 0.515 . . . . 74.43 110.465 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . 0.437 HD12 ' HE3' ' A' ' 401' ' ' LYS . 7.3 tt -112.86 123.89 68.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 CA-C-N 115.454 -0.794 . . . . 71.4 109.278 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.519 HG22 ' HB ' ' A' ' 441' ' ' ILE . 5.1 t -109.8 129.81 64.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-N 115.885 -0.598 . . . . 75.22 111.866 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.1 p -108.32 114.27 28.01 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 107.667 -1.234 . . . . 73.2 107.667 173.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 22.4 t -100.35 123.14 53.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.2 -1.407 . . . . 70.23 107.2 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -120.43 -174.12 2.72 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 120.557 -0.457 . . . . 71.14 110.898 -176.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.506 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 41.0 t -62.21 128.65 37.12 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 123.883 0.873 . . . . 35.42 111.56 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.51 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -162.55 -176.8 35.0 Favored Glycine 0 CA--C 1.495 -1.196 0 N-CA-C 111.256 -0.738 . . . . 75.12 111.256 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 98.9 t -86.48 -37.16 11.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-O 120.975 0.417 . . . . 54.1 109.877 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.449 ' HG2' ' N ' ' A' ' 426' ' ' ASN . 38.5 tt0 -155.87 162.09 40.49 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 109.278 -0.638 . . . . 73.23 109.278 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.692 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 18.8 m120 -63.36 109.1 1.48 Allowed 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 114.591 -1.186 . . . . 64.33 111.147 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -131.45 148.42 52.64 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.646 -1.161 . . . . 41.42 109.013 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 35.5 mm -90.47 113.84 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.364 -1.717 . . . . 73.01 106.364 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.3 t -80.89 -44.31 21.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 112.505 0.557 . . . . 53.0 112.505 -174.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 58.1 p -168.57 162.7 12.14 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 110.043 -0.354 . . . . 73.11 110.043 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.485 HG12 HG21 ' A' ' 369' ' ' ILE . 5.7 p -142.03 119.97 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 N-CA-C 108.81 -0.811 . . . . 54.11 108.81 175.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . 0.435 ' O ' HD23 ' A' ' 440' ' ' LEU . 30.9 tp -127.42 138.06 52.88 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.156 -1.053 . . . . 75.15 108.156 -177.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -80.47 115.84 20.21 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.155 -0.683 . . . . 71.45 109.155 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -76.59 -67.35 0.71 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.478 -0.783 . . . . 52.4 111.014 -176.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -98.08 -76.5 0.53 Allowed 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.764 -0.828 . . . . 62.13 108.764 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.89 -43.85 0.04 OUTLIER 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 115.392 -0.822 . . . . 74.12 110.655 176.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 73.6 m -107.38 8.87 29.85 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.64 0.733 . . . . 74.22 109.191 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.8 tt0 -130.62 134.7 47.19 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.201 -0.909 . . . . 75.41 109.035 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -125.86 148.69 49.09 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 123.733 0.646 . . . . 53.53 109.766 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.456 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.6 pt? -105.2 119.24 38.56 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.499 -0.926 . . . . 75.32 108.499 174.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.519 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.4 mt -117.74 134.73 60.41 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 115.365 -0.834 . . . . 65.21 109.551 -177.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -106.17 140.99 38.27 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.806 -0.813 . . . . 74.14 108.806 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 83.1 mtp -138.74 168.56 19.54 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.641 -0.503 . . . . 62.01 109.641 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.692 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 72.9 mmtt -133.32 161.17 35.21 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.046 -0.724 . . . . 64.32 109.046 177.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 28.7 t -172.1 148.55 2.05 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.639 -0.875 . . . . 64.04 108.639 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.29 -27.49 34.5 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.049 1.832 . . . . 63.31 110.337 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -77.26 -13.51 59.92 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.812 -1.085 . . . . 73.2 110.792 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.752 0 CA-C-O 121.329 0.585 . . . . 72.32 110.147 178.441 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.499 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 97.4 m . . . . . 0 N--CA 1.423 -1.798 0 N-CA-C 107.137 -1.431 . . . . 74.33 107.137 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.669 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 59.2 mtpt -136.25 140.7 43.65 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.626 0.25 . . . . 70.34 110.939 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.427 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 4.2 tmt_? -156.74 132.94 9.8 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.116 -0.698 . . . . 64.21 109.116 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 3.4 mp0 -79.83 129.17 34.26 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 121.02 -0.272 . . . . 65.45 110.498 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.459 HG21 HG12 ' A' ' 431' ' ' VAL . 48.6 mt -136.14 121.12 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 106.117 -1.809 . . . . 60.32 106.117 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.67 3.23 19.94 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 121.421 -0.418 . . . . 52.32 113.765 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 112.06 -15.91 25.51 Favored Glycine 0 N--CA 1.433 -1.511 0 C-N-CA 120.7 -0.762 . . . . 64.12 112.627 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -102.82 141.79 35.03 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 109.77 -0.455 . . . . 75.41 109.77 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 91.9 m -87.65 124.25 33.34 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 116.43 -0.35 . . . . 63.03 110.888 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.669 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.7 OUTLIER -90.56 126.61 35.99 Favored 'General case' 0 N--CA 1.406 -2.632 0 C-N-CA 119.894 -0.722 . . . . 65.34 109.804 175.429 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -121.81 124.99 45.47 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.794 -0.817 . . . . 70.23 108.794 -175.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.499 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.4 p -125.1 124.33 67.28 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 109.888 -0.412 . . . . 71.23 109.888 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.2 t -113.67 116.29 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.692 -1.596 . . . . 72.12 106.692 173.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -62.62 126.55 27.73 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.452 -0.794 . . . . 70.01 112.846 -173.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 72.78 14.88 4.89 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 125.104 1.362 . . . . 72.35 112.985 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -126.73 -83.1 0.62 Allowed 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 113.309 0.855 . . . . 72.12 113.309 174.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.459 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.3 OUTLIER -163.3 156.45 19.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.138 0.792 . . . . 71.4 113.138 -170.166 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.485 HG22 HG23 ' A' ' 376' ' ' VAL . 91.6 t -116.8 145.2 22.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 124.081 0.952 . . . . 55.5 108.992 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.459 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 90.0 m-85 -134.16 147.72 50.83 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.102 0.477 . . . . 73.22 111.389 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.502 ' HB2' HD23 ' A' ' 389' ' ' LEU . 35.9 tt0 -113.05 98.59 7.25 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.972 -1.862 . . . . 71.3 105.972 173.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.5 t70 72.45 -78.57 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 125.445 1.498 . . . . 64.33 109.266 -174.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 14.0 p -142.06 -3.06 1.11 Allowed 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 114.6 -1.182 . . . . 72.31 109.44 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 47.4 mm -80.47 132.01 32.72 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 N-CA-C 108.745 -0.835 . . . . 74.51 108.745 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.516 HD21 HD21 ' A' ' 391' ' ' ASN . 62.1 tp -75.91 113.86 13.89 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 108.797 -0.816 . . . . 63.22 108.797 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.564 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.3 OUTLIER -80.0 -63.88 1.31 Allowed 'General case' 0 N--CA 1.398 -3.052 0 N-CA-C 109.143 -0.688 . . . . 71.13 109.143 -176.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.06 156.64 27.89 Favored Glycine 0 N--CA 1.42 -2.408 0 C-N-CA 119.114 -1.517 . . . . 62.34 111.53 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.516 HD21 HD21 ' A' ' 388' ' ' LEU . 0.8 OUTLIER -99.71 146.36 26.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.694 -1.595 . . . . 74.33 106.694 176.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.401 ' HD2' HE21 ' A' ' 395' ' ' GLN . 1.6 m-85 -71.27 116.01 11.09 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.282 -0.567 . . . . 73.12 109.917 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -92.28 -47.32 7.26 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.719 -0.673 . . . . 42.52 110.408 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 42.3 p -166.68 141.16 4.12 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.939 -0.763 . . . . 60.11 108.939 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.412 ' HB2' HD23 ' A' ' 400' ' ' LEU . 0.1 OUTLIER -142.11 145.71 34.57 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.53 -0.305 . . . . 75.45 110.265 178.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -128.14 110.23 12.26 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.753 -0.832 . . . . 71.32 108.753 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.59 -101.43 0.58 Allowed Glycine 0 N--CA 1.432 -1.58 0 O-C-N 123.918 0.761 . . . . 43.52 112.624 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . 0.572 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 27.4 p-10 -113.28 6.25 17.27 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.47 -0.365 . . . . 64.34 111.97 -176.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.96 116.27 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.186 0 N-CA-C 107.545 -1.28 . . . . 72.42 107.545 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.412 HD23 ' HB2' ' A' ' 395' ' ' GLN . 19.3 mt -114.4 123.84 50.45 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 116.057 -0.519 . . . . 74.31 110.119 -171.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.426 ' NZ ' ' HB3' ' A' ' 401' ' ' LYS . 3.2 mmmp? -108.58 122.34 46.88 Favored 'General case' 0 C--O 1.251 1.143 0 CA-C-O 120.748 0.309 . . . . 61.11 111.474 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.447 ' CE2' HG21 ' A' ' 382' ' ' VAL . 2.8 m-85 -115.68 133.82 55.65 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.413 -0.958 . . . . 72.11 108.413 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -135.11 171.3 14.62 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.553 -0.536 . . . . 62.21 109.553 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 14.3 m120 54.45 41.1 32.16 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.342 1.238 . . . . 63.4 114.342 170.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -78.32 -139.86 1.54 Allowed Glycine 0 CA--C 1.541 1.659 0 C-N-CA 120.795 -0.717 . . . . 62.32 113.479 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -63.24 149.96 44.25 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.656 0.783 . . . . 72.21 110.907 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 49.0 p . . . . . 0 N--CA 1.435 -1.176 0 N-CA-C 109.315 -0.624 . . . . 74.11 109.315 175.755 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 . . . . . 0 C--O 1.224 -0.248 0 N-CA-C 109.99 -0.374 . . . . 63.15 109.99 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -81.07 167.49 19.68 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 120.999 0.428 . . . . 74.32 111.046 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 56.4 p -162.93 160.17 24.52 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.261 -0.881 . . . . 65.54 109.064 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -157.18 136.62 12.11 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 121.21 0.528 . . . . 64.44 111.345 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.2 tt -101.43 121.86 52.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-N 115.253 -0.885 . . . . 72.15 110.42 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.529 HG22 ' HB ' ' A' ' 441' ' ' ILE . 3.9 t -108.57 129.53 62.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.635 -0.711 . . . . 72.54 111.746 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 13.4 p -109.84 114.89 28.82 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.188 -0.914 . . . . 75.34 108.896 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 34.1 t -100.43 114.09 38.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.871 -1.159 . . . . 62.05 107.871 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -114.12 -175.85 2.77 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 120.282 -0.567 . . . . 74.52 110.901 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 44.8 t -58.21 129.52 42.36 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.303 0.641 . . . . 64.34 111.442 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -159.94 -177.73 33.29 Favored Glycine 0 N--CA 1.434 -1.471 0 N-CA-C 110.343 -1.103 . . . . 73.22 110.343 177.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.35 -35.28 6.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.074 -0.713 . . . . 72.01 109.074 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -141.6 148.86 39.93 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.878 -0.601 . . . . 71.44 109.42 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.751 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.2 p-10 -67.68 99.12 0.76 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.816 -1.084 . . . . 53.43 109.977 174.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -132.43 149.9 52.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.174 -0.921 . . . . 62.14 110.526 -175.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.444 HD11 HG12 ' A' ' 376' ' ' VAL . 28.2 mm -81.28 120.7 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 106.065 -1.828 . . . . 74.31 106.065 175.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 50.4 t -86.77 -50.6 13.9 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 N-CA-C 111.84 0.311 . . . . 74.14 111.84 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 43.5 p -164.66 163.8 21.55 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 110.204 -0.295 . . . . 72.2 110.204 -174.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.459 HG12 HG21 ' A' ' 369' ' ' ILE . 3.4 p -142.0 117.07 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-O 121.403 0.62 . . . . 65.13 109.475 177.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 22.3 tp -114.31 134.99 54.56 Favored 'General case' 0 C--N 1.272 -2.803 0 N-CA-C 107.587 -1.264 . . . . 63.45 107.587 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -81.59 113.21 19.46 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 106.791 -1.559 . . . . 74.32 106.791 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.1 -60.8 2.1 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 108.872 -0.788 . . . . 62.02 108.872 -173.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.583 ' C ' ' HD2' ' A' ' 436' ' ' LYS . 49.9 mm-40 -107.04 -84.45 0.52 Allowed 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 106.884 -1.524 . . . . 72.02 106.884 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . 0.583 ' HD2' ' C ' ' A' ' 435' ' ' GLN . 3.9 mptp? -147.66 -56.53 0.24 Allowed 'General case' 0 CA--C 1.5 -0.942 0 C-N-CA 124.468 1.107 . . . . 64.24 109.376 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 57.3 m -90.97 -9.24 46.77 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.569 -1.196 . . . . 71.55 110.526 -176.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 415' ' ' SER . 33.8 tt0 -114.46 128.76 56.5 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 114.48 -1.237 . . . . 64.34 109.314 -175.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 44.2 m-85 -124.84 150.23 46.63 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 123.502 0.501 . . . . 61.34 110.412 -176.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.426 ' O ' HD12 ' A' ' 440' ' ' LEU . 4.3 pp -111.6 125.12 53.6 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.921 -1.511 . . . . 64.15 106.921 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.529 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.6 mt -122.16 133.13 69.4 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 116.234 -0.439 . . . . 65.43 110.602 -174.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -98.55 138.53 35.62 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 109.178 -0.675 . . . . 63.13 109.178 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.407 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.6 mtp -140.25 162.06 36.18 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 109.153 -0.684 . . . . 73.42 109.153 175.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.751 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.9 mmtt -132.22 161.08 34.31 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 107.257 -1.386 . . . . 72.41 107.257 175.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 36.2 t -167.42 147.01 4.46 Favored Pre-proline 0 C--N 1.286 -2.19 0 O-C-N 123.982 0.801 . . . . 73.33 109.03 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.0 -27.77 50.06 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.383 2.056 . . . . 74.21 111.339 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -78.24 -14.79 59.29 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.657 -0.701 . . . . 63.0 110.249 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.849 0 CA-C-O 121.333 0.587 . . . . 43.34 110.227 -178.303 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.479 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 26.1 m . . . . . 0 N--CA 1.423 -1.804 0 N-CA-C 106.123 -1.806 . . . . 70.12 106.123 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 58.5 mtpt -140.52 141.17 35.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 123.043 0.214 . . . . 71.34 110.472 -174.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -159.99 135.08 7.98 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.548 -0.908 . . . . 74.25 108.548 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 5.0 mp0 -79.15 125.28 29.23 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 109.952 -0.388 . . . . 72.43 109.952 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.437 HG21 HG12 ' A' ' 431' ' ' VAL . 49.5 mt -133.87 119.12 31.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 106.893 -1.521 . . . . 75.23 106.893 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.7 14.22 62.44 Favored Glycine 0 C--N 1.308 -0.973 0 C-N-CA 120.526 -0.845 . . . . 72.14 111.977 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 101.66 -15.98 56.69 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 121.417 -0.421 . . . . 63.3 112.956 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -105.17 136.77 44.05 Favored 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 120.684 -0.407 . . . . 74.2 110.502 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 47.5 m -78.16 123.77 27.28 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.182 -0.463 . . . . 74.01 111.234 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.689 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.6 OUTLIER -93.28 124.57 37.35 Favored 'General case' 0 N--CA 1.414 -2.237 0 C-N-CA 120.433 -0.507 . . . . 64.14 110.054 173.499 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 85.1 tttt -123.47 125.13 44.36 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.678 -0.692 . . . . 71.32 110.241 -175.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.479 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.5 p -128.26 116.59 42.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-O 121.141 0.496 . . . . 70.31 110.512 177.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.3 t -113.02 117.03 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 108.009 -1.108 . . . . 72.43 108.009 175.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.53 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 42.6 m-85 -57.88 128.9 39.42 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 114.113 1.153 . . . . 75.1 114.113 -173.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 68.51 9.6 7.39 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 114.054 -1.43 . . . . 74.12 113.356 -178.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -116.3 -82.21 0.62 Allowed 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.193 0.812 . . . . 74.1 113.193 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.529 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -170.13 158.85 7.15 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 112.842 0.682 . . . . 45.14 112.842 -172.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 99.3 t -114.01 145.34 19.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 124.361 1.064 . . . . 75.14 108.878 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.529 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 72.2 m-85 -133.1 150.2 52.09 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.242 0.544 . . . . 73.21 111.452 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.556 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.1 tt0 -119.5 97.26 5.56 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 106.026 -1.842 . . . . 72.54 106.026 173.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.8 t70 70.43 -81.47 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 125.596 1.559 . . . . 75.34 111.392 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 17.8 m -135.53 0.73 2.78 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.345 -0.983 . . . . 53.31 108.345 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 48.4 mm -96.07 134.86 32.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.869 -0.605 . . . . 72.44 109.976 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.522 HD21 HD21 ' A' ' 391' ' ' ASN . 59.8 tp -76.45 115.31 16.08 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.702 -0.851 . . . . 73.24 108.702 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.556 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.5 OUTLIER -80.41 -65.22 1.04 Allowed 'General case' 0 N--CA 1.393 -3.308 0 N-CA-C 109.366 -0.605 . . . . 63.45 109.366 -175.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -156.46 156.1 26.85 Favored Glycine 0 N--CA 1.42 -2.383 0 C-N-CA 118.817 -1.659 . . . . 73.41 112.168 -177.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.522 HD21 HD21 ' A' ' 388' ' ' LEU . 8.6 m120 -99.48 143.39 29.79 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.922 -1.51 . . . . 71.03 106.922 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 2.4 m-85 -71.22 115.95 10.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.584 0.231 . . . . 73.41 110.482 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -101.74 -47.7 4.53 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.352 -0.386 . . . . 71.14 111.46 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 39.3 p -157.38 140.24 15.1 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 110.083 -0.34 . . . . 62.44 110.083 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.605 ' HB2' ' HG ' ' A' ' 400' ' ' LEU . 0.1 OUTLIER -147.25 145.5 29.44 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 116.121 -0.49 . . . . 52.42 111.13 178.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -128.97 110.86 12.44 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.838 -0.619 . . . . 73.51 109.473 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.8 -102.54 0.77 Allowed Glycine 0 C--N 1.31 -0.883 0 CA-C-N 115.877 -0.601 . . . . 61.11 113.956 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -116.43 17.7 15.39 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.146 0.498 . . . . 75.43 111.468 -176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.4 t -128.85 116.35 40.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 107.565 -1.272 . . . . 72.13 107.565 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.605 ' HG ' ' HB2' ' A' ' 395' ' ' GLN . 5.3 mp -120.07 139.61 52.28 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.63 0.604 . . . . 75.13 112.63 -173.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -112.32 122.69 48.42 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 115.596 -0.729 . . . . 71.1 111.885 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.41 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.9 m-85 -118.72 135.97 54.2 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.749 -1.204 . . . . 62.33 107.749 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -146.92 174.55 11.4 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-O 121.496 0.665 . . . . 71.24 112.719 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 64.13 33.41 11.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.609 -1.632 . . . . 73.34 112.953 168.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -72.22 -136.81 0.21 Allowed Glycine 0 CA--C 1.537 1.448 0 CA-C-N 115.599 -0.728 . . . . 53.4 113.437 176.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.58 137.92 46.49 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.567 -0.901 . . . . 72.31 108.567 -175.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 19.0 p . . . . . 0 C--N 1.306 -1.324 0 C-N-CA 124.043 0.937 . . . . 75.33 112.332 179.709 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 CA--C 1.501 -0.93 0 N-CA-C 107.997 -1.112 . . . . 71.02 107.997 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.424 ' HA ' ' HB3' ' A' ' 437' ' ' CYS . 89.7 mtt180 -71.39 159.34 34.72 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.299 0.571 . . . . 73.25 111.797 174.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 41.9 p -161.04 162.23 31.65 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.755 -1.112 . . . . 71.43 109.215 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -158.19 148.39 20.18 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-O 121.404 0.621 . . . . 52.23 110.862 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.2 tt -117.18 120.4 64.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 CA-C-N 115.15 -0.932 . . . . 72.32 110.022 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.536 HG22 ' HB ' ' A' ' 441' ' ' ILE . 8.7 t -105.2 127.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 115.663 -0.699 . . . . 74.43 111.978 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 8.7 p -108.48 114.7 28.74 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.632 -1.167 . . . . 75.21 108.559 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 38.9 t -100.88 112.8 34.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 107.595 -1.261 . . . . 71.05 107.595 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -111.73 -175.36 2.67 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 120.847 0.356 . . . . 63.45 110.716 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.619 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 36.0 t -57.77 128.23 36.0 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 124.321 1.048 . . . . 62.51 110.981 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.641 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -158.1 -177.82 31.56 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.925 -0.655 . . . . 64.21 111.676 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.35 -36.37 8.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.336 -0.616 . . . . 65.21 109.336 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -150.0 153.47 36.59 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.772 -0.825 . . . . 75.42 108.772 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.803 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.7 OUTLIER -73.03 98.54 2.55 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.59 0.71 . . . . 71.1 112.238 178.058 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -131.53 149.94 52.33 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.211 -1.359 . . . . 44.13 109.46 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 28.2 mm -78.64 118.16 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 106.306 -1.739 . . . . 72.33 106.306 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 55.5 t -80.77 -51.2 16.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 111.984 0.365 . . . . 70.24 111.984 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 33.0 t -167.06 165.22 15.81 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 109.184 -0.673 . . . . 74.13 109.184 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.437 HG12 HG21 ' A' ' 369' ' ' ILE . 4.3 p -141.39 119.12 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 108.627 -0.879 . . . . 63.13 108.627 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . 0.437 ' O ' HD23 ' A' ' 440' ' ' LEU . 25.4 tp -118.79 137.35 53.44 Favored 'General case' 0 C--N 1.271 -2.816 0 N-CA-C 107.923 -1.14 . . . . 70.11 107.923 -175.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -80.96 111.74 17.71 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.787 -0.82 . . . . 64.11 108.787 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -72.24 -54.48 9.48 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.419 -0.809 . . . . 75.21 110.269 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -116.94 -73.87 0.63 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.253 -1.017 . . . . 65.32 108.253 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -164.23 -51.79 0.03 OUTLIER 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.19 -1.368 . . . . 65.23 109.821 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 414' ' ' ARG . 72.1 m -103.27 -9.23 19.7 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.416 -0.811 . . . . 61.3 109.167 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.5 tt0 -113.07 132.46 55.41 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.675 -1.148 . . . . 71.01 109.029 -176.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 37.3 m-85 -128.02 150.32 49.98 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.048 -0.524 . . . . 74.44 110.516 -175.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.463 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.7 pt? -109.52 119.79 40.51 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.203 -1.036 . . . . 75.35 108.203 172.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.536 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.3 mt -116.24 136.18 54.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 115.287 -0.869 . . . . 71.15 109.464 -175.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -108.46 141.07 40.86 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 109.187 -0.671 . . . . 62.22 109.187 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 83.1 mtp -136.1 168.18 19.86 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.923 -1.14 . . . . 43.1 107.923 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.803 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 34.2 mmtp -134.05 161.34 35.13 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.002 -1.11 . . . . 71.01 108.002 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 33.9 t -162.68 145.9 8.7 Favored Pre-proline 0 C--N 1.291 -1.958 0 N-CA-C 108.455 -0.943 . . . . 71.42 108.455 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.98 -27.43 66.3 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.452 2.101 . . . . 74.13 111.863 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.68 -12.28 56.1 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.355 0.598 . . . . 44.52 110.976 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.907 0 CA-C-N 115.668 -0.696 . . . . 62.02 109.782 -178.151 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.525 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 87.8 m . . . . . 0 N--CA 1.411 -2.399 0 N-CA-C 107.163 -1.421 . . . . 72.31 107.163 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 10.0 ptmt -139.09 141.08 38.16 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.299 -0.409 . . . . 74.35 110.678 -174.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.418 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 3.7 tmt_? -159.94 138.44 10.44 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.112 -1.44 . . . . 73.31 107.112 -174.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 46.4 mt-10 -89.19 127.22 35.73 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.611 -0.514 . . . . 73.41 109.611 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.502 HG21 HG12 ' A' ' 431' ' ' VAL . 44.6 mt -135.94 121.98 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 N-CA-C 106.867 -1.531 . . . . 74.04 106.867 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.66 12.64 59.62 Favored Glycine 0 C--N 1.306 -1.12 0 C-N-CA 120.571 -0.823 . . . . 54.2 112.883 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.98 -20.27 33.79 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 121.066 -0.588 . . . . 32.03 112.828 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . 0.434 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 12.1 p90 -105.05 146.65 28.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 122.802 -0.234 . . . . 74.41 110.515 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 60.4 m -86.51 126.51 34.49 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 120.957 -0.297 . . . . 75.1 110.471 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.6 OUTLIER -91.61 126.39 36.68 Favored 'General case' 0 N--CA 1.406 -2.651 0 N-CA-C 109.389 -0.597 . . . . 73.44 109.389 172.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 42.2 tttp -121.59 124.34 44.11 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.691 -0.855 . . . . 74.11 108.691 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.525 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.1 p -128.68 123.53 59.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 109.637 -0.505 . . . . 72.31 109.637 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 36.2 t -117.16 117.88 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 N-CA-C 108.083 -1.08 . . . . 73.3 108.083 174.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.412 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 90.1 m-85 -53.22 125.32 17.18 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 124.393 1.058 . . . . 63.32 112.965 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 69.35 12.43 8.33 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 125.189 1.395 . . . . 63.21 113.857 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -117.64 -91.22 0.55 Allowed 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 112.872 0.693 . . . . 61.33 112.872 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.473 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -161.13 157.3 25.71 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.732 0.642 . . . . 74.01 112.732 -173.395 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.471 HG22 HG23 ' A' ' 376' ' ' VAL . 82.5 t -113.69 144.24 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 124.115 0.966 . . . . 73.13 109.525 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.473 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 77.6 m-85 -133.73 147.13 51.31 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.007 0.432 . . . . 74.43 111.355 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.466 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.8 tt0 -113.4 98.75 7.29 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.557 -1.646 . . . . 73.22 106.557 173.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.1 t70 70.17 -77.06 0.06 Allowed 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 124.886 1.274 . . . . 62.43 110.032 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.0 m -138.24 -6.38 1.59 Allowed 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.25 -0.886 . . . . 73.4 109.013 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 62.2 mt -84.88 134.76 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 116.257 -0.429 . . . . 71.44 109.905 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 406' ' ' GLN . 56.4 tp -76.53 113.49 14.2 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.228 -1.027 . . . . 72.41 108.228 176.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.595 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -79.2 -63.85 1.32 Allowed 'General case' 0 N--CA 1.392 -3.337 0 N-CA-C 109.069 -0.715 . . . . 73.52 109.069 -176.13 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.53 156.82 28.18 Favored Glycine 0 N--CA 1.416 -2.65 0 C-N-CA 119.53 -1.319 . . . . 54.14 111.641 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -99.34 147.18 25.48 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.955 -1.128 . . . . 72.34 107.955 175.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.412 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 2.2 m-85 -67.61 116.87 8.81 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.081 0.467 . . . . 74.11 111.233 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -97.87 -47.85 5.4 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.728 -0.669 . . . . 63.12 111.318 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 28.3 m -155.08 149.51 26.2 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.065 -0.346 . . . . 61.24 110.065 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.458 ' CG ' ' HG ' ' A' ' 400' ' ' LEU . 13.8 mp0 -132.91 130.55 39.79 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 106.961 -1.496 . . . . 70.4 106.961 172.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -127.67 110.62 12.85 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.5 -0.926 . . . . 61.13 108.5 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 67.72 -101.82 0.76 Allowed Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.951 -0.568 . . . . 64.35 111.749 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -122.43 19.82 10.46 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.332 0.587 . . . . 73.13 109.907 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 46.6 t -118.37 119.07 60.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 108.273 -1.01 . . . . 71.01 108.273 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.458 ' HG ' ' CG ' ' A' ' 395' ' ' GLN . 4.9 mp -114.87 129.7 56.75 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.243 0.544 . . . . 61.11 110.619 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -113.55 125.86 54.66 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.906 -0.588 . . . . 72.01 110.265 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -118.72 136.67 53.82 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.282 -1.007 . . . . 74.12 108.282 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -144.39 174.17 11.15 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 110.315 -0.254 . . . . 61.42 110.315 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 12.7 m120 60.17 41.7 16.5 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.722 0.809 . . . . 63.32 112.205 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.7 -138.74 1.17 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.471 -0.871 . . . . 64.53 112.039 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 1.0 OUTLIER -81.28 140.62 34.73 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.793 -0.817 . . . . 64.34 108.793 -178.053 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 47.0 m . . . . . 0 C--N 1.319 -0.745 0 N-CA-C 113.551 0.945 . . . . 74.44 113.551 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' HIS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 96.0 m-70 . . . . . 0 CA--C 1.507 -0.705 0 N-CA-C 107.389 -1.337 . . . . 61.41 107.389 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -69.0 159.08 33.48 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-O 121.287 0.565 . . . . 64.25 111.707 174.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 49.0 p -161.6 164.46 29.38 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 114.762 -1.108 . . . . 74.2 109.144 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -158.7 151.02 21.58 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.123 0.487 . . . . 54.2 110.254 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 11.5 tt -118.53 124.39 73.06 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 CA-C-N 115.478 -0.783 . . . . 64.41 109.342 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.532 HG22 ' HB ' ' A' ' 441' ' ' ILE . 5.2 t -111.31 129.61 66.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.534 0.683 . . . . 75.31 112.093 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 14.4 p -111.45 115.17 28.78 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 115.04 -0.982 . . . . 73.45 109.094 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 47.5 t -100.69 111.86 31.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.96 -0.756 . . . . 61.11 108.96 -177.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -113.52 -174.26 2.43 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 120.662 -0.415 . . . . 63.32 111.084 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 19.6 t -59.13 127.19 30.96 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.515 0.674 . . . . 73.31 112.763 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.545 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -154.26 -177.58 27.8 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 110.039 -1.224 . . . . 74.15 110.039 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.57 -28.19 4.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.635 0.731 . . . . 64.41 109.041 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -145.5 151.07 37.59 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.161 -0.927 . . . . 73.44 108.801 -177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.674 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.9 OUTLIER -71.15 98.82 1.75 Allowed 'General case' 0 C--N 1.309 -1.167 0 O-C-N 124.033 0.833 . . . . 32.12 110.191 175.367 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -132.51 148.59 52.39 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-N 115.225 -0.898 . . . . 64.03 111.42 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 367' ' ' ARG . 30.8 mm -81.8 120.31 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 106.043 -1.836 . . . . 63.35 106.043 174.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.445 HG21 ' HG2' ' A' ' 444' ' ' LYS . 53.3 t -86.29 -50.49 14.18 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 116.228 -0.442 . . . . 75.14 112.139 -176.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 44.0 m -159.95 160.73 33.78 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.401 -0.592 . . . . 63.21 109.401 -175.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.502 HG12 HG21 ' A' ' 369' ' ' ILE . 3.6 p -141.14 111.65 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-O 122.017 0.913 . . . . 32.04 108.763 176.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . 0.429 ' O ' HD23 ' A' ' 440' ' ' LEU . 28.7 tp -110.94 136.53 49.82 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 115.321 -0.854 . . . . 73.44 108.711 -177.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -80.92 110.17 16.2 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.489 -0.93 . . . . 63.32 108.489 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -71.47 -36.85 71.33 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.37 -0.832 . . . . 70.52 111.06 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -142.07 -73.85 0.31 Allowed 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.564 -0.744 . . . . 64.51 109.308 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . 0.455 ' NZ ' ' HB3' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -163.69 -49.01 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 116.112 -0.495 . . . . 74.53 110.899 175.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 75.7 m -98.04 -3.9 37.15 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.532 0.682 . . . . 71.03 110.107 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 415' ' ' SER . 34.5 tt0 -124.82 131.39 53.45 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.401 -0.818 . . . . 71.0 109.317 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -126.95 150.6 49.29 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.61 -0.723 . . . . 60.22 110.32 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.46 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.6 pt? -109.85 121.11 44.49 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.013 -1.106 . . . . 75.23 108.013 172.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.532 ' HB ' HG22 ' A' ' 418' ' ' VAL . 97.1 mt -115.51 132.87 63.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 CA-C-N 115.454 -0.794 . . . . 53.32 110.324 -175.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -98.85 136.8 38.34 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.449 -0.945 . . . . 73.35 108.449 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.459 ' SD ' HG11 ' A' ' 418' ' ' VAL . 82.6 mtp -137.46 157.73 45.93 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 109.835 -0.431 . . . . 55.23 109.835 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 31.7 mmtp -131.71 153.15 50.32 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.629 -1.249 . . . . 74.15 107.629 175.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 69.8 m -156.92 149.09 17.65 Favored Pre-proline 0 C--N 1.288 -2.096 0 N-CA-C 108.615 -0.883 . . . . 65.31 108.615 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 39.0 Cg_endo -67.66 -28.13 37.76 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 121.921 1.747 . . . . 74.13 111.975 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -76.28 -22.46 55.05 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.737 -0.665 . . . . 72.01 111.022 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.694 0 CA-C-O 121.741 0.781 . . . . 71.41 109.399 -178.767 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 85.3 m . . . . . 0 C--O 1.215 -0.711 0 N-CA-C 108.491 -0.929 . . . . 51.24 108.491 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.428 ' HB3' ' HG3' ' A' ' 375' ' ' LYS . 0.0 OUTLIER -145.73 151.89 38.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 118.344 0.52 . . . . 71.41 111.591 -177.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.511 HH11 HG12 ' A' ' 369' ' ' ILE . 4.1 tmt_? -161.6 135.47 6.68 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.132 -0.692 . . . . 74.22 109.132 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.22 125.97 30.18 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 110.275 -0.268 . . . . 71.03 110.275 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.553 HG21 HG12 ' A' ' 431' ' ' VAL . 37.2 mt -134.19 119.79 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.828 -1.545 . . . . 74.41 106.828 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.66 12.64 59.62 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 121.164 -0.541 . . . . 65.21 112.07 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 105.78 -23.19 30.19 Favored Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 121.603 -0.332 . . . . 41.33 112.352 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . 0.456 ' CD1' ' HG3' ' A' ' 384' ' ' GLN . 16.0 p90 -98.19 136.76 37.93 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 121.184 0.516 . . . . 70.1 110.548 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 98.9 m -79.54 116.23 19.63 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 115.525 -0.761 . . . . 64.03 110.556 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.12 133.58 34.78 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 107.868 -1.16 . . . . 65.52 107.868 175.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.428 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 36.8 ttpt -133.34 130.78 39.3 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.211 -0.595 . . . . 62.34 109.599 -175.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.409 HG23 HG22 ' A' ' 382' ' ' VAL . 7.2 p -124.0 115.92 46.42 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 O-C-N 123.584 0.552 . . . . 73.44 110.056 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.8 t -108.53 116.45 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.563 -1.273 . . . . 74.32 107.563 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -63.76 126.2 26.82 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 113.895 1.072 . . . . 61.32 113.895 -173.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 73.03 10.66 5.27 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 125.997 1.719 . . . . 64.2 113.117 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.8 -84.49 0.65 Allowed 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 112.489 0.552 . . . . 75.53 112.489 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.522 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -166.38 159.62 14.9 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.99 0.737 . . . . 74.12 112.99 -172.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.409 HG22 HG23 ' A' ' 376' ' ' VAL . 98.7 t -113.74 145.75 19.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 124.642 1.177 . . . . 72.43 109.141 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.522 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 71.1 m-85 -132.77 152.43 51.77 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 122.973 0.509 . . . . 64.32 111.986 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.493 ' HB2' HD23 ' A' ' 389' ' ' LEU . 35.2 tt0 -124.76 102.04 7.38 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.347 -1.723 . . . . 71.12 106.347 173.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 14.3 t70 69.64 -83.84 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.564 1.146 . . . . 73.3 109.543 -175.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.3 m -133.28 -7.37 2.97 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 108.608 -0.886 . . . . 53.14 108.608 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 63.0 mt -80.59 132.91 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.388 -0.823 . . . . 33.14 110.127 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.459 HD21 HD21 ' A' ' 391' ' ' ASN . 64.8 tp -76.9 109.97 11.13 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.499 -0.926 . . . . 72.2 108.499 176.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.2 OUTLIER -77.67 -65.4 0.97 Allowed 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 109.111 -0.7 . . . . 71.21 109.111 -176.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.23 153.58 24.66 Favored Glycine 0 N--CA 1.424 -2.103 0 C-N-CA 119.26 -1.448 . . . . 63.13 111.64 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.47 ' N ' HD22 ' A' ' 391' ' ' ASN . 0.8 OUTLIER -99.46 144.76 28.19 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.711 -1.218 . . . . 61.14 107.711 178.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -73.02 116.3 13.38 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.267 -0.642 . . . . 75.11 109.267 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -111.21 -47.99 3.14 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.939 -0.573 . . . . 72.31 110.863 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 18.7 m -145.63 138.96 26.29 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.504 -0.925 . . . . 62.24 108.504 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.478 ' HB2' HD22 ' A' ' 400' ' ' LEU . 9.8 pt20 -147.4 145.32 29.21 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 120.938 0.399 . . . . 72.23 110.84 173.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -121.17 110.24 15.95 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 115.649 -0.705 . . . . 62.14 109.535 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.19 -104.27 0.79 Allowed Glycine 0 N--CA 1.436 -1.339 0 CA-C-N 115.265 -0.88 . . . . 64.55 113.823 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -116.83 18.2 14.87 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.128 0.489 . . . . 73.03 111.187 -176.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.3 t -125.15 116.09 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 105.159 -2.163 . . . . 64.23 105.159 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.478 HD22 ' HB2' ' A' ' 395' ' ' GLN . 13.6 mt -118.63 136.28 53.98 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.862 -0.735 . . . . 53.04 111.241 -168.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.414 ' HE3' HD12 ' A' ' 417' ' ' ILE . 20.6 mmtp -107.43 124.09 49.35 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.498 0.666 . . . . 74.31 112.076 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.402 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 2.9 m-85 -117.08 125.88 51.98 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.77 -1.566 . . . . 75.24 106.77 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -139.77 175.86 9.22 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 110.113 -0.329 . . . . 75.12 110.113 -176.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.0 m120 64.93 33.3 10.0 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.856 0.722 . . . . 71.21 112.503 173.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.6 -141.23 1.17 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.785 -0.722 . . . . 73.14 113.054 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.77 142.11 38.86 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.95 -1.13 . . . . 73.22 107.95 -177.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 121.413 0.625 . . . . 32.22 111.687 -179.441 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 . . . . . 0 CA--C 1.493 -1.249 0 N-CA-C 105.157 -2.164 . . . . 75.42 105.157 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -69.32 156.33 38.97 Favored 'General case' 0 C--O 1.256 1.407 0 C-N-CA 119.641 -0.824 . . . . 75.12 111.568 174.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 23.7 p -157.59 158.92 36.48 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-N 114.67 -1.15 . . . . 55.02 109.192 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -154.03 149.01 26.73 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.26 0.552 . . . . 74.31 110.656 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . 0.414 HD12 ' HE3' ' A' ' 401' ' ' LYS . 8.4 tt -118.99 123.81 72.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 CA-C-N 115.107 -0.951 . . . . 74.5 109.816 175.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.616 HG22 ' HB ' ' A' ' 441' ' ' ILE . 4.1 t -109.85 130.66 62.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 115.785 -0.643 . . . . 65.3 111.231 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 20.5 p -108.46 115.01 29.3 Favored 'General case' 0 N--CA 1.409 -2.525 0 N-CA-C 108.322 -0.992 . . . . 64.45 108.322 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 38.5 t -100.36 114.72 39.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.039 -1.467 . . . . 74.05 107.039 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.02 -173.94 2.55 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.915 -0.314 . . . . 71.24 110.556 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.525 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 38.3 t -60.5 127.92 34.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.235 0.54 . . . . 75.42 111.71 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.607 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -156.36 -179.7 31.57 Favored Glycine 0 CA--C 1.485 -1.808 0 N-CA-C 110.535 -1.026 . . . . 74.4 110.535 177.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.08 -35.32 7.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.899 -0.778 . . . . 72.31 108.899 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -143.79 152.16 40.87 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.367 -0.833 . . . . 72.32 109.722 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.721 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.9 OUTLIER -69.57 97.95 1.09 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.034 -0.985 . . . . 52.23 110.586 175.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -132.16 149.56 52.36 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.851 -1.068 . . . . 54.41 109.906 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 369' ' ' ILE . 32.6 mm -84.35 119.41 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 105.993 -1.855 . . . . 54.41 105.993 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 54.8 t -83.86 -51.04 14.65 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 CA-C-N 116.409 -0.36 . . . . 70.04 111.623 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 38.5 p -165.26 167.97 17.43 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 120.914 -0.314 . . . . 71.23 110.674 -175.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.553 HG12 HG21 ' A' ' 369' ' ' ILE . 3.3 p -142.19 126.25 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 N-CA-C 109.124 -0.695 . . . . 50.1 109.124 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . 0.438 ' O ' HD23 ' A' ' 440' ' ' LEU . 28.1 tp -126.82 137.96 53.27 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.885 -0.783 . . . . 73.54 108.885 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -81.07 113.0 18.96 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.291 -1.003 . . . . 75.42 108.291 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.02 -50.81 18.13 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-N 115.715 -0.675 . . . . 74.12 110.226 -174.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . 0.539 ' C ' ' HD2' ' A' ' 436' ' ' LYS . 49.4 mt-30 -121.47 -82.24 0.65 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.236 -0.893 . . . . 65.33 108.753 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . 0.539 ' HD2' ' C ' ' A' ' 435' ' ' GLN . 0.2 OUTLIER -145.31 -61.73 0.34 Allowed 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 108.26 -1.015 . . . . 74.02 108.26 177.025 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 92.3 m -93.64 -7.96 42.38 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.158 -1.383 . . . . 53.3 111.693 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 415' ' ' SER . 35.6 tt0 -110.39 128.6 55.66 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-N 115.291 -0.868 . . . . 64.41 109.077 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 46.4 m-85 -124.48 149.72 46.53 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.757 -0.656 . . . . 74.1 109.785 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.445 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.5 pt? -111.47 119.54 39.12 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.341 -0.615 . . . . 74.22 109.341 175.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.616 ' HB ' HG22 ' A' ' 418' ' ' VAL . 3.8 mp -109.62 133.9 53.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.87 -0.604 . . . . 63.52 109.883 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -96.25 135.82 37.56 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 108.397 -0.964 . . . . 62.34 108.397 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 81.8 mtp -138.01 160.53 39.12 Favored 'General case' 0 CA--C 1.478 -1.802 0 N-CA-C 109.678 -0.49 . . . . 74.33 109.678 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.721 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 73.8 mmtt -131.05 160.96 33.11 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.743 -1.206 . . . . 73.32 107.743 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 40.8 t -165.45 145.04 5.49 Favored Pre-proline 0 C--N 1.284 -2.252 0 O-C-N 124.118 0.886 . . . . 71.25 109.023 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -66.42 -27.36 47.13 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.04 1.826 . . . . 75.32 110.618 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -76.52 -17.81 59.05 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.327 -0.851 . . . . 74.52 111.182 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.818 0 CA-C-O 121.546 0.688 . . . . 70.53 110.128 -179.974 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.562 ' HB ' HG13 ' A' ' 376' ' ' VAL . 84.7 m . . . . . 0 N--CA 1.432 -1.328 0 N-CA-C 106.388 -1.708 . . . . 64.11 106.388 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 0.0 OUTLIER -143.49 150.23 38.67 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.418 -0.913 . . . . 52.21 111.108 -175.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -162.37 136.48 6.49 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.741 -0.836 . . . . 62.52 108.741 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -77.81 124.98 28.65 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 109.815 -0.439 . . . . 70.23 109.815 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.508 HG21 HG12 ' A' ' 431' ' ' VAL . 56.4 mt -134.82 118.99 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 N-CA-C 106.883 -1.525 . . . . 73.04 106.883 -178.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.49 13.59 60.93 Favored Glycine 0 C--N 1.305 -1.139 0 C-N-CA 120.538 -0.839 . . . . 62.4 112.675 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 105.56 -17.78 42.35 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 120.997 -0.62 . . . . 73.34 113.252 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -105.26 142.17 35.49 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 120.61 0.243 . . . . 72.25 110.595 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 97.8 m -82.25 119.75 24.49 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.099 0.476 . . . . 73.04 110.057 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.586 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -90.79 126.53 36.04 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 108.533 -0.914 . . . . 73.43 108.533 176.087 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -126.43 127.45 45.44 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.28 -0.568 . . . . 73.55 109.874 -175.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.616 HG23 HG22 ' A' ' 382' ' ' VAL . 5.9 p -124.58 117.07 49.38 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 116.16 -0.473 . . . . 71.22 111.036 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.98 116.22 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.141 -1.429 . . . . 70.32 107.141 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.543 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 95.1 m-85 -70.3 131.29 43.93 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 114.705 1.372 . . . . 73.42 114.705 -170.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 71.64 13.08 6.35 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.254 1.422 . . . . 70.13 112.232 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -125.71 -86.18 0.62 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.484 -0.78 . . . . 72.32 113.044 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.439 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -162.72 153.22 16.7 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.304 0.853 . . . . 70.14 113.304 -173.013 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 376' ' ' VAL . 44.7 t -113.56 149.44 15.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 C-N-CA 124.054 0.942 . . . . 63.42 108.725 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.439 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 62.8 m-85 -139.63 144.7 37.81 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.348 0.405 . . . . 55.45 111.088 -177.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -107.24 110.01 21.94 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 106.346 -1.724 . . . . 74.11 106.346 169.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 17.2 t70 69.1 -87.02 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 123.76 0.824 . . . . 72.32 110.422 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 19.5 m -136.16 -1.88 2.34 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.966 -0.753 . . . . 52.44 108.966 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 47.2 mm -88.66 138.68 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 109.646 -0.501 . . . . 43.22 109.646 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.3 tp -74.25 117.69 16.35 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.24 -1.763 . . . . 75.01 106.24 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.546 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 49.7 tp -91.79 -58.41 2.43 Favored 'General case' 0 N--CA 1.381 -3.877 0 CA-C-N 115.412 -0.813 . . . . 41.53 110.856 -173.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.46 148.13 15.96 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 119.401 -1.381 . . . . 70.34 111.492 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -99.75 145.15 27.99 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.503 -1.295 . . . . 70.31 107.503 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.543 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.5 m-85 -70.26 117.21 11.52 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 120.771 0.32 . . . . 63.11 111.324 -176.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -88.33 -46.81 8.89 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.925 -0.58 . . . . 73.52 110.15 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 60.6 p -169.03 160.75 10.16 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-N 115.765 -0.652 . . . . 75.12 109.599 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.463 HE21 ' HD2' ' A' ' 392' ' ' PHE . 14.8 mp0 -130.67 138.13 49.9 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.657 -1.238 . . . . 74.34 107.657 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -128.43 114.42 16.78 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.869 -0.789 . . . . 74.42 108.869 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 72.18 -101.44 1.05 Allowed Glycine 0 N--CA 1.422 -2.251 0 C-N-CA 119.169 -1.491 . . . . 41.52 112.056 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 21.7 p-10 -128.04 15.7 6.79 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 123.598 0.759 . . . . 41.42 109.381 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.432 HG22 HG23 ' A' ' 419' ' ' THR . 35.9 t -118.89 121.66 67.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.459 -0.941 . . . . 55.22 108.459 -175.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.404 ' HG ' ' CG ' ' A' ' 395' ' ' GLN . 3.2 mp -117.4 132.61 56.54 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 116.078 -0.51 . . . . 72.45 110.669 -175.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . 0.42 ' HE2' HD12 ' A' ' 417' ' ' ILE . 57.0 mmtt -106.29 125.73 51.36 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 115.903 -0.59 . . . . 51.54 111.231 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.422 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 3.7 m-85 -118.48 135.89 54.12 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.98 -1.118 . . . . 71.2 107.98 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.69 176.14 10.08 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.556 0.217 . . . . 74.04 111.538 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 14.1 m120 65.31 33.19 9.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.673 0.789 . . . . 62.14 112.386 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -73.8 -149.16 1.4 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.898 -0.667 . . . . 53.04 112.345 176.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -73.93 137.92 43.92 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 122.106 -0.644 . . . . 74.44 110.069 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 26.4 p . . . . . 0 C--N 1.311 -1.09 0 C-N-CA 124.661 1.184 . . . . 71.01 113.934 -175.124 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 . . . . . 0 CA--C 1.51 -0.579 0 N-CA-C 106.723 -1.584 . . . . 65.34 106.723 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -76.61 158.48 31.07 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.269 0.557 . . . . 64.03 112.457 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 37.4 p -160.69 163.72 32.22 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 114.983 -1.008 . . . . 55.34 109.122 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.52 143.29 13.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 120.77 0.319 . . . . 74.53 110.584 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . 0.42 HD12 ' HE2' ' A' ' 401' ' ' LYS . 7.4 tt -103.84 131.73 51.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.78 -0.822 . . . . 71.41 108.78 173.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.7 t -113.32 125.28 70.56 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-O 121.084 0.469 . . . . 73.35 110.181 174.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.432 HG23 HG22 ' A' ' 399' ' ' VAL . 1.1 m -110.07 114.45 27.97 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 105.878 -1.897 . . . . 61.03 105.878 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 22.0 t -101.17 117.24 46.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.357 -0.979 . . . . 64.31 108.357 -176.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -106.7 -179.05 3.83 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 120.281 -0.568 . . . . 72.13 109.935 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 40.2 t -60.56 128.99 39.34 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 123.37 0.668 . . . . 63.41 110.644 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.554 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -153.16 -177.4 26.67 Favored Glycine 0 CA--C 1.485 -1.812 0 N-CA-C 111.065 -0.814 . . . . 75.11 111.065 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.93 -30.13 4.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.498 0.666 . . . . 75.53 109.213 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -151.02 151.25 31.77 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.369 -0.832 . . . . 74.11 109.222 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.639 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.0 OUTLIER -65.34 100.23 0.46 Allowed 'General case' 0 C--N 1.311 -1.098 0 O-C-N 124.164 0.915 . . . . 74.33 110.841 174.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -131.93 149.25 52.49 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.776 -1.102 . . . . 75.33 110.246 -176.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.441 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 29.7 mm -86.87 122.25 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 106.261 -1.755 . . . . 74.44 106.261 176.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 442' ' ' LYS . 64.9 t -84.37 -50.43 15.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 CA-C-N 116.455 -0.339 . . . . 74.04 111.653 -177.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.5 m -165.66 164.23 19.09 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.151 -0.685 . . . . 72.44 109.151 -175.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.508 HG12 HG21 ' A' ' 369' ' ' ILE . 3.3 p -141.49 125.32 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 107.253 -1.388 . . . . 73.02 107.253 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 42.8 tp -131.73 137.26 48.15 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 108.627 -0.879 . . . . 71.2 108.627 -176.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -81.64 119.04 23.3 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.45 -0.945 . . . . 61.55 108.45 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.3 -56.32 5.01 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.335 -0.848 . . . . 64.13 110.701 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -119.55 -71.49 0.73 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.739 -0.664 . . . . 74.14 110.603 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -162.39 -42.14 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.767 0 CA-C-O 121.332 0.587 . . . . 74.15 111.152 175.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 90.7 m -112.77 13.3 19.75 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.71 0.766 . . . . 62.12 109.959 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 415' ' ' SER . 31.0 tt0 -135.23 131.23 36.39 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.079 -0.964 . . . . 62.33 108.875 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -123.5 150.68 43.65 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 123.591 0.557 . . . . 74.52 111.279 -176.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.467 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.6 pt? -110.58 118.01 35.06 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.428 -0.953 . . . . 64.53 108.428 172.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 92.6 mt -119.29 133.12 67.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.294 -0.867 . . . . 63.44 109.308 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.412 ' O ' ' HB ' ' A' ' 429' ' ' VAL . 37.9 ttpt -111.53 141.38 45.18 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 109.285 -0.635 . . . . 55.11 109.285 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.441 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 79.6 mtp -136.32 169.19 18.06 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 109.272 -0.64 . . . . 71.55 109.272 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 66.8 mmtt -132.22 159.97 37.49 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.97 -1.122 . . . . 74.13 107.97 175.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 41.2 t -172.45 145.69 1.5 Allowed Pre-proline 0 C--N 1.289 -2.05 0 O-C-N 124.187 0.929 . . . . 55.42 109.707 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.0 -24.27 45.62 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.314 2.009 . . . . 72.13 110.917 176.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.09 -18.75 52.77 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.698 -0.683 . . . . 62.11 111.017 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.659 0 CA-C-O 121.66 0.743 . . . . 74.3 109.57 176.868 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 94.0 m . . . . . 0 N--CA 1.432 -1.327 0 N-CA-C 107.932 -1.136 . . . . 62.51 107.932 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.488 ' HB3' ' HG3' ' A' ' 375' ' ' LYS . 13.3 ptmm? -136.52 144.46 44.28 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.51 0.93 . . . . 75.52 113.51 -173.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.4 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 3.3 tmt_? -156.55 135.54 11.9 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.244 -1.391 . . . . 74.44 107.244 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 43.7 mt-10 -86.29 128.43 34.92 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 109.645 -0.502 . . . . 73.42 109.645 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.63 118.76 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 N-CA-C 107.463 -1.31 . . . . 72.5 107.463 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.24 14.41 61.68 Favored Glycine 0 C--N 1.308 -1.016 0 C-N-CA 120.612 -0.804 . . . . 73.53 112.631 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 109.15 -24.53 20.74 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 120.919 -0.658 . . . . 75.45 112.91 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -98.78 136.02 39.42 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 120.946 0.403 . . . . 64.22 111.07 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 41.3 m -77.52 115.3 17.17 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.074 -0.512 . . . . 65.43 110.206 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -91.05 131.34 36.69 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 108.438 -0.949 . . . . 72.42 108.438 175.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.488 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 38.5 ttpt -135.32 125.45 26.09 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 120.165 -0.614 . . . . 55.01 109.994 -177.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.487 HG12 HD11 ' A' ' 428' ' ' ILE . 7.6 p -117.02 115.51 49.13 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 N-CA-C 108.266 -1.013 . . . . 53.11 108.266 176.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 39.5 t -104.96 115.08 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.422 0 N-CA-C 105.662 -1.977 . . . . 74.12 105.662 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.521 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 94.3 m-85 -68.72 127.52 33.34 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 114.216 1.191 . . . . 64.14 114.216 -170.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . 0.27 47.9 m-85 71.19 16.14 6.31 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 113.964 -1.471 . . . . 71.43 112.956 -176.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -125.91 -83.41 0.63 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.258 -0.883 . . . . 54.34 112.566 173.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.516 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.5 OUTLIER -161.6 162.53 30.12 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.701 0.63 . . . . 52.41 112.701 -169.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.46 HG22 HG23 ' A' ' 376' ' ' VAL . 87.1 t -121.16 143.29 33.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 124.305 1.042 . . . . 75.33 108.65 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.516 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 66.4 m-85 -132.25 144.89 50.93 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 123.209 0.604 . . . . 63.52 112.198 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.549 ' HB2' HD23 ' A' ' 389' ' ' LEU . 33.5 tt0 -116.17 102.15 9.34 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 105.776 -1.935 . . . . 73.34 105.776 171.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.4 t70 72.38 -80.67 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 125.065 1.346 . . . . 33.23 109.569 -176.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.4 m -142.69 -1.88 1.1 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.945 -1.025 . . . . 43.03 108.352 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 49.8 mt -88.07 139.31 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.746 -0.661 . . . . 74.34 109.977 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.494 HD21 HD21 ' A' ' 391' ' ' ASN . 58.6 tp -76.43 110.29 10.84 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.56 -0.904 . . . . 61.13 108.56 -178.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.549 HD23 ' HB2' ' A' ' 384' ' ' GLN . 1.0 OUTLIER -80.39 -60.04 2.47 Favored 'General case' 0 N--CA 1.393 -3.324 0 N-CA-C 109.18 -0.674 . . . . 73.32 109.18 -176.487 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.45 160.02 31.4 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 119.475 -1.345 . . . . 63.02 111.644 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.494 HD21 HD21 ' A' ' 388' ' ' LEU . 47.8 m-80 -110.11 151.32 27.38 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.942 -1.133 . . . . 62.34 107.942 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.521 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.8 m-85 -73.56 127.95 34.17 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 111.777 0.288 . . . . 73.43 111.777 -175.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -110.5 -49.57 3.04 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.18 -0.608 . . . . 24.21 112.575 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 54.2 p -167.75 139.92 3.12 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.694 -0.484 . . . . 72.51 109.694 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.444 ' NE2' ' HD2' ' A' ' 392' ' ' PHE . 2.4 mm-40 -118.17 147.12 43.66 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 109.989 -0.374 . . . . 61.53 109.989 -176.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -128.41 110.31 12.21 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.192 -0.67 . . . . 71.04 109.192 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.95 -108.11 2.09 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 116.145 -0.479 . . . . 71.14 112.405 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -117.23 16.77 14.86 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.28 0.562 . . . . 74.14 110.196 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 52.3 t -117.44 116.87 53.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.797 -1.186 . . . . 61.41 107.797 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.63 142.42 39.12 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.571 -0.74 . . . . 63.43 111.386 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -120.1 122.47 41.12 Favored 'General case' 0 C--O 1.25 1.097 0 CA-C-O 121.403 0.62 . . . . 70.52 111.814 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -118.3 137.32 53.15 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.934 -1.136 . . . . 74.31 107.934 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . 0.445 ' HA ' ' CB ' ' A' ' 415' ' ' SER . 46.6 mt-10 -142.47 175.59 9.66 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.008 -0.738 . . . . 74.22 109.008 -177.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.79 33.54 10.17 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.275 1.213 . . . . 73.05 114.275 171.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.72 -141.9 3.02 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 120.233 -0.984 . . . . 61.43 111.602 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -56.0 136.92 51.77 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 123.343 0.657 . . . . 64.54 110.993 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 26.4 p . . . . . 0 N--CA 1.433 -1.314 0 CA-C-O 120.919 0.39 . . . . 71.23 110.806 -179.03 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 . . . . . 0 CA--C 1.5 -0.952 0 N-CA-C 105.678 -1.971 . . . . 71.12 105.678 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -73.24 156.37 38.58 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.156 0.503 . . . . 51.2 109.872 171.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.445 ' CB ' ' HA ' ' A' ' 403' ' ' GLU . 54.2 p -160.54 169.07 23.7 Favored 'General case' 0 N--CA 1.401 -2.916 0 CA-C-N 115.306 -0.861 . . . . 63.34 109.047 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -159.07 151.07 20.93 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.364 0.602 . . . . 42.41 111.281 -177.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.1 tt -115.1 133.01 62.66 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 CA-C-N 115.08 -0.964 . . . . 62.34 108.558 173.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.611 HG22 ' HB ' ' A' ' 441' ' ' ILE . 4.9 t -118.57 129.68 74.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.233 0.54 . . . . 64.35 111.638 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.3 p -108.26 113.24 26.19 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.635 -1.246 . . . . 44.11 107.635 174.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 21.1 t -101.48 112.2 33.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.132 -1.062 . . . . 75.21 108.132 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 444' ' ' LYS . 41.1 mt-10 -108.16 179.52 4.19 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.988 -0.285 . . . . 64.35 110.315 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 43.2 t -59.29 128.76 38.75 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 123.464 0.706 . . . . 65.4 110.863 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.64 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -153.42 -176.89 26.37 Favored Glycine 0 CA--C 1.486 -1.723 0 C-N-CA 120.779 -0.724 . . . . 65.41 111.452 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 50.6 t -89.3 -37.31 9.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.998 -0.741 . . . . 72.22 108.998 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -150.48 160.3 43.87 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.638 -0.71 . . . . 74.3 109.31 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 70.0 m-20 -68.78 101.22 1.29 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.44 0.696 . . . . 73.25 109.709 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -131.89 148.25 52.52 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 110.432 -0.211 . . . . 53.32 110.432 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.487 HD11 HG12 ' A' ' 376' ' ' VAL . 30.5 mm -82.91 115.47 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 105.88 -1.896 . . . . 74.14 105.88 173.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 42.6 t -81.18 -47.49 19.95 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.637 0 N-CA-C 112.553 0.575 . . . . 71.05 112.553 -176.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 26.1 t -166.0 162.35 17.96 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.522 -0.918 . . . . 60.52 108.522 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' A' ' 441' ' ' ILE . 3.1 p -141.27 119.9 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.143 0 N-CA-C 108.666 -0.865 . . . . 64.04 108.666 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . 0.407 ' O ' HD23 ' A' ' 440' ' ' LEU . 30.7 tp -121.21 136.61 54.94 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 108.268 -1.012 . . . . 53.24 108.268 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.449 ' CD ' ' HA ' ' A' ' 436' ' ' LYS . 43.7 tt0 -81.37 116.88 21.41 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.858 -1.164 . . . . 73.12 107.858 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.47 -46.69 38.02 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.887 0.851 . . . . 64.24 109.498 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -129.29 -78.68 0.56 Allowed 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.897 -1.047 . . . . 74.4 109.28 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . 0.471 ' NZ ' ' HB3' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -168.05 -40.25 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 123.367 0.667 . . . . 70.01 110.492 174.048 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 91.4 m -100.72 7.79 43.66 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.749 0.785 . . . . 70.12 109.477 174.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -136.44 129.69 31.51 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.484 -0.78 . . . . 72.32 109.944 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 43.4 m-85 -125.32 150.57 47.02 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 123.522 0.514 . . . . 75.44 110.096 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 432' ' ' LEU . 1.5 pt? -111.9 120.92 43.55 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.369 -0.604 . . . . 45.14 109.369 172.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.611 ' HB ' HG22 ' A' ' 418' ' ' VAL . 4.0 mp -113.74 133.48 59.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 116.127 -0.488 . . . . 64.3 110.105 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -104.01 140.53 37.61 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 107.847 -1.168 . . . . 72.14 107.847 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.423 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 80.7 mtp -138.79 168.33 20.05 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 109.231 -0.655 . . . . 54.12 109.231 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.64 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 71.9 mmtt -133.53 160.02 38.7 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.146 -1.057 . . . . 71.44 108.146 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 46.2 t -165.89 146.13 5.49 Favored Pre-proline 0 C--N 1.284 -2.247 0 O-C-N 124.193 0.933 . . . . 60.42 109.894 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.2 -27.09 41.69 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.158 1.905 . . . . 54.13 110.147 174.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -78.79 -21.65 47.49 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.291 -0.868 . . . . 52.31 110.245 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -1.019 0 CA-C-O 121.162 0.506 . . . . 41.41 110.708 -179.38 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.461 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 93.4 m . . . . . 0 N--CA 1.422 -1.867 0 N-CA-C 107.111 -1.44 . . . . 71.41 107.111 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 56.2 mtpt -131.6 142.44 49.89 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.403 -0.362 . . . . 72.51 110.882 -175.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -160.57 135.42 7.63 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.625 -0.88 . . . . 63.45 108.625 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 2.4 mp0 -79.25 122.99 27.01 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 110.019 -0.363 . . . . 61.44 110.019 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.577 HG21 HG12 ' A' ' 431' ' ' VAL . 47.4 mt -135.74 124.15 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 106.797 -1.557 . . . . 70.42 106.797 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.62 13.08 60.39 Favored Glycine 0 C--N 1.31 -0.906 0 C-N-CA 120.55 -0.833 . . . . 72.12 112.057 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.08 -24.2 27.08 Favored Glycine 0 N--CA 1.429 -1.808 0 C-N-CA 121.209 -0.52 . . . . 74.02 113.113 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . 0.487 ' CD1' ' HG3' ' A' ' 384' ' ' GLN . 22.5 p90 -103.42 147.16 27.47 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 110.17 -0.308 . . . . 75.04 110.17 -176.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.522 HG21 ' HE2' ' A' ' 366' ' ' LYS . 85.8 m -86.44 123.88 32.15 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 116.464 -0.335 . . . . 51.1 110.989 -178.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.655 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.5 134.74 34.15 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 108.945 -0.761 . . . . 64.31 108.945 175.418 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.476 ' HG3' ' HG2' ' A' ' 366' ' ' LYS . 38.0 ttpt -130.12 125.84 36.08 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 110.0 -0.37 . . . . 64.52 110.0 -178.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.461 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.3 p -122.46 118.88 56.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 N-CA-C 109.451 -0.574 . . . . 74.22 109.451 175.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 49.5 t -106.17 116.99 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 106.658 -1.608 . . . . 44.11 106.658 174.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -61.43 126.7 28.28 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 114.668 1.359 . . . . 72.04 114.668 -172.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 71.07 14.35 6.77 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 113.336 -1.756 . . . . 72.13 112.465 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -124.8 -77.24 0.59 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 113.893 1.071 . . . . 73.23 113.893 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -162.76 160.97 26.0 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.882 0.697 . . . . 73.42 112.882 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.458 HG22 HG23 ' A' ' 376' ' ' VAL . 96.8 t -122.86 140.21 47.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.541 -0.754 . . . . 61.43 109.103 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -133.23 147.25 51.98 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.19 0.519 . . . . 72.54 111.872 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.52 ' HB2' HD23 ' A' ' 389' ' ' LEU . 35.9 tt0 -112.07 101.03 9.34 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.317 -2.105 . . . . 71.52 105.317 171.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 21.9 t70 68.19 -84.03 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 124.302 1.041 . . . . 75.15 110.109 -173.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.4 m -134.89 -6.67 2.4 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.214 -0.903 . . . . 65.41 108.678 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 45.6 mm -80.38 134.49 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 116.004 -0.544 . . . . 74.22 109.737 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 61.0 tp -76.92 113.9 15.12 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 109.035 -0.728 . . . . 73.24 109.035 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.3 OUTLIER -80.06 -63.32 1.44 Allowed 'General case' 0 N--CA 1.389 -3.511 0 N-CA-C 108.974 -0.75 . . . . 64.32 108.974 -177.179 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.89 159.41 30.64 Favored Glycine 0 N--CA 1.415 -2.742 0 C-N-CA 119.162 -1.494 . . . . 64.32 111.842 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -105.79 145.07 31.64 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.031 -1.1 . . . . 73.04 108.031 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -69.82 116.34 10.1 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.908 0.385 . . . . 74.43 110.601 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -94.79 -47.03 6.64 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.721 -0.672 . . . . 63.13 110.757 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 62.5 p -173.24 149.8 1.82 Allowed 'General case' 0 C--O 1.246 0.879 0 CA-C-N 116.021 -0.536 . . . . 72.04 109.599 -177.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.485 ' CD ' ' HG ' ' A' ' 400' ' ' LEU . 10.1 pt20 -143.88 142.06 30.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.186 0.517 . . . . 74.41 110.796 175.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -128.5 131.11 48.31 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.666 -0.697 . . . . 75.04 109.624 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 69.59 -107.96 2.31 Favored Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 111.365 -0.694 . . . . 52.14 111.365 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -133.07 24.41 4.22 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.83 0.824 . . . . 71.15 110.053 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.2 t -119.45 116.86 52.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.335 -0.987 . . . . 73.12 108.335 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.485 ' HG ' ' CD ' ' A' ' 395' ' ' GLN . 6.0 mp -106.71 133.55 51.21 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.16 0.584 . . . . 61.54 111.804 -174.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -113.47 121.94 45.79 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 112.513 0.56 . . . . 71.43 112.513 178.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.403 ' CE1' ' HB3' ' A' ' 400' ' ' LEU . 2.8 m-85 -118.58 136.81 53.66 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.328 -0.99 . . . . 62.34 108.328 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -146.31 176.15 9.99 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.141 0.496 . . . . 74.51 111.723 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.15 33.65 9.23 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.382 -1.281 . . . . 73.41 112.679 169.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.26 -136.7 0.67 Allowed Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.445 -0.798 . . . . 51.42 112.931 177.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.34 149.6 40.52 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.816 -1.179 . . . . 73.43 107.816 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 C--N 1.306 -1.309 0 C-N-CA 124.22 1.008 . . . . 64.02 111.36 -175.63 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 . . . . . 0 CA--C 1.507 -0.699 0 N-CA-C 106.839 -1.541 . . . . 44.43 106.839 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -75.31 160.53 30.22 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.179 0.514 . . . . 73.22 111.22 172.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 36.8 p -163.29 163.46 25.29 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 114.908 -1.042 . . . . 72.33 108.643 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.75 146.32 19.25 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.217 0.532 . . . . 75.33 110.195 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.9 tt -111.25 121.29 63.59 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 CA-C-N 115.303 -0.862 . . . . 72.42 109.482 174.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.0 t -105.72 127.8 60.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.775 0.798 . . . . 74.45 111.499 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 12.5 p -107.76 111.7 24.0 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 106.836 -1.542 . . . . 74.32 106.836 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 8.6 p -106.27 120.23 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 108.891 -0.781 . . . . 62.41 108.891 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -116.2 -174.69 2.59 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 120.386 -0.526 . . . . 63.24 111.277 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 43.4 t -59.61 128.74 38.5 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 123.713 0.805 . . . . 72.35 111.2 -177.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -160.26 -177.82 33.7 Favored Glycine 0 CA--C 1.48 -2.101 0 N-CA-C 109.54 -1.424 . . . . 53.33 109.54 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 53.3 t -96.93 -27.96 3.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 121.639 0.733 . . . . 73.2 109.027 177.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -141.34 146.57 36.85 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.791 -0.64 . . . . 72.15 111.234 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.638 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.6 p-10 -68.28 101.21 1.16 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.28 -1.327 . . . . 72.15 110.47 175.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -132.32 149.19 52.41 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.401 -0.818 . . . . 73.01 110.919 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 28.8 mm -88.82 117.33 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 105.841 -1.911 . . . . 63.13 105.841 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.7 -50.83 16.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-O 120.772 0.32 . . . . 74.14 111.438 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 70.3 m -167.08 163.81 15.79 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 110.041 -0.355 . . . . 62.02 110.041 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.577 HG12 HG21 ' A' ' 369' ' ' ILE . 4.2 p -141.45 127.9 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 108.08 -1.082 . . . . 73.31 108.08 176.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . 0.432 ' O ' HD23 ' A' ' 440' ' ' LEU . 29.5 tp -132.21 138.18 47.86 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.665 -0.865 . . . . 55.23 108.665 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -80.65 116.45 20.68 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.89 -0.782 . . . . 74.11 108.89 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.68 -53.74 8.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.28 0.562 . . . . 62.4 109.702 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -120.93 -72.92 0.67 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.312 -0.858 . . . . 73.31 110.37 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . 0.491 ' HG2' ' SG ' ' A' ' 437' ' ' CYS . 0.0 OUTLIER -167.51 -40.61 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.346 0.594 . . . . 61.15 110.483 175.173 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . 0.491 ' SG ' ' HG2' ' A' ' 436' ' ' LYS . 43.7 m -106.65 7.04 30.37 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.678 0.751 . . . . 71.32 109.501 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -135.48 127.92 30.47 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.155 -0.929 . . . . 71.33 109.319 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -123.96 150.22 45.03 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.713 -0.676 . . . . 71.1 109.782 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.477 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.4 pt? -107.52 124.71 50.31 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.491 -0.929 . . . . 75.43 108.491 173.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.6 mt -124.75 133.37 69.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 115.332 -0.849 . . . . 62.22 109.409 -176.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -112.45 141.64 45.96 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 119.934 -0.706 . . . . 74.11 109.614 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 80.0 mtp -137.11 169.03 18.46 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 123.571 0.749 . . . . 63.15 109.059 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.638 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 69.2 mmtt -135.12 153.73 51.91 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.732 -1.21 . . . . 72.22 107.732 175.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 73.0 m -164.57 150.82 9.3 Favored Pre-proline 0 C--N 1.293 -1.89 0 C-N-CA 123.992 0.917 . . . . 55.15 109.287 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.99 -27.51 42.62 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.282 1.988 . . . . 72.4 112.045 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -73.47 -19.74 60.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.677 -0.692 . . . . 70.53 110.94 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.045 0 CA-C-O 121.478 0.656 . . . . 63.3 109.586 -177.826 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 375' ' ' LYS . 99.2 m . . . . . 0 N--CA 1.433 -1.318 0 N-CA-C 109.757 -0.46 . . . . 64.42 109.757 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 18.9 ptpt -143.94 141.14 30.07 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-O 120.801 0.334 . . . . 71.51 111.872 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -154.9 135.1 13.15 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 106.96 -1.496 . . . . 72.04 106.96 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 40.4 mt-10 -89.44 127.86 35.88 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 120.642 0.258 . . . . 74.21 110.817 -174.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.468 HG21 HG12 ' A' ' 431' ' ' VAL . 47.5 mt -137.21 125.47 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 107.133 -1.432 . . . . 75.32 107.133 -174.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.84 5.51 32.27 Favored Glycine 0 C--N 1.306 -1.102 0 C-N-CA 121.177 -0.535 . . . . 60.32 113.188 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 110.34 -13.84 30.69 Favored Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.562 -0.828 . . . . 40.5 113.072 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . 0.428 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 13.5 p90 -109.91 143.68 39.48 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 110.126 -0.324 . . . . 72.43 110.126 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 63.2 m -82.96 121.14 26.6 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.822 -0.351 . . . . 62.21 110.484 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.4 OUTLIER -90.3 125.64 35.58 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 109.335 -0.617 . . . . 74.24 109.335 173.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 365' ' ' THR . 35.1 ttpt -125.64 126.66 45.06 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.451 -0.574 . . . . 75.14 109.451 -176.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.425 HG23 HG22 ' A' ' 382' ' ' VAL . 6.7 p -123.08 115.9 47.05 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 N-CA-C 109.387 -0.597 . . . . 74.5 109.387 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.58 116.15 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 N-CA-C 106.755 -1.572 . . . . 71.32 106.755 174.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -63.14 126.46 27.45 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 113.086 0.773 . . . . 63.33 113.086 -172.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 72.66 6.78 5.47 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.494 1.517 . . . . 71.44 113.068 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -115.89 -83.67 0.63 Allowed 'General case' 0 C--O 1.248 0.98 0 N-CA-C 112.494 0.553 . . . . 71.12 112.494 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.527 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -165.81 159.48 16.1 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.026 0.751 . . . . 73.14 113.026 -172.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.425 HG22 HG23 ' A' ' 376' ' ' VAL . 96.5 t -113.83 145.83 19.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 124.381 1.072 . . . . 74.21 109.51 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.527 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 75.5 m-85 -133.87 144.17 48.74 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 123.322 0.649 . . . . 61.03 111.191 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.467 ' HB2' HD23 ' A' ' 389' ' ' LEU . 35.3 tt0 -111.65 103.5 11.8 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.352 -1.722 . . . . 35.25 106.352 173.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.4 t70 72.03 -76.16 0.07 Allowed 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 124.938 1.295 . . . . 65.21 109.463 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 34.0 t -145.31 -6.52 0.64 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.349 -0.982 . . . . 42.11 108.349 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 65.4 mt -81.49 136.2 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 115.617 -0.72 . . . . 74.21 109.332 -177.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 60.2 tp -76.5 116.55 17.29 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.013 -0.736 . . . . 53.55 109.013 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.568 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.3 OUTLIER -81.33 -67.81 0.75 Allowed 'General case' 0 N--CA 1.386 -3.661 0 N-CA-C 108.207 -1.034 . . . . 61.34 108.207 -178.261 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.94 157.15 28.41 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 119.528 -1.32 . . . . 70.01 111.811 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.21 146.43 26.19 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.039 -1.097 . . . . 52.42 108.039 175.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.439 ' HD2' HE21 ' A' ' 395' ' ' GLN . 1.3 m-85 -71.25 115.97 11.03 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.475 -0.565 . . . . 71.33 109.475 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -93.16 -47.05 7.13 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.382 -0.372 . . . . 51.34 110.346 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 63.8 p -160.37 141.48 12.13 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.898 -0.778 . . . . 71.31 108.898 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.467 ' HB2' ' CD2' ' A' ' 400' ' ' LEU . 0.1 OUTLIER -147.03 141.35 26.31 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 116.343 -0.389 . . . . 63.4 110.926 -179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -128.99 120.32 25.84 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.947 -0.76 . . . . 72.43 108.947 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.33 -103.13 0.62 Allowed Glycine 0 N--CA 1.434 -1.493 0 O-C-N 123.746 0.654 . . . . 63.11 113.33 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 26.8 p-10 -113.7 6.18 16.74 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.01 0.374 . . . . 74.02 112.01 -176.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 28.1 t -116.43 116.93 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 107.932 -1.136 . . . . 74.24 107.932 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.467 ' CD2' ' HB2' ' A' ' 395' ' ' GLN . 11.7 mt -120.01 123.91 44.63 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 115.528 -0.76 . . . . 64.24 110.278 -171.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -103.77 124.0 48.09 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-O 121.032 0.444 . . . . 74.32 111.713 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.402 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 3.1 m-85 -116.21 136.32 53.12 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.933 -1.136 . . . . 64.04 107.933 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -146.29 175.58 10.41 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.846 0.355 . . . . 64.22 111.508 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.39 35.02 20.59 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 124.664 1.186 . . . . 65.1 112.681 172.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.84 -140.43 1.13 Allowed Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.072 -0.967 . . . . 72.13 111.903 176.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.51 139.39 43.79 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.96 -0.755 . . . . 55.43 108.96 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 26.3 t . . . . . 0 C--N 1.321 -0.642 0 CA-C-O 122.026 0.917 . . . . 71.22 112.969 -172.975 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 . . . . . 0 CA--C 1.493 -1.234 0 N-CA-C 105.126 -2.175 . . . . 53.13 105.126 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 437' ' ' CYS . 83.5 mtt180 -75.22 154.6 37.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 119.478 -0.889 . . . . 72.22 110.61 169.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 21.3 p -163.39 162.2 24.79 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 114.801 -1.091 . . . . 64.23 108.831 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.54 151.72 19.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 120.824 0.345 . . . . 75.32 110.818 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.9 tt -113.31 127.74 70.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 108.987 -0.746 . . . . 71.51 108.987 172.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 4.6 t -111.4 128.65 67.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 CA-C-N 115.951 -0.568 . . . . 74.24 110.835 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.26 115.4 27.36 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 105.908 -1.886 . . . . 62.11 105.908 177.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 37.6 t -100.54 127.6 53.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 109.137 -0.69 . . . . 73.4 109.137 -175.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -117.52 -175.09 2.74 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 120.039 -0.665 . . . . 72.44 110.497 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.461 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 33.3 t -62.34 128.03 34.12 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 122.964 0.506 . . . . 72.41 110.876 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -154.08 -178.86 28.93 Favored Glycine 0 CA--C 1.492 -1.351 0 C-N-CA 120.519 -0.848 . . . . 73.43 111.591 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.4 t -85.78 -38.77 13.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 108.81 -0.811 . . . . 72.41 108.81 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -149.65 150.17 31.75 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.359 -0.837 . . . . 71.55 109.629 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.603 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.6 p-10 -51.04 100.73 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.321 -1.309 . . . . 55.53 111.089 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -131.83 144.65 51.06 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 116.268 -0.424 . . . . 72.54 110.444 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.458 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 26.8 mm -84.13 116.87 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 105.885 -1.894 . . . . 74.23 105.885 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 442' ' ' LYS . 56.0 t -82.23 -50.57 16.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 CA-C-O 120.919 0.39 . . . . 73.53 111.986 -175.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 48.7 m -161.68 162.55 29.89 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.104 -0.702 . . . . 73.13 109.104 -174.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.468 HG12 HG21 ' A' ' 369' ' ' ILE . 3.4 p -141.32 111.13 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 N-CA-C 108.754 -0.832 . . . . 62.04 108.754 176.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . 0.479 ' O ' HD23 ' A' ' 440' ' ' LEU . 28.8 tp -112.63 137.72 50.48 Favored 'General case' 0 N--CA 1.401 -2.885 0 N-CA-C 107.679 -1.23 . . . . 72.15 107.679 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . 0.455 ' CD ' ' HA ' ' A' ' 436' ' ' LYS . 39.2 tt0 -80.79 114.3 19.58 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 108.724 -0.843 . . . . 73.42 108.724 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -73.07 -40.18 65.27 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 115.367 -0.833 . . . . 71.11 110.496 -175.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -133.06 -77.93 0.49 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.165 -0.925 . . . . 73.45 108.752 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . 0.467 ' NZ ' ' HB3' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -167.35 -39.8 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 124.029 0.932 . . . . 61.13 110.513 173.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 414' ' ' ARG . 62.8 m -100.69 -5.03 27.11 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.697 0.761 . . . . 73.02 109.586 177.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.626 ' HA ' ' O ' ' A' ' 415' ' ' SER . 38.3 tt0 -127.04 137.63 53.09 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.207 -0.906 . . . . 74.1 109.339 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -129.02 150.52 50.39 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.819 -0.628 . . . . 75.42 110.487 -174.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.8 pt? -109.39 115.57 30.21 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.55 -0.908 . . . . 73.04 108.55 173.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.5 mt -115.25 126.45 72.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.408 -0.814 . . . . 61.13 109.699 -175.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.48 ' O ' ' HB ' ' A' ' 429' ' ' VAL . 38.3 ttpt -103.32 141.48 35.85 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.504 -0.925 . . . . 75.31 108.504 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.458 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.8 mtp -136.32 168.91 18.54 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 109.663 -0.495 . . . . 50.43 109.663 -176.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.8 mmtt -131.77 158.61 40.76 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.123 -1.066 . . . . 73.31 108.123 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 47.2 t -172.92 146.66 1.45 Allowed Pre-proline 0 C--N 1.287 -2.121 0 O-C-N 124.248 0.968 . . . . 71.32 108.774 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -64.49 -23.47 64.59 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.125 1.883 . . . . 63.14 110.64 176.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -68.25 -26.94 65.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.416 -0.811 . . . . 72.23 111.081 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.896 0 CA-C-O 121.365 0.603 . . . . 62.1 109.771 179.759 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.495 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 86.6 m . . . . . 0 N--CA 1.426 -1.64 0 N-CA-C 107.509 -1.293 . . . . 64.31 107.509 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 13.8 ptmm? -141.41 140.73 33.71 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 120.798 -0.361 . . . . 73.12 111.758 -175.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -159.81 138.59 10.7 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.356 -0.979 . . . . 74.45 108.356 -173.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -81.24 123.49 28.52 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 110.075 -0.342 . . . . 75.2 110.075 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.457 HG21 HG12 ' A' ' 431' ' ' VAL . 58.3 mt -128.58 115.9 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 106.956 -1.498 . . . . 73.42 106.956 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.76 12.67 59.94 Favored Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.598 -0.811 . . . . 64.05 112.332 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 111.04 -26.15 12.88 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 121.265 -0.493 . . . . 50.14 112.701 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -98.08 136.36 38.43 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 120.756 -0.377 . . . . 73.52 110.89 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 70.1 m -79.17 119.99 23.04 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 116.039 -0.528 . . . . 55.23 110.228 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -91.02 133.18 35.51 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.577 -0.897 . . . . 75.0 108.577 172.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.457 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 35.0 ttpt -133.19 125.73 30.07 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.087 -0.645 . . . . 62.13 109.706 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.495 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.9 p -120.58 116.4 49.97 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 N-CA-C 109.816 -0.438 . . . . 74.34 109.816 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 26.9 t -107.41 116.09 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 106.988 -1.486 . . . . 63.02 106.988 174.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.452 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 95.7 m-85 -61.74 130.51 46.12 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 113.697 0.999 . . . . 72.34 113.697 -172.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 67.17 14.38 9.75 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.52 1.128 . . . . 73.12 112.884 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -125.34 -82.52 0.63 Allowed 'General case' 0 C--O 1.242 0.696 0 N-CA-C 113.418 0.896 . . . . 73.24 113.418 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.418 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -168.32 155.2 7.62 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.946 0.721 . . . . 73.5 112.946 -174.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.482 HG22 HG23 ' A' ' 376' ' ' VAL . 71.4 t -113.78 146.49 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.044 0.938 . . . . 71.13 109.582 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.418 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 84.3 m-85 -135.08 149.27 50.04 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.399 0.679 . . . . 73.11 111.345 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.524 ' HB2' HD23 ' A' ' 389' ' ' LEU . 32.6 tt0 -123.96 104.81 9.13 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.186 -1.783 . . . . 73.02 106.186 172.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.1 t70 69.17 -87.66 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.933 0.893 . . . . 73.52 110.923 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 18.8 m -133.04 0.32 3.44 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.204 -1.036 . . . . 44.12 108.204 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 45.9 mm -92.19 133.27 34.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.047 -0.979 . . . . 73.53 110.457 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 63.1 tp -75.99 114.73 14.96 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.247 -1.39 . . . . 61.53 107.247 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.5 OUTLIER -78.75 -63.3 1.44 Allowed 'General case' 0 N--CA 1.386 -3.629 0 N-CA-C 108.9 -0.778 . . . . 52.32 108.9 -175.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.0 158.56 29.86 Favored Glycine 0 N--CA 1.423 -2.231 0 C-N-CA 119.258 -1.448 . . . . 73.22 112.281 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -104.08 143.31 33.07 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.305 -0.998 . . . . 74.04 108.305 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.452 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.8 m-85 -68.72 116.5 9.3 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 123.506 0.504 . . . . 72.44 110.668 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.69 -47.35 5.36 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.023 -0.535 . . . . 70.0 110.958 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 48.2 t -159.0 148.19 18.66 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.147 -0.686 . . . . 42.25 109.147 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.421 HE21 ' HD2' ' A' ' 392' ' ' PHE . 18.3 mp0 -123.28 145.75 48.44 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.27 -1.011 . . . . 70.0 108.27 174.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -126.62 109.08 11.71 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.899 -1.148 . . . . 51.23 107.899 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 58.66 -101.37 0.21 Allowed Glycine 0 C--O 1.253 1.301 0 CA-C-O 121.423 0.457 . . . . 72.11 113.193 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -116.07 17.12 15.94 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 124.249 1.02 . . . . 73.04 109.558 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . 0.51 HG13 HD11 ' A' ' 417' ' ' ILE . 60.0 t -121.05 133.45 67.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.197 -1.038 . . . . 74.5 108.197 -177.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 399' ' ' VAL . 3.5 mp -130.33 134.34 47.11 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.513 -0.475 . . . . 74.35 111.53 -176.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -108.26 122.17 46.39 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 123.101 0.56 . . . . 72.11 112.003 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.434 ' CD2' HG21 ' A' ' 382' ' ' VAL . 3.0 m-85 -118.38 129.32 55.35 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.719 -1.215 . . . . 71.44 107.719 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -147.11 175.29 10.82 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 111.637 0.236 . . . . 74.4 111.637 -177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.7 m120 60.07 39.19 20.01 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.738 0.649 . . . . 62.12 111.618 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -80.65 -137.46 1.93 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.737 -0.745 . . . . 72.24 112.069 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -67.37 148.74 51.23 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.744 -0.465 . . . . 71.03 109.744 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 30.4 m . . . . . 0 C--N 1.314 -0.947 0 CA-C-O 121.208 0.527 . . . . 55.41 109.798 178.665 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 108.192 -1.04 . . . . 72.31 108.192 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -82.72 160.76 22.29 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.143 0.497 . . . . 74.54 111.506 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 22.7 p -165.27 160.54 18.47 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-N 114.645 -1.162 . . . . 63.42 109.145 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -157.33 147.87 21.18 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.161 0.505 . . . . 62.03 110.705 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . 0.51 HD11 HG13 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -112.25 114.44 47.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.977 -1.12 . . . . 74.52 107.977 174.028 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.552 HG22 ' HB ' ' A' ' 441' ' ' ILE . 5.0 t -97.91 128.81 48.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-O 121.337 0.589 . . . . 71.54 110.327 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 1.4 m -113.66 114.43 26.39 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 106.372 -1.714 . . . . 72.4 106.372 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 39.1 t -100.78 118.31 47.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.618 -0.882 . . . . 73.42 108.618 -175.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -109.1 -174.88 2.62 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 120.748 0.308 . . . . 54.13 110.393 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 42.0 t -60.5 129.24 40.59 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 123.917 0.887 . . . . 71.23 111.5 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.58 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -158.86 -177.56 32.05 Favored Glycine 0 CA--C 1.491 -1.422 0 N-CA-C 110.641 -0.984 . . . . 72.01 110.641 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.07 -33.52 5.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.578 0.704 . . . . 74.33 109.125 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 426' ' ' ASN . 36.6 tt0 -149.06 162.1 40.62 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.545 -0.752 . . . . 72.1 109.074 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 19.7 m120 -67.62 107.93 2.71 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 114.632 -1.167 . . . . 63.34 110.37 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -131.57 148.48 52.62 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 114.934 -1.03 . . . . 73.11 109.54 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 29.4 mm -91.45 115.06 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 106.089 -1.819 . . . . 75.25 106.089 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 53.9 t -81.12 -48.83 18.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 111.995 0.368 . . . . 53.41 111.995 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 46.9 p -166.64 163.67 16.8 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 109.565 -0.531 . . . . 74.22 109.565 -174.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.457 HG12 HG21 ' A' ' 369' ' ' ILE . 3.2 p -141.36 111.41 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 N-CA-C 108.403 -0.962 . . . . 74.42 108.403 177.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . 0.451 ' HB3' ' HG ' ' A' ' 440' ' ' LEU . 24.4 tp -110.44 136.51 49.48 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 114.892 -1.049 . . . . 70.34 108.408 -175.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -80.86 110.74 16.67 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.465 -1.309 . . . . 75.24 107.465 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -72.66 -42.31 64.47 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.473 -0.785 . . . . 74.32 110.222 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -132.38 -78.03 0.5 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.474 -0.936 . . . . 64.42 108.474 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.22 -50.28 0.07 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.137 0.494 . . . . 70.53 111.0 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 63.4 m -100.9 4.39 42.62 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.817 0.817 . . . . 55.43 109.822 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 415' ' ' SER . 35.9 tt0 -129.45 130.97 46.59 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.904 -1.044 . . . . 64.3 108.948 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 41.1 m-85 -123.51 150.83 43.46 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.209 -0.905 . . . . 74.53 110.075 -174.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.451 ' HG ' ' HB3' ' A' ' 432' ' ' LEU . 4.1 pp -111.08 124.46 52.23 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 106.992 -1.485 . . . . 73.31 106.992 173.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.552 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.7 mt -120.27 135.63 59.91 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 115.753 -0.658 . . . . 51.32 109.813 -175.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -105.7 140.25 39.04 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.235 -1.024 . . . . 74.13 108.235 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.407 ' SD ' HG11 ' A' ' 376' ' ' VAL . 82.7 mtp -140.08 168.7 19.2 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 109.02 -0.733 . . . . 64.52 109.02 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.58 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 71.9 mmtt -132.24 160.28 36.62 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.999 -0.741 . . . . 71.22 108.999 177.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 32.2 t -172.22 148.55 2.0 Allowed Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 124.138 0.899 . . . . 75.01 108.832 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.82 -27.26 51.75 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.197 1.931 . . . . 74.22 111.027 177.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -74.74 -15.79 60.76 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.281 -0.872 . . . . 70.31 111.12 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.107 0 CA-C-O 121.268 0.556 . . . . 64.41 110.08 -179.812 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 97.7 m . . . . . 0 N--CA 1.428 -1.571 0 N-CA-C 108.358 -0.978 . . . . 73.41 108.358 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 10.4 ptpp? -138.48 154.63 48.82 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 110.343 -0.243 . . . . 73.1 110.343 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -164.7 135.34 4.05 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.591 -1.263 . . . . 75.14 107.591 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -84.67 125.31 32.39 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.599 -0.519 . . . . 75.55 109.599 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.518 HG21 HG12 ' A' ' 431' ' ' VAL . 49.4 mt -130.59 116.29 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 107.236 -1.394 . . . . 65.34 107.236 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 67.28 11.71 59.59 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.823 -0.703 . . . . 51.42 112.521 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 111.94 -25.75 12.5 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.806 -0.711 . . . . 74.31 112.575 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -97.84 136.09 38.65 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 120.218 -0.593 . . . . 74.35 110.8 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 92.2 m -79.19 118.48 21.18 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 115.713 -0.676 . . . . 64.14 110.742 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -90.12 133.34 34.93 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 108.234 -1.024 . . . . 60.21 108.234 173.364 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -132.06 125.71 32.07 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.349 -0.541 . . . . 74.11 110.022 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.422 HG23 HG22 ' A' ' 382' ' ' VAL . 7.0 p -119.51 118.08 56.11 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 CA-C-N 116.031 -0.531 . . . . 71.42 109.861 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.4 t -109.25 116.14 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 106.658 -1.608 . . . . 63.04 106.658 173.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.428 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 83.5 m-85 -63.11 130.88 46.54 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.15 -0.932 . . . . 75.34 113.107 -171.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 71.82 6.79 5.74 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.894 1.278 . . . . 70.2 112.314 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -119.42 -84.81 0.66 Allowed 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 116.021 -0.536 . . . . 73.41 112.19 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.511 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.3 OUTLIER -168.37 158.99 10.2 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 112.611 0.597 . . . . 44.25 112.611 -174.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 402' ' ' TYR . 94.6 t -116.29 146.58 20.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 123.858 0.863 . . . . 73.43 109.928 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.511 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 81.1 m-85 -133.06 151.3 52.04 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.662 0.785 . . . . 71.4 111.088 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.521 ' HB2' HD23 ' A' ' 389' ' ' LEU . 30.4 tt0 -126.46 109.66 12.44 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.584 -1.636 . . . . 65.34 106.584 173.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 25.0 t70 70.49 -80.66 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 124.051 0.94 . . . . 63.43 110.528 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 28.4 p -145.37 1.12 0.93 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.176 -0.92 . . . . 63.33 109.27 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 48.2 mm -91.37 137.63 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.003 -0.999 . . . . 72.2 109.558 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.534 HD21 HD21 ' A' ' 391' ' ' ASN . 57.1 tp -76.63 115.94 16.86 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.236 -1.024 . . . . 61.03 108.236 176.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.539 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.4 OUTLIER -79.07 -64.32 1.21 Allowed 'General case' 0 N--CA 1.392 -3.354 0 N-CA-C 109.025 -0.731 . . . . 63.03 109.025 -177.252 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.44 160.63 31.52 Favored Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 118.796 -1.668 . . . . 40.14 111.744 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.534 HD21 HD21 ' A' ' 388' ' ' LEU . 8.7 m120 -99.53 147.48 25.27 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.237 -1.764 . . . . 72.12 106.237 177.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 2.6 m-85 -69.24 116.42 9.66 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.061 -0.656 . . . . 45.43 110.86 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -93.78 -48.1 6.46 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.675 -0.693 . . . . 70.41 110.134 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 46.8 m -154.23 142.45 20.43 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 110.303 -0.258 . . . . 65.3 110.303 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -122.2 130.99 53.71 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 106.593 -1.632 . . . . 72.21 106.593 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -128.67 109.81 11.66 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.922 -0.77 . . . . 75.02 108.922 176.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.19 -101.18 0.58 Allowed Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.988 -0.625 . . . . 34.4 111.948 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -122.48 18.95 10.5 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.269 0.557 . . . . 72.34 109.575 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.01 126.43 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 N-CA-C 107.792 -1.188 . . . . 74.1 107.792 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 22.7 mt -123.82 123.66 40.95 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 110.001 -0.37 . . . . 72.43 110.001 -172.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -106.88 125.1 50.57 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.201 -0.296 . . . . 63.04 110.201 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.485 ' CE2' HG21 ' A' ' 382' ' ' VAL . 2.4 m-85 -118.49 135.54 54.33 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.52 -0.918 . . . . 65.25 108.52 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -146.27 175.85 10.2 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 123.41 0.684 . . . . 75.31 109.771 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 14.7 m120 66.17 27.54 10.36 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.287 0.847 . . . . 62.13 113.287 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -72.6 -139.48 0.32 Allowed Glycine 0 CA--C 1.54 1.619 0 C-N-CA 121.302 -0.475 . . . . 75.4 113.764 176.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.02 144.68 38.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.309 -1.367 . . . . 75.52 107.309 -177.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 C--N 1.305 -1.335 0 CA-C-O 121.669 0.747 . . . . 74.54 111.141 -177.341 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 . . . . . 0 CA--C 1.501 -0.917 0 N-CA-C 106.678 -1.601 . . . . 64.54 106.678 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -64.99 157.15 29.05 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-O 121.677 0.751 . . . . 73.4 111.859 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 40.1 p -159.67 163.66 34.66 Favored 'General case' 0 N--CA 1.403 -2.789 0 CA-C-N 114.305 -1.316 . . . . 71.12 109.063 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.38 151.48 19.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 109.971 -0.381 . . . . 73.41 109.971 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 14.9 tt -117.67 120.98 66.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 108.663 -0.865 . . . . 72.23 108.663 173.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.491 HG22 ' HB ' ' A' ' 441' ' ' ILE . 4.1 t -104.01 123.65 57.89 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 CA-C-N 115.163 -0.926 . . . . 62.43 110.127 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 2.3 m -108.57 114.08 27.62 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 105.525 -2.028 . . . . 75.5 105.525 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.37 116.7 44.32 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.383 0 N-CA-C 108.154 -1.054 . . . . 75.31 108.154 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -110.94 -173.86 2.34 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 120.961 0.41 . . . . 75.04 111.736 -176.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.487 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 39.8 t -64.1 128.67 36.83 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.635 0.774 . . . . 72.1 111.386 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -161.1 -177.5 34.26 Favored Glycine 0 CA--C 1.492 -1.37 0 N-CA-C 109.508 -1.437 . . . . 52.11 109.508 177.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 56.2 t -96.17 -23.42 4.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.539 0.685 . . . . 62.13 109.441 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -142.67 154.44 44.34 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.906 -0.588 . . . . 71.03 110.363 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 72.0 m-20 -71.69 99.3 2.09 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.777 -1.194 . . . . 75.25 107.777 175.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -132.01 148.55 52.51 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 120.999 -0.28 . . . . 52.23 110.398 -177.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.478 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 26.7 mm -85.89 127.49 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.49 -1.67 . . . . 73.42 106.49 176.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 62.6 t -91.54 -51.03 12.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 112.356 0.502 . . . . 73.42 112.356 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 50.5 m -163.23 161.64 24.97 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.507 -0.553 . . . . 53.04 109.507 -174.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.518 HG12 HG21 ' A' ' 369' ' ' ILE . 3.1 p -141.4 116.8 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 123.867 0.729 . . . . 73.24 109.468 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 25.0 tp -123.87 137.34 54.66 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.214 -1.032 . . . . 74.14 108.214 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -84.21 128.41 34.55 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.714 -0.847 . . . . 64.12 108.714 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -89.22 -48.19 7.55 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.11 1.152 . . . . 65.13 114.11 -176.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -122.79 -68.21 0.9 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.191 0.519 . . . . 74.22 111.642 -172.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . 0.482 ' NZ ' ' HB3' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -166.03 -27.28 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 124.031 0.932 . . . . 73.14 109.535 175.096 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 98.3 m -135.78 21.91 3.32 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.718 -0.674 . . . . 75.31 110.934 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.4 tt0 -135.29 119.61 17.86 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.289 0.566 . . . . 75.24 110.564 -176.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -109.44 134.42 51.88 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 115.623 -0.717 . . . . 74.03 110.719 -174.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.0 OUTLIER -96.66 116.65 29.47 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.203 -1.036 . . . . 71.2 108.203 173.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.491 ' HB ' HG22 ' A' ' 418' ' ' VAL . 97.6 mt -118.35 135.1 59.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 115.043 -0.98 . . . . 65.54 110.309 -175.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -105.44 140.93 37.81 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.419 -0.956 . . . . 64.42 108.419 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.478 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.2 mtp -137.78 168.7 19.15 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 108.784 -0.821 . . . . 53.13 108.784 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 73.0 mmtt -131.76 161.24 33.32 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.354 -0.98 . . . . 64.1 108.354 176.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 48.5 t -164.82 146.07 6.45 Favored Pre-proline 0 C--N 1.284 -2.276 0 O-C-N 124.235 0.96 . . . . 73.21 109.025 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 30.4 Cg_endo -65.6 -27.22 53.48 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.159 1.906 . . . . 73.43 110.676 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.34 -19.96 38.26 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.516 -0.766 . . . . 63.21 110.782 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -1.002 0 CA-C-O 121.969 0.89 . . . . 74.42 110.415 -177.587 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.495 ' HB ' HG13 ' A' ' 376' ' ' VAL . 86.4 m . . . . . 0 N--CA 1.437 -1.077 0 N-CA-C 109.46 -0.571 . . . . 62.13 109.46 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 0.0 OUTLIER -145.17 151.62 38.72 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.614 -0.435 . . . . 72.51 111.572 178.021 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -162.56 134.33 5.29 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.31 -1.367 . . . . 74.05 107.31 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 45.7 mt-10 -87.79 127.99 35.32 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 110.113 -0.329 . . . . 71.32 110.113 -175.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.487 HG21 HG12 ' A' ' 431' ' ' VAL . 42.5 mt -134.46 122.64 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 106.642 -1.614 . . . . 74.42 106.642 -175.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.54 9.88 52.15 Favored Glycine 0 C--N 1.306 -1.123 0 C-N-CA 120.894 -0.669 . . . . 65.41 113.194 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 111.97 -23.57 16.49 Favored Glycine 0 N--CA 1.427 -1.94 0 C-N-CA 120.82 -0.705 . . . . 70.32 112.803 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . 0.419 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 17.0 p90 -100.98 144.61 29.71 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.625 0.25 . . . . 74.14 110.809 -177.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 87.3 m -82.47 119.39 24.15 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.817 -0.438 . . . . 75.24 109.817 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.37 125.28 35.49 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 108.451 -0.944 . . . . 60.12 108.451 172.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -126.6 130.9 51.4 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.453 -0.573 . . . . 75.11 109.453 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.512 HG23 HG22 ' A' ' 382' ' ' VAL . 6.6 p -128.07 119.29 50.69 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.928 0 CA-C-O 121.254 0.55 . . . . 75.34 110.246 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 57.9 t -108.14 116.39 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.917 0 N-CA-C 106.825 -1.546 . . . . 74.03 106.825 175.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -62.85 132.48 52.3 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.066 1.135 . . . . 74.25 114.066 -173.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 66.96 17.91 10.55 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.03 -1.441 . . . . 62.42 112.076 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -128.79 -82.75 0.58 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.309 -0.86 . . . . 54.52 113.001 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.454 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -165.55 155.93 13.29 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 113.274 0.842 . . . . 65.1 113.274 -172.358 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.512 HG22 HG23 ' A' ' 376' ' ' VAL . 88.4 t -113.78 145.28 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.388 1.075 . . . . 54.04 109.252 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.454 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 85.6 m-85 -134.81 147.61 49.99 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 123.125 0.57 . . . . 75.22 111.532 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.528 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.2 tt0 -119.39 104.71 10.6 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.151 -1.796 . . . . 73.11 106.151 173.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.4 t70 72.12 -82.96 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.725 0.81 . . . . 63.22 110.286 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 32.1 p -143.84 3.04 1.23 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.852 -1.067 . . . . 71.42 108.574 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 62.1 mt -89.21 133.91 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.967 -1.015 . . . . 71.24 109.378 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 61.2 tp -77.43 115.45 17.21 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.536 -0.913 . . . . 61.41 108.536 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.574 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -80.31 -64.54 1.17 Allowed 'General case' 0 N--CA 1.394 -3.249 0 N-CA-C 108.994 -0.743 . . . . 51.55 108.994 -177.086 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.9 158.57 30.16 Favored Glycine 0 N--CA 1.415 -2.739 0 C-N-CA 119.874 -1.155 . . . . 54.43 111.519 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -103.12 153.14 20.62 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.157 -1.423 . . . . 65.31 107.157 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.488 ' HB3' HE22 ' A' ' 395' ' ' GLN . 1.7 m-85 -73.7 116.13 13.93 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 120.926 0.393 . . . . 71.34 111.306 -175.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.88 -48.12 5.03 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.608 -0.724 . . . . 71.24 110.852 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 51.1 m -157.15 137.75 13.12 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.024 0.44 . . . . 64.22 109.961 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.56 ' CB ' ' HG ' ' A' ' 400' ' ' LEU . 4.8 pm0 -141.17 125.69 17.74 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 115.824 -0.626 . . . . 72.13 110.371 177.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -128.22 132.18 48.8 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.383 -0.969 . . . . 63.25 108.383 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 69.53 -103.53 1.12 Allowed Glycine 0 N--CA 1.422 -2.292 0 N-CA-C 111.057 -0.817 . . . . 73.52 111.057 -177.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -138.77 18.5 2.67 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.789 0.804 . . . . 73.42 110.297 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 63.9 t -117.1 119.78 63.02 Favored 'Isoleucine or valine' 0 C--O 1.244 0.816 0 N-CA-C 108.174 -1.047 . . . . 61.3 108.174 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.56 ' HG ' ' CB ' ' A' ' 395' ' ' GLN . 4.0 mp -113.02 135.54 53.67 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.964 -0.562 . . . . 73.24 110.971 -173.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -115.47 125.16 52.74 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.524 -0.917 . . . . 71.21 108.524 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -115.75 141.55 47.94 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.399 -0.963 . . . . 74.4 108.399 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -146.12 176.46 9.71 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.624 0.77 . . . . 71.54 109.096 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 18.7 m120 65.51 36.05 6.87 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.274 0.629 . . . . 65.34 112.677 173.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -81.01 -137.67 2.11 Favored Glycine 0 C--N 1.305 -1.177 0 C-N-CA 120.562 -0.828 . . . . 55.5 112.681 177.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.73 149.18 36.37 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 106.527 -1.657 . . . . 55.13 106.527 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 46.0 m . . . . . 0 C--N 1.301 -1.525 0 N-CA-C 113.655 0.983 . . . . 61.15 113.655 -173.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' HIS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 90.2 m-70 . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 108.3 -1.0 . . . . 75.15 108.3 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -77.4 164.9 25.06 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 121.043 0.449 . . . . 64.55 110.521 173.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 57.6 p -159.42 166.78 30.3 Favored 'General case' 0 N--CA 1.403 -2.818 0 CA-C-N 115.036 -0.984 . . . . 62.43 109.347 -177.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -157.55 151.8 24.74 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 109.85 -0.426 . . . . 54.23 109.85 -178.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 11.0 tt -122.18 123.14 68.22 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 CA-C-N 115.699 -0.682 . . . . 62.2 109.444 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 441' ' ' ILE . 4.3 t -113.73 130.68 67.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 115.818 -0.628 . . . . 62.12 111.447 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 17.7 p -108.75 114.19 27.77 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 108.357 -0.979 . . . . 73.5 108.357 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 45.1 t -100.83 115.39 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 107.549 -1.278 . . . . 74.51 107.549 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -117.35 -174.68 2.65 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 121.014 -0.274 . . . . 72.51 110.471 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 38.1 t -61.37 128.71 37.65 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 122.976 0.51 . . . . 64.32 110.749 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.647 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -163.12 -177.66 36.27 Favored Glycine 0 CA--C 1.495 -1.158 0 C-N-CA 120.701 -0.761 . . . . 24.04 111.498 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.9 t -81.94 -38.91 16.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.403 0.621 . . . . 74.13 110.445 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -155.92 162.03 40.45 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.12 -0.696 . . . . 75.23 109.12 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 16.7 m120 -63.17 102.88 0.42 Allowed 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.594 1.184 . . . . 71.42 109.024 177.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -133.09 139.24 47.03 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.491 -1.3 . . . . 62.52 107.491 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 30.6 mm -89.06 110.61 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 N-CA-C 106.75 -1.574 . . . . 52.44 106.75 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 57.2 t -80.76 -44.78 21.5 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.688 0 CA-C-N 115.755 -0.657 . . . . 54.41 112.464 -173.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 35.3 p -162.26 158.4 24.25 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 120.494 -0.483 . . . . 50.33 110.727 -176.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.487 HG12 HG21 ' A' ' 369' ' ' ILE . 4.2 p -141.56 115.42 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 N-CA-C 108.547 -0.908 . . . . 73.34 108.547 175.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 29.0 tp -120.57 135.79 54.99 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.029 -1.471 . . . . 63.45 107.029 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -87.98 123.52 32.78 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.431 -1.322 . . . . 75.5 107.431 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -82.19 -46.81 13.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.856 1.058 . . . . 74.35 113.856 -174.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -121.38 -74.36 0.62 Allowed 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.438 0.637 . . . . 63.14 110.839 -172.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . 0.412 ' NZ ' ' HB3' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -175.55 -10.12 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 126.114 1.766 . . . . 63.21 109.373 176.465 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 24.7 m -136.62 5.17 2.89 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 109.528 -0.545 . . . . 74.12 109.528 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 415' ' ' SER . 31.3 tt0 -136.22 126.02 25.68 Favored 'General case' 0 C--O 1.211 -0.972 0 CA-C-O 120.837 0.351 . . . . 72.42 111.55 -173.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 28.4 m-85 -113.7 141.15 47.6 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 116.055 -0.521 . . . . 70.11 110.719 -175.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.436 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.2 pt? -106.29 119.42 39.21 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.373 -0.973 . . . . 74.42 108.373 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.486 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.8 mt -119.45 135.4 59.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.366 -0.834 . . . . 72.21 111.255 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -99.7 139.3 35.57 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 109.489 -0.56 . . . . 70.51 109.489 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 81.5 mtp -141.82 164.68 29.53 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 109.858 -0.423 . . . . 75.12 109.858 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.647 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 71.7 mmtt -134.78 161.35 35.44 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.961 -1.126 . . . . 64.1 107.961 176.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 31.9 t -167.2 145.88 4.29 Favored Pre-proline 0 C--N 1.289 -2.043 0 O-C-N 123.97 0.794 . . . . 62.44 109.277 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.31 -24.68 43.24 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.245 1.963 . . . . 74.54 110.862 177.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.33 -19.59 59.53 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.222 -0.899 . . . . 64.54 110.658 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.244 0 CA-C-O 121.554 0.692 . . . . 70.1 109.458 -178.152 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.406 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 93.5 m . . . . . 0 N--CA 1.435 -1.215 0 N-CA-C 108.823 -0.806 . . . . 71.14 108.823 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 10.4 ptpp? -144.23 141.05 29.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 116.444 -0.344 . . . . 74.23 110.858 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -159.02 135.82 9.51 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.033 -0.729 . . . . 73.44 109.033 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.17 129.98 35.06 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.31 -0.405 . . . . 75.04 110.582 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.553 HG21 HG12 ' A' ' 431' ' ' VAL . 33.3 mt -137.95 128.11 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 106.643 -1.614 . . . . 73.52 106.643 -175.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.58 14.45 49.95 Favored Glycine 0 C--N 1.302 -1.319 0 C-N-CA 120.34 -0.933 . . . . 71.2 113.171 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 99.57 -9.88 60.78 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.749 -0.739 . . . . 75.44 113.537 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . 0.403 ' CD1' ' HG3' ' A' ' 384' ' ' GLN . 9.0 p90 -111.29 144.07 41.05 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 122.438 -0.448 . . . . 70.02 110.571 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 38.2 m -82.16 120.5 25.41 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 110.173 -0.306 . . . . 54.24 110.173 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.4 OUTLIER -91.29 135.89 33.49 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 109.278 -0.638 . . . . 72.12 109.278 173.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -131.93 127.48 36.47 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 123.547 0.529 . . . . 72.11 109.952 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.452 HG23 HG22 ' A' ' 382' ' ' VAL . 7.4 p -127.08 120.57 55.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 120.879 0.371 . . . . 60.22 110.522 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.7 t -115.17 116.96 54.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 N-CA-C 106.837 -1.542 . . . . 73.45 106.837 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . 0.463 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 28.4 m-85 -65.32 128.49 36.07 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 114.757 1.392 . . . . 55.42 114.757 -171.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 68.28 22.38 8.1 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 113.84 -1.527 . . . . 64.01 112.288 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -132.36 -79.8 0.5 Allowed 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.438 -0.801 . . . . 73.3 113.098 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.46 154.72 12.3 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.419 0.896 . . . . 61.31 113.419 -172.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.463 HG21 ' CD2' ' A' ' 402' ' ' TYR . 98.9 t -119.25 145.3 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.166 0.986 . . . . 64.42 109.024 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -134.26 145.59 49.27 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.965 0.412 . . . . 72.32 111.889 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.514 ' HB2' HD23 ' A' ' 389' ' ' LEU . 33.4 tt0 -116.84 108.26 15.62 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.419 -1.697 . . . . 61.34 106.419 172.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.2 t70 71.67 -79.65 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 124.302 1.041 . . . . 75.32 109.931 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.0 m -144.73 -4.02 0.77 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.563 -0.903 . . . . 74.41 108.563 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 50.1 mm -84.09 136.67 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.442 -0.799 . . . . 73.53 109.486 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.467 HD21 HD21 ' A' ' 391' ' ' ASN . 64.5 tp -76.2 110.73 10.94 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.799 -1.186 . . . . 73.11 107.799 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.6 OUTLIER -73.61 -63.1 1.27 Allowed 'General case' 0 N--CA 1.385 -3.682 0 N-CA-C 108.552 -0.907 . . . . 72.15 108.552 -176.271 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.94 158.7 29.99 Favored Glycine 0 N--CA 1.417 -2.585 0 C-N-CA 119.064 -1.541 . . . . 75.21 111.595 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.467 HD21 HD21 ' A' ' 388' ' ' LEU . 45.8 m-80 -106.64 142.21 36.65 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.106 -1.072 . . . . 73.32 108.106 177.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . 0.542 ' HD2' ' NE2' ' A' ' 395' ' ' GLN . 1.9 m-85 -65.99 115.96 6.61 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 123.465 0.478 . . . . 75.23 110.537 -176.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -105.65 -48.47 3.65 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.074 -0.512 . . . . 73.53 111.278 -176.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 56.6 m -155.07 139.87 17.16 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.677 -0.49 . . . . 70.55 109.677 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.542 ' NE2' ' HD2' ' A' ' 392' ' ' PHE . 42.7 mt-30 -134.41 136.46 43.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.242 -1.392 . . . . 75.1 107.242 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -128.78 110.76 12.45 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 109.474 -0.565 . . . . 71.21 109.474 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 70.81 -118.57 7.68 Favored Glycine 0 N--CA 1.424 -2.125 0 N-CA-C 110.665 -0.974 . . . . 70.21 110.665 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 4.2 p-10 -107.29 21.81 16.94 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.446 0.641 . . . . 74.15 110.188 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 40.1 t -124.48 116.91 48.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 107.79 -1.189 . . . . 53.23 107.79 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.451 ' CD2' ' HB3' ' A' ' 395' ' ' GLN . 11.2 mt -116.34 129.51 56.29 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.882 -0.599 . . . . 72.44 110.922 -169.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -105.03 122.02 45.0 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-O 121.06 0.457 . . . . 72.32 112.168 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.463 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.5 m-85 -117.1 119.17 34.44 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 105.807 -1.923 . . . . 72.11 105.807 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -135.73 173.84 11.27 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.31 -0.626 . . . . 72.43 109.31 -174.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 12.9 m120 61.04 37.48 17.93 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.965 0.791 . . . . 62.02 112.503 175.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.58 -141.82 1.24 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.185 -0.531 . . . . 72.03 112.676 176.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.82 137.58 51.93 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.435 -0.95 . . . . 73.44 108.435 -175.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 C--N 1.312 -1.028 0 C-N-CA 123.65 0.78 . . . . 70.15 112.427 -177.015 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 . . . . . 0 CA--C 1.493 -1.243 0 N-CA-C 106.484 -1.673 . . . . 72.44 106.484 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.05 153.32 41.8 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.352 0.596 . . . . 73.11 111.996 174.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.9 p -159.1 160.83 36.14 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 114.698 -1.137 . . . . 64.03 108.908 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -155.39 148.0 24.13 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 109.744 -0.465 . . . . 75.42 109.744 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.9 tt -110.94 118.52 57.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.536 -0.913 . . . . 60.31 108.536 174.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 2.9 t -97.77 125.42 50.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 CA-C-O 121.457 0.646 . . . . 74.32 109.884 177.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 2.5 m -108.43 112.23 24.53 Favored 'General case' 0 N--CA 1.385 -3.707 0 N-CA-C 104.577 -2.379 . . . . 64.12 104.577 174.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 7.9 p -102.0 121.15 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 108.655 -0.868 . . . . 71.33 108.655 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -114.94 -174.4 2.48 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 116.289 -0.414 . . . . 53.54 110.362 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.647 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 22.6 t -60.57 128.16 35.24 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 123.367 0.667 . . . . 64.12 112.572 -176.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.549 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -156.06 -177.75 29.56 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.606 -0.807 . . . . 63.3 111.452 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.4 t -91.76 -34.2 6.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.851 -0.796 . . . . 73.25 108.851 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -148.88 148.06 29.42 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 115.694 -0.685 . . . . 73.54 109.197 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.741 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.1 p-10 -62.36 99.64 0.15 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.991 -1.004 . . . . 64.15 111.536 176.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -131.81 149.07 52.57 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.338 -0.847 . . . . 75.24 110.156 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.441 HG21 HD11 ' A' ' 369' ' ' ILE . 28.2 mm -82.09 119.53 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.198 -1.408 . . . . 73.0 107.198 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . 0.428 HG11 ' HD2' ' A' ' 442' ' ' LYS . 66.0 t -83.69 -51.37 14.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 111.886 0.328 . . . . 74.03 111.886 -177.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 59.7 m -166.04 163.52 18.23 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.438 -0.579 . . . . 70.33 109.438 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.553 HG12 HG21 ' A' ' 369' ' ' ILE . 3.5 p -141.84 116.68 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 107.956 -1.127 . . . . 74.41 107.956 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 34.1 tp -112.16 133.13 54.48 Favored 'General case' 0 C--N 1.263 -3.156 0 N-CA-C 108.143 -1.058 . . . . 61.03 108.143 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -82.15 108.52 15.68 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.596 -1.261 . . . . 74.42 107.596 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -69.75 -53.26 19.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.865 0.841 . . . . 75.54 109.47 -177.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -120.1 -77.79 0.58 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.52 -1.218 . . . . 74.24 108.577 177.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . 0.479 ' NZ ' ' HB3' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -169.94 -47.36 0.02 OUTLIER 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 124.459 1.104 . . . . 74.41 110.383 174.258 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 82.0 m -91.99 5.3 50.67 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.723 0.773 . . . . 52.21 109.562 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -136.49 124.4 22.73 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.107 -0.951 . . . . 74.52 109.08 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 54.4 m-85 -122.56 151.22 41.61 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.016 -0.538 . . . . 75.04 110.118 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.47 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.6 pt? -110.53 124.95 52.78 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.299 -1.371 . . . . 62.1 107.299 170.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 98.4 mt -122.78 134.94 64.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 115.813 -0.63 . . . . 75.35 109.92 -175.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . 0.428 ' HD2' HG11 ' A' ' 429' ' ' VAL . 23.9 ttmm -106.84 140.81 39.08 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 108.776 -0.824 . . . . 60.22 108.776 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.402 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.7 mtp -138.02 164.14 29.81 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.032 -1.099 . . . . 63.24 108.032 177.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.741 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 34.2 mmtp -129.69 151.59 50.11 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 108.063 -1.088 . . . . 65.44 108.063 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 43.4 t -164.74 147.84 7.33 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.786 -0.82 . . . . 61.53 108.786 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.97 -27.22 66.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.072 1.848 . . . . 73.52 110.244 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -69.37 -22.26 63.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.232 -0.894 . . . . 61.43 110.876 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.933 0 CA-C-O 121.358 0.599 . . . . 72.35 109.944 -179.689 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . 0.43 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 92.0 m . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 109.253 -0.647 . . . . 62.2 109.253 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 19.6 ptmt -144.2 145.03 31.82 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 121.21 -0.196 . . . . 61.32 111.209 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -160.76 136.89 8.4 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.223 -1.029 . . . . 74.42 108.223 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.05 125.31 31.98 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 110.017 -0.364 . . . . 51.32 110.017 -178.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.488 HG21 HG12 ' A' ' 431' ' ' VAL . 57.3 mt -130.57 116.27 34.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 107.29 -1.374 . . . . 71.05 107.29 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.6 15.09 63.59 Favored Glycine 0 C--N 1.306 -1.107 0 C-N-CA 121.063 -0.589 . . . . 60.2 112.498 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 109.09 -25.72 17.58 Favored Glycine 0 N--CA 1.427 -1.931 0 C-N-CA 120.401 -0.904 . . . . 65.34 112.578 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -97.77 135.84 38.96 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.007 0.432 . . . . 70.14 111.286 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 85.1 m -79.19 118.5 21.2 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.856 -0.611 . . . . 41.43 110.747 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.595 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -90.66 132.47 35.76 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 108.378 -0.971 . . . . 75.54 108.378 173.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -132.07 127.32 35.87 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.278 -0.638 . . . . 71.23 109.278 -176.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.515 HG23 HG22 ' A' ' 382' ' ' VAL . 6.5 p -125.72 118.37 51.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-O 121.053 0.454 . . . . 75.24 110.16 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.2 t -106.66 116.9 51.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 107.031 -1.47 . . . . 63.42 107.031 174.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -63.65 129.04 38.52 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 114.011 1.115 . . . . 74.51 114.011 -172.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 72.7 13.52 5.19 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 126.166 1.786 . . . . 75.03 112.371 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -124.11 -83.3 0.65 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 113.088 0.773 . . . . 72.22 113.088 176.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -159.05 164.9 35.03 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 112.542 0.571 . . . . 75.53 112.542 -170.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.515 HG22 HG23 ' A' ' 376' ' ' VAL . 72.7 t -126.88 142.16 44.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.242 -0.89 . . . . 64.31 108.837 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -132.97 151.6 52.04 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 122.957 0.503 . . . . 75.02 111.311 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.496 ' HB2' HD23 ' A' ' 389' ' ' LEU . 30.6 tt0 -122.18 106.27 10.99 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 106.217 -1.771 . . . . 71.52 106.217 172.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.0 t70 70.76 -74.66 0.08 Allowed 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 124.87 1.268 . . . . 72.32 110.395 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 64.1 m -146.94 -7.2 0.49 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.75 -0.659 . . . . 55.33 110.155 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 40.1 mt -87.75 135.94 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 116.311 -0.404 . . . . 72.33 110.39 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.424 HD21 HD21 ' A' ' 391' ' ' ASN . 59.5 tp -75.93 120.74 21.68 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.528 0.68 . . . . 42.14 109.387 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.53 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -82.83 -64.39 1.18 Allowed 'General case' 0 N--CA 1.383 -3.777 0 N-CA-C 108.597 -0.89 . . . . 71.12 108.597 -177.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.13 162.34 33.12 Favored Glycine 0 N--CA 1.421 -2.306 0 C-N-CA 118.934 -1.603 . . . . 31.22 111.986 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . 0.424 HD21 HD21 ' A' ' 388' ' ' LEU . 43.0 m-80 -108.44 146.51 33.01 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.343 -1.354 . . . . 74.22 107.343 175.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -64.96 116.47 6.43 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 120.882 0.373 . . . . 64.42 111.555 -175.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -94.76 -49.07 5.77 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.049 -0.523 . . . . 64.41 111.308 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 21.4 p -169.02 140.37 2.46 Favored 'General case' 0 C--O 1.252 1.22 0 N-CA-C 110.127 -0.323 . . . . 74.31 110.127 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.402 ' OE1' HD22 ' A' ' 400' ' ' LEU . 10.6 pt20 -142.39 140.55 32.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.217 0.532 . . . . 65.14 111.726 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -128.78 128.62 44.32 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 108.689 -0.856 . . . . 72.11 108.689 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 68.82 -101.53 0.8 Allowed Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 121.008 -0.615 . . . . 72.54 112.466 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 26.2 p-10 -130.49 11.8 5.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 111.981 0.363 . . . . 71.33 111.981 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 40.7 t -111.65 116.98 54.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.923 -1.14 . . . . 74.43 107.923 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.402 HD22 ' OE1' ' A' ' 395' ' ' GLN . 6.7 mt -114.83 131.45 56.82 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.553 -0.536 . . . . 65.13 109.553 -172.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -116.37 124.43 50.05 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.322 -0.992 . . . . 64.3 108.322 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.451 ' CD2' HG21 ' A' ' 382' ' ' VAL . 3.5 m-85 -114.22 136.19 53.23 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.48 -1.304 . . . . 53.35 107.48 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -144.09 176.4 9.34 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.585 -0.524 . . . . 61.0 109.585 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.96 36.24 12.75 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.837 0.68 . . . . 63.41 112.837 177.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -80.56 -141.65 2.87 Favored Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.25 -0.976 . . . . 64.21 111.243 175.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . 0.408 HE21 ' HB3' ' A' ' 406' ' ' GLN . 1.0 OUTLIER -75.34 134.83 40.92 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.097 -0.705 . . . . 74.2 109.097 -177.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 37.8 m . . . . . 0 C--N 1.323 -0.549 0 N-CA-C 113.354 0.872 . . . . 74.1 113.354 -175.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' HIS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 99.8 m-70 . . . . . 0 CA--C 1.493 -1.218 0 N-CA-C 107.798 -1.186 . . . . 71.14 107.798 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -73.22 159.19 33.83 Favored 'General case' 0 C--O 1.257 1.448 0 CA-C-O 121.374 0.607 . . . . 75.14 111.604 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 33.2 p -162.18 163.56 28.31 Favored 'General case' 0 N--CA 1.406 -2.663 0 CA-C-N 114.488 -1.233 . . . . 74.33 109.121 -177.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -159.15 144.74 16.2 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.819 -0.437 . . . . 34.43 109.819 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.8 tt -109.62 125.12 66.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.099 -1.075 . . . . 72.45 108.099 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.9 t -111.09 131.19 63.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.87 -0.605 . . . . 73.23 110.895 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.84 113.8 26.65 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 106.058 -1.83 . . . . 75.0 106.058 175.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 23.6 t -101.18 112.62 34.72 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.517 0 N-CA-C 109.256 -0.646 . . . . 55.44 109.256 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -109.93 -176.25 2.95 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.745 -0.782 . . . . 75.54 110.965 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.452 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 32.4 t -60.67 128.08 34.82 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 123.568 0.747 . . . . 72.43 111.212 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.547 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -151.23 178.93 28.31 Favored Glycine 0 N--CA 1.428 -1.835 0 N-CA-C 110.086 -1.206 . . . . 74.14 110.086 177.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 41.3 t -93.8 -26.96 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.293 -1.002 . . . . 62.31 108.293 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -141.56 157.42 45.13 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 114.894 -1.048 . . . . 75.34 109.306 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -73.16 100.16 3.0 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 106.858 -1.534 . . . . 74.43 106.858 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -132.18 141.24 49.02 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 120.687 -0.405 . . . . 74.24 111.805 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.439 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 27.3 mm -83.39 118.43 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 105.767 -1.938 . . . . 74.04 105.767 174.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 55.1 t -83.17 -50.65 15.39 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-O 121.042 0.449 . . . . 73.23 111.651 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 37.4 p -161.23 159.49 28.79 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.197 -0.456 . . . . 52.44 110.5 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.488 HG12 HG21 ' A' ' 369' ' ' ILE . 3.3 p -142.15 122.86 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 108.829 -0.804 . . . . 52.05 108.829 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . 0.473 ' O ' HD23 ' A' ' 440' ' ' LEU . 30.2 tp -131.0 137.54 49.27 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.8 -1.185 . . . . 74.33 107.8 -177.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -81.45 116.97 21.5 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.578 -0.849 . . . . 64.12 108.789 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.31 -63.97 1.12 Allowed 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.392 -0.822 . . . . 74.33 110.722 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -106.23 -76.24 0.61 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.75 -0.659 . . . . 74.21 111.821 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -162.8 -30.35 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.048 0.452 . . . . 72.13 112.172 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 86.2 m -131.16 11.65 5.04 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.576 -0.898 . . . . 74.13 108.576 176.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 415' ' ' SER . 34.8 tt0 -131.79 129.62 40.76 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.119 -0.946 . . . . 54.01 108.985 -176.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -117.91 150.41 39.26 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.682 -0.69 . . . . 74.2 110.906 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.477 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.6 pt? -106.4 120.9 43.1 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.598 -1.26 . . . . 61.15 107.598 172.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.7 mt -124.14 128.7 74.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-N 115.41 -0.814 . . . . 71.43 109.746 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -104.27 140.69 37.5 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.873 -0.788 . . . . 74.42 108.873 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.439 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.3 mtp -135.08 167.47 20.9 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 109.409 -0.589 . . . . 70.54 109.409 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.547 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 72.1 mmtt -133.24 156.28 47.83 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.299 -1.371 . . . . 73.15 107.299 174.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 38.3 t -163.77 145.44 7.31 Favored Pre-proline 0 C--N 1.278 -2.542 0 O-C-N 124.075 0.86 . . . . 60.42 109.11 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.4 -21.38 47.14 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.111 1.874 . . . . 42.32 110.646 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.12 -18.58 52.99 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.803 -0.635 . . . . 71.45 110.982 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.798 0 CA-C-O 121.376 0.608 . . . . 72.43 109.857 179.02 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 97.0 m . . . . . 0 N--CA 1.425 -1.724 0 N-CA-C 107.477 -1.305 . . . . 64.14 107.477 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 57.7 mtpt -133.32 143.54 49.08 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 116.239 -0.437 . . . . 61.34 110.529 -174.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.488 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 1.9 tmt_? -157.95 136.85 11.45 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.057 -1.09 . . . . 53.22 108.057 -177.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 40.5 mt-10 -87.98 127.18 35.38 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.713 0.292 . . . . 75.24 110.233 -174.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' ILE . . . . . 0.554 HG21 HG12 ' A' ' 431' ' ' VAL . 38.0 mt -136.96 120.76 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 106.793 -1.558 . . . . 62.11 106.793 -176.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.26 13.71 60.62 Favored Glycine 0 C--N 1.304 -1.21 0 C-N-CA 120.358 -0.925 . . . . 45.34 113.137 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.09 -17.73 40.7 Favored Glycine 0 N--CA 1.429 -1.832 0 C-N-CA 121.084 -0.579 . . . . 73.05 113.107 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -106.87 139.72 40.84 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 120.683 0.278 . . . . 64.5 110.333 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 37.4 m -83.83 122.01 28.11 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 116.259 -0.428 . . . . 61.2 110.166 -178.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' TYR . . . . . 0.625 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.54 129.07 36.73 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 109.301 -0.629 . . . . 73.41 109.301 176.615 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 83.9 tttt -122.48 125.23 45.36 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 123.887 0.742 . . . . 54.23 110.108 -175.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' VAL . . . . . 0.449 HG12 HD11 ' A' ' 428' ' ' ILE . 7.2 p -128.24 118.22 47.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 N-CA-C 109.161 -0.681 . . . . 70.51 109.161 175.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 40.8 t -106.73 116.5 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 106.116 -1.809 . . . . 74.32 106.116 174.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -58.9 123.06 15.22 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 123.807 0.692 . . . . 74.21 112.503 -174.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 72.98 12.23 5.11 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.587 1.555 . . . . 73.55 113.385 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -123.24 -86.84 0.64 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 113.848 1.055 . . . . 70.41 113.848 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.54 169.05 20.41 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 119.392 -0.923 . . . . 73.12 110.322 -176.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 94.9 t -124.95 138.78 53.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 107.643 -1.243 . . . . 65.44 107.643 173.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -132.91 148.1 52.29 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.143 0.497 . . . . 73.22 110.785 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . 0.5 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.8 tt0 -115.28 100.07 7.86 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.387 -1.709 . . . . 63.41 106.387 173.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 13.4 t70 69.89 -78.37 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 125.248 1.419 . . . . 61.45 110.019 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 27.4 m -138.01 -5.69 1.67 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.082 -0.963 . . . . 62.51 109.287 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 47.8 mm -88.39 135.63 25.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.188 -0.46 . . . . 75.41 110.016 -177.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 62.9 tp -76.23 115.1 15.63 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.995 -1.113 . . . . 71.23 107.995 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.6 OUTLIER -80.21 -60.52 2.3 Favored 'General case' 0 N--CA 1.388 -3.539 0 N-CA-C 108.762 -0.829 . . . . 72.13 108.762 -175.684 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.97 158.59 29.88 Favored Glycine 0 N--CA 1.413 -2.892 0 C-N-CA 119.295 -1.431 . . . . 44.0 111.417 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -102.24 143.97 31.36 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.659 -1.608 . . . . 74.15 106.659 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -69.27 116.82 10.14 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.013 0.435 . . . . 71.03 110.737 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.11 -47.56 5.45 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.772 -0.649 . . . . 75.35 110.962 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 65.9 p -168.47 143.67 3.49 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.898 -0.408 . . . . 75.14 109.898 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' GLN . . . . . 0.475 ' OE1' HD22 ' A' ' 400' ' ' LEU . 10.1 pt20 -143.08 136.98 28.85 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.743 0.306 . . . . 74.0 110.503 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -112.52 119.93 39.88 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.518 -0.919 . . . . 65.25 108.518 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.11 -101.67 0.63 Allowed Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 119.651 -1.262 . . . . 33.12 113.178 177.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -123.66 10.68 9.07 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.799 1.24 . . . . 64.32 111.132 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.34 116.69 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.015 0 N-CA-C 106.85 -1.537 . . . . 64.44 106.85 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' LEU . . . . . 0.475 HD22 ' OE1' ' A' ' 395' ' ' GLN . 9.3 mt -113.61 131.61 56.05 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 115.966 -0.561 . . . . 74.02 110.962 -168.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -114.27 121.76 44.68 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-O 121.392 0.615 . . . . 72.33 112.349 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.415 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.3 m-85 -118.25 139.02 51.95 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.537 -1.282 . . . . 75.42 107.537 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -141.46 173.42 11.51 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-O 121.466 0.65 . . . . 61.02 111.45 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 51.1 46.59 26.22 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.095 -1.866 . . . . 72.52 113.16 167.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.22 -132.98 0.57 Allowed Glycine 0 C--N 1.311 -0.831 0 CA-C-N 115.839 -0.618 . . . . 61.42 112.708 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.56 142.64 38.89 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.108 -1.442 . . . . 73.14 107.108 -176.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 27.4 t . . . . . 0 N--CA 1.431 -1.375 0 CA-C-O 121.806 0.812 . . . . 73.23 111.097 -178.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' HIS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 97.1 m-70 . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 108.782 -0.822 . . . . 75.01 108.782 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -74.33 160.53 30.94 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.34 0.59 . . . . 74.24 111.383 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 35.5 p -165.57 162.35 19.02 Favored 'General case' 0 N--CA 1.418 -2.058 0 C-N-CA 124.366 1.066 . . . . 74.33 108.246 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -158.74 151.11 21.6 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.303 0.573 . . . . 74.21 110.8 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 11.6 tt -114.37 131.11 67.37 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 CA-C-N 115.131 -0.94 . . . . 61.34 108.828 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 4.1 t -116.72 131.04 70.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-O 121.329 0.585 . . . . 74.34 111.926 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 62.2 p -108.02 114.97 29.27 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 107.641 -1.244 . . . . 54.13 107.641 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 39.6 t -100.19 111.87 31.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 107.545 -1.279 . . . . 62.55 107.545 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -113.52 -175.14 2.61 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.148 -0.478 . . . . 74.22 110.787 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' CYS . . . . . 0.425 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 43.6 t -60.42 128.66 37.76 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.815 -0.629 . . . . 72.12 111.224 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' GLY . . . . . 0.604 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -154.36 178.59 31.09 Favored Glycine 0 CA--C 1.476 -2.377 0 N-CA-C 110.479 -1.048 . . . . 52.54 110.479 177.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 56.0 t -90.41 -33.79 6.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 108.282 -1.007 . . . . 61.1 108.282 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -150.66 152.66 34.32 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.698 -0.683 . . . . 73.01 109.768 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.3 p-10 -60.1 98.83 0.06 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.597 -1.183 . . . . 55.21 112.427 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -133.08 146.85 52.04 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.038 -0.528 . . . . 63.44 111.783 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 367' ' ' ARG . 31.3 mm -80.17 119.87 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 105.449 -2.056 . . . . 52.53 105.449 171.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 54.6 t -84.55 -51.16 14.2 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.867 0 N-CA-C 112.112 0.412 . . . . 52.11 112.112 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 32.6 p -160.86 162.71 32.25 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.814 -0.354 . . . . 62.33 110.837 -174.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' VAL . . . . . 0.554 HG12 HG21 ' A' ' 369' ' ' ILE . 4.8 p -142.12 111.87 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 108.966 -0.753 . . . . 73.33 108.966 176.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' LEU . . . . . 0.409 ' O ' HD23 ' A' ' 440' ' ' LEU . 34.9 tp -113.97 136.45 52.89 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 108.765 -0.828 . . . . 54.54 108.765 -177.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.66 113.8 19.91 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.837 -0.801 . . . . 70.52 108.837 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.14 -70.42 0.39 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.294 -0.632 . . . . 43.41 109.294 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -100.0 -75.83 0.56 Allowed 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.551 -0.75 . . . . 75.31 109.966 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.1 -51.07 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.461 0.648 . . . . 73.25 110.437 175.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 64.3 m -100.52 13.19 35.44 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.204 -0.907 . . . . 72.5 109.019 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 415' ' ' SER . 33.4 tt0 -135.22 124.85 25.16 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-N 115.185 -0.916 . . . . 61.35 108.873 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -123.01 150.18 43.37 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.142 -0.936 . . . . 75.23 109.567 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . 0.445 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.4 pt? -109.22 121.37 45.02 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.252 -1.018 . . . . 63.11 108.252 173.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' ILE . . . . . 0.558 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 97.1 mt -118.08 135.25 59.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.211 -0.904 . . . . 65.11 110.012 -175.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -109.26 141.42 41.57 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 109.5 -0.556 . . . . 64.42 109.5 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' MET . . . . . 0.43 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.1 mtp -136.38 162.81 32.01 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 108.995 -0.743 . . . . 75.22 108.995 178.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' LYS . . . . . 0.604 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 70.1 mmtt -132.87 151.49 52.02 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.164 -1.05 . . . . 63.44 108.164 176.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 68.1 m -161.24 149.15 12.44 Favored Pre-proline 0 C--N 1.295 -1.792 0 O-C-N 123.865 0.728 . . . . 70.24 109.945 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.44 -27.76 62.48 Favored 'Trans proline' 0 N--CA 1.48 0.695 0 C-N-CA 122.724 2.283 . . . . 74.42 111.95 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.58 -22.25 57.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.6 -0.727 . . . . 74.32 110.643 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.857 0 CA-C-N 115.528 -0.76 . . . . 65.05 111.049 -175.461 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 398' ' ' ASN . 89.6 m-85 . . . . . 0 C--O 1.223 -0.312 0 N-CA-C 110.31 -0.255 . . . . 75.05 110.31 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.405 ' HD2' ' C ' ' A' ' 357' ' ' TYR . 6.4 mpt_? -134.76 173.84 11.24 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.87 -0.418 . . . . 64.12 109.87 176.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -135.84 151.75 50.36 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.877 -1.527 . . . . 73.23 106.877 174.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . 0.616 HG21 ' SD ' ' A' ' 363' ' ' MET . 25.2 mm -81.19 115.76 24.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 C-N-CA 119.923 -0.711 . . . . 75.23 109.75 -172.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.684 ' HD3' ' H ' ' A' ' 361' ' ' LYS . 0.3 OUTLIER -79.77 141.26 36.47 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 112.466 0.543 . . . . 71.03 112.466 -176.219 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 94.41 -27.54 13.44 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.471 -0.786 . . . . 61.31 113.575 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . 0.616 ' SD ' HG21 ' A' ' 360' ' ' ILE . 72.6 mtp -74.79 146.89 41.72 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 113.744 1.016 . . . . 72.54 113.744 -177.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -93.5 126.29 38.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.493 -1.231 . . . . 74.04 107.77 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.468 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 90.7 m -117.53 125.58 51.1 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 107.302 -1.369 . . . . 63.43 107.302 173.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 17.1 ptmt -139.16 141.18 38.02 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 121.099 -0.24 . . . . 60.32 110.913 -174.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.413 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 3.6 tmt_? -156.94 138.4 13.94 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.276 -1.379 . . . . 61.42 107.276 -175.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -86.42 126.84 34.67 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.141 -0.689 . . . . 73.12 109.141 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.51 HG21 HG12 ' A' ' 431' ' ' VAL . 39.8 mt -137.17 124.6 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 106.654 -1.609 . . . . 73.41 106.654 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.58 8.47 46.58 Favored Glycine 0 C--N 1.301 -1.393 0 C-N-CA 120.91 -0.662 . . . . 73.54 113.233 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.09 -14.74 44.24 Favored Glycine 0 N--CA 1.426 -1.978 0 C-N-CA 120.702 -0.761 . . . . 62.14 112.684 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . 0.423 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 17.3 p90 -106.39 141.4 37.78 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 120.839 0.352 . . . . 74.12 110.134 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 51.3 m -83.52 120.24 25.69 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 116.18 -0.463 . . . . 73.42 109.895 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.6 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.66 134.21 34.57 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 108.612 -0.885 . . . . 75.31 108.612 174.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -133.41 125.01 28.15 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.104 -0.702 . . . . 72.55 109.104 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.51 HG23 HG22 ' A' ' 382' ' ' VAL . 7.6 p -121.05 122.54 67.89 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 N-CA-C 109.197 -0.668 . . . . 70.31 109.197 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 48.4 t -110.53 116.71 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 106.902 -1.518 . . . . 73.02 106.902 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -62.92 126.56 27.74 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.119 1.155 . . . . 75.23 114.119 -172.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 72.85 8.51 5.5 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 126.173 1.789 . . . . 72.4 113.276 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -116.68 -85.56 0.63 Allowed 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 112.969 0.729 . . . . 75.0 112.969 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.406 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.5 OUTLIER -162.32 162.75 28.11 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.875 -0.602 . . . . 74.13 112.254 -171.336 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.51 HG22 HG23 ' A' ' 376' ' ' VAL . 66.5 t -122.58 144.86 30.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.049 -0.978 . . . . 73.33 109.585 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.406 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 62.8 m-85 -133.94 148.33 51.17 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 123.094 0.558 . . . . 72.43 111.595 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.46 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.9 tt0 -119.47 103.51 9.51 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 105.818 -1.919 . . . . 63.22 105.818 173.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.5 t70 69.15 -86.44 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 123.962 0.905 . . . . 75.12 109.587 -175.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.6 m -135.37 -2.66 2.46 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.935 -0.765 . . . . 65.01 108.935 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 62.8 mt -83.13 132.66 30.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 115.93 -0.577 . . . . 74.24 109.781 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.2 tp -76.66 115.54 16.51 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.6 -0.889 . . . . 72.32 108.6 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.536 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -79.69 -66.09 0.92 Allowed 'General case' 0 N--CA 1.39 -3.455 0 N-CA-C 108.934 -0.765 . . . . 74.1 108.934 -177.229 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.77 160.15 31.65 Favored Glycine 0 N--CA 1.413 -2.836 0 C-N-CA 118.925 -1.607 . . . . 54.35 111.604 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -104.36 145.28 30.49 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 107.362 -1.347 . . . . 75.23 107.362 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -66.6 116.66 7.78 Favored 'General case' 0 C--N 1.288 -2.088 0 O-C-N 123.351 0.407 . . . . 75.24 110.774 -177.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -101.93 -48.11 4.36 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.107 -0.497 . . . . 75.42 111.227 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 51.3 m -159.5 141.42 13.31 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.945 -0.391 . . . . 74.43 109.945 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.407 ' HB2' ' CD2' ' A' ' 400' ' ' LEU . 9.9 pt20 -144.37 140.47 29.08 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 120.97 0.414 . . . . 74.13 111.888 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -128.05 119.43 25.39 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.493 -0.776 . . . . 75.33 110.416 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 74.72 -101.28 1.28 Allowed Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 115.681 -0.691 . . . . 75.23 111.736 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 357' ' ' TYR . 4.4 p-10 -131.79 15.96 4.79 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.401 0.619 . . . . 73.31 110.071 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.454 HG22 HG23 ' A' ' 419' ' ' THR . 46.9 t -116.71 119.15 61.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 106.874 -1.528 . . . . 75.31 106.874 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.407 ' CD2' ' HB2' ' A' ' 395' ' ' GLN . 9.9 mt -118.04 130.74 56.35 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 116.207 -0.451 . . . . 52.51 110.808 -170.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.457 ' HE3' HD12 ' A' ' 417' ' ' ILE . 22.6 mmtp -105.02 122.99 47.02 Favored 'General case' 0 C--O 1.25 1.093 0 N-CA-C 112.275 0.472 . . . . 73.43 112.275 177.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.435 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.2 m-85 -118.84 132.92 56.13 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.887 -1.153 . . . . 75.32 107.887 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -147.19 177.58 9.07 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 122.582 0.353 . . . . 72.41 110.179 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.5 m120 66.67 36.63 4.66 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.605 0.566 . . . . 73.14 111.226 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -79.88 -138.07 1.78 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 120.582 -0.818 . . . . 73.21 112.824 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.22 143.18 32.5 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.638 -0.505 . . . . 55.22 109.638 -178.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.7 m -60.68 128.47 36.73 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.82 1.044 . . . . 73.24 113.82 -176.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 19.4 p -132.18 159.07 40.07 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.827 -1.175 . . . . 53.32 107.827 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -85.81 147.51 26.27 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 118.03 0.377 . . . . 71.44 111.519 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 77.43 9.83 2.48 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.737 1.615 . . . . 71.2 109.914 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -152.51 166.0 31.1 Favored Glycine 0 N--CA 1.419 -2.469 0 N-CA-C 106.312 -2.715 . . . . 52.43 106.312 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.98 -40.52 0.22 Allowed 'Trans proline' 0 C--N 1.322 -0.847 0 CA-C-N 120.56 2.18 . . . . 73.55 111.409 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -163.82 165.4 22.98 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 105.681 -1.97 . . . . 52.01 105.681 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -63.77 160.49 17.12 Favored 'General case' 0 C--O 1.254 1.313 0 CA-C-O 121.467 0.651 . . . . 75.0 112.662 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.633 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 46.7 t -161.13 159.66 29.31 Favored 'General case' 0 N--CA 1.416 -2.133 0 CA-C-N 114.539 -1.209 . . . . 74.13 107.814 -176.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -159.78 149.93 18.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 120.852 0.358 . . . . 64.23 110.127 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . 0.457 HD12 ' HE3' ' A' ' 401' ' ' LYS . 8.8 tt -110.63 123.8 66.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 N-CA-C 107.737 -1.208 . . . . 62.21 107.737 173.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.3 t -106.28 126.25 61.92 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 CA-C-O 121.164 0.507 . . . . 51.41 109.924 176.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.454 HG23 HG22 ' A' ' 399' ' ' VAL . 3.6 m -108.64 112.95 25.56 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 105.819 -1.919 . . . . 54.21 105.819 176.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 40.6 t -100.8 112.0 32.26 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.94 0 N-CA-C 107.101 -1.444 . . . . 74.13 107.101 -177.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -110.9 -175.37 2.7 Favored 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 120.228 -0.589 . . . . 75.21 111.4 -175.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.48 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 38.9 t -59.92 128.01 34.76 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 123.503 0.721 . . . . 73.15 110.46 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -158.76 -176.93 31.36 Favored Glycine 0 CA--C 1.492 -1.385 0 N-CA-C 110.964 -0.855 . . . . 74.13 110.964 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 42.3 t -94.38 -31.29 4.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-O 121.225 0.536 . . . . 53.45 109.615 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.84 161.09 40.77 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 116.002 -0.545 . . . . 63.34 109.559 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.531 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.1 p-10 -73.03 98.58 2.55 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 124.311 1.007 . . . . 72.45 110.398 175.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -132.44 148.22 52.4 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.912 -0.586 . . . . 74.11 110.754 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.475 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 28.2 mm -84.36 124.03 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 105.963 -1.866 . . . . 74.43 105.963 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.435 HG11 ' HE3' ' A' ' 442' ' ' LYS . 51.9 t -92.55 -47.99 13.7 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 112.888 0.699 . . . . 73.02 112.888 -175.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 42.9 m -158.67 155.64 28.49 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.735 -0.469 . . . . 54.03 109.735 -173.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.51 HG12 HG21 ' A' ' 369' ' ' ILE . 3.2 p -141.3 111.9 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 108.672 -0.862 . . . . 63.01 108.672 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . 0.411 ' O ' HD23 ' A' ' 440' ' ' LEU . 32.0 tp -117.71 137.74 52.48 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 114.96 -1.018 . . . . 71.43 108.507 -175.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -80.58 112.59 18.08 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.962 -0.755 . . . . 73.44 108.962 -176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -73.75 -49.79 23.78 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 115.54 -0.755 . . . . 65.32 110.216 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -126.14 -76.2 0.58 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.166 -0.924 . . . . 75.22 108.993 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.95 -41.31 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 121.043 0.449 . . . . 71.34 110.787 173.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 98.6 m -96.84 -16.88 20.54 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.324 0.583 . . . . 72.33 110.114 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 415' ' ' SER . 37.3 tt0 -112.72 132.31 55.27 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.979 -1.01 . . . . 71.34 109.691 -177.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -125.68 150.16 47.87 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.543 -0.753 . . . . 72.15 109.273 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.478 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.5 pt? -105.47 117.16 33.32 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.566 -0.901 . . . . 75.2 108.566 173.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.6 mt -114.91 132.25 64.7 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-N 115.093 -0.958 . . . . 73.22 109.628 -176.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.435 ' HE3' HG11 ' A' ' 429' ' ' VAL . 36.6 ttpt -109.31 140.16 43.34 Favored 'General case' 0 N--CA 1.408 -2.53 0 N-CA-C 108.51 -0.922 . . . . 72.11 108.51 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.475 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 77.0 mtp -138.08 168.41 19.78 Favored 'General case' 0 CA--C 1.476 -1.871 0 N-CA-C 108.484 -0.932 . . . . 74.55 108.484 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.61 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 71.7 mmtt -134.5 156.45 48.59 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.292 -1.003 . . . . 53.03 108.292 175.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 74.3 m -162.95 147.32 9.08 Favored Pre-proline 0 C--N 1.289 -2.04 0 C-N-CA 124.291 1.036 . . . . 73.43 109.394 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -66.14 -27.25 49.31 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.324 2.016 . . . . 71.02 111.757 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -78.72 -15.6 58.25 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.748 -0.66 . . . . 74.02 110.79 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -93.21 10.3 32.43 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.68 0.752 . . . . 72.2 109.913 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 7.9 t -106.6 119.67 39.91 Favored 'General case' 0 N--CA 1.409 -2.486 0 N-CA-C 106.359 -1.719 . . . . 50.44 106.359 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 26.9 t . . . . . 0 CA--C 1.553 1.06 0 O-C-N 123.991 0.807 . . . . 62.45 109.794 -176.227 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 54.6 p90 . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 120.688 0.28 . . . . 72.22 111.041 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.415 ' NE ' ' HA ' ' A' ' 358' ' ' ARG . 3.4 mmp_? -125.94 177.25 6.44 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.848 0.832 . . . . 73.31 112.29 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -143.98 151.57 39.92 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 104.057 -2.571 . . . . 54.43 104.057 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 360' ' ' ILE . 1.8 mp -81.14 115.63 24.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 119.445 1.02 . . . . 72.11 110.256 -172.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.539 ' HA ' ' HB2' ' A' ' 378' ' ' PHE . 21.0 pttp -90.96 151.69 20.99 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.16 -1.382 . . . . 74.32 112.764 -172.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 79.74 -24.11 3.38 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 115.702 -0.681 . . . . 62.22 113.137 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 56.9 ttp -73.56 -29.27 62.32 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 123.143 0.577 . . . . 74.34 110.225 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.547 ' HG2' HG22 ' A' ' 377' ' ' VAL . 42.0 mt-10 70.72 146.97 0.07 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.145 1.378 . . . . 71.13 109.783 -176.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.493 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 95.7 m -124.59 120.92 33.3 Favored 'General case' 0 C--N 1.265 -3.083 0 N-CA-C 107.711 -1.218 . . . . 74.12 107.711 171.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 0.0 OUTLIER -136.26 141.51 43.9 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.963 -0.695 . . . . 74.3 110.404 180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -159.71 140.34 12.18 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 123.518 0.511 . . . . 72.21 110.313 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -76.34 123.92 26.7 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 110.115 -0.328 . . . . 64.44 110.115 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.46 HG21 HG12 ' A' ' 431' ' ' VAL . 48.6 mt -129.52 117.52 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 N-CA-C 106.194 -1.78 . . . . 72.41 106.194 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.73 14.01 62.14 Favored Glycine 0 C--N 1.304 -1.219 0 C-N-CA 120.781 -0.723 . . . . 53.51 112.244 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.1 -22.05 32.22 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 121.279 -0.486 . . . . 62.34 112.981 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -98.35 135.83 39.38 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 120.916 0.389 . . . . 71.23 111.204 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 85.4 m -79.86 114.54 18.85 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.765 -0.652 . . . . 73.41 110.224 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -91.46 132.92 35.91 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 108.563 -0.903 . . . . 72.34 108.563 176.344 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.534 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 37.6 ttpt -132.01 132.31 43.31 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 120.273 -0.571 . . . . 72.35 110.594 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.493 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.0 p -122.65 118.42 55.05 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 CA-C-N 115.844 -0.616 . . . . 71.33 110.076 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.547 HG22 ' HG2' ' A' ' 364' ' ' GLU . 21.6 t -107.54 116.02 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.55 0 N-CA-C 106.768 -1.568 . . . . 65.15 106.768 175.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.539 ' HB2' ' HA ' ' A' ' 361' ' ' LYS . 98.0 m-85 -64.18 132.56 50.74 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 113.522 0.934 . . . . 73.31 113.522 -173.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 65.18 23.66 12.31 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.053 -1.431 . . . . 75.51 112.286 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -136.49 -83.46 0.37 Allowed 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.505 -0.77 . . . . 71.31 112.914 176.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.422 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -165.81 160.03 16.65 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.569 0.951 . . . . 63.13 113.569 -173.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.476 HG22 HG23 ' A' ' 376' ' ' VAL . 95.9 t -116.21 146.3 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.595 1.158 . . . . 51.02 109.521 -178.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.422 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 85.8 m-85 -134.83 152.36 51.69 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.316 0.646 . . . . 71.51 111.646 -178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.481 ' HB2' HD23 ' A' ' 389' ' ' LEU . 29.1 tt0 -127.63 106.68 9.32 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.337 -1.727 . . . . 70.45 106.337 171.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.5 t70 69.44 -83.35 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 124.175 0.99 . . . . 54.13 110.52 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 45.5 m -135.85 -5.49 2.18 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.961 -0.755 . . . . 44.14 108.961 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 49.7 mm -89.21 132.63 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.497 -0.774 . . . . 62.04 110.565 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 57.7 tp -76.41 116.12 16.8 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.309 -0.997 . . . . 62.44 108.309 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.2 OUTLIER -79.44 -62.63 1.63 Allowed 'General case' 0 N--CA 1.393 -3.287 0 N-CA-C 109.03 -0.73 . . . . 64.14 109.03 -176.535 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.56 160.87 32.23 Favored Glycine 0 N--CA 1.42 -2.422 0 C-N-CA 119.335 -1.412 . . . . 35.1 111.903 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -104.73 151.31 23.89 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.662 -1.236 . . . . 64.52 107.662 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.411 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.8 m-85 -70.41 116.75 11.11 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 121.341 0.591 . . . . 64.12 111.876 -176.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -95.81 -47.18 6.27 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.318 -0.855 . . . . 62.41 110.541 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 38.3 t -164.95 139.27 5.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.461 -0.57 . . . . 64.11 109.461 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.534 ' CB ' ' HG ' ' A' ' 400' ' ' LEU . 5.7 pm0 -141.98 129.71 21.62 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.556 -0.747 . . . . 73.32 110.621 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -128.37 127.07 41.94 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.294 -1.002 . . . . 74.13 108.294 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.93 -117.79 9.65 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.986 -0.625 . . . . 73.01 112.011 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -116.63 20.3 14.12 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.357 0.598 . . . . 73.24 110.773 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 67.4 t -124.91 128.88 73.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.45 -0.944 . . . . 75.41 108.45 179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.534 ' HG ' ' CB ' ' A' ' 395' ' ' GLN . 3.9 mp -126.51 140.39 52.49 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 116.455 -0.339 . . . . 72.21 111.099 -175.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -116.68 124.88 50.78 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.132 0.573 . . . . 74.22 111.133 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.411 ' CD2' HG21 ' A' ' 382' ' ' VAL . 3.8 m-85 -118.16 136.19 53.77 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.061 -0.718 . . . . 73.32 109.061 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.25 178.03 8.91 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 122.654 0.382 . . . . 74.53 110.653 178.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.2 m120 66.58 33.61 6.46 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.079 0.552 . . . . 51.21 111.684 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.15 -130.4 0.44 Allowed Glycine 0 CA--C 1.535 1.334 0 C-N-CA 120.424 -0.893 . . . . 64.1 113.051 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -80.78 147.53 30.45 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 106.402 -1.703 . . . . 65.23 106.402 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 50.8 m -60.18 137.8 58.04 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.839 0.828 . . . . 41.03 112.806 -175.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 45.5 t -107.62 157.98 17.63 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.633 -1.988 . . . . 73.03 105.633 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' TRP . . . . . 0.453 ' CE2' ' HB3' ' A' ' 410' ' ' ASN . 7.6 p-90 -76.42 -51.27 12.16 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 118.866 -1.133 . . . . 73.11 112.112 -172.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . 0.616 ' OD1' ' HG3' ' A' ' 436' ' ' LYS . 9.3 p30 -92.69 -3.96 54.0 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.261 0.553 . . . . 63.52 111.071 -174.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -124.82 -174.41 13.99 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 108.919 -1.672 . . . . 54.44 108.919 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -84.11 -41.49 0.09 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.249 0 CA-C-N 120.275 2.038 . . . . 61.45 112.417 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 94.8 m-70 -160.97 170.68 20.09 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.358 -0.979 . . . . 74.03 108.358 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -76.7 165.08 25.24 Favored 'General case' 0 C--O 1.251 1.157 0 O-C-N 123.597 0.561 . . . . 45.44 111.5 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 22.9 p -161.79 165.3 28.09 Favored 'General case' 0 N--CA 1.411 -2.397 0 CA-C-N 114.548 -1.205 . . . . 72.24 109.235 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -159.54 151.05 20.08 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.422 0.629 . . . . 72.1 110.546 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.4 tt -114.37 131.56 66.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-N 115.333 -0.848 . . . . 74.43 109.102 173.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.454 HG22 ' HB ' ' A' ' 441' ' ' ILE . 4.7 t -119.96 125.71 74.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-O 121.335 0.588 . . . . 73.33 110.97 177.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 21.3 p -109.77 114.59 28.3 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.091 -0.959 . . . . 73.24 108.952 174.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 37.5 t -100.48 112.48 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 108.284 -1.006 . . . . 61.14 108.284 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -110.53 -174.6 2.52 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 116.566 -0.288 . . . . 70.24 110.571 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.547 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 30.4 t -57.36 128.33 36.49 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 123.626 0.771 . . . . 73.13 111.678 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.692 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -154.94 -177.62 28.42 Favored Glycine 0 CA--C 1.478 -2.233 0 C-N-CA 120.467 -0.873 . . . . 72.15 111.806 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.0 t -87.34 -36.01 9.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.64 -0.874 . . . . 75.13 108.64 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -157.62 162.17 38.69 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.566 -0.901 . . . . 74.04 108.566 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 3.9 m120 -61.77 102.36 0.26 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.485 0.659 . . . . 63.41 111.41 173.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -131.9 148.28 52.53 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.938 -1.028 . . . . 71.23 109.687 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 27.0 mm -89.05 114.83 27.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 105.87 -1.9 . . . . 72.31 105.87 175.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 53.0 t -83.02 -51.27 14.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 CA-C-N 116.112 -0.494 . . . . 63.53 112.217 -174.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 49.2 m -155.36 154.45 32.03 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.7 -0.481 . . . . 64.53 109.7 -174.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.46 HG12 HG21 ' A' ' 369' ' ' ILE . 5.6 p -141.8 122.83 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 109.079 -0.711 . . . . 52.24 109.079 175.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 440' ' ' LEU . 29.4 tp -131.25 136.81 48.53 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 107.385 -1.339 . . . . 73.3 107.385 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -83.56 122.14 28.16 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.977 -1.49 . . . . 75.4 106.977 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.518 ' HB2' HD22 ' A' ' 440' ' ' LEU . . . -82.92 -49.83 9.22 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.81 1.041 . . . . 74.13 113.81 -173.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -116.23 -70.26 0.81 Allowed 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 120.064 -0.654 . . . . 71.5 110.616 -170.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.616 ' HG3' ' OD1' ' A' ' 410' ' ' ASN . 0.0 OUTLIER -172.99 -24.27 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 125.058 1.343 . . . . 70.12 109.359 178.371 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . 0.419 ' H ' ' H ' ' A' ' 436' ' ' LYS . 29.9 m -135.59 13.23 3.46 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.733 -0.84 . . . . 64.53 108.733 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 415' ' ' SER . 24.2 tt0 -136.68 119.22 15.91 Favored 'General case' 0 C--O 1.204 -1.317 0 N-CA-C 112.481 0.549 . . . . 63.33 112.481 -174.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 26.9 m-85 -104.12 146.45 28.72 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.944 -0.571 . . . . 72.05 110.953 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 434' ' ' ALA . 1.5 pt? -108.53 120.24 41.85 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.252 -1.018 . . . . 72.13 108.252 172.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.454 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.6 mt -120.01 131.55 72.09 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 115.259 -0.882 . . . . 74.3 110.793 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -98.56 138.32 35.93 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 108.5 -0.926 . . . . 65.12 108.5 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.419 ' SD ' HG11 ' A' ' 376' ' ' VAL . 80.7 mtp -138.79 164.67 29.01 Favored 'General case' 0 CA--C 1.484 -1.591 0 N-CA-C 109.988 -0.375 . . . . 74.44 109.988 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.692 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 32.7 mmtp -133.24 160.56 36.92 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.497 -0.557 . . . . 45.31 109.497 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . 0.465 ' HB2' ' ND2' ' A' ' 426' ' ' ASN . 42.7 t -163.75 142.08 6.04 Favored Pre-proline 0 C--N 1.304 -1.394 0 O-C-N 124.036 0.835 . . . . 62.51 109.041 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -68.16 -26.19 36.59 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 121.973 1.782 . . . . 51.21 109.676 175.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.8 -7.55 58.74 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.922 -1.035 . . . . 61.23 110.652 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -108.35 12.71 26.16 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.311 0.577 . . . . 71.44 109.636 176.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 422' ' ' CYS . 37.1 t -102.02 120.58 40.64 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-O 121.357 0.598 . . . . 72.11 111.757 -174.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 106.74 -1.578 . . . . 62.44 106.74 175.502 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.423 ' HB3' ' HB3' ' A' ' 398' ' ' ASN . 71.9 m-85 . . . . . 0 CA--C 1.512 -0.512 0 N-CA-C 110.451 -0.203 . . . . 74.4 110.451 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -138.94 179.01 6.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.185 0.517 . . . . 75.52 111.397 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -143.3 153.17 42.49 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.24 -1.393 . . . . 64.41 107.24 176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 36.0 mm -80.48 127.51 39.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.469 -0.937 . . . . 50.41 108.469 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.492 ' HG3' ' CE1' ' A' ' 379' ' ' TYR . 0.4 OUTLIER -71.64 128.17 34.93 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.86 0.362 . . . . 74.12 111.242 -178.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . 0.472 ' H ' ' HB2' ' A' ' 378' ' ' PHE . . . 75.79 -99.6 1.26 Allowed Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 110.798 -0.921 . . . . 34.13 110.798 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 10.6 tmm? 50.04 -45.52 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 129.497 3.119 . . . . 72.31 115.754 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 78.24 113.5 0.07 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.009 1.723 . . . . 73.33 112.155 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.461 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 58.0 m -119.33 136.55 54.21 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.266 -0.642 . . . . 71.35 109.266 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 18.2 ptpt -144.6 145.29 31.71 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 123.082 0.239 . . . . 64.53 111.441 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.46 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 4.0 tmt_? -159.4 133.71 7.7 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.556 -1.276 . . . . 71.53 107.556 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 44.2 mt-10 -84.6 125.6 32.6 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.578 -0.527 . . . . 74.41 109.578 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.457 HG21 HG12 ' A' ' 431' ' ' VAL . 47.8 mt -131.08 118.21 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 107.544 -1.28 . . . . 61.45 107.544 -174.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 67.06 13.16 61.5 Favored Glycine 0 C--N 1.313 -0.718 0 C-N-CA 120.936 -0.65 . . . . 62.21 112.365 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 112.89 -29.29 8.2 Favored Glycine 0 N--CA 1.417 -2.58 0 C-N-CA 120.946 -0.645 . . . . 74.33 112.595 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . 0.414 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 20.8 p90 -98.4 140.33 32.82 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 120.914 0.388 . . . . 64.31 111.314 -175.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 36.9 m -81.12 118.19 22.32 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 116.012 -0.54 . . . . 74.31 110.037 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.574 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.5 129.89 36.62 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 108.621 -0.881 . . . . 61.51 108.621 173.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -131.24 128.5 40.02 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.371 -0.532 . . . . 71.35 109.969 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.461 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.6 p -124.17 117.85 52.03 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.452 0 CA-C-O 121.325 0.583 . . . . 73.13 109.576 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.48 116.47 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.378 -1.341 . . . . 73.51 107.378 174.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.474 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 91.9 m-85 -60.52 131.03 49.46 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 113.499 0.926 . . . . 70.45 113.499 -172.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.492 ' CE1' ' HG3' ' A' ' 361' ' ' LYS . 95.3 m-85 68.99 9.49 7.44 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 124.996 1.318 . . . . 71.25 112.612 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -120.82 -84.32 0.66 Allowed 'General case' 0 C--O 1.239 0.552 0 N-CA-C 113.164 0.801 . . . . 71.34 113.164 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.487 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -166.94 158.76 12.79 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.09 0.774 . . . . 72.25 113.09 -173.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.443 HG22 HG23 ' A' ' 376' ' ' VAL . 92.0 t -114.1 146.35 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.992 -1.003 . . . . 72.31 109.535 -178.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.487 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 78.6 m-85 -133.98 146.1 50.12 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 123.048 0.539 . . . . 71.53 111.71 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.498 ' HB2' HD23 ' A' ' 389' ' ' LEU . 35.3 tt0 -117.94 98.38 6.31 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 106.112 -1.81 . . . . 61.32 106.112 172.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 18.7 t70 69.94 -83.93 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 124.325 1.05 . . . . 73.41 110.636 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.3 m -136.43 3.87 2.84 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.161 -1.051 . . . . 72.13 108.161 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 65.2 mt -88.36 132.66 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 114.998 -1.001 . . . . 71.33 109.775 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 64.2 tp -78.01 110.58 13.08 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.383 -1.34 . . . . 75.02 107.383 175.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.54 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -76.81 -65.26 0.96 Allowed 'General case' 0 N--CA 1.393 -3.317 0 N-CA-C 109.036 -0.728 . . . . 73.01 109.036 -175.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.27 157.45 28.8 Favored Glycine 0 N--CA 1.423 -2.184 0 C-N-CA 119.791 -1.195 . . . . 72.31 111.746 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -100.65 150.02 23.16 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.057 -1.09 . . . . 71.44 108.057 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.544 ' HB3' ' NE2' ' A' ' 395' ' ' GLN . 1.9 m-85 -73.04 115.9 12.92 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.205 0.526 . . . . 55.53 110.853 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.9 -43.42 6.73 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.529 -0.76 . . . . 60.52 111.085 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 52.9 m -155.11 143.73 20.57 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.686 -0.234 . . . . 62.21 110.515 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.544 ' NE2' ' HB3' ' A' ' 392' ' ' PHE . 14.2 mp0 -129.88 133.87 47.15 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.873 -1.529 . . . . 74.04 106.873 174.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -128.91 110.91 12.51 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.782 -0.821 . . . . 73.13 108.782 173.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 72.11 -101.66 1.07 Allowed Glycine 0 N--CA 1.409 -3.114 0 C-N-CA 119.415 -1.374 . . . . 72.12 112.056 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . 0.423 ' HB3' ' HB3' ' A' ' 357' ' ' TYR . 5.9 p-10 -130.39 19.15 5.3 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 123.77 0.828 . . . . 44.21 109.124 -177.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.95 116.75 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 N-CA-C 106.887 -1.523 . . . . 72.5 106.887 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.428 HD22 ' CG ' ' A' ' 395' ' ' GLN . 13.1 mt -116.46 130.47 56.78 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.806 -0.634 . . . . 70.42 110.354 -170.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -110.12 121.95 46.46 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 121.031 0.443 . . . . 74.11 111.239 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.42 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 2.9 m-85 -116.19 132.38 56.68 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.14 -1.059 . . . . 63.22 108.14 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 415' ' ' SER . 11.4 pt-20 -147.74 177.55 9.21 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 123.172 0.295 . . . . 70.24 110.96 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 14.7 m120 65.91 34.36 7.25 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 123.7 0.625 . . . . 74.35 111.24 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -79.14 -136.65 1.27 Allowed Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.756 -0.735 . . . . 64.04 112.168 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -74.86 151.14 39.01 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.695 -0.854 . . . . 73.14 108.695 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 49.7 m -60.42 133.19 55.85 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.485 0.66 . . . . 52.24 112.167 -174.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 35.1 t -109.8 144.56 38.06 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.265 -1.754 . . . . 73.22 106.265 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 -82.92 -38.99 22.08 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.567 0.698 . . . . 73.13 109.839 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 436' ' ' LYS . 9.0 p-10 -94.57 19.56 9.65 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 123.763 0.825 . . . . 71.22 111.393 -176.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.496 ' HA3' ' SG ' ' A' ' 437' ' ' CYS . . . -164.16 -163.33 16.89 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 107.829 -2.108 . . . . 65.51 107.829 177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -90.62 -42.42 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.251 0 CA-C-N 120.67 2.235 . . . . 74.54 112.717 176.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -162.6 166.43 24.66 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 106.84 -1.541 . . . . 70.31 106.84 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -77.44 158.27 30.1 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.362 0.601 . . . . 74.23 112.042 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 27.4 p -161.04 165.92 28.99 Favored 'General case' 0 N--CA 1.407 -2.614 0 CA-C-N 114.567 -1.197 . . . . 64.34 109.464 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.26 151.24 19.03 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.223 0.535 . . . . 75.1 110.536 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 8.7 tt -114.16 128.56 71.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 CA-C-N 115.415 -0.811 . . . . 75.42 109.281 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.452 ' CG2' ' HB ' ' A' ' 441' ' ' ILE . 3.4 t -114.13 127.88 71.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-O 121.561 0.696 . . . . 73.42 111.348 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 33.1 p -108.53 114.91 29.12 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 107.943 -1.132 . . . . 75.04 107.943 174.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.81 116.48 44.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.438 -0.949 . . . . 71.45 108.438 -178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -113.83 -173.33 2.25 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 121.021 -0.271 . . . . 74.41 111.328 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.427 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 42.9 t -58.73 129.26 41.24 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 123.621 0.768 . . . . 61.03 111.338 -178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.479 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -160.8 -177.6 34.04 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 110.676 -0.969 . . . . 63.53 110.676 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.44 -34.97 7.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 109.24 -0.652 . . . . 73.01 109.24 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -156.63 160.84 39.77 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 116.024 -0.535 . . . . 74.21 109.675 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 4.1 m120 -60.48 106.12 0.51 Allowed 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 123.703 0.801 . . . . 75.01 112.64 175.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -131.89 148.72 52.56 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.987 -1.006 . . . . 74.55 108.914 176.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 367' ' ' ARG . 36.4 mm -90.41 120.21 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.378 -1.712 . . . . 75.15 106.378 175.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 442' ' ' LYS . 53.5 t -84.66 -48.92 16.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 112.222 0.452 . . . . 44.51 112.222 -176.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 58.2 p -164.82 163.63 21.18 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.925 -0.31 . . . . 74.45 110.66 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.457 HG12 HG21 ' A' ' 369' ' ' ILE . 4.3 p -142.04 119.84 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 123.889 0.743 . . . . 74.14 109.436 176.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 26.8 tp -125.85 137.56 53.76 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.521 -0.918 . . . . 64.32 108.521 -176.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -79.67 116.91 20.14 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.148 -1.056 . . . . 63.25 108.148 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -80.85 -58.08 3.26 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.395 -0.82 . . . . 75.34 110.649 -175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -109.27 -78.44 0.59 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.746 -0.661 . . . . 75.41 110.178 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.439 ' HB2' ' ND2' ' A' ' 410' ' ' ASN . 0.0 OUTLIER -160.67 -40.32 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.627 0.727 . . . . 55.43 111.141 175.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . 0.496 ' SG ' ' HA3' ' A' ' 411' ' ' GLY . 62.5 m -110.86 8.6 22.3 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.19 -1.041 . . . . 64.22 108.19 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.8 tt0 -131.75 131.37 42.94 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.064 -0.971 . . . . 72.22 109.568 -175.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -122.12 150.43 42.2 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.257 -0.883 . . . . 70.32 109.626 -175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 440' ' ' LEU . 4.3 pp -107.3 122.8 47.29 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 107.645 -1.242 . . . . 73.14 107.645 175.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.452 ' HB ' ' CG2' ' A' ' 418' ' ' VAL . 96.1 mt -118.96 129.89 74.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 CA-C-N 115.352 -0.84 . . . . 74.43 110.296 -175.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.469 ' HB3' ' HB ' ' A' ' 429' ' ' VAL . 15.7 tppt? -97.86 138.63 34.93 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.489 -0.93 . . . . 73.13 108.489 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.419 ' SD ' HG11 ' A' ' 376' ' ' VAL . 80.9 mtp -141.93 168.05 20.68 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 110.145 -0.317 . . . . 75.12 110.145 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.1 mmtt -135.7 160.41 38.63 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.834 -0.802 . . . . 61.43 108.834 177.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . 0.497 ' HB2' ' ND2' ' A' ' 426' ' ' ASN . 33.6 t -166.58 147.27 5.28 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 124.058 0.849 . . . . 75.33 109.102 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.62 -26.44 53.89 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.484 2.123 . . . . 64.12 111.23 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -77.55 -18.69 56.7 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.242 -0.89 . . . . 42.21 110.646 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -96.36 13.61 27.16 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.689 0.757 . . . . 65.14 109.864 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 11.6 t -103.17 146.84 27.81 Favored 'General case' 0 N--CA 1.41 -2.428 0 N-CA-C 107.38 -1.341 . . . . 64.34 107.38 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.416 -2.166 0 N-CA-C 107.651 -1.24 . . . . 52.13 107.651 -179.133 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 58.4 t80 . . . . . 0 C--O 1.222 -0.369 0 N-CA-C 109.699 -0.482 . . . . 72.35 109.699 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.501 ' HB2' ' HB1' ' A' ' 447' ' ' ALA . 65.2 mtp180 -138.24 164.63 28.73 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-O 120.978 0.418 . . . . 72.25 110.838 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -140.94 143.11 34.39 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.527 -1.657 . . . . 74.3 106.527 170.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 50.2 mm -82.94 116.95 28.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-O 120.389 0.137 . . . . 74.04 110.74 -174.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.635 ' HD3' ' H ' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -82.51 131.36 35.22 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 111.925 0.343 . . . . 73.23 111.925 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . 0.453 ' H ' ' HB2' ' A' ' 378' ' ' PHE . . . 69.8 67.24 1.98 Allowed Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.577 -0.738 . . . . 55.23 112.739 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 51.6 ttp -146.39 -27.91 0.41 Allowed 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.815 -1.18 . . . . 65.14 107.815 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.45 ' CD ' HG13 ' A' ' 377' ' ' VAL 0.263 0.4 OUTLIER 65.7 139.53 0.02 OUTLIER 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 116.618 2.081 . . . . 72.12 116.618 170.388 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.566 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 39.4 m -128.56 133.36 48.35 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.513 -1.221 . . . . 71.1 109.673 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.664 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 60.4 mtpt -139.36 141.53 37.6 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.072 -0.714 . . . . 72.35 109.072 176.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -161.6 136.95 7.55 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.058 -1.09 . . . . 72.14 108.058 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -86.72 122.98 31.37 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 120.805 0.336 . . . . 61.11 110.279 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.473 HG21 HG12 ' A' ' 431' ' ' VAL . 49.0 mt -133.02 123.68 48.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.174 -1.417 . . . . 63.44 107.174 -175.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.65 8.39 46.63 Favored Glycine 0 C--N 1.309 -0.968 0 C-N-CA 120.821 -0.704 . . . . 74.23 112.124 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 109.94 -23.2 21.97 Favored Glycine 0 N--CA 1.426 -1.996 0 C-N-CA 121.363 -0.446 . . . . 32.43 112.805 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -98.83 143.84 28.71 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 120.677 0.275 . . . . 64.11 110.81 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 57.0 m -86.1 121.03 28.13 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 116.486 -0.325 . . . . 70.24 110.248 -178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.96 137.68 32.18 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.128 -0.693 . . . . 50.04 109.128 176.072 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.486 ' HG3' ' HG2' ' A' ' 366' ' ' LYS . 37.0 ttpt -131.83 129.92 41.08 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.618 -0.512 . . . . 64.24 109.618 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.566 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.0 p -124.85 117.19 49.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-O 121.068 0.461 . . . . 73.05 109.987 176.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.45 HG13 ' CD ' ' A' ' 364' ' ' GLU . 27.6 t -103.71 117.55 49.39 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.137 0 N-CA-C 107.063 -1.458 . . . . 62.45 107.063 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.468 ' HB2' ' HA ' ' A' ' 361' ' ' LYS . 88.7 m-85 -63.88 124.35 21.3 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.555 -0.748 . . . . 70.04 111.994 -173.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 72.79 12.7 5.23 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.064 1.346 . . . . 73.21 113.127 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -125.42 -80.8 0.62 Allowed 'General case' 0 C--O 1.246 0.869 0 N-CA-C 113.645 0.98 . . . . 73.22 113.645 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -160.3 166.9 28.62 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.997 0.74 . . . . 73.45 112.997 -171.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.445 HG22 HG23 ' A' ' 376' ' ' VAL . 74.0 t -125.42 142.32 42.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.932 -1.031 . . . . 74.41 108.423 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -131.7 150.09 52.27 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 123.069 0.547 . . . . 74.4 111.641 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.5 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.6 tt0 -122.62 103.95 9.02 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 106.912 -1.514 . . . . 74.32 106.912 173.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 14.5 t70 72.6 -70.76 0.15 Allowed 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 125.281 1.433 . . . . 63.14 109.479 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . 0.406 ' H ' ' H ' ' A' ' 387' ' ' ILE . 28.6 t -152.87 -0.61 0.26 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.137 -0.938 . . . . 33.21 108.727 176.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.406 ' H ' ' H ' ' A' ' 386' ' ' SER . 62.6 mt -86.42 136.62 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 109.313 -0.625 . . . . 73.31 109.313 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.523 HD21 HD21 ' A' ' 391' ' ' ASN . 63.8 tp -76.27 112.54 12.86 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.288 -1.005 . . . . 72.34 108.288 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.627 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -78.93 -63.83 1.32 Allowed 'General case' 0 N--CA 1.393 -3.313 0 N-CA-C 108.507 -0.923 . . . . 74.35 108.507 -176.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.03 160.88 32.0 Favored Glycine 0 CA--C 1.478 -2.271 0 C-N-CA 119.937 -1.125 . . . . 72.13 110.974 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.523 HD21 HD21 ' A' ' 388' ' ' LEU . 49.3 m-80 -109.53 149.55 29.46 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.175 -1.046 . . . . 62.1 108.175 176.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.542 ' HD2' ' NE2' ' A' ' 395' ' ' GLN . 1.4 m-85 -69.82 122.36 19.08 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 120.814 0.34 . . . . 75.43 110.889 -176.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -99.09 -48.2 4.94 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.973 -0.558 . . . . 71.11 110.909 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 58.6 m -165.74 142.81 5.49 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.887 -1.153 . . . . 64.43 107.887 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.542 ' NE2' ' HD2' ' A' ' 392' ' ' PHE . 40.0 mt-30 -126.51 141.87 51.73 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.012 -1.107 . . . . 73.45 108.012 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -129.13 110.23 11.84 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.559 -0.456 . . . . 62.41 110.294 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 71.19 -101.07 0.92 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 121.008 -0.615 . . . . 74.04 111.891 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -125.61 18.44 8.07 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.408 -0.59 . . . . 74.33 109.408 178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 24.2 t -118.54 116.52 51.56 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.955 0 N-CA-C 107.322 -1.362 . . . . 73.5 107.322 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' A' ' 395' ' ' GLN . 14.8 mt -111.16 125.09 53.42 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 116.118 -0.492 . . . . 73.34 110.079 -171.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -105.14 123.74 48.35 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 112.997 0.74 . . . . 75.43 112.997 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.422 ' O ' ' HB2' ' A' ' 415' ' ' SER . 2.6 m-85 -117.77 139.75 50.63 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.971 -1.122 . . . . 73.2 107.971 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 415' ' ' SER . 70.8 mm-40 -142.54 175.2 9.97 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 124.275 1.03 . . . . 74.44 109.39 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 53.55 47.01 24.91 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 114.423 1.268 . . . . 62.41 114.423 173.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.627 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -80.88 -148.29 5.74 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.349 -0.841 . . . . 73.33 111.413 172.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.19 141.01 43.66 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.333 -1.358 . . . . 70.02 107.333 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 34.3 p -60.78 132.98 55.6 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.149 0.58 . . . . 53.1 112.482 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 7.7 p -111.91 158.57 19.31 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.425 -0.807 . . . . 72.54 109.19 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 20.1 p-90 -76.11 -33.24 59.48 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.823 0.821 . . . . 72.44 109.539 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -95.1 12.98 26.74 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.74 -1.118 . . . . 53.15 112.674 -172.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -167.99 -170.51 32.83 Favored Glycine 0 C--N 1.306 -1.087 0 N-CA-C 109.736 -1.346 . . . . 75.11 109.736 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -85.85 -40.03 0.08 OUTLIER 'Trans proline' 0 CA--C 1.545 1.063 0 CA-C-N 119.674 1.737 . . . . 73.2 112.796 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -161.21 158.46 27.39 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 106.767 -1.568 . . . . 73.24 106.767 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.404 ' HA ' ' HB3' ' A' ' 437' ' ' CYS . 58.3 mtt180 -78.57 157.57 28.74 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.192 -0.603 . . . . 73.41 111.946 172.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 51.4 p -160.22 169.45 23.2 Favored 'General case' 0 N--CA 1.412 -2.367 0 CA-C-N 115.007 -0.997 . . . . 65.23 109.78 -178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -159.98 151.96 20.4 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.287 0.565 . . . . 71.51 110.553 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.4 tt -118.01 127.73 75.2 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 CA-C-N 115.06 -0.973 . . . . 64.42 108.821 174.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.7 t -113.93 129.87 69.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.336 0.589 . . . . 71.14 112.477 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 14.2 p -108.35 113.87 27.28 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.999 -1.0 . . . . 63.04 108.361 175.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 39.6 t -101.53 115.08 42.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-O 120.74 0.305 . . . . 64.33 110.291 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.494 ' OE1' ' HD2' ' A' ' 442' ' ' LYS . 47.9 mt-10 -108.07 -176.38 3.04 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.816 0.341 . . . . 73.02 111.113 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.436 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 36.5 t -60.24 130.99 49.37 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.006 0.922 . . . . 74.52 111.795 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -157.86 -177.61 31.12 Favored Glycine 0 N--CA 1.421 -2.334 0 N-CA-C 109.98 -1.248 . . . . 74.21 109.98 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 61.9 t -97.36 -28.52 3.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 108.371 -0.974 . . . . 72.11 108.371 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -152.42 151.81 31.24 Favored 'General case' 0 CA--C 1.478 -1.815 0 CA-C-N 115.103 -0.953 . . . . 52.05 108.867 -176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.695 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 18.4 p-10 -66.73 105.43 1.56 Allowed 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 113.286 -1.779 . . . . 71.24 110.96 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -131.29 148.27 52.67 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.111 -0.95 . . . . 73.15 110.612 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 26.8 mm -88.28 120.39 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 105.969 -1.863 . . . . 75.54 105.969 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 62.9 t -83.1 -50.76 15.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 CA-C-O 120.845 0.355 . . . . 53.11 111.586 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 48.4 m -164.17 164.5 22.65 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.248 -0.649 . . . . 62.12 109.248 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.473 HG12 HG21 ' A' ' 369' ' ' ILE . 2.8 p -142.05 114.38 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 123.814 0.846 . . . . 65.51 109.245 177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . 0.458 ' O ' HD23 ' A' ' 440' ' ' LEU . 30.7 tp -120.85 138.86 53.85 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 108.895 -0.78 . . . . 73.3 108.895 -175.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -80.37 110.69 16.06 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 119.743 -0.783 . . . . 74.1 109.757 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.405 ' H ' ' HA ' ' A' ' 439' ' ' TYR . . . -74.64 -38.53 62.47 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.027 -0.988 . . . . 65.21 111.249 -175.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -127.64 -80.01 0.59 Allowed 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.609 -0.723 . . . . 72.45 111.683 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -166.73 -36.32 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.3 -0.864 . . . . 73.3 109.772 -174.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . 0.404 ' HB3' ' HA ' ' A' ' 414' ' ' ARG . 97.8 m -122.02 -2.63 9.16 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 115.108 -0.951 . . . . 73.44 109.913 174.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.6 tt0 -119.0 134.43 55.2 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.192 -0.913 . . . . 75.53 109.049 -177.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . 0.405 ' HA ' ' H ' ' A' ' 434' ' ' ALA . 35.9 m-85 -126.04 150.18 48.31 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 123.743 0.652 . . . . 72.21 110.057 -174.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.8 pt? -105.67 123.22 47.58 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.069 -1.085 . . . . 73.11 108.069 173.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.4 mt -122.26 129.93 74.93 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 CA-C-N 115.088 -0.96 . . . . 71.13 109.361 -177.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.494 ' HD2' ' OE1' ' A' ' 421' ' ' GLU . 36.5 ttpt -107.65 142.3 37.82 Favored 'General case' 0 N--CA 1.422 -1.836 0 C-N-CA 119.847 -0.741 . . . . 73.12 110.026 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 78.5 mtp -136.44 168.54 19.25 Favored 'General case' 0 N--CA 1.432 -1.362 0 C-N-CA 123.248 0.619 . . . . 43.44 109.56 -176.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.695 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 70.4 mmtt -131.93 153.52 50.19 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.179 -1.415 . . . . 72.1 107.179 175.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 74.8 m -161.78 150.33 12.74 Favored Pre-proline 0 C--N 1.287 -2.115 0 O-C-N 123.798 0.686 . . . . 65.22 110.346 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.99 -27.16 66.18 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.832 2.355 . . . . 63.14 112.348 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 358' ' ' ARG . . . -82.77 -12.23 57.67 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.708 -0.678 . . . . 61.12 111.9 -177.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -99.48 13.45 33.28 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-O 121.627 0.727 . . . . 74.05 109.845 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 9.6 t -103.41 119.55 39.1 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 115.272 -0.876 . . . . 65.11 108.981 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 C--N 1.31 -1.126 0 C-N-CA 123.871 0.868 . . . . 50.2 108.853 -179.231 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' A' ' 447' ' ' ALA . 54.0 p90 . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.878 -0.416 . . . . 75.34 109.878 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 397' ' ' GLY . 96.4 mtt180 -134.81 -116.62 0.19 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.065 0.765 . . . . 72.4 113.065 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -147.64 153.19 39.05 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.694 -0.854 . . . . 63.54 108.694 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.15 116.88 25.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 108.278 -1.008 . . . . 72.22 108.278 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -89.34 155.18 19.52 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.869 -0.605 . . . . 71.13 112.368 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 68.36 12.15 63.04 Favored Glycine 0 C--O 1.227 -0.302 0 CA-C-N 115.338 -0.846 . . . . 72.12 113.622 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 51.2 ttp -91.18 -28.76 17.65 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.897 0.348 . . . . 63.32 110.993 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 69.72 124.54 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.627 1.171 . . . . 72.41 111.798 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.462 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 80.1 m -125.82 121.36 33.06 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 108.963 -0.754 . . . . 71.23 108.963 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 60.4 mtpt -133.2 140.61 47.64 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 110.106 -0.331 . . . . 63.32 110.106 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -158.08 134.33 9.42 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.395 -0.595 . . . . 62.12 109.395 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 2.8 mp0 -78.58 125.91 30.02 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 110.038 -0.356 . . . . 72.02 110.038 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.467 HG21 HG12 ' A' ' 431' ' ' VAL . 54.4 mt -130.92 117.54 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 N-CA-C 106.863 -1.532 . . . . 75.05 106.863 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 67.24 9.98 55.77 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.555 -0.831 . . . . 74.14 112.592 -177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.59 -7.7 39.56 Favored Glycine 0 N--CA 1.432 -1.597 0 C-N-CA 120.267 -0.968 . . . . 54.12 113.406 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . 0.404 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 15.4 p90 -114.0 136.61 52.72 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.94 0.37 . . . . 75.21 110.168 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 61.8 m -79.85 121.0 24.86 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 116.288 -0.414 . . . . 73.14 111.411 -178.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.67 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.6 OUTLIER -90.96 124.49 35.26 Favored 'General case' 0 N--CA 1.414 -2.244 0 C-N-CA 120.249 -0.58 . . . . 73.13 109.74 174.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 86.4 tttt -120.31 125.44 48.05 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.488 -0.778 . . . . 74.43 109.83 -174.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.462 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.3 p -127.64 116.14 42.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-O 121.425 0.631 . . . . 71.14 110.423 176.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.24 116.44 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 N-CA-C 107.145 -1.428 . . . . 61.33 107.145 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.469 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 75.4 m-85 -61.13 132.43 53.72 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.778 -1.101 . . . . 74.35 112.854 -171.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 64.97 17.84 11.24 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 124.6 1.16 . . . . 75.3 112.283 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -130.93 -84.42 0.52 Allowed 'General case' 0 C--O 1.243 0.722 0 N-CA-C 113.534 0.939 . . . . 74.42 113.534 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -158.65 163.73 36.63 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.726 1.01 . . . . 73.23 113.726 -170.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 99.1 t -125.55 143.7 38.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 124.505 1.122 . . . . 65.21 109.151 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 375' ' ' LYS . 91.6 m-85 -133.91 146.5 50.59 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 122.759 0.423 . . . . 63.21 111.368 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.533 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.8 tt0 -110.99 99.42 8.31 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 105.402 -2.074 . . . . 73.5 105.402 172.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.4 t70 73.23 -72.93 0.11 Allowed 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 125.465 1.506 . . . . 62.3 109.816 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.9 t -148.63 -5.15 0.43 Allowed 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 114.913 -1.039 . . . . 64.42 109.093 176.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 63.8 mt -77.78 134.65 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.356 -0.979 . . . . 75.14 108.356 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.428 HD21 HD21 ' A' ' 391' ' ' ASN . 65.2 tp -75.81 113.69 13.57 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.561 -0.903 . . . . 74.02 108.561 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.533 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.6 OUTLIER -80.73 -63.51 1.39 Allowed 'General case' 0 N--CA 1.383 -3.796 0 N-CA-C 108.348 -0.982 . . . . 64.04 108.348 -176.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.48 160.39 31.33 Favored Glycine 0 N--CA 1.413 -2.886 0 C-N-CA 119.091 -1.528 . . . . 64.22 111.429 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.428 HD21 HD21 ' A' ' 388' ' ' LEU . 41.6 m-80 -108.6 146.58 33.13 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 107.11 -1.441 . . . . 72.12 107.11 176.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.469 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.4 m-85 -68.74 125.88 27.96 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 120.634 0.254 . . . . 72.32 110.585 -176.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -100.36 -48.2 4.66 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.954 0.407 . . . . 73.23 109.947 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 42.4 p -164.22 162.02 22.38 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.686 -0.688 . . . . 73.11 109.488 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.514 ' CG ' HD22 ' A' ' 400' ' ' LEU . 18.5 mp0 -128.4 122.58 31.72 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 108.919 -0.771 . . . . 65.42 108.919 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -97.14 109.99 22.63 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.371 -0.974 . . . . 74.41 108.371 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.55 ' O ' ' HG2' ' A' ' 358' ' ' ARG . . . 55.68 -100.72 0.1 Allowed Glycine 0 N--CA 1.436 -1.345 0 O-C-N 123.921 0.763 . . . . 74.24 112.401 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -122.87 19.26 10.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.948 0.88 . . . . 65.33 109.436 -176.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 66.8 t -123.51 116.9 49.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 107.525 -1.287 . . . . 62.45 107.525 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.514 HD22 ' CG ' ' A' ' 395' ' ' GLN . 12.1 mt -107.19 132.57 52.91 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 116.278 -0.419 . . . . 73.23 110.88 -169.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -103.63 122.82 45.79 Favored 'General case' 0 C--O 1.247 0.955 0 N-CA-C 112.718 0.636 . . . . 73.02 112.718 176.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.47 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.5 m-85 -118.58 132.39 56.2 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.013 -1.477 . . . . 74.22 107.013 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.404 ' HA ' ' CB ' ' A' ' 415' ' ' SER . 7.6 pt-20 -147.59 174.91 11.3 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 112.478 0.548 . . . . 73.4 112.478 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.21 41.22 13.68 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 113.704 -1.589 . . . . 73.12 111.766 170.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.37 -133.24 0.61 Allowed Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.138 -0.937 . . . . 72.31 112.607 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 1.0 OUTLIER -84.8 141.96 30.12 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.436 -0.95 . . . . 75.02 108.436 -177.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 42.9 t -60.7 132.75 54.87 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.874 0.845 . . . . 63.53 112.232 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . 0.506 ' HB2' ' OD1' ' A' ' 410' ' ' ASN . 5.9 p -108.93 158.53 17.6 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.611 -0.722 . . . . 75.32 110.125 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 32.9 p-90 -74.46 -28.86 61.21 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 122.164 0.983 . . . . 72.03 108.6 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . 0.506 ' OD1' ' HB2' ' A' ' 408' ' ' CYS . 8.3 p-10 -96.22 13.41 27.54 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 113.997 -1.456 . . . . 63.24 113.147 -173.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -177.26 -167.22 35.3 Favored Glycine 0 C--O 1.22 -0.72 0 N-CA-C 110.229 -1.148 . . . . 71.23 110.229 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -87.56 -39.52 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.923 0 CA-C-N 119.581 1.69 . . . . 64.11 112.486 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -159.9 158.43 30.85 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 107.191 -1.411 . . . . 73.23 107.191 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -76.81 162.23 27.81 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.134 -0.627 . . . . 64.41 111.026 172.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 47.4 p -164.35 163.09 22.55 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 114.905 -1.043 . . . . 44.14 108.821 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -158.94 146.9 17.9 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.169 0.509 . . . . 74.42 110.551 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 7.4 tt -113.38 126.96 70.9 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 CA-C-N 115.266 -0.879 . . . . 73.22 108.919 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.564 HG22 ' HB ' ' A' ' 441' ' ' ILE . 7.4 t -112.68 131.45 64.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-O 121.108 0.48 . . . . 71.22 111.937 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 35.0 p -107.26 114.14 27.99 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 107.664 -1.235 . . . . 72.04 107.664 175.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 43.1 t -100.82 112.97 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 N-CA-C 107.537 -1.283 . . . . 73.22 107.537 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -115.58 -173.65 2.37 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 120.917 -0.313 . . . . 74.24 110.211 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.547 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 36.9 t -59.18 128.32 36.59 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 122.974 0.51 . . . . 52.31 111.256 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -159.8 -176.1 31.51 Favored Glycine 0 CA--C 1.493 -1.305 0 CA-C-N 115.796 -0.638 . . . . 73.14 111.529 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.0 t -80.58 -38.55 17.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 109.485 -0.561 . . . . 71.2 109.485 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 446' ' ' PRO . 45.6 tt0 -171.08 162.24 7.04 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 123.51 0.724 . . . . 71.13 109.321 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 20.9 m120 -61.52 101.38 0.18 Allowed 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 114.996 -1.002 . . . . 72.25 112.306 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -132.02 149.04 52.53 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 114.6 -1.182 . . . . 62.14 108.651 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 30.5 mm -81.51 118.23 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.791 -1.559 . . . . 63.43 106.791 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 63.8 t -81.24 -50.35 16.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-O 120.716 0.293 . . . . 65.32 111.664 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 42.4 p -166.92 165.68 15.86 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.138 -0.483 . . . . 62.43 109.972 -173.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.467 HG12 HG21 ' A' ' 369' ' ' ILE . 4.3 p -142.0 125.13 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 108.822 -0.807 . . . . 74.0 108.822 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . 0.437 ' O ' HD23 ' A' ' 440' ' ' LEU . 27.2 tp -126.48 136.58 52.8 Favored 'General case' 0 C--N 1.281 -2.375 0 N-CA-C 107.66 -1.237 . . . . 74.24 107.66 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -81.18 108.48 14.86 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.674 -0.862 . . . . 62.13 108.674 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . 0.439 ' H ' ' HA ' ' A' ' 439' ' ' TYR . . . -65.31 -61.18 2.27 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 123.74 0.816 . . . . 71.53 110.781 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -109.33 -75.02 0.64 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.925 -0.58 . . . . 73.34 110.705 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -165.84 -43.02 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.795 -1.093 . . . . 65.41 109.892 -174.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 93.4 m -118.74 14.72 13.49 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 121.969 0.89 . . . . 74.21 109.539 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 415' ' ' SER . 37.1 tt0 -135.14 131.19 36.53 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 108.111 -1.07 . . . . 55.34 108.111 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . 0.439 ' HA ' ' H ' ' A' ' 434' ' ' ALA . 45.0 m-85 -123.08 150.77 42.73 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 124.005 0.816 . . . . 74.13 110.261 -174.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.8 pt? -110.4 122.09 46.87 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.736 -1.209 . . . . 74.31 107.736 172.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.564 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.5 mt -121.28 133.84 66.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 CA-C-N 115.41 -0.814 . . . . 73.32 109.501 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -103.48 140.84 36.95 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 109.131 -0.692 . . . . 63.12 109.131 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.412 ' SD ' HG11 ' A' ' 418' ' ' VAL . 87.4 mtp -138.54 163.36 32.19 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.267 -1.012 . . . . 70.33 108.267 177.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.684 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 73.0 mmtt -130.68 161.3 31.93 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.728 -0.842 . . . . 63.24 108.728 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . 0.417 ' HB2' ' ND2' ' A' ' 426' ' ' ASN . 30.2 t -167.77 147.62 4.42 Favored Pre-proline 0 C--N 1.296 -1.742 0 O-C-N 123.746 0.654 . . . . 74.01 109.759 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 425' ' ' GLU . 55.4 Cg_endo -70.55 -21.5 29.75 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.204 1.936 . . . . 71.43 110.129 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 357' ' ' TYR . . . -75.4 -18.47 59.92 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.83 -1.077 . . . . 41.23 110.775 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -100.84 7.03 43.92 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.751 0.786 . . . . 72.55 109.093 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 13.2 t -103.56 121.26 42.53 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 115.05 -0.977 . . . . 73.04 108.914 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 C--N 1.295 -1.762 0 N-CA-C 108.508 -0.923 . . . . 74.43 108.508 177.361 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 CA--C 1.505 -0.761 0 N-CA-C 110.082 -0.34 . . . . 73.01 110.082 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -129.63 -179.16 5.02 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.206 0.527 . . . . 73.14 110.216 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -88.29 154.07 20.7 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 115.14 -0.936 . . . . 64.5 110.137 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 47.8 mm -79.21 129.89 36.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 107.053 -1.462 . . . . 65.42 107.053 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.584 ' HD3' ' H ' ' A' ' 361' ' ' LYS . 0.2 OUTLIER -109.96 158.44 18.23 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.504 0.927 . . . . 74.43 113.504 -172.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 97.03 -34.52 5.01 Favored Glycine 0 CA--C 1.504 -0.618 0 CA-C-N 115.494 -0.776 . . . . 61.33 111.949 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 51.2 ttp -76.61 132.47 39.47 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 120.903 0.382 . . . . 75.43 111.353 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -74.27 115.38 13.71 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.823 -0.806 . . . . 74.25 108.823 176.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.466 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 59.1 m -103.16 120.3 40.45 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 106.754 -1.573 . . . . 74.42 106.754 173.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 19.4 ptmt -142.29 141.44 32.43 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 111.989 0.366 . . . . 61.04 111.989 -176.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.41 ' NH1' HG12 ' A' ' 369' ' ' ILE . 3.2 tmt_? -159.57 132.18 6.69 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.442 -0.799 . . . . 71.55 109.027 -178.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 44.1 mt-10 -77.93 129.97 36.0 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 116.147 -0.478 . . . . 71.01 110.525 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.485 HG21 HG12 ' A' ' 431' ' ' VAL . 35.5 mt -135.02 121.53 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 106.831 -1.544 . . . . 74.31 106.831 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.39 11.54 56.47 Favored Glycine 0 C--N 1.308 -0.999 0 C-N-CA 120.837 -0.697 . . . . 73.21 112.646 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 110.77 -23.38 19.76 Favored Glycine 0 N--CA 1.429 -1.771 0 C-N-CA 121.186 -0.53 . . . . 70.13 112.85 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -101.81 141.6 34.42 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 122.514 -0.403 . . . . 74.05 111.361 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 90.1 m -81.71 117.56 22.14 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.56 0.219 . . . . 52.53 110.581 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.32 133.6 34.86 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 108.36 -0.978 . . . . 74.42 108.36 174.264 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.48 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 36.8 ttpt -136.84 127.15 26.48 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 120.635 -0.426 . . . . 72.23 110.167 -176.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.489 HG23 HG22 ' A' ' 382' ' ' VAL . 6.5 p -120.63 119.34 59.36 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-O 121.181 0.515 . . . . 74.24 110.337 177.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 57.8 t -110.47 116.15 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 106.451 -1.685 . . . . 52.34 106.451 173.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.527 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 74.9 m-85 -65.56 135.7 55.44 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.018 -0.992 . . . . 63.33 113.496 -170.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 64.99 11.75 7.32 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 124.764 1.226 . . . . 73.53 112.306 -176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -122.61 -84.46 0.66 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 112.548 0.573 . . . . 71.32 112.548 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.46 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -166.09 156.59 12.76 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 113.05 0.759 . . . . 73.01 113.05 -171.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.492 HG21 ' CD2' ' A' ' 402' ' ' TYR . 60.9 t -115.05 147.59 18.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 124.293 1.037 . . . . 65.21 109.141 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.46 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 85.4 m-85 -134.72 145.32 48.37 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.04 0.536 . . . . 72.33 112.119 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.529 ' HB2' HD23 ' A' ' 389' ' ' LEU . 33.2 tt0 -116.68 100.06 7.56 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 105.945 -1.872 . . . . 70.22 105.945 171.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.3 t70 71.52 -82.34 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 124.082 0.953 . . . . 54.11 109.901 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 36.8 t -138.52 -3.43 1.7 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.288 -1.004 . . . . 64.14 108.288 176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.634 HD12 HE22 ' A' ' 406' ' ' GLN . 50.2 mm -77.19 132.47 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 N-CA-C 108.854 -0.795 . . . . 74.44 108.854 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.1 tp -76.45 109.56 10.28 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.763 -1.569 . . . . 74.34 106.763 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.7 OUTLIER -76.41 -62.65 1.55 Allowed 'General case' 0 N--CA 1.389 -3.512 0 N-CA-C 108.94 -0.763 . . . . 71.14 108.94 -175.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.77 157.47 28.7 Favored Glycine 0 N--CA 1.425 -2.089 0 C-N-CA 118.788 -1.673 . . . . 62.25 112.3 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.2 146.02 28.06 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.186 -1.412 . . . . 75.33 107.186 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.527 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 2.1 m-85 -71.84 115.81 11.49 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 109.417 -0.586 . . . . 70.24 109.417 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -99.39 -42.7 6.86 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.293 -0.412 . . . . 73.3 111.172 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 60.3 p -164.41 140.71 6.19 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.885 -0.783 . . . . 72.55 108.885 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.425 ' HB2' ' CD2' ' A' ' 400' ' ' LEU . 0.1 OUTLIER -141.27 145.28 35.32 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.581 -0.282 . . . . 52.25 110.656 177.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -124.8 110.27 14.11 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.875 -0.787 . . . . 73.4 108.875 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 61.86 -105.76 1.01 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.886 -0.597 . . . . 74.34 113.077 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -113.96 17.07 18.13 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.101 0.477 . . . . 75.31 110.892 -176.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.3 t -120.9 118.34 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 106.405 -1.702 . . . . 75.14 106.405 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 395' ' ' GLN . 20.1 mt -119.73 124.83 47.15 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.109 -0.636 . . . . 75.21 111.479 -169.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.437 ' HE3' HD12 ' A' ' 417' ' ' ILE . 19.3 mmtp -100.85 122.27 43.15 Favored 'General case' 0 C--O 1.253 1.24 0 CA-C-O 121.314 0.578 . . . . 61.33 112.366 176.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.492 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.3 m-85 -118.35 130.24 55.89 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.454 -1.313 . . . . 75.31 107.454 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 415' ' ' SER . 10.4 pt-20 -147.22 176.04 10.28 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 122.008 0.123 . . . . 54.42 111.117 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.4 m120 64.97 36.3 7.64 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 123.666 0.604 . . . . 52.14 111.522 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -79.23 -140.16 1.93 Allowed Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.705 -0.76 . . . . 63.01 112.103 176.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.634 HE22 HD12 ' A' ' 387' ' ' ILE . 28.9 tt0 -68.69 150.7 47.62 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 122.447 -0.443 . . . . 72.34 110.001 -177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 44.8 m -64.82 125.47 24.93 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.544 0.688 . . . . 64.12 110.775 -175.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 46.7 t -108.26 124.11 49.8 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 105.342 -2.096 . . . . 71.31 105.342 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -66.36 -37.6 85.67 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.078 0.466 . . . . 72.31 110.823 -174.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -89.89 13.21 15.18 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.787 -0.642 . . . . 70.23 111.743 -174.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.479 ' HA3' ' SG ' ' A' ' 437' ' ' CYS . . . -158.77 -158.75 9.22 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 108.622 -1.791 . . . . 71.53 108.622 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -92.84 -41.55 0.03 OUTLIER 'Trans proline' 0 CA--C 1.557 1.672 0 CA-C-N 120.699 2.25 . . . . 63.1 113.02 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -168.55 161.2 11.45 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 105.893 -1.891 . . . . 73.14 105.893 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 43.6 mtt180 -72.31 157.36 37.84 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.412 0.625 . . . . 63.24 112.481 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 36.2 p -163.18 165.1 24.85 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 114.612 -1.176 . . . . 65.11 109.409 -177.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.1 148.16 16.8 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.182 0.515 . . . . 74.43 110.465 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . 0.437 HD12 ' HE3' ' A' ' 401' ' ' LYS . 7.3 tt -112.86 123.89 68.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 CA-C-N 115.454 -0.794 . . . . 71.4 109.278 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.519 HG22 ' HB ' ' A' ' 441' ' ' ILE . 5.1 t -109.8 129.81 64.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 CA-C-N 115.885 -0.598 . . . . 75.22 111.866 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.1 p -108.32 114.27 28.01 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 107.667 -1.234 . . . . 73.2 107.667 173.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 22.4 t -100.35 123.14 53.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 107.2 -1.407 . . . . 70.23 107.2 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -120.43 -174.12 2.72 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 120.557 -0.457 . . . . 71.14 110.898 -176.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.506 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 41.0 t -62.21 128.65 37.12 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 123.883 0.873 . . . . 35.42 111.56 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.51 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -162.55 -176.8 35.0 Favored Glycine 0 CA--C 1.495 -1.196 0 N-CA-C 111.256 -0.738 . . . . 75.12 111.256 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 98.9 t -86.48 -37.16 11.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-O 120.975 0.417 . . . . 54.1 109.877 177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.449 ' HG2' ' N ' ' A' ' 426' ' ' ASN . 38.5 tt0 -155.87 162.09 40.49 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 109.278 -0.638 . . . . 73.23 109.278 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.692 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 18.8 m120 -63.36 109.1 1.48 Allowed 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 114.591 -1.186 . . . . 64.33 111.147 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -131.45 148.42 52.64 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.646 -1.161 . . . . 41.42 109.013 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 35.5 mm -90.47 113.84 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.364 -1.717 . . . . 73.01 106.364 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 67.3 t -80.89 -44.31 21.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 112.505 0.557 . . . . 53.0 112.505 -174.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 58.1 p -168.57 162.7 12.14 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 110.043 -0.354 . . . . 73.11 110.043 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.485 HG12 HG21 ' A' ' 369' ' ' ILE . 5.7 p -142.03 119.97 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 N-CA-C 108.81 -0.811 . . . . 54.11 108.81 175.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . 0.435 ' O ' HD23 ' A' ' 440' ' ' LEU . 30.9 tp -127.42 138.06 52.88 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 108.156 -1.053 . . . . 75.15 108.156 -177.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -80.47 115.84 20.21 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.155 -0.683 . . . . 71.45 109.155 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -76.59 -67.35 0.71 Allowed 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.478 -0.783 . . . . 52.4 111.014 -176.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -98.08 -76.5 0.53 Allowed 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.764 -0.828 . . . . 62.13 108.764 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.89 -43.85 0.04 OUTLIER 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 115.392 -0.822 . . . . 74.12 110.655 176.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . 0.479 ' SG ' ' HA3' ' A' ' 411' ' ' GLY . 73.6 m -107.38 8.87 29.85 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.64 0.733 . . . . 74.22 109.191 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.8 tt0 -130.62 134.7 47.19 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.201 -0.909 . . . . 75.41 109.035 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -125.86 148.69 49.09 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 123.733 0.646 . . . . 53.53 109.766 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.456 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.6 pt? -105.2 119.24 38.56 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.499 -0.926 . . . . 75.32 108.499 174.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.519 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.4 mt -117.74 134.73 60.41 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 115.365 -0.834 . . . . 65.21 109.551 -177.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -106.17 140.99 38.27 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.806 -0.813 . . . . 74.14 108.806 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 83.1 mtp -138.74 168.56 19.54 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 109.641 -0.503 . . . . 62.01 109.641 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.692 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 72.9 mmtt -133.32 161.17 35.21 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.046 -0.724 . . . . 64.32 109.046 177.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 28.7 t -172.1 148.55 2.05 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 108.639 -0.875 . . . . 64.04 108.639 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.29 -27.49 34.5 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.049 1.832 . . . . 63.31 110.337 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -77.26 -13.51 59.92 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.812 -1.085 . . . . 73.2 110.792 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -102.63 16.96 24.93 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.329 0.585 . . . . 72.32 110.147 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 422' ' ' CYS . 19.6 t -100.31 120.11 39.43 Favored 'General case' 0 N--CA 1.411 -2.381 0 CA-C-O 121.667 0.746 . . . . 65.34 109.3 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 35.3 t . . . . . 0 N--CA 1.425 -1.676 0 N-CA-C 106.614 -1.624 . . . . 64.24 106.614 -177.359 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.714 ' N ' ' HG ' ' A' ' 450' ' ' SER . 36.8 p90 . . . . . 0 C--O 1.224 -0.289 0 CA-C-O 121.641 0.734 . . . . 62.51 110.426 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -146.71 174.58 11.33 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.155 -1.424 . . . . 75.24 107.155 -174.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -129.04 150.12 50.58 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 108.718 -0.845 . . . . 72.2 108.718 175.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 51.9 mt -82.55 116.87 27.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 108.959 -0.756 . . . . 72.21 108.959 -177.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.432 ' HA ' ' CB ' ' A' ' 378' ' ' PHE . 63.1 pttt -84.91 157.34 20.89 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 113.104 0.779 . . . . 73.55 113.104 -175.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 67.8 29.74 73.95 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 114.893 -1.048 . . . . 71.21 113.665 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 49.5 ttm -121.89 143.75 49.26 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.701 -0.481 . . . . 73.3 109.701 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.491 ' HG3' HG22 ' A' ' 377' ' ' VAL . 1.4 mp0 -95.24 130.47 41.97 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 109.571 -0.529 . . . . 55.31 109.571 177.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.499 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 97.4 m -125.69 126.91 45.42 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 107.137 -1.431 . . . . 74.33 107.137 176.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.669 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 59.2 mtpt -136.25 140.7 43.65 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.626 0.25 . . . . 70.34 110.939 -176.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.427 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 4.2 tmt_? -156.74 132.94 9.8 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 109.116 -0.698 . . . . 64.21 109.116 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 3.4 mp0 -79.83 129.17 34.26 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 121.02 -0.272 . . . . 65.45 110.498 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.459 HG21 HG12 ' A' ' 431' ' ' VAL . 48.6 mt -136.14 121.12 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 106.117 -1.809 . . . . 60.32 106.117 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.67 3.23 19.94 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 121.421 -0.418 . . . . 52.32 113.765 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 112.06 -15.91 25.51 Favored Glycine 0 N--CA 1.433 -1.511 0 C-N-CA 120.7 -0.762 . . . . 64.12 112.627 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -102.82 141.79 35.03 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 109.77 -0.455 . . . . 75.41 109.77 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 91.9 m -87.65 124.25 33.34 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 116.43 -0.35 . . . . 63.03 110.888 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.669 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.7 OUTLIER -90.56 126.61 35.99 Favored 'General case' 0 N--CA 1.406 -2.632 0 C-N-CA 119.894 -0.722 . . . . 65.34 109.804 175.429 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -121.81 124.99 45.47 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.794 -0.817 . . . . 70.23 108.794 -175.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.499 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.4 p -125.1 124.33 67.28 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 109.888 -0.412 . . . . 71.23 109.888 176.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.491 HG22 ' HG3' ' A' ' 364' ' ' GLU . 44.2 t -113.67 116.29 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.692 -1.596 . . . . 72.12 106.692 173.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.432 ' CB ' ' HA ' ' A' ' 361' ' ' LYS . 96.6 m-85 -62.62 126.55 27.73 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.452 -0.794 . . . . 70.01 112.846 -173.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 72.78 14.88 4.89 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 125.104 1.362 . . . . 72.35 112.985 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -126.73 -83.1 0.62 Allowed 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 113.309 0.855 . . . . 72.12 113.309 174.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.459 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.3 OUTLIER -163.3 156.45 19.04 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.138 0.792 . . . . 71.4 113.138 -170.166 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.485 HG22 HG23 ' A' ' 376' ' ' VAL . 91.6 t -116.8 145.2 22.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 124.081 0.952 . . . . 55.5 108.992 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.459 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 90.0 m-85 -134.16 147.72 50.83 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.102 0.477 . . . . 73.22 111.389 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.502 ' HB2' HD23 ' A' ' 389' ' ' LEU . 35.9 tt0 -113.05 98.59 7.25 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 105.972 -1.862 . . . . 71.3 105.972 173.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.5 t70 72.45 -78.57 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 125.445 1.498 . . . . 64.33 109.266 -174.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 14.0 p -142.06 -3.06 1.11 Allowed 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 114.6 -1.182 . . . . 72.31 109.44 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 47.4 mm -80.47 132.01 32.72 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 N-CA-C 108.745 -0.835 . . . . 74.51 108.745 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.516 HD21 HD21 ' A' ' 391' ' ' ASN . 62.1 tp -75.91 113.86 13.89 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 108.797 -0.816 . . . . 63.22 108.797 178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.564 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.3 OUTLIER -80.0 -63.88 1.31 Allowed 'General case' 0 N--CA 1.398 -3.052 0 N-CA-C 109.143 -0.688 . . . . 71.13 109.143 -176.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.06 156.64 27.89 Favored Glycine 0 N--CA 1.42 -2.408 0 C-N-CA 119.114 -1.517 . . . . 62.34 111.53 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.516 HD21 HD21 ' A' ' 388' ' ' LEU . 0.8 OUTLIER -99.71 146.36 26.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.694 -1.595 . . . . 74.33 106.694 176.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.401 ' HD2' HE21 ' A' ' 395' ' ' GLN . 1.6 m-85 -71.27 116.01 11.09 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.282 -0.567 . . . . 73.12 109.917 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -92.28 -47.32 7.26 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.719 -0.673 . . . . 42.52 110.408 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 42.3 p -166.68 141.16 4.12 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 108.939 -0.763 . . . . 60.11 108.939 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.412 ' HB2' HD23 ' A' ' 400' ' ' LEU . 0.1 OUTLIER -142.11 145.71 34.57 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 116.53 -0.305 . . . . 75.45 110.265 178.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -128.14 110.23 12.26 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.753 -0.832 . . . . 71.32 108.753 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 65.59 -101.43 0.58 Allowed Glycine 0 N--CA 1.432 -1.58 0 O-C-N 123.918 0.761 . . . . 43.52 112.624 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . 0.572 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 27.4 p-10 -113.28 6.25 17.27 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.47 -0.365 . . . . 64.34 111.97 -176.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.96 116.27 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.186 0 N-CA-C 107.545 -1.28 . . . . 72.42 107.545 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.412 HD23 ' HB2' ' A' ' 395' ' ' GLN . 19.3 mt -114.4 123.84 50.45 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 116.057 -0.519 . . . . 74.31 110.119 -171.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.426 ' NZ ' ' HB3' ' A' ' 401' ' ' LYS . 3.2 mmmp? -108.58 122.34 46.88 Favored 'General case' 0 C--O 1.251 1.143 0 CA-C-O 120.748 0.309 . . . . 61.11 111.474 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.447 ' CE2' HG21 ' A' ' 382' ' ' VAL . 2.8 m-85 -115.68 133.82 55.65 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.413 -0.958 . . . . 72.11 108.413 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -135.11 171.3 14.62 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.553 -0.536 . . . . 62.21 109.553 -174.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 14.3 m120 54.45 41.1 32.16 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 114.342 1.238 . . . . 63.4 114.342 170.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -78.32 -139.86 1.54 Allowed Glycine 0 CA--C 1.541 1.659 0 C-N-CA 120.795 -0.717 . . . . 62.32 113.479 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -63.24 149.96 44.25 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.656 0.783 . . . . 72.21 110.907 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 412' ' ' PRO . 49.0 p -60.42 118.78 6.89 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 109.315 -0.624 . . . . 74.11 109.315 175.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 51.9 t -101.0 160.23 14.55 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.845 -0.616 . . . . 72.23 109.841 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -78.82 -31.58 45.91 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.345 0.593 . . . . 73.22 110.247 -178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . 0.644 ' HB3' ' SG ' ' A' ' 437' ' ' CYS . 14.2 t-20 -96.8 -11.57 24.75 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.859 0.838 . . . . 54.25 110.446 -171.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -160.2 160.54 31.77 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 109.31 -1.516 . . . . 55.33 109.31 -177.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.478 ' O ' ' HA ' ' A' ' 407' ' ' SER . 11.6 Cg_endo -56.97 -38.77 95.21 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.383 2.056 . . . . 70.43 113.958 -174.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -145.12 158.87 43.7 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.99 -0.374 . . . . 63.15 109.99 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -81.07 167.49 19.68 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 120.999 0.428 . . . . 74.32 111.046 174.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 56.4 p -162.93 160.17 24.52 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 115.261 -0.881 . . . . 65.54 109.064 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -157.18 136.62 12.11 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 121.21 0.528 . . . . 64.44 111.345 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.2 tt -101.43 121.86 52.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-N 115.253 -0.885 . . . . 72.15 110.42 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.529 HG22 ' HB ' ' A' ' 441' ' ' ILE . 3.9 t -108.57 129.53 62.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.635 -0.711 . . . . 72.54 111.746 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 13.4 p -109.84 114.89 28.82 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.188 -0.914 . . . . 75.34 108.896 172.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.572 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 34.1 t -100.43 114.09 38.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.871 -1.159 . . . . 62.05 107.871 -178.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -114.12 -175.85 2.77 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 120.282 -0.567 . . . . 74.52 110.901 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 44.8 t -58.21 129.52 42.36 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.303 0.641 . . . . 64.34 111.442 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.449 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -159.94 -177.73 33.29 Favored Glycine 0 N--CA 1.434 -1.471 0 N-CA-C 110.343 -1.103 . . . . 73.22 110.343 177.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 61.5 t -91.35 -35.28 6.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.074 -0.713 . . . . 72.01 109.074 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -141.6 148.86 39.93 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.878 -0.601 . . . . 71.44 109.42 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.751 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.2 p-10 -67.68 99.12 0.76 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 114.816 -1.084 . . . . 53.43 109.977 174.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -132.43 149.9 52.26 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.174 -0.921 . . . . 62.14 110.526 -175.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.444 HD11 HG12 ' A' ' 376' ' ' VAL . 28.2 mm -81.28 120.7 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 N-CA-C 106.065 -1.828 . . . . 74.31 106.065 175.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 50.4 t -86.77 -50.6 13.9 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 N-CA-C 111.84 0.311 . . . . 74.14 111.84 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 43.5 p -164.66 163.8 21.55 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 110.204 -0.295 . . . . 72.2 110.204 -174.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.459 HG12 HG21 ' A' ' 369' ' ' ILE . 3.4 p -142.0 117.07 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.507 0 CA-C-O 121.403 0.62 . . . . 65.13 109.475 177.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 22.3 tp -114.31 134.99 54.56 Favored 'General case' 0 C--N 1.272 -2.803 0 N-CA-C 107.587 -1.264 . . . . 63.45 107.587 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -81.59 113.21 19.46 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 106.791 -1.559 . . . . 74.32 106.791 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.1 -60.8 2.1 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 108.872 -0.788 . . . . 62.02 108.872 -173.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.583 ' C ' ' HD2' ' A' ' 436' ' ' LYS . 49.9 mm-40 -107.04 -84.45 0.52 Allowed 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 106.884 -1.524 . . . . 72.02 106.884 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.583 ' HD2' ' C ' ' A' ' 435' ' ' GLN . 3.9 mptp? -147.66 -56.53 0.24 Allowed 'General case' 0 CA--C 1.5 -0.942 0 C-N-CA 124.468 1.107 . . . . 64.24 109.376 176.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . 0.644 ' SG ' ' HB3' ' A' ' 410' ' ' ASN . 57.3 m -90.97 -9.24 46.77 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.569 -1.196 . . . . 71.55 110.526 -176.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 415' ' ' SER . 33.8 tt0 -114.46 128.76 56.5 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 114.48 -1.237 . . . . 64.34 109.314 -175.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 44.2 m-85 -124.84 150.23 46.63 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 123.502 0.501 . . . . 61.34 110.412 -176.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.426 ' O ' HD12 ' A' ' 440' ' ' LEU . 4.3 pp -111.6 125.12 53.6 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.921 -1.511 . . . . 64.15 106.921 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.529 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.6 mt -122.16 133.13 69.4 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 116.234 -0.439 . . . . 65.43 110.602 -174.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -98.55 138.53 35.62 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 109.178 -0.675 . . . . 63.13 109.178 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.407 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.6 mtp -140.25 162.06 36.18 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 109.153 -0.684 . . . . 73.42 109.153 175.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.751 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.9 mmtt -132.22 161.08 34.31 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 107.257 -1.386 . . . . 72.41 107.257 175.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 36.2 t -167.42 147.01 4.46 Favored Pre-proline 0 C--N 1.286 -2.19 0 O-C-N 123.982 0.801 . . . . 73.33 109.03 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.0 -27.77 50.06 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.383 2.056 . . . . 74.21 111.339 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -78.24 -14.79 59.29 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.657 -0.701 . . . . 63.0 110.249 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -95.61 8.94 41.93 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 121.333 0.587 . . . . 43.34 110.227 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 14.0 t -102.59 121.47 42.46 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 108.476 -0.935 . . . . 64.33 108.476 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . 0.714 ' HG ' ' N ' ' A' ' 357' ' ' TYR . 40.8 m . . . . . 0 C--N 1.306 -1.297 0 N-CA-C 108.825 -0.805 . . . . 73.12 108.825 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.491 ' N ' ' HG ' ' A' ' 450' ' ' SER . 81.6 m-85 . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 120.781 0.324 . . . . 74.4 110.589 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -161.41 -176.61 5.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.838 -0.43 . . . . 75.12 109.838 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -125.69 152.22 45.54 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.715 -1.217 . . . . 60.21 107.715 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 48.2 mm -80.9 138.8 19.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.707 -1.22 . . . . 73.25 107.707 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -117.75 157.35 26.7 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 120.856 0.36 . . . . 73.24 111.751 -172.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . 0.53 ' H ' ' HB2' ' A' ' 378' ' ' PHE . . . 86.67 -21.79 16.87 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 116.455 1.342 . . . . 63.15 116.455 172.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.15 155.89 19.54 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 118.603 1.201 . . . . 74.05 111.363 -175.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -88.67 113.7 24.5 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.901 -0.777 . . . . 61.13 108.901 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.479 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 26.1 m -104.5 120.45 41.3 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.123 -1.806 . . . . 70.12 106.123 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 58.5 mtpt -140.52 141.17 35.35 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 123.043 0.214 . . . . 71.34 110.472 -174.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -159.99 135.08 7.98 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.548 -0.908 . . . . 74.25 108.548 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 5.0 mp0 -79.15 125.28 29.23 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 109.952 -0.388 . . . . 72.43 109.952 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.437 HG21 HG12 ' A' ' 431' ' ' VAL . 49.5 mt -133.87 119.12 31.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 106.893 -1.521 . . . . 75.23 106.893 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.7 14.22 62.44 Favored Glycine 0 C--N 1.308 -0.973 0 C-N-CA 120.526 -0.845 . . . . 72.14 111.977 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 101.66 -15.98 56.69 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 121.417 -0.421 . . . . 63.3 112.956 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -105.17 136.77 44.05 Favored 'General case' 0 C--N 1.291 -1.963 0 C-N-CA 120.684 -0.407 . . . . 74.2 110.502 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 47.5 m -78.16 123.77 27.28 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.182 -0.463 . . . . 74.01 111.234 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.689 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.6 OUTLIER -93.28 124.57 37.35 Favored 'General case' 0 N--CA 1.414 -2.237 0 C-N-CA 120.433 -0.507 . . . . 64.14 110.054 173.499 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 85.1 tttt -123.47 125.13 44.36 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.678 -0.692 . . . . 71.32 110.241 -175.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.479 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.5 p -128.26 116.59 42.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-O 121.141 0.496 . . . . 70.31 110.512 177.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 44.3 t -113.02 117.03 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 108.009 -1.108 . . . . 72.43 108.009 175.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.53 ' HB2' ' H ' ' A' ' 362' ' ' GLY . 42.6 m-85 -57.88 128.9 39.42 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 114.113 1.153 . . . . 75.1 114.113 -173.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 68.51 9.6 7.39 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 114.054 -1.43 . . . . 74.12 113.356 -178.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -116.3 -82.21 0.62 Allowed 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 113.193 0.812 . . . . 74.1 113.193 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.529 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -170.13 158.85 7.15 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 112.842 0.682 . . . . 45.14 112.842 -172.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 99.3 t -114.01 145.34 19.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 124.361 1.064 . . . . 75.14 108.878 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.529 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 72.2 m-85 -133.1 150.2 52.09 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.242 0.544 . . . . 73.21 111.452 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.556 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.1 tt0 -119.5 97.26 5.56 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 106.026 -1.842 . . . . 72.54 106.026 173.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.8 t70 70.43 -81.47 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 125.596 1.559 . . . . 75.34 111.392 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 17.8 m -135.53 0.73 2.78 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.345 -0.983 . . . . 53.31 108.345 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 48.4 mm -96.07 134.86 32.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.869 -0.605 . . . . 72.44 109.976 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.522 HD21 HD21 ' A' ' 391' ' ' ASN . 59.8 tp -76.45 115.31 16.08 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.702 -0.851 . . . . 73.24 108.702 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.556 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.5 OUTLIER -80.41 -65.22 1.04 Allowed 'General case' 0 N--CA 1.393 -3.308 0 N-CA-C 109.366 -0.605 . . . . 63.45 109.366 -175.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -156.46 156.1 26.85 Favored Glycine 0 N--CA 1.42 -2.383 0 C-N-CA 118.817 -1.659 . . . . 73.41 112.168 -177.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.522 HD21 HD21 ' A' ' 388' ' ' LEU . 8.6 m120 -99.48 143.39 29.79 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 106.922 -1.51 . . . . 71.03 106.922 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 2.4 m-85 -71.22 115.95 10.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 120.584 0.231 . . . . 73.41 110.482 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -101.74 -47.7 4.53 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.352 -0.386 . . . . 71.14 111.46 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 39.3 p -157.38 140.24 15.1 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 110.083 -0.34 . . . . 62.44 110.083 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.605 ' HB2' ' HG ' ' A' ' 400' ' ' LEU . 0.1 OUTLIER -147.25 145.5 29.44 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 116.121 -0.49 . . . . 52.42 111.13 178.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -128.97 110.86 12.44 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.838 -0.619 . . . . 73.51 109.473 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.8 -102.54 0.77 Allowed Glycine 0 C--N 1.31 -0.883 0 CA-C-N 115.877 -0.601 . . . . 61.11 113.956 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -116.43 17.7 15.39 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.146 0.498 . . . . 75.43 111.468 -176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.4 t -128.85 116.35 40.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 107.565 -1.272 . . . . 72.13 107.565 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.605 ' HG ' ' HB2' ' A' ' 395' ' ' GLN . 5.3 mp -120.07 139.61 52.28 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.63 0.604 . . . . 75.13 112.63 -173.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -112.32 122.69 48.42 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 115.596 -0.729 . . . . 71.1 111.885 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.41 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.9 m-85 -118.72 135.97 54.2 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.749 -1.204 . . . . 62.33 107.749 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -146.92 174.55 11.4 Favored 'General case' 0 CA--C 1.484 -1.587 0 CA-C-O 121.496 0.665 . . . . 71.24 112.719 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 64.13 33.41 11.95 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 113.609 -1.632 . . . . 73.34 112.953 168.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -72.22 -136.81 0.21 Allowed Glycine 0 CA--C 1.537 1.448 0 CA-C-N 115.599 -0.728 . . . . 53.4 113.437 176.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.58 137.92 46.49 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.567 -0.901 . . . . 72.31 108.567 -175.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 19.0 p -63.66 117.77 7.29 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 124.043 0.937 . . . . 75.33 112.332 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 7.2 p -94.92 158.81 15.32 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.266 -0.879 . . . . 62.25 108.966 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 14.3 p-90 -77.19 -40.24 45.92 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.81 -0.756 . . . . 74.32 109.868 -176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -83.07 1.89 37.88 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 113.222 0.823 . . . . 73.51 113.222 -175.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -152.77 -163.72 11.89 Favored Glycine 0 C--N 1.304 -1.221 0 N-CA-C 109.524 -1.43 . . . . 51.13 109.524 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -95.17 -40.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.317 0 CA-C-N 119.753 1.776 . . . . 74.0 113.258 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -159.71 152.13 21.11 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 107.997 -1.112 . . . . 71.02 107.997 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.424 ' HA ' ' HB3' ' A' ' 437' ' ' CYS . 89.7 mtt180 -71.39 159.34 34.72 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.299 0.571 . . . . 73.25 111.797 174.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 41.9 p -161.04 162.23 31.65 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 114.755 -1.112 . . . . 71.43 109.215 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -158.19 148.39 20.18 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-O 121.404 0.621 . . . . 52.23 110.862 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.2 tt -117.18 120.4 64.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 CA-C-N 115.15 -0.932 . . . . 72.32 110.022 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.536 HG22 ' HB ' ' A' ' 441' ' ' ILE . 8.7 t -105.2 127.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 115.663 -0.699 . . . . 74.43 111.978 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 8.7 p -108.48 114.7 28.74 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.632 -1.167 . . . . 75.21 108.559 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 38.9 t -100.88 112.8 34.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 107.595 -1.261 . . . . 71.05 107.595 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -111.73 -175.36 2.67 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 120.847 0.356 . . . . 63.45 110.716 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.619 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 36.0 t -57.77 128.23 36.0 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 124.321 1.048 . . . . 62.51 110.981 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.641 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -158.1 -177.82 31.56 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.925 -0.655 . . . . 64.21 111.676 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.35 -36.37 8.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.336 -0.616 . . . . 65.21 109.336 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -150.0 153.47 36.59 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.772 -0.825 . . . . 75.42 108.772 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.803 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.7 OUTLIER -73.03 98.54 2.55 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.59 0.71 . . . . 71.1 112.238 178.058 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -131.53 149.94 52.33 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.211 -1.359 . . . . 44.13 109.46 -176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 28.2 mm -78.64 118.16 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 106.306 -1.739 . . . . 72.33 106.306 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 55.5 t -80.77 -51.2 16.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 111.984 0.365 . . . . 70.24 111.984 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 33.0 t -167.06 165.22 15.81 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 109.184 -0.673 . . . . 74.13 109.184 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.437 HG12 HG21 ' A' ' 369' ' ' ILE . 4.3 p -141.39 119.12 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 N-CA-C 108.627 -0.879 . . . . 63.13 108.627 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . 0.437 ' O ' HD23 ' A' ' 440' ' ' LEU . 25.4 tp -118.79 137.35 53.44 Favored 'General case' 0 C--N 1.271 -2.816 0 N-CA-C 107.923 -1.14 . . . . 70.11 107.923 -175.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -80.96 111.74 17.71 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.787 -0.82 . . . . 64.11 108.787 -177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -72.24 -54.48 9.48 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.419 -0.809 . . . . 75.21 110.269 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -116.94 -73.87 0.63 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.253 -1.017 . . . . 65.32 108.253 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -164.23 -51.79 0.03 OUTLIER 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 114.19 -1.368 . . . . 65.23 109.821 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 414' ' ' ARG . 72.1 m -103.27 -9.23 19.7 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.416 -0.811 . . . . 61.3 109.167 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.5 tt0 -113.07 132.46 55.41 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.675 -1.148 . . . . 71.01 109.029 -176.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 37.3 m-85 -128.02 150.32 49.98 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 116.048 -0.524 . . . . 74.44 110.516 -175.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.463 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.7 pt? -109.52 119.79 40.51 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.203 -1.036 . . . . 75.35 108.203 172.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.536 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.3 mt -116.24 136.18 54.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-N 115.287 -0.869 . . . . 71.15 109.464 -175.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -108.46 141.07 40.86 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 109.187 -0.671 . . . . 62.22 109.187 178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 83.1 mtp -136.1 168.18 19.86 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.923 -1.14 . . . . 43.1 107.923 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.803 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 34.2 mmtp -134.05 161.34 35.13 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.002 -1.11 . . . . 71.01 108.002 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 33.9 t -162.68 145.9 8.7 Favored Pre-proline 0 C--N 1.291 -1.958 0 N-CA-C 108.455 -0.943 . . . . 71.42 108.455 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.98 -27.43 66.3 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.452 2.101 . . . . 74.13 111.863 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -83.68 -12.28 56.1 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.355 0.598 . . . . 44.52 110.976 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -95.02 11.48 31.86 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-N 115.668 -0.696 . . . . 62.02 109.782 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 422' ' ' CYS . 14.0 t -103.18 120.76 41.31 Favored 'General case' 0 N--CA 1.412 -2.325 0 N-CA-C 107.51 -1.293 . . . . 74.51 107.51 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . 0.491 ' HG ' ' N ' ' A' ' 357' ' ' TYR . 50.8 m . . . . . 0 C--N 1.3 -1.544 0 CA-C-O 118.408 -0.806 . . . . 64.23 109.02 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.596 ' N ' ' HG ' ' A' ' 450' ' ' SER . 73.5 m-85 . . . . . 0 CA--C 1.509 -0.617 0 N-CA-C 107.334 -1.358 . . . . 73.52 107.334 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -91.69 177.4 6.22 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 109.24 -0.652 . . . . 71.33 109.24 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -68.3 154.04 42.55 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.548 -0.538 . . . . 51.31 109.548 175.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 51.4 mm -79.53 129.96 36.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-O 121.527 0.68 . . . . 43.22 111.247 -171.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -71.07 136.32 48.21 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.664 -1.153 . . . . 71.11 111.252 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 60.63 58.78 12.11 Favored Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 117.248 1.659 . . . . 61.02 117.248 170.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 45.2 mtm -142.35 162.57 35.14 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.972 -0.751 . . . . 72.14 108.972 170.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -94.42 139.36 31.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.271 -0.64 . . . . 64.0 109.271 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.525 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 87.8 m -125.49 120.94 32.31 Favored 'General case' 0 C--N 1.264 -3.109 0 N-CA-C 107.163 -1.421 . . . . 72.31 107.163 168.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 10.0 ptmt -139.09 141.08 38.16 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.299 -0.409 . . . . 74.35 110.678 -174.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.418 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 3.7 tmt_? -159.94 138.44 10.44 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.112 -1.44 . . . . 73.31 107.112 -174.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 46.4 mt-10 -89.19 127.22 35.73 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.611 -0.514 . . . . 73.41 109.611 -176.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.502 HG21 HG12 ' A' ' 431' ' ' VAL . 44.6 mt -135.94 121.98 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 N-CA-C 106.867 -1.531 . . . . 74.04 106.867 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.66 12.64 59.62 Favored Glycine 0 C--N 1.306 -1.12 0 C-N-CA 120.571 -0.823 . . . . 54.2 112.883 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.98 -20.27 33.79 Favored Glycine 0 N--CA 1.425 -2.053 0 C-N-CA 121.066 -0.588 . . . . 32.03 112.828 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . 0.434 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 12.1 p90 -105.05 146.65 28.81 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 122.802 -0.234 . . . . 74.41 110.515 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 60.4 m -86.51 126.51 34.49 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 120.957 -0.297 . . . . 75.1 110.471 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.6 OUTLIER -91.61 126.39 36.68 Favored 'General case' 0 N--CA 1.406 -2.651 0 N-CA-C 109.389 -0.597 . . . . 73.44 109.389 172.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 42.2 tttp -121.59 124.34 44.11 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.691 -0.855 . . . . 74.11 108.691 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.525 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.1 p -128.68 123.53 59.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 N-CA-C 109.637 -0.505 . . . . 72.31 109.637 175.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 36.2 t -117.16 117.88 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.331 0 N-CA-C 108.083 -1.08 . . . . 73.3 108.083 174.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.412 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 90.1 m-85 -53.22 125.32 17.18 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 124.393 1.058 . . . . 63.32 112.965 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 69.35 12.43 8.33 Favored 'General case' 0 C--N 1.346 0.436 0 C-N-CA 125.189 1.395 . . . . 63.21 113.857 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -117.64 -91.22 0.55 Allowed 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 112.872 0.693 . . . . 61.33 112.872 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.473 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -161.13 157.3 25.71 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.732 0.642 . . . . 74.01 112.732 -173.395 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.471 HG22 HG23 ' A' ' 376' ' ' VAL . 82.5 t -113.69 144.24 21.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 124.115 0.966 . . . . 73.13 109.525 -178.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.473 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 77.6 m-85 -133.73 147.13 51.31 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.007 0.432 . . . . 74.43 111.355 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.466 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.8 tt0 -113.4 98.75 7.29 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 106.557 -1.646 . . . . 73.22 106.557 173.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.1 t70 70.17 -77.06 0.06 Allowed 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 124.886 1.274 . . . . 62.43 110.032 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 22.0 m -138.24 -6.38 1.59 Allowed 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.25 -0.886 . . . . 73.4 109.013 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 62.2 mt -84.88 134.76 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-N 116.257 -0.429 . . . . 71.44 109.905 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 406' ' ' GLN . 56.4 tp -76.53 113.49 14.2 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.228 -1.027 . . . . 72.41 108.228 176.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.595 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.5 OUTLIER -79.2 -63.85 1.32 Allowed 'General case' 0 N--CA 1.392 -3.337 0 N-CA-C 109.069 -0.715 . . . . 73.52 109.069 -176.13 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.53 156.82 28.18 Favored Glycine 0 N--CA 1.416 -2.65 0 C-N-CA 119.53 -1.319 . . . . 54.14 111.641 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -99.34 147.18 25.48 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.955 -1.128 . . . . 72.34 107.955 175.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.412 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 2.2 m-85 -67.61 116.87 8.81 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.081 0.467 . . . . 74.11 111.233 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -97.87 -47.85 5.4 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.728 -0.669 . . . . 63.12 111.318 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 28.3 m -155.08 149.51 26.2 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.065 -0.346 . . . . 61.24 110.065 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.458 ' CG ' ' HG ' ' A' ' 400' ' ' LEU . 13.8 mp0 -132.91 130.55 39.79 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 106.961 -1.496 . . . . 70.4 106.961 172.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -127.67 110.62 12.85 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.5 -0.926 . . . . 61.13 108.5 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 67.72 -101.82 0.76 Allowed Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.951 -0.568 . . . . 64.35 111.749 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -122.43 19.82 10.46 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.332 0.587 . . . . 73.13 109.907 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 46.6 t -118.37 119.07 60.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 108.273 -1.01 . . . . 71.01 108.273 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.458 ' HG ' ' CG ' ' A' ' 395' ' ' GLN . 4.9 mp -114.87 129.7 56.75 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.243 0.544 . . . . 61.11 110.619 -176.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -113.55 125.86 54.66 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.906 -0.588 . . . . 72.01 110.265 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -118.72 136.67 53.82 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.282 -1.007 . . . . 74.12 108.282 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -144.39 174.17 11.15 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 110.315 -0.254 . . . . 61.42 110.315 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 12.7 m120 60.17 41.7 16.5 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.722 0.809 . . . . 63.32 112.205 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.7 -138.74 1.17 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.471 -0.871 . . . . 64.53 112.039 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 388' ' ' LEU . 1.0 OUTLIER -81.28 140.62 34.73 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.793 -0.817 . . . . 64.34 108.793 -178.053 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 47.0 m -60.73 123.68 18.18 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.551 0.945 . . . . 74.44 113.551 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 15.5 p -100.58 159.21 15.34 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 106.786 -1.561 . . . . 61.24 106.786 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -82.08 -28.54 32.3 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 119.146 0.884 . . . . 75.42 110.411 -175.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -88.56 -8.48 54.7 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.585 -0.734 . . . . 74.43 110.56 -172.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -145.25 -168.71 13.11 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 109.18 -1.568 . . . . 73.2 109.18 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -85.96 -40.91 0.07 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.101 0 CA-C-N 120.018 1.909 . . . . 71.32 112.792 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 96.0 m-70 -163.39 154.36 16.53 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 107.389 -1.337 . . . . 61.41 107.389 -177.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 85.7 mtt180 -69.0 159.08 33.48 Favored 'General case' 0 C--O 1.247 0.952 0 CA-C-O 121.287 0.565 . . . . 64.25 111.707 174.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 49.0 p -161.6 164.46 29.38 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-N 114.762 -1.108 . . . . 74.2 109.144 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -158.7 151.02 21.58 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.123 0.487 . . . . 54.2 110.254 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 11.5 tt -118.53 124.39 73.06 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 CA-C-N 115.478 -0.783 . . . . 64.41 109.342 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.532 HG22 ' HB ' ' A' ' 441' ' ' ILE . 5.2 t -111.31 129.61 66.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.534 0.683 . . . . 75.31 112.093 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 14.4 p -111.45 115.17 28.78 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 115.04 -0.982 . . . . 73.45 109.094 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 47.5 t -100.69 111.86 31.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 N-CA-C 108.96 -0.756 . . . . 61.11 108.96 -177.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -113.52 -174.26 2.43 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 120.662 -0.415 . . . . 63.32 111.084 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 19.6 t -59.13 127.19 30.96 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.515 0.674 . . . . 73.31 112.763 -177.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.545 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -154.26 -177.58 27.8 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 110.039 -1.224 . . . . 74.15 110.039 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 48.6 t -95.57 -28.19 4.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.635 0.731 . . . . 64.41 109.041 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -145.5 151.07 37.59 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.161 -0.927 . . . . 73.44 108.801 -177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.674 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.9 OUTLIER -71.15 98.82 1.75 Allowed 'General case' 0 C--N 1.309 -1.167 0 O-C-N 124.033 0.833 . . . . 32.12 110.191 175.367 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -132.51 148.59 52.39 Favored 'General case' 0 C--O 1.249 1.061 0 CA-C-N 115.225 -0.898 . . . . 64.03 111.42 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 367' ' ' ARG . 30.8 mm -81.8 120.31 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 106.043 -1.836 . . . . 63.35 106.043 174.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.445 HG21 ' HG2' ' A' ' 444' ' ' LYS . 53.3 t -86.29 -50.49 14.18 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 116.228 -0.442 . . . . 75.14 112.139 -176.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 44.0 m -159.95 160.73 33.78 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.401 -0.592 . . . . 63.21 109.401 -175.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.502 HG12 HG21 ' A' ' 369' ' ' ILE . 3.6 p -141.14 111.65 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-O 122.017 0.913 . . . . 32.04 108.763 176.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . 0.429 ' O ' HD23 ' A' ' 440' ' ' LEU . 28.7 tp -110.94 136.53 49.82 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 115.321 -0.854 . . . . 73.44 108.711 -177.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -80.92 110.17 16.2 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.489 -0.93 . . . . 63.32 108.489 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -71.47 -36.85 71.33 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 115.37 -0.832 . . . . 70.52 111.06 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -142.07 -73.85 0.31 Allowed 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.564 -0.744 . . . . 64.51 109.308 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.455 ' NZ ' ' HB3' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -163.69 -49.01 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 116.112 -0.495 . . . . 74.53 110.899 175.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 75.7 m -98.04 -3.9 37.15 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.532 0.682 . . . . 71.03 110.107 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 415' ' ' SER . 34.5 tt0 -124.82 131.39 53.45 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.401 -0.818 . . . . 71.0 109.317 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -126.95 150.6 49.29 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.61 -0.723 . . . . 60.22 110.32 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.46 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.6 pt? -109.85 121.11 44.49 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.013 -1.106 . . . . 75.23 108.013 172.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.532 ' HB ' HG22 ' A' ' 418' ' ' VAL . 97.1 mt -115.51 132.87 63.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 CA-C-N 115.454 -0.794 . . . . 53.32 110.324 -175.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -98.85 136.8 38.34 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.449 -0.945 . . . . 73.35 108.449 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.459 ' SD ' HG11 ' A' ' 418' ' ' VAL . 82.6 mtp -137.46 157.73 45.93 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 109.835 -0.431 . . . . 55.23 109.835 177.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 31.7 mmtp -131.71 153.15 50.32 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.629 -1.249 . . . . 74.15 107.629 175.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 69.8 m -156.92 149.09 17.65 Favored Pre-proline 0 C--N 1.288 -2.096 0 N-CA-C 108.615 -0.883 . . . . 65.31 108.615 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 39.0 Cg_endo -67.66 -28.13 37.76 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 121.921 1.747 . . . . 74.13 111.975 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -76.28 -22.46 55.05 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.737 -0.665 . . . . 72.01 111.022 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -84.16 0.46 48.52 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.741 0.781 . . . . 71.41 109.399 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 11.4 t -103.92 118.65 37.19 Favored 'General case' 0 N--CA 1.409 -2.498 0 N-CA-C 107.576 -1.268 . . . . 73.52 107.576 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . 0.596 ' HG ' ' N ' ' A' ' 357' ' ' TYR . 52.9 m . . . . . 0 C--N 1.296 -1.742 0 N-CA-C 107.935 -1.135 . . . . 51.4 107.935 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 109.298 -0.63 . . . . 73.2 109.298 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.425 ' HB3' ' HB3' ' A' ' 398' ' ' ASN . 98.7 mtt180 -78.64 -17.54 55.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.345 0.593 . . . . 72.32 111.173 -178.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -139.43 151.79 46.53 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.059 -0.719 . . . . 73.42 109.059 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 49.7 mm -81.59 116.26 25.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 108.886 -0.783 . . . . 62.1 108.886 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -78.81 157.26 28.43 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.924 -0.58 . . . . 75.1 111.846 -174.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 77.19 -47.16 2.58 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 114.879 0.712 . . . . 72.02 114.879 174.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 52.6 ttp -57.59 136.83 56.81 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.431 0.634 . . . . 71.25 112.64 -175.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.455 ' HB3' HG22 ' A' ' 377' ' ' VAL . 8.0 pt-20 -93.95 110.52 22.19 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.197 -0.911 . . . . 70.42 111.476 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 85.3 m -103.97 139.62 38.85 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.491 -0.929 . . . . 51.24 108.491 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.428 ' HB3' ' HG3' ' A' ' 375' ' ' LYS . 0.0 OUTLIER -145.73 151.89 38.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 118.344 0.52 . . . . 71.41 111.591 -177.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.511 HH11 HG12 ' A' ' 369' ' ' ILE . 4.1 tmt_? -161.6 135.47 6.68 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.132 -0.692 . . . . 74.22 109.132 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.22 125.97 30.18 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 110.275 -0.268 . . . . 71.03 110.275 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.553 HG21 HG12 ' A' ' 431' ' ' VAL . 37.2 mt -134.19 119.79 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.828 -1.545 . . . . 74.41 106.828 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.66 12.64 59.62 Favored Glycine 0 C--N 1.31 -0.863 0 C-N-CA 121.164 -0.541 . . . . 65.21 112.07 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 105.78 -23.19 30.19 Favored Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 121.603 -0.332 . . . . 41.33 112.352 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . 0.456 ' CD1' ' HG3' ' A' ' 384' ' ' GLN . 16.0 p90 -98.19 136.76 37.93 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 121.184 0.516 . . . . 70.1 110.548 -176.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 98.9 m -79.54 116.23 19.63 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 115.525 -0.761 . . . . 64.03 110.556 -178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.12 133.58 34.78 Favored 'General case' 0 N--CA 1.417 -2.084 0 N-CA-C 107.868 -1.16 . . . . 65.52 107.868 175.001 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.428 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 36.8 ttpt -133.34 130.78 39.3 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.211 -0.595 . . . . 62.34 109.599 -175.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.409 HG23 HG22 ' A' ' 382' ' ' VAL . 7.2 p -124.0 115.92 46.42 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 O-C-N 123.584 0.552 . . . . 73.44 110.056 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.455 HG22 ' HB3' ' A' ' 364' ' ' GLU . 47.8 t -108.53 116.45 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.563 -1.273 . . . . 74.32 107.563 175.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -63.76 126.2 26.82 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 113.895 1.072 . . . . 61.32 113.895 -173.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 73.03 10.66 5.27 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 125.997 1.719 . . . . 64.2 113.117 -178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.8 -84.49 0.65 Allowed 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 112.489 0.552 . . . . 75.53 112.489 174.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.522 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -166.38 159.62 14.9 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.99 0.737 . . . . 74.12 112.99 -172.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.409 HG22 HG23 ' A' ' 376' ' ' VAL . 98.7 t -113.74 145.75 19.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 124.642 1.177 . . . . 72.43 109.141 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.522 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 71.1 m-85 -132.77 152.43 51.77 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 122.973 0.509 . . . . 64.32 111.986 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.493 ' HB2' HD23 ' A' ' 389' ' ' LEU . 35.2 tt0 -124.76 102.04 7.38 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.347 -1.723 . . . . 71.12 106.347 173.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 14.3 t70 69.64 -83.84 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.564 1.146 . . . . 73.3 109.543 -175.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 23.3 m -133.28 -7.37 2.97 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 108.608 -0.886 . . . . 53.14 108.608 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 63.0 mt -80.59 132.91 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.388 -0.823 . . . . 33.14 110.127 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.459 HD21 HD21 ' A' ' 391' ' ' ASN . 64.8 tp -76.9 109.97 11.13 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.499 -0.926 . . . . 72.2 108.499 176.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.2 OUTLIER -77.67 -65.4 0.97 Allowed 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 109.111 -0.7 . . . . 71.21 109.111 -176.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.23 153.58 24.66 Favored Glycine 0 N--CA 1.424 -2.103 0 C-N-CA 119.26 -1.448 . . . . 63.13 111.64 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.47 ' N ' HD22 ' A' ' 391' ' ' ASN . 0.8 OUTLIER -99.46 144.76 28.19 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.711 -1.218 . . . . 61.14 107.711 178.544 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -73.02 116.3 13.38 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.267 -0.642 . . . . 75.11 109.267 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -111.21 -47.99 3.14 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.939 -0.573 . . . . 72.31 110.863 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 18.7 m -145.63 138.96 26.29 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.504 -0.925 . . . . 62.24 108.504 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.478 ' HB2' HD22 ' A' ' 400' ' ' LEU . 9.8 pt20 -147.4 145.32 29.21 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 120.938 0.399 . . . . 72.23 110.84 173.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -121.17 110.24 15.95 Favored 'General case' 0 N--CA 1.412 -2.353 0 CA-C-N 115.649 -0.705 . . . . 62.14 109.535 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.19 -104.27 0.79 Allowed Glycine 0 N--CA 1.436 -1.339 0 CA-C-N 115.265 -0.88 . . . . 64.55 113.823 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 358' ' ' ARG . 4.5 p-10 -116.83 18.2 14.87 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.128 0.489 . . . . 73.03 111.187 -176.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 56.3 t -125.15 116.09 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 105.159 -2.163 . . . . 64.23 105.159 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.478 HD22 ' HB2' ' A' ' 395' ' ' GLN . 13.6 mt -118.63 136.28 53.98 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 119.862 -0.735 . . . . 53.04 111.241 -168.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.414 ' HE3' HD12 ' A' ' 417' ' ' ILE . 20.6 mmtp -107.43 124.09 49.35 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-O 121.498 0.666 . . . . 74.31 112.076 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.402 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 2.9 m-85 -117.08 125.88 51.98 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.77 -1.566 . . . . 75.24 106.77 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -139.77 175.86 9.22 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 110.113 -0.329 . . . . 75.12 110.113 -176.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.0 m120 64.93 33.3 10.0 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.856 0.722 . . . . 71.21 112.503 173.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.6 -141.23 1.17 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 120.785 -0.722 . . . . 73.14 113.054 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.77 142.11 38.86 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.95 -1.13 . . . . 73.22 107.95 -177.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 50.3 m -60.79 134.74 57.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.413 0.625 . . . . 32.22 111.687 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 14.6 p -132.38 159.46 39.17 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.679 -0.691 . . . . 74.31 110.472 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -66.88 137.38 56.53 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 120.735 0.302 . . . . 72.25 111.615 175.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 80.4 -29.8 0.13 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.84 1.656 . . . . 51.13 112.426 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -107.41 174.52 19.66 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.191 -0.764 . . . . 53.23 111.191 177.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -79.51 -40.5 0.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.483 1.456 . . . . 62.41 111.878 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -163.1 162.45 25.7 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 105.157 -2.164 . . . . 75.42 105.157 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -69.32 156.33 38.97 Favored 'General case' 0 C--O 1.256 1.407 0 C-N-CA 119.641 -0.824 . . . . 75.12 111.568 174.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 23.7 p -157.59 158.92 36.48 Favored 'General case' 0 N--CA 1.408 -2.571 0 CA-C-N 114.67 -1.15 . . . . 55.02 109.192 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -154.03 149.01 26.73 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.26 0.552 . . . . 74.31 110.656 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . 0.414 HD12 ' HE3' ' A' ' 401' ' ' LYS . 8.4 tt -118.99 123.81 72.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.383 0 CA-C-N 115.107 -0.951 . . . . 74.5 109.816 175.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.616 HG22 ' HB ' ' A' ' 441' ' ' ILE . 4.1 t -109.85 130.66 62.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 115.785 -0.643 . . . . 65.3 111.231 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 20.5 p -108.46 115.01 29.3 Favored 'General case' 0 N--CA 1.409 -2.525 0 N-CA-C 108.322 -0.992 . . . . 64.45 108.322 173.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 38.5 t -100.36 114.72 39.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.039 -1.467 . . . . 74.05 107.039 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -118.02 -173.94 2.55 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 120.915 -0.314 . . . . 71.24 110.556 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.525 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 38.3 t -60.5 127.92 34.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.235 0.54 . . . . 75.42 111.71 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.607 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -156.36 -179.7 31.57 Favored Glycine 0 CA--C 1.485 -1.808 0 N-CA-C 110.535 -1.026 . . . . 74.4 110.535 177.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.08 -35.32 7.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.899 -0.778 . . . . 72.31 108.899 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -143.79 152.16 40.87 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 115.367 -0.833 . . . . 72.32 109.722 -178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.721 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 0.9 OUTLIER -69.57 97.95 1.09 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.034 -0.985 . . . . 52.23 110.586 175.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -132.16 149.56 52.36 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.851 -1.068 . . . . 54.41 109.906 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 369' ' ' ILE . 32.6 mm -84.35 119.41 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 105.993 -1.855 . . . . 54.41 105.993 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 54.8 t -83.86 -51.04 14.65 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 CA-C-N 116.409 -0.36 . . . . 70.04 111.623 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 38.5 p -165.26 167.97 17.43 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 120.914 -0.314 . . . . 71.23 110.674 -175.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.553 HG12 HG21 ' A' ' 369' ' ' ILE . 3.3 p -142.19 126.25 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 N-CA-C 109.124 -0.695 . . . . 50.1 109.124 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . 0.438 ' O ' HD23 ' A' ' 440' ' ' LEU . 28.1 tp -126.82 137.96 53.27 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.885 -0.783 . . . . 73.54 108.885 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -81.07 113.0 18.96 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.291 -1.003 . . . . 75.42 108.291 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.02 -50.81 18.13 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-N 115.715 -0.675 . . . . 74.12 110.226 -174.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . 0.539 ' C ' ' HD2' ' A' ' 436' ' ' LYS . 49.4 mt-30 -121.47 -82.24 0.65 Allowed 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.236 -0.893 . . . . 65.33 108.753 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.539 ' HD2' ' C ' ' A' ' 435' ' ' GLN . 0.2 OUTLIER -145.31 -61.73 0.34 Allowed 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 108.26 -1.015 . . . . 74.02 108.26 177.025 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 92.3 m -93.64 -7.96 42.38 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.158 -1.383 . . . . 53.3 111.693 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 415' ' ' SER . 35.6 tt0 -110.39 128.6 55.66 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-N 115.291 -0.868 . . . . 64.41 109.077 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 46.4 m-85 -124.48 149.72 46.53 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.757 -0.656 . . . . 74.1 109.785 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.445 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.5 pt? -111.47 119.54 39.12 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.341 -0.615 . . . . 74.22 109.341 175.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.616 ' HB ' HG22 ' A' ' 418' ' ' VAL . 3.8 mp -109.62 133.9 53.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.87 -0.604 . . . . 63.52 109.883 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -96.25 135.82 37.56 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 108.397 -0.964 . . . . 62.34 108.397 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 81.8 mtp -138.01 160.53 39.12 Favored 'General case' 0 CA--C 1.478 -1.802 0 N-CA-C 109.678 -0.49 . . . . 74.33 109.678 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.721 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 73.8 mmtt -131.05 160.96 33.11 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.743 -1.206 . . . . 73.32 107.743 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 40.8 t -165.45 145.04 5.49 Favored Pre-proline 0 C--N 1.284 -2.252 0 O-C-N 124.118 0.886 . . . . 71.25 109.023 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -66.42 -27.36 47.13 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.04 1.826 . . . . 75.32 110.618 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -76.52 -17.81 59.05 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.327 -0.851 . . . . 74.52 111.182 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -97.12 11.99 34.3 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.546 0.688 . . . . 70.53 110.128 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 16.9 t -102.81 141.02 36.32 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 115.414 -0.812 . . . . 64.21 108.988 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 N--CA 1.417 -2.081 0 N-CA-C 107.305 -1.368 . . . . 64.11 107.305 -179.25 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 . . . . . 0 CA--C 1.51 -0.574 0 N-CA-C 109.204 -0.665 . . . . 72.4 109.204 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 397' ' ' GLY . 0.0 OUTLIER 55.35 -161.11 0.17 Allowed 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.729 0.643 . . . . 73.33 110.962 -178.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -91.9 154.55 18.78 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.766 -1.198 . . . . 64.24 107.766 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 360' ' ' ILE . 2.4 mp -78.55 120.52 29.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.866 0.841 . . . . 74.45 110.417 -172.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.517 ' HG2' ' CD1' ' A' ' 379' ' ' TYR . 54.1 mtpt -68.92 153.89 43.0 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 114.084 -1.416 . . . . 72.42 112.395 -175.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 89.75 -58.84 3.68 Favored Glycine 0 N--CA 1.443 -0.867 0 CA-C-N 115.407 -0.815 . . . . 54.04 115.05 173.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 59.0 mtm -62.7 140.21 58.7 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.079 0.466 . . . . 75.5 112.223 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -85.59 114.8 22.87 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.76 -1.57 . . . . 63.35 106.76 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.562 ' HB ' HG13 ' A' ' 376' ' ' VAL . 84.7 m -94.87 130.3 41.52 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 106.388 -1.708 . . . . 64.11 106.388 176.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 0.0 OUTLIER -143.49 150.23 38.67 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.418 -0.913 . . . . 52.21 111.108 -175.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -162.37 136.48 6.49 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.741 -0.836 . . . . 62.52 108.741 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -77.81 124.98 28.65 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 109.815 -0.439 . . . . 70.23 109.815 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.508 HG21 HG12 ' A' ' 431' ' ' VAL . 56.4 mt -134.82 118.99 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.795 0 N-CA-C 106.883 -1.525 . . . . 73.04 106.883 -178.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.49 13.59 60.93 Favored Glycine 0 C--N 1.305 -1.139 0 C-N-CA 120.538 -0.839 . . . . 62.4 112.675 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 105.56 -17.78 42.35 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 120.997 -0.62 . . . . 73.34 113.252 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -105.26 142.17 35.49 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 120.61 0.243 . . . . 72.25 110.595 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 97.8 m -82.25 119.75 24.49 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.099 0.476 . . . . 73.04 110.057 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.586 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -90.79 126.53 36.04 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 108.533 -0.914 . . . . 73.43 108.533 176.087 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -126.43 127.45 45.44 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.28 -0.568 . . . . 73.55 109.874 -175.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.616 HG23 HG22 ' A' ' 382' ' ' VAL . 5.9 p -124.58 117.07 49.38 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 CA-C-N 116.16 -0.473 . . . . 71.22 111.036 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.98 116.22 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.141 -1.429 . . . . 70.32 107.141 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.543 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 95.1 m-85 -70.3 131.29 43.93 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 114.705 1.372 . . . . 73.42 114.705 -170.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.517 ' CD1' ' HG2' ' A' ' 361' ' ' LYS . 25.4 m-85 71.64 13.08 6.35 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.254 1.422 . . . . 70.13 112.232 -176.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -125.71 -86.18 0.62 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.484 -0.78 . . . . 72.32 113.044 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.439 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -162.72 153.22 16.7 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 113.304 0.853 . . . . 70.14 113.304 -173.013 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 376' ' ' VAL . 44.7 t -113.56 149.44 15.95 Favored 'Isoleucine or valine' 0 C--O 1.244 0.792 0 C-N-CA 124.054 0.942 . . . . 63.42 108.725 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.439 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 62.8 m-85 -139.63 144.7 37.81 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.348 0.405 . . . . 55.45 111.088 -177.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -107.24 110.01 21.94 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 106.346 -1.724 . . . . 74.11 106.346 169.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 17.2 t70 69.1 -87.02 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 123.76 0.824 . . . . 72.32 110.422 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 19.5 m -136.16 -1.88 2.34 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.966 -0.753 . . . . 52.44 108.966 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 47.2 mm -88.66 138.68 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 109.646 -0.501 . . . . 43.22 109.646 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 59.3 tp -74.25 117.69 16.35 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.24 -1.763 . . . . 75.01 106.24 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.546 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 49.7 tp -91.79 -58.41 2.43 Favored 'General case' 0 N--CA 1.381 -3.877 0 CA-C-N 115.412 -0.813 . . . . 41.53 110.856 -173.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.46 148.13 15.96 Favored Glycine 0 N--CA 1.426 -1.997 0 C-N-CA 119.401 -1.381 . . . . 70.34 111.492 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -99.75 145.15 27.99 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.503 -1.295 . . . . 70.31 107.503 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.543 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.5 m-85 -70.26 117.21 11.52 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 120.771 0.32 . . . . 63.11 111.324 -176.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -88.33 -46.81 8.89 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.925 -0.58 . . . . 73.52 110.15 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 60.6 p -169.03 160.75 10.16 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-N 115.765 -0.652 . . . . 75.12 109.599 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.463 HE21 ' HD2' ' A' ' 392' ' ' PHE . 14.8 mp0 -130.67 138.13 49.9 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.657 -1.238 . . . . 74.34 107.657 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -128.43 114.42 16.78 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.869 -0.789 . . . . 74.42 108.869 175.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 358' ' ' ARG . . . 72.18 -101.44 1.05 Allowed Glycine 0 N--CA 1.422 -2.251 0 C-N-CA 119.169 -1.491 . . . . 41.52 112.056 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 21.7 p-10 -128.04 15.7 6.79 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 123.598 0.759 . . . . 41.42 109.381 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.432 HG22 HG23 ' A' ' 419' ' ' THR . 35.9 t -118.89 121.66 67.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.459 -0.941 . . . . 55.22 108.459 -175.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.404 ' HG ' ' CG ' ' A' ' 395' ' ' GLN . 3.2 mp -117.4 132.61 56.54 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 116.078 -0.51 . . . . 72.45 110.669 -175.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . 0.42 ' HE2' HD12 ' A' ' 417' ' ' ILE . 57.0 mmtt -106.29 125.73 51.36 Favored 'General case' 0 C--O 1.248 0.985 0 CA-C-N 115.903 -0.59 . . . . 51.54 111.231 177.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.422 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 3.7 m-85 -118.48 135.89 54.12 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.98 -1.118 . . . . 71.2 107.98 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.69 176.14 10.08 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 120.556 0.217 . . . . 74.04 111.538 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 14.1 m120 65.31 33.19 9.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.673 0.789 . . . . 62.14 112.386 174.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -73.8 -149.16 1.4 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.898 -0.667 . . . . 53.04 112.345 176.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -73.93 137.92 43.92 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 122.106 -0.644 . . . . 74.44 110.069 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 26.4 p -60.68 118.9 7.16 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 124.661 1.184 . . . . 71.01 113.934 -175.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 14.2 p -105.27 158.28 16.72 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.087 -1.449 . . . . 70.12 107.087 175.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -83.17 -27.99 29.66 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.567 -0.853 . . . . 74.35 109.536 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -91.72 19.29 6.57 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.293 -0.867 . . . . 75.41 109.866 -170.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -173.1 -171.5 37.83 Favored Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 108.029 -2.029 . . . . 74.21 108.029 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -87.02 -40.89 0.06 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.152 0 CA-C-N 120.3 2.05 . . . . 73.02 111.775 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -161.24 163.18 31.2 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 106.723 -1.584 . . . . 65.34 106.723 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -76.61 158.48 31.07 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.269 0.557 . . . . 64.03 112.457 174.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 37.4 p -160.69 163.72 32.22 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 114.983 -1.008 . . . . 55.34 109.122 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.52 143.29 13.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 120.77 0.319 . . . . 74.53 110.584 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . 0.42 HD12 ' HE2' ' A' ' 401' ' ' LYS . 7.4 tt -103.84 131.73 51.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.78 -0.822 . . . . 71.41 108.78 173.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.7 t -113.32 125.28 70.56 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-O 121.084 0.469 . . . . 73.35 110.181 174.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.432 HG23 HG22 ' A' ' 399' ' ' VAL . 1.1 m -110.07 114.45 27.97 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 105.878 -1.897 . . . . 61.03 105.878 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 22.0 t -101.17 117.24 46.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.357 -0.979 . . . . 64.31 108.357 -176.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -106.7 -179.05 3.83 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 120.281 -0.568 . . . . 72.13 109.935 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 40.2 t -60.56 128.99 39.34 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 123.37 0.668 . . . . 63.41 110.644 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.554 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -153.16 -177.4 26.67 Favored Glycine 0 CA--C 1.485 -1.812 0 N-CA-C 111.065 -0.814 . . . . 75.11 111.065 179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 57.3 t -90.93 -30.13 4.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 121.498 0.666 . . . . 75.53 109.213 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -151.02 151.25 31.77 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.369 -0.832 . . . . 74.11 109.222 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.639 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.0 OUTLIER -65.34 100.23 0.46 Allowed 'General case' 0 C--N 1.311 -1.098 0 O-C-N 124.164 0.915 . . . . 74.33 110.841 174.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -131.93 149.25 52.49 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.776 -1.102 . . . . 75.33 110.246 -176.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.441 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 29.7 mm -86.87 122.25 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 106.261 -1.755 . . . . 74.44 106.261 176.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 442' ' ' LYS . 64.9 t -84.37 -50.43 15.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 CA-C-N 116.455 -0.339 . . . . 74.04 111.653 -177.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 49.5 m -165.66 164.23 19.09 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.151 -0.685 . . . . 72.44 109.151 -175.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.508 HG12 HG21 ' A' ' 369' ' ' ILE . 3.3 p -141.49 125.32 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 107.253 -1.388 . . . . 73.02 107.253 176.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 42.8 tp -131.73 137.26 48.15 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 108.627 -0.879 . . . . 71.2 108.627 -176.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -81.64 119.04 23.3 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.45 -0.945 . . . . 61.55 108.45 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.3 -56.32 5.01 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.335 -0.848 . . . . 64.13 110.701 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -119.55 -71.49 0.73 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.739 -0.664 . . . . 74.14 110.603 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -162.39 -42.14 0.04 OUTLIER 'General case' 0 C--O 1.214 -0.767 0 CA-C-O 121.332 0.587 . . . . 74.15 111.152 175.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 90.7 m -112.77 13.3 19.75 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.71 0.766 . . . . 62.12 109.959 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 415' ' ' SER . 31.0 tt0 -135.23 131.23 36.39 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.079 -0.964 . . . . 62.33 108.875 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -123.5 150.68 43.65 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 123.591 0.557 . . . . 74.52 111.279 -176.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.467 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.6 pt? -110.58 118.01 35.06 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.428 -0.953 . . . . 64.53 108.428 172.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 92.6 mt -119.29 133.12 67.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.294 -0.867 . . . . 63.44 109.308 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.412 ' O ' ' HB ' ' A' ' 429' ' ' VAL . 37.9 ttpt -111.53 141.38 45.18 Favored 'General case' 0 N--CA 1.421 -1.917 0 N-CA-C 109.285 -0.635 . . . . 55.11 109.285 178.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.441 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 79.6 mtp -136.32 169.19 18.06 Favored 'General case' 0 CA--C 1.483 -1.615 0 N-CA-C 109.272 -0.64 . . . . 71.55 109.272 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 66.8 mmtt -132.22 159.97 37.49 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.97 -1.122 . . . . 74.13 107.97 175.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 41.2 t -172.45 145.69 1.5 Allowed Pre-proline 0 C--N 1.289 -2.05 0 O-C-N 124.187 0.929 . . . . 55.42 109.707 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.0 -24.27 45.62 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.314 2.009 . . . . 72.13 110.917 176.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.09 -18.75 52.77 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.698 -0.683 . . . . 62.11 111.017 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -93.16 9.2 36.99 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.66 0.743 . . . . 74.3 109.57 176.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 10.8 t -102.29 119.34 38.65 Favored 'General case' 0 N--CA 1.408 -2.548 0 N-CA-C 106.983 -1.488 . . . . 43.2 106.983 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.425 -1.718 0 N-CA-C 107.627 -1.249 . . . . 72.14 107.627 -175.611 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 N--CA 1.465 0.289 0 N-CA-C 111.181 0.067 . . . . 73.32 111.181 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? 70.5 -39.47 0.44 Allowed 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 123.954 0.902 . . . . 54.11 111.572 -175.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -131.46 150.38 52.17 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.796 -1.187 . . . . 74.12 107.796 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 50.2 mm -82.65 116.7 27.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 110.208 -0.293 . . . . 73.42 110.208 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.664 ' HA ' ' HB2' ' A' ' 378' ' ' PHE . 21.9 pttp -85.9 157.43 20.18 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.72 0.637 . . . . 75.34 112.72 -175.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 84.71 -39.36 2.94 Favored Glycine 0 C--O 1.238 0.367 0 CA-C-N 116.038 -0.528 . . . . 54.25 113.473 177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 55.9 ttp -77.96 139.94 39.2 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.895 0.378 . . . . 74.2 111.449 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.426 ' HG2' HG22 ' A' ' 377' ' ' VAL . 38.5 mt-10 -81.0 120.21 24.49 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.205 -0.665 . . . . 72.13 109.205 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 94.0 m -108.12 120.77 43.29 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.932 -1.136 . . . . 62.51 107.932 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.488 ' HB3' ' HG3' ' A' ' 375' ' ' LYS . 13.3 ptmm? -136.52 144.46 44.28 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.51 0.93 . . . . 75.52 113.51 -173.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.4 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 3.3 tmt_? -156.55 135.54 11.9 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.244 -1.391 . . . . 74.44 107.244 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 43.7 mt-10 -86.29 128.43 34.92 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 109.645 -0.502 . . . . 73.42 109.645 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . . . . . . . . . 56.5 mt -132.63 118.76 35.87 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.405 0 N-CA-C 107.463 -1.31 . . . . 72.5 107.463 -175.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.24 14.41 61.68 Favored Glycine 0 C--N 1.308 -1.016 0 C-N-CA 120.612 -0.804 . . . . 73.53 112.631 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 109.15 -24.53 20.74 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 120.919 -0.658 . . . . 75.45 112.91 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -98.78 136.02 39.42 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 120.946 0.403 . . . . 64.22 111.07 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 41.3 m -77.52 115.3 17.17 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.074 -0.512 . . . . 65.43 110.206 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -91.05 131.34 36.69 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 108.438 -0.949 . . . . 72.42 108.438 175.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.488 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 38.5 ttpt -135.32 125.45 26.09 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 120.165 -0.614 . . . . 55.01 109.994 -177.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.487 HG12 HD11 ' A' ' 428' ' ' ILE . 7.6 p -117.02 115.51 49.13 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 N-CA-C 108.266 -1.013 . . . . 53.11 108.266 176.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.426 HG22 ' HG2' ' A' ' 364' ' ' GLU . 39.5 t -104.96 115.08 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.422 0 N-CA-C 105.662 -1.977 . . . . 74.12 105.662 176.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.664 ' HB2' ' HA ' ' A' ' 361' ' ' LYS . 94.3 m-85 -68.72 127.52 33.34 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 114.216 1.191 . . . . 64.14 114.216 -170.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . 0.27 47.9 m-85 71.19 16.14 6.31 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 113.964 -1.471 . . . . 71.43 112.956 -176.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -125.91 -83.41 0.63 Allowed 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.258 -0.883 . . . . 54.34 112.566 173.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.516 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.5 OUTLIER -161.6 162.53 30.12 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 112.701 0.63 . . . . 52.41 112.701 -169.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.46 HG22 HG23 ' A' ' 376' ' ' VAL . 87.1 t -121.16 143.29 33.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 124.305 1.042 . . . . 75.33 108.65 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.516 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 66.4 m-85 -132.25 144.89 50.93 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 123.209 0.604 . . . . 63.52 112.198 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.549 ' HB2' HD23 ' A' ' 389' ' ' LEU . 33.5 tt0 -116.17 102.15 9.34 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 105.776 -1.935 . . . . 73.34 105.776 171.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.4 t70 72.38 -80.67 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 125.065 1.346 . . . . 33.23 109.569 -176.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.4 m -142.69 -1.88 1.1 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.945 -1.025 . . . . 43.03 108.352 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 49.8 mt -88.07 139.31 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.746 -0.661 . . . . 74.34 109.977 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.494 HD21 HD21 ' A' ' 391' ' ' ASN . 58.6 tp -76.43 110.29 10.84 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.56 -0.904 . . . . 61.13 108.56 -178.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.549 HD23 ' HB2' ' A' ' 384' ' ' GLN . 1.0 OUTLIER -80.39 -60.04 2.47 Favored 'General case' 0 N--CA 1.393 -3.324 0 N-CA-C 109.18 -0.674 . . . . 73.32 109.18 -176.487 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.45 160.02 31.4 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 119.475 -1.345 . . . . 63.02 111.644 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.494 HD21 HD21 ' A' ' 388' ' ' LEU . 47.8 m-80 -110.11 151.32 27.38 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.942 -1.133 . . . . 62.34 107.942 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.521 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.8 m-85 -73.56 127.95 34.17 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 111.777 0.288 . . . . 73.43 111.777 -175.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -110.5 -49.57 3.04 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.18 -0.608 . . . . 24.21 112.575 -177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 54.2 p -167.75 139.92 3.12 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.694 -0.484 . . . . 72.51 109.694 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.444 ' NE2' ' HD2' ' A' ' 392' ' ' PHE . 2.4 mm-40 -118.17 147.12 43.66 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 109.989 -0.374 . . . . 61.53 109.989 -176.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -128.41 110.31 12.21 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 109.192 -0.67 . . . . 71.04 109.192 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.95 -108.11 2.09 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 116.145 -0.479 . . . . 71.14 112.405 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -117.23 16.77 14.86 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.28 0.562 . . . . 74.14 110.196 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 52.3 t -117.44 116.87 53.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.797 -1.186 . . . . 61.41 107.797 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.63 142.42 39.12 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.571 -0.74 . . . . 63.43 111.386 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -120.1 122.47 41.12 Favored 'General case' 0 C--O 1.25 1.097 0 CA-C-O 121.403 0.62 . . . . 70.52 111.814 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -118.3 137.32 53.15 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 107.934 -1.136 . . . . 74.31 107.934 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.445 ' HA ' ' CB ' ' A' ' 415' ' ' SER . 46.6 mt-10 -142.47 175.59 9.66 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.008 -0.738 . . . . 74.22 109.008 -177.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.79 33.54 10.17 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.275 1.213 . . . . 73.05 114.275 171.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -80.72 -141.9 3.02 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 120.233 -0.984 . . . . 61.43 111.602 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -56.0 136.92 51.77 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 123.343 0.657 . . . . 64.54 110.993 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 26.4 p -73.18 117.5 14.99 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 120.919 0.39 . . . . 71.23 110.806 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 26.4 p -110.43 159.86 17.11 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.804 -0.813 . . . . 43.34 108.804 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 9.4 p-90 -81.74 -32.62 31.43 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 120.245 -0.582 . . . . 71.41 110.715 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -81.88 -17.05 48.63 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.902 -0.59 . . . . 75.31 111.506 -170.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -138.72 -169.36 11.54 Favored Glycine 0 C--N 1.304 -1.235 0 N-CA-C 109.503 -1.439 . . . . 62.41 109.503 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -79.51 -40.49 0.25 Allowed 'Trans proline' 0 N--CA 1.449 -1.125 0 CA-C-N 120.022 1.911 . . . . 74.45 110.903 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -164.61 166.41 20.23 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 105.678 -1.971 . . . . 71.12 105.678 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -73.24 156.37 38.58 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.156 0.503 . . . . 51.2 109.872 171.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.445 ' CB ' ' HA ' ' A' ' 403' ' ' GLU . 54.2 p -160.54 169.07 23.7 Favored 'General case' 0 N--CA 1.401 -2.916 0 CA-C-N 115.306 -0.861 . . . . 63.34 109.047 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -159.07 151.07 20.93 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.364 0.602 . . . . 42.41 111.281 -177.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 10.1 tt -115.1 133.01 62.66 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 CA-C-N 115.08 -0.964 . . . . 62.34 108.558 173.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.611 HG22 ' HB ' ' A' ' 441' ' ' ILE . 4.9 t -118.57 129.68 74.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-O 121.233 0.54 . . . . 64.35 111.638 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 25.3 p -108.26 113.24 26.19 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.635 -1.246 . . . . 44.11 107.635 174.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 21.1 t -101.48 112.2 33.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.132 -1.062 . . . . 75.21 108.132 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 444' ' ' LYS . 41.1 mt-10 -108.16 179.52 4.19 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.988 -0.285 . . . . 64.35 110.315 -176.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 43.2 t -59.29 128.76 38.75 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 123.464 0.706 . . . . 65.4 110.863 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.64 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -153.42 -176.89 26.37 Favored Glycine 0 CA--C 1.486 -1.723 0 C-N-CA 120.779 -0.724 . . . . 65.41 111.452 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 50.6 t -89.3 -37.31 9.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.998 -0.741 . . . . 72.22 108.998 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -150.48 160.3 43.87 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.638 -0.71 . . . . 74.3 109.31 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 70.0 m-20 -68.78 101.22 1.29 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.44 0.696 . . . . 73.25 109.709 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -131.89 148.25 52.52 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 110.432 -0.211 . . . . 53.32 110.432 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.487 HD11 HG12 ' A' ' 376' ' ' VAL . 30.5 mm -82.91 115.47 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 105.88 -1.896 . . . . 74.14 105.88 173.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 42.6 t -81.18 -47.49 19.95 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.637 0 N-CA-C 112.553 0.575 . . . . 71.05 112.553 -176.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 26.1 t -166.0 162.35 17.96 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.522 -0.918 . . . . 60.52 108.522 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' A' ' 441' ' ' ILE . 3.1 p -141.27 119.9 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.143 0 N-CA-C 108.666 -0.865 . . . . 64.04 108.666 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . 0.407 ' O ' HD23 ' A' ' 440' ' ' LEU . 30.7 tp -121.21 136.61 54.94 Favored 'General case' 0 C--N 1.265 -3.095 0 N-CA-C 108.268 -1.012 . . . . 53.24 108.268 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.449 ' CD ' ' HA ' ' A' ' 436' ' ' LYS . 43.7 tt0 -81.37 116.88 21.41 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.858 -1.164 . . . . 73.12 107.858 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.47 -46.69 38.02 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 121.887 0.851 . . . . 64.24 109.498 -176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -129.29 -78.68 0.56 Allowed 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.897 -1.047 . . . . 74.4 109.28 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.471 ' NZ ' ' HB3' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -168.05 -40.25 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 123.367 0.667 . . . . 70.01 110.492 174.048 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 91.4 m -100.72 7.79 43.66 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.749 0.785 . . . . 70.12 109.477 174.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -136.44 129.69 31.51 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.484 -0.78 . . . . 72.32 109.944 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 43.4 m-85 -125.32 150.57 47.02 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 123.522 0.514 . . . . 75.44 110.096 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 432' ' ' LEU . 1.5 pt? -111.9 120.92 43.55 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.369 -0.604 . . . . 45.14 109.369 172.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.611 ' HB ' HG22 ' A' ' 418' ' ' VAL . 4.0 mp -113.74 133.48 59.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 116.127 -0.488 . . . . 64.3 110.105 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -104.01 140.53 37.61 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 107.847 -1.168 . . . . 72.14 107.847 177.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.423 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 80.7 mtp -138.79 168.33 20.05 Favored 'General case' 0 CA--C 1.478 -1.809 0 N-CA-C 109.231 -0.655 . . . . 54.12 109.231 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.64 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 71.9 mmtt -133.53 160.02 38.7 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.146 -1.057 . . . . 71.44 108.146 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 46.2 t -165.89 146.13 5.49 Favored Pre-proline 0 C--N 1.284 -2.247 0 O-C-N 124.193 0.933 . . . . 60.42 109.894 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -67.2 -27.09 41.69 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.158 1.905 . . . . 54.13 110.147 174.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -78.79 -21.65 47.49 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.291 -0.868 . . . . 52.31 110.245 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -89.38 9.62 25.53 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 121.162 0.506 . . . . 41.41 110.708 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 9.0 t -103.04 119.27 38.55 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 107.821 -1.178 . . . . 73.21 107.821 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 35.6 t . . . . . 0 C--N 1.306 -1.322 0 N-CA-C 107.897 -1.149 . . . . 71.31 107.897 -178.964 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.412 ' CD2' ' HG3' ' A' ' 358' ' ' ARG . 59.9 t80 . . . . . 0 C--O 1.214 -0.78 0 N-CA-C 112.416 0.524 . . . . 64.14 112.416 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.412 ' HG3' ' CD2' ' A' ' 357' ' ' TYR . 99.0 mtt180 -115.57 19.08 15.59 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 114.205 1.187 . . . . 72.13 114.205 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -135.23 149.02 49.79 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.791 -1.559 . . . . 71.03 106.791 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 50.3 mm -82.27 115.63 25.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.531 0.681 . . . . 62.31 110.574 -173.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -70.3 155.5 40.58 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.747 -1.115 . . . . 70.21 112.975 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 80.62 -17.58 10.53 Favored Glycine 0 CA--C 1.508 -0.371 0 N-CA-C 116.099 1.199 . . . . 43.05 116.099 171.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 43.8 mtm -94.35 153.6 17.91 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.143 -1.023 . . . . 64.21 111.181 -178.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.427 ' HB3' HG22 ' A' ' 377' ' ' VAL . 10.3 pt-20 -101.57 141.79 33.91 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 115.14 -0.936 . . . . 71.25 109.636 175.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.461 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 93.4 m -125.78 123.97 39.95 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.111 -1.44 . . . . 71.41 107.111 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 56.2 mtpt -131.6 142.44 49.89 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 116.403 -0.362 . . . . 72.51 110.882 -175.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -160.57 135.42 7.63 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.625 -0.88 . . . . 63.45 108.625 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 2.4 mp0 -79.25 122.99 27.01 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 110.019 -0.363 . . . . 61.44 110.019 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.577 HG21 HG12 ' A' ' 431' ' ' VAL . 47.4 mt -135.74 124.15 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 N-CA-C 106.797 -1.557 . . . . 70.42 106.797 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.62 13.08 60.39 Favored Glycine 0 C--N 1.31 -0.906 0 C-N-CA 120.55 -0.833 . . . . 72.12 112.057 -177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.08 -24.2 27.08 Favored Glycine 0 N--CA 1.429 -1.808 0 C-N-CA 121.209 -0.52 . . . . 74.02 113.113 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . 0.487 ' CD1' ' HG3' ' A' ' 384' ' ' GLN . 22.5 p90 -103.42 147.16 27.47 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 110.17 -0.308 . . . . 75.04 110.17 -176.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.522 HG21 ' HE2' ' A' ' 366' ' ' LYS . 85.8 m -86.44 123.88 32.15 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 116.464 -0.335 . . . . 51.1 110.989 -178.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.655 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.5 134.74 34.15 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 108.945 -0.761 . . . . 64.31 108.945 175.418 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.476 ' HG3' ' HG2' ' A' ' 366' ' ' LYS . 38.0 ttpt -130.12 125.84 36.08 Favored 'General case' 0 CA--C 1.487 -1.453 0 N-CA-C 110.0 -0.37 . . . . 64.52 110.0 -178.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.461 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 7.3 p -122.46 118.88 56.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 N-CA-C 109.451 -0.574 . . . . 74.22 109.451 175.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 364' ' ' GLU . 49.5 t -106.17 116.99 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 106.658 -1.608 . . . . 44.11 106.658 174.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -61.43 126.7 28.28 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 114.668 1.359 . . . . 72.04 114.668 -172.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 71.07 14.35 6.77 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 113.336 -1.756 . . . . 72.13 112.465 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -124.8 -77.24 0.59 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 113.893 1.071 . . . . 73.23 113.893 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -162.76 160.97 26.0 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.882 0.697 . . . . 73.42 112.882 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.458 HG22 HG23 ' A' ' 376' ' ' VAL . 96.8 t -122.86 140.21 47.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 115.541 -0.754 . . . . 61.43 109.103 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -133.23 147.25 51.98 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.19 0.519 . . . . 72.54 111.872 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.52 ' HB2' HD23 ' A' ' 389' ' ' LEU . 35.9 tt0 -112.07 101.03 9.34 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 105.317 -2.105 . . . . 71.52 105.317 171.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 21.9 t70 68.19 -84.03 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 124.302 1.041 . . . . 75.15 110.109 -173.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 16.4 m -134.89 -6.67 2.4 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 115.214 -0.903 . . . . 65.41 108.678 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 45.6 mm -80.38 134.49 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 116.004 -0.544 . . . . 74.22 109.737 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 61.0 tp -76.92 113.9 15.12 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 109.035 -0.728 . . . . 73.24 109.035 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.3 OUTLIER -80.06 -63.32 1.44 Allowed 'General case' 0 N--CA 1.389 -3.511 0 N-CA-C 108.974 -0.75 . . . . 64.32 108.974 -177.179 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.89 159.41 30.64 Favored Glycine 0 N--CA 1.415 -2.742 0 C-N-CA 119.162 -1.494 . . . . 64.32 111.842 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -105.79 145.07 31.64 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.031 -1.1 . . . . 73.04 108.031 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -69.82 116.34 10.1 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.908 0.385 . . . . 74.43 110.601 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -94.79 -47.03 6.64 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.721 -0.672 . . . . 63.13 110.757 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 62.5 p -173.24 149.8 1.82 Allowed 'General case' 0 C--O 1.246 0.879 0 CA-C-N 116.021 -0.536 . . . . 72.04 109.599 -177.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.485 ' CD ' ' HG ' ' A' ' 400' ' ' LEU . 10.1 pt20 -143.88 142.06 30.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.186 0.517 . . . . 74.41 110.796 175.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -128.5 131.11 48.31 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.666 -0.697 . . . . 75.04 109.624 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 69.59 -107.96 2.31 Favored Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 111.365 -0.694 . . . . 52.14 111.365 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -133.07 24.41 4.22 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.83 0.824 . . . . 71.15 110.053 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 61.2 t -119.45 116.86 52.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.335 -0.987 . . . . 73.12 108.335 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.485 ' HG ' ' CD ' ' A' ' 395' ' ' GLN . 6.0 mp -106.71 133.55 51.21 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 123.16 0.584 . . . . 61.54 111.804 -174.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -113.47 121.94 45.79 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 112.513 0.56 . . . . 71.43 112.513 178.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.403 ' CE1' ' HB3' ' A' ' 400' ' ' LEU . 2.8 m-85 -118.58 136.81 53.66 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.328 -0.99 . . . . 62.34 108.328 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -146.31 176.15 9.99 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.141 0.496 . . . . 74.51 111.723 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.15 33.65 9.23 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.382 -1.281 . . . . 73.41 112.679 169.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.26 -136.7 0.67 Allowed Glycine 0 CA--C 1.533 1.17 0 CA-C-N 115.445 -0.798 . . . . 51.42 112.931 177.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.34 149.6 40.52 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.816 -1.179 . . . . 73.43 107.816 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 33.3 t -60.34 135.93 57.89 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 124.22 1.008 . . . . 64.02 111.36 -175.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 36.3 t -133.39 154.1 51.05 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.256 -0.884 . . . . 62.54 109.558 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -88.46 141.02 28.88 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.056 0.391 . . . . 74.45 112.056 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 76.84 12.12 2.4 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.393 1.477 . . . . 73.13 108.797 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -151.16 176.98 29.42 Favored Glycine 0 N--CA 1.416 -2.65 0 N-CA-C 107.822 -2.111 . . . . 64.31 107.822 176.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -88.65 -39.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.226 0 CA-C-N 119.706 1.753 . . . . 75.25 112.577 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -159.03 170.23 22.53 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 106.839 -1.541 . . . . 44.43 106.839 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -75.31 160.53 30.22 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.179 0.514 . . . . 73.22 111.22 172.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 36.8 p -163.29 163.46 25.29 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 114.908 -1.042 . . . . 72.33 108.643 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -157.75 146.32 19.25 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.217 0.532 . . . . 75.33 110.195 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 9.9 tt -111.25 121.29 63.59 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.279 0 CA-C-N 115.303 -0.862 . . . . 72.42 109.482 174.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.0 t -105.72 127.8 60.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-O 121.775 0.798 . . . . 74.45 111.499 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 12.5 p -107.76 111.7 24.0 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 106.836 -1.542 . . . . 74.32 106.836 173.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 8.6 p -106.27 120.23 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 108.891 -0.781 . . . . 62.41 108.891 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -116.2 -174.69 2.59 Favored 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 120.386 -0.526 . . . . 63.24 111.277 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 43.4 t -59.61 128.74 38.5 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 123.713 0.805 . . . . 72.35 111.2 -177.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . -160.26 -177.82 33.7 Favored Glycine 0 CA--C 1.48 -2.101 0 N-CA-C 109.54 -1.424 . . . . 53.33 109.54 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 53.3 t -96.93 -27.96 3.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-O 121.639 0.733 . . . . 73.2 109.027 177.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -141.34 146.57 36.85 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.791 -0.64 . . . . 72.15 111.234 -176.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.638 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.6 p-10 -68.28 101.21 1.16 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.28 -1.327 . . . . 72.15 110.47 175.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -132.32 149.19 52.41 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.401 -0.818 . . . . 73.01 110.919 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 28.8 mm -88.82 117.33 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 105.841 -1.911 . . . . 63.13 105.841 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 59.4 t -80.7 -50.83 16.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-O 120.772 0.32 . . . . 74.14 111.438 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 70.3 m -167.08 163.81 15.79 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 110.041 -0.355 . . . . 62.02 110.041 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.577 HG12 HG21 ' A' ' 369' ' ' ILE . 4.2 p -141.45 127.9 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 108.08 -1.082 . . . . 73.31 108.08 176.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . 0.432 ' O ' HD23 ' A' ' 440' ' ' LEU . 29.5 tp -132.21 138.18 47.86 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.665 -0.865 . . . . 55.23 108.665 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -80.65 116.45 20.68 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.89 -0.782 . . . . 74.11 108.89 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.68 -53.74 8.72 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.28 0.562 . . . . 62.4 109.702 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -120.93 -72.92 0.67 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.312 -0.858 . . . . 73.31 110.37 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.491 ' HG2' ' SG ' ' A' ' 437' ' ' CYS . 0.0 OUTLIER -167.51 -40.61 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.346 0.594 . . . . 61.15 110.483 175.173 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . 0.491 ' SG ' ' HG2' ' A' ' 436' ' ' LYS . 43.7 m -106.65 7.04 30.37 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.678 0.751 . . . . 71.32 109.501 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -135.48 127.92 30.47 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.155 -0.929 . . . . 71.33 109.319 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -123.96 150.22 45.03 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.713 -0.676 . . . . 71.1 109.782 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.477 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.4 pt? -107.52 124.71 50.31 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.491 -0.929 . . . . 75.43 108.491 173.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.6 mt -124.75 133.37 69.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 115.332 -0.849 . . . . 62.22 109.409 -176.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -112.45 141.64 45.96 Favored 'General case' 0 N--CA 1.425 -1.693 0 C-N-CA 119.934 -0.706 . . . . 74.11 109.614 177.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 80.0 mtp -137.11 169.03 18.46 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 123.571 0.749 . . . . 63.15 109.059 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.638 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 69.2 mmtt -135.12 153.73 51.91 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.732 -1.21 . . . . 72.22 107.732 175.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 73.0 m -164.57 150.82 9.3 Favored Pre-proline 0 C--N 1.293 -1.89 0 C-N-CA 123.992 0.917 . . . . 55.15 109.287 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.99 -27.51 42.62 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.282 1.988 . . . . 72.4 112.045 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -73.47 -19.74 60.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.677 -0.692 . . . . 70.53 110.94 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -93.23 8.2 41.21 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 121.478 0.656 . . . . 63.3 109.586 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 10.6 t -102.71 120.3 40.33 Favored 'General case' 0 N--CA 1.409 -2.522 0 N-CA-C 107.868 -1.16 . . . . 74.41 107.868 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 25.4 t . . . . . 0 C--N 1.305 -1.36 0 N-CA-C 106.769 -1.567 . . . . 75.14 106.769 -178.93 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 71.2 t80 . . . . . 0 C--O 1.241 0.631 0 N-CA-C 107.342 -1.355 . . . . 75.34 107.342 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.516 ' O ' ' HB1' ' A' ' 447' ' ' ALA . 15.5 ptp180 -98.55 177.97 5.16 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-O 120.824 0.345 . . . . 75.32 110.635 -176.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' A' ' 358' ' ' ARG . . . -78.79 153.59 30.62 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.991 -0.744 . . . . 71.45 108.991 172.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 47.4 mm -78.45 115.86 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.464 0.65 . . . . 61.24 110.414 -171.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.593 ' HD3' ' H ' ' A' ' 361' ' ' LYS . 0.0 OUTLIER -77.14 157.31 31.06 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.924 -1.035 . . . . 73.15 113.676 -175.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 71.69 8.09 66.82 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 114.954 -1.021 . . . . 64.41 114.074 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 47.8 ttp -104.21 140.71 37.44 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 109.548 -0.538 . . . . 73.32 109.548 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.45 ' CB ' HG22 ' A' ' 377' ' ' VAL . 0.0 OUTLIER -107.76 111.34 23.46 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.651 0.738 . . . . 64.2 110.569 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 375' ' ' LYS . 99.2 m -104.01 139.96 38.41 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.468 -0.787 . . . . 64.42 109.757 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 18.9 ptpt -143.94 141.14 30.07 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-O 120.801 0.334 . . . . 71.51 111.872 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -154.9 135.1 13.15 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 106.96 -1.496 . . . . 72.04 106.96 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 40.4 mt-10 -89.44 127.86 35.88 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 120.642 0.258 . . . . 74.21 110.817 -174.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.468 HG21 HG12 ' A' ' 431' ' ' VAL . 47.5 mt -137.21 125.47 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 107.133 -1.432 . . . . 75.32 107.133 -174.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.84 5.51 32.27 Favored Glycine 0 C--N 1.306 -1.102 0 C-N-CA 121.177 -0.535 . . . . 60.32 113.188 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 110.34 -13.84 30.69 Favored Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.562 -0.828 . . . . 40.5 113.072 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . 0.428 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 13.5 p90 -109.91 143.68 39.48 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 110.126 -0.324 . . . . 72.43 110.126 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 63.2 m -82.96 121.14 26.6 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.822 -0.351 . . . . 62.21 110.484 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.4 OUTLIER -90.3 125.64 35.58 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 109.335 -0.617 . . . . 74.24 109.335 173.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 365' ' ' THR . 35.1 ttpt -125.64 126.66 45.06 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.451 -0.574 . . . . 75.14 109.451 -176.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.425 HG23 HG22 ' A' ' 382' ' ' VAL . 6.7 p -123.08 115.9 47.05 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.578 0 N-CA-C 109.387 -0.597 . . . . 74.5 109.387 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.45 HG22 ' CB ' ' A' ' 364' ' ' GLU . 48.6 t -103.58 116.15 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 N-CA-C 106.755 -1.572 . . . . 71.32 106.755 174.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -63.14 126.46 27.45 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 113.086 0.773 . . . . 63.33 113.086 -172.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 72.66 6.78 5.47 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.494 1.517 . . . . 71.44 113.068 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -115.89 -83.67 0.63 Allowed 'General case' 0 C--O 1.248 0.98 0 N-CA-C 112.494 0.553 . . . . 71.12 112.494 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.527 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -165.81 159.48 16.1 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 113.026 0.751 . . . . 73.14 113.026 -172.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.425 HG22 HG23 ' A' ' 376' ' ' VAL . 96.5 t -113.83 145.83 19.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 124.381 1.072 . . . . 74.21 109.51 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.527 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 75.5 m-85 -133.87 144.17 48.74 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 123.322 0.649 . . . . 61.03 111.191 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.467 ' HB2' HD23 ' A' ' 389' ' ' LEU . 35.3 tt0 -111.65 103.5 11.8 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.352 -1.722 . . . . 35.25 106.352 173.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 15.4 t70 72.03 -76.16 0.07 Allowed 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 124.938 1.295 . . . . 65.21 109.463 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 34.0 t -145.31 -6.52 0.64 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.349 -0.982 . . . . 42.11 108.349 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 65.4 mt -81.49 136.2 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 CA-C-N 115.617 -0.72 . . . . 74.21 109.332 -177.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 60.2 tp -76.5 116.55 17.29 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.013 -0.736 . . . . 53.55 109.013 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.568 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.3 OUTLIER -81.33 -67.81 0.75 Allowed 'General case' 0 N--CA 1.386 -3.661 0 N-CA-C 108.207 -1.034 . . . . 61.34 108.207 -178.261 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.94 157.15 28.41 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 119.528 -1.32 . . . . 70.01 111.811 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.21 146.43 26.19 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.039 -1.097 . . . . 52.42 108.039 175.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.439 ' HD2' HE21 ' A' ' 395' ' ' GLN . 1.3 m-85 -71.25 115.97 11.03 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.475 -0.565 . . . . 71.33 109.475 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -93.16 -47.05 7.13 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.382 -0.372 . . . . 51.34 110.346 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 63.8 p -160.37 141.48 12.13 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.898 -0.778 . . . . 71.31 108.898 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.467 ' HB2' ' CD2' ' A' ' 400' ' ' LEU . 0.1 OUTLIER -147.03 141.35 26.31 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 116.343 -0.389 . . . . 63.4 110.926 -179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -128.99 120.32 25.84 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.947 -0.76 . . . . 72.43 108.947 177.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 63.33 -103.13 0.62 Allowed Glycine 0 N--CA 1.434 -1.493 0 O-C-N 123.746 0.654 . . . . 63.11 113.33 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 26.8 p-10 -113.7 6.18 16.74 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 112.01 0.374 . . . . 74.02 112.01 -176.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 28.1 t -116.43 116.93 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 107.932 -1.136 . . . . 74.24 107.932 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.467 ' CD2' ' HB2' ' A' ' 395' ' ' GLN . 11.7 mt -120.01 123.91 44.63 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 115.528 -0.76 . . . . 64.24 110.278 -171.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -103.77 124.0 48.09 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-O 121.032 0.444 . . . . 74.32 111.713 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.402 ' OH ' ' HB ' ' A' ' 418' ' ' VAL . 3.1 m-85 -116.21 136.32 53.12 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 107.933 -1.136 . . . . 64.04 107.933 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -146.29 175.58 10.41 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.846 0.355 . . . . 64.22 111.508 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.39 35.02 20.59 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 124.664 1.186 . . . . 65.1 112.681 172.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.568 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.84 -140.43 1.13 Allowed Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.072 -0.967 . . . . 72.13 111.903 176.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.51 139.39 43.79 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.96 -0.755 . . . . 55.43 108.96 -178.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 26.3 t -60.2 129.16 40.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.026 0.917 . . . . 71.22 112.969 -172.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 37.4 t -132.91 127.72 34.95 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.466 -1.309 . . . . 73.41 107.466 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' TRP . . . . . 0.466 ' O ' ' HB2' ' A' ' 410' ' ' ASN . 45.5 t-105 -86.35 113.81 22.63 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 114.412 1.264 . . . . 75.21 114.412 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 409' ' ' TRP . 16.3 t-20 153.18 -32.57 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.457 0 C-N-CA 128.161 2.585 . . . . 63.04 104.544 166.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -108.06 -166.21 21.39 Favored Glycine 0 N--CA 1.417 -2.62 0 N-CA-C 106.208 -2.757 . . . . 50.42 106.208 168.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -86.5 -39.42 0.08 OUTLIER 'Trans proline' 0 C--N 1.315 -1.23 0 CA-C-N 120.284 2.042 . . . . 73.25 112.429 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -159.9 -177.76 6.56 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 105.126 -2.175 . . . . 53.13 105.126 -178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 437' ' ' CYS . 83.5 mtt180 -75.22 154.6 37.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 119.478 -0.889 . . . . 72.22 110.61 169.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.626 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 21.3 p -163.39 162.2 24.79 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 114.801 -1.091 . . . . 64.23 108.831 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.54 151.72 19.12 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 120.824 0.345 . . . . 75.32 110.818 -178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.9 tt -113.31 127.74 70.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 108.987 -0.746 . . . . 71.51 108.987 172.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 4.6 t -111.4 128.65 67.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 CA-C-N 115.951 -0.568 . . . . 74.24 110.835 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.26 115.4 27.36 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 105.908 -1.886 . . . . 62.11 105.908 177.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 37.6 t -100.54 127.6 53.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 109.137 -0.69 . . . . 73.4 109.137 -175.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -117.52 -175.09 2.74 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 120.039 -0.665 . . . . 72.44 110.497 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.461 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 33.3 t -62.34 128.03 34.12 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 122.964 0.506 . . . . 72.41 110.876 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -154.08 -178.86 28.93 Favored Glycine 0 CA--C 1.492 -1.351 0 C-N-CA 120.519 -0.848 . . . . 73.43 111.591 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 58.4 t -85.78 -38.77 13.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 108.81 -0.811 . . . . 72.41 108.81 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -149.65 150.17 31.75 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.359 -0.837 . . . . 71.55 109.629 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.603 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.6 p-10 -51.04 100.73 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.321 -1.309 . . . . 55.53 111.089 174.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -131.83 144.65 51.06 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 116.268 -0.424 . . . . 72.54 110.444 -177.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.458 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 26.8 mm -84.13 116.87 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 N-CA-C 105.885 -1.894 . . . . 74.23 105.885 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 442' ' ' LYS . 56.0 t -82.23 -50.57 16.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 CA-C-O 120.919 0.39 . . . . 73.53 111.986 -175.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 48.7 m -161.68 162.55 29.89 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.104 -0.702 . . . . 73.13 109.104 -174.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.468 HG12 HG21 ' A' ' 369' ' ' ILE . 3.4 p -141.32 111.13 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 N-CA-C 108.754 -0.832 . . . . 62.04 108.754 176.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . 0.479 ' O ' HD23 ' A' ' 440' ' ' LEU . 28.8 tp -112.63 137.72 50.48 Favored 'General case' 0 N--CA 1.401 -2.885 0 N-CA-C 107.679 -1.23 . . . . 72.15 107.679 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . 0.455 ' CD ' ' HA ' ' A' ' 436' ' ' LYS . 39.2 tt0 -80.79 114.3 19.58 Favored 'General case' 0 C--N 1.277 -2.577 0 N-CA-C 108.724 -0.843 . . . . 73.42 108.724 -178.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -73.07 -40.18 65.27 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 115.367 -0.833 . . . . 71.11 110.496 -175.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -133.06 -77.93 0.49 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.165 -0.925 . . . . 73.45 108.752 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.467 ' NZ ' ' HB3' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -167.35 -39.8 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 124.029 0.932 . . . . 61.13 110.513 173.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 414' ' ' ARG . 62.8 m -100.69 -5.03 27.11 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.697 0.761 . . . . 73.02 109.586 177.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.626 ' HA ' ' O ' ' A' ' 415' ' ' SER . 38.3 tt0 -127.04 137.63 53.09 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.207 -0.906 . . . . 74.1 109.339 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -129.02 150.52 50.39 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.819 -0.628 . . . . 75.42 110.487 -174.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.8 pt? -109.39 115.57 30.21 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.55 -0.908 . . . . 73.04 108.55 173.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.5 mt -115.25 126.45 72.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.408 -0.814 . . . . 61.13 109.699 -175.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.48 ' O ' ' HB ' ' A' ' 429' ' ' VAL . 38.3 ttpt -103.32 141.48 35.85 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.504 -0.925 . . . . 75.31 108.504 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.458 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.8 mtp -136.32 168.91 18.54 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 109.663 -0.495 . . . . 50.43 109.663 -176.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 71.8 mmtt -131.77 158.61 40.76 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.123 -1.066 . . . . 73.31 108.123 175.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 47.2 t -172.92 146.66 1.45 Allowed Pre-proline 0 C--N 1.287 -2.121 0 O-C-N 124.248 0.968 . . . . 71.32 108.774 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -64.49 -23.47 64.59 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.125 1.883 . . . . 63.14 110.64 176.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 358' ' ' ARG . . . -68.25 -26.94 65.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.416 -0.811 . . . . 72.23 111.081 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -98.36 13.65 30.81 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.365 0.603 . . . . 62.1 109.771 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 19.6 t -103.15 120.12 40.12 Favored 'General case' 0 N--CA 1.415 -2.215 0 C-N-CA 120.128 -0.629 . . . . 51.04 110.642 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 74.9 m . . . . . 0 C--N 1.308 -1.199 0 C-N-CA 125.836 1.654 . . . . 65.21 107.637 176.648 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.69 ' N ' ' HH ' ' A' ' 379' ' ' TYR . 63.7 m-85 . . . . . 0 C--O 1.217 -0.645 0 N-CA-C 108.697 -0.853 . . . . 75.32 108.697 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -89.23 36.93 0.84 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.57 0.7 . . . . 74.04 110.709 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -146.8 149.94 34.34 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.66 -1.237 . . . . 44.12 107.66 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 50.5 mm -82.61 116.97 27.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 108.598 -0.89 . . . . 62.34 108.598 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.594 ' HA ' ' HB2' ' A' ' 378' ' ' PHE . 22.2 pttp -90.3 156.45 18.27 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 112.389 0.515 . . . . 62.51 112.389 -174.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 93.6 -19.64 51.51 Favored Glycine 0 CA--C 1.508 -0.372 0 CA-C-N 115.559 -0.746 . . . . 71.31 114.713 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 19.0 ptp -90.88 156.13 18.24 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.087 -1.045 . . . . 74.33 110.445 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.46 ' HB3' HG22 ' A' ' 377' ' ' VAL . 0.2 OUTLIER -103.57 113.02 26.22 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 115.327 -0.851 . . . . 75.3 109.065 175.063 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.495 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 86.6 m -96.11 125.84 40.92 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.509 -1.293 . . . . 64.31 107.509 177.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 13.8 ptmm? -141.41 140.73 33.71 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 120.798 -0.361 . . . . 73.12 111.758 -175.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -159.81 138.59 10.7 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.356 -0.979 . . . . 74.45 108.356 -173.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -81.24 123.49 28.52 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 110.075 -0.342 . . . . 75.2 110.075 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.457 HG21 HG12 ' A' ' 431' ' ' VAL . 58.3 mt -128.58 115.9 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 106.956 -1.498 . . . . 73.42 106.956 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.76 12.67 59.94 Favored Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.598 -0.811 . . . . 64.05 112.332 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 111.04 -26.15 12.88 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 121.265 -0.493 . . . . 50.14 112.701 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -98.08 136.36 38.43 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 120.756 -0.377 . . . . 73.52 110.89 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 70.1 m -79.17 119.99 23.04 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 116.039 -0.528 . . . . 55.23 110.228 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.629 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -91.02 133.18 35.51 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 108.577 -0.897 . . . . 75.0 108.577 172.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.457 ' HG3' ' HB3' ' A' ' 366' ' ' LYS . 35.0 ttpt -133.19 125.73 30.07 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.087 -0.645 . . . . 62.13 109.706 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.495 ' CG1' ' HB ' ' A' ' 365' ' ' THR . 6.9 p -120.58 116.4 49.97 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 N-CA-C 109.816 -0.438 . . . . 74.34 109.816 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 364' ' ' GLU . 26.9 t -107.41 116.09 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 106.988 -1.486 . . . . 63.02 106.988 174.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.594 ' HB2' ' HA ' ' A' ' 361' ' ' LYS . 95.7 m-85 -61.74 130.51 46.12 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 113.697 0.999 . . . . 72.34 113.697 -172.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.69 ' HH ' ' N ' ' A' ' 357' ' ' TYR . 41.6 m-85 67.17 14.38 9.75 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.52 1.128 . . . . 73.12 112.884 -178.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -125.34 -82.52 0.63 Allowed 'General case' 0 C--O 1.242 0.696 0 N-CA-C 113.418 0.896 . . . . 73.24 113.418 178.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.418 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -168.32 155.2 7.62 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.946 0.721 . . . . 73.5 112.946 -174.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.482 HG22 HG23 ' A' ' 376' ' ' VAL . 71.4 t -113.78 146.49 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.044 0.938 . . . . 71.13 109.582 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.418 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 84.3 m-85 -135.08 149.27 50.04 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.399 0.679 . . . . 73.11 111.345 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.524 ' HB2' HD23 ' A' ' 389' ' ' LEU . 32.6 tt0 -123.96 104.81 9.13 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.186 -1.783 . . . . 73.02 106.186 172.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.1 t70 69.17 -87.66 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.933 0.893 . . . . 73.52 110.923 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 18.8 m -133.04 0.32 3.44 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.204 -1.036 . . . . 44.12 108.204 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 45.9 mm -92.19 133.27 34.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.047 -0.979 . . . . 73.53 110.457 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 63.1 tp -75.99 114.73 14.96 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.247 -1.39 . . . . 61.53 107.247 176.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.5 OUTLIER -78.75 -63.3 1.44 Allowed 'General case' 0 N--CA 1.386 -3.629 0 N-CA-C 108.9 -0.778 . . . . 52.32 108.9 -175.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.0 158.56 29.86 Favored Glycine 0 N--CA 1.423 -2.231 0 C-N-CA 119.258 -1.448 . . . . 73.22 112.281 -178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -104.08 143.31 33.07 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.305 -0.998 . . . . 74.04 108.305 177.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.452 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 1.8 m-85 -68.72 116.5 9.3 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 123.506 0.504 . . . . 72.44 110.668 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.69 -47.35 5.36 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.023 -0.535 . . . . 70.0 110.958 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 48.2 t -159.0 148.19 18.66 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.147 -0.686 . . . . 42.25 109.147 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.421 HE21 ' HD2' ' A' ' 392' ' ' PHE . 18.3 mp0 -123.28 145.75 48.44 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.27 -1.011 . . . . 70.0 108.27 174.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -126.62 109.08 11.71 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 107.899 -1.148 . . . . 51.23 107.899 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 58.66 -101.37 0.21 Allowed Glycine 0 C--O 1.253 1.301 0 CA-C-O 121.423 0.457 . . . . 72.11 113.193 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -116.07 17.12 15.94 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 124.249 1.02 . . . . 73.04 109.558 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . 0.51 HG13 HD11 ' A' ' 417' ' ' ILE . 60.0 t -121.05 133.45 67.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.197 -1.038 . . . . 74.5 108.197 -177.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 399' ' ' VAL . 3.5 mp -130.33 134.34 47.11 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.513 -0.475 . . . . 74.35 111.53 -176.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -108.26 122.17 46.39 Favored 'General case' 0 C--O 1.248 0.988 0 C-N-CA 123.101 0.56 . . . . 72.11 112.003 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.434 ' CD2' HG21 ' A' ' 382' ' ' VAL . 3.0 m-85 -118.38 129.32 55.35 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.719 -1.215 . . . . 71.44 107.719 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -147.11 175.29 10.82 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 111.637 0.236 . . . . 74.4 111.637 -177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 13.7 m120 60.07 39.19 20.01 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.738 0.649 . . . . 62.12 111.618 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -80.65 -137.46 1.93 Allowed Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.737 -0.745 . . . . 72.24 112.069 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -67.37 148.74 51.23 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.744 -0.465 . . . . 71.03 109.744 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 30.4 m -60.54 123.62 17.93 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.208 0.527 . . . . 55.41 109.798 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 48.9 t -99.39 144.86 28.02 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.148 -1.427 . . . . 73.32 107.148 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 21.3 p-90 -81.6 -27.0 34.45 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.713 0.768 . . . . 74.2 109.335 -177.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -99.1 9.58 43.2 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.68 -1.145 . . . . 74.11 109.295 -170.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -168.99 -158.75 13.28 Favored Glycine 0 CA--C 1.5 -0.865 0 N-CA-C 108.228 -1.949 . . . . 44.31 108.228 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -89.13 -41.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.552 1.377 0 CA-C-N 121.039 2.419 . . . . 63.55 112.832 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -158.32 171.36 20.32 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.192 -1.04 . . . . 72.31 108.192 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -82.72 160.76 22.29 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.143 0.497 . . . . 74.54 111.506 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 22.7 p -165.27 160.54 18.47 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-N 114.645 -1.162 . . . . 63.42 109.145 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -157.33 147.87 21.18 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.161 0.505 . . . . 62.03 110.705 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . 0.51 HD11 HG13 ' A' ' 399' ' ' VAL . 0.0 OUTLIER -112.25 114.44 47.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.977 -1.12 . . . . 74.52 107.977 174.028 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.552 HG22 ' HB ' ' A' ' 441' ' ' ILE . 5.0 t -97.91 128.81 48.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-O 121.337 0.589 . . . . 71.54 110.327 177.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 1.4 m -113.66 114.43 26.39 Favored 'General case' 0 N--CA 1.406 -2.648 0 N-CA-C 106.372 -1.714 . . . . 72.4 106.372 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 39.1 t -100.78 118.31 47.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.618 -0.882 . . . . 73.42 108.618 -175.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -109.1 -174.88 2.62 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 120.748 0.308 . . . . 54.13 110.393 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 42.0 t -60.5 129.24 40.59 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 123.917 0.887 . . . . 71.23 111.5 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.58 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -158.86 -177.56 32.05 Favored Glycine 0 CA--C 1.491 -1.422 0 N-CA-C 110.641 -0.984 . . . . 72.01 110.641 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.07 -33.52 5.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.578 0.704 . . . . 74.33 109.125 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 426' ' ' ASN . 36.6 tt0 -149.06 162.1 40.62 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.545 -0.752 . . . . 72.1 109.074 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 19.7 m120 -67.62 107.93 2.71 Favored 'General case' 0 N--CA 1.415 -2.207 0 CA-C-N 114.632 -1.167 . . . . 63.34 110.37 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -131.57 148.48 52.62 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 114.934 -1.03 . . . . 73.11 109.54 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 29.4 mm -91.45 115.06 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 106.089 -1.819 . . . . 75.25 106.089 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 53.9 t -81.12 -48.83 18.79 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 111.995 0.368 . . . . 53.41 111.995 -176.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 46.9 p -166.64 163.67 16.8 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 109.565 -0.531 . . . . 74.22 109.565 -174.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.457 HG12 HG21 ' A' ' 369' ' ' ILE . 3.2 p -141.36 111.41 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 N-CA-C 108.403 -0.962 . . . . 74.42 108.403 177.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . 0.451 ' HB3' ' HG ' ' A' ' 440' ' ' LEU . 24.4 tp -110.44 136.51 49.48 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 114.892 -1.049 . . . . 70.34 108.408 -175.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -80.86 110.74 16.67 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 107.465 -1.309 . . . . 75.24 107.465 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -72.66 -42.31 64.47 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.473 -0.785 . . . . 74.32 110.222 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -132.38 -78.03 0.5 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.474 -0.936 . . . . 64.42 108.474 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.22 -50.28 0.07 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.137 0.494 . . . . 70.53 111.0 174.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 63.4 m -100.9 4.39 42.62 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.817 0.817 . . . . 55.43 109.822 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 415' ' ' SER . 35.9 tt0 -129.45 130.97 46.59 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.904 -1.044 . . . . 64.3 108.948 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 41.1 m-85 -123.51 150.83 43.46 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.209 -0.905 . . . . 74.53 110.075 -174.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.451 ' HG ' ' HB3' ' A' ' 432' ' ' LEU . 4.1 pp -111.08 124.46 52.23 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 106.992 -1.485 . . . . 73.31 106.992 173.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.552 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.7 mt -120.27 135.63 59.91 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 115.753 -0.658 . . . . 51.32 109.813 -175.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -105.7 140.25 39.04 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.235 -1.024 . . . . 74.13 108.235 178.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.407 ' SD ' HG11 ' A' ' 376' ' ' VAL . 82.7 mtp -140.08 168.7 19.2 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 109.02 -0.733 . . . . 64.52 109.02 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.58 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 71.9 mmtt -132.24 160.28 36.62 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.999 -0.741 . . . . 71.22 108.999 177.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 32.2 t -172.22 148.55 2.0 Allowed Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 124.138 0.899 . . . . 75.01 108.832 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.82 -27.26 51.75 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.197 1.931 . . . . 74.22 111.027 177.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -74.74 -15.79 60.76 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.281 -0.872 . . . . 70.31 111.12 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -101.27 11.4 39.38 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-O 121.268 0.556 . . . . 64.41 110.08 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 16.9 t -101.85 121.2 41.65 Favored 'General case' 0 N--CA 1.409 -2.507 0 CA-C-N 115.773 -0.649 . . . . 60.41 109.293 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.418 -2.027 0 N-CA-C 106.828 -1.545 . . . . 73.04 106.828 178.215 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 448' ' ' ALA . 90.4 m-85 . . . . . 0 CA--C 1.52 -0.181 0 CA-C-O 121.219 0.533 . . . . 71.15 109.92 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.432 ' H ' ' HA ' ' A' ' 448' ' ' ALA . 32.8 ttm180 -156.8 166.49 33.23 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 106.454 -1.684 . . . . 71.22 106.454 -176.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -132.4 151.41 51.88 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 109.969 -0.382 . . . . 74.13 109.969 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.52 116.32 25.6 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.648 0 N-CA-C 109.208 -0.664 . . . . 64.32 109.208 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -80.76 155.74 26.55 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.761 -0.654 . . . . 74.23 111.5 -177.75 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 84.32 -53.53 4.84 Favored Glycine 0 C--N 1.32 -0.34 0 N-CA-C 115.086 0.795 . . . . 33.12 115.086 174.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 56.1 ttp -71.56 126.28 29.27 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.155 0.502 . . . . 75.21 110.957 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.11 144.89 42.65 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.192 -0.913 . . . . 63.22 110.911 -178.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 97.7 m -125.01 133.73 52.86 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.358 -0.978 . . . . 73.41 108.358 175.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 10.4 ptpp? -138.48 154.63 48.82 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 110.343 -0.243 . . . . 73.1 110.343 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -164.7 135.34 4.05 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.591 -1.263 . . . . 75.14 107.591 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -84.67 125.31 32.39 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.599 -0.519 . . . . 75.55 109.599 -177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.518 HG21 HG12 ' A' ' 431' ' ' VAL . 49.4 mt -130.59 116.29 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 N-CA-C 107.236 -1.394 . . . . 65.34 107.236 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 67.28 11.71 59.59 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.823 -0.703 . . . . 51.42 112.521 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 111.94 -25.75 12.5 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.806 -0.711 . . . . 74.31 112.575 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -97.84 136.09 38.65 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 120.218 -0.593 . . . . 74.35 110.8 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 92.2 m -79.19 118.48 21.18 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 115.713 -0.676 . . . . 64.14 110.742 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -90.12 133.34 34.93 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 108.234 -1.024 . . . . 60.21 108.234 173.364 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -132.06 125.71 32.07 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.349 -0.541 . . . . 74.11 110.022 -178.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.422 HG23 HG22 ' A' ' 382' ' ' VAL . 7.0 p -119.51 118.08 56.11 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 CA-C-N 116.031 -0.531 . . . . 71.42 109.861 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.4 t -109.25 116.14 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 106.658 -1.608 . . . . 63.04 106.658 173.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.469 ' HB2' ' HA ' ' A' ' 361' ' ' LYS . 83.5 m-85 -63.11 130.88 46.54 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.15 -0.932 . . . . 75.34 113.107 -171.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 71.82 6.79 5.74 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.894 1.278 . . . . 70.2 112.314 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -119.42 -84.81 0.66 Allowed 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 116.021 -0.536 . . . . 73.41 112.19 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.511 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.3 OUTLIER -168.37 158.99 10.2 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 112.611 0.597 . . . . 44.25 112.611 -174.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 402' ' ' TYR . 94.6 t -116.29 146.58 20.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 123.858 0.863 . . . . 73.43 109.928 -177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.511 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 81.1 m-85 -133.06 151.3 52.04 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 123.662 0.785 . . . . 71.4 111.088 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.521 ' HB2' HD23 ' A' ' 389' ' ' LEU . 30.4 tt0 -126.46 109.66 12.44 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.584 -1.636 . . . . 65.34 106.584 173.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 25.0 t70 70.49 -80.66 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 124.051 0.94 . . . . 63.43 110.528 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 28.4 p -145.37 1.12 0.93 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.176 -0.92 . . . . 63.33 109.27 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 48.2 mm -91.37 137.63 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.003 -0.999 . . . . 72.2 109.558 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.534 HD21 HD21 ' A' ' 391' ' ' ASN . 57.1 tp -76.63 115.94 16.86 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.236 -1.024 . . . . 61.03 108.236 176.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.539 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.4 OUTLIER -79.07 -64.32 1.21 Allowed 'General case' 0 N--CA 1.392 -3.354 0 N-CA-C 109.025 -0.731 . . . . 63.03 109.025 -177.252 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.44 160.63 31.52 Favored Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 118.796 -1.668 . . . . 40.14 111.744 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.534 HD21 HD21 ' A' ' 388' ' ' LEU . 8.7 m120 -99.53 147.48 25.27 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.237 -1.764 . . . . 72.12 106.237 177.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' A' ' 378' ' ' PHE . 2.6 m-85 -69.24 116.42 9.66 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.061 -0.656 . . . . 45.43 110.86 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -93.78 -48.1 6.46 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.675 -0.693 . . . . 70.41 110.134 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 46.8 m -154.23 142.45 20.43 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 110.303 -0.258 . . . . 65.3 110.303 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -122.2 130.99 53.71 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 106.593 -1.632 . . . . 72.21 106.593 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -128.67 109.81 11.66 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.922 -0.77 . . . . 75.02 108.922 176.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.19 -101.18 0.58 Allowed Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.988 -0.625 . . . . 34.4 111.948 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -122.48 18.95 10.5 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.269 0.557 . . . . 72.34 109.575 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 58.0 t -121.01 126.43 75.19 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 N-CA-C 107.792 -1.188 . . . . 74.1 107.792 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 22.7 mt -123.82 123.66 40.95 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 110.001 -0.37 . . . . 72.43 110.001 -172.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -106.88 125.1 50.57 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 110.201 -0.296 . . . . 63.04 110.201 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.485 ' CE2' HG21 ' A' ' 382' ' ' VAL . 2.4 m-85 -118.49 135.54 54.33 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.52 -0.918 . . . . 65.25 108.52 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -146.27 175.85 10.2 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 123.41 0.684 . . . . 75.31 109.771 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 14.7 m120 66.17 27.54 10.36 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.287 0.847 . . . . 62.13 113.287 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -72.6 -139.48 0.32 Allowed Glycine 0 CA--C 1.54 1.619 0 C-N-CA 121.302 -0.475 . . . . 75.4 113.764 176.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.02 144.68 38.49 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 107.309 -1.367 . . . . 75.52 107.309 -177.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 32.6 t -65.69 130.65 44.05 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.669 0.747 . . . . 74.54 111.141 -177.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 19.5 p -124.24 159.78 29.42 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.168 -1.049 . . . . 54.55 108.168 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 55.8 t-105 -86.99 143.45 27.34 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 119.826 -0.75 . . . . 74.43 111.06 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 78.71 6.03 2.38 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.609 1.563 . . . . 41.53 109.854 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -146.75 172.75 27.18 Favored Glycine 0 N--CA 1.425 -2.053 0 N-CA-C 107.095 -2.402 . . . . 63.23 107.095 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -86.67 -41.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.408 0 CA-C-N 120.458 2.129 . . . . 71.42 112.792 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -161.82 155.38 21.29 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.678 -1.601 . . . . 64.54 106.678 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -64.99 157.15 29.05 Favored 'General case' 0 C--O 1.253 1.275 0 CA-C-O 121.677 0.751 . . . . 73.4 111.859 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 40.1 p -159.67 163.66 34.66 Favored 'General case' 0 N--CA 1.403 -2.789 0 CA-C-N 114.305 -1.316 . . . . 71.12 109.063 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -160.38 151.48 19.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 109.971 -0.381 . . . . 73.41 109.971 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 14.9 tt -117.67 120.98 66.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 108.663 -0.865 . . . . 72.23 108.663 173.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.491 HG22 ' HB ' ' A' ' 441' ' ' ILE . 4.1 t -104.01 123.65 57.89 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 CA-C-N 115.163 -0.926 . . . . 62.43 110.127 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 2.3 m -108.57 114.08 27.62 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 105.525 -2.028 . . . . 75.5 105.525 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.37 116.7 44.32 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.383 0 N-CA-C 108.154 -1.054 . . . . 75.31 108.154 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -110.94 -173.86 2.34 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 120.961 0.41 . . . . 75.04 111.736 -176.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.487 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 39.8 t -64.1 128.67 36.83 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 123.635 0.774 . . . . 72.1 111.386 -177.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -161.1 -177.5 34.26 Favored Glycine 0 CA--C 1.492 -1.37 0 N-CA-C 109.508 -1.437 . . . . 52.11 109.508 177.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 56.2 t -96.17 -23.42 4.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-O 121.539 0.685 . . . . 62.13 109.441 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -142.67 154.44 44.34 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.906 -0.588 . . . . 71.03 110.363 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 72.0 m-20 -71.69 99.3 2.09 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.777 -1.194 . . . . 75.25 107.777 175.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -132.01 148.55 52.51 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 120.999 -0.28 . . . . 52.23 110.398 -177.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.478 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 26.7 mm -85.89 127.49 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.49 -1.67 . . . . 73.42 106.49 176.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 62.6 t -91.54 -51.03 12.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 112.356 0.502 . . . . 73.42 112.356 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 50.5 m -163.23 161.64 24.97 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.507 -0.553 . . . . 53.04 109.507 -174.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.518 HG12 HG21 ' A' ' 369' ' ' ILE . 3.1 p -141.4 116.8 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 123.867 0.729 . . . . 73.24 109.468 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 25.0 tp -123.87 137.34 54.66 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.214 -1.032 . . . . 74.14 108.214 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -84.21 128.41 34.55 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.714 -0.847 . . . . 64.12 108.714 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -89.22 -48.19 7.55 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.11 1.152 . . . . 65.13 114.11 -176.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -122.79 -68.21 0.9 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.191 0.519 . . . . 74.22 111.642 -172.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.482 ' NZ ' ' HB3' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -166.03 -27.28 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 124.031 0.932 . . . . 73.14 109.535 175.096 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 98.3 m -135.78 21.91 3.32 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.718 -0.674 . . . . 75.31 110.934 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 415' ' ' SER . 32.4 tt0 -135.29 119.61 17.86 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.289 0.566 . . . . 75.24 110.564 -176.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -109.44 134.42 51.88 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 115.623 -0.717 . . . . 74.03 110.719 -174.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.0 OUTLIER -96.66 116.65 29.47 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.203 -1.036 . . . . 71.2 108.203 173.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.491 ' HB ' HG22 ' A' ' 418' ' ' VAL . 97.6 mt -118.35 135.1 59.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 CA-C-N 115.043 -0.98 . . . . 65.54 110.309 -175.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -105.44 140.93 37.81 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.419 -0.956 . . . . 64.42 108.419 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.478 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.2 mtp -137.78 168.7 19.15 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 108.784 -0.821 . . . . 53.13 108.784 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 73.0 mmtt -131.76 161.24 33.32 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 108.354 -0.98 . . . . 64.1 108.354 176.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 48.5 t -164.82 146.07 6.45 Favored Pre-proline 0 C--N 1.284 -2.276 0 O-C-N 124.235 0.96 . . . . 73.21 109.025 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 423' ' ' GLY . 30.4 Cg_endo -65.6 -27.22 53.48 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.159 1.906 . . . . 73.43 110.676 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -82.34 -19.96 38.26 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.516 -0.766 . . . . 63.21 110.782 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 357' ' ' TYR . . . -86.99 9.58 19.08 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-O 121.969 0.89 . . . . 74.42 110.415 -177.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 10.4 t -103.53 175.7 5.39 Favored 'General case' 0 N--CA 1.403 -2.809 0 N-CA-C 107.702 -1.221 . . . . 75.24 107.702 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.421 -1.906 0 N-CA-C 107.306 -1.368 . . . . 61.31 107.306 177.351 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.721 ' N ' ' HH ' ' A' ' 379' ' ' TYR . 57.2 t80 . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 108.267 -1.012 . . . . 74.25 108.267 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 73.13 0.73 3.78 Favored 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 124.977 1.311 . . . . 71.41 112.808 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -146.45 150.64 36.01 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.84 -1.17 . . . . 62.1 107.84 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 4.2 tp -81.54 116.25 25.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 122.108 0.956 . . . . 73.33 111.919 -175.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -74.17 129.79 38.52 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.439 -1.255 . . . . 74.15 110.691 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 93.5 -13.25 67.97 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.856 -0.688 . . . . 41.21 114.027 176.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 52.7 ttm -75.64 132.33 40.53 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 119.089 -1.044 . . . . 74.2 110.499 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -94.77 106.06 18.03 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.269 -1.011 . . . . 65.15 108.269 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.495 ' HB ' HG13 ' A' ' 376' ' ' VAL . 86.4 m -101.89 137.42 40.2 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.46 -0.571 . . . . 62.13 109.46 -178.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 0.0 OUTLIER -145.17 151.62 38.72 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.614 -0.435 . . . . 72.51 111.572 178.021 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -162.56 134.33 5.29 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.31 -1.367 . . . . 74.05 107.31 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 45.7 mt-10 -87.79 127.99 35.32 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 110.113 -0.329 . . . . 71.32 110.113 -175.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.487 HG21 HG12 ' A' ' 431' ' ' VAL . 42.5 mt -134.46 122.64 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 106.642 -1.614 . . . . 74.42 106.642 -175.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.54 9.88 52.15 Favored Glycine 0 C--N 1.306 -1.123 0 C-N-CA 120.894 -0.669 . . . . 65.41 113.194 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 111.97 -23.57 16.49 Favored Glycine 0 N--CA 1.427 -1.94 0 C-N-CA 120.82 -0.705 . . . . 70.32 112.803 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . 0.419 ' HE1' ' CE2' ' A' ' 374' ' ' TYR . 17.0 p90 -100.98 144.61 29.71 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.625 0.25 . . . . 74.14 110.809 -177.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 87.3 m -82.47 119.39 24.15 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.817 -0.438 . . . . 75.24 109.817 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.37 125.28 35.49 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 108.451 -0.944 . . . . 60.12 108.451 172.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -126.6 130.9 51.4 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.453 -0.573 . . . . 75.11 109.453 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.512 HG23 HG22 ' A' ' 382' ' ' VAL . 6.6 p -128.07 119.29 50.69 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.928 0 CA-C-O 121.254 0.55 . . . . 75.34 110.246 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 57.9 t -108.14 116.39 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.917 0 N-CA-C 106.825 -1.546 . . . . 74.03 106.825 175.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -62.85 132.48 52.3 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 114.066 1.135 . . . . 74.25 114.066 -173.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.721 ' HH ' ' N ' ' A' ' 357' ' ' TYR . 96.5 m-85 66.96 17.91 10.55 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.03 -1.441 . . . . 62.42 112.076 179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -128.79 -82.75 0.58 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.309 -0.86 . . . . 54.52 113.001 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.454 ' ND2' ' HE1' ' A' ' 383' ' ' PHE . 0.2 OUTLIER -165.55 155.93 13.29 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 113.274 0.842 . . . . 65.1 113.274 -172.358 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.512 HG22 HG23 ' A' ' 376' ' ' VAL . 88.4 t -113.78 145.28 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.388 1.075 . . . . 54.04 109.252 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.454 ' HE1' ' ND2' ' A' ' 381' ' ' ASN . 85.6 m-85 -134.81 147.61 49.99 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 123.125 0.57 . . . . 75.22 111.532 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.528 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.2 tt0 -119.39 104.71 10.6 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.151 -1.796 . . . . 73.11 106.151 173.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 27.4 t70 72.12 -82.96 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.725 0.81 . . . . 63.22 110.286 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 32.1 p -143.84 3.04 1.23 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.852 -1.067 . . . . 71.42 108.574 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 62.1 mt -89.21 133.91 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.967 -1.015 . . . . 71.24 109.378 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 61.2 tp -77.43 115.45 17.21 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.536 -0.913 . . . . 61.41 108.536 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.574 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -80.31 -64.54 1.17 Allowed 'General case' 0 N--CA 1.394 -3.249 0 N-CA-C 108.994 -0.743 . . . . 51.55 108.994 -177.086 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.9 158.57 30.16 Favored Glycine 0 N--CA 1.415 -2.739 0 C-N-CA 119.874 -1.155 . . . . 54.43 111.519 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -103.12 153.14 20.62 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.157 -1.423 . . . . 65.31 107.157 174.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.488 ' HB3' HE22 ' A' ' 395' ' ' GLN . 1.7 m-85 -73.7 116.13 13.93 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-O 120.926 0.393 . . . . 71.34 111.306 -175.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.88 -48.12 5.03 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.608 -0.724 . . . . 71.24 110.852 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 51.1 m -157.15 137.75 13.12 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.024 0.44 . . . . 64.22 109.961 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.56 ' CB ' ' HG ' ' A' ' 400' ' ' LEU . 4.8 pm0 -141.17 125.69 17.74 Favored 'General case' 0 N--CA 1.42 -1.974 0 CA-C-N 115.824 -0.626 . . . . 72.13 110.371 177.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -128.22 132.18 48.8 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.383 -0.969 . . . . 63.25 108.383 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 69.53 -103.53 1.12 Allowed Glycine 0 N--CA 1.422 -2.292 0 N-CA-C 111.057 -0.817 . . . . 73.52 111.057 -177.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -138.77 18.5 2.67 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.789 0.804 . . . . 73.42 110.297 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 63.9 t -117.1 119.78 63.02 Favored 'Isoleucine or valine' 0 C--O 1.244 0.816 0 N-CA-C 108.174 -1.047 . . . . 61.3 108.174 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.56 ' HG ' ' CB ' ' A' ' 395' ' ' GLN . 4.0 mp -113.02 135.54 53.67 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.964 -0.562 . . . . 73.24 110.971 -173.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -115.47 125.16 52.74 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.524 -0.917 . . . . 71.21 108.524 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -115.75 141.55 47.94 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.399 -0.963 . . . . 74.4 108.399 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -146.12 176.46 9.71 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 123.624 0.77 . . . . 71.54 109.096 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 18.7 m120 65.51 36.05 6.87 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.274 0.629 . . . . 65.34 112.677 173.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -81.01 -137.67 2.11 Favored Glycine 0 C--N 1.305 -1.177 0 C-N-CA 120.562 -0.828 . . . . 55.5 112.681 177.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.73 149.18 36.37 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 106.527 -1.657 . . . . 55.13 106.527 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 46.0 m -61.98 142.2 57.6 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 113.655 0.983 . . . . 61.15 113.655 -173.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 48.5 t -120.58 160.03 24.05 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.364 -1.347 . . . . 72.23 107.364 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -80.59 -35.13 34.64 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.798 -0.761 . . . . 73.14 110.403 -178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -96.61 -7.08 35.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.95 0.881 . . . . 72.31 110.865 -170.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -141.78 169.04 25.39 Favored Glycine 0 N--CA 1.419 -2.437 0 N-CA-C 107.724 -2.15 . . . . 73.45 107.724 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.26 -39.14 13.67 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 CA-C-N 119.885 1.843 . . . . 72.44 111.038 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 90.2 m-70 -152.53 171.48 18.05 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.3 -1.0 . . . . 75.15 108.3 -178.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -77.4 164.9 25.06 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 121.043 0.449 . . . . 64.55 110.521 173.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 57.6 p -159.42 166.78 30.3 Favored 'General case' 0 N--CA 1.403 -2.818 0 CA-C-N 115.036 -0.984 . . . . 62.43 109.347 -177.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -157.55 151.8 24.74 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 109.85 -0.426 . . . . 54.23 109.85 -178.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 11.0 tt -122.18 123.14 68.22 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 CA-C-N 115.699 -0.682 . . . . 62.2 109.444 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 441' ' ' ILE . 4.3 t -113.73 130.68 67.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 115.818 -0.628 . . . . 62.12 111.447 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 17.7 p -108.75 114.19 27.77 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 108.357 -0.979 . . . . 73.5 108.357 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 45.1 t -100.83 115.39 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 107.549 -1.278 . . . . 74.51 107.549 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -117.35 -174.68 2.65 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 121.014 -0.274 . . . . 72.51 110.471 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . . . . . . . . . 38.1 t -61.37 128.71 37.65 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 122.976 0.51 . . . . 64.32 110.749 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.647 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -163.12 -177.66 36.27 Favored Glycine 0 CA--C 1.495 -1.158 0 C-N-CA 120.701 -0.761 . . . . 24.04 111.498 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.9 t -81.94 -38.91 16.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.403 0.621 . . . . 74.13 110.445 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -155.92 162.03 40.45 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.12 -0.696 . . . . 75.23 109.12 -177.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 16.7 m120 -63.17 102.88 0.42 Allowed 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.594 1.184 . . . . 71.42 109.024 177.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -133.09 139.24 47.03 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.491 -1.3 . . . . 62.52 107.491 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 30.6 mm -89.06 110.61 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 N-CA-C 106.75 -1.574 . . . . 52.44 106.75 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 57.2 t -80.76 -44.78 21.5 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.688 0 CA-C-N 115.755 -0.657 . . . . 54.41 112.464 -173.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 35.3 p -162.26 158.4 24.25 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 120.494 -0.483 . . . . 50.33 110.727 -176.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.487 HG12 HG21 ' A' ' 369' ' ' ILE . 4.2 p -141.56 115.42 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 N-CA-C 108.547 -0.908 . . . . 73.34 108.547 175.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 29.0 tp -120.57 135.79 54.99 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.029 -1.471 . . . . 63.45 107.029 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -87.98 123.52 32.78 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.431 -1.322 . . . . 75.5 107.431 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -82.19 -46.81 13.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.856 1.058 . . . . 74.35 113.856 -174.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -121.38 -74.36 0.62 Allowed 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.438 0.637 . . . . 63.14 110.839 -172.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.412 ' NZ ' ' HB3' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -175.55 -10.12 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 126.114 1.766 . . . . 63.21 109.373 176.465 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 24.7 m -136.62 5.17 2.89 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 109.528 -0.545 . . . . 74.12 109.528 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 415' ' ' SER . 31.3 tt0 -136.22 126.02 25.68 Favored 'General case' 0 C--O 1.211 -0.972 0 CA-C-O 120.837 0.351 . . . . 72.42 111.55 -173.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 28.4 m-85 -113.7 141.15 47.6 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 116.055 -0.521 . . . . 70.11 110.719 -175.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.436 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.2 pt? -106.29 119.42 39.21 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.373 -0.973 . . . . 74.42 108.373 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.486 ' HB ' HG22 ' A' ' 418' ' ' VAL . 96.8 mt -119.45 135.4 59.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 115.366 -0.834 . . . . 72.21 111.255 -174.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -99.7 139.3 35.57 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 109.489 -0.56 . . . . 70.51 109.489 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . . . . . . . . . 81.5 mtp -141.82 164.68 29.53 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 109.858 -0.423 . . . . 75.12 109.858 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.647 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 71.7 mmtt -134.78 161.35 35.44 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.961 -1.126 . . . . 64.1 107.961 176.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 31.9 t -167.2 145.88 4.29 Favored Pre-proline 0 C--N 1.289 -2.043 0 O-C-N 123.97 0.794 . . . . 62.44 109.277 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.31 -24.68 43.24 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.245 1.963 . . . . 74.54 110.862 177.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.33 -19.59 59.53 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.222 -0.899 . . . . 64.54 110.658 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -94.97 6.16 49.87 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 121.554 0.692 . . . . 70.1 109.458 -178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 10.5 t -103.17 119.87 39.66 Favored 'General case' 0 N--CA 1.405 -2.707 0 N-CA-C 107.313 -1.365 . . . . 70.55 107.313 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 C--N 1.296 -1.757 0 N-CA-C 108.358 -0.979 . . . . 54.13 108.358 -179.473 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.419 ' HB3' ' HB3' ' A' ' 398' ' ' ASN . 98.9 m-85 . . . . . 0 C--O 1.222 -0.388 0 CA-C-O 120.804 0.335 . . . . 74.24 110.787 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.421 ' O ' ' HB1' ' A' ' 447' ' ' ALA . 71.1 ttt180 -82.38 106.78 14.53 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 120.79 0.328 . . . . 74.1 110.137 -176.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -58.29 153.14 15.95 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.344 -0.844 . . . . 63.53 112.451 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 71.3 mt -79.87 127.85 38.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.882 -0.599 . . . . 74.22 109.676 -174.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.439 ' HG2' ' CD1' ' A' ' 379' ' ' TYR . 9.3 mtmp? -91.45 157.81 16.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.73 -0.668 . . . . 74.4 111.578 -173.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 82.18 -31.99 2.82 Favored Glycine 0 N--CA 1.462 0.427 0 N-CA-C 114.93 0.732 . . . . 72.24 114.93 172.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.03 156.77 33.71 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 117.253 0.527 . . . . 53.23 110.938 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -116.56 138.56 51.32 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-O 121.55 0.69 . . . . 74.52 110.724 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.406 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 93.5 m -124.4 139.27 54.05 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 108.823 -0.806 . . . . 71.14 108.823 177.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 10.4 ptpp? -144.23 141.05 29.63 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 116.444 -0.344 . . . . 74.23 110.858 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -159.02 135.82 9.51 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.033 -0.729 . . . . 73.44 109.033 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -83.17 129.98 35.06 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.31 -0.405 . . . . 75.04 110.582 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.553 HG21 HG12 ' A' ' 431' ' ' VAL . 33.3 mt -137.95 128.11 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 106.643 -1.614 . . . . 73.52 106.643 -175.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 62.58 14.45 49.95 Favored Glycine 0 C--N 1.302 -1.319 0 C-N-CA 120.34 -0.933 . . . . 71.2 113.171 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 99.57 -9.88 60.78 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.749 -0.739 . . . . 75.44 113.537 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . 0.403 ' CD1' ' HG3' ' A' ' 384' ' ' GLN . 9.0 p90 -111.29 144.07 41.05 Favored 'General case' 0 N--CA 1.429 -1.514 0 O-C-N 122.438 -0.448 . . . . 70.02 110.571 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 38.2 m -82.16 120.5 25.41 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 110.173 -0.306 . . . . 54.24 110.173 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.522 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.4 OUTLIER -91.29 135.89 33.49 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 109.278 -0.638 . . . . 72.12 109.278 173.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -131.93 127.48 36.47 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 123.547 0.529 . . . . 72.11 109.952 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.452 HG23 HG22 ' A' ' 382' ' ' VAL . 7.4 p -127.08 120.57 55.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 120.879 0.371 . . . . 60.22 110.522 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . . . . . . . . . 47.7 t -115.17 116.96 54.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 N-CA-C 106.837 -1.542 . . . . 73.45 106.837 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.463 ' HA ' ' CE2' ' A' ' 392' ' ' PHE . 28.4 m-85 -65.32 128.49 36.07 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 114.757 1.392 . . . . 55.42 114.757 -171.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . 0.439 ' CD1' ' HG2' ' A' ' 361' ' ' LYS . 65.3 m-85 68.28 22.38 8.1 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 113.84 -1.527 . . . . 64.01 112.288 -176.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -132.36 -79.8 0.5 Allowed 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.438 -0.801 . . . . 73.3 113.098 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.46 154.72 12.3 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.419 0.896 . . . . 61.31 113.419 -172.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.463 HG21 ' CD2' ' A' ' 402' ' ' TYR . 98.9 t -119.25 145.3 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.166 0.986 . . . . 64.42 109.024 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -134.26 145.59 49.27 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.965 0.412 . . . . 72.32 111.889 -178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.514 ' HB2' HD23 ' A' ' 389' ' ' LEU . 33.4 tt0 -116.84 108.26 15.62 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.419 -1.697 . . . . 61.34 106.419 172.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 16.2 t70 71.67 -79.65 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 124.302 1.041 . . . . 75.32 109.931 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 20.0 m -144.73 -4.02 0.77 Allowed 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.563 -0.903 . . . . 74.41 108.563 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 50.1 mm -84.09 136.67 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.442 -0.799 . . . . 73.53 109.486 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.467 HD21 HD21 ' A' ' 391' ' ' ASN . 64.5 tp -76.2 110.73 10.94 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 107.799 -1.186 . . . . 73.11 107.799 177.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.6 OUTLIER -73.61 -63.1 1.27 Allowed 'General case' 0 N--CA 1.385 -3.682 0 N-CA-C 108.552 -0.907 . . . . 72.15 108.552 -176.271 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.94 158.7 29.99 Favored Glycine 0 N--CA 1.417 -2.585 0 C-N-CA 119.064 -1.541 . . . . 75.21 111.595 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.467 HD21 HD21 ' A' ' 388' ' ' LEU . 45.8 m-80 -106.64 142.21 36.65 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.106 -1.072 . . . . 73.32 108.106 177.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . 0.542 ' HD2' ' NE2' ' A' ' 395' ' ' GLN . 1.9 m-85 -65.99 115.96 6.61 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 123.465 0.478 . . . . 75.23 110.537 -176.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -105.65 -48.47 3.65 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.074 -0.512 . . . . 73.53 111.278 -176.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 56.6 m -155.07 139.87 17.16 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.677 -0.49 . . . . 70.55 109.677 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.542 ' NE2' ' HD2' ' A' ' 392' ' ' PHE . 42.7 mt-30 -134.41 136.46 43.32 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.242 -1.392 . . . . 75.1 107.242 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -128.78 110.76 12.45 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 109.474 -0.565 . . . . 71.21 109.474 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 70.81 -118.57 7.68 Favored Glycine 0 N--CA 1.424 -2.125 0 N-CA-C 110.665 -0.974 . . . . 70.21 110.665 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 357' ' ' TYR . 4.2 p-10 -107.29 21.81 16.94 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.446 0.641 . . . . 74.15 110.188 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 40.1 t -124.48 116.91 48.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 107.79 -1.189 . . . . 53.23 107.79 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.451 ' CD2' ' HB3' ' A' ' 395' ' ' GLN . 11.2 mt -116.34 129.51 56.29 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.882 -0.599 . . . . 72.44 110.922 -169.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -105.03 122.02 45.0 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-O 121.06 0.457 . . . . 72.32 112.168 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.463 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.5 m-85 -117.1 119.17 34.44 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 105.807 -1.923 . . . . 72.11 105.807 176.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -135.73 173.84 11.27 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.31 -0.626 . . . . 72.43 109.31 -174.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 12.9 m120 61.04 37.48 17.93 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.965 0.791 . . . . 62.02 112.503 175.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -76.58 -141.82 1.24 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.185 -0.531 . . . . 72.03 112.676 176.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.82 137.58 51.93 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.435 -0.95 . . . . 73.44 108.435 -175.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 48.8 m -64.76 119.27 10.28 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 123.65 0.78 . . . . 70.15 112.427 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 12.3 p -100.62 158.17 16.14 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.257 -1.016 . . . . 63.21 108.257 176.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -86.53 -27.94 23.68 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.261 0.553 . . . . 73.34 109.725 -176.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -89.51 -0.61 57.62 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.358 -0.837 . . . . 72.31 110.523 -172.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -155.58 -159.65 9.48 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 108.642 -1.783 . . . . 60.4 108.642 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -93.11 -42.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.179 0 CA-C-N 120.215 2.008 . . . . 73.33 113.407 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -165.91 154.78 11.48 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 106.484 -1.673 . . . . 72.44 106.484 -176.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -72.05 153.32 41.8 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.352 0.596 . . . . 73.11 111.996 174.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 33.9 p -159.1 160.83 36.14 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 114.698 -1.137 . . . . 64.03 108.908 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 439' ' ' TYR . . . -155.39 148.0 24.13 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 109.744 -0.465 . . . . 75.42 109.744 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.9 tt -110.94 118.52 57.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.536 -0.913 . . . . 60.31 108.536 174.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 2.9 t -97.77 125.42 50.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 CA-C-O 121.457 0.646 . . . . 74.32 109.884 177.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 2.5 m -108.43 112.23 24.53 Favored 'General case' 0 N--CA 1.385 -3.707 0 N-CA-C 104.577 -2.379 . . . . 64.12 104.577 174.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 7.9 p -102.0 121.15 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.971 0 N-CA-C 108.655 -0.868 . . . . 71.33 108.655 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -114.94 -174.4 2.48 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 116.289 -0.414 . . . . 53.54 110.362 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.647 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 22.6 t -60.57 128.16 35.24 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 123.367 0.667 . . . . 64.12 112.572 -176.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.549 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -156.06 -177.75 29.56 Favored Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.606 -0.807 . . . . 63.3 111.452 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 59.4 t -91.76 -34.2 6.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.851 -0.796 . . . . 73.25 108.851 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -148.88 148.06 29.42 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-N 115.694 -0.685 . . . . 73.54 109.197 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.741 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.1 p-10 -62.36 99.64 0.15 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.991 -1.004 . . . . 64.15 111.536 176.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -131.81 149.07 52.57 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.338 -0.847 . . . . 75.24 110.156 -177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.441 HG21 HD11 ' A' ' 369' ' ' ILE . 28.2 mm -82.09 119.53 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.198 -1.408 . . . . 73.0 107.198 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . 0.428 HG11 ' HD2' ' A' ' 442' ' ' LYS . 66.0 t -83.69 -51.37 14.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 111.886 0.328 . . . . 74.03 111.886 -177.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 59.7 m -166.04 163.52 18.23 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.438 -0.579 . . . . 70.33 109.438 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.553 HG12 HG21 ' A' ' 369' ' ' ILE . 3.5 p -141.84 116.68 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 107.956 -1.127 . . . . 74.41 107.956 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 34.1 tp -112.16 133.13 54.48 Favored 'General case' 0 C--N 1.263 -3.156 0 N-CA-C 108.143 -1.058 . . . . 61.03 108.143 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -82.15 108.52 15.68 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.596 -1.261 . . . . 74.42 107.596 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -69.75 -53.26 19.22 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.865 0.841 . . . . 75.54 109.47 -177.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -120.1 -77.79 0.58 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.52 -1.218 . . . . 74.24 108.577 177.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.479 ' NZ ' ' HB3' ' A' ' 436' ' ' LYS . 0.0 OUTLIER -169.94 -47.36 0.02 OUTLIER 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 124.459 1.104 . . . . 74.41 110.383 174.258 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 82.0 m -91.99 5.3 50.67 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.723 0.773 . . . . 52.21 109.562 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -136.49 124.4 22.73 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.107 -0.951 . . . . 74.52 109.08 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 416' ' ' ALA . 54.4 m-85 -122.56 151.22 41.61 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.016 -0.538 . . . . 75.04 110.118 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.47 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.6 pt? -110.53 124.95 52.78 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.299 -1.371 . . . . 62.1 107.299 170.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 98.4 mt -122.78 134.94 64.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 115.813 -0.63 . . . . 75.35 109.92 -175.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.428 ' HD2' HG11 ' A' ' 429' ' ' VAL . 23.9 ttmm -106.84 140.81 39.08 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 108.776 -0.824 . . . . 60.22 108.776 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.402 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.7 mtp -138.02 164.14 29.81 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.032 -1.099 . . . . 63.24 108.032 177.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.741 ' O ' ' HA ' ' A' ' 426' ' ' ASN . 34.2 mmtp -129.69 151.59 50.11 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 108.063 -1.088 . . . . 65.44 108.063 175.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 43.4 t -164.74 147.84 7.33 Favored Pre-proline 0 C--N 1.3 -1.564 0 N-CA-C 108.786 -0.82 . . . . 61.53 108.786 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.97 -27.22 66.36 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.072 1.848 . . . . 73.52 110.244 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 358' ' ' ARG . . . -69.37 -22.26 63.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.232 -0.894 . . . . 61.43 110.876 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -101.95 8.29 41.13 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 121.358 0.599 . . . . 72.35 109.944 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 422' ' ' CYS . 34.6 t -102.47 135.7 43.62 Favored 'General case' 0 N--CA 1.415 -2.221 0 CA-C-N 115.79 -0.641 . . . . 71.32 109.319 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.408 -2.558 0 N-CA-C 106.817 -1.549 . . . . 62.43 106.817 -179.586 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 53.1 t80 . . . . . 0 C--O 1.222 -0.359 0 N-CA-C 108.76 -0.83 . . . . 72.32 108.76 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -163.71 177.7 8.49 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 104.701 -2.333 . . . . 64.45 104.701 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -76.08 151.12 37.15 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 118.258 0.481 . . . . 71.02 110.004 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . 0.432 HG23 ' HB3' ' A' ' 363' ' ' MET . 4.8 tp -81.34 119.3 30.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 112.982 0.734 . . . . 74.33 112.982 -173.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.53 141.43 55.53 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.236 -0.893 . . . . 62.33 111.003 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 91.98 -35.17 4.09 Favored Glycine 0 CA--C 1.495 -1.198 0 CA-C-N 115.916 -0.584 . . . . 33.41 112.157 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . 0.492 ' HG2' ' ND2' ' A' ' 426' ' ' ASN . 46.3 tpp -62.32 129.74 42.09 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.277 0.56 . . . . 70.13 111.162 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.413 ' CB ' HG22 ' A' ' 377' ' ' VAL . 12.3 pt-20 -106.67 119.07 38.34 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 115.343 -0.844 . . . . 63.43 108.882 175.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . 0.43 ' HB ' ' CG1' ' A' ' 376' ' ' VAL . 92.0 m -107.74 137.94 44.85 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 109.253 -0.647 . . . . 62.2 109.253 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 19.6 ptmt -144.2 145.03 31.82 Favored 'General case' 0 N--CA 1.432 -1.36 0 C-N-CA 121.21 -0.196 . . . . 61.32 111.209 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -160.76 136.89 8.4 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.223 -1.029 . . . . 74.42 108.223 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -84.05 125.31 31.98 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 110.017 -0.364 . . . . 51.32 110.017 -178.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.488 HG21 HG12 ' A' ' 431' ' ' VAL . 57.3 mt -130.57 116.27 34.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 107.29 -1.374 . . . . 71.05 107.29 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.6 15.09 63.59 Favored Glycine 0 C--N 1.306 -1.107 0 C-N-CA 121.063 -0.589 . . . . 60.2 112.498 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 109.09 -25.72 17.58 Favored Glycine 0 N--CA 1.427 -1.931 0 C-N-CA 120.401 -0.904 . . . . 65.34 112.578 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -97.77 135.84 38.96 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 121.007 0.432 . . . . 70.14 111.286 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 85.1 m -79.19 118.5 21.2 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.856 -0.611 . . . . 41.43 110.747 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.595 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.2 OUTLIER -90.66 132.47 35.76 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 108.378 -0.971 . . . . 75.54 108.378 173.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -132.07 127.32 35.87 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.278 -0.638 . . . . 71.23 109.278 -176.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.515 HG23 HG22 ' A' ' 382' ' ' VAL . 6.5 p -125.72 118.37 51.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-O 121.053 0.454 . . . . 75.24 110.16 178.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.413 HG22 ' CB ' ' A' ' 364' ' ' GLU . 44.2 t -106.66 116.9 51.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 107.031 -1.47 . . . . 63.42 107.031 174.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -63.65 129.04 38.52 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 114.011 1.115 . . . . 74.51 114.011 -172.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 72.7 13.52 5.19 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 126.166 1.786 . . . . 75.03 112.371 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -124.11 -83.3 0.65 Allowed 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 113.088 0.773 . . . . 72.22 113.088 176.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -159.05 164.9 35.03 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 112.542 0.571 . . . . 75.53 112.542 -170.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.515 HG22 HG23 ' A' ' 376' ' ' VAL . 72.7 t -126.88 142.16 44.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.242 -0.89 . . . . 64.31 108.837 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -132.97 151.6 52.04 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 122.957 0.503 . . . . 75.02 111.311 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.496 ' HB2' HD23 ' A' ' 389' ' ' LEU . 30.6 tt0 -122.18 106.27 10.99 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 106.217 -1.771 . . . . 71.52 106.217 172.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 22.0 t70 70.76 -74.66 0.08 Allowed 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 124.87 1.268 . . . . 72.32 110.395 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 64.1 m -146.94 -7.2 0.49 Allowed 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.75 -0.659 . . . . 55.33 110.155 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 40.1 mt -87.75 135.94 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 116.311 -0.404 . . . . 72.33 110.39 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.424 HD21 HD21 ' A' ' 391' ' ' ASN . 59.5 tp -75.93 120.74 21.68 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-O 121.528 0.68 . . . . 42.14 109.387 -178.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.53 ' O ' ' HA3' ' A' ' 405' ' ' GLY . 0.2 OUTLIER -82.83 -64.39 1.18 Allowed 'General case' 0 N--CA 1.383 -3.777 0 N-CA-C 108.597 -0.89 . . . . 71.12 108.597 -177.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -160.13 162.34 33.12 Favored Glycine 0 N--CA 1.421 -2.306 0 C-N-CA 118.934 -1.603 . . . . 31.22 111.986 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . 0.424 HD21 HD21 ' A' ' 388' ' ' LEU . 43.0 m-80 -108.44 146.51 33.01 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.343 -1.354 . . . . 74.22 107.343 175.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -64.96 116.47 6.43 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 120.882 0.373 . . . . 64.42 111.555 -175.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -94.76 -49.07 5.77 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.049 -0.523 . . . . 64.41 111.308 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 21.4 p -169.02 140.37 2.46 Favored 'General case' 0 C--O 1.252 1.22 0 N-CA-C 110.127 -0.323 . . . . 74.31 110.127 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.402 ' OE1' HD22 ' A' ' 400' ' ' LEU . 10.6 pt20 -142.39 140.55 32.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.217 0.532 . . . . 65.14 111.726 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -128.78 128.62 44.32 Favored 'General case' 0 N--CA 1.424 -1.775 0 N-CA-C 108.689 -0.856 . . . . 72.11 108.689 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 68.82 -101.53 0.8 Allowed Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 121.008 -0.615 . . . . 72.54 112.466 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 420' ' ' VAL . 26.2 p-10 -130.49 11.8 5.36 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 111.981 0.363 . . . . 71.33 111.981 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 40.7 t -111.65 116.98 54.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.923 -1.14 . . . . 74.43 107.923 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.402 HD22 ' OE1' ' A' ' 395' ' ' GLN . 6.7 mt -114.83 131.45 56.82 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.553 -0.536 . . . . 65.13 109.553 -172.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -116.37 124.43 50.05 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.322 -0.992 . . . . 64.3 108.322 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.451 ' CD2' HG21 ' A' ' 382' ' ' VAL . 3.5 m-85 -114.22 136.19 53.23 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.48 -1.304 . . . . 53.35 107.48 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -144.09 176.4 9.34 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.585 -0.524 . . . . 61.0 109.585 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.96 36.24 12.75 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.837 0.68 . . . . 63.41 112.837 177.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -80.56 -141.65 2.87 Favored Glycine 0 N--CA 1.436 -1.334 0 C-N-CA 120.25 -0.976 . . . . 64.21 111.243 175.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . 0.408 HE21 ' HB3' ' A' ' 406' ' ' GLN . 1.0 OUTLIER -75.34 134.83 40.92 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.097 -0.705 . . . . 74.2 109.097 -177.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 37.8 m -60.41 134.37 57.0 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.354 0.872 . . . . 74.1 113.354 -175.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 10.1 p -110.13 159.23 17.53 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.202 -0.908 . . . . 72.13 109.452 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 17.8 p-90 -78.82 -29.96 45.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.551 0.691 . . . . 74.21 109.839 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . 0.633 ' ND2' ' HB2' ' A' ' 436' ' ' LYS . 13.9 p-10 -98.98 8.9 44.56 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.152 -0.931 . . . . 73.35 112.617 -172.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -163.26 -172.1 30.33 Favored Glycine 0 C--N 1.308 -1.013 0 N-CA-C 109.086 -1.605 . . . . 45.12 109.086 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -83.36 -39.72 0.12 Allowed 'Trans proline' 0 CA--C 1.546 1.081 0 CA-C-N 120.057 1.929 . . . . 53.42 112.942 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 99.8 m-70 -162.01 162.29 28.81 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 107.798 -1.186 . . . . 71.14 107.798 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -73.22 159.19 33.83 Favored 'General case' 0 C--O 1.257 1.448 0 CA-C-O 121.374 0.607 . . . . 75.14 111.604 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 33.2 p -162.18 163.56 28.31 Favored 'General case' 0 N--CA 1.406 -2.663 0 CA-C-N 114.488 -1.233 . . . . 74.33 109.121 -177.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -159.15 144.74 16.2 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.819 -0.437 . . . . 34.43 109.819 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 13.8 tt -109.62 125.12 66.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 108.099 -1.075 . . . . 72.45 108.099 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 3.9 t -111.09 131.19 63.0 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.87 -0.605 . . . . 73.23 110.895 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.84 113.8 26.65 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 106.058 -1.83 . . . . 75.0 106.058 175.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 398' ' ' ASN . 23.6 t -101.18 112.62 34.72 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.517 0 N-CA-C 109.256 -0.646 . . . . 55.44 109.256 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -109.93 -176.25 2.95 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 119.745 -0.782 . . . . 75.54 110.965 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.452 ' O ' ' HD2' ' A' ' 444' ' ' LYS . 32.4 t -60.67 128.08 34.82 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 123.568 0.747 . . . . 72.43 111.212 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.547 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -151.23 178.93 28.31 Favored Glycine 0 N--CA 1.428 -1.835 0 N-CA-C 110.086 -1.206 . . . . 74.14 110.086 177.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 41.3 t -93.8 -26.96 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.293 -1.002 . . . . 62.31 108.293 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -141.56 157.42 45.13 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 114.894 -1.048 . . . . 75.34 109.306 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.492 ' ND2' ' HG2' ' A' ' 363' ' ' MET . 65.4 m-20 -73.16 100.16 3.0 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 106.858 -1.534 . . . . 74.43 106.858 174.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -132.18 141.24 49.02 Favored 'General case' 0 C--N 1.286 -2.174 0 C-N-CA 120.687 -0.405 . . . . 74.24 111.805 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.439 ' HA ' ' HG2' ' A' ' 443' ' ' MET . 27.3 mm -83.39 118.43 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 105.767 -1.938 . . . . 74.04 105.767 174.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 55.1 t -83.17 -50.65 15.39 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-O 121.042 0.449 . . . . 73.23 111.651 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . . . . . . . . . 37.4 p -161.23 159.49 28.79 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.197 -0.456 . . . . 52.44 110.5 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.488 HG12 HG21 ' A' ' 369' ' ' ILE . 3.3 p -142.15 122.86 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 108.829 -0.804 . . . . 52.05 108.829 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . 0.473 ' O ' HD23 ' A' ' 440' ' ' LEU . 30.2 tp -131.0 137.54 49.27 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.8 -1.185 . . . . 74.33 107.8 -177.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -81.45 116.97 21.5 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.578 -0.849 . . . . 64.12 108.789 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.31 -63.97 1.12 Allowed 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.392 -0.822 . . . . 74.33 110.722 -175.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -106.23 -76.24 0.61 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.75 -0.659 . . . . 74.21 111.821 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.633 ' HB2' ' ND2' ' A' ' 410' ' ' ASN . 44.9 pttt -162.8 -30.35 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.048 0.452 . . . . 72.13 112.172 -174.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . . . . . . . . . 86.2 m -131.16 11.65 5.04 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.576 -0.898 . . . . 74.13 108.576 176.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 415' ' ' SER . 34.8 tt0 -131.79 129.62 40.76 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.119 -0.946 . . . . 54.01 108.985 -176.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -117.91 150.41 39.26 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.682 -0.69 . . . . 74.2 110.906 -177.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.477 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.6 pt? -106.4 120.9 43.1 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.598 -1.26 . . . . 61.15 107.598 172.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 96.7 mt -124.14 128.7 74.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-N 115.41 -0.814 . . . . 71.43 109.746 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -104.27 140.69 37.5 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 108.873 -0.788 . . . . 74.42 108.873 177.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.439 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 78.3 mtp -135.08 167.47 20.9 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 109.409 -0.589 . . . . 70.54 109.409 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.547 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 72.1 mmtt -133.24 156.28 47.83 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.299 -1.371 . . . . 73.15 107.299 174.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 38.3 t -163.77 145.44 7.31 Favored Pre-proline 0 C--N 1.278 -2.542 0 O-C-N 124.075 0.86 . . . . 60.42 109.11 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.4 -21.38 47.14 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.111 1.874 . . . . 42.32 110.646 175.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -79.12 -18.58 52.99 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.803 -0.635 . . . . 71.45 110.982 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -98.09 10.91 39.32 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.376 0.608 . . . . 72.43 109.857 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 12.7 t -103.39 119.94 39.85 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 108.661 -0.866 . . . . 74.43 108.661 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.428 -1.562 0 N-CA-C 107.446 -1.316 . . . . 61.2 107.446 -179.592 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 CA--C 1.512 -0.512 0 CA-C-O 120.53 0.205 . . . . 73.33 111.162 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -163.15 28.0 0.09 Allowed 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 106.374 -1.713 . . . . 75.22 106.374 171.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -146.7 151.75 37.72 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 104.386 -2.45 . . . . 23.31 104.386 -178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' ILE . . . . . . . . . . . . . 48.0 mm -80.42 115.52 23.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.571 -0.852 . . . . 63.25 109.818 -172.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.539 ' HA ' ' HB2' ' A' ' 378' ' ' PHE . 0.0 OUTLIER -88.14 152.48 21.97 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 115.167 1.543 . . . . 73.44 115.167 -173.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 89.37 -23.4 18.93 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.12 -0.946 . . . . 72.44 112.135 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' MET . . . . . 0.437 ' HE2' ' HB3' ' A' ' 363' ' ' MET . 48.4 ttp -81.51 143.73 31.84 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 123.001 0.52 . . . . 75.24 110.458 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.496 ' HB3' HG22 ' A' ' 377' ' ' VAL . 10.8 pt-20 -99.31 130.83 45.63 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.313 -0.625 . . . . 64.43 109.313 174.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' THR . . . . . . . . . . . . . 97.0 m -118.71 125.49 49.79 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.477 -1.305 . . . . 64.14 107.477 -178.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 374' ' ' TYR . 57.7 mtpt -133.32 143.54 49.08 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 116.239 -0.437 . . . . 61.34 110.529 -174.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.488 ' HB3' ' HB ' ' A' ' 428' ' ' ILE . 1.9 tmt_? -157.95 136.85 11.45 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.057 -1.09 . . . . 53.22 108.057 -177.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 373' ' ' THR . 40.5 mt-10 -87.98 127.18 35.38 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.713 0.292 . . . . 75.24 110.233 -174.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' ILE . . . . . 0.554 HG21 HG12 ' A' ' 431' ' ' VAL . 38.0 mt -136.96 120.76 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.615 0 N-CA-C 106.793 -1.558 . . . . 62.11 106.793 -176.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 66.26 13.71 60.62 Favored Glycine 0 C--N 1.304 -1.21 0 C-N-CA 120.358 -0.925 . . . . 45.34 113.137 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 106.09 -17.73 40.7 Favored Glycine 0 N--CA 1.429 -1.832 0 C-N-CA 121.084 -0.579 . . . . 73.05 113.107 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -106.87 139.72 40.84 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 120.683 0.278 . . . . 64.5 110.333 -178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 368' ' ' GLU . 37.4 m -83.83 122.01 28.11 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 116.259 -0.428 . . . . 61.2 110.166 -178.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' TYR . . . . . 0.625 ' O ' ' HA ' ' A' ' 366' ' ' LYS . 0.3 OUTLIER -90.54 129.07 36.73 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 109.301 -0.629 . . . . 73.41 109.301 176.615 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 382' ' ' VAL . 83.9 tttt -122.48 125.23 45.36 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 123.887 0.742 . . . . 54.23 110.108 -175.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' VAL . . . . . 0.449 HG12 HD11 ' A' ' 428' ' ' ILE . 7.2 p -128.24 118.22 47.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 N-CA-C 109.161 -0.681 . . . . 70.51 109.161 175.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 364' ' ' GLU . 40.8 t -106.73 116.5 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 106.116 -1.809 . . . . 74.32 106.116 174.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' PHE . . . . . 0.539 ' HB2' ' HA ' ' A' ' 361' ' ' LYS . 95.9 m-85 -58.9 123.06 15.22 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 123.807 0.692 . . . . 74.21 112.503 -174.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 72.98 12.23 5.11 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.587 1.555 . . . . 73.55 113.385 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -123.24 -86.84 0.64 Allowed 'General case' 0 C--O 1.237 0.446 0 N-CA-C 113.848 1.055 . . . . 70.41 113.848 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.54 169.05 20.41 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 119.392 -0.923 . . . . 73.12 110.322 -176.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 375' ' ' LYS . 94.9 t -124.95 138.78 53.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 107.643 -1.243 . . . . 65.44 107.643 173.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -132.91 148.1 52.29 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.143 0.497 . . . . 73.22 110.785 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . 0.5 ' HB2' HD23 ' A' ' 389' ' ' LEU . 34.8 tt0 -115.28 100.07 7.86 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.387 -1.709 . . . . 63.41 106.387 173.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 13.4 t70 69.89 -78.37 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 125.248 1.419 . . . . 61.45 110.019 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' SER . . . . . . . . . . . . . 27.4 m -138.01 -5.69 1.67 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.082 -0.963 . . . . 62.51 109.287 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . . . . . . . . . 47.8 mm -88.39 135.63 25.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.188 -0.46 . . . . 75.41 110.016 -177.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 62.9 tp -76.23 115.1 15.63 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 107.995 -1.113 . . . . 71.23 107.995 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 384' ' ' GLN . 0.6 OUTLIER -80.21 -60.52 2.3 Favored 'General case' 0 N--CA 1.388 -3.539 0 N-CA-C 108.762 -0.829 . . . . 72.13 108.762 -175.684 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' GLY . . . . . . . . . . . . . . . -159.97 158.59 29.88 Favored Glycine 0 N--CA 1.413 -2.892 0 C-N-CA 119.295 -1.431 . . . . 44.0 111.417 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -102.24 143.97 31.36 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.659 -1.608 . . . . 74.15 106.659 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -69.27 116.82 10.14 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.013 0.435 . . . . 71.03 110.737 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -98.11 -47.56 5.45 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.772 -0.649 . . . . 75.35 110.962 -178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 65.9 p -168.47 143.67 3.49 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.898 -0.408 . . . . 75.14 109.898 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' GLN . . . . . 0.475 ' OE1' HD22 ' A' ' 400' ' ' LEU . 10.1 pt20 -143.08 136.98 28.85 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.743 0.306 . . . . 74.0 110.503 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -112.52 119.93 39.88 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.518 -0.919 . . . . 65.25 108.518 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . 66.11 -101.67 0.63 Allowed Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 119.651 -1.262 . . . . 33.12 113.178 177.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -123.66 10.68 9.07 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.799 1.24 . . . . 64.32 111.132 -177.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.34 116.69 53.27 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.015 0 N-CA-C 106.85 -1.537 . . . . 64.44 106.85 179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.475 HD22 ' OE1' ' A' ' 395' ' ' GLN . 9.3 mt -113.61 131.61 56.05 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 115.966 -0.561 . . . . 74.02 110.962 -168.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -114.27 121.76 44.68 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-O 121.392 0.615 . . . . 72.33 112.349 178.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.415 ' CD2' HG21 ' A' ' 382' ' ' VAL . 2.3 m-85 -118.25 139.02 51.95 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.537 -1.282 . . . . 75.42 107.537 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -141.46 173.42 11.51 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-O 121.466 0.65 . . . . 61.02 111.45 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 51.1 46.59 26.22 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.095 -1.866 . . . . 72.52 113.16 167.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 389' ' ' LEU . . . -77.22 -132.98 0.57 Allowed Glycine 0 C--N 1.311 -0.831 0 CA-C-N 115.839 -0.618 . . . . 61.42 112.708 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.56 142.64 38.89 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.108 -1.442 . . . . 73.14 107.108 -176.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 413' ' ' HIS . 27.4 t -64.46 128.44 35.79 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-O 121.806 0.812 . . . . 73.23 111.097 -178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' CYS . . . . . . . . . . . . . 6.0 p -99.64 158.39 15.8 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.5 -0.926 . . . . 54.15 108.5 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' TRP . . . . . . . . . . . . . 28.8 p-90 -82.48 -32.14 28.97 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.074 -0.713 . . . . 74.51 109.074 -177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -90.6 12.67 18.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.475 -0.784 . . . . 71.33 112.287 -175.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.403 ' HA3' ' SG ' ' A' ' 437' ' ' CYS . . . -167.41 -160.68 15.2 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 109.521 -1.432 . . . . 61.31 109.521 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -95.65 -40.95 0.02 OUTLIER 'Trans proline' 0 CA--C 1.564 1.99 0 CA-C-N 119.954 1.877 . . . . 75.41 114.033 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' HIS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 407' ' ' SER . 97.1 m-70 -159.15 154.23 25.16 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.062 0.945 . . . . 75.01 108.782 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -74.33 160.53 30.94 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.34 0.59 . . . . 74.24 111.383 174.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 438' ' ' GLU . 35.5 p -165.57 162.35 19.02 Favored 'General case' 0 N--CA 1.418 -2.058 0 C-N-CA 124.366 1.066 . . . . 74.33 108.246 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -158.74 151.11 21.6 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.303 0.573 . . . . 74.21 110.8 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' ILE . . . . . . . . . . . . . 11.6 tt -114.37 131.11 67.37 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 CA-C-N 115.131 -0.94 . . . . 61.34 108.828 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 441' ' ' ILE . 4.1 t -116.72 131.04 70.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-O 121.329 0.585 . . . . 74.34 111.926 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 62.2 p -108.02 114.97 29.27 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 107.641 -1.244 . . . . 54.13 107.641 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . . . . . . . . . 39.6 t -100.19 111.87 31.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 107.545 -1.279 . . . . 62.55 107.545 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -113.52 -175.14 2.61 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.148 -0.478 . . . . 74.22 110.787 -175.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' CYS . . . . . 0.547 ' HB2' ' HA ' ' A' ' 449' ' ' CYS . 43.6 t -60.42 128.66 37.76 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.815 -0.629 . . . . 72.12 111.224 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . 0.604 ' HA3' ' HB3' ' A' ' 444' ' ' LYS . . . -154.36 178.59 31.09 Favored Glycine 0 CA--C 1.476 -2.377 0 N-CA-C 110.479 -1.048 . . . . 52.54 110.479 177.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 56.0 t -90.41 -33.79 6.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 108.282 -1.007 . . . . 61.1 108.282 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -150.66 152.66 34.32 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.698 -0.683 . . . . 73.01 109.768 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 444' ' ' LYS . 1.3 p-10 -60.1 98.83 0.06 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.597 -1.183 . . . . 55.21 112.427 177.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -133.08 146.85 52.04 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.038 -0.528 . . . . 63.44 111.783 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 367' ' ' ARG . 31.3 mm -80.17 119.87 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 N-CA-C 105.449 -2.056 . . . . 52.53 105.449 171.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' VAL . . . . . . . . . . . . . 54.6 t -84.55 -51.16 14.2 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.867 0 N-CA-C 112.112 0.412 . . . . 52.11 112.112 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 441' ' ' ILE . 32.6 p -160.86 162.71 32.25 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.814 -0.354 . . . . 62.33 110.837 -174.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' VAL . . . . . 0.554 HG12 HG21 ' A' ' 369' ' ' ILE . 4.8 p -142.12 111.87 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 108.966 -0.753 . . . . 73.33 108.966 176.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . 0.409 ' O ' HD23 ' A' ' 440' ' ' LEU . 34.9 tp -113.97 136.45 52.89 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 108.765 -0.828 . . . . 54.54 108.765 -177.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.66 113.8 19.91 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.837 -0.801 . . . . 70.52 108.837 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.14 -70.42 0.39 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.294 -0.632 . . . . 43.41 109.294 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -100.0 -75.83 0.56 Allowed 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 115.551 -0.75 . . . . 75.31 109.966 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.1 -51.07 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.461 0.648 . . . . 73.25 110.437 175.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' CYS . . . . . 0.403 ' SG ' ' HA3' ' A' ' 411' ' ' GLY . 64.3 m -100.52 13.19 35.44 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.204 -0.907 . . . . 72.5 109.019 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 415' ' ' SER . 33.4 tt0 -135.22 124.85 25.16 Favored 'General case' 0 C--N 1.283 -2.326 0 CA-C-N 115.185 -0.916 . . . . 61.35 108.873 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -123.01 150.18 43.37 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.142 -0.936 . . . . 75.23 109.567 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.445 ' H ' HD23 ' A' ' 440' ' ' LEU . 1.4 pt? -109.22 121.37 45.02 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.252 -1.018 . . . . 63.11 108.252 173.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' ILE . . . . . 0.558 ' O ' ' HA ' ' A' ' 418' ' ' VAL . 97.1 mt -118.08 135.25 59.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.211 -0.904 . . . . 65.11 110.012 -175.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -109.26 141.42 41.57 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 109.5 -0.556 . . . . 64.42 109.5 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' MET . . . . . 0.43 ' HG2' ' HA ' ' A' ' 428' ' ' ILE . 82.1 mtp -136.38 162.81 32.01 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 108.995 -0.743 . . . . 75.22 108.995 178.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' LYS . . . . . 0.604 ' HB3' ' HA3' ' A' ' 423' ' ' GLY . 70.1 mmtt -132.87 151.49 52.02 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.164 -1.05 . . . . 63.44 108.164 176.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' SER . . . . . . . . . . . . . 68.1 m -161.24 149.15 12.44 Favored Pre-proline 0 C--N 1.295 -1.792 0 O-C-N 123.865 0.728 . . . . 70.24 109.945 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.44 -27.76 62.48 Favored 'Trans proline' 0 N--CA 1.48 0.695 0 C-N-CA 122.724 2.283 . . . . 74.42 111.95 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -75.58 -22.25 57.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.6 -0.727 . . . . 74.32 110.643 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' ALA . . . . . . . . . . . . . . . -97.2 19.09 13.59 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-N 115.528 -0.76 . . . . 65.05 111.049 -175.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 422' ' ' CYS . 23.3 t -99.39 124.41 44.49 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.708 0.766 . . . . 64.52 110.911 -176.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.442 -0.848 0 CA-C-N 114.438 -1.255 . . . . 44.41 108.299 -178.663 . . . . . . . . 0 0 . 1 stop_ save_